32 100 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 BID NNP I-NP B-f
33 LOVENOX NNP I-NP B-m
33 ( ( O I-m
33 ENOXAPARIN NNP B-NP I-m
33 ) ) O I-m
33 120 CD O B-do
33 MG NNP B-NP I-do
33 SC NNP I-NP B-mo
33 BEDTIME NNP I-NP B-f
34 TARCEVA NNP I-NP B-m
34 ( ( O I-m
34 ERLOTINIB NNP B-NP I-m
34 ) ) O I-m
34 100 CD O B-do
34 mg JJ B-NP I-do
34 PO NNP I-NP B-mo
34 DAILY NNP I-NP B-f
35 ( ( O O
35 HT: NNP B-NP O
35 61.0in CD O O
35 154.9cm CD O O
35 WT: NNP B-NP O
35 129.5kg CD O O
35 BSA: NNP B-NP O
35 2.20 CD O O
35 ) ) O O
36 Primary NNP B-NP O
36 DX: NNP I-NP O
36 chest JJS B-NP O
36 pain NN I-NP O
36 Day NNP I-NP O
36 1: CD O O
36 0/11/06 CD O O
37 Previous- JJ B-NP O
37 Weight:136kg NNP I-NP O
37 BSA:2.24 NNP I-NP O
38 Admit- NNP I-NP O
38 Weight:129.5kg NNP I-NP O
38 BSA:2.20 NNP I-NP O
39 FOLIC NNP I-NP B-m
39 ACID NNP I-NP I-m
39 1 CD O B-do
39 MG NNP B-NP I-do
39 PO NNP I-NP B-mo
39 DAILY NNP I-NP B-f
40 FUROSEMIDE NNP I-NP B-m
40 40 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 DAILY NNP I-NP B-f
40 Starting NNP I-NP O
40 IN NNP I-NP O
40 AM NNP I-NP O
40 ( ( O O
40 4/9 CD O O
40 ) ) O O
41 DILAUDID NNP B-NP B-m
41 ( ( O I-m
41 HYDROMORPHONE NNP B-NP I-m
41 HCL NNP I-NP I-m
41 ) ) O I-m
41 0.5 CD O B-do
41 MG NNP B-NP I-do
41 PO NNP I-NP B-mo
41 Q4H NNP I-NP B-f
41 PRN NNP I-NP I-f
41 Pain NNP I-NP B-r
42 Alert NNP I-NP O
42 overridden: NNP I-NP O
42 Override NNP I-NP O
42 added VBD B-VP O
42 on IN B-VP O
42 9/11/06 CD O O
42 by IN B-VP O
43 BORSH NNP B-NP O
43 , , O O
43 WADE NNP B-NP O
43 M NNP I-NP O
43 , , O O
43 M.D NNP B-NP O
44 on IN B-VP O
44 order NN B-NP O
44 for IN B-VP O
44 DILAUDID NNP B-NP B-m
44 PO NNP I-NP B-mo
44 ( ( O O
44 ref JJ O O
44 # # O O
44 925975305 CD O O
44 ) ) O O
45 Pt NNP B-NP O
45 has VBZ O O
45 a DT B-NP O
45 PROBABLE NNP I-NP O
45 allergy NN I-NP O
45 to TO O O
45 PERCOCET; NNP B-NP O
45 reaction NN I-NP O
45 is VBZ O O
46 Unknown JJ B-NP O
46 Reason NNP I-NP O
46 for IN B-VP O
46 override: NN B-NP O
46 aware JJ B-NP O
47 Previous NNP I-NP O
47 Alert NNP I-NP O
47 overridden NNP I-NP O
48 Override NNP I-NP O
48 added VBD B-VP O
48 on IN B-VP O
48 9/11/06 CD O O
48 by IN B-VP O
48 WILBANKS NNP B-NP O
48 , , O O
48 JASPER NNP B-NP O
48 C NNP I-NP O
48 , , O O
48 M.D NNP B-NP O
49 POTENTIALLY NNP I-NP O
49 SERIOUS NNP I-NP O
49 INTERACTION: NNP I-NP O
49 TRAMADOL NNP I-NP B-m
49 HCL NNP I-NP I-m
49 &amp; NNP I-NP O
50 HYDROMORPHONE NNP I-NP B-m
50 HCL NNP I-NP I-m
50 Reason NNP I-NP O
50 for IN B-VP O
50 override: NN B-NP O
50 aware JJ B-NP O
51 LIDODERM NNP I-NP B-m
51 5% CD O I-m
51 PATCH NNP B-NP I-m
51 ( ( O I-m
51 LIDOCAINE NNP B-NP I-m
51 5% CD O I-m
51 PATCH NNP B-NP I-m
51 ) ) O I-m
51 1 CD O B-do
51 EA NNP B-NP I-do
51 TP NNP I-NP B-mo
51 DAILY NNP I-NP B-f
52 Instructions: NNP I-NP O
52 12h CD O O
52 on/12h VBD B-VP O
52 off RB O O
52 , , O O
52 apply VB O O
52 to TO O O
52 L NNP B-NP O
52 breast NN I-NP O
53 PRAVACHOL NNP I-NP B-m
53 ( ( O I-m
53 PRAVASTATIN NNP B-NP I-m
53 ) ) O I-m
53 20 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 BEDTIME NNP I-NP B-f
54 Food/Drug NNP I-NP O
54 Interaction NNP I-NP O
54 Instruction NNP I-NP O
55 Avoid NNP I-NP O
55 grapefruit NN I-NP O
55 unless IN B-VP O
55 MD NNP B-NP O
55 instructs NNS I-NP O
55 otherwise RB O O
56 VITAMIN NNP B-NP B-m
56 B6 NNP I-NP I-m
56 ( ( O I-m
56 PYRIDOXINE NNP B-NP I-m
56 HCL NNP I-NP I-m
56 ) ) O I-m
56 50 CD O B-do
56 MG NNP B-NP I-do
56 PO NNP I-NP B-mo
56 DAILY NNP I-NP B-f
57 ULTRAM NNP I-NP B-m
57 ( ( O I-m
57 TRAMADOL NNP B-NP I-m
57 ) ) O I-m
57 50 CD O B-do
57 MG NNP B-NP I-do
57 PO NNP I-NP B-mo
57 Q6H NNP I-NP B-f
57 PRN NNP I-NP I-f
57 Pain NNP I-NP B-r
58 Override NNP I-NP O
58 Notice: NNP I-NP O
58 Override NNP I-NP O
58 added VBD B-VP O
58 on IN B-VP O
58 9/11/06 CD O O
58 by IN B-VP O
59 INTERIANO NNP B-NP O
59 , , O O
59 FLOYD NNP B-NP O
59 E NNP I-NP O
59 , , O O
59 M.D NNP B-NP O
60 on IN B-VP O
60 order NN B-NP O
60 for IN B-VP O
60 DILAUDID NNP B-NP B-m
60 PO NNP I-NP B-mo
60 ( ( O O
60 ref JJ O O
60 # # O O
60 925975305 CD O O
60 ) ) O O
61 POTENTIALLY NNP B-NP O
61 SERIOUS NNP I-NP O
61 INTERACTION: NNP I-NP O
61 TRAMADOL NNP I-NP B-m
61 HCL NNP I-NP I-m
61 &amp; NNP I-NP O
62 HYDROMORPHONE NNP I-NP B-m
62 HCL NNP I-NP I-m
62 Reason NNP I-NP O
62 for IN B-VP O
62 override: NN B-NP O
62 aware JJ B-NP O
63 Previous NNP I-NP O
63 override NN I-NP O
63 information: NN I-NP O
64 Override NNP I-NP O
64 added VBD B-VP O
64 on IN B-VP O
64 2/29/06 CD O O
64 by IN B-VP O
64 NOGALES NNP B-NP O
64 , , O O
64 ARNOLD NNP B-NP O
64 C NNP I-NP O
64 , , O O
64 M.D NNP B-NP O
64 , , O O
64 PH.D NNP B-NP O
65 on IN B-VP O
65 order NN B-NP O
65 for IN B-VP O
65 ULTRAM NNP B-NP B-m
65 PO NNP I-NP B-mo
65 ( ( O O
65 ref JJ O O
65 # # O O
65 417339527 CD O O
65 ) ) O O
66 Pt NNP B-NP O
66 has VBZ O O
66 a DT B-NP O
66 PROBABLE NNP I-NP O
66 allergy NN I-NP O
66 to TO O O
66 PERCOCET; NNP B-NP O
66 reaction NN I-NP O
66 is VBZ O O
67 Unknown JJ B-NP O
67 Reason NNP I-NP O
67 for IN B-VP O
67 override: NN B-NP O
67 MD NNP I-NP O
67 aware JJ B-NP O
68 Previous NNP I-NP O
68 Alert NNP I-NP O
68 overridden NNP I-NP O
69 Override NNP I-NP O
69 added VBD B-VP O
69 on IN B-VP O
69 2/29/06 CD O O
69 by IN B-VP O
69 BECKLIN NNP B-NP O
69 , , O O
69 JOAN NNP B-NP O
69 N NNP I-NP O
69 , , O O
69 M.D NNP B-NP O
69 , , O O
69 PH.D NNP B-NP O
70 POTENTIALLY NNP I-NP O
70 SERIOUS NNP I-NP O
70 INTERACTION: NNP I-NP O
70 MORPHINE NNP I-NP B-m
70 &amp; NNP I-NP O
70 TRAMADOL NNP I-NP B-m
70 HCL NNP I-NP I-m
71 Reason NNP I-NP O
71 for IN B-VP O
71 override: NN B-NP O
71 will MD O O
71 dc VB O O
71 morphine JJ B-NP B-m
72 Number NNP I-NP B-du
72 Number NNP I-NP B-du
72 of IN B-VP I-du
72 of IN B-VP I-du
72 Doses NNP B-NP I-du
72 Doses NNP I-NP I-du
72 Required NNP I-NP I-du
72 Required NNP I-NP I-du
72 ( ( O I-du
72 ( ( O I-du
72 approximate VB O I-du
72 approximate NN B-NP I-du
72 ): NNP I-NP I-du
72 ): VBD B-VP I-du
72 15 CD O I-du
72 15 CD O I-du
73 DIET: NNP B-NP O
73 Patient NNP I-NP O
73 should MD O O
73 measure VB O O
73 weight JJ B-NP O
73 daily JJ I-NP O
74 DIET: NNP I-NP O
74 House NNP I-NP O
74 / VBD B-VP O
74 Low NNP B-NP O
74 chol/low NN I-NP O
74 sat VBD B-VP O
74 fat JJ B-NP O
75 DIET: NNP I-NP O
75 2 CD O O
75 gram NN B-NP O
75 Sodium NNP I-NP O
76 ACTIVITY: NNP I-NP O
76 Resume NNP I-NP O
76 regular JJ B-NP O
76 exercise NN I-NP O
77 FOLLOW NNP I-NP O
77 UP NNP I-NP O
77 APPOINTMENT( NNP I-NP O
77 S NNP I-NP O
77 ): NNP I-NP O
78 Dr NNP I-NP O
78 Lagnese NNP I-NP O
78 , , O O
78 call NN B-NP O
78 to TO O O
78 schedule NN B-NP O
78 , , O O
79 Dr NNP B-NP O
79 Olufson NNP I-NP O
79 call NN I-NP O
79 to TO O O
79 schedule VB O O
79 246-729-9224 JJ O O
79 , , O O
80 Dr NNP B-NP O
80 Izzard NNP I-NP O
80 cardiology NN I-NP O
80 1/19/07 CD O O
80 11:30 CD O O
80 scheduled VBN O O
80 , , O O
81 ALLERGY: NNP B-NP O
81 PERCOCET NNP I-NP O
81 , , O O
81 DICLOXACILLIN NNP B-NP O
81 , , O O
81 LISINOPRIL NNP B-NP O
81 , , O O
81 WARFARIN NNP B-NP O
81 SODIUM NNP I-NP O
82 ADMIT NNP I-NP O
82 DIAGNOSIS: NNP I-NP O
83 Chest NNP I-NP O
83 pain NN I-NP O
84 PRINCIPAL NNP I-NP O
84 DISCHARGE NNP I-NP O
84 DIAGNOSIS NNP I-NP O
84 ;Responsible JJ O O
84 After IN B-VP O
84 Study NNP B-NP O
84 for IN B-VP O
84 Causing NNP B-NP O
84 Admission NNP I-NP O
84 ) ) O O
85 Non NNP B-NP O
85 cardiac JJ B-NP O
85 chest NN I-NP O
85 pain NN I-NP O
86 OTHER NNP I-NP O
86 DIAGNOSIS;Conditions NNP I-NP O
86 , , O O
86 Infections NNP B-NP O
86 , , O O
86 Complications NNP B-NP O
86 , , O O
86 affecting VBG O O
86 Treatment/Stay NNP B-NP O
87 s/p JJ B-NP O
87 MVA NNP I-NP O
87 10/3 CD O O
87 s/p NN B-NP O
87 B NNP I-NP O
87 TKA NNP I-NP O
87 htn NN I-NP O
88 ( ( O O
88 hypertension NN B-NP O
88 ) ) O O
88 svt NN B-NP O
88 ( ( O O
88 supraventricular JJ B-NP O
88 tachycardia NN I-NP O
88 ) ) O O
88 thrombophlebitis NN B-NP O
89 ( ( O O
89 superficial JJ B-NP O
89 thrombophlebitis NN I-NP O
89 ) ) O O
89 recurrent NN B-NP O
89 bilat JJ B-NP O
89 LE NNP I-NP O
89 cellulitis NN I-NP O
90 ( ( O O
90 cellulitis NN B-NP O
90 ) ) O O
90 pernicious JJ B-NP O
90 anemia NN I-NP O
90 ( ( O O
90 pernicious JJ B-NP O
90 anemia NN I-NP O
90 ) ) O O
90 afib NN B-NP O
90 ( ( O O
90 atrial JJ B-NP O
91 fibrillation NN I-NP O
91 ) ) O O
91 dvt NN B-NP O
91 ( ( O O
91 deep JJ B-NP O
91 venous JJ I-NP O
91 thrombosis NN I-NP O
91 ) ) O O
91 multiple NN B-NP O
91 episodes NNS I-NP O
91 of IN B-VP O
92 cellulitis NN B-NP O
92 ( ( O O
92 cellulitis NN B-NP O
92 ) ) O O
93 OPERATIONS NNP B-NP O
93 AND NNP I-NP O
93 PROCEDURES: NNP I-NP O
94 None NNP I-NP O
95 OTHER NNP I-NP O
95 TREATMENTS/PROCEDURES NNP I-NP O
95 ( ( O O
95 NOT NNP B-NP O
95 IN NNP I-NP O
95 O.R NNP I-NP O
95 ) ) O O
96 None NN B-NP O
97 BRIEF NNP I-NP O
97 RESUME NNP I-NP O
97 OF NNP I-NP O
97 HOSPITAL NNP I-NP O
97 COURSE: NNP I-NP O
98 CC: NNP I-NP O
98 chest JJS B-NP O
98 pain NN I-NP O
99 ***** NN I-NP O
100 81 CD O O
100 year NN B-NP O
100 old JJ B-NP O
100 woman NN I-NP O
100 with IN B-VP O
100 Afib NNP B-NP B-r
100 ( ( O O
100 on IN B-VP O
100 fondaparinux NN B-NP B-m
100 no DT B-NP O
100 coumadin NN I-NP O
100 secondary JJ O O
100 to TO O O
101 prior VB O O
101 epistaxis NN B-NP O
101 ) ) O O
101 , , O O
101 NSC NNP B-NP O
101 lung NN I-NP O
101 ca MD O O
101 , , O O
101 presents NNS B-NP O
101 with IN B-VP O
101 3 CD O O
101 days NNS B-NP O
101 of IN B-VP O
101 constant JJ B-NP O
101 chest NN I-NP O
102 pain NN I-NP O
102 pleuritic JJ O O
102 , , O O
102 not RB O O
102 exertional JJ O O
102 , , O O
102 related VBN O O
102 mostly RB O O
102 to TO O O
102 arm VB O O
102 movement NN B-NP O
102 Concern NNP I-NP O
103 for IN B-VP O
103 bone NN B-NP O
103 met VBD B-VP O
103 vs.subsegmental JJ B-NP O
103 PE NNP I-NP O
103 on IN B-VP O
103 admission NN B-NP O
103 She PRP O O
103 had VBD B-VP O
103 been VBN O O
103 on IN B-VP O
104 fondapurinox NN B-NP B-m
104 as IN B-VP O
104 oupt NN B-NP O
104 ( ( O O
104 hx NN B-NP O
104 of IN B-VP O
104 lung NN B-NP O
104 ca MD O O
104 and CC O O
104 afib VB O O
104 with IN B-VP O
104 intolerance NN B-NP O
104 of IN B-VP O
105 coumadin NN B-NP O
105 ) ) O O
105 Continued VBD B-VP O
105 work NN B-NP O
105 up RB O O
105 with IN B-VP O
105 question NN B-NP O
105 of IN B-VP O
105 breast NN B-NP O
106 nodule NN I-NP O
106 , , O O
106 pt NN B-NP O
106 identifies NNS I-NP O
106 one CD O O
106 particular JJ B-NP O
106 area NN I-NP O
106 which WDT O O
106 she PRP O O
106 feels VBZ O O
106 is VBZ O O
106 the DT B-NP O
106 primary JJ I-NP O
107 site NN I-NP O
107 of IN B-VP O
107 her PRP$ O O
107 pain NN B-NP O
108 ***** NN I-NP O
109 In IN B-VP O
109 ED: NNP B-NP O
109 PE NNP I-NP O
109 CT NNP I-NP O
109 neg VBZ O O
109 No DT B-NP O
109 ekg NN I-NP O
109 changes VBZ O O
109 ASA NNP B-NP B-m
109 and CC O O
109 no DT B-NP O
109 change NN I-NP O
109 with IN B-VP O
110 NGL NNP B-NP B-m
111 ***** NNP I-NP O
112 Patient NNP I-NP O
112 status: NN I-NP O
112 AF NNP I-NP O
112 , , O O
112 BP NNP B-NP O
112 125/51 CD O O
112 P60 NNP B-NP O
112 O2 NNP I-NP O
112 98% CD O O
112 RA NNP B-NP O
113 RR18 NNP I-NP O
113 AAO NNP I-NP O
113 x NNP I-NP O
113 3 CD O O
113 , , O O
113 obese JJ O O
113 , , O O
113 resting VBG O O
113 and CC O O
113 breathing VBG O O
114 comfortably RB O O
114 irr JJ B-NP O
114 irr JJ I-NP O
114 1-2/6 JJ I-NP O
114 SEM NNP I-NP O
115 crackles NNS I-NP O
115 at IN B-VP O
115 left JJ B-NP O
115 base NN I-NP O
115 +palpable JJ B-NP O
115 L NNP I-NP O
115 breast NN I-NP O
116 mass NN I-NP O
116 at IN B-VP O
116 approx $ O O
116 12 CD O O
116 oclock NN B-NP O
116 a DT B-NP O
116 few JJ I-NP O
116 inches NNS I-NP O
116 above IN B-VP O
116 nipple NN B-NP O
116 , , O O
116 diffusely RB O O
116 nodular JJ B-NP O
117 breasts NNS I-NP O
118 abd VBP O O
118 soft JJ B-NP O
118 nt NNS I-NP O
119 Ext NNP I-NP O
119 1+ CD O O
119 edema NN B-NP O
119 , , O O
119 no DT B-NP O
119 calf NN I-NP O
119 tenderness NN I-NP O
120 ***** NNP I-NP O
121 Significant NNP I-NP O
121 studies: VBD B-VP O
122 CT-PE: NNP B-NP O
122 IMPRESSION: NNP I-NP O
123 1 CD O O
123 No NNP B-NP O
123 evidence NN I-NP O
123 of IN B-VP O
123 pulmonary JJ B-NP O
123 embolism NN I-NP O
123 or CC O O
123 deep JJ B-NP O
123 venous JJ I-NP O
123 thrombosis NN I-NP O
124 2 CD O O
124 Post NNP B-NP O
124 right NN I-NP O
124 lower RBR O O
124 lobe NN B-NP O
124 resection NN I-NP O
124 changes NNS I-NP O
125 3 CD O O
125 Interval NNP B-NP O
125 resolution NN I-NP O
125 of IN B-VP O
125 the DT B-NP O
125 left JJ I-NP O
125 upper JJ I-NP O
125 lobe NN I-NP O
125 nodule NN I-NP O
125 without IN B-VP O
125 new JJ B-NP O
126 nodules NNS I-NP O
127 per IN B-VP O
127 discussion NN B-NP O
127 with IN B-VP O
127 radiology NN B-NP O
127 possible JJ B-NP O
127 chronic JJ I-NP O
127 subsegmental JJ I-NP O
127 PE NNP I-NP O
128 CXR-no NNP I-NP O
128 acute NN I-NP O
128 process NN I-NP O
129 +lupus NNP I-NP O
129 anticoag NN I-NP O
130 ***** NN I-NP O
131 Problem NNP I-NP O
131 List/Hospital NNP I-NP O
131 Course: NNP I-NP O
132 * NNP I-NP O
132 Chest NNP I-NP O
132 pain-No NN I-NP O
132 met VBD B-VP O
132 seen VBN O O
132 on IN B-VP O
132 CXR NNP B-NP O
132 or CC O O
132 CT NNP B-NP O
132 No NNP I-NP O
132 large JJ B-NP O
133 PE NNP I-NP O
133 , , O O
133 but CC O O
133 evidence NN B-NP O
133 for IN B-VP O
133 pulm NN B-NP O
133 HTN NNP I-NP O
133 Given NNP I-NP O
133 question NN I-NP O
133 of IN B-VP O
133 chronic JJ B-NP O
133 PE NNP I-NP O
133 and CC O O
133 outpt JJ B-NP O
134 treatment NN I-NP O
134 with IN B-VP O
134 fondapurinox NN B-NP B-m
134 will MD O O
134 transition VB O O
134 to TO O O
134 lovenox VB O B-m
134 while IN B-VP O
134 inpatient NN B-NP O
135 for IN B-VP O
135 maintenance NN B-NP O
135 ( ( O O
135 intolerance NN B-NP O
135 of IN B-VP O
135 coumadin NN B-NP O
135 with IN B-VP O
135 epistaxis NN B-NP O
135 ) ) O O
135 No DT B-NP O
135 evidence NN I-NP O
135 of IN B-VP O
136 cardiac JJ B-NP O
136 process NN I-NP O
136 on IN B-VP O
136 this DT B-NP O
136 admission NN I-NP O
136 no DT B-NP O
136 hypoxia NN I-NP O
136 , , O O
136 unclear JJ B-NP O
136 etiology NN I-NP O
137 of IN B-VP O
137 chest JJS B-NP O
137 pain NN I-NP O
137 may MD O O
137 be VB O O
137 related VBN O O
137 to TO O O
137 painful JJ B-NP O
137 breast NN I-NP O
137 lump NN I-NP O
137 , , O O
137 pt NN B-NP O
137 will MD O O
137 have VB O O
138 mammogram VBN O O
138 next JJ B-NP O
138 week NN I-NP O
138 for IN B-VP O
138 evaluation NN B-NP O
138 , , O O
138 continue VBP O O
138 pain VB O B-r
138 control NN B-NP I-r
138 with IN B-VP O
138 Lidoderm NNP B-NP B-m
139 patch NN I-NP B-mo
139 , , O O
139 ultram JJ O B-m
139 and CC O O
139 low JJ B-NP B-do
139 dose NN I-NP I-do
139 dilaudid NN I-NP B-m
139 as IN B-VP B-f
139 needed VBN O I-f
139 for IN B-VP O
139 severe JJ B-NP B-r
139 pain NN I-NP I-r
140 * JJ B-NP O
140 Lung NNP I-NP O
140 CA- NNP I-NP O
140 Continuing NNP I-NP O
140 tarceva NN I-NP B-m
140 as IN B-VP O
140 per IN B-VP O
140 outpatient NN B-NP O
140 oncologist NN I-NP O
140 Dr NNP I-NP O
140 Goetzke NNP I-NP O
140 , , O O
140 no DT B-NP O
140 new JJ I-NP O
141 findings NNS I-NP O
141 on IN B-VP O
141 imaging NN B-NP O
141 but CC O O
141 would MD O O
141 consider VB O O
141 bone JJ B-NP O
141 scan NN I-NP O
141 as IN B-VP O
141 an DT B-NP O
141 oupatient NN I-NP O
141 if IN B-VP O
142 continues VBZ O O
142 to TO O O
142 have VB O O
142 severe JJ B-NP O
142 pain NN I-NP O
143 * VBD B-VP O
143 A DT B-NP O
143 fib- JJ I-NP O
143 Lowered NNP I-NP O
143 acebutolol NN I-NP B-m
143 acebutolol NN I-NP B-m
143 dose NN I-NP O
143 from IN B-VP O
143 400mg CD O B-do
143 BID NNP B-NP B-f
143 to TO O O
143 400mg CD O B-do
143 daily RB O B-f
143 due JJ O O
143 to TO O O
144 intermittent JJ B-NP O
144 bradycardia NN I-NP O
144 ( ( O O
144 asymptomatic JJ O O
144 ) ) O O
144 Pt NNP B-NP O
144 to TO O O
144 d/c VB O O
144 fondaparinux NN B-NP B-m
144 and CC O O
145 continue VB O O
145 on IN B-VP O
145 lovenox NN B-NP B-m
145 as IN B-VP O
145 outpt JJ O O
146 * IN B-VP O
146 CHF-gently NNP B-NP O
146 diuresing NN I-NP O
146 , , O O
146 restarting VBG O O
146 home NN B-NP O
146 dose NN I-NP O
146 of IN B-VP O
147 lasix NN B-NP B-m
147 on IN B-VP O
147 4/8 CD O O
147 at IN B-VP O
147 40 CD O B-do
147 mg NNS B-NP I-do
147 daily RB O B-f
147 with IN B-VP O
147 improvement NN B-NP O
147 in IN B-VP O
147 crackles NNS B-NP O
147 at IN B-VP O
147 left JJ B-NP O
147 base NN I-NP O
148 Will NNP I-NP O
148 need VBP O O
148 to TO O O
148 follow VB O O
148 daily JJ B-NP O
148 weights NNS I-NP O
148 and CC O O
148 titrate VB O B-do
148 lasix NN B-NP B-m
148 as IN B-VP B-f
148 needed VBN O I-f
149 * NN B-NP O
149 ID NNP I-NP O
149 - : O O
149 Klebsiella NNP B-NP B-r
149 UTI NNP I-NP I-r
149 , , O O
149 treating VBG O O
149 with IN B-VP O
149 Cipro NNP B-NP B-m
149 starting VBG O O
149 4/8 CD O O
149 with IN B-VP O
149 250mg CD O B-do
149 BID NNP B-NP B-f
150 * NNP I-NP O
150 Pain NNP I-NP B-r
150 - : O O
150 tx NN B-NP O
150 with IN B-VP O
150 lidoderm JJ B-NP B-m
150 patch NN I-NP B-mo
150 , , O O
150 ultram JJ O B-m
150 on IN B-VP O
150 day NN B-NP O
150 of IN B-VP O
150 discharge NN B-NP O
150 adding VBG O O
150 low JJ B-NP B-do
151 dose NN I-NP O
151 dilaudid NN I-NP B-m
151 for IN B-VP O
151 treatment NN B-NP O
151 of IN B-VP O
151 breakthrough NN B-NP B-r
151 pain NN I-NP I-r
152 * NNP I-NP O
152 Dispo NNP I-NP O
152 to TO O O
152 rehabilitation NN B-NP O
152 for IN B-VP O
152 continued JJ B-NP O
152 reconditioning NN I-NP O
152 and CC O O
152 improvement NN B-NP O
152 in IN B-VP O
153 functional JJ B-NP O
153 status NN I-NP O
154 * NN I-NP O
154 CODE: NNP I-NP O
154 FULL NNP I-NP O
155 ADDITIONAL NNP I-NP O
155 COMMENTS: NNP I-NP O
155 Ms NNP I-NP O
155 Cheramie NNP I-NP O
155 , , O O
155 it PRP O O
155 was VBD B-VP O
155 a DT B-NP O
155 pleasure NN I-NP O
155 to TO O O
155 be VB O O
155 involved VBN O O
155 in IN B-VP O
155 your PRP$ O O
155 care NN B-NP O
155 Please NNP I-NP O
156 follow VB O O
156 up RP O O
156 with IN B-VP O
156 your PRP$ O O
156 regular JJ B-NP O
156 primary JJ I-NP O
156 care NN I-NP O
156 provider NN I-NP O
156 , , O O
156 Dr NNP B-NP O
156 Sauro NNP I-NP O
156 and CC O O
156 with IN B-VP O
157 your PRP$ O O
157 oncologist NN B-NP O
157 Dr NNP I-NP O
157 Willard NNP I-NP O
157 Camps NNP I-NP O
157 Please NNP I-NP O
157 also RB O O
157 keep VB O O
157 your PRP$ O O
157 appointment NN B-NP O
157 to TO O O
158 have VB O O
158 mammogram VBN O O
158 as IN B-VP O
158 scheduled VBN O O
158 on IN B-VP O
158 November NNP B-NP O
158 at IN B-VP O
158 PNH NNP B-NP O
158 You PRP O O
158 should MD O O
158 also RB O O
158 follow VB O O
158 up RP O O
159 with IN B-VP O
159 yoru NNS B-NP O
159 cardiologist VBP O O
159 Dr NNP B-NP O
159 Bennie NNP I-NP O
159 Tomaselli NNP I-NP O
159 for IN B-VP O
159 continued JJ B-NP O
159 management NN I-NP O
159 of IN B-VP O
160 your PRP$ O O
160 heart NN B-NP O
160 conditions NNS I-NP O
160 Please NNP I-NP O
160 continue VBP O O
160 to TO O O
160 work VB O O
160 with IN B-VP O
160 the DT B-NP O
160 rehabilitation NN I-NP O
161 specialists NNS I-NP O
161 to TO O O
161 try VB O O
161 to TO O O
161 regain VB O O
161 strength NN B-NP O
161 and CC O O
161 function NN B-NP O
162 DISCHARGE NNP I-NP O
162 CONDITION: NNP I-NP O
162 Stable NNP I-NP O
163 TO NNP I-NP O
163 DO/PLAN: NNP I-NP O
164 1 CD O O
164 Check NNP B-NP O
164 Factor NNP I-NP O
164 Xa NNP I-NP O
164 level NN I-NP O
164 to TO O O
164 insure VB O O
164 Lovenox NNP B-NP B-m
164 dosing NN I-NP O
164 is VBZ O O
164 therapeutic JJ O O
165 2 CD O O
165 Follow NNP B-NP O
165 up RB O O
165 on IN B-VP O
165 mammogram NNS B-NP O
165 scheduled VBN O O
165 for IN B-VP O
165 November NNP B-NP O
166 3 CD O O
166 Continue NNP B-NP O
166 to TO O O
166 monitor VB O O
166 heart NN B-NP O
166 rate NN I-NP O
166 intermittently RB O O
166 to TO O O
166 insure VB O O
166 adequate JJ B-NP B-r
166 rate NN I-NP O
167 control NN I-NP O
167 with IN B-VP O
167 decreased JJ B-NP B-do
167 dose NN I-NP I-do
167 of IN B-VP O
167 Acebutolol NNP B-NP B-m
168 4 CD O O
168 Continue NNP B-NP O
168 Lasix NNP I-NP B-m
168 Lasix NNP I-NP B-m
168 Lasix NNP I-NP B-m
168 at IN B-VP O
168 40mg CD O B-do
168 40mg CD O B-do
168 daily JJ O B-f
168 ( ( O O
168 admit NN B-NP O
168 dose NN I-NP O
168 had VBD B-VP O
168 been VBN O O
168 40mg CD O B-do
168 alternating VBG O O
169 with IN B-VP O
169 60mg CD O O
169 ) ) O O
169 and CC O O
169 monitor JJ B-NP O
169 daily JJ I-NP O
169 weights NNS I-NP O
170 5 CD O O
170 Complete NNP B-NP O
170 course NN I-NP O
170 of IN B-VP O
170 Cipro NNP B-NP B-m
170 250mg CD O B-do
170 BID NNP B-NP B-f
170 x VBD B-VP B-du
170 3 CD O I-du
170 days NNS B-NP I-du
170 ( ( O O
170 4 CD O O
170 doses NNS B-NP O
170 to TO O O
170 complete VB O O
170 on IN B-VP O
171 discharge NN B-NP O
171 ) ) O O
171 for IN B-VP O
171 Klebsiella NNP B-NP B-r
171 UTI NNP I-NP I-r
172 6 CD O O
172 Follow NNP B-NP O
172 up RB O O
172 with IN B-VP O
172 oncologist NN B-NP O
172 , , O O
172 PCP NNP B-NP O
172 and CC O O
172 with IN B-VP O
172 cardiologist NN B-NP O
172 as IN B-VP O
172 above IN B-VP O
173 No NNP B-NP O
173 dictated VBD B-VP O
173 summary JJ B-NP O
174 ENTERED NNP I-NP O
174 BY: NNP I-NP O
174 WALLINGER NNP I-NP O
174 , , O O
174 COLIN NNP B-NP O
174 D NNP I-NP O
174 , , O O
174 M.D NNP B-NP O
174 , , O O
174 PH.D NNP B-NP O
174 ( ( O O
174 NG11 NNP B-NP O
174 ) ) O O
174 9/11/06 CD O O
174 @ $ O O
174 04:29 CD O O
174 PM NNP B-NP O
175 ****** JJ B-NP O
175 END NNP I-NP O
175 OF NNP I-NP O
175 DISCHARGE NNP I-NP O
175 ORDERS NNP I-NP O
175 ****** NNP I-NP O
176 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #941312 VBZ O O
2 955804700 CD O O
2 KPMMCO NNP B-NP O
2 96181967 CD O O
2 1176706 CD O O
2 5/8/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CHF NNP I-NP O
2 , , O O
2 pneumonia NN B-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 0/28/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/15/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 SAMU NNP I-NP O
5 , , O O
5 CURTIS NNP B-NP O
5 759-74-53-9 CD O O
6 Beth NNP B-NP O
6 Ba NNP I-NP O
6 Ri NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 1/29/05 CD O O
8 AT NNP B-NP O
8 04:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Attending NNP I-NP O
9 evaluation NN I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 TIMBERLAKE NNP I-NP O
11 , , O O
11 MEL NNP B-NP O
11 WYATT NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Assisted NNP I-NP O
14 Living NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ACETYLSALICYLIC NNP I-NP B-m
16 ACID NNP I-NP I-m
16 81 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 Override NNP I-NP O
17 Notice: NNP I-NP O
17 Override NNP I-NP O
17 added VBD B-VP O
17 on IN B-VP O
17 6/17/05 CD O O
17 by IN B-VP O
18 THEUNISSEN NNP B-NP O
18 , , O O
18 LYNWOOD NNP B-NP O
18 D NNP I-NP O
19 on IN B-VP O
19 order NN B-NP O
19 for IN B-VP O
19 COUMADIN NNP B-NP B-m
19 PO NNP I-NP B-mo
19 ( ( O O
19 ref JJ O O
19 # # O O
19 29937145 CD O O
19 ) ) O O
20 POTENTIALLY NNP B-NP O
20 SERIOUS NNP I-NP O
20 INTERACTION: NNP I-NP O
20 ASPIRIN NNP I-NP B-m
20 &amp; NNP I-NP O
20 WARFARIN NNP I-NP B-m
21 Reason NNP I-NP O
21 for IN B-VP O
21 override: NN B-NP O
21 aware JJ B-NP O
21 Previous NNP I-NP O
21 override NN I-NP O
21 information: NN I-NP O
22 Override NNP I-NP O
22 added VBD B-VP O
22 on IN B-VP O
22 8/0/05 CD O O
22 by IN B-VP O
22 BOURNS NNP B-NP O
22 , , O O
22 WALTON NNP B-NP O
22 JERALD NNP I-NP O
22 , , O O
22 M.D NNP B-NP O
23 on IN B-VP O
23 order NN B-NP O
23 for IN B-VP O
23 COUMADIN NNP B-NP B-m
23 PO NNP I-NP B-mo
23 ( ( O O
23 ref JJ O O
23 # # O O
23 50397676 CD O O
23 ) ) O O
24 POTENTIALLY NNP B-NP O
24 SERIOUS NNP I-NP O
24 INTERACTION: NNP I-NP O
24 ASPIRIN NNP I-NP B-m
24 &amp; NNP I-NP O
24 WARFARIN NNP I-NP B-m
25 Reason NNP I-NP O
25 for IN B-VP O
25 override: NN B-NP O
25 aware JJ B-NP O
26 DIGOXIN NNP I-NP B-m
26 0.125 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 QD NNP I-NP B-f
27 Override NNP I-NP O
27 Notice: NNP I-NP O
27 Override NNP I-NP O
27 added VBD B-VP O
27 on IN B-VP O
27 8/0/05 CD O O
27 by IN B-VP O
27 CHRISTOFFERSE NNP B-NP O
27 , , O O
27 KRIS NNP B-NP O
27 MARCELLUS NNP I-NP O
27 , , O O
27 M.D NNP B-NP O
28 on IN B-VP O
28 order NN B-NP O
28 for IN B-VP O
28 LEVOTHYROXINE NNP B-NP B-m
28 SODIUM NNP I-NP I-m
28 PO NNP I-NP B-mo
28 ( ( O O
28 ref JJ O O
28 # # O O
28 13700176 CD O O
28 ) ) O O
29 POTENTIALLY NNP B-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 DIGOXIN NNP I-NP B-m
29 &amp; NNP I-NP O
29 LEVOTHYROXINE NNP I-NP B-m
30 SODIUM NNP I-NP O
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 aware JJ B-NP O
31 COLACE NNP I-NP B-m
31 ( ( O I-m
31 DOCUSATE NNP B-NP I-m
31 SODIUM NNP I-NP I-m
31 ) ) O I-m
31 100 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 BID NNP I-NP B-f
32 FERROUS NNP I-NP B-m
32 SULFATE NNP I-NP I-m
32 325 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 BID NNP I-NP B-f
33 Food/Drug NNP I-NP O
33 Interaction NNP I-NP O
33 Instruction NNP I-NP O
33 Avoid NNP I-NP O
33 milk NN I-NP O
33 and CC O O
33 antacid JJ B-NP O
34 MOTRIN NNP I-NP B-m
34 ( ( O I-m
34 IBUPROFEN NNP B-NP I-m
34 ) ) O I-m
34 600 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 Q8H NNP I-NP O
34 Starting VBG O O
34 Today NNP B-NP O
34 ( ( O O
34 10/7 CD O O
34 ) ) O O
35 PRN NNP B-NP O
35 Pain NNP I-NP B-r
35 Food/Drug NNP I-NP O
35 Interaction NNP I-NP O
35 Instruction NNP I-NP O
35 Take NNP I-NP O
35 with IN B-VP O
35 food NN B-NP O
36 LEVOTHYROXINE NNP I-NP B-m
36 SODIUM NNP I-NP I-m
36 75 CD O B-do
36 MCG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 QD NNP I-NP B-f
37 Override NNP I-NP O
37 Notice: NNP I-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 6/17/05 CD O O
37 by IN B-VP O
38 CONNELLY NNP B-NP O
38 , , O O
38 ELIAS NNP B-NP O
38 E NNP I-NP O
39 on IN B-VP O
39 order NN B-NP O
39 for IN B-VP O
39 COUMADIN NNP B-NP B-m
39 PO NNP I-NP B-mo
39 ( ( O O
39 ref JJ O O
39 # # O O
39 29937145 CD O O
39 ) ) O O
40 SERIOUS NNP B-NP O
40 INTERACTION: NNP I-NP O
40 LEVOTHYROXINE NNP I-NP B-m
40 SODIUM NNP I-NP I-m
40 &amp; NNP I-NP O
40 WARFARIN NNP I-NP B-m
41 Reason NNP I-NP O
41 for IN B-VP O
41 override: NN B-NP O
41 aware JJ B-NP O
41 Previous NNP I-NP O
41 override NN I-NP O
41 information: NN I-NP O
42 Override NNP I-NP O
42 added VBD B-VP O
42 on IN B-VP O
42 8/0/05 CD O O
42 by IN B-VP O
42 ORMONDE NNP B-NP O
42 , , O O
42 GUY NNP B-NP O
42 NICHOLAS NNP I-NP O
42 , , O O
42 M.D NNP B-NP O
43 POTENTIALLY NNP I-NP O
43 SERIOUS NNP I-NP O
43 INTERACTION: NNP I-NP O
43 DIGOXIN NNP I-NP B-m
43 &amp; NNP I-NP O
43 LEVOTHYROXINE NNP I-NP B-m
44 SODIUM NNP I-NP O
44 SERIOUS NNP I-NP O
44 INTERACTION: NNP I-NP O
44 WARFARIN NNP I-NP B-m
44 &amp; NNP I-NP O
44 LEVOTHYROXINE NNP I-NP B-m
44 SODIUM NNP I-NP I-m
45 Reason NNP I-NP O
45 for IN B-VP O
45 override: NN B-NP O
45 aware JJ B-NP O
46 REGLAN NNP I-NP B-m
46 ( ( O I-m
46 METOCLOPRAMIDE NNP B-NP I-m
46 HCL NNP I-NP I-m
46 ) ) O I-m
46 5 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 AC NNP I-NP B-f
47 SIMETHICONE NNP I-NP B-m
47 80 CD O B-do
47 MG NNP B-NP I-do
47 PO NNP I-NP B-mo
47 QID NNP I-NP B-f
48 VITAMIN NNP I-NP B-m
48 B1 NNP I-NP I-m
48 ( ( O I-m
48 THIAMINE NNP B-NP I-m
48 HCL NNP I-NP I-m
48 ) ) O I-m
48 100 CD O B-do
48 MG NNP B-NP I-do
48 PO NNP I-NP B-mo
48 QD NNP I-NP B-f
49 TRAZODONE NNP I-NP B-m
49 50 CD O B-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 HS NNP I-NP B-f
50 COUMADIN NNP I-NP B-m
50 ( ( O I-m
50 WARFARIN NNP B-NP I-m
50 SODIUM NNP I-NP I-m
50 ) ) O I-m
50 5 CD O B-do
50 MG NNP B-NP I-do
50 PO NNP I-NP B-mo
50 QPM NNP I-NP B-f
51 Starting NNP I-NP O
51 ROUTINE NNP I-NP O
51 , , O O
51 20:00 CD O O
51 ( ( O O
51 Standard NNP B-NP O
51 Admin NNP I-NP O
51 Time NNP I-NP O
51 ) ) O O
52 Food/Drug NNP B-NP O
52 Interaction NNP I-NP O
52 Instruction NNP I-NP O
53 No NNP I-NP O
53 high JJ B-NP O
53 Vitamin-K NNP I-NP O
53 containing VBG O O
53 foods NNS B-NP O
54 Alert NNP I-NP O
54 overridden: VBD B-VP O
54 Override NNP B-NP O
54 added VBD B-VP O
54 on IN B-VP O
54 6/17/05 CD O O
54 by IN B-VP O
55 MORKVE NNP B-NP O
55 , , O O
55 OLLIE NNP B-NP O
55 J NNP I-NP O
56 POTENTIALLY NNP I-NP O
56 SERIOUS NNP I-NP O
56 INTERACTION: NNP I-NP O
56 ASPIRIN NNP I-NP B-m
56 &amp; NNP I-NP O
56 WARFARIN NNP I-NP B-m
57 SERIOUS NNP I-NP O
57 INTERACTION: NNP I-NP O
57 LEVOTHYROXINE NNP I-NP B-m
57 SODIUM NNP I-NP I-m
57 &amp; NNP I-NP O
57 WARFARIN NNP I-NP B-m
58 POTENTIALLY NNP I-NP O
58 SERIOUS NNP I-NP O
58 INTERACTION: NNP I-NP O
58 SIMVASTATIN NNP I-NP B-m
58 &amp; NNP I-NP O
58 WARFARIN NNP I-NP B-m
59 POTENTIALLY NNP I-NP O
59 SERIOUS NNP I-NP O
59 INTERACTION: NNP I-NP O
59 LEVOFLOXACIN NNP I-NP B-m
59 &amp; NNP I-NP O
59 WARFARIN NNP I-NP B-m
60 POTENTIALLY NNP I-NP O
60 SERIOUS NNP I-NP O
60 INTERACTION: NNP I-NP O
60 LEVOFLOXACIN NNP I-NP B-m
60 &amp; NNP I-NP O
60 WARFARIN NNP I-NP B-m
61 Reason NNP I-NP O
61 for IN B-VP O
61 override: NN B-NP O
61 aware JJ B-NP O
62 MVI NNP I-NP B-m
62 THERAPEUTIC NNP I-NP I-m
62 ( ( O I-m
62 THERAPEUTIC NNP B-NP I-m
62 MULTIVITAMINS NNP I-NP I-m
62 ) ) O I-m
62 1 CD O B-do
62 TAB NNP B-NP I-do
62 PO NNP I-NP B-mo
62 QD NNP I-NP B-f
63 Alert NNP I-NP O
63 overridden: NNP I-NP O
63 Override NNP I-NP O
63 added VBD B-VP O
63 on IN B-VP O
63 8/0/05 CD O O
63 by IN B-VP O
64 MUNGO NNP B-NP O
64 , , O O
64 KOREY NNP B-NP O
64 DEON NNP I-NP O
64 , , O O
64 M.D NNP B-NP O
65 POTENTIALLY NNP I-NP O
65 SERIOUS NNP I-NP O
65 INTERACTION: NNP I-NP O
65 SIMVASTATIN NNP I-NP B-m
65 &amp; NNP I-NP O
65 NIACIN NNP I-NP B-m
65 , , O O
66 VIT NNP B-NP B-m
66 B-3 NNP I-NP I-m
66 Reason NNP I-NP O
66 for IN B-VP O
66 override: NN B-NP O
66 aware JJ B-NP O
67 TOPROL NNP I-NP B-m
67 XL NNP I-NP I-m
67 ( ( O I-m
67 METOPROLOL NNP B-NP I-m
67 SUCCINATE NNP I-NP I-m
67 EXTENDED NNP I-NP I-m
67 RELEASE NNP I-NP I-m
67 ) ) O I-m
68 75 CD O B-do
68 MG NNP B-NP I-do
68 PO NNP I-NP B-mo
68 QD NNP I-NP B-f
68 Food/Drug NNP I-NP O
68 Interaction NNP I-NP O
68 Instruction NNP I-NP O
69 Take NNP I-NP O
69 consistently RB O O
69 with IN B-VP O
69 meals NNS B-NP O
69 or CC O O
69 on IN B-VP O
69 empty JJ B-NP O
69 stomach NN I-NP O
70 Number NNP I-NP B-du
70 of IN B-VP I-du
70 Doses NNP B-NP I-du
70 Required NNP I-NP I-du
70 ( ( O I-du
70 approximate JJ B-NP I-du
70 ): NN I-NP I-du
70 10 CD O I-du
71 GABAPENTIN NNP B-NP B-m
71 200 CD O B-do
71 MG NNP B-NP I-do
71 PO NNP I-NP B-mo
71 QD NNP I-NP B-f
72 TORSEMIDE NNP I-NP B-m
72 100 CD O B-do
72 MG NNP B-NP I-do
72 PO NNP I-NP B-mo
72 BID NNP I-NP B-f
73 COZAAR NNP I-NP B-m
73 ( ( O I-m
73 LOSARTAN NNP B-NP I-m
73 ) ) O I-m
73 50 CD O B-do
73 MG NNP B-NP I-do
73 PO NNP I-NP B-mo
73 QD NNP I-NP B-f
74 Number NNP I-NP B-du
74 of IN B-VP I-du
74 Doses NNP B-NP I-du
74 Required NNP I-NP I-du
74 ( ( O I-du
74 approximate JJ B-NP I-du
74 ): NN I-NP I-du
74 10 CD O I-du
75 LEVOCARNITINE NNP B-NP B-m
75 1 CD O B-do
75 GM NNP B-NP I-do
75 PO NNP I-NP B-mo
75 QD NNP I-NP B-f
75 Starting VBG O O
75 Today NNP B-NP O
75 ( ( O O
75 8/21 CD O O
75 ) ) O O
76 Instructions: NNP B-NP O
76 on IN B-VP O
76 15 CD O O
76 ml NN B-NP O
76 at IN B-VP O
76 home NN B-NP O
77 Number NNP I-NP B-du
77 of IN B-VP I-du
77 Doses NNP B-NP I-du
77 Required NNP I-NP I-du
77 ( ( O I-du
77 approximate JJ B-NP I-du
77 ): NN I-NP I-du
77 10 CD O I-du
78 CITALOPRAM NNP B-NP B-m
78 20 CD O B-do
78 MG NNP B-NP I-do
78 PO NNP I-NP B-mo
78 QD NNP I-NP B-f
79 ADVAIR NNP I-NP B-m
79 DISKUS NNP I-NP I-m
79 250/50 CD O I-m
79 ( ( O I-m
79 FLUTICASONE NNP B-NP I-m
79 PROPIONATE/ NNP I-NP I-m
79 ) ) O I-m
80 1 CD O B-do
80 PUFF NNP B-NP I-do
80 INH NNP I-NP B-mo
80 BID NNP I-NP B-f
81 Override NNP I-NP O
81 Notice: NNP I-NP O
81 Override NNP I-NP O
81 added VBD B-VP O
81 on IN B-VP O
81 8/0/05 CD O O
81 by IN B-VP O
81 WHITESELL NNP B-NP O
81 , , O O
81 OTIS NNP B-NP O
81 DARRICK NNP I-NP O
81 , , O O
81 M.D NNP B-NP O
82 on IN B-VP O
82 order NN B-NP O
82 for IN B-VP O
82 LEVOFLOXACIN NNP B-NP B-m
82 PO NNP I-NP B-mo
82 ( ( O O
82 ref JJ O O
82 # # O O
82 24 CD O O
82 of IN B-VP O
82 June NNP B-NP O
82 ) ) O O
83 POTENTIALLY NNP B-NP O
83 SERIOUS NNP I-NP O
83 INTERACTION: NNP I-NP O
83 SALMETEROL NNP I-NP B-m
83 XINAFOATE NNP I-NP I-m
83 &amp; NNP I-NP O
84 LEVOFLOXACIN NNP I-NP B-m
84 Reason NNP I-NP O
84 for IN B-VP O
84 override: NN B-NP O
84 aware JJ B-NP O
85 NEXIUM NNP I-NP B-m
85 ( ( O I-m
85 ESOMEPRAZOLE NNP B-NP I-m
85 ) ) O I-m
85 20 CD O B-do
85 MG NNP B-NP I-do
85 PO NNP I-NP B-mo
85 QD NNP I-NP B-f
86 LANTUS NNP I-NP B-m
86 ( ( O I-m
86 INSULIN NNP B-NP I-m
86 GLARGINE NNP I-NP I-m
86 ) ) O I-m
86 60 CD O B-do
86 UNITS NNP B-NP I-do
86 SC NNP I-NP B-mo
86 QHS NNP I-NP B-f
87 NOVOLOG NNP I-NP B-m
87 NOVOLOG NNP I-NP B-m
87 NOVOLOG NNP I-NP B-m
87 NOVOLOG NNP I-NP B-m
87 NOVOLOG NNP I-NP B-m
87 NOVOLOG NNP I-NP B-m
87 NOVOLOG NNP I-NP B-m
87 NOVOLOG NNP I-NP B-m
87 ( ( O I-m
87 ( ( O I-m
87 ( ( O I-m
87 ( ( O I-m
87 ( ( O I-m
87 ( ( O I-m
87 ( ( O I-m
87 ( ( O I-m
87 INSULIN NNP B-NP I-m
87 INSULIN NNP I-NP I-m
87 INSULIN NNP I-NP I-m
87 INSULIN NNP I-NP I-m
87 INSULIN NNP I-NP I-m
87 INSULIN NNP I-NP I-m
87 INSULIN NNP I-NP I-m
87 INSULIN NNP I-NP I-m
87 ASPART NNP I-NP I-m
87 ASPART NNP I-NP I-m
87 ASPART NNP I-NP I-m
87 ASPART NNP I-NP I-m
87 ASPART NNP I-NP I-m
87 ASPART NNP I-NP I-m
87 ASPART NNP I-NP I-m
87 ASPART NNP I-NP I-m
87 ) ) O I-m
87 ) ) O I-m
87 ) ) O I-m
87 ) ) O I-m
87 ) ) O I-m
87 ) ) O I-m
87 ) ) O I-m
87 ) ) O I-m
88 Sliding VBG O B-do
88 Scale NNP B-NP I-do
88 ( ( O B-mo
88 subcutaneously RB O I-mo
88 ) ) O I-mo
88 SC NNP B-NP I-mo
88 AC NNP I-NP B-f
89 If IN B-VP O
89 BS NNP B-NP O
89 is VBZ O O
89 less JJR O O
89 than IN B-VP O
89 125 CD O O
89 , , O O
89 then RB O O
89 give VB O O
89 0 CD O B-do
89 units NNS B-NP I-do
89 subcutaneously RB O B-mo
90 If IN B-VP O
90 BS NNP B-NP O
90 is VBZ O O
90 125-150 JJ O O
90 , , O O
90 then RB O O
90 give VB O O
90 2 CD O B-do
90 units NNS B-NP I-do
90 subcutaneously RB O B-mo
91 If IN B-VP O
91 BS NNP B-NP O
91 is VBZ O O
91 151-200 CD O O
91 , , O O
91 then RB O O
91 give VB O O
91 3 CD O B-do
91 units NNS B-NP I-do
91 subcutaneously RB O B-mo
92 If IN B-VP O
92 BS NNP B-NP O
92 is VBZ O O
92 201-250 JJ O O
92 , , O O
92 then RB O O
92 give VB O O
92 4 CD O B-do
92 units NNS B-NP I-do
92 subcutaneously RB O B-mo
93 If IN B-VP O
93 BS NNP B-NP O
93 is VBZ O O
93 251-300 JJ O O
93 , , O O
93 then RB O O
93 give VB O O
93 6 CD O B-do
93 units NNS B-NP I-do
93 subcutaneously RB O B-mo
94 If IN B-VP O
94 BS NNP B-NP O
94 is VBZ O O
94 301-350 JJ O O
94 , , O O
94 then RB O O
94 give VB O O
94 8 CD O B-do
94 units NNS B-NP I-do
94 subcutaneously RB O B-mo
95 If IN B-VP O
95 BS NNP B-NP O
95 is VBZ O O
95 351-400 CD O O
95 , , O O
95 then RB O O
95 give VB O O
95 10 CD O B-do
95 units NNS B-NP I-do
95 subcutaneously RB O B-mo
95 and CC O O
96 call VB O O
96 HO NNP B-NP O
96 Call NNP I-NP O
96 HO NNP I-NP O
96 if IN B-VP O
96 BS NNP B-NP O
96 is VBZ O O
96 greater JJR O O
96 than IN B-VP O
96 400 CD O O
97 LIPITOR NNP B-NP B-m
97 ( ( O I-m
97 ATORVASTATIN NNP B-NP I-m
97 ) ) O I-m
97 10 CD O B-do
97 MG NNP B-NP I-do
97 PO NNP I-NP B-mo
97 QPM NNP I-NP B-f
98 Alert NNP I-NP O
98 overridden: NNP I-NP O
98 Override NNP I-NP O
98 added VBD B-VP O
98 on IN B-VP O
98 6/17/05 CD O O
98 by IN B-VP O
98 : : O O
99 POTENTIALLY NNP B-NP O
99 SERIOUS NNP I-NP O
99 INTERACTION: NNP I-NP O
99 NIACIN NNP I-NP B-m
99 , , O O
99 VIT NNP B-NP B-m
99 B-3 NNP I-NP I-m
99 &amp; NNP I-NP O
100 ATORVASTATIN NNP I-NP B-m
100 CALCIUM NNP I-NP I-m
101 POTENTIALLY NNP I-NP O
101 SERIOUS NNP I-NP O
101 INTERACTION: NNP I-NP O
101 WARFARIN NNP I-NP B-m
101 &amp; NNP I-NP O
101 ATORVASTATIN NNP I-NP B-m
102 CALCIUM NNP I-NP O
102 Reason NNP I-NP O
102 for IN B-VP O
102 override: NN B-NP O
102 aware JJ B-NP O
103 COMBIVENT NNP I-NP B-m
103 ( ( O I-m
103 IPRATROPIUM NNP B-NP I-m
103 AND NNP I-NP I-m
103 ALBUTEROL NNP I-NP I-m
103 SULFATE NNP I-NP I-m
103 ) ) O I-m
104 2 CD O B-do
104 PUFF NNP B-NP I-do
104 INH NNP I-NP B-mo
104 QID NNP I-NP B-f
105 DIET: NNP I-NP O
105 House NNP I-NP O
105 / VBD B-VP O
105 Low NNP B-NP O
105 chol/low NN I-NP O
105 sat VBD B-VP O
105 fat JJ B-NP O
106 DIET: NNP I-NP O
106 House NNP I-NP O
106 / NNP I-NP O
106 ADA NNP I-NP O
106 1800 CD O O
106 cals/dy NN B-NP O
107 DIET: NNP I-NP O
107 2 CD O O
107 gram NN B-NP O
107 Sodium NNP I-NP O
108 ACTIVITY: NNP I-NP O
108 Resume NNP I-NP O
108 regular JJ B-NP O
108 exercise NN I-NP O
109 FOLLOW NNP I-NP O
109 UP NNP I-NP O
109 APPOINTMENT( NNP I-NP O
109 S NNP I-NP O
109 ): NNP I-NP O
110 Follow NNP I-NP O
110 up RP O O
110 with IN B-VP O
110 you PRP O O
110 Primary NNP B-NP O
110 Care NNP I-NP O
110 Provider NNP I-NP O
110 within IN B-VP O
110 the DT O O
110 next JJ O O
110 two CD O O
110 weeks NNS B-NP O
110 , , O O
111 Arrange NNP B-NP O
111 INR NNP I-NP O
111 to TO O O
111 be VB O O
111 drawn VBN O O
111 on IN B-VP O
111 8/17/05 CD O O
111 with IN B-VP O
111 f/u JJ B-NP O
111 INR's NNP I-NP O
111 to TO O O
111 be VB O O
111 drawn VBN O O
111 every DT O O
112 2 CD O O
112 days NNS B-NP O
112 INR's NNP I-NP O
112 will MD O O
112 be VB O O
112 followed VBN O O
112 by IN B-VP O
112 Dr NNP B-NP O
112 Hechinger NNP I-NP O
112 AH NNP I-NP O
113 ALLERGY: NNP I-NP O
113 SHRIMP NNP I-NP O
114 ADMIT NNP I-NP O
114 DIAGNOSIS: NNP I-NP O
115 CHF NNP I-NP O
115 , , O O
115 pneumonia NN B-NP O
116 PRINCIPAL NNP I-NP O
116 DISCHARGE NNP I-NP O
116 DIAGNOSIS NNP I-NP O
116 ;Responsible JJ O O
116 After IN B-VP O
116 Study NNP B-NP O
116 for IN B-VP O
116 Causing NNP B-NP O
116 Admission NNP I-NP O
116 ) ) O O
117 CHF NNP B-NP O
117 , , O O
117 pneumonia VBZ O O
118 OTHER NNP B-NP O
118 DIAGNOSIS;Conditions NNP I-NP O
118 , , O O
118 Infections NNP B-NP O
118 , , O O
118 Complications NNP B-NP O
118 , , O O
118 affecting VBG O O
118 Treatment/Stay NNP B-NP O
119 Adriamycin NNP I-NP B-m
119 induced VBD B-VP O
119 CMP NNP B-NP O
119 HTN NNP I-NP O
119 IDDM NNP I-NP O
119 Sarcoid NNP I-NP O
120 Left NNP I-NP O
120 Breast NNP I-NP O
120 CA- NNP I-NP O
120 s/p NN I-NP O
120 lumpect NN I-NP O
120 and CC O O
120 XRT/Adria-'84 JJ B-NP O
120 hypercholesterolemia NN I-NP O
121 ? . B-VP O
121 GI NNP B-NP O
121 origin NN I-NP O
121 of IN B-VP O
121 epigastric JJ B-NP O
121 pain NN I-NP O
121 dvt NN I-NP O
121 ( ( O O
121 deep JJ B-NP O
121 venous JJ I-NP O
121 thrombosis NN I-NP O
121 ) ) O O
122 osteoarthritis NN B-NP O
122 ( ( O O
122 unspecified JJ O O
122 or CC O O
122 generalized JJ B-NP O
122 OA NNP I-NP O
122 ) ) O O
122 hypothyroid NN B-NP O
123 ( ( O O
123 hypothyroidism NN B-NP O
123 ) ) O O
123 cad NN B-NP O
123 ( ( O O
123 ) ) O O
124 OPERATIONS NNP B-NP O
124 AND NNP I-NP O
124 PROCEDURES: NNP I-NP O
125 none NN I-NP O
126 OTHER NNP I-NP O
126 TREATMENTS/PROCEDURES NNP I-NP O
126 ( ( O O
126 NOT NNP B-NP O
126 IN NNP I-NP O
126 O.R NNP I-NP O
126 ) ) O O
127 Midline NNP B-NP O
127 placed VBN O O
127 on IN B-VP O
127 8/10 CD O O
127 for IN B-VP O
127 blood NN B-NP O
127 draws NNS I-NP O
127 but CC O O
127 did VBD B-VP O
127 not RB O O
127 work VB O O
127 Midline NNP B-NP O
127 taken VBN O O
128 out RP O O
128 before IN B-VP O
128 discharge NN B-NP O
129 BRIEF NNP I-NP O
129 RESUME NNP I-NP O
129 OF NNP I-NP O
129 HOSPITAL NNP I-NP O
129 COURSE: NNP I-NP O
130 CC: NNP I-NP O
130 SOB NNP I-NP O
131 HPI: NNP I-NP O
131 61 CD O O
131 yo NN B-NP O
131 F NNP I-NP O
131 with IN B-VP O
131 multiple JJ B-NP O
131 medical JJ I-NP O
131 problems NNS I-NP O
131 , , O O
131 including VBG O O
131 dilated VBN O O
131 CMP NNP B-NP O
131 , , O O
132 s/p NN B-NP O
132 chemo NN I-NP O
132 and CC O O
132 XRT NN B-NP O
132 for IN B-VP O
132 Breast NNP B-NP O
132 CA NNP I-NP O
132 , , O O
132 CAD NNP B-NP O
132 , , O O
132 s/p NN B-NP O
132 MI NNP I-NP O
132 , , O O
132 COPD NNP B-NP O
132 , , O O
132 on IN B-VP O
132 occasional JJ B-NP O
132 O2 NNP I-NP O
132 , , O O
133 presents VBZ O O
133 with IN B-VP O
133 dry JJ B-NP O
133 cough NN I-NP O
133 associated VBN O O
133 with IN B-VP O
133 some DT B-NP O
133 SOB NNP I-NP O
133 x VBD B-VP O
133 2 CD O O
133 days NNS B-NP O
134 and CC O O
134 increased JJ B-NP O
134 DOE NNP I-NP O
134 as RB O O
134 well RB O O
134 At IN B-VP O
134 baseline NN B-NP O
134 pt NN I-NP O
134 is VBZ O O
134 able JJ O O
134 to TO O O
134 walk VB O O
134 1 CD O O
134 block NN B-NP O
135 ( ( O O
135 with IN B-VP O
135 walker NN B-NP O
135 ) ) O O
135 before IN B-VP O
135 DOE NNP B-NP O
135 , , O O
135 now RB O O
135 DOE NNP B-NP O
135 after IN B-VP O
135 1/2 CD O O
135 block NN B-NP O
135 Pt NNP I-NP O
135 denies VBZ O O
135 CP NNP B-NP O
135 Pt NNP I-NP O
136 reports NNS I-NP O
136 orthopnea NN I-NP O
136 and CC O O
136 PND NNP B-NP O
136 Pt NNP I-NP O
136 has VBZ O O
136 chronic VBN O O
136 abd RB O O
136 pain NN B-NP O
136 at IN B-VP O
136 baseline NN B-NP O
136 that WDT O O
137 has VBZ O O
137 been VBN O O
137 evaluated VBN O O
137 in IN B-VP O
137 the DT O O
137 past JJ O O
137 with IN B-VP O
137 Abd NNP B-NP O
137 CT NNP I-NP O
137 , , O O
137 U/S NNP B-NP O
137 showing VBG O O
137 sludge NN B-NP O
137 Pt NNP I-NP O
138 has VBZ O O
138 a DT B-NP O
138 Hx NNP I-NP O
138 of IN B-VP O
138 increased VBN O O
138 Alk NNP B-NP O
138 Phos NNP I-NP O
138 She PRP O O
138 reports VBZ O O
138 no DT B-NP O
138 change NN I-NP O
138 in IN B-VP O
138 abd NN B-NP O
138 pain NN I-NP O
138 at IN B-VP O
139 this DT B-NP O
139 time NN I-NP O
139 , , O O
139 except IN B-VP O
139 increased VBN O O
139 bloating NN B-NP O
139 No DT O O
139 increased VBN O O
139 leg NN B-NP O
139 edema NN I-NP O
139 , , O O
140 but CC O O
140 reports NNS B-NP O
140 increased VBD B-VP O
140 in IN B-VP O
140 size NN B-NP O
140 of IN B-VP O
140 L NNP B-NP O
140 arm NN I-NP O
140 Pt NNP I-NP O
140 also RB O O
140 reports VBZ O O
140 wheezing VBG O O
141 without IN B-VP O
141 increased VBN O O
141 O2 NNP B-NP O
141 need NN I-NP O
141 at IN B-VP O
141 night NN B-NP O
141 No NNP I-NP O
141 sick NN I-NP O
141 contacts NNS I-NP O
141 , , O O
141 no DT B-NP O
141 diarrhea NN I-NP O
141 , , O O
141 no DT B-NP O
142 constipation NN I-NP O
143 **** VBZ O O
144 PE NNP B-NP O
144 on IN B-VP O
144 admission: NN B-NP O
144 VS: NNP I-NP O
144 T97.8 NNP I-NP O
144 HR73 NNP I-NP O
144 BP113/71 NNP I-NP O
144 RR18 NNP I-NP O
144 O2Sat NNP I-NP O
144 92% CD O O
145 Gen: NNP B-NP O
145 NAD NNP I-NP O
146 HEENT: NNP I-NP O
146 oropharynx MD O O
146 clear VB O O
146 , , O O
146 no DT B-NP O
146 JVD NNP I-NP O
147 CV: NNP I-NP O
147 distant JJ B-NP O
147 heart NN I-NP O
147 sounds VBZ O O
147 , , O O
147 1/6 CD O O
147 SEM NNP B-NP O
148 Pulm:ant NNP I-NP O
148 endexp NN I-NP O
148 wheezes NNS I-NP O
148 , , O O
148 no DT B-NP O
148 crackles NNS I-NP O
149 Abd: NNP I-NP O
149 mild NN I-NP O
149 tenderness NN I-NP O
149 in IN B-VP O
149 epigastrium NN B-NP O
149 , , O O
149 RUQ NNP B-NP O
149 , , O O
149 distended VBD B-VP O
150 Ext:Venous JJ B-NP O
150 stasis NN I-NP O
150 , , O O
150 1+ CD O O
150 edema NN B-NP O
150 , , O O
150 L NNP B-NP O
150 arm NN I-NP O
150 larger JJR O O
150 than IN B-VP O
150 R NNP B-NP O
150 arm NN I-NP O
151 ***** NN I-NP O
152 Tests: NNP I-NP O
152 ALK NNP I-NP O
152 Phos: NNP I-NP O
152 627 CD O O
153 ALT: NNP B-NP O
153 71 CD O O
154 AST: NNP B-NP O
154 65 CD O O
155 Card NNP B-NP O
155 Enzymes: NNP I-NP O
155 neg VBD B-VP O
156 WBC: NNP B-NP O
156 6.4 CD O O
157 UA: NNP B-NP O
157 1.011 CD O O
157 , , O O
157 1+prot CD O O
157 , , O O
157 5-10WBC JJ O O
157 , , O O
157 2+bact CD O O
158 CXR: NNP B-NP O
158 LLL NNP I-NP O
158 opacity NN I-NP O
158 , , O O
158 seen VBN O O
158 best JJS O O
158 on IN B-VP O
158 lateral JJ B-NP O
158 view NN I-NP O
159 EKG: NNP I-NP O
159 prolonged VBD B-VP O
159 PR NNP B-NP O
159 , , O O
159 q NN B-NP O
159 in IN B-VP O
159 AVL NNP B-NP O
159 , , O O
159 flat JJ B-NP O
159 Ts NNP I-NP O
159 laterally RB O O
159 , , O O
159 unchanged JJ O O
159 from IN B-VP O
159 9/5 CD O O
160 RUQ NNP B-NP O
160 US: NNP I-NP O
160 sludge NN I-NP O
160 , , O O
160 gall NN B-NP O
160 bladder NN I-NP O
160 wall NN I-NP O
160 thickened VBD B-VP O
160 8mm CD O O
160 , , O O
160 neg JJ B-NP O
160 sonographic JJ I-NP O
161 Murphy's NNP I-NP O
161 sign NN I-NP O
161 , , O O
161 B/L NNP B-NP O
161 small JJ B-NP O
161 pleural JJ I-NP O
161 effusions NNS I-NP O
162 2/4 CD O O
162 Echo: NNP B-NP O
162 EF NNP I-NP O
162 25% CD O O
162 , , O O
162 LV NNP B-NP O
162 mild NN I-NP O
162 to TO O O
162 mod VB O O
162 dilated VBN O O
162 at IN B-VP O
162 4.2cm CD O O
162 , , O O
162 some DT B-NP O
162 RWMA NNP I-NP O
162 , , O O
163 mod-severe JJ B-NP O
163 MR NNP I-NP O
164 6/7 CD O O
164 Abd NNP B-NP O
164 U/S: NNP I-NP O
164 sludge NN I-NP O
164 in IN B-VP O
164 gallbladder NN B-NP O
165 2/4 CD O O
165 Abd NNP B-NP O
165 CT: NNP I-NP O
165 Ascites VBZ O O
166 2/4 CD O O
166 PE NNP B-NP O
166 protocol NN I-NP O
166 CT: NNP I-NP O
166 mild NN I-NP O
166 edema NN I-NP O
166 , , O O
166 bilat JJ B-NP O
166 effusions NNS I-NP O
166 , , O O
166 anasarca VBP O O
167 ********************************************************************** JJ B-NP O
168 HOSPITAL NNP I-NP O
168 COURSE: NNP I-NP O
169 61F CD O O
169 with IN B-VP O
169 LLL NNP B-NP O
169 PNA NNP I-NP O
169 and CC O O
169 CHF NNP B-NP O
170 1 CD O O
170 ) ) O O
170 ID: NNP B-NP O
170 Pt NNP I-NP O
170 placed VBD B-VP O
170 on IN B-VP O
170 po NN B-NP B-mo
170 levofloxacin NN I-NP B-m
170 for IN B-VP O
170 LLL NNP B-NP B-r
170 pneumonia NN I-NP I-r
170 She PRP O O
170 received VBD B-VP O
170 a DT O O
170 7 CD O B-du
171 days NNS B-NP O
171 course NN I-NP O
171 and CC O O
171 symptoms NNS B-NP O
171 resolved VBD B-VP O
171 Stable JJ B-NP O
171 vitals NNS I-NP O
171 and CC O O
171 O2 NNP B-NP O
171 sats VBZ O O
172 2 CD O O
172 ) ) O O
172 Pulm: NNP B-NP O
172 HX NNP I-NP O
172 of IN B-VP O
172 CHF NNP B-NP O
172 Pt's NNP I-NP O
172 weight VBD B-VP O
172 227lbs CD O O
172 7/6/05 CD O O
172 ( ( O O
172 dry JJ B-NP O
172 weight NN I-NP O
172 ~ NNP I-NP O
172 200 CD O O
172 ) ) O O
172 Pt NN B-NP O
173 on IN B-VP O
173 torsemide JJ O B-m
173 100mg CD O B-do
173 bid NN B-NP B-f
173 at IN B-VP O
173 baseline NN B-NP O
173 Pt NNP I-NP O
173 given VBN O O
173 po VBP O B-mo
173 lasix JJ B-NP B-m
173 lasix NN I-NP B-m
173 ( ( O O
173 in IN B-VP O
173 place NN B-NP O
173 of IN B-VP O
174 torsemide NN B-NP B-m
174 on IN B-VP O
174 admit NN B-NP O
174 ) ) O O
174 and CC O O
174 was VBD B-VP O
174 increased VBN O O
174 to TO O O
174 200bid CD O B-do
174 x NNS B-NP B-du
174 2 CD O I-du
174 doses NNS B-NP I-du
174 Then RB O O
174 , , O O
174 pt NN B-NP O
175 placed VBD B-VP O
175 back RB O O
175 on IN B-VP O
175 torsemide NN B-NP B-m
175 and CC O O
175 zaroxyln $ O B-m
175 5mg CD O B-do
175 po NN B-NP B-mo
175 BID NNP I-NP B-f
175 x VBZ O B-du
175 6 CD O I-du
175 doses NNS B-NP I-du
175 was VBD B-VP O
175 added VBN O O
176 Lytes NNP B-NP O
176 closely RB O O
176 monitored VBD B-VP O
176 , , O O
176 however RB O O
176 , , O O
176 pt NN B-NP O
176 was VBD B-VP O
176 difficult JJ O O
176 to TO O O
176 draw VB O O
177 blood NN B-NP O
177 from IN B-VP O
177 secondary JJ O O
177 to TO O O
177 poor JJ B-NP O
177 access NN I-NP O
177 Followed VBD B-VP O
177 daily JJ B-NP O
177 weights NNS I-NP O
177 On IN B-VP O
177 D/C NNP B-NP O
177 , , O O
177 pt's NN B-NP O
178 breathing NN I-NP O
178 was VBD B-VP O
178 improved VBN O O
178 and CC O O
178 she PRP O O
178 was VBD B-VP O
178 ambulating VBG O O
178 with IN B-VP O
178 walker NN B-NP O
178 @ NNP I-NP O
178 her PRP$ O O
178 baseline NN B-NP O
179 Lungs NNPS I-NP O
179 were VBD B-VP O
179 clear JJ O O
179 and CC O O
179 pt NN B-NP O
179 still RB O O
179 had VBD B-VP O
179 BLE NNP B-NP O
179 edema NN I-NP O
179 on IN B-VP O
179 d/c NN B-NP O
180 3 CD O O
180 ) ) O O
180 GI: NNP B-NP O
180 Hx NNP I-NP O
180 of IN B-VP O
180 gallbladder NN B-NP O
180 sludge NN I-NP O
180 , , O O
180 with IN B-VP O
180 chronic JJ B-NP O
180 RUQ NNP I-NP O
180 pain NN I-NP O
180 , , O O
180 w/u NN B-NP O
180 with IN B-VP O
180 CT NNP B-NP O
180 and CC O O
181 US NNP B-NP O
181 in IN B-VP O
181 the DT O O
181 past JJ O O
181 , , O O
181 but CC O O
181 pt VBZ O O
181 not RB O O
181 surgical JJ B-NP O
181 candidate NN I-NP O
181 RUQ NNP I-NP O
181 US NNP I-NP O
181 showed VBD B-VP O
181 just RB O O
181 sludge NN B-NP O
181 , , O O
182 gallbladder NN B-NP O
182 wall NN I-NP O
182 thickened VBD B-VP O
182 8mm CD O O
182 , , O O
182 neg JJ B-NP O
182 sonographic JJ I-NP O
182 murphy's NN I-NP O
182 sign NN I-NP O
183 4 CD O O
183 ) ) O O
183 Rheum- JJ O O
183 6/26 CD O O
183 pt NN B-NP O
183 c/o NN I-NP O
183 right JJ B-NP O
183 thumb NN I-NP O
183 pain- JJ B-NP O
183 thumb NN I-NP O
183 was VBD B-VP O
184 red JJ O O
184 , , O O
184 warm JJ O O
184 , , O O
184 and CC O O
184 painful JJ O O
184 to TO O O
184 touch VB O O
184 at IN B-VP O
184 joint JJ B-NP O
184 Pt NNP I-NP O
184 has VBZ O O
184 h/o VBN O O
184 gout- NN B-NP B-r
185 was VBD B-VP O
185 started VBN O O
185 on IN B-VP O
185 motrin NN B-NP B-m
185 TID NNP I-NP B-f
186 6 CD O O
186 ) ) O O
186 Endo- NN B-NP O
186 BS NNP I-NP B-r
186 were VBD B-VP O
186 high JJ O O
186 during IN B-VP B-du
186 hospitalization NN B-NP I-du
186 and CC O O
186 insulin NN B-NP B-m
186 was VBD B-VP O
186 adjusted VBN O O
187 appropriately RB O O
187 Lantus NNP B-NP B-m
187 Lantus NNP I-NP B-m
187 increased VBD B-VP O
187 to TO O O
187 60mg CD O B-do
187 QHS NNP B-NP B-f
187 and CC O O
187 novolog RB O B-m
187 novolog RB O B-m
187 8u CD O B-do
187 QAC NNP B-NP B-f
187 QAC NNP I-NP B-f
187 and CC O O
188 sliding VBG O B-do
188 scale JJ B-NP I-do
188 Pt NNP I-NP O
188 will MD O O
188 be VB O O
188 d/c'd JJ B-NP O
188 home NN I-NP O
188 on IN B-VP O
188 lantus NN B-NP B-m
188 60u CD O B-do
188 QHS NNP B-NP B-f
188 with IN B-VP O
188 novolog JJ O B-m
189 sliding VBG O B-do
189 scale JJ O I-do
190 7 CD O O
190 ) ) O O
190 Heme- NNP B-NP O
190 Pt NNP I-NP O
190 was VBD B-VP O
190 restarted VBN O O
190 on IN B-VP O
190 coumadin NN B-NP B-m
190 5mg CD O B-do
190 po NN B-NP B-mo
190 QD NNP I-NP B-f
190 for IN B-VP O
190 DVT NNP B-NP B-r
190 on IN B-VP O
191 5/16 CD O O
191 Follow NNP B-NP O
191 up RB O O
191 INR NNP B-NP O
191 to TO O O
191 be VB O O
191 drawn VBN O O
191 on IN B-VP O
191 11/2 CD O O
191 INR NNP B-NP O
191 on IN B-VP O
191 6/26 CD O O
191 was VBD B-VP O
191 1.2 CD O O
192 FULL NNP B-NP O
192 CODE NNP I-NP O
193 ADDITIONAL NNP I-NP O
193 COMMENTS: NNP I-NP O
193 1 CD O O
193 ) ) O O
193 Primary NNP B-NP O
193 care NN I-NP O
193 follow VB O O
193 up RB O O
193 to TO O O
193 check VB O O
193 lytes NNS B-NP O
193 on IN B-VP O
193 torsemide IN B-VP B-m
194 2 CD O O
194 ) ) O O
194 INR NN B-NP O
194 checks NNS I-NP O
194 to TO O O
194 be VB O O
194 arranged VBN O O
194 by IN B-VP O
194 RMC NNP B-NP O
194 and CC O O
194 coumadin VB O B-m
194 dosing NN B-NP O
194 to TO O O
194 be VB O O
194 called VBN O O
195 into IN B-VP O
195 Ak NNP B-NP O
195 Heim NNP I-NP O
195 pharmacy NN I-NP O
196 3 CD O O
196 ) ) O O
196 Monitor NNP B-NP O
196 weight VBD B-VP O
196 2x/week CD O O
197 4 CD O O
197 ) ) O O
197 VNA NNP B-NP O
197 arranged VBD B-VP O
198 DISCHARGE NNP B-NP O
198 CONDITION: NNP I-NP O
198 Stable NNP I-NP O
199 TO NNP I-NP O
199 DO/PLAN: NNP I-NP O
200 1 CD O O
200 INR NNP B-NP O
200 to TO O O
200 be VB O O
200 checked VBN O O
200 on IN B-VP O
200 0/29 CD O O
200 ( ( O O
200 goal NN B-NP O
200 2-3 CD O O
200 ) ) O O
200 Pt NNP B-NP O
200 sent VBD B-VP O
200 home NN B-NP O
200 on IN B-VP O
200 coumadin NN B-NP B-m
200 5mg CD O B-do
200 po NN B-NP B-mo
201 QHS NNP I-NP B-f
201 INR NNP I-NP O
201 results NNS I-NP O
201 interepreted VBN O O
201 by IN B-VP O
201 NH NNP B-NP O
201 and CC O O
201 coumadin NNS B-NP B-m
201 dose VB O O
201 should MD O O
201 be VB O O
201 calle VBN O O
202 into IN B-VP O
202 A NNP B-NP O
202 Larepitbrown NNP I-NP O
202 Lyoco NNP I-NP O
202 pharmacy NN I-NP O
202 862-435-6102 JJ O O
203 2 CD O O
203 Continue NNP B-NP O
203 diuresis NN I-NP B-r
203 with IN B-VP O
203 torsemide JJ O B-m
203 100mg CD O B-do
203 twice RB O B-f
203 a DT B-NP I-f
203 day NN I-NP I-f
203 and CC O O
203 monitor NN B-NP O
204 weights NNS I-NP O
204 2x/week CD O O
204 Keep NNP B-NP O
204 legs NNS I-NP O
204 elevated VBD B-VP O
204 while IN B-VP O
204 in IN B-VP O
204 bed NN B-NP O
204 to TO O O
204 help VB O O
204 reduce VB O O
204 swelling VBG O O
205 3 CD O O
205 Please NNP B-NP O
205 make VB O O
205 follow VB O O
205 up RP O O
205 appointment NN B-NP O
205 with IN B-VP O
205 Dr NNP B-NP O
205 Danahy NNP I-NP O
205 within IN B-VP O
205 the DT O O
206 next JJ O O
206 two CD O O
206 weeks NNS B-NP O
206 You PRP O O
206 will MD O O
206 need VB O O
206 follow VB O O
206 up RP O O
206 blood NN B-NP O
206 work NN I-NP O
207 4 CD O O
207 Take NNP B-NP O
207 motrin NN I-NP B-m
207 600mg CD O B-do
207 as IN B-VP B-f
207 needed VBN O I-f
207 for IN B-VP O
207 your PRP$ O B-r
207 thumb NN B-NP I-r
207 pain NN I-NP I-r
207 Once RB O O
207 pain JJ B-NP O
207 resolves NNS I-NP O
207 , , O O
208 resume VB O O
208 taking VBG O O
208 your PRP$ O O
208 allopurinol NN B-NP B-m
208 100mg CD O B-do
208 daily NN B-NP B-f
208 for IN B-VP O
208 gout NN B-NP B-r
208 prophylaxis NN I-NP I-r
209 5 CD O O
209 Your PRP$ O O
209 lantus NN B-NP B-m
209 insulin NN I-NP I-m
209 dose NN I-NP O
209 was VBD B-VP O
209 increased VBN O O
209 to TO O O
209 60units CD O B-do
209 at IN B-VP B-f
209 night NN B-NP I-f
209 Please NNP I-NP O
210 continue VB O O
210 your PRP$ O O
210 sliding VBG O O
210 scale NN B-NP O
210 as IN B-VP O
210 usual JJ O O
211 6 CD O O
211 You PRP O O
211 no RB O O
211 longer RBR O O
211 need VB O O
211 procrit RB O O
211 , , O O
211 as IN B-VP O
211 your PRP$ O O
211 blood NN B-NP O
211 levels NNS I-NP O
211 were VBD B-VP O
211 within IN B-VP O
211 normal JJ B-NP O
212 range NN I-NP O
212 Follow NNP I-NP O
212 up RP O O
212 with IN B-VP O
212 your PRP$ O O
212 PCP NNP B-NP O
212 for IN B-VP O
212 bloodwork NN B-NP O
212 monitoring NN I-NP O
213 7 CD O O
213 Contact NNP B-NP O
213 your PRP$ O O
213 primary JJ B-NP O
213 care NN I-NP O
213 provider NN I-NP O
213 or CC O O
213 come VBN O O
213 to TO O O
213 the DT B-NP O
213 emergency NN I-NP O
213 room NN I-NP O
213 if IN B-VP O
214 you PRP O O
214 experience VBP O O
214 difficulty NN B-NP O
214 breathing NN I-NP O
214 , , O O
214 chest NN B-NP O
214 pain NN I-NP O
214 , , O O
214 or CC O O
214 fever RB O O
215 No RB O O
215 dictated JJ B-NP O
215 summary NN I-NP O
216 ENTERED NNP I-NP O
216 BY: NNP I-NP O
216 FLY NNP I-NP O
216 , , O O
216 RENATO NNP B-NP O
216 T NNP I-NP O
216 ( ( O O
216 GN51 NNP B-NP O
216 ) ) O O
216 1/29/05 CD O O
216 @ $ O O
216 01:29 CD O O
216 PM NNP B-NP O
217 ****** JJ B-NP O
217 END NNP I-NP O
217 OF NNP I-NP O
217 DISCHARGE NNP I-NP O
217 ORDERS NNP I-NP O
217 ****** NNP I-NP O
218 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #941507 VBZ O O
2 333596015 CD O O
2 NAFCH NNP B-NP O
2 64068685 CD O O
2 8123326 CD O O
2 1/21/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 chronic JJ B-NP O
2 cough NN I-NP O
2 , , O O
2 LBBB NNP B-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 7/24/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 0/25/2006 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 SARP NNP I-NP O
5 , , O O
5 TYRONE NNP B-NP O
5 L NNP I-NP O
5 306-51-94-4 JJ B-NP O
6 Pla NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 8/2/06 CD O O
8 AT NNP B-NP O
8 12:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 ESCOBEDO NNP I-NP O
11 , , O O
11 FRANK NNP B-NP O
11 JULIUS NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 LIPITOR NNP I-NP B-m
16 ( ( O I-m
16 ATORVASTATIN NNP B-NP I-m
16 ) ) O I-m
16 40 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 DAILY NNP I-NP B-f
17 Alert NNP I-NP O
17 overridden: NNP I-NP O
17 Override NNP I-NP O
17 added VBD B-VP O
17 on IN B-VP O
17 8/2/06 CD O O
17 by IN B-VP O
17 : : O O
18 POTENTIALLY NNP B-NP O
18 SERIOUS NNP I-NP O
18 INTERACTION: NNP I-NP O
18 AZITHROMYCIN NNP I-NP B-m
18 &amp; NNP I-NP O
19 ATORVASTATIN NNP I-NP B-m
19 CALCIUM NNP I-NP I-m
19 Reason NNP I-NP O
19 for IN B-VP O
19 override: NN B-NP O
20 will MD O O
20 be VB O O
20 monitored VBN O O
20 by IN B-VP O
20 PCP NNP B-NP O
21 AZITHROMYCIN NNP I-NP B-m
21 250 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 DAILY NNP I-NP B-f
21 X NNP I-NP B-du
21 3 CD O I-du
21 doses NNS B-NP I-du
22 Starting VBG O O
22 IN NNP B-NP O
22 AM NNP I-NP O
22 ( ( O O
22 7/9 CD O O
22 ) ) O O
22 Food/Drug NNP B-NP O
22 Interaction NNP I-NP O
22 Instruction NNP I-NP O
23 Avoid NNP I-NP O
23 antacids NNS I-NP O
23 Take VBP O O
23 with IN B-VP O
23 food NN B-NP O
24 Alert NNP I-NP O
24 overridden: NNP I-NP O
24 Override NNP I-NP O
24 added VBD B-VP O
24 on IN B-VP O
24 8/15/06 CD O O
24 by IN B-VP O
25 DZIUBAN NNP B-NP O
25 , , O O
25 GERMAN NNP B-NP O
25 W NNP I-NP O
25 , , O O
25 M.D NNP B-NP O
26 SERIOUS NNP I-NP O
26 INTERACTION: NNP I-NP O
26 SIMVASTATIN NNP I-NP B-m
26 &amp; NNP I-NP O
26 AZITHROMYCIN NNP I-NP B-m
27 POTENTIALLY NNP I-NP O
27 SERIOUS NNP I-NP O
27 INTERACTION: NNP I-NP O
27 SIMVASTATIN NNP I-NP B-m
27 &amp; NNP I-NP O
27 AZITHROMYCIN NNP I-NP B-m
28 Reason NNP I-NP O
28 for IN B-VP O
28 override: NN B-NP O
28 will MD O O
28 monitor VB O O
29 ECASA NNP B-NP B-m
29 325 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 DAILY NNP I-NP B-f
30 FLONASE NNP I-NP B-m
30 NASAL NNP I-NP I-m
30 SPRAY NNP I-NP I-m
30 ( ( O I-m
30 FLUTICASONE NNP B-NP I-m
30 NASAL NNP I-NP I-m
30 SPRAY NNP I-NP I-m
30 ) ) O I-m
31 2 CD O B-do
31 SPRAY NNP B-NP I-do
31 NA NNP I-NP B-mo
31 DAILY NNP I-NP B-f
32 Number NNP I-NP B-du
32 of IN B-VP I-du
32 Doses NNP B-NP I-du
32 Required NNP I-NP I-du
32 ( ( O I-du
32 approximate JJ B-NP I-du
32 ): NN I-NP I-du
32 6 CD O I-du
33 LANTUS NNP B-NP B-m
33 ( ( O I-m
33 INSULIN NNP B-NP I-m
33 GLARGINE NNP I-NP I-m
33 ) ) O I-m
33 100 CD O B-do
33 UNITS NNP B-NP I-do
33 SC NNP I-NP B-mo
33 DAILY NNP I-NP B-f
34 HUMALOG NNP I-NP B-m
34 INSULIN NNP I-NP I-m
34 ( ( O I-m
34 INSULIN NNP B-NP I-m
34 LISPRO NNP I-NP I-m
34 ) ) O I-m
34 12 CD O B-do
34 UNITS NNP B-NP I-do
34 SC NNP I-NP B-mo
34 AC NNP I-NP B-f
35 COMBIVENT NNP I-NP B-m
35 ( ( O I-m
35 IPRATROPIUM NNP B-NP I-m
35 AND NNP I-NP I-m
35 ALBUTEROL NNP I-NP I-m
35 SULFATE NNP I-NP I-m
35 ) ) O I-m
36 2 CD O B-do
36 PUFF NNP B-NP I-do
36 INH NNP I-NP B-mo
36 QID NNP I-NP O
36 Starting VBG O O
36 Today NNP B-NP O
36 ( ( O O
36 5/25 CD O O
36 ) ) O O
36 PRN NNP B-NP O
36 Wheezing NNP I-NP B-r
37 Instructions: NNP I-NP O
37 use NN I-NP O
37 with IN B-VP O
37 a DT B-NP O
37 spacer NN I-NP O
38 LORATADINE NNP I-NP B-m
38 10 CD O B-do
38 MG NNP B-NP I-do
38 PO NNP I-NP B-mo
38 DAILY NNP I-NP B-f
38 Starting VBG O O
38 Today NNP B-NP O
38 ( ( O O
38 5/25 CD O O
38 ) ) O O
39 Instructions: IN B-VP O
39 you PRP O O
39 can MD O O
39 buy VB O O
39 the DT O O
39 over IN B-VP O
39 the DT B-NP O
39 counter JJ I-NP O
39 version NN I-NP O
39 of IN B-VP O
40 this DT B-NP B-m
40 medication NN I-NP I-m
40 Food/Drug NNP I-NP O
40 Interaction NNP I-NP O
40 Instruction NNP I-NP O
41 Avoid NNP I-NP O
41 grapefruit NN I-NP O
41 unless IN B-VP O
41 MD NNP B-NP O
41 instructs NNS I-NP O
41 otherwise RB O O
42 Give VBP O O
42 on IN B-VP O
42 an DT B-NP O
42 empty JJ I-NP O
42 stomach NN I-NP O
42 ( ( O O
42 give JJ O O
42 1hr CD O O
42 before IN B-VP O
42 or CC O O
42 2hr CD O O
42 after IN B-VP O
43 food NN B-NP O
43 ) ) O O
44 METFORMIN NNP B-NP B-m
44 1 CD O B-do
44 , , O I-do
44 000 CD O I-do
44 MG NNP B-NP I-do
44 PO NNP I-NP B-mo
44 BID NNP I-NP B-f
45 PRILOSEC NNP I-NP B-m
45 ( ( O I-m
45 OMEPRAZOLE NNP B-NP I-m
45 ) ) O I-m
45 20 CD O B-do
45 MG NNP B-NP I-do
45 PO NNP I-NP B-mo
45 DAILY NNP I-NP B-f
46 Starting VBG O O
46 Today NNP B-NP O
46 ( ( O O
46 5/25 CD O O
46 ) ) O O
47 Instructions: IN B-VP O
47 You PRP O O
47 can MD O O
47 by IN B-VP O
47 the DT O O
47 over IN B-VP O
47 the DT B-NP O
47 counter JJ I-NP O
47 version NN I-NP O
47 of IN B-VP O
48 prilosec NN B-NP B-m
49 DIOVAN NNP I-NP B-m
49 ( ( O I-m
49 VALSARTAN NNP B-NP I-m
49 ) ) O I-m
49 160 CD O B-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 DAILY NNP I-NP B-f
50 Override NNP I-NP O
50 Notice: NNP I-NP O
50 Override NNP I-NP O
50 added VBD B-VP O
50 on IN B-VP O
50 8/15/06 CD O O
50 by IN B-VP O
51 NAUMANN NNP B-NP O
51 , , O O
51 CLAIR NNP B-NP O
51 L NNP I-NP O
51 , , O O
51 M.D NNP B-NP O
52 on IN B-VP O
52 order NN B-NP O
52 for IN B-VP O
52 POTASSIUM NNP B-NP B-m
52 CHLORIDE NNP I-NP I-m
52 IMMED NNP I-NP I-m
52 REL NNP I-NP I-m
52 PO NNP I-NP B-mo
52 ( ( O O
52 ref JJ O O
52 # # O O
53 845941861 CD O O
53 ) ) O O
54 POTENTIALLY NNP B-NP O
54 SERIOUS NNP I-NP O
54 INTERACTION: NNP I-NP O
54 VALSARTAN NNP I-NP B-m
54 &amp; NNP I-NP O
54 POTASSIUM NNP I-NP B-m
55 CHLORIDE NNP I-NP O
55 Reason NNP I-NP O
55 for IN B-VP O
55 override: NN B-NP O
55 will MD O O
55 monitor VB O O
56 Number NNP B-NP O
56 of IN B-VP O
56 Doses NNP B-NP O
56 Required NNP I-NP O
56 ( ( O O
56 approximate JJ B-NP O
56 ): NN I-NP O
56 6 CD O O
57 DIET: NNP B-NP O
57 House NNP I-NP O
57 / VBD B-VP O
57 Low NNP B-NP O
57 chol/low NN I-NP O
57 sat VBD B-VP O
57 fat JJ B-NP O
58 DIET: NNP I-NP O
58 House NNP I-NP O
58 / NNP I-NP O
58 ADA NNP I-NP O
58 2100 CD O O
58 cals/dy NN B-NP O
59 DIET: NNP I-NP O
59 2 CD O O
59 gram NN B-NP O
59 Sodium NNP I-NP O
60 ACTIVITY: NNP I-NP O
60 Resume NNP I-NP O
60 regular JJ B-NP O
60 exercise NN I-NP O
61 FOLLOW NNP I-NP O
61 UP NNP I-NP O
61 APPOINTMENT( NNP I-NP O
61 S NNP I-NP O
61 ): NNP I-NP O
62 Dr NNP I-NP O
62 Teskey NNP I-NP O
62 063-074-7637 JJ B-NP O
62 call NN I-NP O
62 to TO O O
62 make VB O O
62 appt NN B-NP O
62 at IN B-VP O
62 your PRP$ O O
62 convenience NN B-NP O
62 1-2 JJ B-NP O
62 weeks NNS I-NP O
62 , , O O
63 ALLERGY: NNP B-NP O
63 NKA NNP I-NP O
64 ADMIT NNP I-NP O
64 DIAGNOSIS: NNP I-NP O
65 chronic JJ B-NP O
65 cough NN I-NP O
65 , , O O
65 atypical JJ B-NP O
65 chest NN I-NP O
65 pain NN I-NP O
66 PRINCIPAL NNP I-NP O
66 DISCHARGE NNP I-NP O
66 DIAGNOSIS NNP I-NP O
66 ;Responsible JJ O O
66 After IN B-VP O
66 Study NNP B-NP O
66 for IN B-VP O
66 Causing NNP B-NP O
66 Admission NNP I-NP O
66 ) ) O O
67 chronic JJ B-NP O
67 cough NN I-NP O
67 , , O O
67 LBBB NNP B-NP O
68 OTHER NNP I-NP O
68 DIAGNOSIS;Conditions NNP I-NP O
68 , , O O
68 Infections NNP B-NP O
68 , , O O
68 Complications NNP B-NP O
68 , , O O
68 affecting VBG O O
68 Treatment/Stay NNP B-NP O
69 htn NN I-NP O
69 iddm NN I-NP O
69 CRI NNP I-NP O
69 Colon NNP I-NP O
69 CA NNP I-NP O
69 Prostate NNP I-NP O
69 CA NNP I-NP O
69 hyperchol NN I-NP O
69 otitis NN I-NP O
69 externa VBP O O
69 bullous JJ B-NP O
70 myringitis NN I-NP O
71 OPERATIONS NNP I-NP O
71 AND NNP I-NP O
71 PROCEDURES: NNP I-NP O
72 none NN I-NP O
73 OTHER NNP I-NP O
73 TREATMENTS/PROCEDURES NNP I-NP O
73 ( ( O O
73 NOT NNP B-NP O
73 IN NNP I-NP O
73 O.R NNP I-NP O
73 ) ) O O
74 none NN B-NP O
75 BRIEF NNP I-NP O
75 RESUME NNP I-NP O
75 OF NNP I-NP O
75 HOSPITAL NNP I-NP O
75 COURSE: NNP I-NP O
76 CC: NNP I-NP O
76 upper JJ B-NP O
76 respiratory NN I-NP O
76 sx NN I-NP O
77 ************************** NNP I-NP O
78 HPI: NNP I-NP O
78 63 CD O O
78 yo NN B-NP O
78 M NNP I-NP O
78 w/hx NN I-NP O
78 of IN B-VP O
78 IDDM NNP B-NP O
78 , , O O
78 HTN NNP B-NP O
78 , , O O
78 hyperchol NN B-NP O
78 , , O O
78 obesity NN B-NP O
78 p/w NN I-NP O
78 URI NNP I-NP O
78 sx VBD B-VP O
78 4 CD O O
78 wks NN B-NP O
79 chronic JJ B-NP O
79 productive JJ I-NP O
79 cough NN I-NP O
79 , , O O
79 rhinorrhea NN B-NP O
79 , , O O
79 sensation NN B-NP O
79 of IN B-VP O
79 nasal NN B-NP O
79 discharge VBP O O
80 down RP O O
80 back RB O O
80 of IN B-VP O
80 throat NN B-NP O
80 Also RB O O
80 w/assoc JJ B-NP O
80 episode NN I-NP O
80 of IN B-VP O
80 mild JJ B-NP O
80 CP NNP I-NP O
80 2 CD O O
80 days NNS B-NP O
81 2 CD O O
81 episodes NNS B-NP O
81 of IN B-VP O
81 CP NNP B-NP O
81 assoc NN I-NP O
81 w/cough NN I-NP O
81 , , O O
81 lasting VBG O O
81 min NN B-NP O
81 , , O O
81 did VBD B-VP O
81 not RB O O
81 occur JJ B-NP O
82 w/exertion NN I-NP O
82 , , O O
82 no DT B-NP O
82 SOB NNP I-NP O
82 , , O O
82 no DT B-NP O
82 N/V/diaphoresis NNP I-NP O
82 , , O O
82 resolved VBD B-VP O
82 spontaneously RB O O
83 Presented VBN O O
83 to TO O O
83 ED NNP B-NP O
83 2/2 CD O O
83 cough NN B-NP O
83 which WDT O O
83 was VBD B-VP O
83 keeping VBG O O
83 him PRP O O
83 up RP O O
83 at IN B-VP O
83 night NN B-NP O
83 No NNP I-NP O
84 F/C/SOB/DOE/PND/orthopnea NNP I-NP O
84 No NNP I-NP O
84 LE NNP I-NP O
84 edema VBZ O O
84 Able JJ O O
84 to TO O O
84 walk VB O O
84 3-4 JJ B-NP O
84 miles NNS I-NP O
84 2-3 JJ B-NP O
85 times NNS I-NP O
85 per IN B-VP O
85 wk NN B-NP O
85 w/ VBP O O
85 exertional JJ B-NP O
85 symptoms NNS I-NP O
85 Noted VBD B-VP O
85 to TO O O
85 have VB O O
85 LBBB NNP B-NP O
85 that WDT O O
85 was VBD B-VP O
85 new JJ O O
86 from IN B-VP O
86 last JJ B-NP O
86 ekg NN I-NP O
86 done VBN O O
86 12 CD O O
86 yrs NN B-NP O
86 ago RB O O
86 , , O O
86 admitted VBD B-VP O
86 for IN B-VP O
86 ROMI NNP B-NP O
87 *************************** NNP I-NP O
88 PMH: NNP I-NP O
88 as IN B-VP O
88 above IN B-VP O
88 , , O O
88 colon NN B-NP O
88 CA NNP I-NP O
88 s/p VBZ O O
88 partial JJ B-NP O
88 colectomy NN I-NP O
88 1992 CD O O
88 , , O O
88 prostate NN B-NP O
88 CA NNP I-NP O
88 s/p NN I-NP O
89 XRT NNP I-NP O
89 ( ( O O
89 dx JJ O O
89 6 CD O O
89 yrs NN B-NP O
89 ago RB O O
89 ) ) O O
89 , , O O
89 CRI NNP B-NP O
89 ( ( O O
89 Cr NNP B-NP O
89 1.0-1.9 CD O O
89 ) ) O O
89 2/2 CD O O
89 htn NN B-NP O
89 , , O O
89 dm; NN B-NP O
90 LBP NNP I-NP O
91 *************************** NNP I-NP O
92 MEDS: NNP I-NP O
92 diovan NN I-NP B-m
92 , , O O
92 asa NN B-NP B-m
92 , , O O
92 lisinopril NN B-NP B-m
92 , , O O
92 lipitor NN B-NP B-m
92 , , O O
92 metformin NN B-NP B-m
92 , , O O
92 lantus NN B-NP B-m
92 , , O O
93 humalog NN B-NP B-m
94 *************************** NNP I-NP O
95 STUDIES: NNP I-NP O
95 LABS: NNP I-NP O
95 nl MD O O
95 chem7 VB O O
95 , , O O
95 nl FW O O
95 CBC NNP B-NP O
95 , , O O
95 neg JJ B-NP O
95 cardiac JJ I-NP O
96 enzymes NNS I-NP O
96 x3 VBP O O
96 CXR: NNP B-NP O
96 no DT B-NP O
96 acute JJ I-NP O
97 process NN I-NP O
98 **************************** NNP I-NP O
99 HOSPITAL NNP I-NP O
99 COURSE: NNP I-NP O
99 63M CD O O
99 w/ NN B-NP O
99 hx NN I-NP O
99 of IN B-VP O
99 DM NNP B-NP O
99 , , O O
99 HTN NNP B-NP O
99 , , O O
99 obesity NN B-NP O
99 , , O O
99 hyperlipidemia NN B-NP O
99 a/w NN I-NP O
100 chest NN I-NP O
100 pain NN I-NP O
100 2 CD O O
100 d NN B-NP O
100 ago RB O O
100 atypical JJ O O
100 of IN B-VP O
100 cardiac JJ B-NP O
100 etiology NN I-NP O
100 with IN B-VP O
100 LBBB NNP B-NP O
100 from IN B-VP O
100 last JJ B-NP O
101 ekg NN I-NP O
101 in IN B-VP O
101 1994 CD O O
101 C/V: NNP B-NP O
102 I: NNP I-NP O
102 hx VBD B-VP O
102 very RB O O
102 atypical JJ O O
102 of IN B-VP O
102 cardiac JJ B-NP O
102 chest NN I-NP O
102 pain NN I-NP O
102 , , O O
102 more RBR O O
102 likely JJ O O
102 related VBN O O
102 to TO O O
103 cough VB O O
103 Given NNP B-NP O
103 LBBB NNP I-NP O
103 , , O O
103 cardiac JJ B-NP O
103 enzymes NNS I-NP O
103 were VBD B-VP O
103 checked VBN O O
103 and CC O O
103 were VBD B-VP O
103 negative JJ O O
103 x JJ O O
103 3 CD O O
104 ( ( O O
104 would MD O O
104 have VB O O
105 expected VBN O O
105 + JJ B-NP O
105 enzymes NNS I-NP O
105 on IN B-VP O
105 initial JJ B-NP O
105 set NN I-NP O
105 if IN B-VP O
105 ischemia NN B-NP O
105 was VBD B-VP O
105 present JJ O O
105 given VBN O O
105 pain NN B-NP O
105 was VBD B-VP O
106 &gt;24 JJ B-NP O
106 hrs NN I-NP O
106 prior RB O O
106 to TO O O
106 presentation NN B-NP O
106 ) ) O O
106 Lipid NNP B-NP O
106 panel NN I-NP O
106 shows VBZ O O
106 LDL NNP B-NP O
106 at IN B-VP O
106 goal NN B-NP O
106 for IN B-VP O
107 diabetic; NN B-NP O
107 HDL NNP I-NP O
107 slightly RB O O
107 low JJ O O
107 but CC O O
107 can MD O O
107 be VB O O
107 followed VBN O O
107 up RP O O
107 by IN B-VP O
107 PCP NNP B-NP O
107 Cont NNP I-NP O
107 ASA NNP I-NP B-m
107 and CC O O
108 statin JJ B-NP B-m
108 Consider NNP I-NP O
108 outpt MD O O
108 ETT-mibi NNP B-NP O
108 ( ( O O
108 LBBB NNP B-NP O
109 precludes VBZ O O
109 simple JJ B-NP O
109 ETT NNP I-NP O
109 ) ) O O
109 , , O O
109 but CC O O
109 will MD O O
109 defer VB O O
109 to TO O O
109 PCP VB O O
109 at IN B-VP O
109 this DT B-NP O
109 point NN I-NP O
109 P: NNP I-NP O
109 Cont NNP I-NP O
109 home NN I-NP O
110 anti-htnsive JJ B-NP B-m
110 regimen NNS I-NP I-m
110 No DT B-NP O
110 sx NN I-NP O
110 of IN B-VP O
110 CHF NNP B-NP O
111 to TO O O
111 warrant VB O O
111 echo NN B-NP O
111 at IN B-VP O
111 this DT B-NP O
112 time NN I-NP O
112 R: NNP I-NP O
112 new JJ B-NP O
112 LBBB NNP I-NP O
112 since IN B-VP O
112 last JJ O O
112 ekg JJ O O
112 12 CD O O
112 yrs NN B-NP O
112 ago RB O O
112 , , O O
112 no DT B-NP O
112 events NNS I-NP O
112 on IN B-VP O
112 tele NN B-NP O
113 Pulm/Chronic NNP I-NP O
113 Cough: NNP I-NP O
113 Most NNP I-NP O
113 likely JJ B-NP O
113 gerd NN I-NP O
113 v NN I-NP O
113 PND NNP I-NP O
113 v NN I-NP O
114 bronchitis NN I-NP O
114 Given NNP I-NP O
114 sx VBD B-VP O
114 worse JJR O O
114 at IN B-VP O
114 night NN B-NP O
114 , , O O
114 may MD O O
114 have VB O O
114 GERD NNP B-NP B-r
114 component NN I-NP O
114 given VBN O O
115 body NN B-NP O
115 habitus- JJ B-NP O
115 trial NN I-NP O
115 of IN B-VP O
115 PPI NNP B-NP B-m
115 Given NNP I-NP O
115 sx VBD B-VP O
115 for IN B-VP O
115 1 CD O O
115 mo NN B-NP O
115 , , O O
115 started VBD B-VP O
115 on IN B-VP O
115 z-pak NN B-NP B-m
116 Added NNP I-NP O
116 flonase NN I-NP B-m
116 and CC O O
116 loratidine NN B-NP B-m
116 for IN B-VP O
116 PND NNP B-NP B-r
116 PND NNP I-NP B-r
116 Inhalers NNP I-NP B-m
116 for IN B-VP O
117 wheezing VBG O B-r
117 prn NN B-NP B-f
117 ( ( O O
117 improved VBN O O
117 prior RB O O
117 to TO O O
117 d/c VB O O
117 ) ) O O
117 ENDO: NNP B-NP O
117 cont NN I-NP O
117 home NN I-NP O
118 regimen NNS I-NP O
118 ONC: NNP I-NP O
118 no DT B-NP O
118 active JJ I-NP O
118 inpatient NN I-NP O
119 issues NNS I-NP O
119 RENAL: NNP I-NP O
119 at IN B-VP O
119 baseline JJ B-NP O
120 creatinine NN I-NP O
120 FEN: NNP I-NP O
120 cardiac NN I-NP O
120 , , O O
120 diabetic JJ O O
120 , , O O
121 diet JJ B-NP O
121 PROPHY: NNP I-NP O
121 lovenox NN I-NP B-m
121 , , O O
122 nexium JJ B-NP B-m
122 nexium NN I-NP B-m
122 CODE: NNP I-NP O
123 full JJ B-NP O
123 DISPO: NNP I-NP O
123 f/u NN I-NP O
123 w/ NN I-NP O
123 PCP NNP I-NP O
123 for IN B-VP O
123 poss NN B-NP O
123 outpt NN I-NP O
124 stress NN I-NP O
124 imaging VBG O O
125 ADDITIONAL NNP B-NP O
125 COMMENTS: NNP I-NP O
126 DISCHARGE NNP I-NP O
126 CONDITION: NNP I-NP O
126 Stable NNP I-NP O
127 TO NNP I-NP O
127 DO/PLAN: NNP I-NP O
128 1 CD O O
128 ) ) O O
128 Follow NNP B-NP O
128 up RP O O
128 with IN B-VP O
128 Dr NNP B-NP O
128 Kreager NNP I-NP O
128 he PRP O O
128 can MD O O
128 decide VB O O
128 to TO O O
128 have VB O O
128 you PRP O O
128 undergo VBP O O
128 a DT B-NP O
128 stress JJ I-NP O
129 test NN I-NP O
129 as IN B-VP O
129 an DT O O
129 outpatient JJ O O
129 2 CD O O
129 ) ) O O
129 Take VB O O
129 your PRP$ O B-m
129 medications NNS B-NP I-m
129 as IN B-VP O
129 directed JJ B-NP O
130 No NNP I-NP O
130 dictated VBD B-VP O
130 summary JJ B-NP O
131 ENTERED NNP I-NP O
131 BY: NNP I-NP O
131 PIH NNP I-NP O
131 , , O O
131 DEANDRE NNP B-NP O
131 B NNP I-NP O
131 , , O O
131 M.D NNP B-NP O
131 ( ( O O
131 CS01 NNP B-NP O
131 ) ) O O
131 8/2/06 CD O O
131 @ $ O O
131 11 CD O O
132 ****** JJ B-NP O
132 END NN I-NP O
132 OF NNP I-NP O
132 DISCHARGE NNP I-NP O
132 ORDERS NNP I-NP O
132 ****** NNP I-NP O
133 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #942556 VBZ O O
4 152184884 CD O O
4 ESHMC NNP B-NP O
4 03895233 CD O O
4 3083193 CD O O
4 8/2/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Coronary NNP I-NP O
4 artery NN I-NP O
4 disease NN I-NP O
4 414.01 CD O O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/29/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 4/25/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 MCLYMAN NNP I-NP O
8 , , O O
8 ANDREAS NNP B-NP O
8 764-41-05-5 CD O O
9 Pervgle NNP B-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 7/24/06 CD O O
11 AT NNP B-NP O
11 02:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Attending NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 FERGE NNP I-NP O
14 , , O O
14 WALLY NNP B-NP O
14 E NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ENTERIC NNP I-NP B-m
19 COATED NNP I-NP I-m
19 ASA NNP I-NP I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 TESSALON NNP I-NP B-m
20 PERLES NNP I-NP I-m
20 ( ( O I-m
20 BENZONATATE NNP B-NP I-m
20 ) ) O I-m
20 100 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 TID NNP I-NP B-f
21 PRN NNP I-NP O
21 Shortness NNP I-NP B-r
21 of IN B-VP I-r
21 Breath NNP B-NP I-r
22 Number NNP I-NP B-du
22 of IN B-VP I-du
22 Doses NNP B-NP I-du
22 Required NNP I-NP I-du
22 ( ( O I-du
22 approximate JJ B-NP I-du
22 ): NN I-NP I-du
22 6 CD O I-du
23 PLAVIX NNP B-NP B-m
23 ( ( O I-m
23 CLOPIDOGREL NNP B-NP I-m
23 ) ) O I-m
23 75 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 DAILY NNP I-NP B-f
24 Starting NNP I-NP O
24 IN NNP I-NP O
24 AM NNP I-NP O
24 ( ( O O
24 6/9 CD O O
24 ) ) O O
25 CODEINE NNP B-NP B-m
25 PHOSPHATE NNP I-NP I-m
25 15 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 Q3H NNP I-NP B-f
25 PRN NNP I-NP I-f
25 Pain NNP I-NP B-r
26 HOLD NNP I-NP O
26 IF: NNP I-NP O
26 sedated VBD B-VP O
26 , , O O
26 rr&lt;12 VB O O
27 DEXTROMETHORPHAN NNP B-NP B-m
27 HBR NNP I-NP I-m
27 10 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 Q6H NNP I-NP B-f
27 PRN NNP I-NP I-f
27 Other:cough NNP I-NP B-r
28 HOLD NNP I-NP O
28 IF: NNP I-NP O
28 sedated VBD B-VP O
28 , , O O
28 rr&lt;12 JJ B-NP O
29 Number NNP I-NP O
29 of IN B-VP O
29 Doses NNP B-NP O
29 Required NNP I-NP O
29 ( ( O O
29 approximate JJ B-NP O
29 ): NN I-NP O
29 6 CD O O
30 ZETIA NNP B-NP B-m
30 ( ( O I-m
30 EZETIMIBE NNP B-NP I-m
30 ) ) O I-m
30 10 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 DAILY NNP I-NP B-f
31 LANTUS NNP I-NP B-m
31 ( ( O I-m
31 INSULIN NNP B-NP I-m
31 GLARGINE NNP I-NP I-m
31 ) ) O I-m
31 20 CD O B-do
31 UNITS NNP B-NP I-do
31 SC NNP I-NP B-mo
31 BEDTIME NNP I-NP B-f
32 HOLD NNP I-NP O
32 IF: NNP I-NP O
32 call VB O O
32 HO NNP B-NP O
32 if IN B-VP O
32 BG NNP B-NP O
32 &lt;90 NNP I-NP O
33 POTASSIUM NNP I-NP B-m
33 CHLORIDE NNP I-NP I-m
33 IMMED NNP I-NP I-m
33 REL NNP I-NP I-m
33 ( ( O I-m
33 KCL NNP B-NP I-m
33 IMMEDIATE NNP I-NP I-m
33 ) ) O I-m
34 *** VBD B-VP O
34 LOW NNP B-NP O
34 KCL NNP I-NP O
34 REPLACEMENT NNP I-NP O
34 SCALE NNP I-NP O
34 ORAL NNP I-NP O
34 PO NNP I-NP O
34 Scale NNP I-NP O
34 Frequency NNP I-NP O
35 1.Only CD O O
35 KCL NNP B-NP B-m
35 Immediate NNP I-NP I-m
35 Release NNP I-NP I-m
35 products NNS I-NP O
35 may MD O O
35 be VB O O
35 used VBN O O
35 for IN B-VP O
35 KCL NNP B-NP B-m
36 scales NNS I-NP O
37 2.Do CD O O
37 not RB O O
37 use VB O O
37 sustained-release JJ B-NP O
37 potassium NN I-NP O
37 for IN B-VP O
37 KCL NNP B-NP O
37 scale NN I-NP O
38 doses VBZ O O
38 3.Replace CD O O
38 KCL NNP B-NP O
38 based VBN O O
38 on IN B-VP O
38 lab NN B-NP O
38 values NNS I-NP O
39 4.As CD O O
39 per IN B-VP O
39 SMH NNP B-NP O
39 Potassium NNP I-NP B-m
39 Chloride NNP I-NP I-m
39 Policy: NNP I-NP O
39 each DT O O
39 20 CD O B-do
39 mEq NN B-NP I-do
39 dose NN I-NP O
40 is VBZ O O
40 to TO O O
40 be VB O O
40 given VBN O O
40 with IN B-VP O
40 4oz CD O O
40 of IN B-VP O
40 fluid NN B-NP O
41 5.A CD O O
41 serum NN B-NP O
41 creatinine NN I-NP O
41 must MD O O
41 be VB O O
41 ordered VBN O O
41 and CC O O
41 checked VBN O O
41 daily RB O O
42 while IN B-VP O
42 patient NN B-NP O
42 is VBZ O O
42 ordered VBN O O
42 for IN B-VP O
42 a DT B-NP O
42 K-scale JJ I-NP O
43 6.K-scale JJ I-NP O
43 cannot NN I-NP O
43 be VB O O
43 used VBN O O
43 on IN B-VP O
43 patients NNS B-NP O
43 with: JJ O O
44 * VBP O O
44 A DT B-NP O
44 serum NN I-NP O
44 creatinine NN I-NP O
44 greater JJR O O
44 than IN B-VP O
44 or CC O O
44 equal JJ O O
44 to TO O O
44 2.0 CD O O
44 mg/dl; NN B-NP O
44 or CC O O
45 * VB O O
45 A DT B-NP O
45 serum NN I-NP O
45 creatinine JJ B-NP O
45 increase NN I-NP O
45 of IN B-VP O
45 0.5 CD O O
45 mg/dl NNS B-NP O
45 within IN B-VP O
45 24 CD O O
46 hours NNS B-NP O
47 * VBP O O
47 Hold NNP B-NP O
47 scale NN I-NP O
47 and CC O O
47 contact NN B-NP O
47 MD NNP I-NP O
47 if IN B-VP O
47 SCr NNP B-NP O
47 is VBZ O O
47 greater JJR O O
47 than IN B-VP O
47 2.0 CD O O
48 ----------------------------------------------------------- JJ B-NP O
49 ----------- NN I-NP O
49 If IN B-VP O
49 K+ NNP B-NP O
49 Level NNP I-NP O
49 is VBZ O O
49 less JJR O O
49 than IN B-VP O
49 3.1 CD O O
49 then RB O O
49 call VB O O
49 H.O NNP B-NP O
50 If IN B-VP O
50 K+ NNP B-NP O
50 Level NNP I-NP O
50 is VBZ O O
50 3.1-3.3 JJ O O
50 , , O O
50 then RB O O
50 administer RB O O
50 KCL NNP B-NP B-m
50 KCL NNP I-NP B-m
50 40 CD O B-do
50 meq NN B-NP I-do
50 orally RB O B-mo
51 followed VBN O O
51 by IN B-VP O
51 20 CD O B-do
52 meq NNS B-NP O
52 orally RB O B-mo
52 2 CD O O
52 hours NNS B-NP O
52 later RB O O
52 Recheck NNP B-NP O
52 K+ NNP I-NP O
52 Level NNP I-NP O
52 2 CD O O
52 hours NNS B-NP O
52 after IN B-VP O
53 dose NN B-NP O
53 was VBD B-VP O
53 given VBN O O
54 If IN B-VP O
54 K+ NNP B-NP O
54 Level NNP I-NP O
54 is VBZ O O
54 3.4-3.6 JJ O O
54 , , O O
54 then RB O O
54 administer RB O O
54 KCL NNP B-NP B-m
54 40 CD O B-do
54 meq NN B-NP I-do
54 orally RB O B-mo
55 Recheck NNP B-NP O
55 K+ NNP I-NP O
55 Level NNP I-NP O
55 2 CD O O
55 hours NNS B-NP O
55 after IN B-VP O
55 dose NN B-NP O
55 was VBD B-VP O
55 given VBN O O
56 If IN B-VP O
56 K+ NNP B-NP O
56 Level NNP I-NP O
56 is VBZ O O
56 3.7-4.0 JJ O O
56 , , O O
56 then RB O O
56 administer RB O O
56 KCL NNP B-NP B-m
56 20 CD O B-do
56 meq NN B-NP I-do
56 orally RB O B-mo
57 Recheck NNP B-NP O
57 K+ NNP I-NP O
57 Level NNP I-NP O
57 2 CD O O
57 hours NNS B-NP O
57 after IN B-VP O
57 dose NN B-NP O
57 was VBD B-VP O
57 given VBN O O
58 If IN B-VP O
58 K+ NNP B-NP O
58 Level NNP I-NP O
58 is VBZ O O
58 4.1-5.0 JJ O O
58 , , O O
58 then RB O O
58 DO NNP B-NP O
58 NOT NNP I-NP O
58 administer VB O O
58 KCL NNP B-NP B-m
59 Recheck NNP I-NP O
59 K+ NNP I-NP O
59 Level NNP I-NP O
59 in IN B-VP O
59 QAM NNP B-NP O
60 If IN B-VP O
60 K+ NNP B-NP O
60 Level NNP I-NP O
60 is VBZ O O
60 greater JJR O O
60 than IN B-VP O
60 5.0 CD O O
60 then RB O O
60 call VB O O
60 H.O NNP B-NP O
61 ----------------------------------------------------------- NNP I-NP O
62 ----------- NNP I-NP O
63 Override NNP I-NP O
63 Notice: NNP I-NP O
63 Override NNP I-NP O
63 added VBD B-VP O
63 on IN B-VP O
63 7/24/06 CD O O
63 by IN B-VP O
64 MERLING NN B-NP O
64 , , O O
64 SHIRLEY NNP B-NP O
64 M NNP I-NP O
64 , , O O
64 M.D NNP B-NP O
65 on IN B-VP O
65 order NN B-NP O
65 for IN B-VP O
65 DIOVAN NNP B-NP B-m
65 PO NNP I-NP B-mo
65 ( ( O O
65 ref JJ O O
65 # # O O
65 032637277 CD O O
65 ) ) O O
66 POTENTIALLY NNP B-NP O
66 SERIOUS NNP I-NP O
66 INTERACTION: NNP I-NP O
66 POTASSIUM NNP I-NP B-m
66 CHLORIDE NNP I-NP I-m
66 &amp; NNP I-NP O
67 VALSARTAN NNP I-NP B-m
67 Reason NNP I-NP O
67 for IN B-VP O
67 override: NN B-NP O
67 aware JJ B-NP O
68 MAALOX-TABLETS NNP I-NP B-m
68 QUICK NNP I-NP I-m
68 DISSOLVE/CHEWABLE NNP I-NP I-m
68 1-2 JJ B-NP B-do
68 TAB NNP I-NP I-do
68 PO NNP I-NP B-mo
68 Q6H NNP I-NP B-f
69 PRN NNP I-NP O
69 Upset NNP I-NP B-r
69 Stomach NNP I-NP I-r
70 MAGNESIUM NNP I-NP B-m
70 GLUCONATE NNP I-NP I-m
70 Sliding NNP I-NP B-do
70 Scale NNP I-NP I-do
70 PO NNP I-NP B-mo
70 ( ( O I-mo
70 orally RB O I-mo
70 ) ) O I-mo
70 DAILY NNP B-NP B-f
71 -&gt; NNP I-NP O
71 Mg-scales NNP I-NP O
71 cannot NN I-NP O
71 be VB O O
71 used VBN O O
71 and CC O O
71 magnesium JJ B-NP B-m
71 doses NNS I-NP O
71 must MD O O
71 be VB O O
72 individualized VBN O O
72 for IN B-VP O
72 patients NNS B-NP O
72 who WP O O
72 have: VBP O O
73 - : O O
73 a DT B-NP O
73 serum JJ I-NP O
73 creatinine NN I-NP O
73 greater JJR O O
73 than IN B-VP O
73 or CC O O
73 equal JJ O O
73 to TO O O
73 2.0 CD O O
73 mg/dL; NN B-NP O
73 or CC O O
74 - : O O
74 a DT B-NP O
74 serum JJ I-NP O
74 creatinine NN I-NP O
74 greater JJR O O
74 than IN B-VP O
74 or CC O O
74 equal JJ O O
74 to TO O O
74 1.5 CD O O
74 mg/dL NN B-NP O
75 and CC O O
75 an DT B-NP O
75 increase NN I-NP O
75 of IN B-VP O
75 0.5mg/dL CD O O
75 within IN B-VP O
75 24 CD O O
75 hours NNS B-NP O
76 Call NNP I-NP O
76 HO NNP I-NP O
76 if IN B-VP O
76 Mg NNP B-NP O
76 level NN I-NP O
76 is VBZ O O
76 less JJR O O
76 than IN B-VP O
76 0.8 CD O O
77 If IN B-VP O
77 Mg NNP B-NP O
77 level NN I-NP O
77 is VBZ O O
77 less JJR O O
77 than IN B-VP O
77 1 CD O O
77 , , O O
77 then RB O O
77 give VB O O
77 3 CD O B-do
77 gm NN B-NP I-do
77 Mg NNP I-NP B-m
77 Gluconate NNP I-NP I-m
78 orally RB O B-mo
78 and CC O O
78 call VB O O
78 HO NNP B-NP O
79 If IN B-VP O
79 Mg NNP B-NP O
79 level NN I-NP O
79 is VBZ O O
79 1.0-1.5 JJ O O
79 , , O O
79 then RB O O
79 give VB O O
79 2 CD O B-do
79 gm NN B-NP I-do
79 Mg NNP I-NP B-m
79 Gluconate NNP I-NP I-m
79 orally RB O B-mo
80 If IN B-VP O
80 Mg NNP B-NP O
80 level NN I-NP O
80 is VBZ O O
80 1.6-1.9 JJ O O
80 , , O O
80 then RB O O
80 give VB O O
80 1 CD O B-do
80 gm NN B-NP I-do
80 Mg NNP I-NP B-m
80 Gluconate NNP I-NP I-m
80 orally RB O B-mo
81 If IN B-VP O
81 Mg NNP B-NP O
81 level NN I-NP O
81 is VBZ O O
81 2.0-2.5 JJ O O
81 , , O O
81 then RB O O
81 Do NNP B-NP O
81 Not RB O O
81 administer VB O O
81 Mg NNP B-NP O
82 Gluconate NNP I-NP O
82 Call NNP I-NP O
82 HO NNP I-NP O
82 if IN B-VP O
82 Mg NNP B-NP O
82 level NN I-NP O
82 is VBZ O O
82 greater JJR O O
82 than IN B-VP O
82 2.5 CD O O
83 NITROGLYCERIN JJ O B-m
83 1/150 CD O I-m
83 ( ( O I-m
83 0.4 CD O I-m
83 MG NNP B-NP I-m
83 ) ) O I-m
83 1 CD O B-do
83 TAB NNP B-NP I-do
83 SL NNP I-NP B-mo
83 q5min VBD B-VP B-f
83 x $ O B-du
83 3 CD O I-du
84 PRN NNP B-NP O
84 chest NN I-NP B-r
84 pain NN I-NP I-r
84 HOLD NNP I-NP O
84 IF: NNP I-NP O
84 SBP NNP I-NP O
84 &lt; VBD B-VP O
84 100 CD O O
85 OXYCODONE NNP B-NP B-m
85 5-10 JJ B-NP B-do
85 MG NNP I-NP I-do
85 PO NNP I-NP B-mo
85 Q6H NNP I-NP B-f
85 PRN NNP I-NP I-f
85 Pain NNP I-NP B-r
86 PINDOLOL NNP I-NP B-m
86 5 CD O B-do
86 MG NNP B-NP I-do
86 PO NNP I-NP B-mo
86 BID NNP I-NP B-f
86 HOLD NNP I-NP O
86 IF: NNP I-NP O
86 sbp&lt;90 NN I-NP O
86 , , O O
86 HR&lt;50 NNP B-NP O
87 Food/Drug NNP I-NP O
87 Interaction NNP I-NP O
87 Instruction NNP I-NP O
88 Take NNP I-NP O
88 consistently RB O O
88 with IN B-VP O
88 meals NNS B-NP O
88 or CC O O
88 on IN B-VP O
88 empty JJ B-NP O
88 stomach NN I-NP O
89 ZOCOR NNP I-NP B-m
89 ( ( O I-m
89 SIMVASTATIN NNP B-NP I-m
89 ) ) O I-m
89 80 CD O B-do
89 MG NNP B-NP I-do
89 PO NNP I-NP B-mo
89 BEDTIME NNP I-NP B-f
90 Food/Drug NNP I-NP O
90 Interaction NNP I-NP O
90 Instruction NNP I-NP O
91 Avoid NNP I-NP O
91 grapefruit NN I-NP O
91 unless IN B-VP O
91 MD NNP B-NP O
91 instructs NNS I-NP O
91 otherwise RB O O
92 DIOVAN NNP B-NP B-m
92 ( ( O I-m
92 VALSARTAN NNP B-NP I-m
92 ) ) O I-m
92 160 CD O B-do
92 MG NNP B-NP I-do
92 PO NNP I-NP B-mo
92 DAILY NNP I-NP B-f
93 Starting NNP I-NP O
93 IN NNP I-NP O
93 AM NNP I-NP O
93 ( ( O O
93 11/12 CD O O
93 ) ) O O
94 Alert NNP B-NP O
94 overridden: NNP I-NP O
94 Override NNP I-NP O
94 added VBD B-VP O
94 on IN B-VP O
94 7/24/06 CD O O
94 by IN B-VP O
95 MCCALEBB NNP B-NP O
95 , , O O
95 TYRONE NNP B-NP O
95 A NNP I-NP O
95 , , O O
95 M.D NNP B-NP O
96 POTENTIALLY NNP I-NP O
96 SERIOUS NNP I-NP O
96 INTERACTION: NNP I-NP O
96 POTASSIUM NNP I-NP B-m
96 CHLORIDE NNP I-NP I-m
96 &amp; NNP I-NP O
97 VALSARTAN NNP I-NP B-m
97 Reason NNP I-NP O
97 for IN B-VP O
97 override: NN B-NP O
97 aware JJ B-NP O
98 Number NNP I-NP O
98 of IN B-VP O
98 Doses NNP B-NP O
98 Required NNP I-NP O
98 ( ( O O
98 approximate JJ B-NP O
98 ): NN I-NP O
98 5 CD O O
99 DIET: NNP B-NP O
99 House NNP I-NP O
99 / VBD B-VP O
99 Low NNP B-NP O
99 chol/low NN I-NP O
99 sat VBD B-VP O
99 fat JJ B-NP O
100 DIET: NNP I-NP O
100 House NNP I-NP O
100 / NNP I-NP O
100 ADA NNP I-NP O
100 2100 CD O O
100 cals/dy NN B-NP O
101 DIET: NNP I-NP O
101 2 CD O O
101 gram NN B-NP O
101 Sodium NNP I-NP O
102 ACTIVITY: NNP I-NP O
102 Walking NNP I-NP O
102 as IN B-VP O
102 tolerated JJ B-NP O
103 Lift NNP I-NP O
103 restrictions: NN I-NP O
103 Do NNP I-NP O
103 not RB O O
103 lift VB O O
103 greater JJR O O
103 then RB O O
103 15 CD O O
103 pounds NNS B-NP O
104 FOLLOW NNP I-NP O
104 UP NNP I-NP O
104 APPOINTMENT( NNP I-NP O
104 S NNP I-NP O
104 ): NNP I-NP O
105 Dr NNP I-NP O
105 Muehl NNP I-NP O
105 He PRP O O
105 will MD O O
105 arrange VB O O
105 , , O O
106 ALLERGY: NNP B-NP O
106 NKA NNP I-NP O
107 ADMIT NNP I-NP O
107 DIAGNOSIS: NNP I-NP O
108 Elective NNP I-NP O
108 cardiac JJ B-NP O
108 catheterization NN I-NP O
108 with IN B-VP O
108 PCI NNP B-NP O
109 PRINCIPAL NNP I-NP O
109 DISCHARGE NNP I-NP O
109 DIAGNOSIS NNP I-NP O
109 ;Responsible JJ O O
109 After IN B-VP O
109 Study NNP B-NP O
109 for IN B-VP O
109 Causing NNP B-NP O
109 Admission NNP I-NP O
109 ) ) O O
110 Coronary NNP B-NP O
110 artery NN I-NP O
110 disease NN I-NP O
110 414.01 CD O O
111 OTHER NNP B-NP O
111 DIAGNOSIS;Conditions NNP I-NP O
111 , , O O
111 Infections NNP B-NP O
111 , , O O
111 Complications NNP B-NP O
111 , , O O
111 affecting VBG O O
111 Treatment/Stay NNP B-NP O
112 CAD NNP I-NP O
113 OPERATIONS NNP I-NP O
113 AND NNP I-NP O
113 PROCEDURES: NNP I-NP O
114 Cardiac NNP I-NP O
114 catheterization NN I-NP O
114 with IN B-VP O
114 stent NN B-NP O
114 to TO O O
114 old JJ B-NP O
114 CABG NNP I-NP O
114 vessel NN I-NP O
115 OTHER NNP I-NP O
115 TREATMENTS/PROCEDURES NNP I-NP O
115 ( ( O O
115 NOT NNP B-NP O
115 IN NNP I-NP O
115 O.R NNP I-NP O
115 ) ) O O
116 CXR NNP B-NP O
117 BRIEF NNP I-NP O
117 RESUME NNP I-NP O
117 OF NNP I-NP O
117 HOSPITAL NNP I-NP O
117 COURSE: NNP I-NP O
118 CC: NNP I-NP O
118 Elective NNP I-NP O
118 Cardiac NNP I-NP O
118 Cath NNP I-NP O
119 HPI: NNP I-NP O
119 58 CD O O
119 yo NNP B-NP O
119 female JJ B-NP O
119 smoker NN I-NP O
119 with IN B-VP O
119 hx NN B-NP O
119 of IN B-VP O
119 CAD NNP B-NP O
119 , , O O
119 s/p NN B-NP O
119 CABG NNP I-NP O
119 x3 NNP I-NP O
119 , , O O
119 DM NNP B-NP O
119 II NNP I-NP O
119 , , O O
119 HTN NNP B-NP O
119 , , O O
119 and CC O O
120 hyperlipidemia RB O O
120 admitted VBN O O
120 to TO O O
120 the DT B-NP O
120 CCU NNP I-NP O
120 after IN B-VP O
120 elective JJ B-NP O
120 cardiac JJ I-NP O
120 cath NN I-NP O
120 s/p NN I-NP O
121 abnormal JJ B-NP O
121 stress NN I-NP O
121 test NN I-NP O
121 Cath NN I-NP O
121 showed VBD B-VP O
121 impaired JJ B-NP O
121 flow NN I-NP O
121 in IN B-VP O
121 the DT O O
121 inferior JJ O O
122 and CC O O
122 posterolateral JJ B-NP O
122 zones NNS I-NP O
122 due JJ O O
122 to TO O O
122 obstructive JJ B-NP O
122 degenerative JJ I-NP O
122 disease NN I-NP O
122 in IN B-VP O
123 the DT B-NP O
123 SVGs NNP I-NP O
123 to TO O O
123 the DT B-NP O
123 RCA NNP I-NP O
123 and CC O O
123 LCF-OM NNP B-NP O
123 Stent NNP I-NP O
123 placed VBD B-VP O
123 in IN B-VP O
123 the DT B-NP O
123 RCA NNP I-NP O
123 graft NN I-NP O
123 though IN B-VP O
124 there EX O O
124 was VBD B-VP O
124 extensive JJ B-NP O
124 calcification NN I-NP O
124 and CC O O
124 difficulty NN B-NP O
125 obtaining VBG O O
125 full JJ B-NP O
125 stent NN I-NP O
125 expansion NN I-NP O
125 , , O O
125 and CC O O
125 following VBG O O
125 the DT B-NP O
125 stent JJ I-NP O
125 deployment NN I-NP O
126 there EX O O
126 was VBD B-VP O
126 poor JJ O O
126 reflow JJ O O
126 accompanied VBN O O
126 by IN B-VP O
126 mild JJ B-NP O
126 chest NN I-NP O
126 pain NN I-NP O
126 and CC O O
126 EKG NNP B-NP O
126 changes NNS I-NP O
126 , , O O
127 without IN B-VP O
127 hemodynamic JJ B-NP O
127 embarrassment NN I-NP O
127 Pt NNP I-NP O
127 was VBD B-VP O
127 transferred VBN O O
127 back RB O O
128 to TO O O
128 the DT B-NP O
128 CCU NNP I-NP O
128 stable JJ O O
128 and CC O O
128 without IN B-VP O
128 pain NN B-NP O
128 Pt NNP I-NP O
128 was VBD B-VP O
128 scheduled VBN O O
128 for IN B-VP O
128 call NN B-NP O
128 out IN B-VP O
128 to TO O O
129 floor NN B-NP O
129 , , O O
129 but CC O O
129 had VBD B-VP O
129 an DT B-NP O
129 episode NN I-NP O
129 of IN B-VP O
129 jaw NN B-NP O
129 sensation NN I-NP O
129 , , O O
129 different JJ O O
129 from IN B-VP O
129 previous JJ B-NP O
130 angina NNS I-NP O
130 Pt NNP I-NP O
130 was VBD B-VP O
130 upset VBN O O
130 by IN B-VP O
130 turn NN B-NP O
130 of IN B-VP O
130 events NNS B-NP O
130 , , O O
130 but CC O O
130 was VBD B-VP O
130 calmed VBN O O
130 by IN B-VP O
130 staff NN B-NP O
130 Was NNP I-NP O
131 then RB O O
131 evaluated VBD B-VP O
131 by IN B-VP O
131 Dr NNP B-NP O
131 Demora NNP I-NP O
131 and CC O O
131 came VBD B-VP O
131 out RB O O
131 to TO O O
131 the DT B-NP O
131 floor NN I-NP O
131 Seygo NNP I-NP O
131 No NNP I-NP O
131 Wood NNP I-NP O
131 night NN I-NP O
132 PMH NNP I-NP O
133 DMII NNP I-NP O
133 , , O O
133 HTN NNP B-NP O
133 , , O O
133 Hyperlipidemia NNP B-NP O
133 , , O O
133 Cirrhosis NNP B-NP O
133 s/p VBD B-VP O
133 CABG NNP B-NP O
133 x NNP I-NP O
133 3 CD O O
134 1997 CD O O
134 s/p NN B-NP O
134 AAA NNP I-NP O
134 repair NN I-NP O
135 1996 CD O O
135 s/p NN B-NP O
135 aorto-fem JJ B-NP O
135 bypass NN I-NP O
136 1996 CD O O
136 s/p NN B-NP O
137 TAHBSO NNP I-NP O
137 Meds NNP I-NP O
138 Lantus NNP I-NP B-m
138 40u CD O B-do
138 qd NN B-NP B-f
138 Estradiol NNP I-NP B-m
138 0.05 CD O I-m
139 Diltiazem NNP B-NP B-m
139 180 CD O B-do
139 mg NN B-NP I-do
139 qd NN I-NP B-f
139 HCTZ NNP I-NP B-m
139 25 CD O B-do
139 mg NN B-NP I-do
140 qd NN I-NP B-f
140 Zetia NNP I-NP B-m
140 10mg CD O B-do
141 qd NN B-NP B-f
141 Diovan NNP I-NP B-m
141 160 CD O B-do
141 mg NN B-NP I-do
142 qd NN I-NP B-f
142 Plavix NNP I-NP B-m
142 75 CD O B-do
142 mg NN B-NP I-do
143 qd NN I-NP B-f
143 Zocor NNP I-NP B-m
143 80 CD O B-do
143 mg NN B-NP I-do
144 qd NN I-NP B-f
144 ASA NNP I-NP B-m
144 325 CD O B-do
144 mg NN B-NP I-do
145 qd NN I-NP B-f
145 MV NNP I-NP O
146 Meds NNP I-NP O
146 in IN B-VP O
146 CCU NNP B-NP O
146 ASA NNP I-NP B-m
146 325 CD O B-do
146 mg NN B-NP I-do
146 qd NN I-NP B-f
147 Lantus NNP I-NP B-m
147 20u CD O B-do
147 qd NN B-NP B-f
147 Plavix NNP I-NP B-m
147 75 CD O B-do
147 mg NN B-NP I-do
148 qd NN I-NP B-f
148 Zetia NNP I-NP B-m
148 10mg CD O B-do
149 qd NN B-NP B-f
149 Famotidine NNP I-NP B-m
149 20 CD O B-do
149 mg NN B-NP I-do
150 BID NNP I-NP B-f
150 Pindolol NNP I-NP B-m
150 5 CD O B-do
150 mg NN B-NP I-do
151 BID NNP I-NP B-f
151 Lovenox NNP I-NP B-m
151 40 CD O B-do
151 sc NN B-NP B-mo
152 qd NN I-NP B-f
152 nicotine JJ B-NP B-m
153 patch NN I-NP O
153 MgSO4 NNP I-NP B-m
154 SS NNP I-NP B-do
154 KCL NNP I-NP B-m
154 SS NNP I-NP O
155 Novolog NNP I-NP B-m
155 SS NNP I-NP O
155 Pt NNP I-NP O
156 Status NNP I-NP O
156 Vitals NNP I-NP O
157 Gen NNP I-NP O
157 - : O O
157 Awake NNP B-NP O
157 , , O O
157 Alert NNP B-NP O
157 , , O O
157 NAD NNP B-NP O
157 HEENT NNP I-NP O
157 - : O O
157 JVP NNP B-NP O
157 6 CD O O
157 cm NN B-NP O
157 , , O O
157 No NNP B-NP O
158 bruits VBZ O O
158 Chest NNP B-NP O
158 - : O O
158 CTAB NN B-NP O
158 with IN B-VP O
158 mild JJ B-NP O
158 rhonchi/wheezes NNS I-NP O
159 R&gt;L NNP I-NP O
159 CV NNP I-NP O
159 - : O O
159 RRR NNP B-NP O
159 , , O O
159 Nml NNP B-NP O
159 S1 NNP I-NP O
159 , , O O
159 S2 NNP B-NP O
159 , , O O
159 II/VI NNP B-NP O
159 SEM NNP I-NP O
159 at IN B-VP O
160 LLSB NNP B-NP O
160 Abd NNP I-NP O
160 - : O O
160 Soft JJ O O
160 , , O O
160 NT NNP B-NP O
160 , , O O
160 ND NNP B-NP O
160 , , O O
160 No NNP B-NP O
161 organomegaly NN I-NP O
161 Extr NNP I-NP O
161 - : O O
161 L NNP B-NP O
161 femoral JJ B-NP O
161 bruit NN I-NP O
161 , , O O
161 R NNP B-NP O
161 cath NN I-NP O
161 site NN I-NP O
161 , , O O
161 oozing VBG O O
161 , , O O
161 no DT B-NP O
162 edema NN I-NP O
162 , , O O
162 hematoma NN B-NP O
162 , , O O
162 ecchymosis NN B-NP O
162 present JJ B-NP O
163 Studies NNPS I-NP O
163 CAth NNP I-NP O
163 - : O O
164 Right JJ B-NP O
164 Dominant NNP I-NP O
164 Circulation NNP I-NP O
165 Left NNP I-NP O
165 Main NNP I-NP O
165 Coronary NNP I-NP O
165 Artery NNP I-NP O
166 No NNP I-NP O
166 significant JJ B-NP O
166 LM NNP I-NP O
166 lesions NNS I-NP O
166 identified VBD B-VP O
167 Left NNP B-NP O
167 Anterior NNP I-NP O
167 Descending NNP I-NP O
167 Artery NNP I-NP O
168 LAD NNP I-NP O
168 ( ( O O
168 Proximal NNP B-NP O
168 ) ) O O
168 , , O O
168 Discrete NNP B-NP O
168 90% CD O O
168 lesion NN B-NP O
169 LAD NNP I-NP O
169 ( ( O O
169 Ostial NNP B-NP O
169 ) ) O O
169 , , O O
169 Discrete NNP B-NP O
169 90% CD O O
169 lesion NN B-NP O
170 Left NNP I-NP O
170 Circumflex NNP I-NP O
170 Artery NNP I-NP O
171 CX NNP I-NP O
171 ( ( O O
171 Proximal NNP B-NP O
171 ) ) O O
171 , , O O
171 Discrete NNP B-NP O
171 90% CD O O
171 lesion NN B-NP O
172 Right NNP I-NP O
172 Coronary NNP I-NP O
172 Artery NNP I-NP O
173 RCA NNP I-NP O
173 ( ( O O
173 Proximal NNP B-NP O
173 ) ) O O
173 , , O O
173 Discrete NNP B-NP O
173 100% CD O O
173 lesion NN B-NP O
174 RT NNP I-NP O
174 PDA NNP I-NP O
174 ( ( O O
174 Mid NNP B-NP O
174 ) ) O O
174 , , O O
174 Discrete NNP B-NP O
174 100% CD O O
174 lesion NN B-NP O
175 Coronary NNP I-NP O
175 Artery NNP I-NP O
175 Bypass NNP I-NP O
175 Grafts: NNP I-NP O
176 SVG NNP I-NP O
176 Graft NNP I-NP O
176 to TO O O
176 RT NNP B-NP O
176 PDA NNP I-NP O
176 ( ( O O
176 Mid NNP B-NP O
176 ) ) O O
176 , , O O
176 Discrete NNP B-NP O
176 90% CD O O
176 lesion NN B-NP O
176 STENT NNP I-NP O
176 to TO O O
176 20% CD O O
177 LIMA NNP B-NP O
177 Graft NNP I-NP O
177 to TO O O
177 LAD NNP B-NP O
178 SVG NNP I-NP O
178 Graft NNP I-NP O
178 to TO O O
178 MARG1 NNP B-NP O
178 ( ( O O
178 Ostial NNP B-NP O
178 ) ) O O
178 , , O O
178 Discrete NNP B-NP O
178 90% CD O O
178 lesion NN B-NP O
179 SVG NNP I-NP O
179 Graft NNP I-NP O
179 to TO O O
179 MARG1 NNP B-NP O
179 ( ( O O
179 Proximal NNP B-NP O
179 ) ) O O
179 , , O O
179 Discrete NNP B-NP O
179 90% CD O O
179 lesion NN B-NP O
180 Collateral NNP I-NP O
180 flow NN I-NP O
180 from IN B-VP O
180 LAD NNP B-NP O
180 to TO O O
180 RT NNP B-NP O
180 PDA NNP I-NP O
181 A/P NNP I-NP O
182 1 CD O O
182 Cardiac NNP B-NP O
182 Ischemia- NNP I-NP O
182 Pt NNP I-NP O
182 had VBD B-VP O
182 elective JJ B-NP O
182 PCI NNP I-NP O
182 on IN B-VP O
182 10/28/06 CD O O
182 with IN B-VP O
182 results NNS B-NP O
182 as IN B-VP O
183 mentioned JJ O O
183 previously RB O O
183 She PRP O O
183 did VBD B-VP O
183 experience VB O O
183 jaw NN B-NP O
183 sensations NNS I-NP O
183 and CC O O
183 chest JJS B-NP O
183 pain NN I-NP O
184 post NN I-NP O
184 procedure NN I-NP O
184 that IN B-VP O
184 she PRP O O
184 describes VBZ O O
184 as IN B-VP O
184 different JJ O O
184 from IN B-VP O
184 periprocedure NN B-NP O
184 pain NN I-NP O
184 , , O O
185 and CC O O
185 previous JJ B-NP O
185 episodes NNS I-NP O
185 of IN B-VP O
185 angina NN B-NP O
185 After IN B-VP O
185 release NN B-NP O
185 from IN B-VP O
185 CCU NNP B-NP O
185 , , O O
185 had VBD B-VP O
185 no DT B-NP O
185 further JJ I-NP O
186 events NNS I-NP O
186 No DT B-NP O
186 current JJ I-NP O
186 chest NN I-NP O
186 or CC O O
186 jaw NN B-NP O
186 pain NN I-NP O
186 Continuing NNP I-NP O
186 plavix NN I-NP B-m
186 , , O O
186 zocor NN B-NP B-m
186 , , O O
186 zetia NN B-NP B-m
187 as IN B-VP O
187 outpt NN B-NP O
187 and CC O O
187 heparin NN B-NP B-m
187 and CC O O
187 Integrelin NNP B-NP O
187 have VBP O O
187 been VBN O O
187 discontinued VBN O O
188 Pump- NNP B-NP O
188 PT NNP I-NP O
188 has VBZ O O
188 preserved VBN O O
188 fxn NNS B-NP O
188 , , O O
188 BP NNP B-NP O
188 low JJ O O
188 normal JJ O O
188 , , O O
188 pt JJ B-NP O
188 euvolemic JJ I-NP O
189 Rhythm NNP I-NP O
189 - : O O
189 NSR NN B-NP O
189 on IN B-VP O
189 telemetry NN B-NP O
189 will MD O O
189 d/c VB O O
189 on IN B-VP O
189 Betablocker NNP B-NP O
190 2 CD O O
190 Pulm NNP B-NP O
190 - : O O
190 Pt NN B-NP O
190 has VBZ O O
190 chronic JJ B-NP O
190 cough NN I-NP O
190 due JJ O O
190 to TO O O
190 Post NNP B-NP O
190 nasal NN I-NP O
190 drip NN I-NP O
190 Taken NNP I-NP O
190 off NN I-NP O
190 of IN B-VP O
190 her PRP$ O O
191 antihistamine NN B-NP O
191 on IN B-VP O
191 admission NN B-NP O
191 It PRP O O
191 is VBZ O O
191 USOH NNP B-NP O
191 per IN B-VP O
191 pt NN B-NP O
191 DID NNP I-NP O
191 NOT NNP I-NP O
191 GIVE NNP I-NP O
192 ANTIHISTAMINES NNP I-NP O
192 in IN B-VP O
192 this DT B-NP O
192 hospital NN I-NP O
192 course NN I-NP O
192 CXR NNP I-NP O
192 was VBD B-VP O
192 normal JJ O O
192 with IN B-VP O
192 no DT B-NP O
192 acute NN I-NP O
193 changes NNS I-NP O
193 on IN B-VP O
193 admission NN B-NP O
194 3 CD O O
194 Renal NNP B-NP O
194 - : O O
194 NO DT B-NP O
194 hx NN I-NP O
194 of IN B-VP O
194 renal JJ B-NP O
194 dz NN I-NP O
194 , , O O
194 No NNP B-NP O
194 renal JJ B-NP O
194 issues NNS I-NP O
194 during IN B-VP O
194 hospital JJ B-NP O
194 course NN I-NP O
195 4 CD O O
195 Endo NNP B-NP O
195 - : O O
195 DMII NN B-NP O
195 on IN B-VP O
195 Lantus NNP B-NP B-m
195 , , O O
195 Novolog NNP B-NP B-m
195 SS NNP I-NP O
195 , , O O
195 while IN B-VP O
195 in IN B-VP O
195 the DT B-NP O
195 hospital NN I-NP O
196 FS NNP I-NP O
196 Glu NNP I-NP O
196 monitored VBD B-VP O
196 No DT B-NP O
196 adjustment NN I-NP O
196 needed VBN O O
196 Will NNP B-NP O
196 send VB O O
196 out RP O O
196 on IN B-VP O
196 home NN B-NP B-do
196 doses NNS I-NP I-do
196 o VBP O O
197 insulin NN B-NP B-m
198 5 CD O O
198 Heme NNP B-NP O
198 - : O O
198 Pt NN B-NP O
198 had VBD B-VP O
198 cath NN B-NP O
198 and CC O O
198 subsequent JJ B-NP O
198 oozing NN I-NP O
198 from IN B-VP O
198 site NN B-NP O
198 in IN B-VP O
198 groin JJ B-NP O
198 Hct NNP I-NP O
198 was VBD B-VP O
199 stable JJ B-NP O
199 post NN I-NP O
199 cath NN I-NP O
199 , , O O
199 Anticoagulation NNP B-NP B-m
199 stopped VBD B-VP O
199 Pt NNP B-NP O
199 to TO O O
199 be VB O O
199 discharged VBN O O
199 on IN B-VP O
199 home NN B-NP O
200 meds NNS I-NP O
200 including VBG O O
200 plavix NN B-NP B-m
200 and CC O O
200 ASA NNP B-NP B-m
201 ADDITIONAL NNP I-NP O
201 COMMENTS: NNP I-NP O
201 Please NNP I-NP O
201 return VB O O
201 if IN B-VP O
201 you PRP O O
201 have VBP O O
201 any DT B-NP O
201 chest NN I-NP O
201 pain NN I-NP O
201 , , O O
201 jaw NN B-NP O
201 pain NN I-NP O
201 , , O O
201 shortness NN B-NP O
201 of IN B-VP O
201 breath NN B-NP O
201 , , O O
202 groin NN B-NP O
202 pain NN I-NP O
202 , , O O
202 groin NN B-NP O
202 swelling NN I-NP O
202 , , O O
202 dizziness NN B-NP O
202 , , O O
202 or CC O O
202 fever NN B-NP O
202 and CC O O
202 chills VBZ O O
202 Please NNP B-NP O
202 take VB O O
203 medicines NNS B-NP O
203 as IN B-VP O
203 previously RB O O
203 prescribed VBN O O
203 Please NNP B-NP O
203 limit NN I-NP O
203 activity NN I-NP O
203 for IN B-VP O
203 the DT B-NP O
203 next JJ I-NP O
204 few JJ I-NP O
204 day NN I-NP O
204 to TO O O
204 non-strenuous JJ B-NP O
204 work NN I-NP O
204 Please NNP I-NP O
204 make VB O O
204 follow VB O O
204 up RP O O
204 appts NNS B-NP O
204 with IN B-VP O
204 primary JJ B-NP O
205 care NN I-NP O
205 physician NN I-NP O
205 and CC O O
205 cardiologist NN B-NP O
205 within IN B-VP O
205 the DT O O
205 next JJ O O
205 2 CD O O
205 weeks NNS B-NP O
206 DISCHARGE NNP I-NP O
206 CONDITION: NNP I-NP O
206 Stable NNP I-NP O
207 TO NNP I-NP O
207 DO/PLAN: NNP I-NP O
208 Please NNP I-NP O
208 follow VB O O
208 up RP O O
208 on IN B-VP O
208 groin NNS B-NP O
208 site NN I-NP O
208 and CC O O
208 evaluate NN B-NP O
208 for IN B-VP O
208 bruits NNS B-NP O
208 or CC O O
208 hematoma NN B-NP O
209 Please NNP I-NP O
209 follow VB O O
209 Hct NNP B-NP O
209 to TO O O
209 ensure VB O O
209 no DT B-NP O
209 acute JJ I-NP O
209 blood NN I-NP O
209 loss NN I-NP O
210 No NNP I-NP O
210 dictated VBD B-VP O
210 summary JJ B-NP O
211 ENTERED NNP I-NP O
211 BY: NNP I-NP O
211 TRANER NNP I-NP O
211 , , O O
211 BLAINE NNP B-NP O
211 D NNP I-NP O
211 , , O O
211 M.D NNP B-NP O
211 ( ( O O
211 RR0 NNP B-NP O
211 ) ) O O
211 7/24/06 CD O O
211 @ $ O O
211 05:01 CD O O
211 PM NNP B-NP O
212 REVIEWED NNP I-NP O
212 BY: NNP I-NP O
212 ELLERBECK NNP I-NP O
212 , , O O
212 JAIME NNP B-NP O
212 R NNP I-NP O
212 , , O O
212 M.D NNP B-NP O
213 ****** NNP I-NP O
213 END NNP I-NP O
213 OF NNP I-NP O
213 DISCHARGE NNP I-NP O
213 ORDERS NNP I-NP O
213 ****** NNP I-NP O
214 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #943779 VBZ O O
2 867779708 CD O O
2 RH NNP B-NP O
2 47134929 CD O O
2 0640935 CD O O
2 6/12/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 pyelonephritis NN I-NP O
2 , , O O
2 urosepsis JJ B-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 6/12/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 11/12/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 WOODBURY NNP I-NP O
5 , , O O
5 CHRISTOPHER NNP B-NP O
5 C NNP I-NP O
5 020-11-72-4 JJ B-NP O
6 Own NNP I-NP O
6 Si NNP I-NP O
6 A NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 9/24/05 CD O O
8 AT NNP B-NP O
8 01:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 TRUSSELL NNP I-NP O
11 , , O O
11 JERE NNP B-NP O
11 SCOT NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 DISPOSITION: NNP I-NP O
12 Home NNP I-NP O
12 w/ NN I-NP O
12 services NNS I-NP O
13 DISCHARGE NNP I-NP O
13 MEDICATIONS: NNP I-NP O
14 ACETYLSALICYLIC NNP I-NP B-m
14 ACID NNP I-NP I-m
14 81 CD O B-do
14 MG NNP B-NP I-do
14 PO NNP I-NP B-mo
14 QD NNP I-NP B-f
15 LISINOPRIL NNP I-NP B-m
15 10 CD O B-do
15 MG NNP B-NP I-do
15 PO NNP I-NP B-mo
15 QD NNP I-NP B-f
15 Starting VBG O O
15 Today NNP B-NP O
15 ( ( O O
15 6/25 CD O O
15 ) ) O O
16 HOLD NNP B-NP O
16 IF: NNP I-NP O
16 sbp&lt;95 VBD B-VP O
17 Override NNP B-NP O
17 Notice: NNP I-NP O
17 Override NNP I-NP O
17 added VBD B-VP O
17 on IN B-VP O
17 11/4/05 CD O O
17 by IN B-VP O
18 PRAWL NNP B-NP O
18 , , O O
18 LUCIO NNP B-NP O
18 A NNP I-NP O
19 on IN B-VP O
19 order NN B-NP O
19 for IN B-VP O
19 KCL NNP B-NP B-m
19 SLOW NNP I-NP I-m
19 RELEASE NNP I-NP I-m
19 PO NNP I-NP B-mo
19 ( ( O O
19 ref JJ O O
19 # # O O
19 761602437 CD O O
19 ) ) O O
20 POTENTIALLY NNP B-NP O
20 SERIOUS NNP I-NP O
20 INTERACTION: NNP I-NP O
20 LISINOPRIL NNP I-NP O
20 &amp; NNP I-NP O
20 POTASSIUM NNP I-NP O
21 CHLORIDE NNP I-NP O
21 Reason NNP I-NP O
21 for IN B-VP O
21 override: NN B-NP O
21 aware JJ B-NP O
22 Previous NNP I-NP O
22 override NN I-NP O
22 information: NN I-NP O
23 Override NNP I-NP O
23 added VBD B-VP O
23 on IN B-VP O
23 11/4/05 CD O O
23 by IN B-VP O
23 MILTZ NNP B-NP O
23 , , O O
23 DOMINIC NNP B-NP O
23 , , O O
23 M.D NNP B-NP O
24 on IN B-VP O
24 order NN B-NP O
24 for IN B-VP O
24 LISINOPRIL NNP B-NP B-m
24 PO NNP I-NP B-mo
24 ( ( O O
24 ref JJ O O
24 # # O O
24 362261331 CD O O
24 ) ) O O
25 Pt NNP B-NP O
25 has VBZ O O
25 a DT B-NP O
25 PROBABLE NNP I-NP O
25 allergy NN I-NP O
25 to TO O O
25 ENALAPRIL NNP B-NP O
25 MALEATE; NNP I-NP O
25 reactions NNS I-NP O
26 are VBP O O
26 HOT NNP B-NP O
26 FLASHES NNP I-NP O
26 , , O O
26 FACIAL NNP B-NP O
26 FLUSHING NNP I-NP O
26 Reason NNP I-NP O
26 for IN B-VP O
26 override: NN B-NP O
27 pt NN I-NP O
27 has VBZ O O
27 tolerated VBN O O
28 TOPROL NNP B-NP B-m
28 XL NNP I-NP I-m
28 ( ( O I-m
28 METOPROLOL NNP B-NP I-m
28 SUCCINATE NNP I-NP I-m
28 EXTENDED NNP I-NP I-m
28 RELEASE NNP I-NP I-m
28 ) ) O I-m
29 100 CD O B-do
29 MG NNP B-NP I-do
29 PO NNP I-NP B-mo
29 BID NNP I-NP B-f
29 HOLD NNP I-NP O
29 IF: NNP I-NP O
29 hr&lt;55 NN I-NP O
29 , , O O
29 sbp&lt;95 JJ B-NP O
30 Food/Drug NNP I-NP O
30 Interaction NNP I-NP O
30 Instruction NNP I-NP O
31 Take NNP I-NP O
31 consistently RB O O
31 with IN B-VP O
31 meals NNS B-NP O
31 or CC O O
31 on IN B-VP O
31 empty JJ B-NP O
31 stomach NN I-NP O
32 Alert NNP I-NP O
32 overridden: NNP I-NP O
32 Override NNP I-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 11/4/05 CD O O
32 by IN B-VP O
33 APODACA NNP B-NP O
33 , , O O
33 RORY NNP B-NP O
33 , , O O
33 M.D NNP B-NP O
34 POTENTIALLY NNP I-NP O
34 SERIOUS NNP I-NP O
34 INTERACTION: NNP I-NP O
34 DILTIAZEM NNP I-NP O
34 HCL NNP I-NP O
34 &amp; NNP I-NP O
35 METOPROLOL NNP I-NP O
35 TARTRATE NNP I-NP O
35 Reason NNP I-NP O
35 for IN B-VP O
35 override: NN B-NP O
35 aware JJ B-NP O
36 Number NNP I-NP O
36 of IN B-VP O
36 Doses NNP B-NP O
36 Required NNP I-NP O
36 ( ( O O
36 approximate JJ B-NP O
36 ): NN I-NP O
36 6 CD O O
37 LANTUS NNP B-NP B-m
37 LANTUS NNP I-NP B-m
37 ( ( O I-m
37 ( ( O I-m
37 INSULIN NNP B-NP I-m
37 INSULIN NNP I-NP I-m
37 GLARGINE NNP I-NP I-m
37 GLARGINE NNP I-NP I-m
37 ) ) O I-m
37 ) ) O I-m
37 19 CD O B-do
37 19 CD O B-do
37 UNITS NNP B-NP I-do
37 UNITS NNP I-NP I-do
37 QAM NNP I-NP B-f
37 QAM NNP I-NP B-f
37 SC NNP I-NP B-mo
37 SC NNP I-NP B-mo
37 QAM NNP I-NP O
38 19 CD O O
38 UNITS NNP B-NP O
38 QAM NNP I-NP O
38 Starting VBG O O
38 Today NNP B-NP O
38 ( ( O O
38 6/17 CD O O
38 ) ) O O
39 Instructions: NNP B-NP O
39 1/2 CD O O
39 dose NN B-NP O
39 if IN B-VP O
39 pt JJ B-NP O
39 npo NN I-NP O
39 or CC O O
39 decreased VBN O O
39 po's JJ B-NP O
40 WARFARIN NNP I-NP B-m
40 SODIUM NNP I-NP I-m
40 5 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QPM NNP I-NP O
41 Starting NNP I-NP O
41 ROUTINE NNP I-NP O
41 , , O O
41 20:00 CD O O
41 ( ( O O
41 Standard NNP B-NP O
41 Admin NNP I-NP O
41 Time NNP I-NP O
41 ) ) O O
42 Food/Drug NNP B-NP O
42 Interaction NNP I-NP O
42 Instruction NNP I-NP O
43 No NNP I-NP O
43 high JJ B-NP O
43 Vitamin-K NNP I-NP O
43 containing VBG O O
43 foods NNS B-NP O
44 Alert NNP I-NP O
44 overridden: VBD B-VP O
44 Override NNP B-NP O
44 added VBD B-VP O
44 on IN B-VP O
44 11/4/05 CD O O
44 by IN B-VP O
44 : : O O
45 POTENTIALLY NNP B-NP O
45 SERIOUS NNP I-NP O
45 INTERACTION: NNP I-NP O
45 ASPIRIN NNP I-NP O
45 &amp; NNP I-NP O
45 WARFARIN NNP I-NP O
46 POTENTIALLY NNP I-NP O
46 SERIOUS NNP I-NP O
46 INTERACTION: NNP I-NP O
46 ATORVASTATIN NNP I-NP O
46 CALCIUM NNP I-NP O
46 &amp; NNP I-NP O
47 WARFARIN NNP I-NP O
47 Reason NNP I-NP O
47 for IN B-VP O
47 override: NN B-NP O
47 aware JJ B-NP O
48 ROSIGLITAZONE NNP I-NP B-m
48 2 CD O B-do
48 MG NNP B-NP I-do
48 PO NNP I-NP B-mo
48 QD NNP I-NP B-f
49 FUROSEMIDE NNP I-NP B-m
49 20 CD O B-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 BID NNP I-NP O
49 Starting VBG O O
49 Today NNP B-NP O
49 ( ( O O
49 6/25 CD O O
49 ) ) O O
50 PRN NNP B-NP O
50 Other:LE NNP I-NP O
50 edema NN I-NP B-r
51 Instructions: NNP I-NP O
51 Do NNP I-NP O
51 not RB O O
51 use VB O O
51 more JJR O O
51 than IN B-VP O
51 1-2 JJ B-NP O
51 days NNS I-NP O
51 per IN B-VP O
51 week NN B-NP O
51 for IN B-VP O
52 potential JJ B-NP O
52 toxicity NN I-NP O
52 with IN B-VP O
52 digoxin NN B-NP O
53 SIMVASTATIN NNP I-NP B-m
53 10 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 QHS NNP I-NP B-f
54 Food/Drug NNP I-NP O
54 Interaction NNP I-NP O
54 Instruction NNP I-NP O
55 Avoid NNP I-NP O
55 grapefruit NN I-NP O
55 unless IN B-VP O
55 MD NNP B-NP O
55 instructs NNS I-NP O
55 otherwise RB O O
56 Alert NNP B-NP O
56 overridden: NNP I-NP O
56 Override NNP I-NP O
56 added VBD B-VP O
56 on IN B-VP O
56 11/4/05 CD O O
56 by IN B-VP O
56 : : O O
57 POTENTIALLY NNP B-NP O
57 SERIOUS NNP I-NP O
57 INTERACTION: NNP I-NP O
57 WARFARIN NNP I-NP O
57 &amp; NNP I-NP O
57 SIMVASTATIN NNP I-NP O
58 Reason NNP I-NP O
58 for IN B-VP O
58 override: NN B-NP O
58 already RB O O
58 tolerated VBN O O
58 , , O O
58 home NN B-NP B-m
58 medication NN I-NP I-m
58 , , O O
59 aware JJ B-NP O
60 CEFPODOXIME NNP I-NP B-m
60 PROXETIL NNP I-NP I-m
60 200 CD O B-do
60 MG NNP B-NP I-do
60 PO NNP I-NP B-mo
60 BID NNP I-NP O
60 X NNP I-NP B-du
60 16 CD O I-du
60 doses NNS B-NP I-du
61 Starting VBG O O
61 Today NNP B-NP O
61 ( ( O O
61 6/25 CD O O
61 ) ) O O
61 HOLD NNP B-NP O
61 IF: NNP I-NP O
61 rash VBP O O
62 Food/Drug NNP B-NP O
62 Interaction NNP I-NP O
62 Instruction NNP I-NP O
62 Give NNP I-NP O
62 with IN B-VP O
62 meals NNS B-NP O
63 Alert NNP I-NP O
63 overridden: VBD B-VP O
63 Override NNP B-NP O
63 added VBD B-VP O
63 on IN B-VP O
63 11/4/05 CD O O
63 by IN B-VP O
63 : : O O
64 on IN B-VP O
64 order NN B-NP O
64 for IN B-VP O
64 CEFPODOXIME NNP B-NP B-m
64 PROXETIL NNP I-NP I-m
64 PO NNP I-NP B-mo
64 ( ( O O
64 ref JJ O O
64 # # O O
64 703442345 CD O O
64 ) ) O O
65 Pt NNP B-NP O
65 has VBZ O O
65 a DT B-NP O
65 POSSIBLE NNP I-NP O
65 allergy NN I-NP O
65 to TO O O
65 Penicillins; NNP B-NP O
65 reaction NN I-NP O
65 is VBZ O O
66 RASH NNP B-NP O
66 Reason NNP I-NP O
66 for IN B-VP O
66 override: NN B-NP O
66 cannot NN I-NP O
66 tolerate NN I-NP O
66 floroquinolones NNS I-NP O
67 and CC O O
67 needs VBZ O O
67 gram JJ B-NP O
67 neg NN I-NP O
67 coverage NN I-NP O
67 has VBZ O O
68 tolerated VBN O O
68 cefalosporins NNS B-NP B-m
68 well RB O O
68 in IN B-VP O
68 the DT B-NP O
68 past JJ I-NP O
69 DIGOXIN NNP I-NP B-m
69 0.125 CD O B-do
69 MG NNP B-NP I-do
69 PO NNP I-NP B-mo
69 QOD NNP I-NP B-f
70 DIET: NNP I-NP O
70 House NNP I-NP O
70 / NNP I-NP O
70 NAS NNP I-NP O
70 / NNP I-NP O
70 ADA NNP I-NP O
70 2000 CD O O
70 cals/day NN B-NP O
70 / NNP I-NP O
70 Low NNP I-NP O
70 saturated VBD B-VP O
70 fat JJ B-NP O
71 low JJ I-NP O
71 cholesterol NN I-NP O
71 / NNP I-NP O
71 low JJ B-NP O
71 vit NN I-NP O
71 k NN I-NP O
71 foods NNS I-NP O
71 (FDI) VBP O O
72 ACTIVITY: NNP B-NP O
72 Walking NNP I-NP O
72 as IN B-VP O
72 tolerated VBN O O
73 FOLLOW NNP B-NP O
73 UP NNP I-NP O
73 APPOINTMENT( NNP I-NP O
73 S NNP I-NP O
73 ): NNP I-NP O
74 Dr NNP I-NP O
74 Maobi NNP I-NP O
74 within IN B-VP O
74 1wk CD O O
74 , , O O
75 ALLERGY: NNP B-NP O
75 Penicillins NNP I-NP O
75 , , O O
75 ENALAPRIL NNP B-NP O
75 MALEATE NNP I-NP O
76 ADMIT NNP I-NP O
76 DIAGNOSIS: NNP I-NP O
77 pyelonephritis NN I-NP O
77 , , O O
77 urosepsis NN B-NP O
78 PRINCIPAL NNP I-NP O
78 DISCHARGE NNP I-NP O
78 DIAGNOSIS NNP I-NP O
78 ;Responsible JJ O O
78 After IN B-VP O
78 Study NNP B-NP O
78 for IN B-VP O
78 Causing NNP B-NP O
78 Admission NNP I-NP O
78 ) ) O O
79 pyelonephritis NN B-NP O
79 , , O O
79 urosepsis NN B-NP O
80 OTHER NNP I-NP O
80 DIAGNOSIS;Conditions NNP I-NP O
80 , , O O
80 Infections NNP B-NP O
80 , , O O
80 Complications NNP B-NP O
80 , , O O
80 affecting VBG O O
80 Treatment/Stay NNP B-NP O
81 AFIB NNP I-NP O
81 ( ( O O
81 atrial JJ B-NP O
81 fibrillation NN I-NP O
81 ) ) O O
81 PYELONEPHRITIS NNP B-NP O
81 ( ( O O
81 pyelonephritis NN B-NP O
81 ) ) O O
81 DM NNP B-NP O
82 ( ( O O
82 diabetes VBZ O O
82 mellitus VBP O O
82 type JJ O O
82 2 CD O O
82 ) ) O O
82 HTN NNP B-NP O
83 ( ( O O
83 hypertension NN B-NP O
83 ) ) O O
83 HYPERLIPID NNP B-NP O
83 ( ( O O
83 hyperlipidemia NN B-NP O
83 ) ) O O
84 OPERATIONS NNP B-NP O
84 AND NNP I-NP O
84 PROCEDURES: NNP I-NP O
85 none NN I-NP O
86 OTHER NNP I-NP O
86 TREATMENTS/PROCEDURES NNP I-NP O
86 ( ( O O
86 NOT NNP B-NP O
86 IN NNP I-NP O
86 O.R NNP I-NP O
86 ) ) O O
87 TTE NNP B-NP O
87 , , O O
87 Adenosine-MIBI NNP B-NP B-m
87 , , O O
87 PE NNP B-NP O
87 protocol NN I-NP O
87 CT NNP I-NP O
88 BRIEF NNP I-NP O
88 RESUME NNP I-NP O
88 OF NNP I-NP O
88 HOSPITAL NNP I-NP O
88 COURSE: NNP I-NP O
89 77 CD O O
89 year NN B-NP O
89 old JJ B-NP O
89 woman NN I-NP O
89 admitted VBN O O
89 with IN B-VP O
89 complaint NN B-NP O
89 of IN B-VP O
89 urinary JJ B-NP O
89 frequency NN I-NP O
89 and CC O O
89 AMS NNP B-NP O
90 The DT B-NP O
90 patient NN I-NP O
90 has VBZ O O
90 positive JJ B-NP O
90 blood NN I-NP O
90 and CC O O
90 urine JJ B-NP O
90 cultures NNS I-NP O
90 for IN B-VP O
90 Klebsiella NNP B-NP O
90 and CC O O
90 her PRP$ O O
91 AFIB NNP B-NP O
91 became VBD B-VP O
91 tachy JJ O O
91 to TO O O
91 140's CD O O
91 She PRP O O
91 was VBD B-VP O
91 also RB O O
91 noted VBN O O
91 to TO O O
91 have VB O O
91 an DT O O
91 elevated VBN O O
92 troponin NN B-NP O
92 to TO O O
92 1.69 CD O O
92 which WDT O O
92 rose VBD B-VP O
92 to TO O O
92 a DT B-NP O
92 max NN I-NP O
92 of IN B-VP O
92 2.41 CD O O
92 with IN B-VP O
92 no DT B-NP O
92 ekg NN I-NP O
92 changes VBZ O O
92 She PRP O O
92 was VBD B-VP O
93 rate NN B-NP O
93 controlled VBN O O
93 and CC O O
93 started VBN O O
93 on IN B-VP O
93 Levofloxacin NNP B-NP B-m
93 Her NNP I-NP O
93 mental NN I-NP O
93 status NN I-NP O
93 improved VBN O O
94 and CC O O
94 fever RB O O
94 resolved VBD B-VP O
94 She PRP O O
94 remained VBD B-VP O
94 tachycardic JJ O O
94 and CC O O
94 nodal JJ B-NP O
94 block NN I-NP O
94 was VBD B-VP O
95 supressing VBG O O
95 blood NN B-NP O
95 pressure NN I-NP O
95 She PRP O O
95 was VBD B-VP O
95 started VBN O O
95 on IN B-VP O
95 digoxin NN B-NP B-m
95 with IN B-VP O
95 excellent JJ B-NP O
96 response NN I-NP O
96 HR NNP I-NP O
96 stayed VBD B-VP O
96 in IN B-VP O
96 70-80's CD O O
96 and CC O O
96 up RB O O
96 to TO O O
96 100's CD O O
96 with IN B-VP O
96 exersion NN B-NP O
96 Her NNP I-NP O
96 cardiac NN I-NP O
97 workup NN I-NP O
97 included VBD B-VP O
97 an DT B-NP O
97 echocardiogram NN I-NP O
97 with IN B-VP O
97 RV NNP B-NP O
97 dialation NN I-NP O
97 and CC O O
97 wall NN B-NP O
97 akinesis NN I-NP O
98 with IN B-VP O
98 apical JJ B-NP O
98 sparing NN I-NP O
98 , , O O
98 a DT B-NP O
98 new JJ I-NP O
98 finding NN I-NP O
98 since IN B-VP O
98 last JJ B-NP O
98 echo NN I-NP O
98 in IN B-VP O
98 '03 NNP B-NP O
98 Right NNP I-NP O
98 sided VBD B-VP O
99 EKG NNP B-NP O
99 neg IN B-VP O
99 A NNP B-NP O
99 PE NNP I-NP O
99 was VBD B-VP O
99 then RB O O
99 ruled VBN O O
99 out RP O O
99 with IN B-VP O
99 PE NNP B-NP O
99 protocol NN I-NP O
99 CT NNP I-NP O
99 The DT B-NP O
99 following JJ I-NP O
99 day NN I-NP O
100 the DT B-NP O
100 patient NN I-NP O
100 had VBD B-VP O
100 a DT B-NP O
100 adenosine JJ I-NP B-m
100 MIBI NNP I-NP O
100 that WDT O O
100 showed VBD B-VP O
100 no DT B-NP O
100 perfusion NN I-NP O
100 defects VBZ O O
100 Her PRP$ O O
101 INR NNP B-NP O
101 was VBD B-VP O
101 increasing VBG O O
101 due JJ O O
101 to TO O O
101 the DT B-NP O
101 levofloxacin JJ I-NP B-m
101 effect NN I-NP O
101 and CC O O
101 was VBD B-VP O
101 switched VBN O O
101 to TO O O
102 ceftriaxone VB O B-m
102 consistant NN B-NP O
102 with IN B-VP O
102 blood NN B-NP O
102 culture NN I-NP O
102 succeptabilities NNS I-NP O
102 Follow VBP O O
102 up RP O O
103 blood NN B-NP O
103 cultures NNS I-NP O
103 on IN B-VP O
103 0/27 CD O O
103 then RB O O
103 demostrated VBD B-VP O
103 gram JJ B-NP O
103 positive JJ I-NP O
103 cocci NN I-NP O
103 in IN B-VP O
103 clusters NNS B-NP O
104 and CC O O
104 the DT B-NP O
104 patient NN I-NP O
104 was VBD B-VP O
104 given VBN O O
104 2 CD O B-du
104 doses NNS B-NP I-du
104 of IN B-VP O
104 vancomycin NN B-NP B-m
104 to TO O O
104 cover VB O O
104 potential JJ B-NP B-r
104 staph JJ I-NP O
105 infection NN I-NP O
105 Cultures NNS I-NP O
105 were VBD B-VP O
105 found VBN O O
105 to TO O O
105 be VB O O
105 skin JJ B-NP O
105 flora NNS I-NP O
105 and CC O O
105 patient JJ O O
105 asymptomatic JJ O O
106 and CC O O
106 antibiotics NNS B-NP B-m
106 d/c'd VBP O O
106 Repeat NNP B-NP O
106 cultures NNS I-NP O
106 were VBD B-VP O
106 negative JJ B-NP O
106 Patient NNP I-NP O
106 was VBD B-VP O
107 discharged VBN O O
107 in IN B-VP O
107 good JJ B-NP O
107 condition NN I-NP O
107 and CC O O
107 will MD O O
107 return VB O O
107 to TO O O
107 PCP NNP B-NP O
107 for IN B-VP O
107 close RB O O
107 follow VBP O O
107 up RP O O
108 ADDITIONAL NNP B-NP O
108 COMMENTS: NNP I-NP O
108 Call NNP I-NP O
108 PCP NNP I-NP O
108 with IN B-VP O
108 any DT B-NP O
108 changes NNS I-NP O
108 in IN B-VP O
108 urinary JJ B-NP O
108 symptoms NNS I-NP O
108 , , O O
108 or CC O O
108 fever RB O O
108 &gt;101.0 JJ B-NP O
108 Return NNP I-NP O
108 to TO O O
109 ER VB O O
109 if IN B-VP O
109 any DT B-NP O
109 changes NNS I-NP O
109 in IN B-VP O
109 mental JJ B-NP O
109 status NN I-NP O
109 , , O O
109 chest NN B-NP O
109 pain NN I-NP O
109 , , O O
109 SOB NNP B-NP O
109 , , O O
109 or CC O O
109 syncope VB O O
109 Complete JJ O O
110 the DT B-NP O
110 full JJ I-NP O
110 course NN I-NP O
110 of IN B-VP O
110 antibiotics NNS B-NP B-m
110 which WDT O O
110 cover VBP O O
110 the DT O O
110 next JJ O O
110 8days CD O B-du
110 F/U NNP B-NP O
110 with IN B-VP O
110 PCP NNP B-NP O
111 within IN B-VP O
111 the DT B-NP O
111 next JJ I-NP O
111 week NN I-NP O
111 with IN B-VP O
111 INR NNP B-NP O
111 and CC O O
111 digoxin NN B-NP B-m
111 levels NNS I-NP O
111 Do VBP O O
111 not RB O O
111 use VB O O
111 lasix JJ O B-m
111 unless IN B-VP O
112 necessary JJ O O
112 and CC O O
112 contact JJ B-NP O
112 PCP NNP I-NP O
112 if IN B-VP O
112 using VBG O O
112 more JJR O O
112 than IN B-VP O
112 1-2 JJ B-NP O
112 times NNS I-NP O
112 per IN B-VP O
112 week NN B-NP O
112 due JJ O O
112 to TO O O
113 possible JJ B-NP O
113 toxicity NN I-NP O
113 with IN B-VP O
113 digoxin NN B-NP O
113 use NN I-NP O
114 DISCHARGE NNP I-NP O
114 CONDITION: NNP I-NP O
114 Stable NNP I-NP O
115 TO NNP I-NP O
115 DO/PLAN: NNP I-NP O
116 VNA NNP I-NP O
116 instructions: NN I-NP O
116 Please NNP I-NP O
116 do VBP O O
116 vital JJ B-NP O
116 signs NNS I-NP O
116 checks NNS I-NP O
116 Patient NNP I-NP O
116 needs VBZ O O
116 a DT B-NP O
116 digoxin NN I-NP O
117 level NN I-NP O
117 and CC O O
117 INR NNP B-NP O
117 checked VBD B-VP O
117 weekly JJ O O
117 , , O O
117 and CC O O
117 the DT B-NP O
117 first JJ I-NP O
117 set NN I-NP O
117 of IN B-VP O
117 labs NN B-NP O
117 should MD O O
117 be VB O O
117 drawn VBN O O
118 1-2 JJ B-NP O
118 days NNS I-NP O
118 after IN B-VP O
118 discharge NN B-NP O
118 PCP NNP I-NP O
118 will MD O O
118 follow-up VB O O
118 labs JJ B-NP O
118 Guiac NNP I-NP O
118 + NNP I-NP O
118 x VBD B-VP O
118 1 CD O O
118 needs NNS B-NP O
118 f/u NN I-NP O
119 TO VBP O O
119 THE NNP B-NP O
119 PATIENT: NNP I-NP O
119 We PRP O O
119 have VBP O O
119 altered VBN O O
119 cardiac JJ B-NP B-m
119 medications NNS I-NP I-m
119 for IN B-VP O
119 better JJR B-NP B-r
119 rate NN I-NP O
120 control NN I-NP O
120 We PRP O O
120 have VBP O O
120 cancelled VBN O O
120 the DT B-NP O
120 coreg( NN I-NP B-m
120 carvedelol NN I-NP I-m
120 ) ) O I-m
120 and CC O O
121 Norvasc( NNP B-NP B-m
121 amilodipine NN I-NP I-m
121 ) ) O I-m
121 and CC O O
121 replaced VBD B-VP O
121 them PRP O O
121 with IN B-VP O
121 a DT B-NP O
121 blood NN I-NP O
121 pressure NN I-NP O
121 medication NN I-NP O
121 , , O O
122 Toprol NNP B-NP B-m
122 XL( NNP I-NP I-m
122 Metoprolol NNP I-NP I-m
122 XL NNP I-NP I-m
122 ) ) O I-m
122 to TO O O
122 better RBR O O
122 control VB O O
122 the DT B-NP O
122 rate NN I-NP O
122 of IN B-VP O
122 your PRP$ O O
122 atrial JJ B-NP B-r
123 fibrillation NN I-NP O
123 The DT B-NP O
123 digoxin NN I-NP B-m
123 was VBD B-VP O
123 also RB O O
123 added VBN O O
123 for IN B-VP O
123 heart NN B-NP B-r
123 rate NN I-NP I-r
123 control NN I-NP I-r
124 No NNP I-NP O
124 dictated VBD B-VP O
124 summary JJ B-NP O
125 ENTERED NNP I-NP O
125 BY: NNP I-NP O
125 FASSNACHT NNP I-NP O
125 , , O O
125 LUCAS NNP B-NP O
125 , , O O
125 M.D NNP B-NP O
125 ( ( O O
125 HD39 NNP B-NP O
125 ) ) O O
125 9/24/05 CD O O
125 @ $ O O
125 01 CD O O
126 ****** JJ B-NP O
126 END NN I-NP O
126 OF NNP I-NP O
126 DISCHARGE NNP I-NP O
126 ORDERS NNP I-NP O
126 ****** NNP I-NP O
127 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #944118 VBZ O O
4 908771041 CD O O
4 GSRH NNP B-NP O
4 57601693 CD O O
4 6324061 CD O O
4 7/10/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 2 CD O O
4 episodes NNS B-NP O
4 lethargy JJ O O
4 , , O O
4 unsteady JJ B-NP O
4 gait NN I-NP O
4 of IN B-VP O
4 unclear JJ B-NP O
4 etiology NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 8/14/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 9/24/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 MYREN NNP I-NP O
8 , , O O
8 JAYSON NNP B-NP O
8 E NNP I-NP O
8 502-87-60-2 JJ B-NP O
9 E NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 10/5/06 CD O O
11 AT NNP B-NP O
11 01:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 QUESNELL NNP I-NP O
14 , , O O
14 ABRAHAM NNP B-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 81 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 Starting VBG O O
20 Today NNP B-NP O
20 ( ( O O
20 10/27 CD O O
20 ) ) O O
21 LIPITOR NNP B-NP B-m
21 ( ( O I-m
21 ATORVASTATIN NNP B-NP I-m
21 ) ) O I-m
21 10 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 DAILY NNP I-NP B-f
22 GLYBURIDE NNP I-NP B-m
22 2.5 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 DAILY NNP I-NP B-f
22 X NNP I-NP B-du
22 60 CD O I-du
22 doses NNS B-NP I-du
23 METFORMIN NNP I-NP B-m
23 500 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 BID NNP I-NP B-f
24 DIET: NNP I-NP O
24 House NNP I-NP O
24 / VBD B-VP O
24 Low NNP B-NP O
24 chol/low NN I-NP O
24 sat VBD B-VP O
24 fat JJ B-NP O
25 RETURN NNP I-NP O
25 TO NNP I-NP O
25 WORK: NNP I-NP O
25 Immediately RB O O
26 FOLLOW NNP B-NP O
26 UP NNP I-NP O
26 APPOINTMENT( NNP I-NP O
26 S NNP I-NP O
26 ): NNP I-NP O
27 Dr NNP I-NP O
27 Rigoberto NNP I-NP O
27 Lannom NNP I-NP O
27 Monday NNP I-NP O
27 February NNP I-NP O
27 scheduled VBD B-VP O
27 , , O O
28 ALLERGY: NNP B-NP O
28 NKA NNP I-NP O
29 ADMIT NNP I-NP O
29 DIAGNOSIS: NNP I-NP O
30 2 CD O O
30 episodes NNS B-NP O
30 lethargy JJ O O
30 , , O O
30 unsteady JJ B-NP O
30 gait NN I-NP O
31 PRINCIPAL NNP I-NP O
31 DISCHARGE NNP I-NP O
31 DIAGNOSIS NNP I-NP O
31 ;Responsible JJ O O
31 After IN B-VP O
31 Study NNP B-NP O
31 for IN B-VP O
31 Causing NNP B-NP O
31 Admission NNP I-NP O
31 ) ) O O
32 2 CD O O
32 episodes NNS B-NP O
32 lethargy JJ O O
32 , , O O
32 unsteady JJ B-NP O
32 gait NN I-NP O
32 of IN B-VP O
32 unclear JJ B-NP O
32 etiology NN I-NP O
33 OTHER NNP I-NP O
33 DIAGNOSIS;Conditions NNP I-NP O
33 , , O O
33 Infections NNP B-NP O
33 , , O O
33 Complications NNP B-NP O
33 , , O O
33 affecting VBG O O
33 Treatment/Stay NNP B-NP O
34 newly-diagnosed JJ B-NP O
34 DM NNP I-NP O
34 h/o NN I-NP O
34 EtOH NNP I-NP O
34 abuse NN I-NP O
34 ( ( O O
34 7 CD O O
34 ) ) O O
34 hyperlipidemia NN B-NP O
35 glaucoma NN I-NP O
35 L NNP I-NP O
35 eye NN I-NP O
35 ( ( O O
35 3 CD O O
35 ) ) O O
35 erectile NN B-NP O
35 dysfunction NN I-NP O
35 dysfunction NN I-NP O
36 OPERATIONS NNP I-NP O
36 AND NNP I-NP O
36 PROCEDURES: NNP I-NP O
37 none NN I-NP O
38 OTHER NNP I-NP O
38 TREATMENTS/PROCEDURES NNP I-NP O
38 ( ( O O
38 NOT NNP B-NP O
38 IN NNP I-NP O
38 O.R NNP I-NP O
38 ) ) O O
39 none NN B-NP O
40 BRIEF NNP I-NP O
40 RESUME NNP I-NP O
40 OF NNP I-NP O
40 HOSPITAL NNP I-NP O
40 COURSE: NNP I-NP O
41 CC: NNP I-NP O
41 lethargy NN I-NP O
41 , , O O
41 unsteady JJ B-NP O
41 gait NN I-NP O
41 -- : O O
41 readmission NN B-NP O
41 after IN B-VP O
42 similar JJ B-NP O
42 symptoms NNS I-NP O
42 Wed NNP I-NP O
43 HPI:60M NNP I-NP O
43 w/ VBD B-VP O
43 newly-diagnosed JJ B-NP O
43 DM NNP I-NP O
43 , , O O
43 hyperlipidemia NN B-NP O
43 , , O O
43 glaucoma NN B-NP O
43 , , O O
43 h/o NN B-NP O
43 EtOH NNP I-NP O
44 abuse NN I-NP O
44 , , O O
44 and CC O O
44 erectile JJ B-NP O
44 dysfunction NN I-NP O
44 presents NNS I-NP O
44 to TO O O
44 ED NNP B-NP O
44 for IN B-VP O
44 2nd CD O O
44 time NN B-NP O
44 in IN B-VP O
44 3 CD O O
44 days NNS B-NP O
45 w/ JJ O O
45 unsteadiness JJ O O
45 and CC O O
45 sleepiness NN B-NP O
45 He PRP O O
45 was VBD B-VP O
45 admitted VBN O O
45 8/4/06 CD O O
45 with IN B-VP O
45 similar JJ B-NP O
46 sleepiness NN I-NP O
46 and CC O O
46 poor JJ B-NP O
46 hand NN I-NP O
46 coordination NN I-NP O
46 and CC O O
46 trouble NN B-NP O
46 driving NN I-NP O
46 , , O O
46 was VBD B-VP O
46 brought VBN O O
47 to TO O O
47 ED NNP B-NP O
47 somnolent NN I-NP O
47 and CC O O
47 found VBN O O
47 to TO O O
47 have VB O O
47 BS NNP B-NP O
47 200-300 JJ B-NP O
47 Workup NNP I-NP O
47 including VBG O O
47 head NN B-NP O
48 CTA NNP I-NP O
48 , , O O
48 MR NNP B-NP O
48 were VBD B-VP O
48 negative JJ O O
48 and CC O O
48 patient JJ B-NP O
48 d/c'ed NN I-NP O
48 Thursday NNP I-NP O
48 night NN I-NP O
48 w/ NN I-NP O
48 metformin NN I-NP B-m
48 and CC O O
49 plans NNS B-NP O
49 for IN B-VP O
49 Holter NNP B-NP O
49 and CC O O
49 TTE NNP B-NP O
49 on IN B-VP O
49 Monday NNP B-NP O
49 Patient NNP I-NP O
49 felt VBD B-VP O
49 great JJ O O
49 until IN B-VP O
49 Friday NNP B-NP O
50 morning NN I-NP O
50 when WRB O O
50 noted VBN O O
50 to TO O O
50 have VB O O
50 unsteadiness JJ O O
50 and CC O O
50 sleepiness NN B-NP O
50 , , O O
50 similar JJ O O
50 but CC O O
50 less RBR O O
51 severe JJ O O
51 than IN B-VP O
51 Wed NNP B-NP O
51 Returned VBD B-VP O
51 to TO O O
51 ED NNP B-NP O
51 with IN B-VP O
51 BS NNP B-NP O
51 277 CD O O
51 No NNP B-NP O
51 fevers NNS I-NP O
51 , , O O
51 headaches NNS B-NP O
51 , , O O
51 focal JJ B-NP O
52 neuro NN I-NP O
52 findings NNS I-NP O
52 , , O O
52 vertigo NN B-NP O
52 , , O O
52 visual JJ B-NP O
52 changes NNS I-NP O
52 , , O O
52 CP NNP B-NP O
52 , , O O
52 SOB NNP B-NP O
52 , , O O
52 n/v RB O O
52 , , O O
52 abd JJ B-NP O
52 pain NN I-NP O
52 , , O O
53 dysuria NN B-NP O
53 , , O O
53 joint JJ B-NP O
53 pain NN I-NP O
53 Reported VBD B-VP O
53 small JJ B-NP B-r
53 rash NN I-NP I-r
53 on IN B-VP I-r
53 penis NN B-NP I-r
53 for IN B-VP I-r
53 which WDT O I-r
53 was VBD B-VP I-r
53 taking VBG O I-r
54 acyclovir NN B-NP B-m
54 this DT B-NP B-du
54 week NN I-NP I-du
54 but CC O O
54 stopped VBD B-VP O
54 Wed NNP B-NP O
54 for IN B-VP O
54 possible JJ B-NP O
54 neuro JJ I-NP O
54 side NN I-NP O
54 effects NNS I-NP O
55 Admit NNP I-NP O
55 labs VBD B-VP O
55 significant JJ O O
55 for IN B-VP O
55 glucose JJ O O
55 314 CD O O
55 , , O O
55 elevated VBN O O
55 lipids NNS B-NP O
55 ( ( O O
55 Chol NNP B-NP O
55 302 CD O O
55 , , O O
55 Trig NNP B-NP O
56 323 CD O O
56 , , O O
56 LDL NNP B-NP O
56 189 CD O O
56 ) ) O O
56 , , O O
56 otherwise RB O O
56 normal JJ O O
56 , , O O
56 negative JJ B-NP O
56 cardiac NN I-NP O
56 enzymes NNS I-NP O
56 Urine NNP I-NP O
56 toxin NN I-NP O
57 screen NN I-NP O
57 was VBD B-VP O
57 negative JJ B-NP O
57 CBC NNP I-NP O
57 normal JJ O O
57 except IN B-VP O
57 for IN B-VP O
57 MCV NNP B-NP O
57 78 CD O O
57 with IN B-VP O
57 normal JJ B-NP O
57 iron NN I-NP O
58 studies NNS I-NP O
58 and CC O O
58 normal JJ B-NP O
58 RBC NNP I-NP O
58 mass NN I-NP O
58 HbA1c NNP I-NP O
58 was VBD B-VP O
58 11.1% CD O O
58 EKG NNP B-NP O
58 had VBD B-VP O
58 old JJ B-NP O
58 j-point JJ I-NP O
59 elevation NN I-NP O
59 laterally RB O O
59 , , O O
59 otherwise RB O O
59 NSR NNP B-NP O
59 without IN B-VP O
59 LVH NNP B-NP O
59 or CC O O
59 LAE NNP B-NP O
59 Physical NNP I-NP O
59 and CC O O
59 neuro JJ B-NP O
60 exam NN I-NP O
60 normal JJ B-NP O
60 MRI/MRA NNP I-NP O
60 and CC O O
60 CTA NNP B-NP O
60 were VBD B-VP O
60 unremarkable JJ O O
60 in IN B-VP O
60 1st CD O O
60 admission NN B-NP O
60 2 CD O O
60 days NNS B-NP O
61 prior RB O O
61 and CC O O
61 so RB O O
61 were VBD B-VP O
61 not RB O O
61 repeated VBN O O
61 Patient NNP B-NP O
61 was VBD B-VP O
61 stable JJ O O
61 overnight JJ O O
61 and CC O O
61 felt VBD B-VP O
62 great JJ O O
62 on IN B-VP O
62 Saturday NNP B-NP O
62 0/11/06 CD O O
62 morning NN B-NP O
62 No NNP I-NP O
62 abnormal JJ B-NP O
62 events NNS I-NP O
62 were VBD B-VP O
62 recorded VBN O O
62 on IN B-VP O
63 telemetry NN B-NP O
63 overnight NN I-NP O
63 and CC O O
63 after IN B-VP O
63 patient NN B-NP O
63 was VBD B-VP O
63 walked VBN O O
63 around IN B-VP O
63 the DT B-NP O
63 floor NN I-NP O
64 Patient NNP I-NP O
64 sugars NNS I-NP O
64 were VBD B-VP O
64 managed VBN O O
64 o/n NN B-NP O
64 with IN B-VP O
64 sliding VBG O B-do
64 scale JJ B-NP I-do
64 insulin NN I-NP B-m
64 and CC O O
64 diabetic JJ B-NP O
65 low-fat JJ I-NP O
65 house NN I-NP O
65 diet NN I-NP O
65 , , O O
65 and CC O O
65 blood NN B-NP B-r
65 sugar NN I-NP I-r
65 in IN B-VP O
65 morning NN B-NP O
65 responded VBD B-VP O
65 down RB O O
65 to TO O O
65 185 CD O O
67 Explanations NNS B-NP O
67 for IN B-VP O
67 episodes NNS B-NP O
67 considered VBN O O
67 were VBD B-VP O
67 TIA NNP B-NP O
67 of IN B-VP O
67 posterior JJ B-NP O
67 circulation NN I-NP O
68 vs NN I-NP O
68 seizure NN I-NP O
68 , , O O
68 less RBR O O
68 likely JJ B-NP O
68 atypical JJ I-NP O
68 migraine NN I-NP O
68 or CC O O
68 sleep JJ B-NP O
68 disorder NN I-NP O
68 -- : O O
68 see VB O O
68 admit JJ B-NP O
69 notes NNS I-NP O
69 for IN B-VP O
69 discussion NN B-NP O
71 At IN B-VP O
71 time NN B-NP O
71 of IN B-VP O
71 discharge NN B-NP O
71 , , O O
71 patient NN B-NP O
71 was VBD B-VP O
71 stable JJ O O
71 and CC O O
71 feeling JJ O O
71 very RB O O
71 good JJ O O
71 , , O O
71 eager JJ O O
71 to TO O O
72 leave VB O O
72 for IN B-VP O
72 an DT B-NP O
72 afternoon NN I-NP O
72 function NN I-NP O
72 and CC O O
72 preferred VBD B-VP O
72 not RB O O
72 to TO O O
72 stay VB O O
72 for IN B-VP O
72 further JJ B-NP O
73 workup NN I-NP O
73 He PRP O O
73 will MD O O
73 followup VB O O
73 with IN B-VP O
73 Dr NNP B-NP O
73 Clesen NNP I-NP O
73 on IN B-VP O
73 Monday NNP B-NP O
73 He PRP O O
73 will MD O O
73 be VB O O
73 evaluated VBN O O
74 this DT B-NP O
74 week NN I-NP O
74 with IN B-VP O
74 TTE NNP B-NP O
74 with IN B-VP O
74 bubble-study NN B-NP O
74 to TO O O
74 r/o VB O O
74 intracardiac JJ B-NP O
74 source NN I-NP O
74 or CC O O
74 PFO NNP B-NP O
75 Would NNP I-NP O
75 also RB O O
75 consider VBP O O
75 EEG NNP B-NP O
75 if IN B-VP O
75 Neurology NNP B-NP O
75 deems VBZ O O
75 possibility NN B-NP O
75 of IN B-VP O
75 seizure NN B-NP O
75 In IN B-VP O
75 the DT B-NP O
76 meantime NN I-NP O
76 , , O O
76 added VBD B-VP O
76 low-dose JJ B-NP B-do
76 glyburide NN I-NP B-m
76 to TO O O
76 metformin VB O B-m
76 to TO O O
76 manage VB O O
76 hyperglycemia NN B-NP B-r
77 at IN B-VP O
77 home NN B-NP O
77 , , O O
77 with IN B-VP O
77 more RBR O O
77 strips NNS B-NP O
77 to TO O O
77 monitor VB O O
77 blood NN B-NP O
77 sugars NNS I-NP O
77 3-4x JJ B-NP O
77 / NNP I-NP O
77 day NN I-NP O
77 Have NNP I-NP O
77 also RB O O
78 increased VBD B-VP O
78 aspirin JJ B-NP B-m
78 aspirin NN I-NP B-m
78 dose NN I-NP O
78 from IN B-VP O
78 81 CD O B-do
78 mg NNS B-NP I-do
78 to TO O O
78 325 CD O B-do
78 mg NNS B-NP I-do
78 qd JJ B-NP B-f
78 qd JJ I-NP B-f
78 Patient NNP I-NP O
78 was VBD B-VP O
78 also RB O O
78 given VBN O O
79 prescription NN B-NP O
79 for IN B-VP O
79 automatic JJ B-NP O
79 BP NNP I-NP O
79 cuff NN I-NP O
79 for IN B-VP O
79 monitoring NN B-NP O
79 at IN B-VP O
79 home NN B-NP O
80 ADDITIONAL NNP I-NP O
80 COMMENTS: NNP I-NP O
80 To TO O O
80 better RBR O O
80 manage VB O O
80 your PRP$ O O
80 blood NN B-NP B-r
80 sugars NNS I-NP I-r
80 , , O O
80 added VBD B-VP O
80 glyburide NN B-NP B-m
80 which WDT O O
80 you PRP O O
80 should MD O O
80 take VB O O
81 once RB O B-f
81 a DT B-NP I-f
81 day NN I-NP I-f
81 in IN B-VP O
81 addition NN B-NP O
81 to TO O O
81 metformin VB O B-m
81 twice RB O B-f
81 a DT B-NP I-f
81 day NN I-NP I-f
81 Continue NNP I-NP O
81 to TO O O
81 check VB O O
81 your PRP$ O O
82 blood NN B-NP O
82 sugars NNS I-NP O
82 3-4 JJ B-NP O
82 times NNS I-NP O
82 per IN B-VP O
82 day NN B-NP O
82 You PRP O O
82 can MD O O
82 also RB O O
82 obtain VB O O
82 an DT B-NP O
82 automatic JJ I-NP O
82 BP NNP I-NP O
82 cuff NN I-NP O
83 for IN B-VP O
83 monitoring NN B-NP O
83 at IN B-VP O
83 home NN B-NP O
83 If IN B-VP O
83 episode JJ B-NP O
83 recurs NNS I-NP O
83 , , O O
83 do VBP O O
83 not RB O O
83 drive VB O O
83 , , O O
83 check VB O O
84 sugars NNS B-NP O
84 and CC O O
84 BP NNP B-NP O
84 , , O O
84 drink NN B-NP O
84 fluids NNS I-NP O
84 , , O O
84 contact NN B-NP O
84 MD NNP I-NP O
84 or CC O O
84 return VB O O
84 to TO O O
84 ED NNP B-NP O
84 as RB O O
84 soon RB O O
84 as IN B-VP O
85 possible JJ B-NP O
86 DISCHARGE NNP I-NP O
86 CONDITION: NNP I-NP O
86 Stable NNP I-NP O
87 TO NNP I-NP O
87 DO/PLAN: NNP I-NP O
88 f/u NN I-NP O
88 with IN B-VP O
88 Dr NNP B-NP O
88 Wantuck NNP I-NP O
88 on IN B-VP O
88 February NNP B-NP O
88 , , O O
88 that IN B-VP O
88 week NN B-NP O
88 should MD O O
88 have VB O O
88 TTE NNP B-NP O
88 with IN B-VP O
88 bubble JJ B-NP O
89 study NN I-NP O
89 to TO O O
89 evaluate VB O O
89 heart NN B-NP O
89 , , O O
89 EEG NNP B-NP O
89 to TO O O
89 r/o VB O O
89 seizure NN B-NP O
89 , , O O
89 titer NN B-NP O
89 hyperglycemia NN I-NP O
89 meds VBZ O O
90 No NNP B-NP O
90 dictated VBD B-VP O
90 summary JJ B-NP O
91 ENTERED NNP I-NP O
91 BY: NNP I-NP O
91 RIEGLE NNP I-NP O
91 , , O O
91 TRISTAN NNP B-NP O
91 F NNP I-NP O
91 , , O O
91 M.D NNP B-NP O
91 ( ( O O
91 SN83 NNP B-NP O
91 ) ) O O
91 10/5/06 CD O O
91 @ $ O O
91 01:46 CD O O
91 PM NNP B-NP O
92 ****** JJ B-NP O
92 END NNP I-NP O
92 OF NNP I-NP O
92 DISCHARGE NNP I-NP O
92 ORDERS NNP I-NP O
92 ****** NNP I-NP O
93 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #945230 VBZ O O
4 955804700 CD O O
4 OH NNP B-NP O
4 96181967 CD O O
4 3755263 CD O O
4 5/19/2004 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Congestive NNP I-NP O
4 Heart NNP I-NP O
4 Failure NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/6/2004 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 5/22/2004 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 TURTURO NNP I-NP O
8 , , O O
8 RAYFORD NNP B-NP O
8 759-74-53-9 CD O O
9 Reve NNP B-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 4/12/04 CD O O
11 AT NNP B-NP O
11 04:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 CORKERN NNP I-NP O
14 , , O O
14 ROBERTO NNP B-NP O
14 R NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
17 w/ NN I-NP O
17 services NNS I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 Override NNP I-NP O
20 Notice: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 1/16/04 CD O O
20 by IN B-VP O
20 JAHNS NNP B-NP O
20 , , O O
20 WINFRED NNP B-NP O
20 M NNP I-NP O
20 W NNP I-NP O
20 , , O O
20 M.D NNP B-NP O
20 , , O O
20 M.P.H NNP B-NP O
21 on IN B-VP O
21 order NN B-NP O
21 for IN B-VP O
21 WARFARIN NNP B-NP B-m
21 SODIUM NNP I-NP I-m
21 PO NNP I-NP B-mo
21 ( ( O O
21 ref JJ O O
21 # # O O
21 94959833 CD O O
21 ) ) O O
22 POTENTIALLY NNP B-NP O
22 SERIOUS NNP I-NP O
22 INTERACTION: NNP I-NP O
22 ASPIRIN NNP I-NP B-m
22 &amp; NNP I-NP O
22 WARFARIN NNP I-NP B-m
23 Reason NNP I-NP O
23 for IN B-VP O
23 override: NN B-NP O
23 pt NN I-NP O
23 on IN B-VP O
23 as IN B-VP O
23 outpt JJ B-NP O
24 ALLOPURINOL NNP I-NP B-m
24 100 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QD NNP I-NP B-f
25 Alert NNP I-NP O
25 overridden: NNP I-NP O
25 Override NNP I-NP O
25 added VBD B-VP O
25 on IN B-VP O
25 1/16/04 CD O O
25 by IN B-VP O
25 ZORRILLA NNP B-NP O
25 , , O O
25 OMAR NNP B-NP O
25 C NNP I-NP O
25 E NNP I-NP O
25 , , O O
25 M.D NNP B-NP O
25 , , O O
25 M.P.H NNP B-NP O
25 SERIOUS NNP I-NP O
25 INTERACTION: NNP I-NP O
25 WARFARIN NNP I-NP B-m
25 &amp; NNP I-NP O
25 ALLOPURINOL NNP I-NP B-m
26 Reason NNP I-NP O
26 for IN B-VP O
26 override: NN B-NP O
26 will MD O O
26 monitor VB O O
27 DIGOXIN NNP B-NP B-m
27 0.125 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QD NNP I-NP B-f
28 Override NNP I-NP O
28 Notice: NNP I-NP O
28 Override NNP I-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 1/16/04 CD O O
28 by IN B-VP O
28 BEGUN NNP B-NP O
28 , , O O
28 LANNY NNP B-NP O
28 E NNP I-NP O
28 F NNP I-NP O
28 , , O O
28 M.D NNP B-NP O
28 , , O O
28 M.P.H NNP B-NP O
28 on IN B-VP O
28 order NN B-NP O
28 for IN B-VP O
28 LEVOXYL NNP B-NP B-m
28 PO NNP I-NP B-mo
28 ( ( O O
28 ref JJ O O
28 # # O O
28 70031810 CD O O
28 ) ) O O
29 POTENTIALLY NNP B-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 DIGOXIN NNP I-NP B-m
29 &amp; NNP I-NP O
29 LEVOTHYROXINE NNP I-NP B-m
30 SODIUM NNP I-NP O
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 pt NN I-NP O
30 has VBZ O O
30 been VBN O O
30 on IN B-VP O
30 this DT O O
30 as IN B-VP O
30 an DT B-NP O
30 outpt NN I-NP O
31 LEVOXYL NNP I-NP B-m
31 ( ( O I-m
31 LEVOTHYROXINE NNP B-NP I-m
31 SODIUM NNP I-NP I-m
31 ) ) O I-m
31 75 CD O B-do
31 MCG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QD NNP I-NP B-f
32 Override NNP I-NP O
32 Notice: NNP I-NP O
32 Override NNP I-NP O
32 added VBD B-VP O
32 on IN B-VP O
32 1/16/04 CD O O
32 by IN B-VP O
32 CUZCO NNP B-NP O
32 , , O O
32 JAMISON NNP B-NP O
32 D NNP I-NP O
32 V NNP I-NP O
32 , , O O
32 M.D NNP B-NP O
32 , , O O
32 M.P.H NNP B-NP O
33 on IN B-VP O
33 order NN B-NP O
33 for IN B-VP O
33 WARFARIN NNP B-NP B-m
33 SODIUM NNP I-NP I-m
33 PO NNP I-NP B-mo
33 ( ( O O
33 ref JJ O O
33 # # O O
33 94959833 CD O O
33 ) ) O O
34 SERIOUS NNP B-NP O
34 INTERACTION: NNP I-NP O
34 LEVOTHYROXINE NNP I-NP B-m
34 SODIUM NNP I-NP I-m
34 &amp; NNP I-NP O
34 WARFARIN NNP I-NP B-m
35 Reason NNP I-NP O
35 for IN B-VP O
35 override: NN B-NP O
35 pt NN I-NP O
35 on IN B-VP O
35 as IN B-VP O
35 outpt JJ B-NP O
36 Previous NNP I-NP O
36 override IN B-VP O
36 information: JJ B-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 1/16/04 CD O O
37 by IN B-VP O
37 BRIDGETTE NNP B-NP O
37 , , O O
37 OSWALDO NNP B-NP O
37 T NNP I-NP O
37 , , O O
37 M.D NNP B-NP O
37 , , O O
37 M.P.H NNP B-NP O
38 POTENTIALLY NNP I-NP O
38 SERIOUS NNP I-NP O
38 INTERACTION: NNP I-NP O
38 DIGOXIN NNP I-NP B-m
38 &amp; NNP I-NP O
38 LEVOTHYROXINE NNP I-NP B-m
39 SODIUM NNP I-NP O
39 Reason NNP I-NP O
39 for IN B-VP O
39 override: NN B-NP O
39 pt NN I-NP O
39 has VBZ O O
39 been VBN O O
39 on IN B-VP O
39 this DT O O
39 as IN B-VP O
39 an DT B-NP O
39 outpt NN I-NP O
40 TOPROL NNP I-NP B-m
40 XL NNP I-NP I-m
40 ( ( O I-m
40 METOPROLOL NNP B-NP I-m
40 ( ( O I-m
40 SUST NNP B-NP I-m
40 REL NNP I-NP I-m
40 ) ) O I-m
40 ) ) O I-m
40 50 CD O B-do
40 MG NNP B-NP I-do
40 PO NNP I-NP B-mo
40 QD NNP I-NP B-f
41 Food/Drug NNP I-NP O
41 Interaction NNP I-NP O
41 Instruction NNP I-NP O
42 Take NNP I-NP O
42 consistently RB O O
42 with IN B-VP O
42 meals NNS B-NP O
42 or CC O O
42 on IN B-VP O
42 empty JJ B-NP O
42 stomach NN I-NP O
43 Number NNP I-NP B-du
43 of IN B-VP I-du
43 Doses NNP B-NP I-du
43 Required NNP I-NP I-du
43 ( ( O I-du
43 approximate JJ B-NP I-du
43 ): NN I-NP I-du
43 8 CD O I-du
44 NEURONTIN NNP B-NP B-m
44 ( ( O I-m
44 GABAPENTIN NNP B-NP I-m
44 ) ) O I-m
44 200 CD O B-do
44 MG NNP B-NP I-do
44 PO NNP I-NP B-mo
44 QD NNP I-NP B-f
45 COZAAR NNP I-NP B-m
45 ( ( O I-m
45 LOSARTAN NNP B-NP I-m
45 ) ) O I-m
45 100 CD O B-do
45 MG NNP B-NP I-do
45 PO NNP I-NP B-mo
45 QD NNP I-NP B-f
45 HOLD NNP I-NP O
45 IF: NNP I-NP O
45 sbp&lt;100 VBD B-VP O
46 Number NNP B-NP B-du
46 of IN B-VP I-du
46 Doses NNP B-NP I-du
46 Required NNP I-NP I-du
46 ( ( O I-du
46 approximate JJ B-NP I-du
46 ): NN I-NP I-du
46 9 CD O I-du
47 CELEXA NNP B-NP B-m
47 ( ( O I-m
47 CITALOPRAM NNP B-NP I-m
47 ) ) O I-m
47 20 CD O B-do
47 MG NNP B-NP I-do
47 PO NNP I-NP B-mo
47 QD NNP I-NP B-f
48 LANTUS NNP I-NP B-m
48 ( ( O I-m
48 INSULIN NNP B-NP I-m
48 GLARGINE NNP I-NP I-m
48 ) ) O I-m
48 50 CD O B-do
48 UNITS NNP B-NP I-do
48 SC NNP I-NP B-mo
48 QHS NNP I-NP B-f
49 WARFARIN NNP I-NP B-m
49 SODIUM NNP I-NP I-m
49 3 CD O B-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 QPM NNP I-NP B-f
50 Starting NNP I-NP O
50 ROUTINE NNP I-NP O
50 , , O O
50 20:00 CD O O
50 ( ( O O
50 7/5 CD O O
50 ) ) O O
51 Food/Drug NNP B-NP O
51 Interaction NNP I-NP O
51 Instruction NNP I-NP O
52 No NNP I-NP O
52 high JJ B-NP O
52 Vitamin-K NNP I-NP O
52 containing VBG O O
52 foods NNS B-NP O
53 Alert NNP I-NP O
53 overridden: VBD B-VP O
53 Override NNP B-NP O
53 added VBD B-VP O
53 on IN B-VP O
53 5/18/04 CD O O
53 by IN B-VP O
53 : : O O
54 POTENTIALLY NNP B-NP O
54 SERIOUS NNP I-NP O
54 INTERACTION: NNP I-NP O
54 SIMVASTATIN NNP I-NP B-m
54 &amp; NNP I-NP O
54 WARFARIN NNP I-NP B-m
55 SERIOUS NNP I-NP O
55 INTERACTION: NNP I-NP O
55 LEVOTHYROXINE NNP I-NP B-m
55 SODIUM NNP I-NP I-m
55 &amp; NNP I-NP O
55 WARFARIN NNP I-NP B-m
56 POTENTIALLY NNP I-NP O
56 SERIOUS NNP I-NP O
56 INTERACTION: NNP I-NP O
56 ASPIRIN NNP I-NP B-m
56 &amp; NNP I-NP O
56 WARFARIN NNP I-NP B-m
57 SERIOUS NNP I-NP O
57 INTERACTION: NNP I-NP O
57 ALLOPURINOL NNP I-NP B-m
57 &amp; NNP I-NP O
57 WARFARIN NNP I-NP B-m
58 POTENTIALLY NNP I-NP O
58 SERIOUS NNP I-NP O
58 INTERACTION: NNP I-NP O
58 LEVOFLOXACIN NNP I-NP B-m
58 &amp; NNP I-NP O
58 WARFARIN NNP I-NP B-m
59 POTENTIALLY NNP I-NP O
59 SERIOUS NNP I-NP O
59 INTERACTION: NNP I-NP O
59 LEVOFLOXACIN NNP I-NP B-m
59 &amp; NNP I-NP O
59 WARFARIN NNP I-NP B-m
60 Reason NNP I-NP O
60 for IN B-VP O
60 override: NN B-NP O
60 pt NN I-NP O
60 on IN B-VP O
60 as IN B-VP O
60 outpt NN B-NP O
60 will MD O O
60 monitor VB O O
61 LIPITOR NNP B-NP B-m
61 ( ( O I-m
61 ATORVASTATIN NNP B-NP I-m
61 ) ) O I-m
61 10 CD O B-do
61 MG NNP B-NP I-do
61 PO NNP I-NP B-mo
61 QD NNP I-NP B-f
62 PRILOSEC NNP I-NP B-m
62 ( ( O I-m
62 OMEPRAZOLE NNP B-NP I-m
62 ) ) O I-m
62 20 CD O B-do
62 MG NNP B-NP I-do
62 PO NNP I-NP B-mo
62 QD NNP I-NP B-f
63 TORSEMIDE NNP I-NP B-m
63 100 CD O B-do
63 MG NNP B-NP I-do
63 PO NNP I-NP B-mo
63 QAM NNP I-NP B-f
64 TORSEMIDE NNP I-NP B-m
64 50 CD O B-do
64 MG NNP B-NP I-do
64 PO NNP I-NP B-mo
64 QPM NNP I-NP B-f
65 DIET: NNP I-NP O
65 Patient NNP I-NP O
65 should MD O O
65 measure VB O O
65 weight JJ B-NP O
65 daily JJ I-NP O
66 DIET: NNP I-NP O
66 Fluid NNP I-NP O
66 restriction: VBD B-VP O
66 2 CD O O
66 liters NNS B-NP O
67 DIET: NNP I-NP O
67 House NNP I-NP O
67 / VBD B-VP O
67 Low NNP B-NP O
67 chol/low NN I-NP O
67 sat VBD B-VP O
67 fat JJ B-NP O
68 DIET: NNP I-NP O
68 House NNP I-NP O
68 / NNP I-NP O
68 ADA NNP I-NP O
68 1800 CD O O
68 cals/dy NN B-NP O
69 DIET: NNP I-NP O
69 2 CD O O
69 gram NN B-NP O
69 Sodium NNP I-NP O
70 ACTIVITY: NNP I-NP O
70 Walking NNP I-NP O
70 as IN B-VP O
70 tolerated VBN O O
71 FOLLOW NNP B-NP O
71 UP NNP I-NP O
71 APPOINTMENT( NNP I-NP O
71 S NNP I-NP O
71 ): NNP I-NP O
72 Dr NNP I-NP O
72 Wilfinger NNP I-NP O
72 , , O O
72 PCP NNP B-NP O
72 2 CD O O
72 weeks NNS B-NP O
72 , , O O
73 Corey NNP B-NP O
73 Ortmeyer NNP I-NP O
73 , , O O
73 CHF NNP B-NP O
73 clinic NN I-NP O
73 , , O O
73 Laxo NNP B-NP O
73 Hospital NNP I-NP O
73 , , O O
73 10:30am CD O O
73 11/28/04 CD O O
73 scheduled VBN O O
73 , , O O
74 Salvatore NNP B-NP O
74 Angeli NNP I-NP O
74 , , O O
74 pacer/icd NN B-NP O
74 clinic JJ O O
74 9:30am CD O O
74 ( ( O O
74 463 CD O O
74 ) ) O O
74 281 CD O O
74 7305 CD O O
74 7/1/04 CD O O
74 scheduled VBN O O
74 , , O O
75 INR NNP B-NP O
75 check NN I-NP O
75 at IN B-VP O
75 regular JJ B-NP O
75 location NN I-NP O
75 11/28/04 CD O O
75 , , O O
76 ALLERGY: NNP B-NP O
76 SHRIMP NNP I-NP O
77 ADMIT NNP I-NP O
77 DIAGNOSIS: NNP I-NP O
78 Congestive NNP I-NP O
78 Heart NNP I-NP O
78 Failure NNP I-NP O
79 PRINCIPAL NNP I-NP O
79 DISCHARGE NNP I-NP O
79 DIAGNOSIS NNP I-NP O
79 ;Responsible JJ O O
79 After IN B-VP O
79 Study NNP B-NP O
79 for IN B-VP O
79 Causing NNP B-NP O
79 Admission NNP I-NP O
79 ) ) O O
80 Congestive NNP B-NP O
80 Heart NNP I-NP O
80 Failure NNP I-NP O
81 OTHER NNP I-NP O
81 DIAGNOSIS;Conditions NNP I-NP O
81 , , O O
81 Infections NNP B-NP O
81 , , O O
81 Complications NNP B-NP O
81 , , O O
81 affecting VBG O O
81 Treatment/Stay NNP B-NP O
82 Adriamycin NNP I-NP B-m
82 induced VBD B-VP O
82 CMP NNP B-NP O
82 , , O O
82 HTN NNP B-NP O
82 , , O O
82 IDDM NNP B-NP O
82 , , O O
82 Sarcoid NNP B-NP O
82 , , O O
82 Left NNP B-NP O
82 Breast NNP I-NP O
82 CA- NNP I-NP O
82 s/p NN I-NP O
82 lumpect NN I-NP O
83 and CC O O
83 XRT/Adria-'84 NN B-NP O
83 , , O O
83 hypercholesterolemia NN B-NP O
83 , , O O
83 ? . B-VP O
83 GI NNP B-NP O
83 origin NN I-NP O
83 of IN B-VP O
83 epigastric JJ B-NP O
84 pain NN I-NP O
84 , , O O
84 dvt NN B-NP O
84 ( ( O O
84 deep JJ B-NP O
84 venous JJ I-NP O
84 thrombosis NN I-NP O
84 ) ) O O
84 , , O O
84 osteoarthritis FW O O
84 ( ( O O
84 unspecified JJ O O
84 or CC O O
85 generalized JJ B-NP O
85 OA NNP I-NP O
85 ) ) O O
85 , , O O
85 hypothyroid JJ O O
85 ( ( O O
85 hypothyroidism NN B-NP O
85 ) ) O O
85 cad NN B-NP O
85 ( ( O O
85 ) ) O O
86 OPERATIONS NNP B-NP O
86 AND NNP I-NP O
86 PROCEDURES: NNP I-NP O
87 VVI/R NNP I-NP O
87 ICD NNP I-NP O
87 placement NN I-NP O
87 11/16/4 CD O O
87 by IN B-VP O
87 Dr NNP B-NP O
87 Chan NNP I-NP O
88 OTHER NNP I-NP O
88 TREATMENTS/PROCEDURES NNP I-NP O
88 ( ( O O
88 NOT NNP B-NP O
88 IN NNP I-NP O
88 O.R NNP I-NP O
88 ) ) O O
89 none NN B-NP O
90 BRIEF NNP I-NP O
90 RESUME NNP I-NP O
90 OF NNP I-NP O
90 HOSPITAL NNP I-NP O
90 COURSE: NNP I-NP O
91 This DT O O
91 is VBZ O O
91 a DT O O
91 60 CD O O
91 year NN B-NP O
91 old JJ B-NP O
91 female NN I-NP O
91 with IN B-VP O
91 a DT B-NP O
91 history NN I-NP O
91 of IN B-VP O
91 breast NN B-NP O
91 cancer NN I-NP O
91 and CC O O
92 chemotherapy NN B-NP O
92 induced VBD B-VP O
92 CMP( NNP B-NP O
92 EF NNP I-NP O
92 20% CD O O
92 , , O O
92 followed VBN O O
92 by IN B-VP O
92 CMP NNP B-NP O
92 clinic; NN I-NP O
92 on IN B-VP O
92 2 CD O O
92 L NNP B-NP O
92 O2 NNP I-NP O
92 at IN B-VP O
93 night NN B-NP O
93 ) ) O O
93 , , O O
93 COPD NNP B-NP O
93 , , O O
93 s/p JJ B-NP O
93 DVT NNP I-NP O
93 now RB O O
93 anticoagulated VBD B-VP O
93 , , O O
93 HTN NNP B-NP O
93 , , O O
93 afib NN B-NP O
93 , , O O
93 DM NNP B-NP O
93 , , O O
93 admitted VBD B-VP O
94 with IN B-VP O
94 presumed JJ B-NP O
94 CHF NNP I-NP O
94 flare NN I-NP O
94 Ms NNP I-NP O
94 Guerena NNP I-NP O
94 was VBD B-VP O
94 recently RB O O
94 admitted VBN O O
94 for IN B-VP O
95 CHF NNP B-NP O
95 flare NN I-NP O
95 and CC O O
95 received VBD B-VP O
95 intravenous JJ B-NP O
95 diuresis NN I-NP O
95 She PRP O O
95 reponded VBD B-VP O
95 well RB O O
95 and CC O O
96 was VBD B-VP O
96 discharged VBN O O
96 at IN B-VP O
96 a DT B-NP O
96 dry JJ I-NP O
96 weight NN I-NP O
96 of IN B-VP O
96 approximately RB O O
96 185 CD O O
96 pounds NNS B-NP O
96 Ms NNP I-NP O
97 Kimmell NNP I-NP O
97 presented VBD B-VP O
97 on IN B-VP O
97 this DT B-NP O
97 admission NN I-NP O
97 with IN B-VP O
97 2 CD O O
97 days NNS B-NP O
97 of IN B-VP O
97 increasing VBG O O
97 SOB NNP B-NP O
97 , , O O
98 abdominal JJ B-NP O
98 discomfort NN I-NP O
98 , , O O
98 nausea NN B-NP O
98 and CC O O
98 vomitting VBG O O
98 She PRP O O
98 denied VBD B-VP O
98 increasing VBG O O
99 edema NN B-NP O
99 , , O O
99 change NN B-NP O
99 in IN B-VP O
99 number NN B-NP O
99 of IN B-VP O
99 pillows NNS B-NP O
99 She PRP O O
99 did VBD B-VP O
99 endorse VB O O
99 PND NNP B-NP O
99 present JJ O O
99 but CC O O
100 states VBZ O O
100 that IN B-VP O
100 it PRP O O
100 is VBZ O O
100 unchanged JJ O O
100 In IN B-VP O
100 ED NNP B-NP O
100 , , O O
100 the DT B-NP O
100 patient NN I-NP O
100 was VBD B-VP O
100 afebile RB O O
100 , , O O
100 inital JJ B-NP O
101 ly NN I-NP O
101 with IN B-VP O
101 oxygen NN B-NP O
101 saturation NN I-NP O
101 in IN B-VP O
101 the DT O O
101 high JJ O O
101 90's CD O O
101 on IN B-VP O
101 2 CD O O
101 L NNP B-NP O
101 BP NNP I-NP O
101 154/84 CD O O
101 BNP NNP B-NP O
101 was VBD B-VP O
102 greater JJR O O
102 than IN B-VP O
102 3000 CD O O
102 CXR NNP B-NP O
102 showed VBD B-VP O
102 pulmonary JJ B-NP O
102 edema JJ I-NP O
102 Abdominal NNP I-NP O
102 CT NNP I-NP O
102 was VBD B-VP O
103 obtained VBN O O
103 due JJ O O
103 to TO O O
103 concern NN B-NP O
103 for IN B-VP O
103 the DT B-NP O
103 patients NNS I-NP O
103 abdominal JJ B-NP O
103 pain NN I-NP O
103 and CC O O
103 showed VBD B-VP O
104 an DT O O
104 engorged VBN O O
104 , , O O
104 fatty JJ B-NP O
104 liver NN I-NP O
104 , , O O
104 ascites NNS B-NP O
104 , , O O
104 pleural JJ B-NP O
104 effusions NNS I-NP O
104 ( ( O O
104 not RB O O
104 seen VBN O O
105 on IN B-VP O
105 CXR NNP B-NP O
105 ) ) O O
105 A NNP B-NP O
105 surgical JJ B-NP O
105 consult NN I-NP O
105 was VBD B-VP O
105 obtained VBN O O
105 and CC O O
105 the DT B-NP O
105 surgeons NNS I-NP O
105 felt VBD B-VP O
105 the DT B-NP O
106 patients NNS I-NP O
106 abdominal JJ B-NP O
106 pain NN I-NP O
106 was VBD B-VP O
106 not RB O O
106 surgical JJ O O
106 in IN B-VP O
106 nature NN B-NP O
106 but CC O O
106 rather RB O O
106 secondary JJ O O
107 to TO O O
107 CHF NNP B-NP O
108 Hospital NNP I-NP O
108 Course: NNP I-NP O
109 1 CD O O
109 ) ) O O
109 Cardiovascular: NNP B-NP O
109 a DT O O
109 ) ) O O
109 Pump- NNP B-NP O
109 CHF NNP I-NP O
109 exacerbation NN I-NP O
109 We PRP O O
109 diuresed VBD B-VP O
109 the DT B-NP O
109 patient NN I-NP O
110 initially RB O O
110 with IN B-VP O
110 intravenous JJ B-NP B-mo
110 lasix NN I-NP B-m
110 until IN B-VP B-du
110 her PRP$ O O
110 respiratory NN B-NP O
110 status NN I-NP O
111 imroved VBN O O
111 and CC O O
111 the DT B-NP O
111 patient NN I-NP O
111 was VBD B-VP O
111 able JJ O O
111 to TO O O
111 maintain VB O O
111 good JJ B-NP O
111 oxygen NN I-NP O
111 saturation NN I-NP O
111 on IN B-VP O
112 room NN B-NP O
112 air NN I-NP O
112 At IN B-VP O
112 the DT B-NP O
112 time NN I-NP O
112 of IN B-VP O
112 discharge NN B-NP O
112 her PRP$ O O
112 oxygen NN B-NP O
112 saturation NN I-NP O
112 on IN B-VP O
112 room NN B-NP O
112 air NN I-NP O
113 was VBD B-VP O
113 in IN B-VP O
113 the DT O O
113 high JJ O O
113 90's CD O O
113 and CC O O
113 was VBD B-VP O
113 between IN B-VP O
113 94-96 CD O O
113 % NN B-NP O
113 with IN B-VP O
113 ambulation NN B-NP O
113 We PRP O O
114 continued VBD B-VP O
114 the DT B-NP O
114 patient's NN I-NP O
114 home NN I-NP B-do
114 doses NNS I-NP I-do
114 of IN B-VP O
114 beta NN B-NP B-m
114 blocker NN I-NP I-m
114 , , O O
114 angiotension NN B-NP B-m
115 receptor NN I-NP O
115 blocker NN I-NP O
115 and CC O O
115 statin VB O B-m
115 The DT B-NP O
115 patient NN I-NP O
115 was VBD B-VP O
115 again RB O O
115 encouraged VBN O O
115 to TO O O
116 adhere VB O O
116 to TO O O
116 a DT B-NP O
116 low-salt JJ I-NP O
116 diet NN I-NP O
116 and CC O O
116 weight VBD B-VP O
116 herself PRP O O
116 daily RB O O
116 The DT B-NP O
116 patient NN I-NP O
116 will MD O O
116 be VB O O
117 discharged VBN O O
117 on IN B-VP O
117 Torsemide NNP B-NP B-m
117 Torsemide NNP I-NP B-m
117 100 CD O B-do
117 mg NN B-NP I-do
117 po NN I-NP B-mo
117 q NN I-NP B-f
117 am VBP O I-f
117 and CC O O
117 50 CD O B-do
117 mg NN B-NP I-do
117 po NN I-NP B-mo
117 q NN I-NP B-f
117 pm NN I-NP I-f
117 , , O O
117 a DT B-NP O
117 regimine NN I-NP O
117 t NN I-NP O
118 has VBZ O O
118 worked VBN O O
118 will MD O O
118 for IN B-VP O
118 the DT B-NP O
118 patient NN I-NP O
118 in IN B-VP O
118 the DT O O
118 past JJ O O
118 She PRP O O
118 will MD O O
118 f/uw VB O O
118 iht VB O O
118 the DT B-NP O
119 Naiimo NNP I-NP O
119 Hospital NNP I-NP O
119 CHF NNP I-NP O
119 Clinic NNP I-NP O
119 ( ( O O
119 Harold NNP B-NP O
119 Gohring NNP I-NP O
119 ) ) O O
119 on IN B-VP O
119 5/10 CD O O
119 at IN B-VP O
119 10:30 CD O O
119 am VBP O O
119 The DT B-NP O
120 patient NN I-NP O
120 will MD O O
120 be VB O O
120 followed VBN O O
120 by IN B-VP O
120 Rangespo NNP B-NP O
120 Chica NNP I-NP O
120 Li NNP I-NP O
120 VNA NNP I-NP O
120 who WP O O
120 will MD O O
120 assist VB O O
120 in IN B-VP O
120 her PRP$ O O
120 CHF NNP B-NP O
121 monitoring NN I-NP O
121 and CC O O
121 assess VB O O
121 her PRP$ O O
121 for IN B-VP O
121 home NN B-NP O
121 PT NNP I-NP O
121 b NN I-NP O
121 ) ) O O
121 Rhythm- NNP B-NP O
121 The DT B-NP O
122 pa NN I-NP O
122 tient NN I-NP O
122 is VBZ O O
122 know VBN O O
122 to TO O O
122 have VB O O
122 frequent JJ B-NP O
122 PVCs NNP I-NP O
122 and CC O O
122 non-sustained JJ B-NP O
122 ventricular NN I-NP O
123 tachycardia NN I-NP O
123 which WDT O O
123 was VBD B-VP O
123 agian JJ O O
123 noted VBN O O
123 on IN B-VP O
123 this DT B-NP O
123 admission NN I-NP O
123 on IN B-VP O
123 telemetry NN B-NP O
124 She PRP O O
124 was VBD B-VP O
124 asymptomatic JJ O O
124 with IN B-VP O
124 the DT B-NP O
124 NSVT NNP I-NP O
124 and CC O O
124 remains VBZ O O
124 hemodynamically RB O O
124 stable JJ O O
125 We PRP O O
125 obtained VBD B-VP O
125 an DT B-NP O
125 electrophysiology NN I-NP O
125 consult NN I-NP O
125 to TO O O
125 evaluate VB O O
125 the DT B-NP O
125 need NN I-NP O
125 for IN B-VP O
125 an DT B-NP O
126 AICD NNP I-NP O
126 or CC O O
126 biventricular JJ O O
126 pacing VBG O O
126 The DT B-NP O
126 patietns NN I-NP O
126 electrolytes NNS I-NP O
126 and CC O O
126 magnesium NN B-NP O
127 were VBD B-VP O
127 monitored VBN O O
127 and CC O O
127 rempleted VBN O O
127 and CC O O
127 she PRP O O
127 was VBD B-VP O
127 maintained VBN O O
127 on IN B-VP O
127 a DT B-NP O
127 beta NN I-NP B-m
127 blocker NN I-NP I-m
128 On IN B-VP O
128 10/7 CD O O
128 the DT B-NP O
128 EP NNP I-NP O
128 service NN I-NP O
128 placed VBD B-VP O
128 a DT B-NP O
128 VVI/R NNP I-NP O
128 ICD NNP I-NP O
128 device NN I-NP O
128 without IN B-VP O
128 complications NNS B-NP O
129 It PRP O O
129 was VBD B-VP O
129 interogated VBN O O
129 ont IN B-VP O
129 he PRP O O
129 day NN B-NP O
129 of IN B-VP O
129 d/c NN B-NP O
129 and CC O O
129 the DT B-NP O
129 patietn NN I-NP O
129 was VBD B-VP O
129 provided VBN O O
129 with IN B-VP O
130 written VBN O O
130 instructions NNS B-NP O
130 from IN B-VP O
130 the DT B-NP O
130 EP NNP I-NP O
130 service NN I-NP O
130 for IN B-VP O
130 d/c NN B-NP O
130 She PRP O O
130 will MD O O
130 follow-up VB O O
131 with IN B-VP O
131 the DT B-NP O
131 Dr NNP I-NP O
131 Cradduck NNP I-NP O
131 on IN B-VP O
131 6/22 CD O O
131 as IN B-VP O
131 described VBN O O
131 c NN B-NP O
131 ) ) O O
131 Ischemia: NNP B-NP O
132 Patient NNP I-NP O
132 with IN B-VP O
132 a DT B-NP O
132 history NN I-NP O
132 of IN B-VP O
132 CAD NNP B-NP O
133 ED NNP I-NP O
133 initially RB O O
133 concerned VBD B-VP O
133 for IN B-VP O
133 a DT B-NP O
133 myocardial JJ I-NP O
133 infarction NN I-NP O
133 She PRP O O
133 was VBD B-VP O
133 ruled VBN O O
133 o RP O O
134 ut JJ O O
134 for IN B-VP O
134 an DT B-NP O
134 MI NNP I-NP O
134 with IN B-VP O
134 negative JJ B-NP O
134 cardiac JJ I-NP O
134 enzymes NNS I-NP O
134 x VBP O O
134 3 CD O O
134 Serial JJ B-NP O
134 EKG's NNP I-NP O
135 were VBD B-VP O
135 unchanged JJ O O
135 We PRP O O
135 continued VBD B-VP O
135 the DT B-NP O
135 patient NN I-NP O
135 on IN B-VP O
135 ASA NNP B-NP B-m
135 , , O O
135 beta NN B-NP B-m
135 blocker NN I-NP I-m
135 , , O O
135 s JJ B-NP O
136 tatin NN I-NP O
136 and CC O O
136 ARB NNP B-NP B-m
136 2 CD O O
136 )Heme: NNP B-NP O
136 Ms NNP I-NP O
136 Egerton NNP I-NP O
136 has VBZ O O
136 a DT B-NP O
136 history NN I-NP O
136 of IN B-VP O
136 DVT NNP B-NP B-r
136 , , O O
136 therapeutic JJ O O
137 on IN B-VP O
137 coumadin NN B-NP B-m
137 at IN B-VP O
137 the DT B-NP O
137 time NN I-NP O
137 of IN B-VP O
137 admission NN B-NP O
137 We PRP O O
137 did VBD B-VP O
137 decreased VBD B-VP O
137 her PRP$ O O
138 dose NN B-NP O
138 while IN B-VP O
138 being VBG O O
138 treated VBN O O
138 with IN B-VP O
138 levofloxacin NN B-NP B-m
138 In IN B-VP O
138 addition NN B-NP O
138 her PRP$ O O
138 coumadin NN B-NP B-m
139 was VBD B-VP O
139 held VBN O O
139 for IN B-VP O
139 her PRP$ O B-r
139 EP JJ B-NP I-r
139 procedure NN I-NP I-r
139 At IN B-VP O
139 the DT B-NP O
139 time NN I-NP O
139 of IN B-VP O
139 d/c NN B-NP O
139 she PRP O O
139 will MD O O
139 be VB O O
140 resuming VBG O O
140 her PRP$ O O
140 regular JJ B-NP B-do
140 dose NN I-NP I-do
140 of IN B-VP O
140 coumadin NN B-NP B-m
140 and CC O O
140 should MD O O
140 follow-up VB O O
140 at IN B-VP O
140 her PRP$ O O
141 usualy JJ B-NP O
141 JMC NNP I-NP O
141 lab NN I-NP O
141 to TO O O
141 have VB O O
141 her PRP$ O O
141 INR NNP B-NP O
141 checked NN I-NP O
141 on IN B-VP O
141 Thursday NNP B-NP O
141 5/10 CD O O
141 3 CD O O
141 )ID: JJ B-NP O
141 +UA NN I-NP O
141 on IN B-VP O
142 admission NN B-NP O
142 treated VBN O O
142 for IN B-VP B-du
142 three CD O I-du
142 days NNS B-NP I-du
142 with IN B-VP O
142 levofloxacin NN B-NP B-m
142 ( ( O O
142 Last JJ B-NP O
142 day NN I-NP O
142 was VBD B-VP O
143 1/16/4 CD O O
143 ) ) O O
143 Her PRP$ O O
143 cx NN B-NP O
143 grew VBD B-VP O
143 citrobacter NN B-NP O
143 which WDT O O
143 was VBD B-VP O
143 sensitive JJ O O
143 to TO O O
143 levo VB O B-m
143 Repeat NNP B-NP O
144 UA NNP I-NP O
144 was VBD B-VP O
144 negative JJ O O
144 4 CD O O
144 ) ) O O
144 GI: NNP B-NP O
144 Abdominal NNP I-NP O
144 discomfort NN I-NP O
144 presumably RB O O
144 due JJ O O
145 to TO O O
145 hepatic JJ B-NP O
145 congestion NN I-NP O
145 Abdominal NNP I-NP O
145 CT NNP I-NP O
145 showed VBD B-VP O
145 no DT B-NP O
145 acute JJ I-NP O
145 surgical JJ I-NP O
145 process NN I-NP O
146 Abdominal NNP I-NP O
146 pain NN I-NP O
146 was VBD B-VP O
146 resolved VBN O O
146 with IN B-VP O
146 diuresis NN B-NP O
146 She PRP O O
146 does VBZ O O
146 have VB O O
146 a DT B-NP O
147 chronic JJ I-NP O
147 elevated JJ I-NP O
147 alk NN I-NP O
147 phos NN I-NP O
147 which WDT O O
147 may MD O O
147 be VB O O
147 related VBN O O
147 to TO O O
147 her PRP$ O O
148 sarcoid JJ O O
148 6 CD O O
148 )Endocrine: JJ B-NP O
148 Continued NNP I-NP O
149 levoxyl NN I-NP B-m
149 for IN B-VP O
149 the DT B-NP B-r
149 patient's NN I-NP I-r
149 hypothyroid NN I-NP I-r
149 Pt NNP I-NP O
149 with IN B-VP O
149 IDDM NNP B-NP O
149 We PRP O O
149 decreased VBD B-VP O
150 her PRP O O
150 lantus NN B-NP B-m
150 lantus NN I-NP B-m
150 dose NN I-NP O
150 from IN B-VP O
150 50 CD O B-do
150 u JJ B-NP I-do
150 sc NN I-NP B-mo
150 to TO O O
150 30 CD O B-do
150 u JJ B-NP I-do
150 sc NN I-NP B-mo
150 on IN B-VP O
150 admission NN B-NP O
150 as IN B-VP O
150 po JJ B-NP O
151 intake NN I-NP O
151 was VBD B-VP O
151 initially RB O O
151 low JJ B-NP O
151 Pt NNP I-NP O
151 can MD O O
151 resume VB O O
151 regular JJ B-NP B-m
152 insulin NN I-NP O
152 dose NN I-NP O
152 after IN B-VP O
152 discharge NN B-NP O
152 when WRB O O
152 she PRP O O
152 resumes VBZ O O
152 her PRP$ O O
153 outpatient JJ B-NP O
153 eating JJ I-NP O
153 habits NNS I-NP O
153 7 CD O O
153 ) ) O O
153 General: NNP B-NP O
153 PT NNP I-NP O
153 consulted VBD B-VP O
153 to TO O O
153 assist VB O O
153 in IN B-VP O
154 prevention NN B-NP O
154 deconditioning VBG O O
154 while IN B-VP O
154 in IN B-VP O
154 the DT B-NP O
154 hospital NN I-NP O
154 VNA NNP I-NP O
154 will MD O O
154 evaluate VB O O
154 need NN B-NP O
155 for IN B-VP O
155 home NN B-NP O
155 PT NNP I-NP O
155 services NNS I-NP O
156 ADDITIONAL NNP I-NP O
156 COMMENTS: NNP I-NP O
156 1 CD O O
156 Weight NNP B-NP O
156 yourself PRP O O
156 daily RB O O
156 , , O O
156 call VB O O
156 your PRP$ O O
156 doctor NN B-NP O
156 when WRB O O
156 your PRP$ O O
156 weight NN B-NP O
156 increases VBZ O O
157 2 CD O O
157 Follow-up JJ O O
157 with IN B-VP O
157 your PRP$ O O
157 Primary NNP B-NP O
157 Care NNP I-NP O
157 Physician NNP I-NP O
157 in IN B-VP O
157 2 CD O O
157 weeks NNS B-NP O
158 3 CD O O
158 Follow-up NN B-NP O
158 at IN B-VP O
158 the DT B-NP O
158 CHF NNP I-NP O
158 clinic NN I-NP O
158 on IN B-VP O
158 Thursday NNP B-NP O
158 5/10 CD O O
158 with IN B-VP O
158 Jeffry NNP B-NP O
158 Vaudrain NNP I-NP O
158 at IN B-VP O
159 10:30am CD O O
160 4.New CD O O
160 Medication: NNP B-NP O
160 ( ( O O
160 Replaces NNP B-NP O
160 lasix RB O B-m
160 ) ) O O
160 Torsemide NNP B-NP B-m
160 Torsemide NNP I-NP B-m
160 100 CD O B-do
160 mg NN B-NP I-do
160 every DT B-NP B-f
160 morning NN I-NP I-f
160 and CC O O
161 100 CD O B-do
161 mg NN B-NP I-do
161 po NN I-NP B-mo
161 everynight VBD B-VP B-f
162 5 CD O O
162 Follow-up JJ O O
162 with IN B-VP O
162 Dr NNP B-NP O
162 Newsome NNP I-NP O
162 ( ( O O
162 377 CD O O
162 )062-0660 JJ O O
162 0/27 CD O O
162 at IN B-VP O
162 9:30 CD O O
162 am VBP O O
162 for IN B-VP O
162 your PRP$ O O
162 ICD NNP B-NP O
163 DISCHARGE NNP I-NP O
163 CONDITION: NNP I-NP O
163 Stable NNP I-NP O
164 TO NNP I-NP O
164 DO/PLAN: NNP I-NP O
165 1 CD O O
165 Keep NNP B-NP O
165 appointments NNS I-NP O
165 as IN B-VP O
165 outlined VBN O O
165 above IN B-VP O
166 2 CD O O
166 Have VBP O O
166 your PRP$ O O
166 INR NNP B-NP O
166 checked VBD B-VP O
166 on IN B-VP O
166 Friday NNP B-NP O
166 5/10 CD O O
167 3 CD O O
167 Weight NNP B-NP O
167 yourself PRP O O
167 daily RB O O
167 Call VB O O
167 your PRP$ O O
167 PCP NNP B-NP O
167 if IN B-VP O
167 your PRP$ O O
167 weight NN B-NP O
167 increases VBZ O O
168 4 CD O O
168 Follow NNP B-NP O
168 written VBN O O
168 EP NNP B-NP O
168 discharge NN I-NP O
168 instructions NNS I-NP O
169 5 CD O O
169 Fort NNP B-NP O
169 VNA NNP I-NP O
169 will MD O O
169 resume VB O O
169 services NNS B-NP O
169 adn RB O O
169 follow VBP O O
169 pt NN B-NP O
169 for IN B-VP O
169 CHF NNP B-NP O
169 as RB O O
169 well RB O O
169 as IN B-VP O
170 assess NN B-NP O
170 need NN I-NP O
170 for IN B-VP O
170 home NN B-NP O
170 PT NNP I-NP O
171 No NNP I-NP O
171 dictated VBD B-VP O
171 summary JJ B-NP O
172 ENTERED NNP I-NP O
172 BY: NNP I-NP O
172 HAMON NNP I-NP O
172 , , O O
172 DANIAL NNP B-NP O
172 A NNP I-NP O
172 , , O O
172 M.D NNP B-NP O
172 , , O O
172 M.P.H NNP B-NP O
172 ( ( O O
172 YM190 NNP B-NP O
172 ) ) O O
172 4/12/04 CD O O
172 @ $ O O
172 04:06 CD O O
172 PM NNP B-NP O
173 ****** JJ B-NP O
173 END NNP I-NP O
173 OF NNP I-NP O
173 DISCHARGE NNP I-NP O
173 ORDERS NNP I-NP O
173 ****** NNP I-NP O
174 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #948640 VBZ O O
2 459567785 CD O O
2 C NNP B-NP O
2 08087955 CD O O
2 1334797 CD O O
2 0/10/2004 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Dehydration NNP I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 0/23/2004 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/17/2004 CD O O
4 ****** NNP B-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 KIMME NNP I-NP O
5 , , O O
5 ODELL NNP B-NP O
5 037-96-25-8 NNP I-NP O
6 Saso NNP I-NP O
6 Downallge NNP I-NP O
6 As IN B-VP O
7 Service: NNP B-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 2/21/04 CD O O
8 AT NNP B-NP O
8 04:30 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 HO NNP I-NP O
9 evaluation NN I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 PESTRONK NNP I-NP O
11 , , O O
11 VERN NNP B-NP O
11 N NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 No NNP I-NP O
13 CPR NNP I-NP O
13 / VBZ O O
13 No DT B-NP O
13 defib NN I-NP O
13 / VBZ O O
13 No DT B-NP O
13 intubation NN I-NP O
13 / VBZ O O
14 DISPOSITION: NNP B-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ECASA NNP I-NP B-m
16 ( ( O I-m
16 ASPIRIN NNP B-NP I-m
16 ENTERIC NNP I-NP I-m
16 COATED NNP I-NP I-m
16 ) ) O I-m
16 325 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
17 Override NNP I-NP O
17 Notice: NNP I-NP O
17 Override NNP I-NP O
17 added VBD B-VP O
17 on IN B-VP O
17 4/24/04 CD O O
17 by IN B-VP O
17 BLAIN NNP B-NP O
17 , , O O
17 GUILLERMO NNP B-NP O
17 P NNP I-NP O
17 , , O O
17 M.D NNP B-NP O
17 on IN B-VP O
17 order NN B-NP O
17 for IN B-VP O
17 COUMADIN NNP B-NP B-m
17 PO NNP I-NP B-mo
17 ( ( O O
17 ref JJ O O
17 # # O O
17 11219725 CD O O
17 ) ) O O
18 POTENTIALLY NNP B-NP O
18 SERIOUS NNP I-NP O
18 INTERACTION: NNP I-NP O
18 ASPIRIN NNP I-NP B-m
18 &amp; NNP I-NP O
18 WARFARIN NNP I-NP B-m
19 Reason NNP I-NP O
19 for IN B-VP O
19 override: NN B-NP O
19 will MD O O
19 monitor VB O O
20 FOLATE NNP B-NP B-m
20 ( ( O I-m
20 FOLIC NNP B-NP I-m
20 ACID NNP I-NP I-m
20 ) ) O I-m
20 1 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
20 Starting VBG O O
20 Today NNP B-NP O
20 ( ( O O
20 9/24 CD O O
20 ) ) O O
21 LISINOPRIL FW O B-m
21 30 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
22 Override NNP I-NP O
22 Notice: NNP I-NP O
22 Override NNP I-NP O
22 added VBD B-VP O
22 on IN B-VP O
22 4/24/04 CD O O
22 by IN B-VP O
22 HIND NNP B-NP O
22 , , O O
22 JORGE NNP B-NP O
22 M NNP I-NP O
22 , , O O
22 M.D NNP B-NP O
23 on IN B-VP O
23 order NN B-NP O
23 for IN B-VP O
23 POTASSIUM NNP B-NP B-m
23 CHLORIDE NNP I-NP I-m
23 IMMED NNP I-NP I-m
23 REL NNP I-NP I-m
23 PO NNP I-NP B-mo
23 ( ( O O
23 ref JJ O O
23 # # O O
24 22545591 CD O O
24 ) ) O O
25 POTENTIALLY NNP B-NP O
25 SERIOUS NNP I-NP O
25 INTERACTION: NNP I-NP O
25 LISINOPRIL NNP I-NP B-m
25 &amp; NNP I-NP O
25 POTASSIUM NNP I-NP B-m
26 CHLORIDE NNP I-NP O
26 Reason NNP I-NP O
26 for IN B-VP O
26 override: NN B-NP O
26 will MD O O
26 monitor VB O O
27 THIAMINE NNP B-NP B-m
27 HCL NNP I-NP I-m
27 100 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QD NNP I-NP B-f
28 MVI NNP I-NP B-m
28 THERAPEUTIC NNP I-NP I-m
28 ( ( O I-m
28 THERAPEUTIC NNP B-NP I-m
28 MULTIVITAMINS NNP I-NP I-m
28 ) ) O I-m
28 1 CD O B-do
28 TAB NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QD NNP I-NP B-f
29 Override NNP I-NP O
29 Notice: NNP I-NP O
29 Override NNP I-NP O
29 added VBD B-VP O
29 on IN B-VP O
29 4/24/04 CD O O
29 by IN B-VP O
29 DEGRANGE NNP B-NP O
29 , , O O
29 DIEGO NNP B-NP O
29 A NNP I-NP O
29 , , O O
29 M.D NNP B-NP O
29 on IN B-VP O
29 order NN B-NP O
29 for IN B-VP O
29 SIMVASTATIN NNP B-NP B-m
29 PO NNP I-NP B-mo
29 ( ( O O
29 ref JJ O O
29 # # O O
29 59315078 CD O O
29 ) ) O O
30 POTENTIALLY NNP B-NP O
30 SERIOUS NNP I-NP O
30 INTERACTION: NNP I-NP O
30 NIACIN NNP I-NP B-m
30 , , O O
30 VIT NNP B-NP B-m
30 B-3 NNP I-NP I-m
30 &amp; NNP I-NP O
31 SIMVASTATIN NNP I-NP B-m
31 Reason NNP I-NP O
31 for IN B-VP O
31 override: NN B-NP O
31 will MD O O
31 monitor VB O O
32 CREON NNP B-NP B-m
32 20 CD O I-m
32 ( ( O I-m
32 PANCRELIPASE NNP B-NP I-m
32 20000U CD O I-m
32 ) ) O I-m
32 4 CD O B-do
32 CAPSULE NNP B-NP I-do
32 PO NNP I-NP B-mo
32 TID NNP I-NP B-f
33 Instructions: NNP I-NP O
33 with IN B-VP O
33 meals NNS B-NP O
34 LEVOFLOXACIN NNP I-NP B-m
34 500 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 QD NNP I-NP B-f
34 Starting VBG O O
34 Today NNP B-NP O
34 ( ( O O
34 9/24 CD O O
34 ) ) O O
35 Food/Drug NNP B-NP O
35 Interaction NNP I-NP O
35 Instruction NNP I-NP O
36 Administer NNP I-NP O
36 iron NN I-NP B-m
36 products NNS I-NP I-m
36 a DT B-NP O
36 minimum NN I-NP O
36 of IN B-VP O
36 2 CD O O
36 hours NNS B-NP O
36 before IN B-VP O
36 or CC O O
37 after IN B-VP O
37 a DT B-NP O
37 levofloxacin NN I-NP B-m
37 or CC O O
37 ciprofloxacin NN B-NP B-m
37 dose VBP O O
37 dose JJ O O
38 If IN B-VP O
38 on IN B-VP O
38 tube NN B-NP O
38 feeds NNS I-NP O
38 , , O O
38 please VB O O
38 cycle NN B-NP O
38 ( ( O O
38 hold VB O O
38 1 CD O O
38 hr NN B-NP O
38 before IN B-VP O
38 to TO O O
38 2 CD O O
38 hr NNS B-NP O
39 after IN B-VP O
39 ) ) O O
39 Take VBP O O
39 2 CD O O
39 hours NNS B-NP O
39 before IN B-VP O
39 or CC O O
39 2 CD O O
39 hours NNS B-NP O
39 after IN B-VP O
39 dairy NN B-NP O
39 products NNS I-NP O
40 Alert NNP I-NP O
40 overridden: MD O O
40 Override NNP B-NP O
40 added VBD B-VP O
40 on IN B-VP O
40 11/16/04 CD O O
40 by IN B-VP O
41 NORSETH NNP B-NP O
41 , , O O
41 ARMANDO NNP B-NP O
41 T NNP I-NP O
41 , , O O
41 M.D NNP B-NP O
41 , , O O
41 PH.D NNP B-NP O
42 POTENTIALLY NNP I-NP O
42 SERIOUS NNP I-NP O
42 INTERACTION: NNP I-NP O
42 WARFARIN NNP I-NP B-m
42 &amp; NNP I-NP O
42 LEVOFLOXACIN NNP I-NP B-m
43 Reason NNP I-NP O
43 for IN B-VP O
43 override: NN B-NP O
43 monitoring NN I-NP O
44 LANTUS NNP I-NP B-m
44 ( ( O I-m
44 INSULIN NNP B-NP I-m
44 GLARGINE NNP I-NP I-m
44 ) ) O I-m
44 20 CD O B-do
44 UNITS NNP B-NP I-do
44 SC NNP I-NP B-mo
44 QD NNP I-NP B-f
45 Starting VBG O O
45 Today NNP B-NP O
45 ( ( O O
45 9/24 CD O O
45 ) ) O O
46 LASIX NNP B-NP B-m
46 ( ( O I-m
46 FUROSEMIDE NNP B-NP I-m
46 ) ) O I-m
46 40 CD O B-do
46 MG NNP B-NP I-do
46 PO NNP I-NP B-mo
46 QD NNP I-NP B-f
47 LIPITOR NNP I-NP B-m
47 ( ( O I-m
47 ATORVASTATIN NNP B-NP I-m
47 ) ) O I-m
47 20 CD O B-do
47 MG NNP B-NP I-do
47 PO NNP I-NP B-mo
47 QD NNP I-NP B-f
48 Alert NNP I-NP O
48 overridden: NNP I-NP O
48 Override NNP I-NP O
48 added VBD B-VP O
48 on IN B-VP O
48 2/21/04 CD O O
48 by IN B-VP O
48 : : O O
49 POTENTIALLY NNP B-NP O
49 SERIOUS NNP I-NP O
49 INTERACTION: NNP I-NP O
49 NIACIN NNP I-NP B-m
49 , , O O
49 VIT NNP B-NP B-m
49 B-3 NNP I-NP I-m
49 &amp; NNP I-NP O
50 ATORVASTATIN NNP I-NP B-m
50 CALCIUM NNP I-NP I-m
50 Reason NNP I-NP O
50 for IN B-VP O
50 override: NN B-NP O
51 will MD O O
51 not RB O O
51 prescribe VB O O
51 niacin JJ B-NP O
52 COUMADIN NNP I-NP B-m
52 ( ( O I-m
52 WARFARIN NNP B-NP I-m
52 SODIUM NNP I-NP I-m
52 ) ) O I-m
52 5 CD O B-do
52 MG NNP B-NP I-do
52 PO NNP I-NP B-mo
52 QPM NNP I-NP B-f
53 Food/Drug NNP I-NP O
53 Interaction NNP I-NP O
53 Instruction NNP I-NP O
54 No NNP I-NP O
54 high JJ B-NP O
54 Vitamin-K NNP I-NP O
54 containing VBG O O
54 foods NNS B-NP O
55 Alert NNP I-NP O
55 overridden: VBD B-VP O
55 Override NNP B-NP O
55 added VBD B-VP O
55 on IN B-VP O
55 2/21/04 CD O O
55 by IN B-VP O
55 : : O O
56 POTENTIALLY NNP B-NP O
56 SERIOUS NNP I-NP O
56 INTERACTION: NNP I-NP O
56 ASPIRIN NNP I-NP B-m
56 &amp; NNP I-NP O
56 WARFARIN NNP I-NP B-m
57 POTENTIALLY NNP I-NP O
57 SERIOUS NNP I-NP O
57 INTERACTION: NNP I-NP O
57 SIMVASTATIN NNP I-NP B-m
57 &amp; NNP I-NP O
57 WARFARIN NNP I-NP B-m
58 POTENTIALLY NNP I-NP O
58 SERIOUS NNP I-NP O
58 INTERACTION: NNP I-NP O
58 LEVOFLOXACIN NNP I-NP B-m
58 &amp; NNP I-NP O
58 WARFARIN NNP I-NP B-m
59 POTENTIALLY NNP I-NP O
59 SERIOUS NNP I-NP O
59 INTERACTION: NNP I-NP O
59 LEVOFLOXACIN NNP I-NP B-m
59 &amp; NNP I-NP O
59 WARFARIN NNP I-NP B-m
60 Reason NNP I-NP O
60 for IN B-VP O
60 override: NN B-NP O
60 will MD O O
60 follow VB O O
60 closely RB O O
61 DIET: NNP B-NP O
61 Patient NNP I-NP O
61 should MD O O
61 measure VB O O
61 weight JJ B-NP O
61 daily JJ I-NP O
62 DIET: NNP I-NP O
62 House NNP I-NP O
62 / VBD B-VP O
62 Low NNP B-NP O
62 chol/low NN I-NP O
62 sat VBD B-VP O
62 fat JJ B-NP O
63 DIET: NNP I-NP O
63 House NNP I-NP O
63 / NNP I-NP O
63 ADA NNP I-NP O
63 2100 CD O O
63 cals/dy NN B-NP O
64 DIET: NNP I-NP O
64 2 CD O O
64 gram NN B-NP O
64 Sodium NNP I-NP O
65 ACTIVITY: NNP I-NP O
65 Resume NNP I-NP O
65 regular JJ B-NP O
65 exercise NN I-NP O
66 FOLLOW NNP I-NP O
66 UP NNP I-NP O
66 APPOINTMENT( NNP I-NP O
66 S NNP I-NP O
66 ): NNP I-NP O
67 Dr NNP I-NP O
67 Clemente NNP I-NP O
67 Bollozos NNP I-NP O
67 - : O O
67 You PRP O O
67 will MD O O
67 be VB O O
67 contacted VBN O O
67 with IN B-VP O
67 an DT B-NP O
67 appointment NN I-NP O
67 for IN B-VP O
67 this DT B-NP O
67 week NN I-NP O
67 , , O O
68 Arrange NNP B-NP O
68 INR NNP I-NP O
68 to TO O O
68 be VB O O
68 drawn VBN O O
68 on IN B-VP O
68 8/26/04 CD O O
68 with IN B-VP O
68 f/u JJ B-NP O
68 INR's NNP I-NP O
68 to TO O O
68 be VB O O
68 drawn VBN O O
68 every DT O O
69 3 CD O O
69 days NNS B-NP O
69 INR's NNP I-NP O
69 will MD O O
69 be VB O O
69 followed VBN O O
69 by IN B-VP O
69 Dr NNP B-NP O
69 Tedeschi NNP I-NP O
70 No NNP I-NP O
70 Known NNP I-NP O
70 Allergies NNP I-NP O
71 ADMIT NNP I-NP O
71 DIAGNOSIS: NNP I-NP O
72 Hyperglycemia NNP I-NP O
72 , , O O
72 dehydration NN B-NP O
73 PRINCIPAL NNP I-NP O
73 DISCHARGE NNP I-NP O
73 DIAGNOSIS NNP I-NP O
73 ;Responsible JJ O O
73 After IN B-VP O
73 Study NNP B-NP O
73 for IN B-VP O
73 Causing NNP B-NP O
73 Admission NNP I-NP O
73 ) ) O O
74 Dehydration NNP B-NP O
75 OTHER NNP I-NP O
75 DIAGNOSIS;Conditions NNP I-NP O
75 , , O O
75 Infections NNP B-NP O
75 , , O O
75 Complications NNP B-NP O
75 , , O O
75 affecting VBG O O
75 Treatment/Stay NNP B-NP O
76 CAD NNP I-NP O
76 , , O O
76 complete JJ B-NP O
76 heart NN I-NP O
76 block NN I-NP O
76 ETOH NNP I-NP O
76 , , O O
76 HTN NNP B-NP O
76 , , O O
76 substance NN B-NP O
76 abuse NN I-NP O
77 S/P NNP I-NP O
77 PACER NNP I-NP O
77 PLCT NNP I-NP O
77 1980 CD O O
77 H/O NNP B-NP O
77 SILENT NNP I-NP O
77 IMI NNP I-NP O
77 s/p VBD B-VP O
77 l JJ B-NP O
78 nephrectomy JJ I-NP O
78 s/p NN I-NP O
78 appy JJ B-NP O
78 h/o NN I-NP O
78 spinal JJ B-NP O
78 stenosis NN I-NP O
78 DM NNP I-NP O
78 2/2 CD O O
78 pancreatitis NN B-NP O
79 OPERATIONS NNP I-NP O
79 AND NNP I-NP O
79 PROCEDURES: NNP I-NP O
80 None NNP I-NP O
81 OTHER NNP I-NP O
81 TREATMENTS/PROCEDURES NNP I-NP O
81 ( ( O O
81 NOT NNP B-NP O
81 IN NNP I-NP O
81 O.R NNP I-NP O
81 ) ) O O
82 ECHOCARDIOGRAM NNP B-NP O
82 6/12/04 CD O O
82 - : O O
82 EF NN B-NP O
82 20-25% JJ O O
82 , , O O
82 moderate JJ O O
82 to TO O O
82 severe VB O O
82 global JJ B-NP O
83 hypokinesis NN I-NP O
83 , , O O
83 trace NN B-NP O
83 AI NNP I-NP O
83 , , O O
83 mild JJ B-NP O
83 MR NNP I-NP O
83 , , O O
83 TV NN B-NP O
83 pacer NN I-NP O
83 wire NN I-NP O
83 still RB O O
83 has VBZ O O
83 clot/veg VBN O O
84 OFFICIAL NNP B-NP O
84 READ NNP I-NP O
84 STILL NNP I-NP O
84 PENDING NNP I-NP O
84 AT NNP I-NP O
84 TIME NNP I-NP O
84 OF NNP I-NP O
84 DISCHARGE NNP I-NP O
85 ABDMONINAL NNP I-NP O
85 CT NNP I-NP O
85 7/20/04 CD O O
85 - : O O
85 No DT B-NP O
85 acute JJ I-NP O
85 disease NN I-NP O
85 , , O O
85 gall JJ B-NP O
85 stones NNS I-NP O
85 , , O O
85 RLL NNP B-NP O
85 inflammation NN I-NP O
86 ? . B-VP O
86 PNA NNP B-NP O
86 , , O O
86 ectatic JJ B-NP O
86 aorta NN I-NP O
86 , , O O
86 non-obstructing JJ B-NP O
86 ventral JJ I-NP O
86 hernia NN I-NP O
87 V/Q NNP I-NP O
87 SCAN NNP I-NP O
87 7/20/04 CD O O
87 - : O O
87 Low JJ B-NP O
87 probability NN I-NP O
88 BRIEF NNP I-NP O
88 RESUME NNP I-NP O
88 OF NNP I-NP O
88 HOSPITAL NNP I-NP O
88 COURSE: NNP I-NP O
89 66 CD O O
89 YO NNP B-NP O
89 male NN I-NP O
89 with IN B-VP O
89 complicated JJ B-NP O
89 PMH NNP I-NP O
89 including VBG O O
89 CHF NNP B-NP O
89 w/ NN I-NP O
89 EF NNP I-NP O
89 25% CD O O
89 , , O O
89 COPD NNP B-NP O
89 , , O O
89 PVD NNP B-NP O
89 , , O O
90 DM2 NNP B-NP O
90 , , O O
90 CHB NNP B-NP O
90 with IN B-VP O
90 pacer NN B-NP O
90 and CC O O
90 evidence NN B-NP O
90 of IN B-VP O
90 clot NN B-NP O
90 on IN B-VP O
90 pacer NN B-NP O
90 wire NN I-NP O
90 , , O O
90 non-compliant JJ O O
91 with IN B-VP O
91 medications NNS B-NP O
91 and CC O O
91 diet JJ O O
91 and CC O O
91 who WP O O
91 developed VBD B-VP O
91 sx NN B-NP O
91 of IN B-VP O
91 abd NN B-NP O
91 pain NN I-NP O
91 and CC O O
91 SOB NNP B-NP O
91 with IN B-VP O
92 FS NNP B-NP O
92 of IN B-VP O
92 500-600 JJ B-NP O
92 PCP NNP I-NP O
92 asked VBD B-VP O
92 patient NN B-NP O
92 to TO O O
92 come VB O O
92 to TO O O
92 ED NNP B-NP O
92 where WRB O O
92 he PRP O O
92 was VBD B-VP O
92 found VBN O O
92 to TO O O
93 have VB O O
93 FS NNP B-NP O
93 of IN B-VP O
93 700 CD O O
93 with IN B-VP O
93 hypotension NN B-NP O
93 70s-80s CD O O
93 SBP NNP B-NP O
93 but CC O O
93 mentating VBG O O
93 No NNP B-NP O
93 gap NN I-NP O
93 and CC O O
94 no DT B-NP O
94 ketones NNS I-NP O
94 No DT B-NP O
94 signs NNS I-NP O
94 or CC O O
94 sx NN B-NP O
94 of IN B-VP O
94 infection NN B-NP O
94 with IN B-VP O
94 admission NN B-NP O
94 for IN B-VP O
94 medical JJ B-NP O
95 management NN I-NP O
96 VS: NNP I-NP O
96 99.5 CD O O
96 101/62 CD O O
96 70s CD O O
96 SaO2 NNP B-NP O
96 96% CD O O
96 on IN B-VP O
96 room NN B-NP O
96 air NN I-NP O
97 EXAM: NNP I-NP O
98 GEN: NNP I-NP O
98 elderly JJ B-NP O
98 ill NN I-NP O
98 appearing VBG O O
98 male NN B-NP O
98 in IN B-VP O
98 NAD NNP B-NP O
99 HEENT: NNP I-NP O
99 Anicteric NNP I-NP O
99 sclera NN I-NP O
99 , , O O
99 PERRL NNP B-NP O
99 , , O O
99 dry JJ B-NP O
99 mucous JJ I-NP O
99 membranes NNS I-NP O
99 , , O O
99 poor JJ B-NP O
99 dentition NN I-NP O
100 NECK: NNP I-NP O
100 Supple NNP I-NP O
100 , , O O
100 no DT B-NP O
100 adenopathy NN I-NP O
100 , , O O
100 JVP NNP B-NP O
100 flat JJ B-NP O
101 CHEST: NNP I-NP O
101 CTA NNP I-NP O
101 bilaterally RB O O
102 CV: NNP B-NP O
102 RRR NNP I-NP O
102 with IN B-VP O
102 diffuse NN B-NP O
102 PMI NNP I-NP O
102 , , O O
102 Nl NNP B-NP O
102 S1 NNP I-NP O
102 , , O O
102 S2 NNP B-NP O
102 S3 NNP I-NP O
102 present JJ B-NP O
103 ABD: NNP I-NP O
103 Reducible NNP I-NP O
103 ventral JJ B-NP O
103 hernia NN I-NP O
103 , , O O
103 NT NNP B-NP O
103 , , O O
103 ND NNP B-NP O
103 , , O O
103 bowel NN B-NP O
103 sounds NNS I-NP O
103 present JJ B-NP O
104 EXT: NNP I-NP O
104 No NNP I-NP O
104 edema NN I-NP O
104 or CC O O
104 wounds NNS B-NP O
105 SKIN: NNP I-NP O
105 No NNP I-NP O
105 rashes VBZ O O
106 EKG: NNP B-NP O
106 paced VBD B-VP O
107 CXR: NNP B-NP O
107 clear JJ O O
107 with IN B-VP O
107 NAD NNP B-NP O
108 ABD NNP I-NP O
108 CT: NNP I-NP O
108 small JJ B-NP O
108 ventral JJ I-NP O
108 hernia NN I-NP O
108 , , O O
108 gallstones NNS B-NP O
108 , , O O
108 ectasia NN B-NP O
108 of IN B-VP O
108 the DT B-NP O
108 infrarenal JJ I-NP O
109 aorta NN I-NP O
109 , , O O
109 RLL NNP B-NP O
109 inflammatory NN I-NP O
109 changes NNS I-NP O
109 suggestive VBP O O
109 of IN B-VP O
109 PNA NNP B-NP O
110 VQ: NNP I-NP O
110 Low NNP I-NP O
110 probability NN I-NP O
111 LABS: NNP I-NP O
111 Creatinine NNP I-NP O
111 of IN B-VP O
111 2.2 CD O O
111 that WDT O O
111 dropped VBD B-VP O
111 to TO O O
111 1.5 CD O O
111 with IN B-VP O
111 hydration NN B-NP O
111 ( ( O O
111 BL NNP B-NP O
112 1.2-1.3 CD O O
112 ) ) O O
112 HCT $ O O
112 41.6 CD O O
112 with IN B-VP O
112 drop NN B-NP O
112 after IN B-VP O
112 aggresive JJ B-NP O
112 hydration NN I-NP O
112 Lipase NNP I-NP O
112 of IN B-VP O
112 132 CD O O
113 but CC O O
113 has VBZ O O
113 chronic JJ B-NP O
113 pancreatitis NN I-NP O
113 and CC O O
113 is VBZ O O
113 now RB O O
113 normalizing VBG O O
113 UA NNP B-NP O
113 and CC O O
113 ACE NNP B-NP O
114 negative JJ B-NP O
115 ASSESSMENT NNP I-NP O
115 &amp; NNP I-NP O
115 PLAN: NNP I-NP O
115 66 CD O O
115 YO NNP B-NP O
115 male NN I-NP O
115 with IN B-VP O
115 complicated VBN O O
115 PMH NNP B-NP O
115 admitted VBN O O
115 with IN B-VP O
116 hyperglycemia NN B-NP O
116 likely RB O O
116 due JJ O O
116 to TO O O
116 non-compliance JJ O O
116 and CC O O
116 hypotension NN B-NP O
116 likely RB O O
116 due JJ O O
117 to TO O O
117 hypovolemia VB O B-r
117 In IN B-VP O
117 ED NNP B-NP O
117 the DT B-NP O
117 patient NN I-NP O
117 received VBD B-VP O
117 5 CD O B-do
117 liters NNS B-NP I-do
117 of IN B-VP O
117 IVF NNP B-NP B-m
117 and CC O O
117 36U CD O B-do
117 of IN B-VP O
118 insulin NN B-NP B-m
118 His PRP$ O O
118 blood NN B-NP O
118 pressure NN I-NP O
118 stabilized VBN O O
118 with IN B-VP O
118 volume NN B-NP O
118 and CC O O
118 he PRP O O
118 was VBD B-VP O
119 transfered VBN O O
119 to TO O O
119 the DT B-NP O
119 medical JJ I-NP O
119 floor NN I-NP O
120 ENDOCRINE NNP I-NP O
120 - : O O
120 DMII NN B-NP B-r
120 but CC O O
120 with IN B-VP O
120 history NN B-NP O
120 of IN B-VP O
120 pancreatitis NN B-NP O
120 so RB O O
120 behaves VBZ O O
120 more RBR O O
120 like IN B-VP O
121 type NN B-NP O
121 1 CD O O
121 - : O O
121 needs NNS B-NP O
121 insulin VBP O B-m
121 all PDT O O
121 the DT B-NP O
121 time NN I-NP O
121 Per NNP I-NP O
121 patient NN I-NP O
121 he PRP O O
121 had VBD B-VP O
121 been VBN O O
121 taking VBG O O
121 20 CD O B-do
122 units NNS B-NP O
122 of IN B-VP O
122 Lantus NNP B-NP B-m
122 QAM NNP I-NP B-f
122 QAM NNP I-NP B-f
122 but CC O O
122 patient JJ O O
122 admitted VBN O O
122 to TO O O
122 poor JJ B-NP O
122 compliance NN I-NP O
122 with IN B-VP O
122 both DT O O
123 diet JJ O O
123 and CC O O
123 insulin VB O B-m
123 His PRP$ O O
123 A1C NNP B-NP O
123 was VBD B-VP O
123 checked VBN O O
123 and CC O O
123 returned VBN O O
123 at IN B-VP O
123 19 CD O O
123 The DT B-NP O
123 patient NN I-NP O
124 was VBD B-VP O
124 started VBN O O
124 on IN B-VP O
124 Lantus NNP B-NP B-m
124 and CC O O
124 Lispro NNP B-NP B-m
124 and CC O O
124 maintained VBN O O
124 on IN B-VP O
124 an DT B-NP O
124 ADA NNP I-NP O
124 diet NN I-NP O
124 He PRP O O
124 was VBD B-VP O
125 titrated VBN O B-do
125 to TO O I-do
125 20 CD O I-do
125 units NNS B-NP I-do
125 of IN B-VP O
125 Lantus NNP B-NP B-m
125 QHS NNP I-NP B-f
125 and CC O O
125 was VBD B-VP O
125 requring VBG O O
125 Lispro NNP B-NP B-m
125 for IN B-VP O
125 FS NNP B-NP B-r
126 ranging VBG O O
126 from IN B-VP O
126 120-600 JJ O O
126 By IN B-VP O
126 10/21 CD O O
126 his PRP$ O B-r
126 FS NN B-NP I-r
126 remained VBD B-VP O
126 better RBR O O
126 controlled VBN O O
126 but CC O O
127 were VBD B-VP O
127 still RB O O
127 high JJ O O
127 ranging VBG O O
127 from IN B-VP O
127 200 CD O O
127 to TO O O
127 400 CD O O
127 on IN B-VP O
127 Lantus NNP B-NP B-m
127 16 CD O B-do
127 On IN B-VP O
127 3/23 CD O O
127 the DT B-NP O
128 patient NN I-NP O
128 expressed VBD B-VP O
128 that IN B-VP O
128 he PRP O O
128 would MD O O
128 like VB O O
128 to TO O O
128 leave VB O O
128 He PRP O O
128 is VBZ O O
128 discharged VBN O O
128 o JJ B-NP O
129 n JJ I-NP O
129 Lantus NNP I-NP B-m
129 20 CD O B-do
129 and CC O O
129 Lispro NNP B-NP B-m
129 SS NNP I-NP B-do
129 with IN B-VP O
129 VNA NNP B-NP O
129 to TO O O
129 follow VB O O
129 finger NN B-NP O
129 sticks NNS I-NP O
129 He PRP O O
130 was VBD B-VP O
130 maintained VBN O O
130 on IN B-VP O
130 an DT B-NP O
130 ADA NNP I-NP O
130 diet NN I-NP O
130 , , O O
130 however RB O O
130 , , O O
130 there EX O O
130 was VBD B-VP O
130 some DT B-NP O
130 concern NN I-NP O
130 he PRP O O
131 may MD O O
131 have VB O O
131 been VBN O O
131 eating VBG O O
131 sweets NNS B-NP O
131 on IN B-VP O
131 his PRP$ O O
131 own JJ B-NP O
131 Nutrition NNP I-NP O
131 was VBD B-VP O
131 consulted VBN O O
132 and CC O O
132 provided VBN O O
132 teaching VBG O O
132 regaring VBG O O
132 diet JJ O O
132 and CC O O
132 diabetes VBZ O O
132 The DT B-NP O
132 patient NN I-NP O
132 is VBZ O O
133 discharged VBN O O
133 to TO O O
133 home NN B-NP O
133 on IN B-VP O
133 Lantus NNP B-NP B-m
133 and CC O O
133 lispro JJ O B-m
133 with IN B-VP O
133 VNA NNP B-NP O
133 following VBG O O
134 HEME NNP B-NP O
134 - : O O
134 on IN B-VP O
134 coumadin NN B-NP B-m
134 for IN B-VP O
134 hx NN B-NP O
134 of IN B-VP O
134 pacer NN B-NP B-r
134 clot NN I-NP I-r
134 Echo NNP I-NP O
134 shows VBZ O O
134 pacer NN B-NP O
134 clot NN I-NP B-r
134 but CC O O
135 not RB O O
135 clear JJ O O
135 whether IN B-VP O
135 patient NN B-NP O
135 will MD O O
135 be VB O O
135 compliant JJ O O
135 enough JJ O O
135 to TO O O
135 go VB O O
135 home NN B-NP O
135 on IN B-VP O
136 coumadin NN B-NP B-m
136 as IN B-VP O
136 he PRP O O
136 has VBZ O O
136 not RB O O
136 been VBN O O
136 in IN B-VP O
136 the DT O O
136 past JJ O O
136 After IN B-VP O
136 discussion NN B-NP O
136 with IN B-VP O
137 patient JJ B-NP O
137 agreement NN I-NP O
137 is VBZ O O
137 that IN B-VP O
137 we PRP O O
137 will MD O O
137 d/c VB O O
137 on IN B-VP O
137 coumadin NN B-NP B-m
137 5 CD O B-do
137 QD NNP B-NP B-f
137 ( ( O O
137 INR NNP B-NP O
137 on IN B-VP O
138 day NN B-NP O
138 of IN B-VP O
138 d/c $ O O
138 1.2 CD O O
138 ) ) O O
138 with IN B-VP O
138 enough JJ B-NP O
138 supply NN I-NP O
138 for IN B-VP B-du
138 one CD O I-du
138 week NN B-NP I-du
138 He PRP O O
138 will MD O O
138 have VB O O
139 blood VBN O O
139 drawn VBN O O
139 by IN B-VP O
139 VNA NNP B-NP O
139 with IN B-VP O
139 results NNS B-NP O
139 sent VBD B-VP O
139 to TO O O
139 Dr NNP B-NP O
139 Zarkin NNP I-NP O
139 If IN B-VP O
139 he PRP O O
139 his PRP$ O O
139 not RB O O
140 compliant VB O O
140 with IN B-VP O
140 his PRP$ O O
140 lab NN B-NP O
140 work NN I-NP O
140 the DT B-NP O
140 coumadin NN I-NP B-m
140 will MD O O
140 be VB O O
140 stopped VBN O O
141 CV NNP B-NP O
141 - : O O
142 ISCHEMIA: NNP B-NP O
142 Nonobstuctive NNP I-NP O
142 CAD NNP I-NP O
142 on IN B-VP O
142 cath NN B-NP O
142 in IN B-VP O
142 July NNP B-NP O
142 with IN B-VP O
142 no DT B-NP O
142 evidence NN I-NP O
143 of IN B-VP O
143 acute JJ B-NP O
143 episode NN I-NP O
143 Maintained VBD B-VP O
143 on IN B-VP O
143 ASA NNP B-NP B-m
143 , , O O
143 ACEi NNP B-NP B-m
143 , , O O
143 and CC O O
143 Statin NNP B-NP B-m
143 No NNP I-NP O
143 BB NNP I-NP O
143 as IN B-VP O
144 current JJ B-NP O
144 cocaine NN I-NP O
144 user NN I-NP O
144 and CC O O
144 considered VBN O O
144 to TO O O
144 dangerous JJ B-NP O
145 PUMP: NNP I-NP O
145 EF: NNP I-NP O
145 20-25% JJ B-NP O
145 Hypovolemic NNP I-NP O
145 at IN B-VP O
145 admission NN B-NP O
145 with IN B-VP O
145 good JJ B-NP O
145 response NN I-NP O
145 to TO O O
146 hydration NN B-NP O
146 No NNP I-NP O
146 episodes NNS I-NP O
146 of IN B-VP O
146 volume NN B-NP O
146 overload NN I-NP O
146 On IN B-VP O
146 ACEi NNP B-NP O
146 for IN B-VP O
146 AL NNP B-NP O
146 reduction NN I-NP O
147 RHYTHM: NNP I-NP O
147 CHB NNP I-NP O
147 with IN B-VP O
147 PPM NNP B-NP O
147 in IN B-VP O
147 place NN B-NP O
148 GI: NNP I-NP O
148 elevated VBD B-VP O
148 lipase NN B-NP O
148 with IN B-VP O
148 chronic JJ B-NP O
148 pancreatitis NN I-NP O
148 with IN B-VP O
148 no DT B-NP O
148 symptoms NNS I-NP O
148 and CC O O
149 resolution NN B-NP O
149 after IN B-VP O
149 hydration NN B-NP O
150 DISPO: NNP I-NP O
150 The DT B-NP O
150 patient NN I-NP O
150 is VBZ O O
150 discharged VBN O O
150 to TO O O
150 home NN B-NP O
150 in IN B-VP O
150 fair JJ B-NP O
150 condition NN I-NP O
150 He PRP O O
150 has VBZ O O
150 been VBN O O
151 given VBN O O
151 teaching VBG O O
151 regarding VBG O O
151 nutrition NN B-NP O
151 , , O O
151 diabetes VBZ O O
151 , , O O
151 and CC O O
151 coumadin VB O B-m
151 His PRP$ O O
152 medications NNS B-NP O
152 has VBZ O O
152 been VBN O O
152 discussed VBN O O
152 with IN B-VP O
152 him PRP O O
152 He PRP O O
152 agrees VBZ O O
152 to TO O O
152 be VB O O
152 compliant JJ O O
152 with IN B-VP O
153 all DT B-NP O
153 medications NNS I-NP O
153 , , O O
153 to TO O O
153 work VB O O
153 with IN B-VP O
153 VNA NNP B-NP O
153 , , O O
153 and CC O O
153 to TO O O
153 attend VB O O
153 all DT O O
153 of IN B-VP O
153 his PRP$ O O
154 appointments NNS B-NP O
154 and CC O O
154 blood NN B-NP O
154 draws NN I-NP O
154 He PRP O O
154 is VBZ O O
154 discharged VBN O O
154 home NN B-NP O
154 on IN B-VP O
154 coumadin NN B-NP B-m
154 and CC O O
155 Lantus NNP B-NP B-m
155 to TO O O
155 be VB O O
155 followed VBN O O
155 by IN B-VP O
155 VNA NNP B-NP O
155 He PRP O O
155 is VBZ O O
155 to TO O O
155 follow VB O O
155 up RP O O
155 with IN B-VP O
155 Dr NNP B-NP O
155 Harnage NNP I-NP O
155 within IN B-VP O
156 the DT B-NP O
156 next JJ I-NP O
156 week NN I-NP O
156 and CC O O
156 will MD O O
156 be VB O O
156 contacted VBN O O
156 with IN B-VP O
156 an DT B-NP O
156 appointment NN I-NP O
157 CODE: NNP I-NP O
157 DNR/DNI NNP I-NP O
158 ADDITIONAL NNP I-NP O
158 COMMENTS: NNP I-NP O
158 1 CD O O
158 ) ) O O
158 Please NNP B-NP O
158 take VB O O
158 your PRP$ O O
158 insulin NN B-NP B-m
158 shot NN I-NP O
158 ( ( O O
158 20 CD O B-do
158 units NNS B-NP I-do
158 of IN B-VP O
158 Lantus NNP B-NP B-m
158 ) ) O O
158 every DT B-NP B-f
158 night NN I-NP O
158 at IN B-VP O
159 10 CD O O
159 PM NNP B-NP O
159 You PRP O O
159 will MD O O
159 get VB O O
159 your PRP$ O O
159 dose NN B-NP O
159 for IN B-VP O
159 Sunday NNP B-NP O
159 3/23 CD O O
159 in IN B-VP O
159 the DT B-NP O
159 hospital NN I-NP O
159 You PRP O O
160 first RB O O
160 dose VB O O
160 at IN B-VP O
160 home NN B-NP O
160 will MD O O
160 be VB O O
160 Monday NNP B-NP O
160 7/28 CD O O
160 at IN B-VP O
160 10 CD O O
160 PM NNP B-NP O
161 2 CD O O
161 ) ) O O
161 Visiting VBG O O
161 nursing NN B-NP O
161 will MD O O
161 come VB O O
161 to TO O O
161 your PRP$ O O
161 home NN B-NP O
161 tomorrow NN I-NP O
161 to TO O O
161 help VB O O
161 you PRP O O
161 with IN B-VP O
162 your PRP$ O B-m
162 medications NNS B-NP I-m
163 3 CD O O
163 ) ) O O
163 Please NNP B-NP O
163 take VB O O
163 all DT O O
163 your PRP$ O O
163 medications NNS B-NP O
163 as IN B-VP O
163 directed VBN O O
163 It PRP O O
163 is VBZ O O
163 very RB O O
163 important JJ O O
164 to TO O O
164 have VB O O
164 your PRP$ O O
164 blood NN B-NP O
164 checked VBD B-VP O
164 regularly RB O O
164 to TO O O
164 make VB O O
164 sure JJ O O
164 your PRP$ O O
164 medications NNS B-NP O
164 are VBP O O
165 at IN B-VP O
165 the DT B-NP O
165 right JJ I-NP O
165 level NN I-NP O
166 DISCHARGE NNP I-NP O
166 CONDITION: NNP I-NP O
166 Fair NNP I-NP O
167 TO NNP I-NP O
167 DO/PLAN: NNP I-NP O
168 1 CD O O
168 ) ) O O
168 Take VB O O
168 your PRP$ O O
168 Lantus NNP B-NP B-m
168 every DT B-NP B-f
168 night NN I-NP I-f
168 at IN B-VP I-f
168 10 CD O I-f
168 PM NNP B-NP I-f
168 starting VBG O O
168 on IN B-VP O
168 Monday NNP B-NP O
168 7/7/04 CD O O
169 Take NNP B-NP O
169 a DT B-NP O
169 shot NN I-NP B-mo
169 with IN B-VP O
169 20 CD O B-do
169 units NNS B-NP I-do
169 of IN B-VP O
169 insulin NN B-NP B-m
169 in IN B-VP O
169 it PRP O O
170 2 CD O O
170 ) ) O O
170 Check VB O O
170 your PRP$ O O
170 fingersticks NNS B-NP O
170 daily RB O O
170 and CC O O
170 record VB O O
170 the DT B-NP O
170 level NN I-NP O
170 Please NNP I-NP O
170 call VB O O
170 Dr NNP B-NP O
171 Mattias NNP I-NP O
171 if IN B-VP O
171 your PRP$ O O
171 blood NN B-NP O
171 sugar NN I-NP O
171 is VBZ O O
171 higher JJR O O
171 then RB O O
171 350 CD O O
171 or CC O O
171 lower JJR O O
171 then RB O O
171 50 CD O O
172 3 CD O O
172 ) ) O O
172 Take VB O O
172 all DT O O
172 you PRP O O
172 other JJ B-NP B-m
172 medications NNS I-NP I-m
172 as IN B-VP O
172 directed VBN O O
172 Do NNP B-NP O
172 not RB O O
172 take VB O O
172 any DT B-NP O
173 medications NNS I-NP O
173 that WDT O O
173 are VBP O O
173 not RB O O
173 on IN B-VP O
173 this DT B-NP O
173 list NN I-NP O
174 4 CD O O
174 ) ) O O
174 Please NNP B-NP O
174 attend VBP O O
174 all DT O O
174 of IN B-VP O
174 your PRP$ O O
174 appointments NNS B-NP O
174 and CC O O
174 blood NN B-NP O
174 draws NN I-NP O
175 No NNP I-NP O
175 dictated VBD B-VP O
175 summary JJ B-NP O
176 ENTERED NNP I-NP O
176 BY: NNP I-NP O
176 MARCUSSEN NNP I-NP O
176 , , O O
176 WILL NNP B-NP O
176 JAE NNP I-NP O
176 , , O O
176 M.D NNP B-NP O
176 ( ( O O
176 AV507 NNP B-NP O
176 ) ) O O
176 2/21/04 CD O O
176 @ $ O O
176 04 CD O O
177 ****** JJ B-NP O
177 END NN I-NP O
177 OF NNP I-NP O
177 DISCHARGE NNP I-NP O
177 ORDERS NNP I-NP O
177 ****** NNP I-NP O
178 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #948961 VBZ O O
2 288978562 CD O O
2 THO NNP B-NP O
2 40164507 CD O O
2 6818698 CD O O
2 5/8/2007 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 bilateral JJ B-NP O
2 breast NN I-NP O
2 reduction NN I-NP O
2 , , O O
2 panniculectomy NN B-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/28/2007 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 10/20/2007 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 HUNTZINGER NNP I-NP O
5 , , O O
5 HOWARD NNP B-NP O
5 940-78-98-8 CD O O
6 U NNP B-NP O
6 Sa NNP I-NP O
6 Fre NNP I-NP O
7 Service: NNP I-NP O
7 PLA NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 11/24/07 CD O O
8 AT NNP B-NP O
8 09:00 CD O O
8 AM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 SNF/rehab NNP I-NP O
10 WILL NNP I-NP O
10 D/C NNP I-NP O
10 ORDER NNP I-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 MEDE NNP I-NP O
11 , , O O
11 HOBERT NNP B-NP O
11 JODY NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Skilled VBD B-VP O
14 Nursing NNP B-NP O
14 Facility NNP I-NP O
15 MEDICATIONS NNP I-NP O
15 ON NNP I-NP O
15 ADMISSION: NNP I-NP O
16 1 CD O O
16 ACETAMINOPHEN NNP B-NP B-m
16 1000 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 Q6H NNP I-NP B-f
17 2 CD O O
17 LEVOTHYROXINE NNP B-NP B-m
17 SODIUM NNP I-NP I-m
17 75 CD O B-do
17 MCG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QD NNP I-NP B-f
18 3 CD O O
18 QUINAPRIL NNP B-NP B-m
18 20 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QAM NNP I-NP B-f
19 4 CD O O
19 RANITIDINE NNP B-NP B-m
19 HCL NNP I-NP I-m
19 150 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 5 CD O O
20 MULTIVITAMINS NNP B-NP B-m
20 1 CD O B-do
20 CAPSULE NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 MEDICATIONS NNP I-NP O
21 ON NNP I-NP O
21 DISCHARGE: NNP I-NP O
22 TYLENOL NNP I-NP B-m
22 ( ( O I-m
22 ACETAMINOPHEN NNP B-NP I-m
22 ) ) O I-m
22 650 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 Q4H NNP I-NP B-f
22 PRN NNP I-NP I-f
22 Headache NNP I-NP B-r
23 VITAMIN NNP I-NP B-m
23 C NNP I-NP I-m
23 ( ( O I-m
23 ASCORBIC NNP B-NP I-m
23 ACID NNP I-NP I-m
23 ) ) O I-m
23 500 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 BID NNP I-NP B-f
24 DULCOLAX NNP I-NP B-m
24 ( ( O I-m
24 BISACODYL NNP B-NP I-m
24 ) ) O I-m
24 5-10 JJ B-NP B-do
24 MG NNP I-NP I-do
24 PO NNP I-NP B-mo
24 DAILY NNP I-NP B-f
24 PRN NNP I-NP I-f
24 Constipation NNP I-NP B-r
25 KEFLEX NNP I-NP B-m
25 ( ( O I-m
25 CEPHALEXIN NNP B-NP I-m
25 ) ) O I-m
25 500 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QID NNP I-NP B-f
26 COLACE NNP I-NP B-m
26 ( ( O I-m
26 DOCUSATE NNP B-NP I-m
26 SODIUM NNP I-NP I-m
26 ) ) O I-m
26 100 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 BID NNP I-NP B-f
27 PEPCID NNP I-NP B-m
27 ( ( O I-m
27 FAMOTIDINE NNP B-NP I-m
27 ) ) O I-m
27 20 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 BID NNP I-NP B-f
28 DILAUDID NNP I-NP B-m
28 ( ( O I-m
28 HYDROMORPHONE NNP B-NP I-m
28 HCL NNP I-NP I-m
28 ) ) O I-m
28 2-4 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 Q3H NNP I-NP B-f
28 PRN NNP I-NP I-f
28 Pain NNP I-NP B-r
29 Alert NNP I-NP O
29 overridden: NNP I-NP O
29 Override NNP I-NP O
29 added VBD B-VP O
29 on IN B-VP O
29 5/8/07 CD O O
29 by IN B-VP O
29 : : O O
30 on IN B-VP O
30 order NN B-NP O
30 for IN B-VP O
30 DILAUDID NNP B-NP B-m
30 PO NNP I-NP B-mo
30 2-4 JJ B-NP B-do
30 MG NNP I-NP I-do
30 Q3H NNP I-NP B-f
30 ( ( O O
30 ref JJ O O
30 # # O O
30 901341233 CD O O
30 ) ) O O
31 Pt NNP B-NP O
31 has VBZ O O
31 a DT B-NP O
31 PROBABLE NNP I-NP O
31 allergy NN I-NP O
31 to TO O O
31 Morphine; NNP B-NP O
31 reaction NN I-NP O
31 is VBZ O O
31 GI NNP B-NP O
32 Intolerance NNP I-NP O
32 Reason NNP I-NP O
32 for IN B-VP O
32 override: NN B-NP O
32 fine VBP O O
33 Previous NNP B-NP O
33 Alert NNP I-NP O
33 overridden NNP I-NP O
34 Override NNP I-NP O
34 added VBD B-VP O
34 on IN B-VP O
34 5/8/07 CD O O
34 by IN B-VP O
34 SIENKIEWICZ NNP B-NP O
34 , , O O
34 BRODERICK NNP B-NP O
34 GINO NNP I-NP O
34 , , O O
34 M.D NNP B-NP O
34 , , O O
34 PH.D NNP B-NP O
35 on IN B-VP O
35 order NN B-NP O
35 for IN B-VP O
35 DILAUDID NNP B-NP B-m
35 PO NNP I-NP B-mo
35 ( ( O O
35 ref JJ O O
35 # # O O
35 797774923 CD O O
35 ) ) O O
36 Pt NNP B-NP O
36 has VBZ O O
36 a DT B-NP O
36 PROBABLE NNP I-NP O
36 allergy NN I-NP O
36 to TO O O
36 Morphine; NNP B-NP O
36 reaction NN I-NP O
36 is VBZ O O
36 GI NNP B-NP O
37 Intolerance NNP I-NP O
37 Reason NNP I-NP O
37 for IN B-VP O
37 override: NN B-NP O
37 aware JJ B-NP O
38 INSULIN NNP I-NP B-m
38 REGULAR NNP I-NP I-m
38 HUMAN NNP I-NP I-m
39 Sliding NNP I-NP B-do
39 Scale NNP I-NP I-do
39 ( ( O B-mo
39 subcutaneously RB O I-mo
39 ) ) O I-mo
39 SC NNP B-NP I-mo
39 AC+HS NNP I-NP B-f
39 Medium NNP I-NP O
39 Scale NNP I-NP O
40 Call NNP I-NP O
40 HO NNP I-NP O
40 if IN B-VP O
40 BS NNP B-NP O
40 less JJR O O
40 than IN B-VP O
40 60 CD O O
41 If IN B-VP O
41 BS NNP B-NP O
41 is VBZ O O
41 less JJR O O
41 than IN B-VP O
41 125 CD O O
41 , , O O
41 then RB O O
41 DO NNP B-NP O
41 NOT NNP I-NP O
41 Administer NNP I-NP O
42 supplemental NN I-NP O
42 ( ( O O
42 sliding VBG O O
42 scale NN B-NP O
42 ) ) O O
42 insulin NN B-NP B-m
42 insulin NN I-NP B-m
42 insulin NN I-NP B-m
42 insulin NN I-NP B-m
42 insulin NN I-NP B-m
42 insulin NN I-NP B-m
43 If IN B-VP O
43 BS NNP B-NP O
43 is VBZ O O
43 125-150 JJ O O
43 , , O O
43 then RB O O
43 give VB O O
43 0 CD O B-do
43 units NNS B-NP I-do
43 subcutaneously RB O B-mo
44 If IN B-VP O
44 BS NNP B-NP O
44 is VBZ O O
44 151-200 CD O O
44 , , O O
44 then RB O O
44 give VB O O
44 1 CD O B-do
44 units NNS B-NP I-do
44 subcutaneously RB O B-mo
45 If IN B-VP O
45 BS NNP B-NP O
45 is VBZ O O
45 201-250 JJ O O
45 , , O O
45 then RB O O
45 give VB O O
45 3 CD O B-do
45 units NNS B-NP I-do
45 subcutaneously RB O B-mo
46 If IN B-VP O
46 BS NNP B-NP O
46 is VBZ O O
46 251-300 JJ O O
46 , , O O
46 then RB O O
46 give VB O O
46 5 CD O B-do
46 units NNS B-NP I-do
46 subcutaneously RB O B-mo
47 If IN B-VP O
47 BS NNP B-NP O
47 is VBZ O O
47 301-350 JJ O O
47 , , O O
47 then RB O O
47 give VB O O
47 7 CD O B-do
47 units NNS B-NP I-do
47 subcutaneously RB O B-mo
48 If IN B-VP O
48 BS NNP B-NP O
48 is VBZ O O
48 351-400 CD O O
48 , , O O
48 then RB O O
48 give VB O O
48 8 CD O B-do
48 units NNS B-NP I-do
48 subcutaneously RB O B-mo
49 Call NNP B-NP O
49 HO NNP I-NP O
49 if IN B-VP O
49 BS NNP B-NP O
49 is VBZ O O
49 greater JJR O O
49 than IN B-VP O
49 350 CD O O
50 If IN B-VP O
50 receiving VBG O O
50 standing VBG O O
50 regular JJ B-NP B-m
50 insulin NN I-NP I-m
50 , , O O
50 please VB O O
50 give VB O O
50 at IN B-VP O
50 same JJ B-NP O
51 time NN I-NP O
51 and CC O O
51 in IN B-VP O
51 addition NN B-NP O
51 to TO O O
51 standing VBG O O
51 regular JJ B-NP B-m
51 insulin NN I-NP I-m
52 SYNTHROID NNP I-NP B-m
52 ( ( O I-m
52 LEVOTHYROXINE NNP B-NP I-m
52 SODIUM NNP I-NP I-m
52 ) ) O I-m
52 75 CD O B-do
52 MCG NNP B-NP I-do
52 PO NNP I-NP B-mo
52 DAILY NNP I-NP B-f
53 MAALOX-TABLETS NNP I-NP B-m
53 QUICK NNP I-NP I-m
53 DISSOLVE/CHEWABLE NNP I-NP I-m
53 1-2 JJ B-NP B-do
53 TAB NNP I-NP I-do
53 PO NNP I-NP B-mo
53 Q6H NNP I-NP B-f
54 PRN NNP I-NP O
54 Upset NNP I-NP B-r
54 Stomach NNP I-NP I-r
55 MILK NNP I-NP B-m
55 OF NNP I-NP I-m
55 MAGNESIA NNP I-NP I-m
55 ( ( O I-m
55 MAGNESIUM NNP B-NP I-m
55 HYDROXIDE NNP I-NP I-m
55 ) ) O I-m
56 30 CD O B-do
56 MILLILITERS NNP B-NP I-do
56 PO NNP I-NP B-mo
56 DAILY NNP I-NP B-f
56 PRN NNP I-NP I-f
56 Constipation NNP I-NP B-r
57 REGLAN NNP I-NP B-m
57 ( ( O I-m
57 METOCLOPRAMIDE NNP B-NP I-m
57 HCL NNP I-NP I-m
57 ) ) O I-m
57 10 CD O B-do
57 MG NNP B-NP I-do
57 IV NNP I-NP B-mo
57 Q6H NNP I-NP B-f
57 PRN NNP I-NP I-f
57 Nausea NNP I-NP B-r
58 ZOFRAN NNP I-NP B-m
58 ( ( O I-m
58 POST-OP NNP B-NP I-m
58 N/V NNP I-NP I-m
58 ) ) O I-m
58 ( ( O I-m
58 ONDANSETRON NNP B-NP I-m
58 HCL NNP I-NP I-m
58 ( ( O I-m
58 POST- NNP B-NP I-m
58 ) ) O I-m
59 1 CD O B-do
59 MG NNP B-NP I-do
59 IV NNP I-NP B-mo
59 Q6H NNP I-NP O
59 X NNP I-NP B-du
59 2 CD O I-du
59 doses NNS B-NP I-du
59 PRN NNP I-NP O
59 Nausea NNP I-NP B-r
60 QUINAPRIL NNP I-NP B-m
60 20 CD O B-do
60 MG NNP B-NP I-do
60 PO NNP I-NP B-mo
60 DAILY NNP I-NP B-f
61 Override NNP I-NP O
61 Notice: NNP I-NP O
61 Override NNP I-NP O
61 added VBD B-VP O
61 on IN B-VP O
61 5/8/07 CD O O
61 by IN B-VP O
62 REBURN NNP B-NP O
62 , , O O
62 CHARLEY NNP B-NP O
62 M NNP I-NP O
62 , , O O
62 M.D NNP B-NP O
63 on IN B-VP O
63 order NN B-NP O
63 for IN B-VP O
63 KCL NNP B-NP B-m
63 IV NNP I-NP I-m
63 ( ( O O
63 ref JJ O O
63 # # O O
63 964491549 CD O O
63 ) ) O O
64 POTENTIALLY NNP B-NP O
64 SERIOUS NNP I-NP O
64 INTERACTION: NNP I-NP O
64 QUINAPRIL NNP I-NP B-m
64 HCL NNP I-NP I-m
64 &amp; NNP I-NP O
64 POTASSIUM NNP I-NP B-m
65 CHLORIDE NNP I-NP O
66 POTENTIALLY NNP I-NP O
66 SERIOUS NNP I-NP O
66 INTERACTION: NNP I-NP O
66 QUINAPRIL NNP I-NP B-m
66 HCL NNP I-NP I-m
66 &amp; NNP I-NP O
66 POTASSIUM NNP I-NP B-m
67 CHLORIDE NNP I-NP O
67 Reason NNP I-NP O
67 for IN B-VP O
67 override: NN B-NP O
67 needs NNS I-NP O
68 Number NNP I-NP O
68 of IN B-VP O
68 Doses NNP B-NP O
68 Required NNP I-NP O
68 ( ( O O
68 approximate JJ B-NP O
68 ): NN I-NP O
68 2 CD O O
69 SIMETHICONE NNP B-NP B-m
69 80 CD O B-do
69 MG NNP B-NP I-do
69 PO NNP I-NP B-mo
69 QID NNP I-NP B-f
69 PRN NNP I-NP I-f
69 Upset NNP I-NP B-r
69 Stomach NNP I-NP I-r
70 MULTIVITAMIN NNP I-NP B-m
70 THERAPEUTIC NNP I-NP I-m
70 ( ( O I-m
70 THERAPEUTIC NNP B-NP I-m
70 MULTIVI NNP I-NP I-m
70 ) ) O I-m
71 1 CD O B-do
71 TAB NNP B-NP I-do
71 PO NNP I-NP B-mo
71 DAILY NNP I-NP B-f
72 TIGAN NNP I-NP B-m
72 ( ( O I-m
72 TRIMETHOBENZAMIDE NNP B-NP I-m
72 HCL NNP I-NP I-m
72 ) ) O I-m
72 200 CD O B-do
72 MG NNP B-NP I-do
72 PR NNP I-NP B-mo
72 Q6H NNP I-NP B-f
72 PRN NNP I-NP I-f
72 Nausea NNP I-NP B-r
73 TIGAN NNP I-NP B-m
73 ( ( O I-m
73 TRIMETHOBENZAMIDE NNP B-NP I-m
73 HCL NNP I-NP I-m
73 ) ) O I-m
73 300 CD O B-do
73 MG NNP B-NP I-do
73 PO NNP I-NP B-mo
73 Q6H NNP I-NP B-f
73 PRN NNP I-NP I-f
73 Nausea NNP I-NP B-r
74 Number NNP I-NP B-du
74 of IN B-VP I-du
74 Doses NNP B-NP I-du
74 Required NNP I-NP I-du
74 ( ( O I-du
74 approximate JJ B-NP I-du
74 ): NN I-NP I-du
74 10 CD O I-du
75 DIET: NNP B-NP O
75 No NNP I-NP O
75 Restrictions NNP I-NP O
76 ACTIVITY: NNP I-NP O
76 Walking NNP I-NP O
76 as IN B-VP O
76 tolerated JJ B-NP O
77 Lift NNP I-NP O
77 restrictions: NN I-NP O
77 Do NNP I-NP O
77 not RB O O
77 lift VB O O
77 greater JJR O O
77 then RB O O
77 10 CD O O
77 pounds NNS B-NP O
78 FOLLOW NNP I-NP O
78 UP NNP I-NP O
78 APPOINTMENT( NNP I-NP O
78 S NNP I-NP O
78 ): NNP I-NP O
79 dr NN I-NP O
79 w NN I-NP O
79 , , O O
79 - : O O
79 please NN B-NP O
79 call VB O O
79 810 CD O O
79 676-4625 JJ O O
79 to TO O O
79 schedule VB O O
79 7 CD O O
79 days NNS B-NP O
79 , , O O
80 ALLERGY: NNP B-NP O
80 Morphine NNP I-NP O
81 ADMIT NNP I-NP O
81 DIAGNOSIS: NNP I-NP O
82 macromastia NN I-NP O
82 , , O O
82 panniculectomy NN B-NP O
83 PRINCIPAL NNP I-NP O
83 DISCHARGE NNP I-NP O
83 DIAGNOSIS NNP I-NP O
83 ;Responsible JJ O O
83 After IN B-VP O
83 Study NNP B-NP O
83 for IN B-VP O
83 Causing NNP B-NP O
83 Admission NNP I-NP O
83 ) ) O O
84 bilateral VBD B-VP O
84 breast NN B-NP O
84 reduction NN I-NP O
84 , , O O
84 panniculectomy NN B-NP O
85 OTHER NNP I-NP O
85 DIAGNOSIS;Conditions NNP I-NP O
85 , , O O
85 Infections NNP B-NP O
85 , , O O
85 Complications NNP B-NP O
85 , , O O
85 affecting VBG O O
85 Treatment/Stay NNP B-NP O
86 s/p RB O O
86 massive JJ B-NP O
86 weight NN I-NP O
86 loss NN I-NP O
86 2/2 CD O O
86 gastric JJ B-NP O
86 bypass NN I-NP O
86 , , O O
86 breast NN B-NP O
86 reduction NN I-NP O
86 , , O O
87 panniculectomy JJ B-NP O
88 OPERATIONS NNP I-NP O
88 AND NNP I-NP O
88 PROCEDURES: NNP I-NP O
89 5/8/07 CD O O
89 CHALET NNP B-NP O
89 , , O O
89 ODIS NNP B-NP O
89 RONALD NNP I-NP O
89 , , O O
89 M.D NNP B-NP O
90 BILATERAL NNP I-NP O
90 REDUCTION NNP I-NP O
90 MAMMOPLASTY NNP I-NP O
90 , , O O
90 EXCISION NNP B-NP O
90 PUBIC NNP I-NP O
90 PANNICUECTOMY NNP I-NP O
91 OTHER NNP I-NP O
91 TREATMENTS/PROCEDURES NNP I-NP O
91 ( ( O O
91 NOT NNP B-NP O
91 IN NNP I-NP O
91 O.R NNP I-NP O
91 ) ) O O
92 none NN B-NP O
93 BRIEF NNP I-NP O
93 RESUME NNP I-NP O
93 OF NNP I-NP O
93 HOSPITAL NNP I-NP O
93 COURSE: NNP I-NP O
94 57 CD O O
94 y.o NNS B-NP O
94 female JJ O O
94 with IN B-VP O
94 macromastia NN B-NP O
94 and CC O O
94 abdominal JJ B-NP O
94 skin NN I-NP O
94 laxity NN I-NP O
94 s/p VBP O O
94 massive JJ B-NP O
95 weight NN I-NP O
95 loss NN I-NP O
95 2/2 CD O O
95 gastric JJ B-NP O
95 bypass NN I-NP O
95 , , O O
95 admitted VBN O O
95 to TO O O
95 plastic VB O O
95 surgery NN B-NP O
95 on IN B-VP O
95 5/8/07 CD O O
96 for IN B-VP O
96 bilateral JJ B-NP O
96 breast NN I-NP O
96 reduction NN I-NP O
96 and CC O O
96 panniculectomy NN B-NP O
96 pt NN I-NP O
96 tolerated VBD B-VP O
96 all DT B-NP O
97 procedures NNS I-NP O
97 without IN B-VP O
97 difficulty NN B-NP O
97 post-op JJ B-NP O
97 period NN I-NP O
97 has VBZ O O
97 been VBN O O
97 uneventful JJ O O
97 at IN B-VP O
98 discharge NN B-NP O
98 pt NN I-NP O
98 is VBZ O O
98 afebrile JJ O O
98 with IN B-VP O
98 stable JJ B-NP O
98 vitals NNS I-NP O
98 , , O O
98 taking VBG O O
98 po's/voiding VBG O O
98 q JJ B-NP O
99 shift NN I-NP O
99 , , O O
99 ambulating VBG O O
99 independently RB O O
99 and CC O O
99 pain NN B-NP O
99 has VBZ O O
99 been VBN O O
99 well RB O O
99 managed VBN O O
100 Incisions NNS B-NP O
100 are VBP O O
100 clean JJ O O
100 , , O O
100 dry JJ O O
100 and CC O O
100 intact JJ B-NP O
100 Jp's NNP I-NP O
100 with IN B-VP O
100 moderate JJ B-NP O
100 serosanguinous JJ I-NP O
101 output NN I-NP O
101 remain VBP O O
101 in IN B-VP O
101 place NN B-NP O
101 Pt NNP I-NP O
101 is VBZ O O
101 discharged VBN O O
101 to TO O O
101 home VB O O
101 rehab NN B-NP O
101 stable JJ B-NP O
101 condition NN I-NP O
102 instructions NNS I-NP O
102 given VBN O O
103 ADDITIONAL NNP B-NP O
103 COMMENTS: NNP I-NP O
103 1 CD O O
103 Medications: NNP B-NP O
103 resume NN I-NP O
103 previously RB O O
103 prescribed VBN O O
103 medications NNS B-NP O
103 Do VBP O O
103 not RB O O
103 take VB O O
104 medications NNS B-NP O
104 that WDT O O
104 cause VBP O O
104 bleeding VBG O O
104 - : O O
104 no DT B-NP O
104 aspirin NN I-NP O
104 , , O O
104 motrin NN B-NP O
104 , , O O
104 aleve VBP O O
104 , , O O
104 advil VBP O O
104 or CC O O
105 ibuprfen VBP O O
105 Do NNP B-NP O
105 not RB O O
105 drink/drive/operate VB O O
105 machinery NN B-NP O
105 with IN B-VP O
105 pain NN B-NP B-m
105 medications NNS I-NP I-m
106 Take VBP O O
106 a DT B-NP O
106 stool NN I-NP B-m
106 softener NN I-NP I-m
106 to TO O O
106 prevent VB O O
106 constipation NN B-NP B-r
107 2 CD O O
107 Monitor/return NNP B-NP O
107 for IN B-VP O
107 increased VBN O O
107 pain NN B-NP O
107 , , O O
107 swelling VBG O O
107 , , O O
107 redness NN B-NP O
107 , , O O
107 fever NN B-NP O
107 or CC O O
107 other JJ B-NP O
108 concerns NNS I-NP O
108 Call NNP I-NP O
108 dr NN I-NP O
108 xx NN I-NP O
108 , , O O
108 or CC O O
108 Garret NNP B-NP O
108 Murak NNP I-NP O
108 NP NNP I-NP O
108 for IN B-VP O
108 questions NNS B-NP O
108 525 CD O O
108 503-3214 JJ B-NP O
109 pager NN I-NP O
109 85184 CD O O
110 3 CD O O
110 Activity NNP B-NP O
110 - : O O
110 sponge NN B-NP O
110 baths NNS I-NP O
110 only RB O O
110 while IN B-VP O
110 drains NNS B-NP O
110 are VBP O O
110 in IN B-VP O
110 place NN B-NP O
110 Walking NNP I-NP O
110 as IN B-VP O
111 tolerated VBN O O
111 No NNP B-NP O
111 lifting VBG O O
111 more JJR O O
111 than IN B-VP O
111 10 CD O O
111 pounds NNS B-NP O
111 No DT B-NP O
111 jogging NN I-NP O
111 , , O O
111 swimming NN B-NP O
111 , , O O
111 or CC O O
112 aerobics NNS B-NP O
112 x JJ B-NP O
112 4-6 JJ I-NP O
112 weeks NNS I-NP O
113 4 CD O O
113 Continue NNP B-NP O
113 your PRP$ O O
113 antibiotics NNS B-NP B-m
113 as RB O B-du
113 long RB O I-du
113 as IN B-VP I-du
113 you PRP O I-du
113 have VBP O I-du
113 a DT B-NP I-du
113 drain NN I-NP I-du
113 in IN B-VP I-du
113 place NN B-NP I-du
114 Drain NNP I-NP O
114 care NN I-NP O
114 - : O O
114 monitor/record NN B-NP O
114 drain NN I-NP O
114 output NN I-NP O
114 , , O O
114 when WRB O O
114 less JJR O O
114 than IN B-VP O
114 30 CD O O
114 cc NN B-NP O
114 in IN B-VP O
114 24 CD O O
115 hours NNS B-NP O
115 , , O O
115 call NN B-NP O
115 for IN B-VP O
115 appointment NN B-NP O
115 for IN B-VP O
115 removal JJ B-NP O
115 change NN I-NP O
115 drain NN I-NP O
115 sponges NNS I-NP O
115 daily RB O O
116 strip VBP O O
116 drains NNS B-NP O
116 twice RB O O
116 daily RB O O
117 5 CD O O
117 daily JJ B-NP O
117 wound NN I-NP O
117 check NN I-NP O
117 , , O O
117 dsd NN B-NP O
117 as IN B-VP O
117 needed VBN O O
118 DISCHARGE NNP B-NP O
118 CONDITION: NNP I-NP O
118 Stable NNP I-NP O
119 TO NNP I-NP O
119 DO/PLAN: NNP I-NP O
120 wound NN I-NP O
120 check NN I-NP O
120 , , O O
120 drain NN B-NP O
120 care NN I-NP O
121 No NNP I-NP O
121 dictated VBD B-VP O
121 summary JJ B-NP O
122 ENTERED NNP I-NP O
122 BY: NNP I-NP O
122 GLANCY NNP I-NP O
122 , , O O
122 CURTIS NNP B-NP O
122 T NNP I-NP O
122 , , O O
122 NP NNP B-NP O
122 ( ( O O
122 ) ) O O
122 11/24/07 CD O O
122 @ $ O O
122 09:51 CD O O
122 AM NNP B-NP O
123 ****** JJ B-NP O
123 END NN I-NP O
123 OF NNP I-NP O
123 DISCHARGE NNP I-NP O
123 ORDERS NNP I-NP O
123 ****** NNP I-NP O
124 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #952189 VBZ O O
4 663835632 CD O O
4 B NNP B-NP O
4 02570459 CD O O
4 3290042 CD O O
4 7/3/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 right JJ B-NP O
4 leg NN I-NP O
4 pain NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/9/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 8/17/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 MALATESTA NNP I-NP O
8 , , O O
8 TRISTAN NNP B-NP O
8 606-71-69-4 CD O O
9 Re NNP B-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 1/12/06 CD O O
11 AT NNP B-NP O
11 04:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 SANLUIS NNP I-NP O
14 , , O O
14 EDUARDO NNP B-NP O
14 MALCOLM NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
14 , , O O
14 PH.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 TYLENOL NNP I-NP B-m
19 ( ( O I-m
19 ACETAMINOPHEN NNP B-NP I-m
19 ) ) O I-m
19 650 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 Q6H NNP I-NP B-f
20 CALCIUM NNP I-NP B-m
20 CARBONATE NNP I-NP I-m
20 ( ( O I-m
20 500 CD O I-m
20 MG NNP B-NP I-m
20 ELEMENTAL NNP I-NP I-m
20 CA++ NNP I-NP I-m
20 ) ) O I-m
20 500 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 TID NNP I-NP B-f
21 HYDROCHLOROTHIAZIDE NNP I-NP B-m
21 25 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
21 Starting VBG O O
21 Today NNP B-NP O
21 ( ( O O
21 2/4 CD O O
21 ) ) O O
22 LISINOPRIL FW O B-m
22 20 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QD NNP I-NP B-f
23 MULTIVITAMIN NNP I-NP B-m
23 THERAPEUTIC NNP I-NP I-m
23 ( ( O I-m
23 THERAPEUTIC NNP B-NP I-m
23 MULTIVI NNP I-NP I-m
23 ) ) O I-m
24 1 CD O B-do
24 TAB NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QD NNP I-NP B-f
25 LIPITOR NNP I-NP B-m
25 ( ( O I-m
25 ATORVASTATIN NNP B-NP I-m
25 ) ) O I-m
25 10 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QD NNP I-NP B-f
26 Alert NNP I-NP O
26 overridden: NNP I-NP O
26 Override NNP I-NP O
26 added VBD B-VP O
26 on IN B-VP O
26 1/12/06 CD O O
26 by IN B-VP O
26 : : O O
27 POTENTIALLY NNP B-NP O
27 SERIOUS NNP I-NP O
27 INTERACTION: NNP I-NP O
27 NIACIN NNP I-NP B-m
27 , , O O
27 VIT NNP B-NP B-m
27 B-3 NNP I-NP I-m
27 &amp; NNP I-NP O
28 ATORVASTATIN NNP I-NP B-m
28 CALCIUM NNP I-NP I-m
28 Reason NNP I-NP O
28 for IN B-VP O
28 override: NN B-NP O
28 aware JJ B-NP O
29 DIET: NNP I-NP O
29 House NNP I-NP O
29 / VBD B-VP O
29 Low NNP B-NP O
29 chol/low NN I-NP O
29 sat VBD B-VP O
29 fat JJ B-NP O
30 ACTIVITY: NNP I-NP O
30 Walking NNP I-NP O
30 as IN B-VP O
30 tolerated VBN O O
31 FOLLOW NNP B-NP O
31 UP NNP I-NP O
31 APPOINTMENT( NNP I-NP O
31 S NNP I-NP O
31 ): NNP I-NP O
32 Please NNP I-NP O
32 call VB O O
32 Sol NNP B-NP O
32 Newville NNP I-NP O
32 NP NNP I-NP O
32 at IN B-VP O
32 Westhey NNP B-NP O
32 Hospital NNP I-NP O
32 center NN I-NP O
32 for IN B-VP O
32 appointment NN B-NP O
32 within IN B-VP O
32 2 CD O O
32 weeks NNS B-NP O
32 - : O O
32 291-543-8499 JJ O O
32 , , O O
33 ALLERGY: NNP B-NP O
33 NKA NNP I-NP O
34 ADMIT NNP I-NP O
34 DIAGNOSIS: NNP I-NP O
35 right JJ B-NP O
35 leg NN I-NP O
35 pain NN I-NP O
36 PRINCIPAL NNP I-NP O
36 DISCHARGE NNP I-NP O
36 DIAGNOSIS NNP I-NP O
36 ;Responsible JJ O O
36 After IN B-VP O
36 Study NNP B-NP O
36 for IN B-VP O
36 Causing NNP B-NP O
36 Admission NNP I-NP O
36 ) ) O O
37 right VBD B-VP O
37 leg NN B-NP O
37 pain NN I-NP O
38 OTHER NNP I-NP O
38 DIAGNOSIS;Conditions NNP I-NP O
38 , , O O
38 Infections NNP B-NP O
38 , , O O
38 Complications NNP B-NP O
38 , , O O
38 affecting VBG O O
38 Treatment/Stay NNP B-NP O
39 HTN NNP I-NP O
39 ( ( O O
39 hypertension NN B-NP O
39 ) ) O O
39 dyslipidemia NN B-NP O
39 ( ( O O
39 dyslipidemia NN B-NP O
39 ) ) O O
39 s/p NN B-NP O
40 CCK NNP I-NP O
40 s/p NN I-NP O
40 hysterectomy NN I-NP O
40 ( ( O O
40 S/P NNP B-NP O
40 hysterectomy NN I-NP O
40 ) ) O O
40 arthritis NN B-NP O
40 ( ( O O
40 arthritis NN B-NP O
40 ) ) O O
41 OPERATIONS NNP B-NP O
41 AND NNP I-NP O
41 PROCEDURES: NNP I-NP O
42 none NN I-NP O
43 OTHER NNP I-NP O
43 TREATMENTS/PROCEDURES NNP I-NP O
43 ( ( O O
43 NOT NNP B-NP O
43 IN NNP I-NP O
43 O.R NNP I-NP O
43 ) ) O O
44 tylenol NN B-NP B-m
44 , , O O
44 ibuprofen JJ B-NP B-m
45 BRIEF NNP I-NP O
45 RESUME NNP I-NP O
45 OF NNP I-NP O
45 HOSPITAL NNP I-NP O
45 COURSE: NNP I-NP O
46 cc: VBZ O O
46 admit NN B-NP O
46 for IN B-VP O
46 right JJ B-NP O
46 leg NN I-NP O
46 pain NN I-NP O
46 , , O O
46 poor JJ B-NP O
46 ambulation NN I-NP O
47 hpi: NN I-NP O
47 80F CD O O
47 , , O O
47 h/o NN B-NP O
47 OA NNP I-NP O
47 , , O O
47 poor JJ B-NP O
47 baseline NN I-NP O
47 ambulation NN I-NP O
47 , , O O
47 has VBZ O O
47 had VBN O O
48 chronic VBN O O
48 right RB O O
48 sided VBN O O
48 hip/knee NN B-NP O
48 pain NN I-NP O
48 w/ambulation NN I-NP O
48 p/w IN B-VP O
48 acute JJ B-NP O
48 worsening NN I-NP O
48 of IN B-VP O
49 R NNP B-NP O
49 leg NN I-NP O
49 pain NN I-NP O
49 Localizes NNP I-NP O
49 another DT B-NP O
49 pain NN I-NP O
49 x3days VBZ O O
49 to TO O O
49 right VB O O
49 medial JJ B-NP O
50 supramalleolar JJ I-NP O
50 area NN I-NP O
50 , , O O
50 no DT B-NP O
50 trauma NN I-NP O
50 , , O O
50 f/c/ns NN B-NP O
50 , , O O
50 redness NN B-NP O
50 , , O O
50 swelling VBG O O
50 +pn JJ B-NP O
51 w/ambulation NN I-NP O
51 to TO O O
51 right JJ B-NP O
51 leg NN I-NP O
51 , , O O
51 hip NN B-NP O
51 , , O O
51 achy IN B-VP O
51 not RB O O
51 sharp JJ B-NP O
51 Denies NNPS I-NP O
51 bowl/bladder NN I-NP O
52 changes NNS I-NP O
52 In IN B-VP O
52 ED NNP B-NP O
52 got VBD B-VP O
52 ASA NNP B-NP B-m
53 PMH: NNP I-NP O
53 see VBP O O
53 problems NNS B-NP O
53 SH: NNP I-NP O
53 lives VBZ O O
53 with IN B-VP O
53 older JJR B-NP O
53 son NN I-NP O
53 , , O O
53 seen VBN O O
53 with IN B-VP O
53 other JJ B-NP O
53 son NN I-NP O
53 , , O O
54 doesn't VB O O
54 do VB O O
54 much JJ B-NP O
54 activity NN I-NP O
54 without IN B-VP O
54 assistance NN B-NP O
54 STATUS: NNP I-NP O
54 VS NNP I-NP O
54 97.8 CD O O
54 , , O O
54 80 CD O O
54 , , O O
55 179/83 CD O O
55 , , O O
55 16 CD O O
55 , , O O
55 96%RA CD O O
55 , , O O
55 exam FW O O
55 wnl NN B-NP O
55 except IN B-VP O
55 4x6cm CD O O
55 area NN B-NP O
55 of IN B-VP O
55 dark JJ B-NP O
55 induration NN I-NP O
55 on IN B-VP O
56 medial JJ B-NP O
56 area NN I-NP O
56 above IN B-VP O
56 ankle NN B-NP O
56 , , O O
56 ttp NN B-NP O
56 , , O O
56 no DT O O
56 red JJ O O
56 , , O O
56 slight JJ B-NP O
56 warm NN I-NP O
56 no DT B-NP O
56 edema NN I-NP O
57 2+b/l CD O O
57 ext JJ B-NP O
57 pulses NNS I-NP O
57 Str NNP I-NP O
57 5/5 CD O O
57 all DT B-NP O
57 ext JJ I-NP O
57 Stands NNP I-NP O
57 and CC O O
57 walks NNS B-NP O
57 w/o VBP O O
57 intalgia JJ B-NP O
58 neuro JJ I-NP O
58 sensory JJ I-NP O
58 intact NN I-NP O
58 to TO O O
58 LT NNP B-NP O
58 bil NN I-NP O
58 MEDS: NNP I-NP O
58 lisinopril VBZ O B-m
58 20 CD O B-do
58 , , O O
58 hctz NN B-NP B-m
58 25 CD O B-do
58 , , O O
58 lipitor NN B-NP B-m
59 10 CD O B-do
59 , , O O
59 mvi NN B-NP B-m
59 , , O O
59 fosomax JJ B-NP B-m
60 NKDA NNP I-NP O
60 LABS: NNP I-NP O
60 WNL NNP I-NP O
60 , , O O
60 ddimer NN B-NP O
60 &lt;500 NNP I-NP O
61 STUDIES: NNP I-NP O
61 ECG NNP I-NP O
61 - : O O
61 NSR NN B-NP O
61 , , O O
61 ??old JJ B-NP O
61 septal JJ I-NP O
61 infract NN I-NP O
61 with IN B-VP O
61 q's NN B-NP O
61 in IN B-VP O
61 v1 NN B-NP O
61 , , O O
61 v2 FW O O
62 infarct NN B-NP O
62 CXR NNP I-NP O
62 - : O O
62 no DT B-NP O
62 effusion NN I-NP O
62 , , O O
62 infiltrate NN B-NP O
62 , , O O
62 or CC O O
62 acute JJ B-NP O
62 abnl NN I-NP O
63 RIGHT NNP I-NP O
63 HIP NNP I-NP O
63 , , O O
63 KNEE NNP B-NP O
63 , , O O
63 ANKLE NNP B-NP O
63 , , O O
63 LEG NNP B-NP O
63 Xrays NNP I-NP O
63 - : O O
63 no DT B-NP O
63 joint JJ I-NP O
63 space NN I-NP O
63 disease NN I-NP O
63 or CC O O
64 fractures VBZ O O
65 ****HOSPITAL JJ B-NP O
65 COURSE**** NNP I-NP O
66 Patient NNP I-NP O
66 was VBD B-VP O
66 admitted VBN O O
66 for IN B-VP O
66 difficulty NN B-NP O
66 for IN B-VP O
66 ambulation NN B-NP O
66 and CC O O
66 work NN B-NP O
66 up RB O O
66 of IN B-VP O
66 her PRP$ O O
67 leg NN B-NP O
67 pains VBZ O O
67 She PRP O O
67 had VBD B-VP O
67 two CD O O
67 pain NN B-NP O
67 syndromes NNS I-NP O
67 ( ( O O
67 1 CD O O
67 ) ) O O
67 focal JJ B-NP O
67 area NN I-NP O
67 of IN B-VP O
67 induration NN B-NP O
67 2cm CD O O
68 above IN B-VP O
68 right JJ B-NP O
68 medial JJ I-NP O
68 malleolus NN I-NP O
68 with IN B-VP O
68 slight JJ B-NP O
68 warmth NNS I-NP O
68 but CC O O
68 not RB O O
68 true JJ B-NP O
68 redness NN I-NP O
69 or CC O O
69 swelling VBG O O
69 Likely JJ B-NP O
69 chronic JJ I-NP O
69 venous JJ I-NP O
69 stasis NN I-NP O
69 vs NN I-NP O
69 superficial JJ B-NP O
70 thrombophlebitis NN I-NP O
70 DDimer NNP I-NP O
70 was VBD B-VP O
70 &lt;500 JJ O O
70 and CC O O
70 negative JJ O O
70 This DT O O
70 improved VBN O O
70 with IN B-VP O
71 tylenol NN B-NP B-m
71 and CC O O
71 though IN B-VP O
71 cellulitis NN B-NP O
71 was VBD B-VP O
71 considered VBN O O
71 she PRP O O
71 was VBD B-VP O
71 afebrile RB O O
71 , , O O
71 nl JJ B-NP O
71 WBC NNP I-NP O
72 count NN I-NP O
72 , , O O
72 and CC O O
72 it PRP O O
72 did VBD B-VP O
72 not RB O O
72 have VB O O
72 the DT B-NP O
72 clinical JJ I-NP O
72 signs NNS I-NP O
72 consistent JJ O O
72 with IN B-VP O
73 cellulitis NN B-NP O
73 Regardless NNP I-NP O
73 it PRP O O
73 should MD O O
73 be VB O O
73 followed VBN O O
73 for IN B-VP O
73 progression NN B-NP O
73 Also RB O O
74 considered VBD B-VP O
74 atypical JJ B-NP O
74 gout NN I-NP O
74 and CC O O
74 this DT O O
74 should MD O O
74 be VB O O
74 considered VBN O O
74 in IN B-VP O
74 the DT B-NP O
74 future NN I-NP O
74 if IN B-VP O
75 it PRP O O
75 persists VBZ O O
76 ( ( O O
76 2 CD O O
76 ) ) O O
76 Pt NNP B-NP O
76 complained VBD B-VP O
76 of IN B-VP O
76 right NN B-NP O
76 sided VBD B-VP O
76 aching VBG O O
76 lower JJR B-NP O
76 extremity NN I-NP O
76 pain NN I-NP O
76 that WDT O O
76 was VBD B-VP O
77 present JJ O O
77 with IN B-VP O
77 ambulation NN B-NP O
77 Xrays NNS I-NP O
77 of IN B-VP O
77 the DT B-NP O
77 right JJ I-NP O
77 lower JJR I-NP O
77 extremity NN I-NP O
77 joints NNS I-NP O
78 including VBG O O
78 hip NN B-NP O
78 , , O O
78 knee NN B-NP O
78 , , O O
78 ankle NN B-NP O
78 , , O O
78 and CC O O
78 LE NNP B-NP O
78 bones NNS I-NP O
78 showed VBD B-VP O
78 no DT B-NP O
78 abnormality NN I-NP O
78 She PRP O O
79 was VBD B-VP O
79 evaluated VBN O O
79 by IN B-VP O
79 physical JJ B-NP O
79 therapy NN I-NP O
79 which WDT O O
79 recommended VBD B-VP O
79 use NN B-NP O
79 of IN B-VP O
79 her PRP$ O O
79 cane NN B-NP O
80 and CC O O
80 that IN B-VP O
80 she PRP O O
80 did VBD B-VP O
80 not RB O O
80 have VB O O
80 acute JJ B-NP O
80 PT NNP I-NP O
80 needs NNS I-NP O
80 Cleared NNP I-NP O
80 to TO O O
80 go VB O O
80 home NN B-NP O
80 Her NNP I-NP B-r
80 Her NNP I-NP B-r
80 pains NN I-NP I-r
80 pains NNS I-NP I-r
81 were VBD B-VP O
81 treated VBN O O
81 with IN B-VP O
81 tylenol JJ O B-m
81 650mg CD O B-do
81 po NN B-NP B-mo
81 q6hr NN I-NP B-f
81 ATC NNP I-NP O
81 and CC O O
81 PRN NNP B-NP B-f
81 ibuprofen VBP O B-m
81 The DT B-NP O
81 day NN I-NP O
82 after IN B-VP O
82 admission NN B-NP O
82 her PRP$ O O
82 pain NN B-NP O
82 had VBD B-VP O
82 improved VBN O O
82 and CC O O
82 she PRP O O
82 was VBD B-VP O
82 ambulating VBG O O
82 at IN B-VP O
82 baseline NN B-NP O
83 with IN B-VP O
83 decreased JJ B-NP O
83 discomfort NN I-NP O
83 She PRP O O
83 was VBD B-VP O
83 maintained VBN O O
83 on IN B-VP O
83 her PRP$ O O
83 outpatient JJ B-NP O
84 cardiovascular JJ I-NP B-m
84 medications NNS I-NP I-m
84 Notably RB O O
84 she PRP O O
84 was VBD B-VP O
84 hypertensive JJ O O
84 but CC O O
84 her PRP$ O O
85 medications NNS B-NP O
85 were VBD B-VP O
85 not RB O O
85 altered VBN O O
85 Her NNP B-NP O
85 BP NNP I-NP O
85 should MD O O
85 be VB O O
85 followed VBN O O
85 up RP O O
85 as IN B-VP O
85 an DT B-NP O
86 outpatient NN I-NP O
86 and CC O O
86 he PRP O O
86 BP NNP B-NP B-m
86 meds RB O I-m
86 titrated VBD B-VP B-do
86 as IN B-VP B-f
86 needed VBN O I-f
87 She PRP O O
87 was VBD B-VP O
87 discharged VBN O O
87 in IN B-VP O
87 stable JJ B-NP O
87 condition NN I-NP O
87 to TO O O
87 her PRP$ O O
87 son NN B-NP O
87 Her PRP$ O O
87 NP NNP B-NP O
87 Ezekiel NNP I-NP O
87 Boyton NNP I-NP O
88 was VBD B-VP O
88 contacted VBN O O
88 to TO O O
88 continue VB O O
88 follow VB O O
88 up RP O O
88 care NN B-NP O
88 ( ( O O
88 291-543-8499 JJ O O
88 ) ) O O
89 ADDITIONAL NNP B-NP O
89 COMMENTS: NNP I-NP O
89 Please NNP I-NP O
89 take VB O O
89 tylenol NN B-NP B-m
89 at IN B-VP B-f
89 least JJS O I-f
89 twice JJ O I-f
89 daily RB O I-f
89 to TO O O
89 help VB O O
89 improve VB O O
89 you PRP O O
89 leg VBP O B-r
89 pain VB O I-r
90 Seek NNP B-NP O
90 medical JJ B-NP O
90 attention NN I-NP O
90 if IN B-VP O
90 your PRP$ O O
90 leg NN B-NP O
90 becomes VBZ O O
90 more RBR O O
90 red JJ O O
90 , , O O
90 swollen JJ O O
90 , , O O
90 or CC O O
90 tender NN B-NP O
90 , , O O
91 or CC O O
91 if IN B-VP O
91 you PRP O O
91 have VBP O O
91 any DT B-NP O
91 fevers NNS I-NP O
91 , , O O
91 or CC O O
91 if IN B-VP O
91 you PRP O O
91 have VBP O O
91 any DT B-NP O
91 new JJ I-NP O
91 problems NNS I-NP O
91 with IN B-VP O
91 your PRP$ O O
91 leg NN B-NP O
92 Please NNP I-NP O
92 try NN I-NP O
92 to TO O O
92 use VB O O
92 you PRP O O
92 cane VBP O O
92 to TO O O
92 assist VB O O
92 with IN B-VP O
92 your PRP$ O O
92 walking VBG O O
92 Please NNP B-NP O
92 call VB O O
92 your PRP$ O O
93 nurse NN B-NP O
93 practioner NN I-NP O
93 within IN B-VP O
93 2 CD O O
93 weeks NNS B-NP O
93 for IN B-VP O
93 an DT B-NP O
93 appointment NN I-NP O
94 DISCHARGE NNP I-NP O
94 CONDITION: NNP I-NP O
94 Stable NNP I-NP O
95 TO NNP I-NP O
95 DO/PLAN: NNP I-NP O
96 1 CD O O
96 tylenol NN B-NP B-m
96 for IN B-VP O
96 pain NN B-NP B-r
97 2 CD O O
97 ibuprofen NN B-NP B-m
97 as IN B-VP B-f
97 needed JJ O I-f
98 3 CD O O
98 follow VBP O O
98 up RP O O
98 with IN B-VP O
98 lenard JJ B-NP O
98 dimmitt NN I-NP O
98 for IN B-VP O
98 blood NN B-NP O
98 pressure NN I-NP O
99 No NNP I-NP O
99 dictated VBD B-VP O
99 summary JJ B-NP O
100 ENTERED NNP I-NP O
100 BY: NNP I-NP O
100 BUCKEY NNP I-NP O
100 , , O O
100 REED NNP B-NP O
100 S NNP I-NP O
100 , , O O
100 M.D NNP B-NP O
100 ( ( O O
100 LQ21 NNP B-NP O
100 ) ) O O
100 1/12/06 CD O O
100 @ $ O O
100 01:40 CD O O
100 PM NNP B-NP O
101 ****** JJ B-NP O
101 END NNP I-NP O
101 OF NNP I-NP O
101 DISCHARGE NNP I-NP O
101 ORDERS NNP I-NP O
101 ****** NNP I-NP O
102 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #957953 VBZ O O
4 895562413 CD O O
4 REH NNP B-NP O
4 55829947 CD O O
4 817500 CD O O
4 11/16/1990 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/2/1990 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 8/0/1990 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 This DT O O
7 is VBZ O O
7 a DT O O
7 39 CD O O
7 year NN B-NP O
7 old JJ B-NP O
7 Wark NNP I-NP O
7 Na NNP I-NP O
7 Bo NNP I-NP O
8 female NN I-NP O
8 with IN B-VP O
8 a DT B-NP O
8 history NN I-NP O
8 of IN B-VP O
8 discoid JJ B-NP O
8 lupus NN I-NP O
9 and CC O O
9 pericarditis NN B-NP O
9 , , O O
9 who WP O O
9 presents VBZ O O
9 with IN B-VP O
9 severe JJ B-NP O
9 substernal JJ I-NP O
9 chest NN I-NP O
9 pain NN I-NP O
10 after IN B-VP O
10 having VBG O O
10 prednisone NN B-NP B-m
10 and CC O O
10 Plaquenil NNP B-NP B-m
10 discontinued VBD B-VP O
10 She PRP O O
10 first RB O O
11 developed VBD B-VP O
11 discoid JJ B-NP O
11 lupus NN I-NP O
11 in IN B-VP O
11 1983 CD O O
11 She PRP O O
11 subsequently RB O O
11 over IN B-VP O
11 the DT B-NP O
11 years NNS I-NP O
12 developed VBD B-VP O
12 arthralgias JJ B-NP B-r
12 arthralgias NNS I-NP B-r
12 of IN B-VP O
12 various JJ B-NP O
12 joints NNS I-NP O
12 , , O O
12 was VBD B-VP O
12 treated VBN O O
12 with IN B-VP O
12 aspirin NN B-NP B-m
12 , , O O
13 Motrin NNP B-NP O
13 and CC O O
13 steroids NNS B-NP B-m
13 In IN B-VP O
13 1985 CD O O
13 , , O O
13 she PRP O O
13 developed VBD B-VP O
13 pleuritic JJ B-NP O
13 substernal JJ I-NP O
14 chest NN I-NP O
14 pain NN I-NP O
14 She PRP O O
14 was VBD B-VP O
14 diagnosed VBN O O
14 at IN B-VP O
14 Westten NNP B-NP O
14 Hospital NNP I-NP O
14 with IN B-VP O
14 pericarditis NN B-NP O
15 and CC O O
15 underwent JJ B-NP O
15 pericardiocentesis NN I-NP O
15 In IN B-VP O
15 1988 CD O O
15 , , O O
15 she PRP O O
15 was VBD B-VP O
15 seen VBN O O
15 at IN B-VP O
15 the DT B-NP O
16 Arthritis NNP I-NP O
16 Clinic NNP I-NP O
16 by IN B-VP O
16 Dr NNP B-NP O
16 Goerlitz NNP I-NP O
16 , , O O
16 who WP O O
16 noted VBD B-VP O
16 a DT B-NP O
16 discoid JJ I-NP O
16 lupus NN I-NP O
16 on IN B-VP O
17 examination NN B-NP O
17 , , O O
17 a DT B-NP O
17 mild JJ I-NP O
17 anemia NN I-NP O
17 , , O O
17 sedimentation NN B-NP O
17 rate NN I-NP O
17 85 CD O O
17 , , O O
17 CH-50 NNP B-NP O
17 178 CD O O
17 , , O O
17 VNA NNP B-NP O
18 positive JJ O O
18 at IN B-VP O
18 1:160 CD O O
18 , , O O
18 positive JJ B-NP O
18 anti-double-stranded JJ I-NP O
18 DNA NN I-NP O
18 and CC O O
18 3+ CD O O
19 positive JJ B-NP O
19 Smith/anti-Smith NNP I-NP O
19 antibody NN I-NP O
19 She PRP O O
19 was VBD B-VP O
19 treated VBN O O
19 with IN B-VP O
19 Plaquenil NNP B-NP B-m
20 200 CD O B-do
20 bid NN B-NP B-f
20 , , O O
20 plus CC O O
20 aspirin NN B-NP B-m
20 and CC O O
20 Naprosyn NNP B-NP B-m
20 In IN B-VP O
20 22 CD O O
20 of IN B-VP O
20 May NNP B-NP O
20 , , O O
20 she PRP O O
20 was VBD B-VP O
20 diagnosed VBN O O
21 with IN B-VP O
21 a DT B-NP B-r
21 lupus NN I-NP I-r
21 flare NN I-NP I-r
21 and CC O O
21 was VBD B-VP O
21 put VBN O O
21 on IN B-VP O
21 prednisone NN B-NP B-m
21 30 CD O B-do
21 q NN B-NP B-f
21 am VBP O I-f
21 She PRP O O
21 did VBD B-VP O
21 well RB O O
22 and CC O O
22 in IN B-VP O
22 23 CD O O
22 of IN B-VP O
22 March NNP B-NP O
22 the DT B-NP O
22 steroids NNS I-NP B-m
22 were VBD B-VP O
22 tapered VBN O O
22 off RB O O
22 and CC O O
22 discontinued VBN O O
23 However RB O O
23 , , O O
23 she PRP O O
23 presented VBD B-VP O
23 with IN B-VP O
23 substernal JJ B-NP B-r
23 chest NN I-NP I-r
23 pain NN I-NP I-r
23 at IN B-VP O
23 that DT B-NP O
23 time NN I-NP O
23 and CC O O
24 had VBD B-VP O
24 her PRP$ O O
24 prednisone NN B-NP B-m
24 restarted VBD B-VP O
24 She PRP O O
24 was VBD B-VP O
24 put VBN O O
24 on IN B-VP O
24 another DT B-NP O
24 prednisone NN I-NP B-m
25 taper NN I-NP O
25 In IN B-VP O
25 26 CD O O
25 of IN B-VP O
25 May NNP B-NP O
25 , , O O
25 she PRP O O
25 had VBD B-VP O
25 a DT B-NP O
25 negative JJ I-NP O
25 brain NN I-NP O
25 magnetic JJ B-NP O
25 resonance NN I-NP O
26 imaging NN I-NP O
26 In IN B-VP O
26 1 CD O O
26 of IN B-VP O
26 October NNP B-NP O
26 , , O O
26 she PRP O O
26 had VBD B-VP O
26 an DT B-NP O
26 echocardiogram NN I-NP O
26 which WDT O O
26 showed VBD B-VP O
27 pericardial JJ B-NP O
27 thickening NN I-NP O
27 without IN B-VP O
27 evidence NN B-NP O
27 of IN B-VP O
27 constriction NN B-NP O
27 consistent NN I-NP O
28 with IN B-VP O
28 prior JJ B-NP O
28 pericarditis NN I-NP O
28 Over IN B-VP O
28 the DT B-NP O
28 following JJ I-NP O
28 several JJ I-NP O
28 months NNS I-NP O
28 , , O O
28 she PRP O O
29 had VBD B-VP O
29 occasional JJ B-NP O
29 flares NNS I-NP O
29 because IN B-VP O
29 of IN B-VP O
29 medical JJ B-NP O
29 noncompliance NN I-NP O
29 She PRP O O
29 was VBD B-VP O
30 put VBN O O
30 on IN B-VP O
30 Plaquenil NNP B-NP B-m
30 Plaquenil NNP I-NP B-m
30 200 CD O B-do
30 200 CD O B-do
30 bid NN B-NP B-f
30 , , O O
30 which WDT O O
30 was VBD B-VP O
30 increased VBN O O
30 to TO O O
30 tid VB O B-f
30 , , O O
30 and CC O O
30 Motrin NNP B-NP B-m
31 800 CD O B-do
31 bid NN B-NP B-f
31 In IN B-VP O
31 15 CD O O
31 of IN B-VP O
31 January NNP B-NP O
31 , , O O
31 she PRP O O
31 again RB O O
31 came VBD B-VP O
31 to TO O O
31 the DT B-NP O
31 emergency NN I-NP O
31 room NN I-NP O
31 with IN B-VP O
32 substernal JJ B-NP O
32 chest NN I-NP O
32 pain NN I-NP O
32 and CC O O
32 a DT B-NP O
32 mild JJ I-NP O
32 pulsus NN I-NP O
32 paradoxus NN I-NP O
32 , , O O
32 no DT B-NP O
32 jugular JJ I-NP O
33 venous JJ I-NP O
33 distention NN I-NP O
33 An DT B-NP O
33 electrocardiogram NN I-NP O
33 was VBD B-VP O
33 without IN B-VP O
33 change NN B-NP O
33 Chest NNP I-NP O
34 x-ray NN I-NP O
34 showed VBD B-VP O
34 slight JJ B-NP O
34 increase NN I-NP O
34 in IN B-VP O
34 the DT B-NP O
34 heart NN I-NP O
34 size NN I-NP O
34 She PRP O O
34 was VBD B-VP O
34 placed VBN O O
34 on IN B-VP O
35 prednisone NN B-NP B-m
35 30 CD O B-do
35 q JJ B-NP B-f
35 day NN I-NP I-f
35 , , O O
35 Tylenol NNP B-NP B-m
35 with IN B-VP I-m
35 codeine NN B-NP I-m
35 and CC O O
35 did VBD B-VP O
35 well RB O O
35 On IN B-VP O
36 21 CD O O
36 of IN B-VP O
36 January NNP B-NP O
36 , , O O
36 she PRP O O
36 was VBD B-VP O
36 seen VBN O O
36 in IN B-VP O
36 the DT B-NP O
36 clinic NN I-NP O
36 and CC O O
36 had VBD B-VP O
36 substernal JJ B-NP O
36 chest NN I-NP O
36 pain NN I-NP O
37 consistent JJ O O
37 with IN B-VP O
37 pericardial JJ B-NP O
37 pain NN I-NP O
37 , , O O
37 dyspnea NN B-NP O
37 on IN B-VP O
37 exertion NN B-NP O
37 , , O O
37 increased VBD B-VP O
38 arthralgias RB O B-r
38 secondary JJ O I-r
38 to TO O O
38 discontinuing VBG O O
38 her PRP$ O O
38 steroids NNS B-NP B-m
38 At IN B-VP O
38 that DT B-NP O
38 time NN I-NP O
38 , , O O
39 she PRP O O
39 had VBD B-VP O
39 her PRP O O
39 Plaquenil NNP B-NP B-m
39 and CC O O
39 prednisone NN B-NP B-m
39 restarted VBN O O
39 Over IN B-VP O
39 the DT O O
39 last JJ O O
39 3 CD O O
40 weeks NNS B-NP O
40 prior RB O O
40 to TO O O
40 admission VB O O
40 she PRP O O
40 noticed VBD B-VP O
40 that IN B-VP O
40 the DT B-NP O
40 prednisone NN I-NP B-m
40 and CC O O
41 Plaquenil NNP B-NP B-m
41 increased VBD B-VP O
41 stomachaches NNS B-NP O
41 and CC O O
41 she PRP O O
41 stopped VBD B-VP O
41 the DT B-NP O
41 medication NN I-NP O
42 Over IN B-VP O
42 the DT O O
42 last JJ O O
42 7 CD O O
42 days NNS B-NP O
42 prior RB O O
42 to TO O O
42 admission NN B-NP O
42 , , O O
42 she PRP O O
42 has VBZ O O
42 had VBD B-VP O
42 increasing VBG O O
43 dyspnea NN B-NP O
43 on IN B-VP O
43 exertion NN B-NP O
43 and CC O O
43 substernal JJ B-NP O
43 chest NN I-NP O
43 pain NN I-NP O
43 , , O O
43 which WDT O O
43 is VBZ O O
43 sharp JJ O O
43 , , O O
44 increases NNS B-NP O
44 with IN B-VP O
44 cough NN B-NP O
44 or CC O O
44 deep JJ B-NP O
44 breaths NNS I-NP O
44 She PRP O O
44 denied VBD B-VP O
44 any DT B-NP O
44 orthopnea NN I-NP O
44 or CC O O
45 paroxysmal JJ B-NP O
45 nocturnal JJ I-NP O
45 dyspnea NN I-NP O
45 , , O O
45 palpitations NNS B-NP O
45 or CC O O
45 syncope NN B-NP O
45 She PRP O O
45 has VBZ O O
45 no DT B-NP O
46 nausea NN I-NP O
46 , , O O
46 vomiting VBG O O
46 , , O O
46 fevers NNS B-NP O
46 , , O O
46 chills NNS B-NP O
46 or CC O O
46 melena VB O O
46 She PRP O O
46 does VBZ O O
46 have VB O O
47 increasing VBG O O
47 joint JJ B-NP O
47 pain NN I-NP O
47 PAST NNP I-NP O
47 MEDICAL NNP I-NP O
47 HISTORY NNP I-NP O
47 revealed VBD B-VP O
47 seizure NN B-NP B-r
48 disorder NN I-NP O
48 with IN B-VP O
48 Dilantin NNP B-NP B-m
48 , , O O
48 hypothyroidism NN B-NP B-r
48 treated VBN O O
48 with IN B-VP O
48 L-thyroxine NNP B-NP B-m
48 , , O O
49 iron NN B-NP O
49 deficiency NN I-NP O
49 anemia NN I-NP O
49 without IN B-VP O
49 prior JJ B-NP O
49 work-up NN I-NP O
49 , , O O
49 thoracic JJ B-NP O
49 spine NN I-NP O
50 compression NN I-NP O
50 fractures NNS I-NP O
50 , , O O
50 gastritis NN B-NP O
50 questionably RB O O
50 secondary JJ O O
50 to TO O O
51 Naprosyn NNP B-NP B-m
51 She PRP O O
51 has VBZ O O
51 no DT O O
51 known VBN O O
51 ALLERGIES NNP B-NP O
51 MEDICATIONS NNP I-NP O
51 ON NNP I-NP O
51 ADMISSION NNP I-NP O
52 were VBD B-VP O
52 Plaquenil NNP B-NP B-m
52 200 CD O B-do
52 bid NN B-NP B-f
52 , , O O
52 Motrin NNP B-NP B-m
52 80 CD O B-do
52 tid NN B-NP B-f
52 , , O O
52 prednisone NN B-NP B-m
52 10 CD O B-do
52 q NN B-NP B-f
52 am VBP O I-f
52 , , O O
52 Dilantin NNP B-NP B-m
52 Dilantin NNP I-NP B-m
53 400 CD O B-do
53 400 CD O B-do
53 q NN B-NP B-f
53 am VBP O I-f
53 , , O O
53 L-thyroxine JJ O B-m
53 0.2 CD O B-do
53 q JJ B-NP B-f
53 q JJ I-NP B-f
53 day NN I-NP I-f
53 day NN I-NP I-f
53 , , O O
53 folate VBP O B-m
53 1 CD O B-do
53 mg NN B-NP I-do
53 po NN I-NP B-mo
53 q JJ B-NP B-f
53 day NN I-NP I-f
53 , , O O
53 iron NN B-NP B-m
53 sulfate NN I-NP I-m
54 225 CD O B-do
54 tid NN B-NP B-f
54 , , O O
54 Diprosone NNP B-NP B-m
54 Ointment NNP I-NP I-m
54 bid NN I-NP B-f
54 She PRP O O
54 does VBZ O O
54 not RB O O
54 smoke VB O O
54 or CC O O
54 drink VB O O
55 FAMILY NNP B-NP O
55 HISTORY NNP I-NP O
55 is VBZ O O
55 negative JJ O O
55 for IN B-VP O
55 collagen NN B-NP O
55 vascular NN I-NP O
55 diseases NNS I-NP O
55 She PRP O O
55 is VBZ O O
56 the DT B-NP O
56 mother NN I-NP O
56 of IN B-VP O
56 5 CD O O
56 children NNS B-NP O
57 PHYSICAL NNP I-NP O
57 EXAMINATION: NNP I-NP O
57 She PRP O O
57 was VBD B-VP O
57 an DT B-NP O
57 obese JJ I-NP O
57 Hispanic JJ I-NP O
57 female NN I-NP O
57 in IN B-VP O
57 mild JJ B-NP O
58 distress JJ I-NP O
58 Temperature NN I-NP O
58 was VBD B-VP O
58 99 CD O O
58 , , O O
58 pulse RB O O
58 60 CD O O
58 , , O O
59 blood NN B-NP O
59 pressure NN I-NP O
59 130/70 CD O O
59 , , O O
59 respirations NNS B-NP O
59 18 CD O O
59 , , O O
59 pulsus NN B-NP O
59 paradoxus NN I-NP O
59 of IN B-VP O
59 10 CD O O
60 Skin NNP B-NP O
60 showed VBD B-VP O
60 numerous JJ B-NP O
60 discoid JJ I-NP O
60 lesions NNS I-NP O
60 of IN B-VP O
60 the DT B-NP O
60 scalp NN I-NP O
60 , , O O
60 face NN B-NP O
60 and CC O O
60 right JJ B-NP O
61 forearm NN I-NP O
61 and CC O O
61 lower JJR B-NP O
61 extremities NNS I-NP O
61 with IN B-VP O
61 patchy JJ B-NP O
61 alopecia JJ I-NP O
61 Head NNP I-NP O
61 , , O O
61 eyes NNS B-NP O
61 , , O O
62 ears NNS B-NP O
62 , , O O
62 nose RB O O
62 and CC O O
62 throat VB O O
62 examination NN B-NP O
62 was VBD B-VP O
62 unremarkable JJ B-NP O
62 Neck NNP I-NP O
62 was VBD B-VP O
63 supple JJ O O
63 , , O O
63 no DT B-NP O
63 adenopathy NN I-NP O
63 noted VBD B-VP O
63 Chest NNP B-NP O
63 was VBD B-VP O
63 clear JJ B-NP O
63 Cardiac NNP I-NP O
63 examination NN I-NP O
64 showed VBD B-VP O
64 regular JJ B-NP O
64 rate NN I-NP O
64 and CC O O
64 rhythm NN B-NP O
64 , , O O
64 normal JJ B-NP O
64 S1 NNP I-NP O
64 , , O O
64 S2 NNP B-NP O
64 , , O O
64 with IN B-VP O
64 a DT B-NP O
64 I/VI NNP I-NP O
64 systolic JJ B-NP O
65 ejection NN I-NP O
65 murmur NN I-NP O
65 at IN B-VP O
65 the DT B-NP O
65 left NN I-NP O
65 lower RBR O O
65 sternal JJ B-NP O
65 border NN I-NP O
65 , , O O
65 otherwise RB O O
65 no DT B-NP O
65 rubs NN I-NP O
66 or CC O O
66 gallops NNS B-NP O
66 Back RP O O
66 showed VBD B-VP O
66 no DT B-NP O
66 costovertebral JJ I-NP O
66 angle NN I-NP O
66 or CC O O
66 spinal JJ B-NP O
67 tenderness JJ I-NP O
67 Abdominal NNP I-NP O
67 examination NN I-NP O
67 was VBD B-VP O
67 benign JJ O O
67 , , O O
67 liver EX O O
67 is VBZ O O
67 10 CD O O
67 cm NN B-NP O
67 , , O O
67 and CC O O
68 the DT B-NP O
68 spleen JJ I-NP O
68 tip NN I-NP O
68 is VBZ O O
68 not RB O O
68 palpable JJ B-NP O
68 Rectal JJ I-NP O
68 examination NN I-NP O
68 was VBD B-VP O
68 guaiac JJ O O
69 negative JJ O O
69 , , O O
69 soft JJ B-NP O
69 brown NN I-NP O
69 stools NNS I-NP O
69 She PRP O O
69 does VBZ O O
69 have VB O O
69 external JJ B-NP O
69 hemorrhoids NNS I-NP O
70 Extremities NNS I-NP O
70 were VBD B-VP O
70 negative JJ O O
70 without IN B-VP O
70 cords NNS B-NP O
70 or CC O O
70 Homan's NNP B-NP O
70 sign NN I-NP O
70 Neurologic NNP I-NP O
71 examination NN I-NP O
71 was VBD B-VP O
71 grossly RB O O
71 intact JJ O O
71 , , O O
71 with IN B-VP O
71 normal JJ B-NP O
71 cranial JJ I-NP O
71 nerve NN I-NP O
71 function NN I-NP O
71 , , O O
72 motor NN B-NP O
72 , , O O
72 sensory NN B-NP O
72 , , O O
72 coordination NN B-NP O
72 and CC O O
72 deep JJ B-NP O
72 tendon NN I-NP O
72 reflexes NNS I-NP O
72 , , O O
72 except IN B-VP O
72 for IN B-VP O
73 question NN B-NP O
73 of IN B-VP O
73 slight JJ B-NP O
73 slowing NN I-NP O
73 of IN B-VP O
73 the DT B-NP O
73 relaxation NN I-NP O
73 phase NN I-NP O
73 of IN B-VP O
73 the DT B-NP O
73 reflexes NNS I-NP O
74 in IN B-VP O
74 the DT O O
74 upper JJ O O
74 and CC O O
74 lower JJR B-NP O
74 extremities NNS I-NP O
74 Musculoskeletal NNP I-NP O
74 examination NN I-NP O
75 showed VBD B-VP O
75 diffuse IN B-VP O
75 bilateral JJ O O
75 asymmetric JJ O O
75 synovial JJ O O
75 thickening VBG O O
75 with IN B-VP O
76 slightly RB O O
76 decreased VBN O O
76 range NN B-NP O
76 of IN B-VP O
76 motion NN B-NP O
76 most RBS O O
76 notably RB O O
76 in IN B-VP O
76 the DT B-NP O
76 right JJ I-NP O
76 elbow NN I-NP O
76 , , O O
77 right JJ B-NP O
77 metacarpophalangeal NN I-NP O
77 joint NN I-NP O
77 , , O O
77 left VBD B-VP O
77 carpal JJ O O
77 , , O O
77 bilateral JJ B-NP O
77 knees NNS I-NP O
77 and CC O O
78 ankles NNS B-NP O
79 LABORATORY NNP I-NP O
79 EXAMINATION: NNP I-NP O
79 Electrolytes NNP I-NP O
79 were VBD B-VP O
79 all DT O O
79 within IN B-VP O
79 normal JJ B-NP O
80 limits NNS I-NP O
80 Her PRP$ O O
80 CK NNP B-NP O
80 was VBD B-VP O
80 76 CD O O
80 Dilantin NNP B-NP O
80 level NN I-NP O
81 5.6 CD O O
81 White NNP B-NP O
81 count NN I-NP O
81 was VBD B-VP O
81 4.7 CD O O
81 , , O O
81 hematocrit NN B-NP O
81 30 CD O O
81 , , O O
81 platelets NNS B-NP O
81 352 CD O O
81 , , O O
81 000 CD O O
81 , , O O
81 mean JJ B-NP O
82 corpuscular JJ I-NP O
82 volume NN I-NP O
82 83 CD O O
82 , , O O
82 ESR NNP B-NP O
82 88 CD O O
82 , , O O
82 oxygen NN B-NP O
82 saturation NN I-NP O
82 99% CD O O
82 on IN B-VP O
82 room NN B-NP O
82 air NN I-NP O
83 Urinalysis NNP I-NP O
83 showed VBD B-VP O
83 specific JJ B-NP O
83 gravity NN I-NP O
83 1.026 CD O O
83 , , O O
83 2+ CD O O
83 protein NN B-NP O
83 , , O O
83 10 CD O O
83 to TO O O
83 15 CD O O
84 white JJ B-NP O
84 cells NNS I-NP O
84 , , O O
84 8 CD O O
84 to TO O O
84 10 CD O O
84 red JJ B-NP O
84 blood NN I-NP O
84 cells NNS I-NP O
84 and CC O O
84 a DT B-NP O
84 few JJ I-NP O
84 granular JJ I-NP O
84 casts NNS I-NP O
85 Chest NNP I-NP O
85 x-ray NN I-NP O
85 showed VBD B-VP O
85 increased JJ B-NP O
85 heart NN I-NP O
85 size NN I-NP O
85 , , O O
85 otherwise RB O O
85 negative JJ O O
85 , , O O
85 no DT B-NP O
86 change NN I-NP O
86 from IN B-VP O
86 15 CD O O
86 of IN B-VP O
86 January NNP B-NP O
86 She PRP O O
86 does VBZ O O
86 have VB O O
86 multiple JJ B-NP O
86 thoracic JJ I-NP O
86 compression NN I-NP O
87 fractures NNS I-NP O
87 and CC O O
87 osteopenia VB O O
87 The DT B-NP O
87 electrocardiogram NN I-NP O
87 showed VBD B-VP O
87 sinus JJ B-NP O
88 rhythm NN I-NP O
88 with IN B-VP O
88 frequent JJ B-NP O
88 premature NN I-NP O
88 ventricular JJ B-NP O
88 contractions NNS I-NP O
88 at IN B-VP O
88 a DT B-NP O
88 rate NN I-NP O
89 of IN B-VP O
89 approximately RB O O
89 70 CD O O
89 , , O O
89 positive JJ O O
89 45 CD O O
89 degree JJ B-NP O
89 axis NN I-NP O
89 , , O O
89 normal JJ B-NP O
89 intervals NNS I-NP O
89 , , O O
90 T-wave NNP B-NP O
90 inversion NN I-NP O
90 in IN B-VP O
90 III NNP B-NP O
90 and CC O O
90 V2 NNP B-NP O
90 through IN B-VP O
90 V3 NNP B-NP O
90 without IN B-VP O
90 changes NNS B-NP O
90 in IN B-VP O
90 the DT B-NP O
90 PR NNP I-NP O
91 or CC O O
91 ST NNP B-NP O
91 segments NNS I-NP O
91 compared VBN O O
91 with IN B-VP O
91 15 CD O O
91 of IN B-VP O
91 January NNP B-NP O
91 , , O O
91 and CC O O
91 no DT B-NP O
91 decrease NN I-NP O
91 in IN B-VP O
91 the DT B-NP O
92 voltages NNS I-NP O
93 HOSPITAL NNP I-NP O
93 COURSE: NNP I-NP O
93 Problem NNP I-NP O
93 #1 NNP I-NP O
93 was VBD B-VP O
93 substernal JJ B-NP O
93 chest NN I-NP O
93 pain NN I-NP O
93 This DT O O
94 seemed VBD B-VP O
94 to TO O O
94 be VB O O
94 a DT B-NP O
94 pericardial JJ I-NP O
94 pain NN I-NP O
94 secondary JJ O O
94 to TO O O
95 discontinuation NN B-NP O
95 of IN B-VP O
95 her PRP$ O O
95 prednisone NN B-NP B-m
95 and CC O O
95 Plaquenil NNP B-NP B-m
95 as IN B-VP O
95 it PRP O O
95 happened VBD B-VP O
96 numerous JJ B-NP O
96 times NNS I-NP O
96 in IN B-VP O
96 the DT O O
96 past JJ O O
96 She PRP O O
96 was VBD B-VP O
96 ruled VBN O O
96 out RP O O
96 for IN B-VP O
96 a DT B-NP O
96 myocardial JJ I-NP O
97 infarction NN I-NP O
97 She PRP O O
97 had VBD B-VP O
97 an DT B-NP O
97 echocardiogram NN I-NP O
97 which WDT O O
97 showed VBD B-VP O
97 a DT B-NP O
97 small JJ I-NP O
97 amount NN I-NP O
98 of IN B-VP O
98 pericardial JJ B-NP O
98 fluid NN I-NP O
98 without IN B-VP O
98 evidence NN B-NP O
98 of IN B-VP O
98 right JJ B-NP O
98 ventricular JJ I-NP O
99 indentation NN I-NP O
99 or CC O O
99 compromise NN B-NP O
99 She PRP O O
99 was VBD B-VP O
99 placed VBN O O
99 back RB O O
99 on IN B-VP O
99 her PRP$ O O
99 Plaquenil NNP B-NP B-m
100 200 CD O B-do
100 bid NN B-NP B-f
100 , , O O
100 and CC O O
100 prednisone RB O B-m
100 30 CD O B-do
100 q JJ B-NP B-f
100 day NN I-NP I-f
100 and CC O O
100 did VBD B-VP O
100 well RB O O
100 in IN B-VP O
100 that DT B-NP O
100 regard NN I-NP O
101 Problem NNP I-NP O
101 #2 NNP I-NP O
101 was VBD B-VP O
101 decreased VBN O O
101 hematocrit NN B-NP O
101 This DT O O
101 was VBD B-VP O
101 felt VBN O O
101 to TO O O
101 be VB O O
101 probably RB O O
102 secondary JJ O O
102 to TO O O
102 hydration NN B-NP O
102 as IN B-VP O
102 the DT B-NP O
102 hematocrit NN I-NP O
102 on IN B-VP O
102 hospital JJ B-NP O
102 day NN I-NP O
102 #2 VB O O
102 went VBD B-VP O
103 from IN B-VP O
103 31 CD O O
103 to TO O O
103 27 CD O O
103 with IN B-VP O
103 several JJ B-NP O
103 liters NNS I-NP O
103 of IN B-VP O
103 intravenous JJ B-NP O
103 fluid JJ I-NP O
103 Stool NNP I-NP O
104 guaiacs NN I-NP O
104 were VBD B-VP O
104 negative JJ O O
104 throughout IN B-VP O
104 the DT B-NP O
104 hospitalization NN I-NP O
104 The DT B-NP O
105 hematocrit NN I-NP O
105 remained VBD B-VP O
105 stable JJ O O
105 between IN B-VP O
105 27 CD O O
105 and CC O O
105 30 CD O O
105 without IN B-VP O
105 transfusions NNS B-NP O
106 or CC O O
106 further JJ B-NP O
106 intervention NN I-NP O
106 She PRP O O
106 did VBD B-VP O
106 have VB O O
106 a DT B-NP O
106 Coombs NNP I-NP O
106 test NN I-NP O
106 sent VBD B-VP O
106 which WDT O O
106 was VBD B-VP O
107 mildly RB O O
107 positive JJ O O
107 , , O O
107 although IN B-VP O
107 her PRP$ O O
107 hematocrit NN B-NP O
107 was VBD B-VP O
107 stable JJ O O
107 She PRP O O
107 was VBD B-VP O
108 discharged VBN O O
108 on IN B-VP O
108 folate NN B-NP B-m
108 and CC O O
108 iron NN B-NP O
108 Problem NNP I-NP O
108 #3 NNP I-NP O
108 is VBZ O O
108 hematuria JJ O O
108 and CC O O
108 pyuria NN B-NP O
109 at IN B-VP O
109 the DT B-NP O
109 time NN I-NP O
109 of IN B-VP O
109 admission NN B-NP O
109 Urine NNP I-NP O
109 culture NN I-NP O
109 and CC O O
109 urine JJ B-NP O
109 gram NN I-NP O
109 stain NN I-NP O
109 were VBD B-VP O
110 both DT O O
110 negative JJ O O
110 for IN B-VP O
110 infection NN B-NP O
110 and CC O O
110 this DT O O
110 was VBD B-VP O
110 followed VBN O O
110 up RP O O
110 with IN B-VP O
110 a DT B-NP O
110 24-hour JJ I-NP O
111 urine JJ I-NP O
111 collection NN I-NP O
111 for IN B-VP O
111 protein NN B-NP O
111 to TO O O
111 assess VB O O
111 for IN B-VP O
111 potential JJ B-NP O
111 lupus JJ I-NP O
112 involvement NN I-NP O
112 of IN B-VP O
112 the DT B-NP O
112 kidney NN I-NP O
112 , , O O
112 and CC O O
112 this DT O O
112 will MD O O
112 need VB O O
112 to TO O O
112 be VB O O
112 followed VBN O O
112 up RP O O
112 on IN B-VP O
113 DISPOSITION: NNP B-NP O
113 The DT B-NP O
113 patient NN I-NP O
113 was VBD B-VP O
113 discharged VBN O O
113 for IN B-VP O
113 FOLLOW-UP NNP B-NP O
113 in IN B-VP O
114 Rheumatology NNP B-NP O
114 Clinic NNP I-NP O
114 with IN B-VP O
114 Dr NNP B-NP O
114 Grondin NNP I-NP O
114 MEDICATIONS NNP I-NP O
115 ON NNP I-NP O
115 DISCHARGE NNP I-NP O
115 included VBD B-VP O
115 Plaquenil NNP B-NP B-m
115 200 CD O B-do
115 bid NN B-NP B-f
115 , , O O
115 prednisone NN B-NP B-m
115 20 CD O B-do
115 q JJ B-NP B-f
115 day NN I-NP I-f
115 , , O O
116 Dilantin NNP B-NP B-m
116 400 CD O B-do
116 q NN B-NP B-f
116 day NN I-NP I-f
116 , , O O
116 L-thyroxine JJ O B-m
116 0.2 CD O B-do
116 q NN B-NP B-f
116 am VBP O I-f
116 , , O O
116 Motrin NNP B-NP B-m
116 800 CD O B-do
116 tid NN B-NP B-f
116 , , O O
116 Carafate NNP B-NP B-m
116 , , O O
117 iron NN B-NP O
117 and CC O O
117 folate VB O B-m
118 ________________________________ NNP B-NP O
118 PC935/9478 NNP I-NP O
119 DARRELL NNP I-NP O
119 PITCAVAGE NNP I-NP O
119 , , O O
119 M.D NNP B-NP O
119 NJ8 NNP I-NP O
119 D: NNP I-NP O
119 9/23/90 CD O O
120 Batch: NNP B-NP O
120 5309 CD O O
120 Report: NNP B-NP O
120 Q6251C81 NNP I-NP O
120 T: NNP I-NP O
120 10/14/90 CD O O
121 Dictated NNP B-NP O
121 By: NNP I-NP O
121 JOESPH NNP I-NP O
121 ZUEHL NNP I-NP O
121 , , O O
121 M.D NNP B-NP O
122 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #961115 VBZ O O
4 895226877 CD O O
4 YMC NNP B-NP O
4 33406917 CD O O
4 2170940 CD O O
4 9/12/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Upper NNP I-NP O
4 Respiratory NNP I-NP O
4 Infection NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 6/27/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/26/2005 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 GREGSTON NNP I-NP O
8 , , O O
8 DARREL NNP B-NP O
8 163-08-42-8 CD O O
9 MT NNP B-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 3/26/05 CD O O
11 AT NNP B-NP O
11 02:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 HO NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 OELTJEN NNP I-NP O
14 , , O O
14 DONN NNP B-NP O
14 EARLE NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 DISPOSITION: NNP I-NP O
15 Home NNP I-NP O
16 DISCHARGE NNP I-NP O
16 MEDICATIONS: NNP I-NP O
17 IBUPROFEN NNP I-NP B-m
17 600-800 JJ B-NP B-do
17 MG NNP I-NP I-do
17 PO NNP I-NP B-mo
17 TID NNP I-NP B-f
17 PRN NNP I-NP I-f
17 Pain NNP I-NP B-r
18 Food/Drug NNP I-NP O
18 Interaction NNP I-NP O
18 Instruction NNP I-NP O
18 Take NNP I-NP O
18 with IN B-VP O
18 food NN B-NP O
19 DIET: NNP I-NP O
19 No NNP I-NP O
19 Restrictions NNP I-NP O
20 ACTIVITY: NNP I-NP O
20 Resume NNP I-NP O
20 regular JJ B-NP O
20 exercise NN I-NP O
21 FOLLOW NNP I-NP O
21 UP NNP I-NP O
21 APPOINTMENT( NNP I-NP O
21 S NNP I-NP O
21 ): NNP I-NP O
22 primary JJ B-NP O
22 care NN I-NP O
22 doctor NN I-NP O
22 25 CD O O
22 of IN B-VP O
22 October NNP B-NP O
22 , , O O
23 ALLERGY: NNP B-NP O
23 NKA NNP I-NP O
24 ADMIT NNP I-NP O
24 DIAGNOSIS: NNP I-NP O
25 Shortness NNP I-NP O
25 of IN B-VP O
25 breath NN B-NP O
26 PRINCIPAL NNP I-NP O
26 DISCHARGE NNP I-NP O
26 DIAGNOSIS NNP I-NP O
26 ;Responsible JJ O O
26 After IN B-VP O
26 Study NNP B-NP O
26 for IN B-VP O
26 Causing NNP B-NP O
26 Admission NNP I-NP O
26 ) ) O O
27 Upper NNP B-NP O
27 Respiratory NNP I-NP O
27 Infection NNP I-NP O
28 OTHER NNP I-NP O
28 DIAGNOSIS;Conditions NNP I-NP O
28 , , O O
28 Infections NNP B-NP O
28 , , O O
28 Complications NNP B-NP O
28 , , O O
28 affecting VBG O O
28 Treatment/Stay NNP B-NP O
29 hypertension NN I-NP O
29 ( ( O O
29 hypertension NN B-NP O
29 ) ) O O
29 appendectomy NN B-NP O
29 ( ( O O
29 appendectomy NN B-NP O
29 ) ) O O
29 obesity NN B-NP O
30 ( ( O O
30 obesity NN B-NP O
30 ) ) O O
30 sleep NN B-NP O
30 apnea NN I-NP O
30 ( ( O O
30 sleep JJ B-NP O
30 apnea NN I-NP O
30 ) ) O O
31 OPERATIONS NNP B-NP O
31 AND NNP I-NP O
31 PROCEDURES: NNP I-NP O
32 none NN I-NP O
33 OTHER NNP I-NP O
33 TREATMENTS/PROCEDURES NNP I-NP O
33 ( ( O O
33 NOT NNP B-NP O
33 IN NNP I-NP O
33 O.R NNP I-NP O
33 ) ) O O
34 Lower NNP B-NP O
34 extremity NN I-NP O
34 ultrasound NN I-NP O
34 of IN B-VP O
34 the DT B-NP O
34 Right NNP I-NP O
34 leg NN I-NP O
34 Negative NNP I-NP O
34 for IN B-VP O
34 deep RB O O
34 venous JJ B-NP O
35 thrombus NN I-NP O
36 BRIEF NNP I-NP O
36 RESUME NNP I-NP O
36 OF NNP I-NP O
36 HOSPITAL NNP I-NP O
36 COURSE: NNP I-NP O
37 26 CD O O
37 M NNP B-NP O
37 PMHx NNP I-NP O
37 of IN B-VP O
37 HTN NNP B-NP O
37 , , O O
37 obesity NN B-NP O
37 , , O O
37 sleep JJ B-NP O
37 apnea NN I-NP O
37 who WP O O
37 was VBD B-VP O
37 in IN B-VP O
38 NH NNP B-NP O
38 until IN B-VP O
38 2 CD O O
38 days NNS B-NP O
38 prior RB O O
38 to TO O O
38 admit VB O O
38 when WRB O O
38 developed JJ B-NP O
38 SOB NNP I-NP O
38 Pt NNP I-NP O
38 was VBD B-VP O
38 otherwise RB O O
39 well RB O O
39 until IN B-VP O
39 this DT B-NP O
39 AM NNP I-NP O
39 when WRB O O
39 he PRP O O
39 reports VBZ O O
39 palpitations NNS B-NP O
39 , , O O
39 cough NN B-NP O
39 with IN B-VP O
39 sputum NN B-NP O
39 , , O O
40 SOB NNP B-NP O
40 Feeling NNP I-NP O
40 warm NN I-NP O
40 but CC O O
40 no DT B-NP O
40 cp NN I-NP O
40 , , O O
40 vomiting VBG O O
40 , , O O
40 hemoptysis NN B-NP O
40 , , O O
41 BRBPR NNP B-NP O
41 , , O O
41 abdominal JJ B-NP O
41 pain NN I-NP O
41 , , O O
41 diarrhea VBZ O O
41 No NNP B-NP O
41 sick JJ B-NP O
41 contacts NNS I-NP O
41 Also RB O O
41 reports VBP O O
41 R NNP B-NP O
41 leg NN I-NP O
42 pain NN I-NP O
42 which WDT O O
42 he PRP O O
42 has VBZ O O
42 gotten VBN O O
42 in IN B-VP O
42 past NN B-NP O
42 in IN B-VP O
42 setting NN B-NP O
42 of IN B-VP O
43 pna NN B-NP O
44 VS NNP I-NP O
44 T NNP I-NP O
44 101.2 CD O O
44 P NNP B-NP O
44 110 CD O O
44 BP NNP B-NP O
44 128/72 CD O O
44 O2 NNP B-NP O
44 SAT NNP I-NP O
44 95% CD O O
44 RA NNP B-NP O
44 , , O O
44 98% CD O O
44 while IN B-VP O
44 ambulating VBG O O
45 Exam: NNP B-NP O
46 Gen: NNP I-NP O
46 NAD NNP I-NP O
46 HEENT: NNP I-NP O
46 Dry NNP I-NP O
46 mm NN I-NP O
47 Chest: NNP I-NP O
47 Dec NNP I-NP O
47 BS NNP I-NP O
47 R NNP I-NP O
47 lower JJR B-NP O
47 base NN I-NP O
47 no DT O O
47 wheezing VBG O O
48 CV: NNP B-NP O
48 Tachy NNP I-NP O
48 regular JJ B-NP O
48 rhythm NN I-NP O
49 ABD: NNP I-NP O
49 +BS NNP I-NP O
49 non JJ B-NP O
49 tender NN I-NP O
50 Ext: NNP I-NP O
50 no DT B-NP O
50 edema NN I-NP O
50 TTP NNP I-NP O
50 R NNP I-NP O
50 calf NN I-NP O
51 All: NNP I-NP O
52 Nkda NNP I-NP O
52 denies VBZ O O
52 smoking VBG O O
53 LABS: NNP B-NP O
53 WBC NNP I-NP O
53 14 CD O O
53 MCV NNP B-NP O
53 70 CD O O
53 HCT NNP B-NP O
53 47 CD O O
53 Nl NNP B-NP O
53 chem NN I-NP O
53 7 CD O O
53 BNP NNP B-NP O
53 2 CD O O
54 D-dimer NNP B-NP O
54 226 CD O O
54 Cardiac NNP B-NP O
54 enzymes NNS I-NP O
54 Neg NNP I-NP O
55 EKG: NNP I-NP O
55 sinus VBD B-VP O
55 tachy JJ B-NP O
55 T NNP I-NP O
55 wave NN I-NP O
55 inv NN I-NP O
55 III NNP I-NP O
55 unchanged JJ O O
55 from IN B-VP O
55 prior JJ B-NP O
56 CXR: NNP I-NP O
56 NL NNP I-NP O
57 a/p: VBD B-VP O
57 26 CD O O
57 obese JJ O O
57 , , O O
57 HTN NNP B-NP O
57 , , O O
57 male NN B-NP O
57 with IN B-VP O
57 SOB NNP B-NP O
58 1 CD O O
58 URI: NNP B-NP O
58 likely JJ B-NP O
58 viral NN I-NP O
58 in IN B-VP O
58 nature NN B-NP O
58 Nl NNP I-NP O
58 CXR NNP I-NP O
58 , , O O
58 nl JJ B-NP O
58 SATs NNP I-NP O
58 , , O O
59 albuterol NN B-NP B-m
59 prn NN I-NP B-f
59 wheezing VBG O B-r
59 while IN B-VP B-du
59 in IN B-VP I-du
59 hospital NN B-NP I-du
59 but CC O O
59 did VBD B-VP O
59 not RB O O
59 affect VB O O
59 patient's NN B-NP O
60 sob JJ B-NP O
60 Neg NNP I-NP O
60 D-dimer NNP I-NP O
60 but CC O O
60 due JJ O O
60 to TO O O
60 acute VB O O
60 onset JJ B-NP O
60 SOB NNP I-NP O
60 and CC O O
60 concominant VB O O
60 Right NNP B-NP O
60 lower JJR B-NP O
61 extremity NN I-NP O
61 pain NN I-NP O
61 , , O O
61 LENI's NNP B-NP O
61 done VBN O O
61 which WDT O O
61 were VBD B-VP O
61 negative JJ O O
61 for IN B-VP O
61 DVT NNP B-NP O
61 Patient NNP I-NP O
61 felt VBD B-VP O
62 better RBR O O
62 with IN B-VP O
62 IVF NNP B-NP B-m
62 given VBN O O
62 in IN B-VP O
62 ER NNP B-NP O
62 and CC O O
62 did VBD B-VP O
62 not RB O O
62 take VB O O
62 any DT B-NP O
62 nebulizers NNS I-NP O
62 while IN B-VP O
62 on IN B-VP O
62 the DT B-NP O
63 floor NN I-NP O
64 2.HTN: CD O O
64 BP NNP B-NP O
64 well RB O O
64 controlled VBD B-VP O
64 , , O O
64 pt NN B-NP O
64 has VBZ O O
64 never RB O O
64 taken VBN O O
64 HCTZ NNP B-NP O
64 or CC O O
64 any DT B-NP O
64 other JJ I-NP O
64 Rx NNP I-NP O
64 HTN NNP I-NP O
65 medications NNS I-NP O
65 will MD O O
65 go VB O O
65 home NN B-NP O
65 on IN B-VP O
65 no DT B-NP O
65 medications NNS I-NP O
66 3.Palpitations: CD O O
66 resolved VBD B-VP O
66 , , O O
66 no DT B-NP O
66 cp NN I-NP O
66 , , O O
66 no DT B-NP O
66 changes NNS I-NP O
66 in IN B-VP O
66 EKG NNP B-NP O
66 , , O O
67 neg JJ O O
67 enzymes RB O O
68 4.proph: CD O O
68 Lovenox NNP B-NP B-m
69 5.Right CD O B-r
69 leg NN B-NP I-r
69 pain: NN I-NP I-r
69 likely JJ B-NP O
69 musculoskeletal NN I-NP O
69 in IN B-VP O
69 nature NN B-NP O
69 No NNP I-NP O
69 DVT NNP I-NP O
69 found VBD B-VP O
69 on IN B-VP O
69 LENI NNP B-NP O
70 treat NN I-NP O
70 with IN B-VP O
70 elevation NN B-NP O
70 and CC O O
70 Ibuprofen NNP B-NP B-m
70 prn NN I-NP B-f
70 follow VB O O
70 up RP O O
70 with IN B-VP O
70 primary JJ B-NP O
70 care NN I-NP O
71 doctor NN I-NP O
71 if IN B-VP O
71 right JJ B-NP O
71 lower JJR I-NP O
71 extremity NN I-NP O
71 pain NN I-NP O
71 persists VBZ O O
72 6 CD O O
72 Low JJ B-NP O
72 MCV: NNP I-NP O
72 Consider NNP I-NP O
72 outpt MD O O
72 workup VB O O
72 for IN B-VP O
72 thalasemia JJ B-NP O
73 ADDITIONAL NNP I-NP O
73 COMMENTS: NNP I-NP O
73 follow VB O O
73 up RP O O
73 with IN B-VP O
73 your PRP$ O O
73 primary JJ B-NP O
73 care NN I-NP O
73 doctor NN I-NP O
73 for IN B-VP O
73 further JJ B-NP O
73 evaluation NN I-NP O
73 of IN B-VP O
73 your PRP$ O O
74 leg NN B-NP O
74 pain NN I-NP O
74 You PRP O O
74 can MD O O
74 elevate VB O O
74 your PRP$ O O
74 leg NN B-NP O
74 and CC O O
74 use NN B-NP O
74 Ibuprofen NNP I-NP B-m
74 as IN B-VP B-f
74 needed VBN O I-f
74 for IN B-VP O
74 pain NN B-NP B-r
75 control NN I-NP O
76 DISCHARGE NNP I-NP O
76 CONDITION: NNP I-NP O
76 Stable NNP I-NP O
77 TO NNP I-NP O
77 DO/PLAN: NNP I-NP O
78 as IN B-VP O
78 above IN B-VP O
79 No NNP B-NP O
79 dictated VBD B-VP O
79 summary JJ B-NP O
80 ENTERED NNP I-NP O
80 BY: NNP I-NP O
80 MOLLENHAUER NNP I-NP O
80 , , O O
80 REGINALD NNP B-NP O
80 P NNP I-NP O
80 , , O O
80 M.D NNP B-NP O
80 ( ( O O
80 WK163 NNP B-NP O
80 ) ) O O
80 3/26/05 CD O O
80 @ $ O O
80 01:44 CD O O
80 PM NNP B-NP O
81 ****** JJ B-NP O
81 END NNP I-NP O
81 OF NNP I-NP O
81 DISCHARGE NNP I-NP O
81 ORDERS NNP I-NP O
81 ****** NNP I-NP O
82 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #966404 VBZ O O
4 267363543 CD O O
4 VUMC NNP B-NP O
4 41289795 CD O O
4 6085758 CD O O
4 0/19/2003 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 atypical JJ B-NP O
4 noncardiac NN I-NP O
4 chest NN I-NP O
4 pain NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 0/19/2003 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/13/2003 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 KOSLOSKY NNP I-NP O
8 , , O O
8 ALEXANDER NNP B-NP O
8 580-29-32-0 CD O O
9 Denwood NNP B-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 8/4/03 CD O O
11 AT NNP B-NP O
11 02:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 WIESELER NNP I-NP O
14 , , O O
14 RUSSELL NNP B-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
20 Starting VBG O O
20 Today NNP B-NP O
20 ( ( O O
20 9/3 CD O O
20 ) ) O O
21 Instructions: NNP B-NP O
21 increased VBD B-VP O
21 dose NN B-NP O
21 for IN B-VP O
21 costochondritis NN B-NP B-r
21 , , O O
21 pt NN B-NP O
21 does VBZ O O
22 not RB O O
22 wish VB O O
22 to TO O O
22 take VB O O
22 650 CD O O
22 QID NNP B-NP O
22 dosing VBG O O
23 COLACE NNP B-NP B-m
23 ( ( O I-m
23 DOCUSATE NNP B-NP I-m
23 SODIUM NNP I-NP I-m
23 ) ) O I-m
23 100 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 BID NNP I-NP B-f
24 ENALAPRIL NNP I-NP B-m
24 MALEATE NNP I-NP I-m
24 5 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QD NNP I-NP B-f
25 ZOCOR NNP I-NP B-m
25 ( ( O I-m
25 SIMVASTATIN NNP B-NP I-m
25 ) ) O I-m
25 20 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QHS NNP I-NP B-f
26 Food/Drug NNP I-NP O
26 Interaction NNP I-NP O
26 Instruction NNP I-NP O
27 Avoid NNP I-NP O
27 grapefruit NN I-NP O
27 unless IN B-VP O
27 MD NNP B-NP O
27 instructs NNS I-NP O
27 otherwise RB O O
28 INSULIN NNP B-NP B-m
28 INSULIN NNP I-NP B-m
28 INSULIN NNP I-NP B-m
28 INSULIN NNP I-NP B-m
28 70/30 CD O I-m
28 70/30 CD O I-m
28 70/30 CD O I-m
28 70/30 CD O I-m
28 ( ( O I-m
28 ( ( O I-m
28 ( ( O I-m
28 ( ( O I-m
28 HUMAN NNP B-NP I-m
28 HUMAN NNP I-NP I-m
28 HUMAN NNP I-NP I-m
28 HUMAN NNP I-NP I-m
28 ) ) O I-m
28 ) ) O I-m
28 ) ) O I-m
28 ) ) O I-m
28 80 CD O B-do
28 UNITS NNP B-NP I-do
28 QAM; NNP I-NP B-f
28 60 CD O B-do
28 UNITS NNP B-NP I-do
28 QPM NNP I-NP B-f
28 SC NNP I-NP B-mo
28 SC NNP I-NP B-mo
29 80 CD O B-do
29 UNITS NNP B-NP I-do
29 QAM NNP I-NP B-f
29 60 CD O B-do
29 UNITS NNP B-NP I-do
29 QPM NNP I-NP B-f
30 Number NNP I-NP O
30 of IN B-VP O
30 Doses NNP B-NP O
30 Required NNP I-NP O
30 ( ( O O
30 approximate JJ B-NP O
30 ): NN I-NP O
30 6 CD O O
31 PLAVIX NNP B-NP B-m
31 ( ( O I-m
31 CLOPIDOGREL NNP B-NP I-m
31 ) ) O I-m
31 75 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QD NNP I-NP B-f
32 PSYLLIUM NNP I-NP B-m
32 2 CD O B-do
32 TSP NNP B-NP I-do
32 PO NNP I-NP B-mo
32 QD NNP I-NP B-f
33 TOPROL NNP I-NP B-m
33 XL NNP I-NP I-m
33 ( ( O I-m
33 METOPROLOL NNP B-NP I-m
33 ( ( O I-m
33 SUST NNP B-NP I-m
33 REL NNP I-NP I-m
33 ) ) O I-m
33 ) ) O I-m
33 25 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QD NNP I-NP B-f
34 Food/Drug NNP I-NP O
34 Interaction NNP I-NP O
34 Instruction NNP I-NP O
35 Take NNP I-NP O
35 consistently RB O O
35 with IN B-VP O
35 meals NNS B-NP O
35 or CC O O
35 on IN B-VP O
35 empty JJ B-NP O
35 stomach NN I-NP O
36 LASIX NNP I-NP B-m
36 ( ( O I-m
36 FUROSEMIDE NNP B-NP I-m
36 ) ) O I-m
36 20 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 QD NNP I-NP B-f
37 FAMOTIDINE NNP I-NP B-m
37 20 CD O B-do
37 MG NNP B-NP I-do
37 PO NNP I-NP B-mo
37 BID NNP I-NP B-f
38 DIET: NNP I-NP O
38 Patient NNP I-NP O
38 should MD O O
38 measure VB O O
38 weight JJ B-NP O
38 daily JJ I-NP O
39 DIET: NNP I-NP O
39 Fluid NNP I-NP O
39 restriction: VBD B-VP O
39 2 CD O O
39 liters NNS B-NP O
40 DIET: NNP I-NP O
40 House NNP I-NP O
40 / VBD B-VP O
40 Low NNP B-NP O
40 chol/low NN I-NP O
40 sat VBD B-VP O
40 fat JJ B-NP O
41 DIET: NNP I-NP O
41 2 CD O O
41 gram NN B-NP O
41 Sodium NNP I-NP O
42 ACTIVITY: NNP I-NP O
42 Resume NNP I-NP O
42 regular JJ B-NP O
42 exercise NN I-NP O
43 FOLLOW NNP I-NP O
43 UP NNP I-NP O
43 APPOINTMENT( NNP I-NP O
43 S NNP I-NP O
43 ): NNP I-NP O
44 Curts NNP I-NP O
44 1-2 JJ B-NP O
44 weeks NNS I-NP O
44 , , O O
45 ALLERGY: NNP B-NP O
45 Codeine NNP I-NP O
46 ADMIT NNP I-NP O
46 DIAGNOSIS: NNP I-NP O
47 chest JJS B-NP O
47 pain NN I-NP O
47 , , O O
47 cad NN B-NP O
48 PRINCIPAL NNP I-NP O
48 DISCHARGE NNP I-NP O
48 DIAGNOSIS NNP I-NP O
48 ;Responsible JJ O O
48 After IN B-VP O
48 Study NNP B-NP O
48 for IN B-VP O
48 Causing NNP B-NP O
48 Admission NNP I-NP O
48 ) ) O O
49 atypical JJ B-NP O
49 noncardiac JJ I-NP O
49 chest NN I-NP O
49 pain NN I-NP O
50 OTHER NNP I-NP O
50 DIAGNOSIS;Conditions NNP I-NP O
50 , , O O
50 Infections NNP B-NP O
50 , , O O
50 Complications NNP B-NP O
50 , , O O
50 affecting VBG O O
50 Treatment/Stay NNP B-NP O
51 HTN NNP I-NP O
51 ( ( O O
51 hypertension NN B-NP O
51 ) ) O O
51 CAD NNP B-NP O
51 ( ( O O
51 coronary JJ B-NP O
51 artery NN I-NP O
51 disease NN I-NP O
51 ) ) O O
51 s/p NN B-NP O
51 cabg NN I-NP O
51 ( ( O O
51 S/P NNP B-NP O
52 cardiac JJ B-NP O
52 bypass NN I-NP O
52 graft NN I-NP O
52 surgery NN I-NP O
52 ) ) O O
52 IDDM NNP B-NP O
53 ( ( O O
53 ) ) O O
53 hypercholesterolemia NN B-NP O
53 ( ( O O
53 elevated VBN O O
53 cholesterol NN B-NP O
53 ) ) O O
53 peripheral NN B-NP O
53 neuropathy JJ O O
53 ( ( O O
53 ) ) O O
54 OPERATIONS NNP B-NP O
54 AND NNP I-NP O
54 PROCEDURES: NNP I-NP O
55 none NN I-NP O
56 OTHER NNP I-NP O
56 TREATMENTS/PROCEDURES NNP I-NP O
56 ( ( O O
56 NOT NNP B-NP O
56 IN NNP I-NP O
56 O.R NNP I-NP O
56 ) ) O O
57 adenosine VBP O B-m
57 MIBI NNP B-NP O
58 BRIEF NNP I-NP O
58 RESUME NNP I-NP O
58 OF NNP I-NP O
58 HOSPITAL NNP I-NP O
58 COURSE: NNP I-NP O
59 62M CD O O
59 with IN B-VP O
59 history NN B-NP O
59 of IN B-VP O
59 CAD NNP B-NP O
59 and CC O O
59 prior RB O O
59 MI NNP B-NP O
59 leading VBG O O
59 to TO O O
59 CABG NNP B-NP O
59 in IN B-VP O
59 5/23 CD O O
59 Frequent JJ B-NP O
60 chest NN I-NP O
60 pain NN I-NP O
60 since IN B-VP O
60 on IN B-VP O
60 exertion NN B-NP O
60 and CC O O
60 in IN B-VP O
60 times NNS B-NP O
60 of IN B-VP O
60 stress NN B-NP O
60 Admitted VBN O O
60 to TO O O
60 RCH VB O O
61 6/17 CD O O
61 with IN B-VP O
61 CP NNP B-NP O
61 and CC O O
61 ruled VBD B-VP O
61 out RP O O
61 for IN B-VP O
61 MI NNP B-NP O
61 Cath NNP I-NP O
61 showed VBD B-VP O
61 non-occlusive JJ B-NP O
61 disease NN I-NP O
62 ( ( O O
62 70% CD O O
62 ) ) O O
62 an DT B-NP O
62 OM NNP I-NP O
62 which WDT O O
62 was VBD B-VP O
62 stented VBN O O
62 Well NNP B-NP O
62 since IN B-VP O
62 with IN B-VP O
62 frequent JJ B-NP O
62 CP NNP I-NP O
62 with IN B-VP O
62 very RB O O
63 minimal JJ B-NP O
63 exertion NN I-NP O
63 Today NNP I-NP O
63 walking VBG O O
63 outside RB O O
63 after IN B-VP O
63 dinner NN B-NP O
63 had VBD B-VP O
63 another DT B-NP O
64 episode NN I-NP O
64 of IN B-VP O
64 his PRP$ O O
64 usual JJ B-NP O
64 chest NN I-NP O
64 pain NN I-NP O
64 , , O O
64 +SOB NNP B-NP O
64 , , O O
64 5/10 CD O O
64 , , O O
64 no DT B-NP O
64 radiation/LH/ NN I-NP O
65 palpitations NNS I-NP O
65 , , O O
65 c/o NN B-NP O
65 nausea NN I-NP O
65 and CC O O
65 vomiting; NN B-NP O
65 called VBN O O
65 EMS NNP B-NP O
65 -&gt; NNP I-NP O
65 BSMH NNP I-NP O
65 EW NNP I-NP O
65 , , O O
65 given VBN O O
65 2 CD O B-do
66 NTG NNP B-NP B-m
66 with IN B-VP O
66 resolution NN B-NP O
66 of IN B-VP O
66 symptoms NNS B-NP O
66 Concerning VBG O O
66 for IN B-VP O
66 increasing VBG O O
66 frequency NN B-NP O
67 of IN B-VP O
67 CP NNP B-NP O
68 OUTPT NNP I-NP O
68 MEDS: NNP I-NP O
68 plavix VBD B-VP B-m
68 75/lasix CD O B-m
68 75/lasix CD O B-do
68 20/enalapril CD O B-m
68 20/enalapril CD O B-do
68 5/pepcid CD O B-do
68 5/pepcid CD O B-m
68 20/toprol CD O B-m
68 20/toprol CD O B-do
68 xl NN B-NP I-m
68 25/ASA CD O B-do
68 25/ASA CD O B-m
69 325/insulin CD O B-do
69 325/insulin CD O B-m
69 325/insulin CD O B-m
69 70/30/ CD O I-m
69 70/30/ CD O I-m
69 80units CD O B-do
69 am VBP O B-f
69 , , O O
69 60 CD O B-do
69 units NNS B-NP I-do
69 pm/zocor VBP O B-f
69 pm/zocor JJ B-NP B-m
70 Hospital NNP I-NP O
70 course: NN I-NP O
71 1 CD O O
71 Card NNP B-NP O
71 - : O O
71 ruled VBD B-VP O
71 out RP O O
71 for IN B-VP O
71 MI NNP B-NP O
71 , , O O
71 repeated VBD B-VP O
71 Adenosine NNP B-NP B-m
71 MIBI NNP I-NP O
71 which WDT O O
71 confirmed VBD B-VP O
71 no DT B-NP O
72 ischemia NN I-NP O
72 continue VBP O O
72 outpt JJ B-NP O
72 regimen NNS I-NP O
72 of IN B-VP O
72 enalapril/lasix/toprol/zocor NN B-NP B-m
73 2 CD O O
73 GI: NNP B-NP O
73 pt NN I-NP O
73 with IN B-VP O
73 rapid JJ B-NP O
73 new JJ I-NP O
73 rise NN I-NP O
73 in IN B-VP O
73 transaminases NNS B-NP O
73 ddx: VBP O O
73 most RBS O O
73 likely JJ O O
73 due JJ O O
74 to TO O O
74 relative JJ B-NP O
74 hypotension NN I-NP O
74 early RB O O
74 in IN B-VP O
74 admission NN B-NP O
74 per IN B-VP O
74 GI NNP B-NP O
74 c/s NN I-NP O
74 , , O O
74 vs NN B-NP O
74 NASH NNP I-NP O
74 ( ( O O
74 fatt JJ B-NP O
75 y NN I-NP O
75 infiltrate NN I-NP O
75 on IN B-VP O
75 RUQ NNP B-NP O
75 US NNP I-NP O
75 , , O O
75 no DT B-NP O
75 evidence NN I-NP O
75 of IN B-VP O
75 stones NNS B-NP O
75 ) ) O O
75 also RB O O
75 on IN B-VP O
75 ddx NNS B-NP O
75 are VBP O O
75 ETOH NNP B-NP O
75 , , O O
76 viral JJ B-NP O
76 hepatitis NN I-NP O
76 , , O O
76 hepatic JJ B-NP O
76 congestion NN I-NP O
76 , , O O
76 hemochromatosis NN B-NP O
76 - : O O
76 labs NN B-NP O
76 not RB O O
76 c/w VB O O
77 those DT B-NP O
78 Finally NNP I-NP O
78 , , O O
78 pt NN B-NP O
78 experienced VBD B-VP O
78 droplets NNS B-NP O
78 of IN B-VP O
78 bright JJ B-NP O
78 red JJ I-NP O
78 blood NN I-NP O
78 when WRB O O
78 straining VBG O O
79 for IN B-VP O
79 BM NNP B-NP O
79 Have NNP I-NP O
79 advised VBN O O
79 pt NN B-NP O
79 to TO O O
79 follow VB O O
79 up RP O O
79 with IN B-VP O
79 Dr NNP B-NP O
79 Kump NNP I-NP O
79 regarding VBG O O
79 this DT O O
80 to TO O O
80 determine VB O O
80 the DT B-NP O
80 need NN I-NP O
80 for IN B-VP O
80 a DT B-NP O
80 GI NNP I-NP O
80 work NN I-NP O
80 up RB O O
80 Have NNP B-NP O
80 left VBN O O
80 message NN B-NP O
80 with IN B-VP O
80 OGMC NNP B-NP O
81 answering VBG O O
81 service NN B-NP O
81 to TO O O
81 advise VB O O
81 the DT B-NP O
81 nurse JJ I-NP O
81 practitioner NN I-NP O
81 and CC O O
81 primary JJ B-NP O
81 care NN I-NP O
81 phy NN I-NP O
82 sician NN I-NP O
82 of IN B-VP O
82 these DT B-NP O
82 issues NNS I-NP O
83 FULL NNP I-NP O
83 CODE NNP I-NP O
84 ADDITIONAL NNP I-NP O
84 COMMENTS: NNP I-NP O
84 1 CD O O
84 See NNP B-NP O
84 Dr NNP I-NP O
84 Sixkiller NNP I-NP O
84 to TO O O
84 follow VB O O
84 up RP O O
84 on IN B-VP O
84 your PRP$ O O
84 liver NN B-NP O
84 function NN I-NP O
84 tests NNS I-NP O
84 that WDT O O
85 were VBD B-VP O
85 elevated VBN O O
85 when WRB O O
85 you PRP O O
85 were VBD B-VP O
85 admitted VBN O O
86 2 CD O O
86 See NNP B-NP O
86 Dr NNP I-NP O
86 Tippen NNP I-NP O
86 to TO O O
86 evaluate VB O O
86 the DT B-NP O
86 bleeding NN I-NP O
86 you PRP O O
86 experience VBP O O
86 with IN B-VP O
86 bowel NN B-NP O
87 movements NNS I-NP O
88 DISCHARGE NNP I-NP O
88 CONDITION: NNP I-NP O
88 Stable NNP I-NP O
89 TO NNP I-NP O
89 DO/PLAN: NNP I-NP O
90 1 CD O O
90 Call NNP B-NP O
90 to TO O O
90 make VB O O
90 an DT B-NP O
90 appointment NN I-NP O
90 with IN B-VP O
90 your PRP$ O O
90 primary JJ B-NP O
90 care NN I-NP O
90 doctor NN I-NP O
90 within IN B-VP O
90 a DT B-NP O
91 week NN I-NP O
91 of IN B-VP O
91 your PRP$ O O
91 discharge NN B-NP O
92 No RB O O
92 dictated VBD B-VP O
92 summary JJ B-NP O
93 ENTERED NNP I-NP O
93 BY: NNP I-NP O
93 GUTTMAN NNP I-NP O
93 , , O O
93 AUGUST NNP B-NP O
93 DAMIAN NNP I-NP O
93 , , O O
93 M.D NNP B-NP O
93 ( ( O O
93 OQ00 NNP B-NP O
93 ) ) O O
93 8/4/03 CD O O
93 @ $ O O
93 01:36 CD O O
93 PM NNP B-NP O
94 ****** JJ B-NP O
94 END NNP I-NP O
94 OF NNP I-NP O
94 DISCHARGE NNP I-NP O
94 ORDERS NNP I-NP O
94 ****** NNP I-NP O
95 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #968181 VBZ O O
4 812857745 CD O O
4 LCFH NNP B-NP O
4 10364873 CD O O
4 521624 CD O O
4 6/10/1994 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/20/1994 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/9/1994 CD O O
7 PRINCIPLE NNP B-NP O
7 DIAGNOSIS: NNP I-NP O
7 PLEURISY NNP I-NP O
7 , , O O
7 POSSIBLY NNP B-NP O
7 SECONDARY NNP I-NP O
7 TO NNP I-NP O
7 A NNP I-NP O
7 POST NNP I-NP O
8 VIRAL NNP I-NP O
8 SYNDROME NNP I-NP O
9 SECONDARY NNP I-NP O
9 DIAGNOSIS: NNP I-NP O
9 1 CD O O
9 HISTORY NNP B-NP O
9 OF NNP I-NP O
9 PULMONARY NNP I-NP O
9 EMBOLI NNP I-NP O
9 IN NNP I-NP O
9 1971 CD O O
10 AND NNP B-NP O
10 IN NNP I-NP O
10 1988 CD O O
11 2 CD O O
11 HISTORY NNP B-NP O
11 OF NNP I-NP O
11 STREP NNP I-NP B-r
11 PHARYNGITIS NNP I-NP I-r
11 IN NNP I-NP O
11 August NNP I-NP O
12 OF IN B-VP O
12 1994 CD O O
12 , , O O
12 TREATED NNP B-NP O
12 WITH NNP I-NP O
12 PENICILLIN NNP I-NP B-m
13 HISTORY NNP I-NP O
13 OF NNP I-NP O
13 PRESENT NNP I-NP O
13 ILLNESS: NNP I-NP O
13 This DT O O
13 is VBZ O O
13 a DT O O
13 54 CD O O
13 year NN B-NP O
13 old JJ B-NP O
13 female NN I-NP O
13 with IN B-VP O
14 a DT B-NP O
14 history NN I-NP O
14 of IN B-VP O
14 pulmonary JJ B-NP O
14 emboli NN I-NP O
14 in IN B-VP O
14 the DT O O
15 past JJ O O
15 , , O O
15 now RB O O
15 with IN B-VP O
15 complaint NN B-NP O
15 of IN B-VP O
15 four CD O O
15 days NNS B-NP O
15 of IN B-VP O
15 pleuritic JJ B-NP O
15 chest NN I-NP O
15 pain NN I-NP O
15 and CC O O
16 left VBD B-VP O
16 arm NN B-NP O
16 heaviness NN I-NP O
16 Coronary NNP I-NP O
16 risk NN I-NP O
16 factors NNS I-NP O
16 include VBP O O
16 a DT B-NP O
16 positive JJ I-NP O
17 family NN I-NP O
17 history NN I-NP O
17 , , O O
17 no DT B-NP O
17 smoking NN I-NP O
17 , , O O
17 diabetes VBZ O O
17 mellitus NN B-NP O
17 , , O O
17 hypertension NN B-NP O
17 or CC O O
18 elevated VBN O O
18 cholesterol NN B-NP O
18 The DT B-NP O
18 patient's JJ I-NP O
18 history NN I-NP O
18 begins VBZ O O
18 in IN B-VP O
18 1971 CD O O
18 when WRB O O
18 , , O O
19 after IN B-VP O
19 a DT B-NP O
19 tubal JJ I-NP O
19 ligation NN I-NP O
19 , , O O
19 she PRP O O
19 had VBD B-VP O
19 a DT B-NP B-r
19 pulmonary JJ I-NP I-r
19 emboli NN I-NP I-r
19 which WDT O O
19 was VBD B-VP O
19 felt VBN O O
20 to TO O O
20 be VB O O
20 secondary JJ O O
20 to TO O O
20 prolonged VB O O
20 bedrest JJS O O
20 She PRP O O
20 received VBD B-VP O
20 Heparin NNP B-NP B-m
20 and CC O O
20 was VBD B-VP O
21 coumadinized VBN O O
21 for IN B-VP O
21 one CD O O
21 year NN B-NP O
21 In IN B-VP O
21 1988 CD O O
21 she PRP O O
21 had VBD B-VP O
21 lower JJR B-NP O
21 abdominal JJ I-NP O
21 pain NN I-NP O
21 , , O O
22 extensive JJ B-NP O
22 work NN I-NP O
22 up IN B-VP O
22 of IN B-VP O
22 which WDT O O
22 revealed VBD B-VP O
22 a DT B-NP O
22 pulmonary JJ I-NP O
22 emboli NN I-NP O
22 , , O O
22 and CC O O
22 again RB O O
23 she PRP O O
23 was VBD B-VP O
23 heparinized VBN O O
23 and CC O O
23 coumadinized VBN O O
23 for IN B-VP O
23 one CD O O
23 year NN B-NP O
23 On IN B-VP O
23 July NNP B-NP O
23 , , O O
23 1994 CD O O
24 she PRP O O
24 developed VBD B-VP O
24 the DT B-NP O
24 acute JJ I-NP O
24 onset NN I-NP O
24 of IN B-VP O
24 intermittent JJ B-NP O
24 chest NN I-NP O
24 pressure NN I-NP O
24 and CC O O
25 left VBD B-VP O
25 arm NN B-NP O
25 heaviness NN I-NP O
25 , , O O
25 associated VBN O O
25 with IN B-VP O
25 night NN B-NP O
25 sweats NNS I-NP O
25 There EX O O
25 was VBD B-VP O
25 no DT B-NP O
26 shortness NN I-NP O
26 of IN B-VP O
26 breath NN B-NP O
26 , , O O
26 palpitations NNS B-NP O
26 , , O O
26 light-headedness JJ O O
26 , , O O
26 nausea NN B-NP O
26 or CC O O
27 vomiting VBG O O
27 The DT B-NP O
27 pain NN I-NP O
27 was VBD B-VP O
27 exacerbated VBN O O
27 by IN B-VP O
27 deep JJ B-NP O
27 breaths NNS I-NP O
27 as RB O O
27 well RB O O
27 as IN B-VP O
28 yawning NN B-NP O
28 and CC O O
28 movement NN B-NP O
28 It PRP O O
28 was VBD B-VP O
28 not RB O O
28 relieved VBN O O
28 by IN B-VP O
28 any DT B-NP O
28 factors NNS I-NP O
28 On IN B-VP O
28 the DT B-NP O
29 morning NN I-NP O
29 of IN B-VP O
29 admission NN B-NP O
29 the DT B-NP B-r
29 discomfort NN I-NP I-r
29 progressed VBD B-VP O
29 from IN B-VP O
29 intermittent NN B-NP O
29 to TO O O
30 constant VB O O
30 and CC O O
30 was VBD B-VP O
30 unrelieved VBN O O
30 with IN B-VP O
30 two CD O B-do
30 Advils NNS B-NP B-m
30 , , O O
30 at IN B-VP O
30 which WDT O O
30 time NN B-NP O
30 she PRP O O
31 subsequently RB O O
31 presented VBD B-VP O
31 to TO O O
31 the DT B-NP O
31 W.coness- NNP I-NP O
31 County NNP I-NP O
31 General NNP I-NP O
31 Hospital NNP I-NP O
32 Emergency NNP I-NP O
32 Ward NNP I-NP O
32 In IN B-VP O
32 the DT B-NP O
32 Emergency NNP I-NP O
32 Ward NNP I-NP O
32 her PRP$ O O
32 examination NN B-NP O
32 was VBD B-VP O
33 negative JJ B-NP O
33 Chest NNP I-NP O
33 x-ray NN I-NP O
33 was VBD B-VP O
33 negative JJ B-NP O
33 VQ NNP I-NP O
33 scan NN I-NP O
33 was VBD B-VP O
33 with IN B-VP O
33 intermediate JJ B-NP O
34 probability NN I-NP O
34 She PRP O O
34 received VBD B-VP O
34 Heparin NNP B-NP B-m
34 and CC O O
34 was VBD B-VP O
34 subsequently RB O O
34 transferred VBN O O
35 to TO O O
35 the DT B-NP O
35 floor NN I-NP O
35 She PRP O O
35 denied VBD B-VP O
35 any DT B-NP O
35 fevers NNS I-NP O
35 , , O O
35 chills NNS B-NP O
35 , , O O
35 cough NN B-NP O
35 , , O O
35 shortness NN B-NP O
35 of IN B-VP O
36 breath NN B-NP O
36 , , O O
36 diarrhea NN B-NP O
36 , , O O
36 constipation NN B-NP O
36 , , O O
36 abdominal JJ B-NP O
36 pain NN I-NP O
36 or CC O O
36 dysuria NN B-NP O
36 It PRP O O
36 is VBZ O O
37 noteworthy JJ O O
37 that IN B-VP O
37 the DT B-NP O
37 patient NN I-NP O
37 had VBD B-VP O
37 an DT B-NP O
37 Emergency NNP I-NP O
37 Ward NNP I-NP O
37 visit NN I-NP O
37 on IN B-VP O
37 May NNP B-NP O
38 at IN B-VP O
38 which WDT O O
38 time NN B-NP O
38 she PRP O O
38 complained VBD B-VP O
38 of IN B-VP O
38 sore NN B-NP O
38 throat NN I-NP O
38 Rapid NNP I-NP O
38 Strep NNP I-NP O
38 test NN I-NP O
38 was VBD B-VP O
39 positive JJ O O
39 for IN B-VP O
39 Strep NNP B-NP B-r
39 pharyngitis NN I-NP I-r
39 She PRP O O
39 was VBD B-VP O
39 treated VBN O O
39 with IN B-VP O
39 a DT B-NP O
39 course NN I-NP O
39 of IN B-VP O
40 Penicillin NNP B-NP B-m
40 PAST NNP I-NP O
40 MEDICAL NNP I-NP O
40 HISTORY: NNP I-NP O
40 Her NNP I-NP O
40 past JJ B-NP O
40 medical JJ I-NP O
40 history NN I-NP O
40 is VBZ O O
40 as IN B-VP O
41 above IN B-VP O
41 She PRP O O
41 also RB O O
41 has VBZ O O
41 a DT B-NP O
41 history NN I-NP O
41 of IN B-VP O
41 dysfunctional JJ B-NP O
41 uterine JJ I-NP O
41 bleeding NN I-NP O
41 , , O O
42 iron NN B-NP O
42 deficiency NN I-NP O
42 anemia NN I-NP O
42 , , O O
42 lumbosacral JJ B-NP O
42 disc NN I-NP O
42 disease NN I-NP O
42 , , O O
42 status NN B-NP O
42 post NN I-NP O
43 laminectomy NN I-NP O
43 times NNS I-NP O
43 three CD O O
43 MEDICATIONS NNP B-NP O
43 ON NNP I-NP O
43 ADMISSION: NNP I-NP O
43 Medications NNP I-NP O
43 on IN B-VP O
44 admission NN B-NP O
44 are VBP O O
44 Motrin NNP B-NP B-m
44 prn NN I-NP B-f
44 ALLERGIES: NNP I-NP O
44 She PRP O O
44 has VBZ O O
44 no DT O O
44 known VBN O O
44 drug NN B-NP O
45 allergies NNS I-NP O
45 FAMILY NNP I-NP O
45 HISTORY: NNP I-NP O
45 Her NNP I-NP O
45 mother NN I-NP O
45 died VBD B-VP O
45 from IN B-VP O
45 complications NNS B-NP O
46 from IN B-VP O
46 hypertension NN B-NP O
46 Her PRP$ O O
46 father NN B-NP O
46 died VBD B-VP O
46 from IN B-VP O
46 a DT B-NP O
46 cerebrovascular JJ I-NP O
47 accident NN I-NP O
47 She PRP O O
47 has VBZ O O
47 one CD O O
47 sister NN B-NP O
47 who WP O O
47 is VBZ O O
47 deceased VBN O O
47 from IN B-VP O
47 burn NN B-NP O
47 injuries NNS I-NP O
47 , , O O
48 one CD O O
48 brother NN B-NP O
48 who WP O O
48 passed VBD B-VP O
48 away RB O O
48 from IN B-VP O
48 a DT B-NP O
48 myocardial JJ I-NP O
48 infarction NN I-NP O
48 at IN B-VP O
48 age NN B-NP O
48 57 CD O O
48 , , O O
49 and CC O O
49 two CD O O
49 brothers NNS B-NP O
49 who WP O O
49 passed VBD B-VP O
49 away RB O O
49 from IN B-VP O
49 natural JJ B-NP O
49 causes NNS I-NP O
49 SOCIAL NNP I-NP O
50 HISTORY: NNP I-NP O
50 She PRP O O
50 is VBZ O O
50 a DT B-NP O
50 clerk NN I-NP O
50 She PRP O O
50 is VBZ O O
50 divorced VBN O O
50 with IN B-VP O
50 five CD O O
50 children NNS B-NP O
50 She PRP O O
51 never RB O O
51 smoked VBD B-VP O
51 She PRP O O
51 drinks VBZ O O
51 alcohol NN B-NP O
51 occasionally RB O O
51 She PRP O O
51 has VBZ O O
51 no DT B-NP O
51 HIV NNP I-NP O
52 risk NN I-NP O
52 factors NNS I-NP O
52 and CC O O
52 no DT O O
52 known VBN O O
52 TB NNP B-NP O
52 exposures VBZ O O
53 PHYSICAL NNP B-NP O
53 EXAMINATION: NNP I-NP O
53 On IN B-VP O
53 physical JJ B-NP O
53 examination NN I-NP O
53 she PRP O O
53 is VBZ O O
53 a DT O O
54 well-developed JJ O O
54 , , O O
54 well-nourished JJ B-NP O
54 female NN I-NP O
55 appearing VBG O O
55 her PRP$ O O
55 stated JJ B-NP O
55 age NN I-NP O
55 and CC O O
55 in IN B-VP O
55 no DT B-NP O
55 apparent JJ I-NP O
55 distress NN I-NP O
55 Temperature NNP I-NP O
56 is VBZ O O
56 98 CD O O
56 , , O O
56 pulse RB O O
56 94 CD O O
56 , , O O
56 blood NN B-NP O
56 pressure NN I-NP O
56 140/88 CD O O
56 , , O O
56 and CC O O
56 respirations NNS B-NP O
56 16 CD O O
56 Heent NNP B-NP O
57 shows NNS I-NP O
57 extraocular JJ B-NP O
57 movements NNS I-NP O
57 were VBD B-VP O
57 intact JJ B-NP O
57 Oropharynx NNP I-NP O
57 revealed VBD B-VP O
57 no DT B-NP O
58 erythema NN I-NP O
58 , , O O
58 edema NN B-NP O
58 or CC O O
58 exudate VBP O O
58 Mucous JJ B-NP O
58 membranes NNS I-NP O
58 were VBD B-VP O
58 moist JJ B-NP O
58 Neck NNP I-NP O
58 was VBD B-VP O
59 supple JJ O O
59 with IN B-VP O
59 no DT B-NP O
59 lymphadenopathy JJ I-NP O
59 Carotids NNS I-NP O
59 were VBD B-VP O
59 2+ CD O O
59 bilaterally RB O O
60 Lungs NNP B-NP O
60 revealed VBD B-VP O
60 right JJ B-NP O
60 basilar NN I-NP O
60 rales NNS I-NP O
60 Coronary NNP I-NP O
60 examination NN I-NP O
60 revealed VBD B-VP O
61 a DT B-NP O
61 regular JJ I-NP O
61 rate NN I-NP O
61 and CC O O
61 rhythm NN B-NP O
61 with IN B-VP O
61 positive JJ B-NP O
61 S1 NNP I-NP O
61 and CC O O
61 S2 NNP B-NP O
61 and CC O O
61 no DT B-NP O
61 S3 NNP I-NP O
61 or CC O O
61 S4 NNP B-NP O
62 There EX O O
62 were VBD B-VP O
62 no DT B-NP O
62 murmurs NNS I-NP O
62 , , O O
62 rubs NNS B-NP O
62 or CC O O
62 gallops NNS B-NP O
62 Abdomen NNP I-NP O
62 is VBZ O O
62 soft JJ O O
62 and CC O O
63 non-tender JJ O O
63 with IN B-VP O
63 positive JJ B-NP O
63 bowel NN I-NP O
63 sounds NNS I-NP O
63 There EX O O
63 was VBD B-VP O
63 no DT B-NP O
64 hepatosplenomegaly NN I-NP O
64 or CC O O
64 masses NNS B-NP O
64 noted VBD B-VP O
64 Rectal NNP B-NP O
64 was VBD B-VP O
64 guaiac JJ O O
64 negative JJ O O
64 in IN B-VP O
65 the DT B-NP O
65 Emergency NNP I-NP O
65 Ward NNP I-NP O
65 Extremities NNP I-NP O
65 revealed VBD B-VP O
65 no DT B-NP O
65 clubbing NN I-NP O
65 , , O O
65 cyanosis NN B-NP O
65 or CC O O
66 edema VB O O
66 Neurological JJ B-NP O
66 examination NN I-NP O
66 was VBD B-VP O
66 non-focal JJ B-NP O
67 LABORATORY NNP I-NP O
67 DATA: NNP I-NP O
67 Sodium NNP I-NP O
67 was VBD B-VP O
67 142 CD O O
67 , , O O
67 potassium NN B-NP O
67 4.1 CD O O
67 , , O O
67 BUN NNP B-NP O
67 15 CD O O
67 , , O O
67 creatinine NN B-NP O
68 .8 NN I-NP O
68 , , O O
68 and CC O O
68 glucose VB O O
68 74 CD O O
68 Liver NNP B-NP O
68 function NN I-NP O
68 tests NNS I-NP O
68 were VBD B-VP O
69 within IN B-VP O
69 normal JJ B-NP O
69 limits NNS I-NP O
69 CK NNP I-NP O
69 was VBD B-VP O
69 697 CD O O
69 with IN B-VP O
69 an DT B-NP O
69 MB NNP I-NP O
69 of IN B-VP O
69 8.5 CD O O
69 White NNP B-NP O
69 count NN I-NP O
70 was VBD B-VP O
70 4.1 CD O O
70 , , O O
70 hematocrit NN B-NP O
70 37 CD O O
70 and CC O O
70 platelet NN B-NP O
70 count NN I-NP O
70 was VBD B-VP O
70 252 CD O O
70 , , O O
70 000 CD O O
70 PT NNP B-NP O
70 was VBD B-VP O
71 12.5 CD O O
71 , , O O
71 PTT NNP B-NP O
71 29.3 CD O O
71 Chest NNP B-NP O
71 x-ray NN I-NP O
71 , , O O
71 which WDT O O
71 was VBD B-VP O
71 a DT B-NP O
71 portable JJ I-NP O
71 film NN I-NP O
71 , , O O
71 was VBD B-VP O
71 clear JJ B-NP O
72 VQ NNP I-NP O
72 scan NN I-NP O
72 was VBD B-VP O
72 read VBN O O
72 as IN B-VP O
72 intermediate JJ B-NP O
72 probability NN I-NP O
72 EKG NNP I-NP O
72 revealed VBD B-VP O
72 a DT B-NP O
72 sinus JJ I-NP O
73 bradycardia NN I-NP O
73 at IN B-VP O
73 54 CD O O
73 with IN B-VP O
73 normal JJ B-NP O
73 axis NNS I-NP O
73 and CC O O
73 intervals NNS B-NP O
73 She PRP O O
73 had VBD B-VP O
73 flipped VBN O O
74 T NNP B-NP O
74 waves NNS I-NP O
74 in IN B-VP O
74 leads NNS B-NP O
74 3 CD O O
74 , , O O
74 F NNP B-NP O
74 , , O O
74 and CC O O
74 V1 NNP B-NP O
74 through IN B-VP O
74 V3 NNP B-NP O
74 , , O O
74 biphasic JJ B-NP O
74 T NNP I-NP O
74 waves NNS I-NP O
74 in IN B-VP O
74 V4 NNP B-NP O
74 , , O O
75 flat JJ B-NP O
75 T NNP I-NP O
75 waves NNS I-NP O
75 in IN B-VP O
75 V5 NNP B-NP O
75 and CC O O
75 V6 NNP B-NP O
75 There EX O O
75 was VBD B-VP O
75 poor JJ B-NP O
75 R NNP I-NP O
75 wave NN I-NP O
75 progression NN I-NP O
75 and CC O O
75 Q NNP B-NP O
76 waves NNS I-NP O
76 in IN B-VP O
76 1 CD O O
76 and CC O O
76 L NNP B-NP O
77 HOSPITAL NNP I-NP O
77 COURSE: NNP I-NP O
77 It PRP O O
77 was VBD B-VP O
77 felt VBN O O
77 that IN B-VP O
77 during IN B-VP O
77 the DT B-NP O
77 patient's JJ I-NP O
78 presentation NN I-NP O
78 the DT O O
78 most RBS O O
78 likely JJ B-NP O
78 diagnosis NN I-NP O
78 was VBD B-VP O
78 a DT B-NP O
79 pulmonary JJ I-NP O
79 embolus NN I-NP O
79 , , O O
79 given VBN O O
79 her PRP$ O O
79 clinical JJ B-NP O
79 history NN I-NP O
79 and CC O O
79 her PRP$ O O
79 intermediate JJ B-NP O
80 probability NN I-NP O
80 of IN B-VP O
80 VQ NNP B-NP O
80 scan VBD B-VP O
80 The DT B-NP O
80 elevated JJ I-NP O
80 CK NNP I-NP O
80 with IN B-VP O
80 the DT O O
80 very RB O O
80 low JJ B-NP O
80 MB NNP I-NP O
80 was VBD B-VP O
81 felt VBN O O
81 not RB O O
81 to TO O O
81 represent VB O O
81 a DT B-NP O
81 myocardial JJ I-NP O
81 infarction NN I-NP O
81 but CC O O
81 to TO O O
81 represent VB O O
81 a DT B-NP O
81 CK NNP I-NP O
82 leak NN I-NP O
82 from IN B-VP O
82 presumed JJ B-NP O
82 pulmonary JJ I-NP O
82 infarction NN I-NP O
82 The DT B-NP O
82 patient NN I-NP O
82 was VBD B-VP O
83 heparinized VBN O O
83 with IN B-VP O
83 the DT B-NP O
83 goal NN I-NP O
83 of IN B-VP O
83 maintaining VBG O O
83 her PRP$ O O
83 PTT NN B-NP O
83 in IN B-VP O
83 the DT O O
83 60 CD O O
83 to TO O O
83 80 CD O O
84 range NN B-NP O
84 She PRP O O
84 had VBD B-VP O
84 a DT B-NP O
84 thrombotic JJ I-NP O
84 work NN I-NP O
84 up RB O O
84 sent VBD B-VP O
84 off RP O O
84 , , O O
84 namely RB O O
84 an DT B-NP O
85 antithrombin NN I-NP O
85 3 CD O O
85 , , O O
85 protein NN B-NP O
85 C NNP I-NP O
85 and CC O O
85 protein NN B-NP O
85 S NNP I-NP O
85 , , O O
85 all DT O O
85 of IN B-VP O
85 which WDT O O
85 , , O O
85 with IN B-VP O
85 the DT B-NP O
86 exception NN I-NP O
86 of IN B-VP O
86 the DT B-NP O
86 Russell NNP I-NP O
86 viper NNP I-NP O
86 venom NN I-NP O
86 , , O O
86 returned VBD B-VP O
86 within IN B-VP O
86 normal JJ B-NP O
87 limits NNS I-NP O
87 The DT B-NP O
87 Russell NNP I-NP O
87 viper IN B-VP O
87 venom NN B-NP O
87 is VBZ O O
87 pending VBG O O
87 at IN B-VP O
87 the DT B-NP O
87 time NN I-NP O
87 of IN B-VP O
88 dictation NN B-NP O
88 The DT B-NP O
88 patient NN I-NP O
88 underwent NN I-NP O
88 lower JJR B-NP O
88 extremity NN I-NP O
88 noninvasives NNS I-NP O
88 on IN B-VP O
89 hospital JJ B-NP O
89 day NN I-NP O
89 number NN I-NP O
89 one CD O O
89 which WDT O O
89 returned VBD B-VP O
89 as IN B-VP O
89 negative JJ O O
89 She PRP O O
89 had VBD B-VP O
89 a DT B-NP O
89 D NNP I-NP O
90 dimer NN I-NP O
90 sent VBD B-VP O
90 which WDT O O
90 was VBD B-VP O
90 also RB O O
90 normal JJ O O
90 At IN B-VP O
90 this DT B-NP O
90 point NN I-NP O
90 the DT B-NP O
90 DVT NNP I-NP O
90 Team NNP I-NP O
90 here RB O O
91 at IN B-VP O
91 the DT B-NP O
91 Otver NNP I-NP O
91 Hospital NNP I-NP O
91 was VBD B-VP O
91 consulted VBN O O
91 , , O O
91 given VBN O O
91 the DT O O
92 conflicted VBN O O
92 data NN B-NP O
92 for IN B-VP O
92 pulmonary JJ B-NP O
92 emboli NN I-NP O
92 The DT B-NP O
92 team NN I-NP O
92 felt VBD B-VP O
92 that IN B-VP O
92 , , O O
92 given VBN O O
93 the DT B-NP O
93 patient's JJ I-NP O
93 clinical JJ I-NP O
93 history NN I-NP O
93 and CC O O
93 the DT B-NP O
93 implications NNS I-NP O
93 of IN B-VP O
93 chronic JJ B-NP O
94 Coumadin NNP I-NP B-m
94 therapy NN I-NP O
94 , , O O
94 that IN B-VP O
94 a DT B-NP O
94 pulmonary JJ I-NP O
94 embolus NN I-NP O
94 should MD O O
94 be VB O O
94 definitely RB O O
95 ruled VBN O O
95 out RP O O
95 by IN B-VP O
95 pulmonary JJ B-NP O
95 arteriogram NN I-NP O
95 On IN B-VP O
95 hospital JJ B-NP O
95 day NN I-NP O
95 number NN I-NP O
95 two CD O O
95 the DT B-NP O
96 patient NN I-NP O
96 underwent NN I-NP O
96 a DT B-NP O
96 PA NNP I-NP O
96 gram NN I-NP O
96 which WDT O O
96 revealed VBD B-VP O
96 a DT B-NP O
96 mean JJ I-NP O
96 RA NNP I-NP O
96 pressure NN I-NP O
96 of IN B-VP O
96 7 CD O O
97 mm NN B-NP O
97 of IN B-VP O
97 mercury NN B-NP O
97 , , O O
97 a DT B-NP O
97 mean JJ I-NP O
97 RV NNP I-NP O
97 pressure NN I-NP O
97 of IN B-VP O
97 12 CD O O
97 mm NN B-NP O
97 of IN B-VP O
97 mercury NN B-NP O
97 , , O O
97 and CC O O
97 no DT B-NP O
98 filling NN I-NP O
98 defects VBZ O O
98 to TO O O
98 suggest VB O O
98 a DT B-NP O
98 pulmonary JJ I-NP O
98 embolus NN I-NP O
98 At IN B-VP O
98 this DT B-NP O
98 point NN I-NP O
98 the DT B-NP O
99 patient's NN I-NP O
99 Heparin NNP I-NP B-m
99 was VBD B-VP O
99 discontinued VBN O O
99 The DT B-NP O
99 day NN I-NP O
99 prior RB O O
99 to TO O O
99 obtaining VBG O O
99 the DT B-NP O
100 pulmonary JJ I-NP O
100 arteriogram NN I-NP O
100 the DT B-NP O
100 patient NN I-NP O
100 had VBD B-VP O
100 a DT B-NP O
100 good JJ I-NP O
100 PA NNP I-NP O
100 and CC O O
100 lateral JJ B-NP O
100 film NN I-NP O
100 , , O O
101 which WDT O O
101 revealed VBD B-VP O
101 no DT B-NP O
101 focal JJ I-NP O
101 infiltrates NNS I-NP O
101 and CC O O
101 no DT B-NP O
101 effusions NNS I-NP O
101 On IN B-VP O
101 hospital JJ B-NP O
102 day NN I-NP O
102 number NN I-NP O
102 three CD O O
102 the DT B-NP O
102 patient NN I-NP O
102 underwent VBD B-VP O
102 an DT B-NP O
102 echocardiogram NN I-NP O
102 which WDT O O
103 revealed VBD B-VP O
103 normal JJ O O
103 left VBD B-VP O
103 ventricular JJ B-NP O
103 size NN I-NP O
103 and CC O O
103 mild NN B-NP O
103 left VBD B-VP O
103 ventricular JJ B-NP O
104 hypertrophy NN I-NP O
104 with IN B-VP O
104 vigorous JJ B-NP O
104 function NN I-NP O
104 and CC O O
104 no DT B-NP O
104 regional JJ I-NP O
104 wall NN I-NP O
104 motion NN I-NP O
105 abnormalities NNS I-NP O
105 She PRP O O
105 had VBD B-VP O
105 no DT B-NP O
105 pericardial JJ I-NP O
105 thickening NN I-NP O
105 or CC O O
105 pericardial JJ B-NP O
106 effusion NN I-NP O
106 to TO O O
106 suggest VB O O
106 pericarditis NN B-NP O
106 She PRP O O
106 had VBD B-VP O
106 structurally RB O O
106 normal JJ B-NP O
107 cardiac JJ I-NP O
107 valves NNS I-NP O
107 , , O O
107 no DT B-NP O
107 significant JJ I-NP O
107 mitral NN I-NP O
107 or CC O O
107 tricuspid JJ B-NP O
107 regurge NN I-NP O
107 She PRP O O
108 had VBD B-VP O
108 a DT B-NP O
108 minimal JJ I-NP O
108 amount NN I-NP O
108 of IN B-VP O
108 aortic JJ B-NP O
108 regurgitation NN I-NP O
108 and CC O O
108 normal JJ B-NP O
108 right JJ I-NP O
108 heart NN I-NP O
109 size NN I-NP O
109 and CC O O
109 function NN B-NP O
109 At IN B-VP O
109 this DT B-NP O
109 point NN I-NP O
109 , , O O
109 given VBN O O
109 the DT B-NP O
109 fact NN I-NP O
109 that IN B-VP O
109 the DT B-NP O
109 patient NN I-NP O
110 was VBD B-VP O
110 not RB O O
110 felt VBN O O
110 to TO O O
110 have VB O O
110 a DT B-NP O
110 myocardial JJ I-NP O
110 infarction NN I-NP O
110 , , O O
110 given VBN O O
110 her PRP$ O O
110 low JJ B-NP O
110 MB NNP I-NP O
111 total NN I-NP O
111 CK NNP I-NP O
111 ratio NN I-NP O
111 , , O O
111 and CC O O
111 also RB O O
111 that IN B-VP O
111 she PRP O O
111 was VBD B-VP O
111 not RB O O
111 felt VBN O O
111 to TO O O
111 have VB O O
111 a DT B-NP O
111 pulmonary JJ I-NP O
112 embolus NN I-NP O
112 , , O O
112 given VBN O O
112 the DT B-NP O
112 negative JJ I-NP O
112 PA NNP I-NP O
112 gram NN I-NP O
112 , , O O
112 the DT B-NP O
112 diagnosis NN I-NP O
112 of IN B-VP O
112 pleurisy NN B-NP O
113 secondary JJ O O
113 to TO O O
113 possible JJ B-NP O
113 close JJ I-NP O
113 viral JJ I-NP O
113 syndrome NN I-NP O
113 was VBD B-VP O
113 considered VBN O O
113 The DT B-NP O
114 patient NN I-NP O
114 was VBD B-VP O
114 started VBN O O
114 on IN B-VP O
114 Naprosyn NNP B-NP B-m
114 at IN B-VP O
114 500 CD O B-do
114 mg NN B-NP I-do
114 p.o NN I-NP B-mo
114 b.i.d NN I-NP B-f
114 on IN B-VP O
114 hospital JJ B-NP O
115 day NN I-NP O
115 number NN I-NP O
115 three CD O O
115 , , O O
115 to TO O O
115 which WDT O O
115 she PRP O O
115 responded VBD B-VP O
115 quite RB O O
115 well RB O O
115 After IN B-VP O
116 discussion NN B-NP O
116 with IN B-VP O
116 the DT B-NP O
116 patient's NN I-NP O
116 primary JJ B-NP O
116 doctor NN I-NP O
116 it PRP O O
116 was VBD B-VP O
116 felt VBN O O
116 that IN B-VP O
116 , , O O
117 given VBN O O
117 the DT B-NP O
117 fact NN I-NP O
117 that IN B-VP O
117 serious JJ B-NP O
117 causes NNS I-NP O
117 for IN B-VP O
117 pleuritic JJ B-NP O
117 chest NN I-NP O
117 pain NN I-NP O
117 had VBD B-VP O
118 been VBN O O
118 ruled VBN O O
118 out RP O O
118 , , O O
118 the DT B-NP O
118 patient's NN I-NP O
118 management NN I-NP O
118 could MD O O
118 be VB O O
118 followed VBN O O
118 in IN B-VP O
118 an DT B-NP O
119 outpatient JJ I-NP O
119 setting NN I-NP O
119 On IN B-VP O
119 hospital JJ B-NP O
119 day NN I-NP O
119 number NN I-NP O
119 four CD O O
119 it PRP O O
119 was VBD B-VP O
119 felt VBN O O
119 that IN B-VP O
120 she PRP O O
120 was VBD B-VP O
120 safe JJ O O
120 to TO O O
120 be VB O O
120 discharged VBN O O
120 to TO O O
120 home VB O O
120 Operations NNP B-NP O
120 and CC O O
120 procedures NNS B-NP O
121 performed VBN O O
121 during IN B-VP O
121 this DT B-NP O
121 hospitalization NN I-NP O
121 were VBD B-VP O
121 pulmonary JJ B-NP O
121 arteriogram NN I-NP O
121 by IN B-VP O
122 Pa NNP B-NP O
122 Hospital NNP I-NP O
122 on IN B-VP O
122 May NNP B-NP O
122 , , O O
122 1994 CD O O
122 There EX O O
122 were VBD B-VP O
122 no DT B-NP O
122 complications NNS I-NP O
123 DISPOSITION: NNP I-NP O
123 MEDICATIONS NNP I-NP O
123 ON NNP I-NP O
123 DISCHARGE: NNP I-NP O
123 Discharge NNP I-NP O
123 medications NNS I-NP O
124 include VBP O O
124 Naprosyn NNP B-NP B-m
124 500 CD O B-do
124 mg NN B-NP I-do
124 p.o NN I-NP B-mo
124 b.i.d NN I-NP B-f
124 with IN B-VP I-f
124 meals NNS B-NP I-f
124 The DT B-NP O
125 patient NN I-NP O
125 is VBZ O O
125 being VBG O O
125 discharged VBN O O
125 to TO O O
125 home VB O O
125 FOLLOW NNP B-NP O
125 UP: NNP I-NP O
125 She PRP O O
125 will MD O O
125 follow VB O O
126 up RP O O
126 with IN B-VP O
126 Dr NNP B-NP O
126 Owen NNP I-NP O
126 Albertine NNP I-NP O
126 on IN B-VP O
126 November NNP B-NP O
126 , , O O
126 1994 CD O O
126 at IN B-VP O
126 1:30 CD O O
126 p.m RB O O
127 Dictated NNP B-NP O
127 By: NNP I-NP O
127 RUDY NNP I-NP O
127 EZZO NNP I-NP O
127 , , O O
127 M.D NNP B-NP O
127 XA96 NNP I-NP O
128 Attending: NNP I-NP O
128 BRITT NNP I-NP O
128 FOGAL NNP I-NP O
128 , , O O
128 M.D NNP B-NP O
128 IB3 NNP I-NP O
128 YQ458/6388 NNP I-NP O
129 Batch: NNP I-NP O
129 9990 CD O O
129 Index NNP B-NP O
129 No NNP I-NP O
129 IDIB931ZD NNP I-NP O
129 D: NNP I-NP O
129 6/26/94 CD O O
130 T: NNP B-NP O
130 6/30/94 CD O O
131 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #970511 VBZ O O
2 098098801 CD O O
2 RGH NNP B-NP O
2 04710426 CD O O
2 3809298 CD O O
2 8/14/2006 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 bone NN I-NP O
2 cancer NN I-NP O
2 Unsigned VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 8/14/2006 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Unsigned NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 4/17/2006 CD O O
4 ATTENDING: NNP B-NP O
4 KOLLING NNP I-NP O
4 , , O O
4 OREN NNP B-NP O
4 ROMEO NNP I-NP O
4 MD NNP I-NP O
5 PRIMARY NNP I-NP O
5 ADMITTING NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 Pulmonary NNP I-NP O
5 embolism NN I-NP O
6 SECONDARY NNP I-NP O
6 DIAGNOSES: NNP I-NP O
6 Diabetes NNP I-NP O
6 , , O O
6 hypertension NN B-NP O
6 , , O O
6 hypothyroid NN B-NP O
6 and CC O O
7 GERD NNP B-NP O
8 ADMISSION NNP I-NP O
8 MEDICATIONS: NNP I-NP O
8 Atenolol NNP I-NP B-m
8 50 CD O B-do
8 daily RB O B-f
8 , , O O
8 lisinopril VBD B-VP B-m
8 5 CD O B-do
8 daily RB O B-f
8 , , O O
9 Protonix NNP B-NP B-m
9 40 CD O B-do
9 daily RB O B-f
9 , , O O
9 metformin JJ O B-m
9 1500 CD O B-do
9 daily RB O B-f
9 , , O O
9 Lantus NNP B-NP B-m
9 60 CD O B-do
9 daily RB O B-f
9 , , O O
9 Humalog NNP B-NP B-m
10 20 CD O B-do
10 before IN B-VP B-f
10 meals NNS B-NP I-f
10 , , O O
10 Byetta NNP B-NP B-m
10 5 CD O B-do
10 mcg NN B-NP I-do
10 twice RB O B-f
10 daily RB O I-f
10 , , O O
10 levothyroxine NN B-NP B-m
10 ( ( O O
10 dose JJ B-NP O
11 unknown NN I-NP O
11 ) ) O O
11 , , O O
11 OxyContin NNP B-NP B-m
11 40 CD O B-do
11 every DT O B-f
11 eight CD O I-f
11 hours NNS B-NP I-f
11 , , O O
11 Percocet NNP B-NP B-m
11 two CD O B-do
11 tabs NN B-NP I-do
11 every DT O B-f
12 3 CD O O
12 hours NNS B-NP O
12 as IN B-VP O
12 needed VBN O O
12 for IN B-VP O
12 pain NN B-NP B-r
12 and CC O O
12 gabapentin NN B-NP B-m
12 ( ( O O
12 dose JJ B-NP O
12 unknown NN I-NP O
12 ) ) O O
13 CHIEF NNP B-NP O
13 COMPLAINT: NNP I-NP O
13 Syncope NNP I-NP O
14 HISTORY NNP I-NP O
14 OF NNP I-NP O
14 PRESENT NNP I-NP O
14 ILLNESS: NNP I-NP O
14 This DT O O
14 is VBZ O O
14 a DT B-NP O
14 66-year-old JJ I-NP O
14 man NN I-NP O
14 with IN B-VP O
15 diabetes NNS B-NP O
15 , , O O
15 hypertension NN B-NP O
15 , , O O
15 obesity NN B-NP O
15 and CC O O
15 non-Hodgkin's JJ B-NP B-r
15 lymphoma NN I-NP I-r
15 of IN B-VP O
15 the DT B-NP O
16 right JJ I-NP O
16 hip NN I-NP O
16 on IN B-VP O
16 chemotherapy NN B-NP O
16 ( ( O O
16 R-CHOP NNP B-NP B-m
16 ) ) O O
16 , , O O
16 which WDT O O
16 began VBD B-VP O
16 on IN B-VP O
16 4/10/06 CD O O
16 and CC O O
17 will MD O O
17 continue VB O O
17 for IN B-VP B-du
17 18 CD O I-du
17 weeks NNS B-NP I-du
17 He PRP O O
17 reported VBD B-VP O
17 no DT B-NP O
17 complications NNS I-NP O
17 from IN B-VP O
18 ischemic JJ B-NP O
18 chemotherapy NN I-NP O
18 At IN B-VP O
18 baseline NN B-NP O
18 he PRP O O
18 cannot VBD B-VP O
18 bear JJ B-NP O
18 weight NN I-NP O
18 on IN B-VP O
18 his PRP$ O O
19 right JJ B-NP O
19 leg NN I-NP O
19 and CC O O
19 he PRP O O
19 devised VBD B-VP O
19 this DT B-NP O
19 complicated JJ I-NP O
19 system NN I-NP O
19 where WRB O O
19 he PRP O O
19 shifts VBZ O O
20 himself PRP O O
20 down RP O O
20 the DT B-NP O
20 stairs NN I-NP O
20 to TO O O
20 the DT B-NP O
20 bottom NN I-NP O
20 of IN B-VP O
20 the DT B-NP O
20 steps NNS I-NP O
20 using VBG O O
20 his PRP$ O O
21 upper JJ B-NP O
21 body NN I-NP O
21 strength NN I-NP O
21 and CC O O
21 a DT B-NP O
21 family NN I-NP O
21 member NN I-NP O
21 to TO O O
21 assist VB O O
21 him PRP O O
21 All DT O O
22 during IN B-VP O
22 this DT B-NP O
22 maneuver NN I-NP O
22 he PRP O O
22 felt VBD B-VP O
22 unusually RB O O
22 short JJ O O
22 of IN B-VP O
22 breath NN B-NP O
22 the DT B-NP O
22 day NN I-NP O
22 of IN B-VP O
23 admission NN B-NP O
23 and CC O O
23 in IN B-VP O
23 the DT B-NP O
23 context NN I-NP O
23 of IN B-VP O
23 breathing VBG O O
23 heavily RB O O
23 began VBD B-VP O
23 to TO O O
23 sweat VB O O
24 and CC O O
24 feel VB O O
24 lightheaded VBN O O
24 and CC O O
24 then RB O O
24 lost VBD B-VP O
24 consciousness JJ O O
24 temporarily RB O O
25 Sister NNP B-NP O
25 was VBD B-VP O
25 present JJ O O
25 and CC O O
25 called VBD B-VP O
25 EMS NNP B-NP O
25 On IN B-VP O
25 arrival NN B-NP O
25 to TO O O
25 the DT B-NP O
25 emergency NN I-NP O
26 room NN I-NP O
26 , , O O
26 he PRP O O
26 was VBD B-VP O
26 hypotensive JJ O B-r
26 and CC O O
26 received JJ B-NP O
26 IV NNP I-NP B-mo
26 normal JJ B-NP B-m
26 saline NN I-NP I-m
26 as IN B-VP O
26 volume NN B-NP O
27 resuscitations NNS I-NP O
27 His PRP$ O O
27 pressures NNS B-NP O
27 initially RB O O
27 were VBD B-VP O
27 noted VBN O O
27 to TO O O
27 be VB O O
27 in IN B-VP O
27 the DT O O
28 70s CD O O
28 to TO O O
28 80s CD O O
28 systolic NN B-NP O
28 and CC O O
28 improved VBN O O
28 to TO O O
28 90 CD O O
28 systolic NN B-NP O
28 after IN B-VP O
28 4 CD O O
28 L NNP B-NP O
28 of IN B-VP O
29 fluid NN B-NP O
29 from IN B-VP O
29 the DT B-NP O
29 emergency NN I-NP O
29 room NN I-NP O
29 The DT B-NP O
29 patient NN I-NP O
29 was VBD B-VP O
29 admitted VBN O O
29 for IN B-VP O
30 syncope NN B-NP O
30 On IN B-VP O
30 admission NN B-NP O
30 as IN B-VP O
30 part NN B-NP O
30 of IN B-VP O
30 the DT B-NP O
30 workup NN I-NP O
30 for IN B-VP O
30 syncope NN B-NP O
30 an DT B-NP O
31 initial JJ I-NP O
31 set NN I-NP O
31 of IN B-VP O
31 cardiac JJ B-NP O
31 enzymes NNS I-NP O
31 was VBD B-VP O
31 negative JJ B-NP O
32 PHYSICAL NNP I-NP O
32 EXAMINATION: NNP I-NP O
32 On IN B-VP O
32 physical JJ B-NP O
32 exam NN I-NP O
32 , , O O
32 the DT B-NP O
32 patient NN I-NP O
32 was VBD B-VP O
33 afebrile RB O O
33 , , O O
33 heart NN B-NP O
33 rate NN I-NP O
33 in IN B-VP O
33 the DT O O
33 90s CD O O
33 , , O O
33 blood NN B-NP O
33 pressure NN I-NP O
33 systolic JJ O O
33 100 CD O O
33 , , O O
34 respirations NNS B-NP O
34 20 CD O O
34 and CC O O
34 O2 NNP B-NP O
34 sat VBD B-VP O
34 94% CD O O
34 on IN B-VP O
34 room NN B-NP O
34 air NN I-NP O
34 Pupils NNPS I-NP O
34 were VBD B-VP O
34 equal JJ O O
34 , , O O
35 round NN B-NP O
35 and CC O O
35 reactive JJ O O
35 to TO O O
35 light VB O O
35 There EX O O
35 was VBD B-VP O
35 no DT B-NP O
35 cervical JJ I-NP O
36 lymphadenopathy NN I-NP O
36 JVP NNP I-NP O
36 was VBD B-VP O
36 not RB O O
36 visualized VBN O O
36 due JJ O O
36 to TO O O
36 large JJ B-NP O
36 neck NN I-NP O
37 Lungs NNS I-NP O
37 were VBD B-VP O
37 clear JJ O O
37 The DT B-NP O
37 heart NN I-NP O
37 was VBD B-VP O
37 regular JJ O O
37 There EX O O
37 was VBD B-VP O
37 an DT B-NP O
37 S1 NNP I-NP O
37 , , O O
37 S2 NNP B-NP O
38 with IN B-VP O
38 a DT B-NP O
38 loud NN I-NP O
38 and CC O O
38 widened VBD B-VP O
38 split NN B-NP O
38 P2 NNP I-NP O
38 component NN I-NP O
38 of IN B-VP O
38 the DT B-NP O
38 second JJ I-NP O
38 heart NN I-NP O
39 sound NN I-NP O
39 Abdomen NNP I-NP O
39 was VBD B-VP O
39 soft JJ O O
39 and CC O O
39 nontender VBP O O
39 The DT B-NP O
39 right JJ I-NP O
39 hip NN I-NP O
39 was VBD B-VP O
39 tender NN B-NP O
40 to TO O O
40 palpation VB O O
40 The DT B-NP O
40 extremities NNS I-NP O
40 had VBD B-VP O
40 1+ CD O O
40 edema NN B-NP O
40 bilaterally RB O O
41 The DT B-NP O
41 patient NN I-NP O
41 was VBD B-VP O
41 admitted VBN O O
41 with IN B-VP O
41 a DT B-NP O
41 preliminary JJ I-NP O
41 diagnosis NN I-NP O
41 of IN B-VP O
41 syncope NN B-NP O
42 HOSPITAL NNP I-NP O
42 COURSE: NNP I-NP O
42 The DT B-NP O
42 second JJ I-NP O
42 set NN I-NP O
42 of IN B-VP O
42 cardiac JJ B-NP O
42 enzymes NNS I-NP O
42 was VBD B-VP O
42 positive JJ O O
43 with IN B-VP O
43 a DT B-NP O
43 troponin NN I-NP O
43 of IN B-VP O
43 2 CD O O
43 Echocardiogram NNP B-NP O
43 the DT B-NP O
43 morning NN I-NP O
43 following VBG O O
44 admission NN B-NP O
44 showed VBD B-VP O
44 a DT B-NP O
44 dilated JJ I-NP O
44 right JJ I-NP O
44 ventricle NN I-NP O
44 consistent JJ O O
44 with IN B-VP O
44 right JJ B-NP O
45 ventricular NN I-NP O
45 strain NN I-NP O
45 This DT O O
45 was VBD B-VP O
45 followed VBN O O
45 by IN B-VP O
45 a DT B-NP O
45 PE NNP I-NP O
45 protocol NN I-NP O
45 CT NNP I-NP O
45 scan NN I-NP O
45 , , O O
46 which WDT O O
46 showed VBD B-VP O
46 a DT O O
46 large JJ O O
46 saddle JJ O O
46 embolus CC O O
46 The DT B-NP O
46 patient NN I-NP O
46 was VBD B-VP O
46 treated VBN O O
47 initially RB O O
47 with IN B-VP O
47 IV NNP B-NP B-mo
47 heparin NN I-NP B-m
47 , , O O
47 transitioned VBD B-VP O
47 to TO O O
47 Coumadin NNP B-NP B-m
47 and CC O O
47 then RB O O
47 the DT B-NP O
48 decision NN I-NP O
48 was VBD B-VP O
48 made VBN O O
48 to TO O O
48 try VB O O
48 Lovenox NNP B-NP B-m
48 therapy NN I-NP O
48 for IN B-VP O
48 long-term JJ B-NP B-r
49 anticoagulation NN I-NP O
49 Cardiac NNP I-NP O
49 enzymes VBZ O O
49 normalized JJ B-NP O
49 Repeat NNP I-NP O
50 echocardiogram NN I-NP O
50 showed VBD B-VP O
50 mild JJ B-NP O
50 improvement NN I-NP O
50 in IN B-VP O
50 right JJ B-NP O
50 heart NN I-NP O
50 function NN I-NP O
51 eScription NN I-NP O
51 document: VBZ O O
51 5-3408110 JJ B-NP O
51 CSSten NNP I-NP O
51 Tel NNP I-NP O
52 Dictated NNP I-NP O
52 By: NNP I-NP O
52 REFF NNP I-NP O
52 , , O O
52 ELBERT NNP B-NP O
53 Attending: NNP I-NP O
53 HACKEL NNP I-NP O
53 , , O O
53 MICAH NNP B-NP O
53 ED NNP I-NP O
54 Dictation NNP I-NP O
54 ID NNP I-NP O
54 7113327 CD O O
55 D: NNP B-NP O
55 2/29/06 CD O O
56 T: NNP B-NP O
56 2/29/06 CD O O
57 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #973184 VBZ O O
2 097075110 CD O O
2 NMH NNP B-NP O
2 26639961 CD O O
2 9095112 CD O O
2 4/20/2004 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 UNSTABLE NNP I-NP O
2 ANGINA NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/15/2004 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 7/1/2004 CD O O
4 ATTENDING: NNP B-NP O
4 WM NNP I-NP O
4 BRYANT NNP I-NP O
4 STENT NNP I-NP O
4 MD NNP I-NP O
5 PRINCIPAL NNP I-NP O
5 DISCHARGE NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 Status NNP I-NP O
5 post NN I-NP O
5 AVR NNP I-NP O
5 , , O O
5 CABG NNP B-NP O
5 x3 NNP I-NP O
6 OTHER NNP I-NP O
6 DIAGNOSIS: NNP I-NP O
6 Diagnoses NNP I-NP O
6 hypertension NN I-NP O
6 , , O O
6 diabetes VBZ O O
6 mellitus VBP O O
6 type NN B-NP O
7 I PRP O O
7 , , O O
7 dyslipidemia NN B-NP O
7 , , O O
7 COPD NNP B-NP O
7 and CC O O
7 asthma JJ B-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 This DT O O
8 is VBZ O O
8 a DT B-NP O
8 55-year-old JJ I-NP O
8 female NN I-NP O
8 who WP O O
8 was VBD B-VP O
9 admitted VBN O O
9 to TO O O
9 Hend NNP B-NP O
9 Ratal/creek NNP I-NP O
9 Hospital NNP I-NP O
9 on IN B-VP O
9 6/2/04 CD O O
9 complaining NN B-NP O
9 of IN B-VP O
9 chest NN B-NP O
10 pain NN I-NP O
10 on IN B-VP O
10 exertion NN B-NP O
10 and CC O O
10 was VBD B-VP O
10 ruled VBN O O
10 in IN B-VP O
10 for IN B-VP O
10 NSTEMI NNP B-NP O
10 by IN B-VP O
10 enzymes NNS B-NP O
10 peaking VBG O O
11 on IN B-VP O
11 8/21/04 CD O O
11 CK NNP B-NP O
11 381 CD O O
11 and CC O O
11 TNI NNP B-NP O
11 0.18 CD O O
11 No NNP B-NP O
11 acute NN I-NP O
11 EKG NNP I-NP O
11 changes NNS I-NP O
11 were VBD B-VP O
12 noted VBN O O
12 The DT B-NP O
12 patient NN I-NP O
12 was VBD B-VP O
12 transferred VBN O O
12 to TO O O
12 Woduatesit NNP B-NP O
12 General NNP I-NP O
12 Hospital NNP I-NP O
12 for IN B-VP O
12 catheterization NN B-NP O
12 and CC O O
12 possible JJ B-NP O
12 CABG NNP I-NP O
12 Preoperative NNP I-NP O
13 cardiac NN I-NP O
13 status NN I-NP O
13 myocardial JJ B-NP O
13 infarction NN I-NP O
13 6/2/04 CD O O
13 requiring VBG O O
14 hospitalization NN B-NP O
14 associated VBN O O
14 with IN B-VP O
14 prolonged JJ B-NP O
14 chest NN I-NP O
14 pain NN I-NP O
14 Peak NNP I-NP O
14 CK NNP I-NP O
15 389 CD O O
15 , , O O
15 troponin VBD B-VP O
15 0.18 CD O O
16 PREOPERATIVE NNP B-NP O
16 CARDIAC NNP I-NP O
16 STATUS: NNP I-NP O
16 The DT B-NP O
16 patient NN I-NP O
16 has VBZ O O
16 a DT B-NP O
16 history NN I-NP O
16 of IN B-VP O
16 class NN B-NP O
17 II NNP I-NP O
17 angina NN I-NP O
17 There EX O O
17 has VBZ O O
17 been VBN O O
17 no DT B-NP O
17 recent JJ I-NP O
17 angina NN I-NP O
17 There EX O O
17 is VBZ O O
17 history NN B-NP O
17 of IN B-VP O
18 class NN B-NP O
18 II NNP I-NP O
18 heart NN I-NP O
18 failure NN I-NP O
18 The DT B-NP O
18 patient NN I-NP O
18 is VBZ O O
18 in IN B-VP O
18 normal JJ B-NP O
18 sinus NN I-NP O
18 rhythm VBP O O
19 PREVIOUS NNP B-NP O
19 CARDIOVASCULAR NNP I-NP O
19 INTERVENTIONS: NNP I-NP O
19 None NNP I-NP O
20 PAST NNP I-NP O
20 MEDICAL NNP I-NP O
20 HISTORY: NNP I-NP O
20 Hypertension NNP I-NP O
20 , , O O
20 diabetes VBZ O O
20 mellitus NN B-NP O
20 , , O O
20 insulin NN B-NP O
21 therapy NN I-NP O
21 , , O O
21 dyslipidemia NN B-NP O
21 , , O O
21 COPD NNP B-NP O
21 , , O O
21 bronchodilator NN B-NP O
21 therapy NN I-NP O
21 , , O O
21 asthma NN B-NP O
21 for IN B-VP O
22 the DT B-NP O
22 last JJ I-NP O
22 7-10 JJ I-NP O
22 years NNS I-NP O
23 PAST NNP I-NP O
23 SURGICAL NNP I-NP O
23 HISTORY: NNP I-NP O
23 Knees NNP I-NP O
23 bilateral JJ B-NP O
23 arthroscopy NN I-NP O
23 6/18 CD O O
23 , , O O
24 10/14 CD O O
25 FAMILY NNP B-NP O
25 HISTORY: NNP I-NP O
25 Family NNP I-NP O
25 history NN I-NP O
25 of IN B-VP O
25 coronary JJ B-NP O
25 artery NN I-NP O
25 disease NN I-NP O
26 Mother NNP I-NP O
26 with IN B-VP O
26 MI NNP B-NP O
26 Father NNP I-NP O
26 died VBD B-VP O
26 at IN B-VP O
26 an DT B-NP O
26 early JJ I-NP O
26 age NN I-NP O
26 due JJ O O
26 to TO O O
26 questionable JJ B-NP O
27 PE NNP I-NP O
28 SOCIAL NNP I-NP O
28 HISTORY: NNP I-NP O
28 A NNP I-NP O
28 history NN I-NP O
28 of IN B-VP O
28 tobacco NN B-NP O
28 use NN I-NP O
28 70-pack-year JJ B-NP O
28 cigarette NN I-NP O
29 smoking VBG O O
29 history NN B-NP O
29 , , O O
29 quit NN B-NP O
29 smoking NN I-NP O
29 30 CD O O
29 years NNS B-NP O
29 ago RB O O
29 Single NNP B-NP O
29 , , O O
29 lives VBZ O O
29 with IN B-VP O
30 her PRP$ O O
30 children NNS B-NP O
31 ALLERGIES: NNP I-NP O
31 To TO O O
31 lisinopril VB O O
31 and CC O O
31 metformin VB O O
32 PREOP NNP B-NP O
32 MEDICATIONS: NNP I-NP O
32 Verapamil NNP I-NP B-m
32 80 CD O B-do
32 mg NN B-NP I-do
32 b.i.d NN I-NP B-f
32 , , O O
32 Avapro NNP B-NP B-m
32 150 CD O B-do
32 mg NN B-NP I-do
32 q.d NN I-NP B-f
32 , , O O
33 aspirin RB O B-m
33 325 CD O B-do
33 mg NNS B-NP I-do
33 q.d JJ B-NP B-f
33 IV NNP I-NP B-mo
33 heparin NN I-NP B-m
33 , , O O
33 hydrochlorothiazide RB O B-m
33 50 CD O B-do
33 mg NN B-NP I-do
33 q.d NN I-NP B-f
33 , , O O
34 albuterol VBP O B-m
34 2 CD O B-do
34 puffs NNS B-NP I-do
34 b.i.d RB O B-f
34 , , O O
34 fluticasone RB O B-m
34 2 CD O B-do
34 puffs NNS B-NP I-do
34 q.i.d RB O B-f
34 , , O O
35 atorvastatin VBD B-VP B-m
35 10 CD O B-do
35 mg NN B-NP I-do
35 q.d NN I-NP B-f
35 , , O O
35 Celexa NNP B-NP B-m
35 20 CD O B-do
35 mg NN B-NP I-do
35 q.d NN I-NP B-f
35 , , O O
35 ibuprofen JJ O B-m
35 800 CD O B-do
35 mg NN B-NP I-do
36 b.i.d NN I-NP B-f
36 NPH NNP I-NP B-m
36 insulin NN I-NP I-m
36 30 CD O B-do
36 units NNS B-NP I-do
36 b.i.d RB O B-f
37 PHYSICAL NNP B-NP O
37 EXAMINATION: NNP I-NP O
37 Height NNP I-NP O
37 and CC O O
37 weight: $ O O
37 5 CD O O
37 feet NNS B-NP O
37 1 CD O O
37 inches NNS B-NP O
37 , , O O
37 103 CD O O
38 kilograms NNS B-NP O
38 Vital NNP I-NP O
38 signs: VBD B-VP O
38 Temperature NNP B-NP O
38 96 CD O O
38 , , O O
38 heart NN B-NP O
38 rate NN I-NP O
38 80 CD O O
38 , , O O
38 BP NNP B-NP O
38 right VBD B-VP O
39 arm NN B-NP O
39 140/80 CD O O
39 HEENT: NNP B-NP O
39 PERRLA NNP I-NP O
39 , , O O
39 dentition NN B-NP O
39 without IN B-VP O
39 evidence NN B-NP O
39 of IN B-VP O
40 infection NN B-NP O
40 , , O O
40 left VBD B-VP O
40 carotid JJ B-NP O
40 bruits NNS I-NP O
40 , , O O
40 right JJ B-NP O
40 carotid NN I-NP O
40 bruit NN I-NP O
40 Carotid NNP I-NP O
41 bruits VBZ O O
41 hard JJ O O
41 to TO O O
41 distinguish VB O O
41 from IN B-VP O
41 radiated VBN O O
41 systolic JJ B-NP O
41 murmur NN I-NP O
41 into IN B-VP O
42 carotids NNS B-NP O
42 Chest: NNP I-NP O
42 No NNP I-NP O
42 incisions NNS I-NP O
42 Cardiovascular: NNP I-NP O
42 Regular NNP I-NP O
42 rate NN I-NP O
43 and CC O O
43 rhythm NN B-NP O
43 , , O O
43 systolic JJ B-NP O
43 III/VI NNP I-NP O
43 murmur NN I-NP O
43 radiating VBG O O
43 to TO O O
43 carotids VB O O
44 Pulses: NNP B-NP O
44 Carotid NNP I-NP O
44 2+ CD O O
44 bilaterally RB O O
44 , , O O
44 femoral JJ O O
44 2+ CD O O
44 bilaterally RB O O
44 , , O O
44 radial JJ O O
45 2+ CD O O
45 bilaterally RB O O
45 , , O O
45 dorsalis JJ B-NP O
45 pedis NN I-NP O
45 present NN I-NP O
45 by IN B-VP O
45 Doppler NNP B-NP O
45 bilaterally RB O O
45 , , O O
46 posterior JJ B-NP O
46 tibial JJ I-NP O
46 present NN I-NP O
46 by IN B-VP O
46 Doppler NNP B-NP O
46 bilaterally RB O O
46 Allen's NNP B-NP O
46 test NN I-NP O
47 left VBD B-VP O
47 upper JJ B-NP O
47 extremity NN I-NP O
47 normal JJ O O
47 , , O O
47 right JJ B-NP O
47 upper JJ I-NP O
47 extremity NN I-NP O
47 normal JJ O O
47 , , O O
47 left VBD B-VP O
48 handed VBN O O
48 patient JJ B-NP O
48 Please NNP I-NP O
48 use NN I-NP O
48 right JJ B-NP O
48 forearm NN I-NP O
48 for IN B-VP O
48 graft NN B-NP O
48 takedown NN I-NP O
49 Respiratory: NNP I-NP O
49 Breath NNP I-NP O
49 sounds VBZ O O
49 clear JJ O O
49 bilaterally RB O O
49 Abdomen: NNP B-NP O
49 No NNP I-NP O
50 incisions NNS I-NP O
50 , , O O
50 soft JJ O O
50 , , O O
50 no DT B-NP O
50 masses NNS I-NP O
50 Extremities NNS I-NP O
50 without IN B-VP O
50 scarring VBG O O
50 , , O O
51 varicosities NNS B-NP O
51 or CC O O
51 edema VB O O
51 Neuro: NNP B-NP O
51 Alert NNP I-NP O
51 and CC O O
51 oriented VBN O O
51 , , O O
51 no DT B-NP O
51 focal JJ I-NP O
52 deficits NNS I-NP O
53 LABORATORY NNP I-NP O
53 DATA: NNP I-NP O
53 Chemistry NNP I-NP O
53 sodium NN I-NP O
53 138 CD O O
53 , , O O
53 potassium NN B-NP O
53 3.9 CD O O
53 , , O O
53 chloride RB O O
54 103 CD O O
54 , , O O
54 CO2 NNP B-NP O
54 26 CD O O
54 , , O O
54 BUN NNP B-NP O
54 16 CD O O
54 , , O O
54 creatinine NN B-NP O
54 0.7 CD O O
54 , , O O
54 glucose VBD B-VP O
54 164 CD O O
54 Hematology NNP B-NP O
54 WBC NNP I-NP O
55 9.58 CD O O
55 , , O O
55 hematocrit NN B-NP O
55 30.9 CD O O
55 , , O O
55 hemoglobin NN B-NP O
55 10.7 CD O O
55 , , O O
55 platelets NNS B-NP O
55 287 CD O O
55 , , O O
55 PT NNP B-NP O
55 13.6 CD O O
55 , , O O
56 INR NNP B-NP O
56 1.0 CD O O
56 , , O O
56 PTT NNP B-NP O
56 36.9 CD O O
56 Carotid NNP B-NP O
56 imaging: NN I-NP O
56 CNIS NNP I-NP O
56 Ultrasound NNP I-NP O
56 left VBD B-VP O
57 internal JJ B-NP O
57 carotid NN I-NP O
57 artery NN I-NP O
57 , , O O
57 zero CD O O
57 percent NN B-NP O
57 occlusion NN I-NP O
57 , , O O
57 right JJ B-NP O
57 internal JJ I-NP O
58 carotid NN I-NP O
58 artery NN I-NP O
58 zero CD O O
58 percent NN B-NP O
58 occlusion NN I-NP O
58 Cardiac NNP I-NP O
58 catheterization NN I-NP O
59 data NNS I-NP O
59 from IN B-VP O
59 3/0/04 CD O O
59 showed VBD B-VP O
59 coronary JJ B-NP O
59 anatomy NN I-NP O
59 , , O O
59 95% CD O O
59 osteo NN B-NP O
59 LAD NNP I-NP O
59 , , O O
59 40% CD O O
60 proximal JJ B-NP O
60 LAD NNP I-NP O
60 , , O O
60 60% CD O O
60 proximal JJ B-NP O
60 ramus NN I-NP O
60 , , O O
60 90% CD O O
60 mid NN B-NP O
60 circumflex NN I-NP O
60 , , O O
60 90% CD O O
60 mid NN B-NP O
61 OM1 NNP I-NP O
61 , , O O
61 right JJ B-NP O
61 dominant JJ I-NP O
61 circulation NN I-NP O
61 Echo NNP I-NP O
61 from IN B-VP O
61 0/20/04 CD O O
61 showed VBD B-VP O
61 57% CD O O
62 ejection NN B-NP O
62 fraction NN I-NP O
62 , , O O
62 aortic JJ B-NP O
62 stenosis NN I-NP O
62 mean JJ B-NP O
62 gradient NN I-NP O
62 22 CD O O
62 mmHg NN B-NP O
62 , , O O
62 peak JJ B-NP O
63 gradient NN I-NP O
63 37 CD O O
63 mmHg NN B-NP O
63 , , O O
63 calculated VBD B-VP O
63 valve JJ B-NP O
63 area NN I-NP O
63 of IN B-VP O
63 1 CD O O
63 cm2 NN B-NP O
63 , , O O
63 mild JJ B-NP O
63 mitral JJ I-NP O
64 insufficiency NN I-NP O
64 , , O O
64 trivial JJ B-NP O
64 tricuspid JJ I-NP O
64 insufficiency NN I-NP O
64 , , O O
64 mid NN B-NP O
64 and CC O O
64 inferior JJ B-NP O
65 septal JJ I-NP O
65 hypokinesis NN I-NP O
65 , , O O
65 normal JJ B-NP O
65 RV NNP I-NP O
65 function NN I-NP O
65 EKG NNP I-NP O
65 from IN B-VP O
65 3/0/04 CD O O
65 showed VBD B-VP O
66 normal JJ B-NP O
66 sinus NNS I-NP O
66 rhythm VBP O O
66 rate NN B-NP O
66 of IN B-VP O
66 69 CD O O
66 , , O O
66 ST NNP B-NP O
66 depression NN I-NP O
66 in IN B-VP O
66 I PRP O O
66 , , O O
66 V4 NNP B-NP O
66 , , O O
66 V5 NNP B-NP O
66 , , O O
66 V6 NNP B-NP O
66 , , O O
67 inverted VBD B-VP O
67 T's NNP B-NP O
67 in IN B-VP O
67 I PRP O O
67 AVL NNP B-NP O
67 , , O O
67 V4 NNP B-NP O
67 , , O O
67 V5 NNP B-NP O
67 , , O O
67 V6 NNP B-NP O
67 Chest NNP I-NP O
67 x-ray NN I-NP O
67 from IN B-VP O
67 3/0/04 CD O O
68 showed VBD B-VP O
68 increased VBN O O
68 pulmonary JJ B-NP O
68 vascular JJ I-NP O
68 markings NNS I-NP O
68 , , O O
68 otherwise RB O O
68 clear JJ B-NP O
69 Right NNP I-NP O
69 ICA NNP I-NP O
69 proximal JJ B-NP O
69 65-70% JJ I-NP O
69 stenosis NN I-NP O
69 , , O O
69 left VBD B-VP O
69 ICA NNP B-NP O
69 proximal JJ B-NP O
69 75-80% JJ I-NP O
70 stenosis NN I-NP O
70 The DT B-NP O
70 patient NN I-NP O
70 was VBD B-VP O
70 admitted VBN O O
70 to TO O O
70 our PRP$ O O
70 service NN B-NP O
70 and CC O O
70 stabilized VBN O O
71 for IN B-VP O
71 surgery NN B-NP O
71 Date NNP I-NP O
71 of IN B-VP O
71 surgery NN B-NP O
71 4/15/04 CD O O
72 PREOPERATIVE NNP B-NP O
72 STATUS: NNP I-NP O
72 Urgent NNP I-NP O
72 The DT B-NP O
72 patient NN I-NP O
72 presented VBN O O
72 with IN B-VP O
72 AMI NNP B-NP O
73 critical JJ B-NP O
73 coronary NN I-NP O
73 anatomy NN I-NP O
73 , , O O
73 rest NN B-NP O
73 angina NN I-NP O
73 , , O O
73 valve FW O O
73 dysfunction NN B-NP O
74 PREOPERATIVE NNP I-NP O
74 DIAGNOSIS: NNP I-NP O
74 CAD NNP I-NP O
74 , , O O
74 aortic JJ B-NP O
74 stenosis NN I-NP O
75 PROCEDURE: NNP I-NP O
75 An DT B-NP O
75 AVR NNP I-NP O
75 with IN B-VP O
75 a DT O O
75 21 CD O O
75 Carpentier-Edwards JJ B-NP O
75 pericardial JJ I-NP O
75 valve NN I-NP O
76 and CC O O
76 a DT B-NP O
76 CABG NNP I-NP O
76 x3 NNP I-NP O
76 LIMA NNP I-NP O
76 to TO O O
76 LAD NNP B-NP O
76 , , O O
76 SVG1 NNP B-NP O
76 to TO O O
76 PDA NNP B-NP O
76 , , O O
76 SVG2-OM2 NNP B-NP O
76 with IN B-VP O
76 a DT B-NP O
76 Robichek NNP I-NP O
77 closure NN I-NP O
77 Bypass NNP I-NP O
77 time NN I-NP O
77 201 CD O O
77 minutes NNS B-NP O
77 , , O O
77 crossclamp JJ B-NP O
77 time NN I-NP O
77 156 CD O O
77 minutes NNS B-NP O
78 FINDINGS: NNP I-NP O
78 Obesity NNP I-NP O
78 , , O O
78 heart NN B-NP O
78 fused VBD B-VP O
78 pericardium NN B-NP O
78 which WDT O O
78 had VBD B-VP O
78 severe JJ B-NP O
79 calcification NN I-NP O
79 , , O O
79 adhesions NNS B-NP O
79 between IN B-VP O
79 heart NN B-NP O
79 and CC O O
79 pericardium NN B-NP O
79 taken VBN O O
79 down RP O O
80 on IN B-VP O
80 CPB NNP B-NP O
80 There EX O O
80 are VBP O O
80 no DT B-NP O
80 complications NNS I-NP O
80 The DT B-NP O
80 patient NN I-NP O
80 was VBD B-VP O
80 transferred VBN O O
81 to TO O O
81 the DT B-NP O
81 unit NN I-NP O
81 in IN B-VP O
81 stable JJ B-NP O
81 fashion NN I-NP O
81 with IN B-VP O
81 lines NNS B-NP O
81 and CC O O
81 tubes NNS B-NP O
81 intact JJ B-NP O
82 HOSPITAL NNP I-NP O
82 COURSE: NNP I-NP O
82 Initial NNP I-NP O
82 postoperative JJ B-NP O
82 period: NN I-NP O
82 Rufus NNP I-NP O
82 Leanard NNP I-NP O
82 was VBD B-VP O
83 extubated VBN O O
83 without IN B-VP O
83 difficulty NN B-NP O
83 and CC O O
83 had VBD B-VP O
83 reasonable JJ B-NP O
83 saturations NNS I-NP O
83 on IN B-VP O
84 nasal JJ B-NP O
84 cannula JJ I-NP O
84 Chest NNP I-NP O
84 x-ray NN I-NP O
84 appeared VBD B-VP O
84 wet JJ O O
84 and CC O O
84 diuresis NN B-NP O
84 was VBD B-VP O
85 increased VBN O O
85 The DT B-NP O
85 history NN I-NP O
85 of IN B-VP O
85 COPD NNP B-NP O
85 and CC O O
85 thus RB O O
85 preoperative JJ B-NP O
85 COPD NNP I-NP B-m
86 medications NNS I-NP O
86 were VBD B-VP O
86 restarted VBN O O
86 She PRP O O
86 was VBD B-VP O
86 in IN B-VP O
86 sinus JJ B-NP O
86 rhythm NN I-NP O
86 with IN B-VP O
86 a DT B-NP B-r
87 systolic JJ I-NP O
87 blood NN I-NP O
87 pressure NN I-NP O
87 of IN B-VP O
87 110 CD O O
87 and CC O O
87 started VBD B-VP O
87 on IN B-VP O
87 beta-blocker NN B-NP B-m
87 She PRP O O
88 was VBD B-VP O
88 given VBN O O
88 Toradol NNP B-NP B-m
88 initially RB O O
88 for IN B-VP O
88 pain NN B-NP B-r
88 and CC O O
88 Percocet NNP B-NP B-m
88 for IN B-VP O
88 break NN B-NP B-r
89 through IN B-VP O
89 pain NN B-NP O
89 Gentle NNP I-NP O
89 diuresis NN I-NP O
89 was VBD B-VP O
89 initiated VBN O O
89 and CC O O
89 in IN B-VP O
89 the DT B-NP O
89 initial JJ I-NP O
90 postoperative JJ I-NP O
90 period NN I-NP O
90 she PRP O O
90 was VBD B-VP O
90 on IN B-VP O
90 the DT B-NP O
90 Portland NNP I-NP O
90 protocol NN I-NP O
90 for IN B-VP O
91 elevated JJ B-NP O
91 postoperative JJ I-NP O
91 blood NN I-NP O
91 sugars NNS I-NP O
91 She PRP O O
91 was VBD B-VP O
91 transferred VBN O O
91 to TO O O
91 the DT B-NP O
92 step-down JJ I-NP O
92 unit NN I-NP O
92 on IN B-VP O
92 9/2/04 CD O O
92 where WRB O O
92 she PRP O O
92 continued VBD B-VP O
92 to TO O O
92 improve VB O O
93 Diuresis NNP B-NP O
93 was VBD B-VP O
93 continued VBN O O
93 and CC O O
93 increased VBN O O
93 as IN B-VP O
93 needed JJ O O
93 She PRP O O
93 was VBD B-VP O
93 on IN B-VP O
93 96% CD O O
94 saturation NN B-NP O
94 with IN B-VP O
94 3 CD O B-do
94 liters NNS B-NP I-do
94 of IN B-VP O
94 oxygen NN B-NP B-m
94 delivered VBN O O
94 via IN B-VP O
94 nasal NN B-NP B-mo
94 cannula VBZ O I-mo
95 Her PRP$ O O
95 hematocrit NN B-NP O
95 postoperative NN I-NP O
95 fluctuated VBD B-VP O
95 between IN B-VP O
95 23-25 JJ O O
95 and CC O O
95 the DT B-NP O
96 patient NN I-NP O
96 was VBD B-VP O
96 asymptomatic JJ O O
96 She PRP O O
96 continued VBD B-VP O
96 to TO O O
96 be VB O O
96 followed VBN O O
96 by IN B-VP O
97 cardiology NN B-NP O
97 for IN B-VP O
97 the DT B-NP O
97 duration NN I-NP O
97 of IN B-VP O
97 her PRP$ O O
97 hospital JJ B-NP O
97 course NN I-NP O
97 Gentle NNP I-NP O
98 ambulation NN I-NP O
98 was VBD B-VP O
98 increased VBN O O
98 She PRP O O
98 remained VBD B-VP O
98 in IN B-VP O
98 sinus NN B-NP O
98 rhythm NN I-NP O
98 in IN B-VP O
98 the DT O O
99 80's CD O O
99 and CC O O
99 pressure NN B-NP O
99 was VBD B-VP O
99 stable JJ O O
99 120's/80's CD O O
99 and CC O O
99 oxygen NN B-NP B-m
99 was VBD B-VP O
100 progressively RB O O
100 weaned VBN O O
100 Her NNP B-NP O
100 temporary JJ B-NP O
100 pacing NN I-NP O
100 wires NNS I-NP O
100 were VBD B-VP O
100 DC'd NNP B-NP O
101 without IN B-VP O
101 incident NN B-NP O
101 on IN B-VP O
101 3/28/04 CD O O
101 She PRP O O
101 was VBD B-VP O
101 followed VBN O O
101 by IN B-VP O
101 Diabetes NNP B-NP O
102 Management NNP I-NP O
102 Service NNP I-NP O
102 for IN B-VP O
102 the DT B-NP O
102 duration NN I-NP O
102 of IN B-VP O
102 her PRP$ O O
102 hospital JJ B-NP O
102 course NN I-NP O
103 Chest NNP I-NP O
103 tubes NNS I-NP O
103 were VBD B-VP O
103 DC'd NNP B-NP O
103 without IN B-VP O
103 incident NN B-NP O
103 on IN B-VP O
103 7/12/04 CD O O
103 Physical JJ B-NP O
104 therapy NN I-NP O
104 was VBD B-VP O
104 consulted VBN O O
104 and CC O O
104 they PRP O O
104 cleared VBD B-VP O
104 her PRP O O
104 for IN B-VP O
104 home NN B-NP O
104 discharge NN I-NP O
105 secondary JJ O O
105 to TO O O
105 elevated VBN O O
105 white JJ B-NP O
105 count NN I-NP O
105 and CC O O
105 low-grade JJ B-NP O
105 temperatures NNS I-NP O
105 on IN B-VP O
106 9/7/04 CD O O
106 She PRP O O
106 was VBD B-VP O
106 pan RB O O
106 cultured VBN O O
106 Resultant JJ B-NP O
106 culture NN I-NP O
106 showed VBD B-VP O
106 a DT B-NP O
106 UTI NNP I-NP O
107 and CC O O
107 all DT B-NP O
107 cultures NNS I-NP O
107 were VBD B-VP O
107 negative JJ B-NP O
107 Wounds NNS I-NP O
107 were VBD B-VP O
107 stable JJ B-NP O
107 Diuresis NN I-NP O
108 was VBD B-VP O
108 continued VBN O O
108 and CC O O
108 increased VBN O O
108 Sid NNP B-NP O
108 Loving NNP I-NP O
108 had VBD B-VP O
108 a DT B-NP O
108 postoperative JJ I-NP O
109 echocardiogram NN I-NP O
109 on IN B-VP O
109 2/18/04 CD O O
109 which WDT O O
109 showed VBD B-VP O
109 an DT B-NP O
109 ejection NN I-NP O
109 fraction NN I-NP O
109 of IN B-VP O
110 55-60% JJ O O
110 , , O O
110 trace NN B-NP O
110 MR NNP I-NP O
110 , , O O
110 trace NN B-NP O
110 TR NNP I-NP O
110 and CC O O
110 no DT B-NP O
110 AI NNP I-NP O
110 and CC O O
110 no DT B-NP O
110 regional JJ I-NP O
110 wall NN I-NP O
110 motion NN I-NP O
111 abnormalities VBZ O O
111 She PRP O O
111 continued VBD B-VP O
111 to TO O O
111 progress VB O O
111 well RB O O
111 and CC O O
111 was VBD B-VP O
111 evaluated VBN O O
112 by IN B-VP O
112 cardiac JJ B-NP O
112 surgery NN I-NP O
112 service NN I-NP O
112 to TO O O
112 be VB O O
112 stable JJ O O
112 to TO O O
112 discharge VB O O
112 to TO O O
112 home NN B-NP O
112 with IN B-VP O
113 VNA NNP B-NP O
113 service NN I-NP O
113 on IN B-VP O
113 3/8/04 CD O O
113 with IN B-VP O
113 the DT O O
113 following VBG O O
113 discharge NN B-NP O
113 instructions NNS I-NP O
114 Diet: NNP I-NP O
114 Low-cholesterol NNP I-NP O
114 low JJ O O
114 saturated VBD B-VP O
114 fat NN B-NP O
114 , , O O
114 ADA NNP B-NP O
114 2100 CD O O
114 calories NNS B-NP O
114 per IN B-VP O
115 day NN B-NP O
116 FOLLOWUP NNP I-NP O
116 APPOINTMENTS: NNP I-NP O
116 With IN B-VP O
116 Dr NNP B-NP O
116 Feder NNP I-NP O
116 652 CD O O
116 042-3264 NN B-NP O
116 in IN B-VP O
116 5-6 JJ B-NP O
116 weeks NNS I-NP O
116 , , O O
117 Dr NNP B-NP O
117 Burkhead NNP I-NP O
117 364-329-0928 JJ O O
117 in IN B-VP O
117 1-2 JJ B-NP O
117 weeks NNS I-NP O
117 , , O O
117 and CC O O
117 Dr NNP B-NP O
117 Saltmarsh NNP I-NP O
117 262-598-9932 JJ O O
118 in IN B-VP O
118 1-2 JJ B-NP O
118 weeks NNS I-NP O
119 ADDITIONAL NNP I-NP O
119 COMMENTS: NNP I-NP O
119 Please NNP I-NP O
119 have VBP O O
119 PCP/cardiologist NNP B-NP O
119 draw VB O O
119 CBC NNP B-NP O
119 at IN B-VP O
120 first JJ B-NP O
120 office NN I-NP O
120 visit NN I-NP O
120 and CC O O
120 repeat NN B-NP O
120 UA NNP I-NP O
120 and CC O O
120 culture NN B-NP O
120 to TO O O
120 determine VB O O
120 need NN B-NP O
121 for IN B-VP O
121 treatment NN B-NP O
121 of IN B-VP O
121 possible JJ B-NP O
121 UTI NNP I-NP O
121 , , O O
121 is VBZ O O
121 completing VBG O O
121 antibiotic JJ B-NP B-m
121 course NN I-NP O
121 as IN B-VP O
122 outpatient NN B-NP O
123 TO NNP I-NP O
123 DO NNP I-NP O
123 PLAN: NNP I-NP O
123 Make NNP I-NP O
123 all DT O O
123 follow VBP O O
123 up RP O O
123 appointments NNS B-NP O
123 Local NNP I-NP O
123 wound NN I-NP O
123 care: NN I-NP O
124 Wash NNP I-NP O
124 all DT B-NP O
124 wounds NNS I-NP O
124 daily RB O O
124 with IN B-VP O
124 soap NN B-NP O
124 and CC O O
124 water NN B-NP O
124 Watch NNP I-NP O
124 all DT B-NP O
124 wounds NNS I-NP O
124 for IN B-VP O
125 signs NNS B-NP O
125 of IN B-VP O
125 infection NN B-NP O
125 , , O O
125 redness NN B-NP O
125 , , O O
125 drainage NN B-NP O
125 , , O O
125 pain NN B-NP O
125 , , O O
125 swelling VBG O O
125 , , O O
125 fever RB O O
126 Keep NNP B-NP O
126 legs NNS I-NP O
126 elevated VBD B-VP O
126 while IN B-VP O
126 sitting/in JJ B-NP O
126 bed NN I-NP O
126 Call NNP I-NP O
126 PCP/cardiologist NNP I-NP O
127 or CC O O
127 Ole NNP B-NP O
127 Health NNP I-NP O
127 Of IN B-VP O
127 cardiac JJ B-NP O
127 surgery NN I-NP O
127 service NN I-NP O
128 282-008-4347 JJ O O
128 with IN B-VP O
128 any DT B-NP O
128 questions NNS I-NP O
129 DISCHARGE NNP I-NP O
129 CONDITION: NNP I-NP O
129 Stable NNP I-NP O
130 DISCHARGE NNP I-NP O
130 MEDICATIONS: NNP I-NP O
130 Enteric-coated NNP I-NP B-m
130 aspirin VBZ O I-m
130 325 CD O B-do
130 mg NN B-NP I-do
130 q.d NN I-NP B-f
130 , , O O
130 Lasix NNP B-NP B-m
130 Lasix NNP I-NP B-m
131 60 CD O B-do
131 mg NN B-NP I-do
131 b.i.d NN I-NP B-f
131 for IN B-VP B-du
131 3 CD O I-du
131 days NNS B-NP I-du
131 then RB O O
131 40 CD O B-do
131 mg NNS B-NP I-do
131 b.i.d NN I-NP B-f
131 for IN B-VP B-du
131 3 CD O I-du
131 days NNS B-NP I-du
131 , , O O
131 ibuprofen JJ O B-m
132 600 CD O B-do
132 mg NN B-NP I-do
132 q.6h NN I-NP B-f
132 p.r.n NN I-NP I-f
132 pain NN I-NP B-r
132 , , O O
132 Lopressor NNP B-NP B-m
132 50 CD O B-do
132 mg NN B-NP I-do
132 t.i.d NN I-NP B-f
132 , , O O
132 niferex RB O B-m
132 150 CD O I-m
132 150 CD O B-do
133 mg NN B-NP O
133 b.i.d NN I-NP B-f
133 , , O O
133 simvastatin VBD B-VP B-m
133 20 CD O B-do
133 mg NN B-NP I-do
133 q.h.s NN I-NP B-f
133 , , O O
133 K-Dur NNP B-NP B-m
133 K-Dur NNP I-NP B-m
133 30 CD O B-do
133 mEq NN B-NP I-do
133 b.i.d NN I-NP B-f
133 and CC O O
133 then RB O O
134 20 CD O B-do
134 mEq NNS B-NP I-do
134 b.i.d NN I-NP B-f
134 , , O O
134 fluticasone RB O B-m
134 44 CD O B-do
134 mcg NNS B-NP I-do
134 inhaled VBN O B-mo
134 b.i.d NN B-NP B-f
134 , , O O
134 levofloxacin VBZ O B-m
135 500 CD O B-do
135 mg NN B-NP I-do
135 q.d NN I-NP B-f
135 for IN B-VP B-du
135 2 CD O I-du
135 days NNS B-NP I-du
135 to TO O O
135 complete JJ B-NP O
135 course NN I-NP O
135 for IN B-VP O
135 UTI NNP B-NP B-r
135 , , O O
135 Humalog NNP B-NP B-m
135 , , O O
136 insulin NN B-NP B-m
136 on IN B-VP O
136 sliding VBG O B-do
136 scale NN B-NP I-do
136 , , O O
136 Humalog NNP B-NP B-m
136 insulin VBZ O I-m
136 12 CD O B-do
136 units NNS B-NP I-do
136 subq VBN O B-mo
136 with IN B-VP B-f
137 lunch NN B-NP O
137 and CC O O
137 dinner NN B-NP O
137 , , O O
137 Humalog NNP B-NP B-m
137 insulin VBZ O I-m
137 16 CD O B-do
137 units NNS B-NP I-do
137 subcutaneous JJ O B-mo
137 with IN B-VP B-f
138 breakfast NN B-NP O
138 , , O O
138 Celexa NNP B-NP B-m
138 20 CD O B-do
138 mg NN B-NP I-do
138 q.d NN I-NP B-f
138 , , O O
138 Combivent NNP B-NP B-m
138 2 CD O B-do
138 puffs NNS B-NP I-do
138 inhaled VBD B-VP B-mo
138 q.i.d NN B-NP B-f
138 , , O O
139 Nexium NNP B-NP B-m
139 20 CD O B-do
139 mg NN B-NP I-do
139 q.d NN I-NP B-f
139 , , O O
139 and CC O O
139 Lantus NNP B-NP B-m
139 insulin VBP O I-m
139 62 CD O B-do
139 units NNS B-NP I-do
139 subcutaneous JJ B-NP B-mo
140 q.h.s JJ I-NP B-f
141 eScription NN I-NP O
141 document: VBZ O O
141 7-6609130 JJ B-NP O
141 DBSSten NNP I-NP O
141 Tel NNP I-NP O
142 Dictated NNP I-NP O
142 By: NNP I-NP O
142 ROEHR NNP I-NP O
142 , , O O
142 BILLIE NNP B-NP O
142 LUPE NNP I-NP O
143 Attending: NNP I-NP O
143 VELAQUEZ NNP I-NP O
143 , , O O
143 TYSON NNP B-NP O
143 ALAN NNP I-NP O
144 Dictation NNP I-NP O
144 ID NNP I-NP O
144 1243617 CD O O
145 D: NNP B-NP O
145 7/15/04 CD O O
146 T: NNP B-NP O
146 7/15/04 CD O O
147 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #974209 VBZ O O
4 338403609 CD O O
4 GMHAMC NNP B-NP O
4 30508109 CD O O
4 8380058 CD O O
4 11/27/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 " NNP I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 11/8/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 3/5/2005 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 KARPINSKY NNP I-NP O
8 , , O O
8 LOYD NNP B-NP O
8 O NNP I-NP O
8 033-89-98-3 JJ B-NP O
9 Midbluff NNP I-NP O
9 Drive NNP I-NP O
10 Service: NNP I-NP O
10 GGI NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 4/15/05 CD O O
11 AT NNP B-NP O
11 02:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 NIEDERMAYER NNP I-NP O
14 , , O O
14 ARMAND NNP B-NP O
14 KERMIT NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 DISPOSITION: NNP I-NP O
15 Home NNP I-NP O
16 DISCHARGE NNP I-NP O
16 MEDICATIONS: NNP I-NP O
17 LANTUS NNP I-NP B-m
17 ( ( O I-m
17 INSULIN NNP B-NP I-m
17 GLARGINE NNP I-NP I-m
17 ) ) O I-m
17 10 CD O B-do
17 UNITS NNP B-NP I-do
17 SC NNP I-NP B-mo
17 QD NNP I-NP B-f
18 HOLD NNP I-NP O
18 IF: NNP I-NP O
18 FS NNP I-NP O
18 &lt;150 NNP I-NP O
19 RANITIDINE NNP I-NP B-m
19 HCL NNP I-NP I-m
19 SYRUP NNP I-NP I-m
19 150 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
20 ROXICET NNP I-NP B-m
20 ELIXIR NNP I-NP I-m
20 ( ( O I-m
20 OXYCODONE+APAP NNP B-NP I-m
20 LIQUID NNP I-NP I-m
20 ) ) O I-m
21 5-10 JJ B-NP B-do
21 MILLILITERS NNP I-NP I-do
21 PO NNP I-NP B-mo
21 Q4H NNP I-NP B-f
21 PRN NNP I-NP I-f
21 Pain NNP I-NP B-r
22 COLACE NNP I-NP B-m
22 ( ( O I-m
22 DOCUSATE NNP B-NP I-m
22 SODIUM NNP I-NP I-m
22 ) ) O I-m
22 100 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 TID NNP I-NP B-f
22 HOLD NNP I-NP O
22 IF: NNP I-NP O
22 diarrhea VBZ O O
23 Instructions: NNP B-NP O
23 as IN B-VP O
23 elixir NN B-NP O
24 PHENERGAN NNP I-NP B-m
24 ( ( O I-m
24 PROMETHAZINE NNP B-NP I-m
24 HCL NNP I-NP I-m
24 ) ) O I-m
24 25 CD O B-do
24 MG NNP B-NP I-do
24 PR NNP I-NP B-mo
24 Q6H NNP I-NP B-f
24 PRN NNP I-NP I-f
24 Nausea NNP I-NP B-r
25 AUGMENTIN NNP I-NP B-m
25 SUSP NNP I-NP I-m
25 250MG/62.5 CD O I-m
25 MG NNP B-NP I-m
25 ( ( O I-m
25 5ML CD O I-m
25 ) ) O I-m
25 ( ( O I-m
25 AMOXICIL NNP B-NP I-m
25 ) ) O I-m
26 10 CD O B-do
26 MILLILITERS NNP B-NP I-do
26 PO NNP I-NP B-mo
26 TID NNP I-NP B-f
26 Instructions: NNP I-NP O
26 for IN B-VP B-du
26 five CD O I-du
26 days NNS B-NP I-du
27 Food/Drug NNP I-NP O
27 Interaction NNP I-NP O
27 Instruction NNP I-NP O
28 May NNP I-NP O
28 be VB O O
28 taken VBN O O
28 without IN B-VP O
28 regard NN B-NP O
28 to TO O O
28 meals NNS B-NP O
29 DIET: NNP I-NP O
29 stage NN I-NP O
29 2 CD O O
29 post NN B-NP O
29 band NN I-NP O
29 diet JJ B-NP O
30 ACTIVITY: NNP I-NP O
30 Resume NNP I-NP O
30 regular JJ B-NP O
30 exercise NN I-NP O
31 Walking NNP I-NP O
31 as IN B-VP O
31 tolerated VBN O O
32 FOLLOW NNP B-NP O
32 UP NNP I-NP O
32 APPOINTMENT( NNP I-NP O
32 S NNP I-NP O
32 ): NNP I-NP O
33 Dr NNP I-NP O
33 Hinsley NNP I-NP O
33 1-2 JJ B-NP O
33 weeks NNS I-NP O
33 , , O O
34 Diabetes NNP B-NP O
34 Management NNP I-NP O
34 Service NNP I-NP O
34 3 CD O O
34 weeks NNS B-NP O
34 , , O O
35 ALLERGY: NNP B-NP O
35 Sulfa NNP I-NP O
35 , , O O
35 Erythromycins NNP B-NP O
36 ADMIT NNP I-NP O
36 DIAGNOSIS: NNP I-NP O
37 s/p VBD B-VP O
37 lap RBR O O
37 gastic JJ B-NP O
37 band NN I-NP O
38 PRINCIPAL NNP I-NP O
38 DISCHARGE NNP I-NP O
38 DIAGNOSIS NNP I-NP O
38 ;Responsible JJ O O
38 After IN B-VP O
38 Study NNP B-NP O
38 for IN B-VP O
38 Causing NNP B-NP O
38 Admission NNP I-NP O
38 ) ) O O
39 " VBZ O O
40 OTHER NNP B-NP O
40 DIAGNOSIS;Conditions NNP I-NP O
40 , , O O
40 Infections NNP B-NP O
40 , , O O
40 Complications NNP B-NP O
40 , , O O
40 affecting VBG O O
40 Treatment/Stay NNP B-NP O
42 OPERATIONS NNP I-NP O
42 AND NNP I-NP O
42 PROCEDURES: NNP I-NP O
43 11/12/05 CD O O
43 GIACCIO NNP B-NP O
43 , , O O
43 HARLEY NNP B-NP O
43 JARROD NNP I-NP O
43 , , O O
43 M.D NNP B-NP O
44 LAPARO NNP I-NP O
44 PLACEMENT NNP I-NP O
44 ADJUSTABLE NNP I-NP O
44 GASTRIC NNP I-NP O
44 BAND NNP I-NP O
45 OTHER NNP I-NP O
45 TREATMENTS/PROCEDURES NNP I-NP O
45 ( ( O O
45 NOT NNP B-NP O
45 IN NNP I-NP O
45 O.R NNP I-NP O
45 ) ) O O
46 upper IN B-VP O
46 GI NNP B-NP O
46 series NN I-NP O
46 - : O O
46 negative JJ B-NP O
47 BRIEF NNP I-NP O
47 RESUME NNP I-NP O
47 OF NNP I-NP O
47 HOSPITAL NNP I-NP O
47 COURSE: NNP I-NP O
48 this DT O O
48 very RB O O
48 pleasant JJ O O
48 54yo CD O O
48 with IN B-VP O
48 a DT B-NP O
48 history NN I-NP O
48 of IN B-VP O
48 NIDDM NNP B-NP O
48 failure NN I-NP O
48 of IN B-VP O
48 other JJ B-NP O
49 conventional JJ I-NP O
49 methods NNS I-NP O
49 of IN B-VP O
49 weight JJ B-NP O
49 loss NN I-NP O
49 , , O O
49 underwent VBD B-VP O
49 a DT B-NP O
49 laparoscopic NN I-NP O
49 adjustable JJ B-NP O
50 gastric JJ I-NP O
50 band NN I-NP O
50 placement NN I-NP O
50 without IN B-VP O
50 complication NN B-NP O
50 The DT B-NP O
50 pt NN I-NP O
50 was VBD B-VP O
50 transferred VBN O O
50 to TO O O
51 the DT B-NP O
51 PACU NNP I-NP O
51 in IN B-VP O
51 stable JJ B-NP O
51 condition NN I-NP O
51 Her NNP I-NP O
51 pain NN I-NP B-r
51 was VBD B-VP O
51 well RB O O
51 controlled VBN O O
51 with IN B-VP O
51 PCA NNP B-NP B-m
52 analgesia NN I-NP O
52 on IN B-VP O
52 POD0 NNP B-NP O
52 and CC O O
52 transitioned VBD B-VP O
52 to TO O O
52 po VB O B-mo
52 elixir JJ B-NP B-m
52 analgesia NN I-NP I-m
52 following VBG O O
52 a DT B-NP O
53 negative JJ I-NP O
53 upper JJ I-NP O
53 GI NNP I-NP O
53 studfy NN I-NP O
53 exhibiting VBG O O
53 no DT O O
53 leaks FW O O
53 Her PRP$ O O
53 diet NN B-NP O
53 was VBD B-VP O
53 advanced VBN O O
53 from IN B-VP O
54 NPO NNP B-NP O
54 to TO O O
54 stage VB O O
54 2 CD O O
54 post NN B-NP O
54 gastric JJ B-NP O
54 banding NN I-NP O
54 diet NN I-NP O
54 , , O O
54 which WDT O O
54 she PRP O O
54 tolerated VBD B-VP O
54 with IN B-VP O
54 no DT O O
55 nausea/vomiting VBG O O
55 On IN B-VP O
55 POD NNP B-NP O
55 1 CD O O
55 the DT B-NP O
55 surgical JJ I-NP O
55 site NN I-NP O
55 was VBD B-VP O
55 examined VBN O O
55 and CC O O
55 there EX O O
55 were VBD B-VP O
56 no DT B-NP O
56 signs NNS I-NP O
56 of IN B-VP O
56 hematoma NN B-NP O
56 The DT B-NP O
56 pt NN I-NP O
56 remained VBD B-VP O
56 hemodynamically RB O O
56 stable JJ O O
56 and CC O O
56 was VBD B-VP O
57 making VBG O O
57 good JJ B-NP O
57 urine NN I-NP O
57 At IN B-VP O
57 the DT B-NP O
57 time NN I-NP O
57 of IN B-VP O
57 discharge NN B-NP O
57 the DT B-NP O
57 pt's NN I-NP O
57 pain NN I-NP O
57 was VBD B-VP O
57 well RB O O
58 controlled VBN O O
58 and CC O O
58 she PRP O O
58 was VBD B-VP O
58 tolerating VBG O O
58 a DT B-NP O
58 stage NN I-NP O
58 2 CD O O
58 diet JJ O O
58 and CC O O
58 was VBD B-VP O
58 afebrile VBN O O
58 with IN B-VP O
59 all DT B-NP O
59 incisions NNS I-NP O
59 were VBD B-VP O
59 clean JJ O O
59 dry JJ O O
59 and CC O O
59 intact JJ B-NP O
59 Pt NNP I-NP O
59 is VBZ O O
59 being VBG O O
59 sent VBN O O
59 home NN B-NP O
59 on IN B-VP O
59 roxicet NN B-NP B-m
60 and CC O O
60 ranitidine NN B-NP B-m
60 elixir NN I-NP I-m
60 as RB O O
60 wel NN B-NP O
60 as IN B-VP O
60 a DT B-NP O
60 course NN I-NP O
60 of IN B-VP O
60 qugmentin JJ B-NP B-m
60 suspension NN I-NP I-m
60 as RB O O
60 well RB O O
61 as IN B-VP O
61 previous JJ B-NP B-m
61 home NN I-NP I-m
61 medications NNS I-NP I-m
62 She PRP O O
62 will MD O O
62 follow VB O O
62 up RP O O
62 her PRP$ O B-r
62 diabetes NNS B-NP I-r
62 in IN B-VP O
62 DM NNP B-NP O
62 clinic NN I-NP O
62 as IN B-VP O
62 previously RB O O
62 arranged VBN O O
62 and CC O O
63 will MD O O
63 take VB O O
63 only RB O O
63 her PRP$ O O
63 lantus NN B-NP B-m
63 in IN B-VP O
63 the DT B-NP O
63 interim JJ I-NP O
64 ADDITIONAL NNP I-NP O
64 COMMENTS: NNP I-NP O
64 Please NNP I-NP O
64 call VB O O
64 your PRP$ O O
64 physician NN B-NP O
64 or CC O O
64 go VB O O
64 to TO O O
64 the DT B-NP O
64 ER NNP I-NP O
64 if IN B-VP O
64 you PRP O O
64 develop VBP O O
64 abdominal JJ B-NP O
64 pain NN I-NP O
64 , , O O
65 vomiting VBG O O
65 or CC O O
65 overt JJ B-NP O
65 distension NN I-NP O
65 increased VBD B-VP O
65 pain NN B-NP O
65 , , O O
65 increased VBD B-VP O
65 swelling NN B-NP O
65 , , O O
66 bruising NN B-NP O
66 , , O O
66 fever&gt;101.2/chills NNS B-NP O
66 , , O O
66 change NN B-NP O
66 in IN B-VP O
66 wound NN B-NP O
66 appearance NN I-NP O
66 ( ( O O
66 increased JJ B-NP O
67 redness NN I-NP O
67 or CC O O
67 discharge NN B-NP O
67 ) ) O O
67 or CC O O
67 chest JJS B-NP O
67 pain NN I-NP O
67 &amp; JJ B-NP O
67 shortness NN I-NP O
67 of IN B-VP O
67 breath NN B-NP O
67 Please NNP I-NP O
67 avoid VBZ O O
68 strenuous JJ B-NP O
68 activity NN I-NP O
68 You PRP O O
68 may MD O O
68 take VB O O
68 dressings NNS B-NP O
68 off IN B-VP O
68 and CC O O
68 shower VB O O
68 48 CD O O
68 hours NNS B-NP O
68 after IN B-VP O
69 surgery NN B-NP O
69 Do NNP I-NP O
69 not RB O O
69 go VB O O
69 swimming NN B-NP O
69 , , O O
69 bathing VBG O O
69 or CC O O
69 hot JJ O O
69 tubbing VBG O O
69 Do NNP B-NP O
69 not RB O O
69 drive VB O O
69 or CC O O
70 drink VB O O
70 alcohol NN B-NP O
70 while IN B-VP O
70 taking VBG O O
70 prescription NN B-NP O
70 narcotic JJ O B-m
70 ( ( O I-m
70 pain NN B-NP I-m
70 ) ) O I-m
70 medications NNS B-NP I-m
71 DISCHARGE NNP I-NP O
71 CONDITION: NNP I-NP O
71 Stable NNP I-NP O
72 TO NNP I-NP O
72 DO/PLAN: NNP I-NP O
73 No NNP I-NP O
73 dictated VBD B-VP O
73 summary JJ B-NP O
74 ENTERED NNP I-NP O
74 BY: NNP I-NP O
74 KELCOURSE NNP I-NP O
74 , , O O
74 JOHN NNP B-NP O
74 , , O O
74 M.B.B.S NNP B-NP O
74 ( ( O O
74 CQ451 NNP B-NP O
74 ) ) O O
74 4/15/05 CD O O
74 @ $ O O
74 01:35 CD O O
74 PM NNP B-NP O
75 ****** JJ B-NP O
75 END NNP I-NP O
75 OF NNP I-NP O
75 DISCHARGE NNP I-NP O
75 ORDERS NNP I-NP O
75 ****** NNP I-NP O
76 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #975588 VBZ O O
2 039777095 CD O O
2 GCH NNP B-NP O
2 19126555 CD O O
2 0135055 CD O O
2 4/29/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 chest JJS B-NP O
2 discomfort NN I-NP O
2 unclear JJ B-NP O
2 etiology NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 2/17/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 2/17/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 KRATZ NNP I-NP O
5 , , O O
5 DEANGELO NNP B-NP O
5 Z NNP I-NP O
5 993-80-55-1 CD O O
6 Grovemont NNP B-NP O
6 Ton NNP I-NP O
6 A NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 5/28/05 CD O O
8 AT NNP B-NP O
8 06:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 CHAPMAN NNP I-NP O
11 , , O O
11 CLAIR NNP B-NP O
11 S NNP I-NP O
11 , , O O
11 M.D NNP B-NP O
12 DISPOSITION: NNP I-NP O
12 Home NNP I-NP O
13 DISCHARGE NNP I-NP O
13 MEDICATIONS: NNP I-NP O
14 ECASA NNP I-NP B-m
14 ( ( O I-m
14 ASPIRIN NNP B-NP I-m
14 ENTERIC NNP I-NP I-m
14 COATED NNP I-NP I-m
14 ) ) O I-m
14 81 CD O B-do
14 MG NNP B-NP I-do
14 PO NNP I-NP B-mo
14 3x/Week CD O B-f
14 M-W-F NNP B-NP I-f
15 Alert NNP I-NP O
15 overridden: NNP I-NP O
15 Override NNP I-NP O
15 added VBD B-VP O
15 on IN B-VP O
15 5/28/05 CD O O
15 by IN B-VP O
16 CALEMINE NNP B-NP O
16 , , O O
16 HUGH NNP B-NP O
16 , , O O
16 M.D NNP B-NP O
16 , , O O
16 PH.D NNP B-NP O
17 on IN B-VP O
17 order NN B-NP O
17 for IN B-VP O
17 ECASA NNP B-NP B-m
17 PO NNP I-NP B-mo
17 ( ( O O
17 ref JJ O O
17 # # O O
17 65555559 CD O O
17 ) ) O O
18 Pt NNP B-NP O
18 has VBZ O O
18 a DT B-NP O
18 DEFINITE NNP I-NP O
18 allergy NN I-NP O
18 to TO O O
18 Aspirin; NNP B-NP O
18 reaction NN I-NP O
18 is VBZ O O
18 GI NNP B-NP O
19 upset JJ B-NP O
19 Reason NNP I-NP O
19 for IN B-VP O
19 override: NN B-NP O
19 Takes NNP I-NP O
19 as IN B-VP O
19 outpatient JJ B-NP O
20 LISINOPRIL NNP I-NP B-m
20 1.25 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 Alert NNP I-NP O
21 overridden: NNP I-NP O
21 Override NNP I-NP O
21 added VBD B-VP O
21 on IN B-VP O
21 5/28/05 CD O O
21 by IN B-VP O
22 BARKE NNP B-NP O
22 , , O O
22 LEANDRO NNP B-NP O
22 , , O O
22 M.D NNP B-NP O
22 , , O O
22 PH.D NNP B-NP O
23 POTENTIALLY NNP I-NP O
23 SERIOUS NNP I-NP O
23 INTERACTION: NNP I-NP O
23 POTASSIUM NNP I-NP B-m
23 CHLORIDE NNP I-NP I-m
23 &amp; NNP I-NP O
24 LISINOPRIL NNP I-NP B-m
24 Reason NNP I-NP O
24 for IN B-VP O
24 override: NN B-NP O
24 Aware NNP I-NP O
25 PLAVIX NNP I-NP B-m
25 ( ( O I-m
25 CLOPIDOGREL NNP B-NP I-m
25 ) ) O I-m
25 75 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QD NNP I-NP B-f
26 ATENOLOL NNP I-NP B-m
26 50 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 QD NNP I-NP B-f
27 LIPITOR NNP I-NP B-m
27 ( ( O I-m
27 ATORVASTATIN NNP B-NP I-m
27 ) ) O I-m
27 40 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QD NNP I-NP B-f
28 GLYBURIDE NNP I-NP B-m
28 1.25 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QD NNP I-NP B-f
29 DIET: NNP I-NP O
29 House NNP I-NP O
29 / VBD B-VP O
29 Low NNP B-NP O
29 chol/low NN I-NP O
29 sat VBD B-VP O
29 fat JJ B-NP O
30 DIET: NNP I-NP O
30 House NNP I-NP O
30 / NNP I-NP O
30 ADA NNP I-NP O
30 2100 CD O O
30 cals/dy NN B-NP O
31 ACTIVITY: NNP I-NP O
31 Resume NNP I-NP O
31 regular JJ B-NP O
31 exercise NN I-NP O
32 FOLLOW NNP I-NP O
32 UP NNP I-NP O
32 APPOINTMENT( NNP I-NP O
32 S NNP I-NP O
32 ): NNP I-NP O
33 pcp SYM O O
33 - : O O
33 Dr NN B-NP O
33 Claudio NNP I-NP O
33 Conorich NNP I-NP O
33 ( ( O O
33 329-1910 JJ B-NP O
33 1-2 JJ I-NP O
33 weeks NNS I-NP O
33 , , O O
34 cardiology NN B-NP O
34 - : O O
34 Truman NNP B-NP O
34 Shinoda NNP I-NP O
34 8/10 CD O O
34 3.20p CD O O
34 , , O O
35 vascular NN B-NP O
35 surgery NN I-NP O
35 - : O O
35 Travillian JJ O O
35 ( ( O O
35 603-819-2768 JJ O O
35 ) ) O O
35 9/13 CD O O
35 ( ( O O
35 call VB O O
35 for IN B-VP O
35 time NN B-NP O
35 ) ) O O
35 , , O O
36 ALLERGY: NNP B-NP O
36 Penicillins NNP I-NP O
36 , , O O
36 IV NNP B-NP O
36 Contrast NNP I-NP O
36 , , O O
36 AZITHROMYCIN NNP B-NP O
36 , , O O
36 Shellfish NNP B-NP O
36 , , O O
37 Aspirin NNP B-NP O
38 ADMIT NNP I-NP O
38 DIAGNOSIS: NNP I-NP O
39 atypical JJ B-NP O
39 chest NN I-NP O
39 pain NN I-NP O
40 PRINCIPAL NNP I-NP O
40 DISCHARGE NNP I-NP O
40 DIAGNOSIS NNP I-NP O
40 ;Responsible JJ O O
40 After IN B-VP O
40 Study NNP B-NP O
40 for IN B-VP O
40 Causing NNP B-NP O
40 Admission NNP I-NP O
40 ) ) O O
41 chest JJS B-NP O
41 discomfort NN I-NP O
41 unclear JJ B-NP O
41 etiology NN I-NP O
42 OTHER NNP I-NP O
42 DIAGNOSIS;Conditions NNP I-NP O
42 , , O O
42 Infections NNP B-NP O
42 , , O O
42 Complications NNP B-NP O
42 , , O O
42 affecting VBG O O
42 Treatment/Stay NNP B-NP O
43 unstable JJ B-NP O
43 angina NNS I-NP O
43 hypercholesterol VBP O O
43 s/p JJ B-NP O
43 TAH NNP I-NP O
43 , , O O
43 RSO NNP B-NP O
43 s/p VBZ O O
43 splenectomy JJ O O
43 - : O O
43 stab NN B-NP O
43 woun NN I-NP O
44 asthma NN I-NP O
44 h/o NN I-NP O
44 hepatitis NN I-NP O
44 s/p NN I-NP O
44 L NNP I-NP O
44 hemicolectomy NN I-NP O
44 - : O O
44 polyp NN B-NP O
44 r/o NN I-NP O
44 for IN B-VP O
44 mi NN B-NP O
44 4/7 CD O O
45 8/15 CD O O
45 GIB NNP B-NP O
45 from IN B-VP O
45 diverticuli NN B-NP O
45 , , O O
45 7/24 CD O O
45 MIBI NNP B-NP O
45 old JJ B-NP O
45 scar NN I-NP O
45 inf/lat JJ B-NP O
46 OPERATIONS NNP I-NP O
46 AND NNP I-NP O
46 PROCEDURES: NNP I-NP O
47 none NN I-NP O
48 OTHER NNP I-NP O
48 TREATMENTS/PROCEDURES NNP I-NP O
48 ( ( O O
48 NOT NNP B-NP O
48 IN NNP I-NP O
48 O.R NNP I-NP O
48 ) ) O O
49 prelim NN B-NP O
49 STRESS NNP I-NP O
49 MIBI NNP I-NP O
49 - : O O
49 negative JJ O O
49 for IN B-VP O
49 acute NN B-NP O
49 or CC O O
49 reversible JJ B-NP O
49 defects NNS I-NP O
50 non-reversible JJ B-NP O
50 scar NN I-NP O
50 inf/lat JJ B-NP O
50 final JJ I-NP O
50 read NN I-NP O
50 P NNP I-NP O
51 BRIEF NNP I-NP O
51 RESUME NNP I-NP O
51 OF NNP I-NP O
51 HOSPITAL NNP I-NP O
51 COURSE: NNP I-NP O
52 Pt NNP I-NP O
52 is VBZ O O
52 a DT O O
52 64F JJ O O
52 with IN B-VP O
52 hx NN B-NP O
52 of IN B-VP O
52 CAD NNP B-NP O
52 ( ( O O
52 NSTEMIs NNP B-NP O
52 x VBZ O O
52 2 CD O O
52 in IN B-VP O
52 1997/2001 CD O O
52 , , O O
52 cath NN B-NP O
52 2000 CD O O
52 RCA NNP B-NP O
52 , , O O
52 LCx NNP B-NP O
53 in IN B-VP O
53 2000 CD O O
53 , , O O
53 which WDT O O
53 were VBD B-VP O
54 complicated VBN O O
54 by IN B-VP O
54 in-stent JJ B-NP O
54 thrombosis NN I-NP O
54 ?3 CD O O
54 years NNS B-NP O
54 ago RB O O
54 ) ) O O
54 , , O O
54 HTN NNP B-NP O
54 , , O O
54 DM NNP B-NP O
54 ( ( O O
54 hba1c VB O O
54 6.2 CD O O
54 ) ) O O
54 , , O O
55 PVD NNP B-NP O
55 , , O O
55 recent JJ B-NP O
55 admit NN I-NP O
55 ( ( O O
55 4/8 CD O O
55 ) ) O O
55 for IN B-VP O
55 ROMI NNP B-NP O
55 ( ( O O
55 negative JJ O O
55 and CC O O
55 declined VBD B-VP O
55 inpatient JJ B-NP O
56 stress NN I-NP O
56 ) ) O O
56 , , O O
56 presents VBZ O O
56 with IN B-VP O
56 atypical JJ B-NP O
56 chest NN I-NP O
56 pain NN I-NP O
56 Constant NNP I-NP O
56 x VBZ O O
56 6 CD O O
56 days NNS B-NP O
56 SSCP NNP I-NP O
56 , , O O
56 no RB O O
57 associated VBN O O
57 sx VBZ O O
57 No DT B-NP O
57 pulm/infectious JJ I-NP O
57 component NN I-NP O
58 In IN B-VP O
58 the DT B-NP O
58 ED NNP I-NP O
58 , , O O
58 BP NNP B-NP O
58 159/69 CD O O
58 , , O O
58 P NNP B-NP O
58 60 CD O O
58 No NNP B-NP O
58 EKG NNP I-NP O
58 changes VBZ O O
58 new JJ B-NP O
58 first JJ I-NP O
58 set NN I-NP O
58 of IN B-VP O
58 enzymes NNS B-NP O
59 negative JJ B-NP O
59 d JJ I-NP O
59 dimer NN I-NP O
59 negative JJ B-NP O
60 ********** NNP I-NP O
61 Hospital NNP I-NP O
61 Course NNP I-NP O
62 Pt NNP I-NP O
62 was VBD B-VP O
62 admitted VBN O O
62 for IN B-VP O
62 observation NN B-NP O
62 and CC O O
62 ROMI NNP B-NP O
62 with IN B-VP O
62 stress JJ B-NP O
62 test NN I-NP O
62 There EX O O
62 was VBD B-VP O
62 low JJ B-NP O
63 suspicion NN I-NP O
63 for IN B-VP O
63 ACS NNP B-NP O
63 given VBN O O
63 her PRP$ O O
63 history NN B-NP O
63 However RB O O
63 , , O O
63 pt NN B-NP O
63 with IN B-VP O
63 multiple JJ B-NP O
63 CRF NNP I-NP O
63 and CC O O
64 felt VBD B-VP O
64 that IN B-VP O
64 inpatient NN B-NP O
64 stress NN I-NP O
64 was VBD B-VP O
64 warranted VBN O O
64 ( ( O O
64 last JJ B-NP O
64 MIBI NNP I-NP O
64 2002 CD O O
64 ) ) O O
65 Pt NNP B-NP O
65 underwent JJ B-NP O
65 chemical-MIBI NN I-NP O
65 on IN B-VP O
65 6/25 CD O O
65 ( ( O O
65 hx NN B-NP O
65 of IN B-VP O
65 PVD NNP B-NP O
65 can MD O O
65 only RB O O
65 walk VB O O
65 2 CD O O
65 block NN B-NP O
66 equivalent NN I-NP O
66 ) ) O O
66 that WDT O O
66 was VBD B-VP O
66 negative JJ O O
66 for IN B-VP O
66 any DT B-NP O
66 acute NN I-NP O
66 , , O O
66 reversible JJ B-NP O
66 changes NNS I-NP O
66 ( ( O O
66 final JJ B-NP O
67 P NNP I-NP O
67 ) ) O O
68 Unclear NNP B-NP O
68 etiology NN I-NP O
68 for IN B-VP O
68 her PRP$ O O
68 pain NN B-NP O
68 The DT B-NP O
68 diagnosis NN I-NP O
68 of IN B-VP O
68 potential JJ B-NP O
68 pericarditis NN I-NP O
69 was VBD B-VP O
69 entertained VBN O O
69 , , O O
69 but CC O O
69 again RB O O
69 , , O O
69 the DT B-NP O
69 history NN I-NP O
69 was VBD B-VP O
69 not RB O O
69 consistent JJ O O
69 , , O O
69 no DT B-NP O
69 viral JJ I-NP O
70 prodome NN I-NP O
70 , , O O
70 no DT B-NP O
70 EKG NNP I-NP O
70 changes NNS I-NP O
70 , , O O
70 no DT B-NP O
70 pulsus/rub NN I-NP O
70 appreciated VBD B-VP O
70 No DT B-NP O
70 reproducible/MSK NN I-NP O
71 pain VB O O
72 Her NNP B-NP O
72 pain NN I-NP B-r
72 was VBD B-VP O
72 only RB O O
72 controlled VBN O O
72 with IN B-VP O
72 oxycodone NN B-NP B-m
72 She PRP O O
72 was VBD B-VP O
72 pain-free JJ O O
72 at IN B-VP O
73 discharge.Pt NN B-NP O
73 was VBD B-VP O
73 continued VBN O O
73 on IN B-VP O
73 all DT O O
73 her PRP$ O O
73 outpatient JJ B-NP O
73 medications NNS I-NP O
73 no DT B-NP O
73 changes NNS I-NP O
74 Pt NNP I-NP O
74 will MD O O
74 be VB O O
74 discharged VBN O O
74 to TO O O
74 home NN B-NP O
74 with IN B-VP O
74 follow-up JJ O O
74 already RB O O
74 scheduled VBN O O
74 with IN B-VP O
74 Dr NNP B-NP O
75 Hassenger NNP I-NP O
75 , , O O
75 her PRP$ O O
75 cardiologist NN B-NP O
75 at IN B-VP O
75 the DT B-NP O
75 end NN I-NP O
75 of IN B-VP O
75 the DT B-NP O
75 month NN I-NP O
76 Of IN B-VP O
76 note NN B-NP O
76 pt NN I-NP O
76 had VBD B-VP O
76 an DT O O
76 elevated VBN O O
76 WBC NNP B-NP O
76 ( ( O O
76 15.2 CD O O
76 ) ) O O
76 which WDT O O
76 seems VBZ O O
76 to TO O O
76 be VB O O
76 chronic JJ O O
76 in IN B-VP O
76 nature NN B-NP O
77 No NNP I-NP O
77 fevers NNS I-NP O
77 , , O O
77 localizing VBG O O
77 signs/symptoms NNS B-NP O
77 of IN B-VP O
77 infection NN B-NP O
78 ADDITIONAL NNP I-NP O
78 COMMENTS: NNP I-NP O
78 please NN I-NP O
78 continue NN I-NP O
78 to TO O O
78 take VB O O
78 the DT B-NP O
78 same JJ I-NP O
78 medications NNS I-NP O
78 as IN B-VP O
78 you PRP O O
78 were VBD B-VP O
78 before IN B-VP O
78 this DT B-NP O
79 admission NN I-NP O
79 call VB O O
79 your PRP$ O O
79 PCP NN B-NP O
79 to TO O O
79 make VB O O
79 an DT B-NP O
79 appointment NN I-NP O
79 in IN B-VP O
79 1-2 JJ B-NP O
79 weeks NNS I-NP O
79 ( ( O O
79 number NN B-NP O
80 above IN B-VP O
80 ) ) O O
80 Your PRP$ O O
80 cardiology NN B-NP O
80 appts NNS I-NP O
80 with IN B-VP O
80 dr JJ B-NP O
80 nik NNS I-NP O
80 and CC O O
80 surgery NN B-NP O
80 appointment NN I-NP O
81 with IN B-VP O
81 dr NN B-NP O
81 prosonic NN I-NP O
81 , , O O
81 also RB O O
81 listed VBN O O
81 above IN B-VP O
82 your PRP$ O O
82 stress JJ B-NP O
82 test NN I-NP O
82 was VBD B-VP O
82 negative JJ O O
82 for IN B-VP O
82 any DT B-NP O
82 new JJ I-NP O
82 heart NN I-NP O
82 disease NN I-NP O
82 - : O O
82 your PRP$ O O
82 chest JJS B-NP O
82 pain NN I-NP O
83 was VBD B-VP O
83 unlikely JJ O O
83 due JJ O O
83 to TO O O
83 heart NN B-NP O
83 disease VB O O
84 return NN B-NP O
84 to TO O O
84 the DT B-NP O
84 ED NNP I-NP O
84 or CC O O
84 call VB O O
84 your PRP$ O O
84 PCP NNP B-NP O
84 with IN B-VP O
84 new JJ B-NP O
84 chest NN I-NP O
84 pain NN I-NP O
84 , , O O
84 shortness NN B-NP O
84 of IN B-VP O
85 breath NN B-NP O
85 , , O O
85 palpitations NNS B-NP O
86 DISCHARGE NNP I-NP O
86 CONDITION: NNP I-NP O
86 Stable NNP I-NP O
87 TO NNP I-NP O
87 DO/PLAN: NNP I-NP O
88 1 CD O O
88 pt NN B-NP O
88 has VBZ O O
88 follow VBN O O
88 up RP O O
88 with IN B-VP O
88 cardiology NN B-NP O
88 and CC O O
88 vascular JJ B-NP O
88 surgery NN I-NP O
88 scheduled VBN O O
89 no DT B-NP O
89 new JJ I-NP O
89 medications NNS I-NP O
89 this DT B-NP O
89 admission NN I-NP O
90 No RB O O
90 dictated VBD B-VP O
90 summary JJ B-NP O
91 ENTERED NNP I-NP O
91 BY: NNP I-NP O
91 GETCHMAN NNP I-NP O
91 , , O O
91 MAN NNP B-NP O
91 DAREN NNP I-NP O
91 , , O O
91 M.D NNP B-NP O
91 ( ( O O
91 FE09 NNP B-NP O
91 ) ) O O
91 5/28/05 CD O O
91 @ $ O O
91 05 CD O O
92 ****** JJ B-NP O
92 END NN I-NP O
92 OF NNP I-NP O
92 DISCHARGE NNP I-NP O
92 ORDERS NNP I-NP O
92 ****** NNP I-NP O
93 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #976089 VBZ O O
2 450657129 CD O O
2 PMH NNP B-NP O
2 92496595 CD O O
2 007885 CD O O
2 8/22/1990 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Unsigned VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 11/10/1990 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Unsigned NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 2/17/1990 CD O O
4 HISTORY NNP B-NP O
4 OF NNP I-NP O
4 PRESENT NNP I-NP O
4 ILLNESS: NNP I-NP O
4 The DT B-NP O
4 patient NN I-NP O
4 is VBZ O O
4 a DT O O
4 58 CD O O
4 year NN B-NP O
4 old JJ B-NP O
4 woman NN I-NP O
4 , , O O
5 status NN B-NP O
5 post NN I-NP O
5 CABG NNP I-NP O
5 times NNS I-NP O
5 three CD O O
5 in IN B-VP O
5 9/9 CD O O
5 , , O O
6 status NN B-NP O
6 post NN I-NP O
6 inferior JJ B-NP O
6 myocardial JJ I-NP O
6 infarction NN I-NP O
6 in IN B-VP O
6 1/28 CD O O
6 with IN B-VP O
6 a DT B-NP O
6 peak JJ I-NP O
6 CPK NNP I-NP O
7 of IN B-VP O
7 714 CD O O
7 She PRP O O
7 has VBZ O O
7 a DT B-NP O
7 history NN I-NP O
7 of IN B-VP O
7 chest NN B-NP O
7 pain NN I-NP O
7 since IN B-VP O
7 the DT B-NP O
7 CABG NNP I-NP O
7 The DT B-NP O
7 CABG NNP I-NP O
8 consisted VBD B-VP O
8 of IN B-VP O
8 a DT B-NP O
8 LIMA NNP I-NP O
8 to TO O O
8 the DT B-NP O
8 LAD NNP I-NP O
8 , , O O
8 saphenous JJ B-NP O
8 vein NN I-NP O
8 grafts NNS I-NP O
8 to TO O O
8 the DT B-NP O
8 OMB-2 NNP I-NP O
9 and CC O O
9 RCA NNP B-NP O
9 In IN B-VP O
9 8/2 CD O O
9 , , O O
9 she PRP O O
9 had VBD B-VP O
9 been VBN O O
9 cathed VBN O O
9 and CC O O
9 a DT O O
9 70% CD O O
9 RCA NNP B-NP O
9 occlusion NN I-NP O
9 with IN B-VP O
10 a DT B-NP O
10 question NN I-NP O
10 of IN B-VP O
10 thrombus NN B-NP O
10 was VBD B-VP O
10 seen VBN O O
10 A DT O O
10 90% CD O O
10 OMB-2 NN B-NP O
10 was VBD B-VP O
10 seen; VBN O O
10 a DT B-NP O
11 circumflex NN I-NP O
11 of IN B-VP O
11 60% CD O O
11 was VBD B-VP O
11 seen; VBN O O
11 an DT B-NP O
11 LAD NNP I-NP O
11 of IN B-VP O
11 70% CD O O
11 was VBD B-VP O
11 seen VBN O O
11 An DT O O
11 LV-gram JJ O O
12 showed VBD B-VP O
12 inferior JJ B-NP O
12 akinesis NN I-NP O
12 and CC O O
12 posterior JJ B-NP O
12 hypokinesis NN I-NP O
12 with IN B-VP O
12 a DT B-NP O
12 left JJ I-NP O
13 ventricular JJ I-NP O
13 ejection NN I-NP O
13 fraction NN I-NP O
13 of IN B-VP O
13 78% CD O O
13 Post NNP B-NP O
13 CABG NNP I-NP O
13 at IN B-VP O
13 baseline NN B-NP O
13 , , O O
13 she PRP O O
14 had VBD B-VP O
14 substernal JJ B-NP B-r
14 chest NN I-NP I-r
14 pain NN I-NP I-r
14 at IN B-VP O
14 rest NN B-NP O
14 with IN B-VP O
14 rare JJ B-NP O
14 use NN I-NP O
14 of IN B-VP O
14 sublingual JJ B-NP B-mo
15 nitroglycerin NN I-NP B-m
15 She PRP O O
15 has VBZ O O
15 a DT B-NP O
15 history NN I-NP O
15 of IN B-VP O
15 peptic JJ B-NP O
15 ulcer NN I-NP O
15 disease NN I-NP O
15 which WDT O O
15 was VBD B-VP O
16 a DT B-NP O
16 duodenal JJ I-NP O
16 ulcer NN I-NP O
16 with IN B-VP O
16 melena NN B-NP O
16 She PRP O O
16 had VBD B-VP O
16 an DT B-NP O
16 EGD NNP I-NP O
16 in IN B-VP O
16 8/27 CD O O
16 which WDT O O
16 showed VBD B-VP O
17 mild JJ B-NP O
17 antral JJ I-NP O
17 gastritis NN I-NP O
17 without IN B-VP O
17 ulcers NNS B-NP O
17 She PRP O O
17 is VBZ O O
17 status NN B-NP O
17 post NN I-NP O
18 colonoscopy NN I-NP O
18 in IN B-VP O
18 8/2 CD O O
18 which WDT O O
18 showed VBD B-VP O
18 diverticulitis NN B-NP O
18 She PRP O O
18 has VBZ O O
18 a DT B-NP O
18 history NN I-NP O
19 of IN B-VP O
19 anemia NN B-NP B-r
19 anemia NN I-NP B-r
19 with IN B-VP O
19 a DT B-NP O
19 hematocrit NN I-NP O
19 of IN B-VP O
19 29 CD O O
19 , , O O
19 MCV NNP B-NP O
19 of IN B-VP O
19 68 CD O O
19 She PRP O O
19 was VBD B-VP O
19 treated VBN O O
19 with IN B-VP O
20 iron NN B-NP B-m
20 sulfate NN I-NP I-m
20 and CC O O
20 H2 NNP B-NP B-m
20 blockers NNS I-NP I-m
20 She PRP O O
20 noted VBD B-VP O
20 a DT B-NP O
20 history NN I-NP O
20 in IN B-VP O
20 two CD O O
20 months NNS B-NP O
20 of IN B-VP O
21 a DT O O
21 20 CD O O
21 pound NN B-NP O
21 weight VBD B-VP O
21 loss NN B-NP O
21 One CD O O
21 week NN B-NP O
21 prior RB O O
21 to TO O O
21 admission NN B-NP O
21 , , O O
21 she PRP O O
21 had VBD B-VP O
22 melena NN B-NP O
22 of IN B-VP O
22 loose JJ B-NP O
22 stool NN I-NP O
22 She PRP O O
22 felt VBD B-VP O
22 light-headed JJ O O
22 She PRP O O
22 had VBD B-VP O
22 a DT B-NP O
22 cough NN I-NP O
22 and CC O O
23 nocturia NNS B-NP O
23 Three NNP I-NP O
23 days NNS I-NP O
23 prior RB O O
23 to TO O O
23 admission NN B-NP O
23 , , O O
23 she PRP O O
23 noted VBD B-VP O
23 a DT O O
23 stabbing VBG O O
24 periodic JJ B-NP O
24 epigastric JJ I-NP O
24 pain NN I-NP O
24 with IN B-VP O
24 nausea NN B-NP O
24 and CC O O
24 vomiting VBG O O
24 twice; NN B-NP O
24 no DT B-NP O
24 coffee NN I-NP O
25 grounds VBZ O O
25 or CC O O
25 hematemesis NN B-NP O
25 She PRP O O
25 had VBD B-VP O
25 dysphagia NN B-NP O
25 for IN B-VP O
25 months NNS B-NP O
25 to TO O O
25 liquids NNS B-NP O
26 and CC O O
26 solids NNS B-NP O
26 with IN B-VP O
26 the DT B-NP O
26 sensation NN I-NP O
26 of IN B-VP O
26 aspiration NN B-NP O
26 on IN B-VP O
26 swallowing VBG O O
26 She PRP O O
26 had VBD B-VP O
27 a DT B-NP O
27 sharp JJ I-NP O
27 pain NN I-NP O
27 radiating VBG O O
27 to TO O O
27 the DT B-NP O
27 left JJ I-NP O
27 arm NN I-NP O
27 and CC O O
27 shortness NN B-NP O
27 of IN B-VP O
27 breath NN B-NP O
28 The DT B-NP O
28 pain NN I-NP O
28 was VBD B-VP O
28 similar JJ O O
28 to TO O O
28 the DT B-NP O
28 inferior JJ I-NP O
28 MI NNP I-NP O
28 in IN B-VP O
28 1988 CD O O
28 On IN B-VP O
28 0/16 CD O O
28 , , O O
28 she PRP O O
28 came VBD B-VP O
29 to TO O O
29 the DT B-NP O
29 emergency NN I-NP O
29 ward NN I-NP O
29 , , O O
29 where WRB O O
29 her PRP$ O O
29 blood NN B-NP O
29 pressure NN I-NP O
29 was VBD B-VP O
29 found VBN O O
29 to TO O O
29 be VB O O
30 110/68 CD O O
30 lying VBG O O
30 and CC O O
30 90/palp CD O O
30 sitting VBG O O
30 O2 NNP B-NP O
30 sat VBD B-VP O
30 was VBD B-VP O
30 97% CD O O
30 on IN B-VP O
30 room NN B-NP O
30 air NN I-NP O
30 Her NNP I-NP O
31 JVP NNP I-NP O
31 was VBD B-VP O
31 9 CD O O
31 cm NN B-NP O
31 with IN B-VP O
31 crackles NNS B-NP O
31 at IN B-VP O
31 the DT B-NP O
31 right JJ I-NP O
31 base NN I-NP O
31 She PRP O O
31 was VBD B-VP O
31 given VBN O O
31 three CD O B-do
32 sublingual JJ B-NP B-mo
32 nitroglycerins NNS I-NP B-m
32 and CC O O
32 Maalox NNP B-NP B-m
32 Her NNP I-NP O
32 hematocrit NN I-NP O
32 was VBD B-VP O
32 20.8 CD O O
33 She PRP O O
33 was VBD B-VP O
33 given VBN O O
33 10 CD O B-do
33 mg NN B-NP I-do
33 of IN B-VP O
33 IV NNP B-NP B-mo
33 Lopressor NNP I-NP B-m
33 from IN B-VP O
33 which WDT O O
33 she PRP O O
33 became VBD B-VP O
34 hypotensive JJ O O
34 , , O O
34 but CC O O
34 this DT O O
34 resolved VBD B-VP O
34 She PRP O O
34 was VBD B-VP O
34 transfused VBN O O
34 three CD O B-do
34 units NNS B-NP I-do
34 of IN B-VP O
35 packed JJ B-NP B-m
35 red JJ I-NP I-m
35 blood NN I-NP I-m
35 cells NNS I-NP I-m
35 , , O O
35 given VBN O O
35 Lasix NNP B-NP B-m
35 and CC O O
35 IV NNP B-NP B-mo
35 H2 NNP I-NP B-m
35 blockers NNS I-NP I-m
35 She PRP O O
35 went VBD B-VP O
36 to TO O O
36 the DT B-NP O
36 unit NN I-NP O
36 and CC O O
36 ruled VBD B-VP O
36 out RP O O
36 for IN B-VP O
36 an DT B-NP O
36 MI NNP I-NP O
36 by IN B-VP O
36 EKG NNP B-NP O
36 and CC O O
36 enzymes VBZ O O
36 The DT B-NP O
36 A-set NNP I-NP O
37 revealed VBD B-VP O
37 a DT B-NP O
37 CPK NNP I-NP O
37 of IN B-VP O
37 54; CD O O
37 B-set NNP B-NP O
37 was VBD B-VP O
37 48; CD O O
37 C-set NNP B-NP O
37 was VBD B-VP O
37 36 CD O O
37 An DT B-NP O
37 ABG NNP I-NP O
37 was VBD B-VP O
37 132 CD O O
37 , , O O
38 99 CD O O
38 , , O O
38 7.43 CD O O
38 , , O O
38 33 CD O O
38 Potassium NN B-NP O
38 was VBD B-VP O
38 4.2 CD O O
38 , , O O
38 BUN NNP B-NP O
38 20 CD O O
38 , , O O
38 creatinine NN B-NP O
38 0.9 CD O O
39 ALLERGIES: NNP B-NP O
39 None NNP I-NP O
39 known VBN O O
40 PHYSICAL NNP B-NP O
40 EXAMINATION: NNP I-NP O
40 JVD NNP I-NP O
40 was VBD B-VP O
40 9 CD O O
40 cm NN B-NP O
40 on IN B-VP O
40 admission NN B-NP O
40 and CC O O
40 decreased; NN B-NP O
41 scar NN I-NP O
41 at IN B-VP O
41 the DT B-NP O
41 left JJ I-NP O
41 base NN I-NP O
41 of IN B-VP O
41 the DT B-NP O
41 neck NN I-NP O
41 secondary JJ O O
42 to TO O O
42 a DT B-NP O
42 basal NN I-NP O
42 cell NN I-NP O
42 resection; NN I-NP O
42 II/VI NNP I-NP O
42 systolic JJ B-NP O
42 ejection NN I-NP O
42 murmur NN I-NP O
42 at IN B-VP O
42 the DT B-NP O
43 left JJ I-NP O
43 sternal JJ I-NP O
43 border NN I-NP O
43 without IN B-VP O
43 gallop PDT O O
43 The DT B-NP O
43 lungs NNS I-NP O
43 revealed VBD B-VP O
43 crackles NNS B-NP O
43 at IN B-VP O
44 the DT B-NP O
44 right JJ I-NP O
44 base NN I-NP O
44 one CD O O
44 quarter NN B-NP O
44 She PRP O O
44 had VBD B-VP O
44 a DT B-NP O
44 kyphoscoliosis NN I-NP O
44 The DT B-NP O
44 abdomen NNS I-NP O
45 was VBD B-VP O
45 benign IN B-VP O
45 The DT B-NP O
45 neuro JJ I-NP O
45 exam NN I-NP O
45 was VBD B-VP O
45 nonfocal JJ O O
45 , , O O
45 though IN B-VP O
45 she PRP O O
45 had VBD B-VP O
45 some DT B-NP O
45 past JJ I-NP O
46 pointing NN I-NP O
46 secondary NN I-NP O
46 to TO O O
46 poor JJ B-NP O
46 eyesight JJ I-NP O
47 HOSPITAL NNP I-NP O
47 COURSE: NNP I-NP O
47 On IN B-VP O
47 10/17 CD O O
47 , , O O
47 she PRP O O
47 was VBD B-VP O
47 transferred VBN O O
47 to TO O O
47 the DT B-NP O
47 floor NN I-NP O
47 She PRP O O
48 complained VBD B-VP O
48 of IN B-VP O
48 some DT B-NP O
48 left JJ I-NP O
48 arm NN I-NP O
48 pain NN I-NP O
48 secondary JJ O O
48 to TO O O
48 her PRP$ O O
49 IV NNP B-NP O
49 , , O O
49 but CC O O
49 she PRP O O
49 had VBD B-VP O
49 no DT B-NP O
49 EKG NNP I-NP O
49 changes NNS I-NP O
49 and CC O O
49 this DT O O
49 improved VBN O O
49 with IN B-VP O
49 hot JJ B-NP O
50 compresses NNS I-NP O
50 She PRP O O
50 was VBD B-VP O
50 guaiac JJ O O
50 negative JJ O O
50 On IN B-VP O
50 the DT B-NP O
50 evening NN I-NP O
50 of IN B-VP O
50 0/12 CD O O
50 , , O O
50 she PRP O O
51 was VBD B-VP O
51 noted VBN O O
51 to TO O O
51 be VB O O
51 trace JJ O O
51 guaiac JJ O O
51 positive JJ O O
51 in IN B-VP O
51 the DT B-NP O
51 stool NN I-NP O
51 On IN B-VP O
51 9/9 CD O O
51 at IN B-VP O
51 7:30 CD O O
52 AM NNP B-NP O
52 , , O O
52 she PRP O O
52 complained VBD B-VP O
52 of IN B-VP O
52 substernal JJ B-NP B-r
52 substernal JJ I-NP B-r
52 substernal JJ I-NP B-r
52 chest NN I-NP I-r
52 chest NN I-NP I-r
52 chest NN I-NP I-r
52 pain NN I-NP I-r
52 pain NN I-NP I-r
52 pain NN I-NP I-r
52 which WDT O O
52 radiated VBD B-VP O
52 to TO O O
52 both DT B-NP O
53 upper JJ I-NP O
53 extremities NNS I-NP O
53 with IN B-VP O
53 tingling VBG O O
53 bilaterally RB O O
53 This DT O O
53 did VBD B-VP O
53 not RB O O
53 resolve VB O O
53 , , O O
54 even RB O O
54 after IN B-VP O
54 giving VBG O O
54 Maalox NNP B-NP B-m
54 , , O O
54 four CD O B-do
54 sublinguals NNS B-NP B-mo
54 and CC O O
54 12 CD O B-do
54 mg NN B-NP I-do
54 of IN B-VP O
54 morphine NN B-NP B-m
55 and CC O O
55 three CD O B-do
55 inches NNS B-NP I-do
55 of IN B-VP O
55 Nitropaste NNP B-NP B-m
55 Her NNP I-NP O
55 blood NN I-NP O
55 pressure NN I-NP O
55 was VBD B-VP O
55 stable JJ O O
55 at IN B-VP O
56 130/80 CD O O
56 , , O O
56 heart NN B-NP O
56 rate NN I-NP O
56 was VBD B-VP O
56 68 CD O O
56 , , O O
56 and CC O O
56 she PRP O O
56 was VBD B-VP O
56 afebrile IN B-VP O
56 Her NNP B-NP O
56 substernal JJ B-NP O
57 chest NN I-NP O
57 pain NN I-NP O
57 ranged VBD B-VP O
57 between IN B-VP O
57 7-3 NNP B-NP O
57 , , O O
57 and CC O O
57 she PRP O O
57 was VBD B-VP O
57 given VBN O O
57 20 CD O B-do
57 mEq NN B-NP I-do
57 of IN B-VP O
57 Kay NNP B-NP B-m
58 Ciel NNP I-NP O
58 Her NNP I-NP O
58 potassium NN I-NP O
58 was VBD B-VP O
58 3.8 CD O O
58 , , O O
58 hematocrit NN B-NP O
58 32.8 CD O O
58 and CC O O
58 stable JJ O O
58 She PRP O O
58 was VBD B-VP O
59 given VBN O O
59 two CD O B-do
59 more JJR B-NP I-do
59 units NNS I-NP I-do
59 of IN B-VP O
59 packed JJ B-NP B-m
59 red JJ I-NP I-m
59 blood NN I-NP I-m
59 cells NNS I-NP I-m
59 after IN B-VP O
59 having VBG O O
59 been VBN O O
60 given VBN O O
60 two CD O B-do
60 more JJR B-NP I-do
60 units NNS I-NP I-do
60 of IN B-VP O
60 packed JJ B-NP B-m
60 red JJ I-NP I-m
60 blood NN I-NP I-m
60 cells NNS I-NP I-m
60 between IN B-VP O
60 10/17 CD O O
60 and CC O O
60 2/10 CD O O
61 IV NNP B-NP B-mo
61 IV NNP I-NP B-mo
61 nitroglycerin VBD B-VP B-m
61 nitroglycerin JJ O B-m
61 50 CD O B-do
61 units NNS B-NP I-do
61 was VBD B-VP O
61 started VBN O O
61 after IN B-VP O
61 one CD O O
61 hour NN B-NP O
61 and CC O O
61 15 CD O O
61 minutes NNS B-NP O
62 of IN B-VP O
62 pain NN B-NP B-r
62 pain NN I-NP B-r
62 This DT O O
62 was VBD B-VP O
62 increased VBN O O
62 to TO O O
62 100 CD O B-do
62 units NNS B-NP I-do
62 EKG NNP I-NP O
62 changes NNS I-NP O
62 were VBD B-VP O
62 noted VBN O O
63 as IN B-VP O
63 a DT B-NP O
63 flattening NN I-NP O
63 in IN B-VP O
63 V4 NNP B-NP O
63 through IN B-VP O
63 V6 NNP B-NP O
63 with IN B-VP O
63 no DT B-NP O
63 ST NNP I-NP O
63 depressions NNS I-NP O
63 , , O O
63 and CC O O
63 she PRP O O
64 had VBD B-VP O
64 a DT B-NP O
64 T NNP I-NP O
64 wave VBP O O
64 down RP O O
64 in IN B-VP O
64 V3 NNP B-NP O
64 which WDT O O
64 was VBD B-VP O
64 new JJ O O
64 since IN B-VP O
64 admission NN B-NP O
64 On IN B-VP O
64 9/9 CD O O
64 , , O O
64 she PRP O O
65 was VBD B-VP O
65 transferred VBN O O
65 to TO O O
65 the DT B-NP O
65 unit NN I-NP O
65 Her PRP$ O O
65 CKs NNP B-NP O
65 were VBD B-VP O
65 negative; JJ B-NP O
65 A-set NNP I-NP O
65 was VBD B-VP O
65 27 CD O O
65 , , O O
66 B-set NNP B-NP O
66 was VBD B-VP O
66 29 CD O O
66 , , O O
66 C-set NNP B-NP O
66 was VBD B-VP O
66 57 CD O O
66 and CC O O
66 D-set NNP B-NP O
66 was VBD B-VP O
66 65 CD O O
66 A NNP B-NP O
66 catheterization NN I-NP O
67 showed VBD B-VP O
67 right JJ B-NP O
67 atrial JJ I-NP O
67 pressures NNS I-NP O
67 of IN B-VP O
67 12 CD O O
67 , , O O
67 PCWP NNP B-NP O
67 of IN B-VP O
67 16 CD O O
67 , , O O
67 SVR NNP B-NP O
67 1 CD O O
67 , , O O
67 000 CD O O
67 , , O O
67 PVR NNP B-NP O
67 76 CD O O
67 , , O O
68 PA NNP B-NP O
68 34/14 CD O O
68 , , O O
68 cardiac JJ B-NP O
68 output NN I-NP O
68 6.8 CD O O
68 Grafts NNP B-NP O
68 from IN B-VP O
68 the DT B-NP O
68 aorta NN I-NP O
68 to TO O O
68 the DT B-NP O
68 OM NNP I-NP O
68 , , O O
69 aorta NN B-NP O
69 to TO O O
69 the DT B-NP O
69 RCA NNP I-NP O
69 and CC O O
69 LIMA NNP B-NP O
69 to TO O O
69 the DT B-NP O
69 LAD NNP I-NP O
69 were VBD B-VP O
69 all DT B-NP O
69 patent NN I-NP O
69 LAD NNP I-NP O
69 showed VBD B-VP O
70 100% CD O O
70 proximal JJ B-NP O
70 occlusion NN I-NP O
70 , , O O
70 LAD NNP B-NP O
70 diagonal NN I-NP O
70 showed VBD B-VP O
70 a DT O O
70 50% CD O O
70 long JJ B-NP O
70 proximal NN I-NP O
71 and CC O O
71 circumflex NN B-NP O
71 showed VBD B-VP O
71 a DT O O
71 50% CD O O
71 proximal NN B-NP O
71 , , O O
71 OM-2 NNP B-NP O
71 showed VBD B-VP O
71 a DT O O
71 70% CD O O
71 occlusion NN B-NP O
72 at IN B-VP O
72 the DT B-NP O
72 origin NN I-NP O
72 There EX O O
72 was VBD B-VP O
72 a DT B-NP O
72 mild JJ I-NP O
72 increase NN I-NP O
72 in IN B-VP O
72 right JJ O O
72 and CC O O
72 left VBD B-VP O
72 sided VBN O O
73 pressures NNS B-NP O
73 She PRP O O
73 was VBD B-VP O
73 readmitted VBN O O
73 to TO O O
73 the DT B-NP O
73 floor NN I-NP O
73 and CC O O
73 watched VBD B-VP O
73 Her NNP B-NP O
74 hematocrit NN I-NP O
74 remained VBD B-VP O
74 stable JJ O O
74 She PRP O O
74 had VBD B-VP O
74 an DT B-NP O
74 endoscopy NN I-NP O
74 done VBN O O
74 on IN B-VP O
74 the DT B-NP O
75 morning NN I-NP O
75 of IN B-VP O
75 3/28 CD O O
75 , , O O
75 and CC O O
75 the DT B-NP O
75 impression NN I-NP O
75 was VBD B-VP O
75 of IN B-VP O
75 a DT B-NP O
75 large JJ I-NP O
75 hiatal JJ I-NP O
75 hernia NN I-NP O
76 with IN B-VP O
76 no DT B-NP O
76 evidence NN I-NP O
76 of IN B-VP O
76 GI NNP B-NP O
76 bleeding VBG O O
76 at IN B-VP O
76 this DT B-NP O
76 time NN I-NP O
76 It PRP O O
76 was VBD B-VP O
76 recommended VBN O O
77 that IN B-VP O
77 she PRP O O
77 had VBD B-VP O
77 an DT B-NP O
77 upper JJ I-NP O
77 GI NNP I-NP O
77 and CC O O
77 small JJ B-NP O
77 bowel NN I-NP O
77 follow VBP O O
77 through IN B-VP O
77 or CC O O
77 repeat VB O O
78 colonoscopy NN B-NP O
78 in IN B-VP O
78 the DT B-NP O
78 future NN I-NP O
78 as IN B-VP O
78 an DT B-NP O
78 outpatient NN I-NP O
78 Her NNP I-NP O
78 hematocrit NN I-NP O
79 remained VBD B-VP O
79 stable JJ O O
79 at IN B-VP O
79 approximately RB O O
79 33 CD O O
79 for IN B-VP O
79 the DT O O
79 past JJ O O
79 four CD O O
79 days NNS B-NP O
79 The DT B-NP O
80 sed JJ I-NP O
80 rate NN I-NP O
80 was VBD B-VP O
80 25 CD O O
80 , , O O
80 PT NNP B-NP O
80 and CC O O
80 PTT NNP B-NP O
80 within IN B-VP O
80 normal JJ B-NP O
80 limits NNS I-NP O
80 , , O O
80 potassium NN B-NP O
80 4.2 CD O O
80 , , O O
81 iron NN B-NP O
81 182 CD O O
81 , , O O
81 TIBC NNP B-NP O
81 432 CD O O
81 , , O O
81 vitamin VBD B-VP O
81 B-12 NNP B-NP O
81 371 CD O O
81 , , O O
81 folate NN B-NP O
81 3.9 CD O O
81 , , O O
81 ferritin RB O O
81 16 CD O O
81 , , O O
82 cholesterol NN B-NP O
82 153 CD O O
82 , , O O
82 triglyceride RB O O
82 112 CD O O
83 DISPOSITION: NNP B-NP O
83 The DT B-NP O
83 patient NN I-NP O
83 was VBD B-VP O
83 discharged VBN O O
83 home NN B-NP O
83 in IN B-VP O
83 stable JJ B-NP O
83 condition NN I-NP O
84 MEDICATIONS NNP I-NP O
84 ON NNP I-NP O
84 DISCHARGE: NNP I-NP O
84 Pepcid NNP I-NP B-m
84 20 CD O B-do
84 mg NN B-NP I-do
84 p.o NN I-NP B-mo
84 b.i.d.; NN I-NP B-f
85 metoprolol VBD B-VP B-m
85 50 CD O B-do
85 mg NN B-NP I-do
85 p.o NN I-NP B-mo
85 b.i.d.; NN I-NP B-f
85 nitroglycerin VBD B-VP B-m
85 1/150 CD O I-m
85 0.4 CD O B-do
85 mg NNS B-NP I-do
85 sublingual JJ B-NP B-mo
86 p.r.n NN I-NP B-f
86 FOLLOW NNP I-NP O
86 UP NNP I-NP O
86 will MD O O
86 be VB O O
86 with IN B-VP O
86 Dr NNP B-NP O
86 Pichard NNP I-NP O
86 and CC O O
86 with IN B-VP O
86 the DT B-NP O
86 GI NNP I-NP O
86 service NN I-NP O
87 DISCHARGE NNP I-NP O
87 DIAGNOSES: NNP I-NP O
87 1 CD O O
87 UPPER NNP B-NP O
87 GASTROINTESTINAL NNP I-NP O
87 BLEED NNP I-NP O
88 2 CD O O
88 CORONARY NNP B-NP O
88 ARTERY NNP I-NP O
88 DISEASE NNP I-NP O
88 , , O O
88 STATUS NNP B-NP O
88 POST NNP I-NP O
89 CORONARY NNP I-NP O
89 ARTERY NNP I-NP O
89 BYPASS NNP I-NP O
89 GRAFTING NNP I-NP O
90 3 CD O O
90 PEPTIC NNP B-NP O
90 ULCER NNP I-NP O
90 DISEASE NNP I-NP O
91 4 CD O O
91 IRON NNP B-NP O
91 DEFICIENCY NNP I-NP O
91 ANEMIA NNP I-NP O
92 5 CD O O
92 HISTORY NNP B-NP O
92 OF NNP I-NP O
92 CHOLELITHIASIS NNP I-NP O
93 ________________________________ NNP I-NP O
93 FV787/1724 NNP I-NP O
94 THEO NNP I-NP O
94 GARRINGER NNP I-NP O
94 , , O O
94 M.D NNP B-NP O
94 VP05 NNP I-NP O
94 D: NNP I-NP O
94 3/0/90 CD O O
95 Batch: NNP B-NP O
95 7012 CD O O
95 Report: NNP B-NP O
95 Z5468N7 NNP I-NP O
95 T: NNP I-NP O
95 5/23/90 CD O O
96 Dictated NNP B-NP O
96 By: NNP I-NP O
96 WILL NNP I-NP O
96 HEINECK NNP I-NP O
96 , , O O
96 M.D NNP B-NP O
97 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #978271 VBZ O O
4 484126147 CD O O
4 CCH NNP B-NP O
4 55327920 CD O O
4 9437699 CD O O
4 1/24/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 PPM NNP I-NP O
4 placement NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 1/18/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/7/2005 CD O O
7 ****** NNP B-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 POBRE NNP I-NP O
8 , , O O
8 JACOB NNP B-NP O
8 M NNP I-NP O
8 647-60-35-2 JJ B-NP O
9 Atl NNP I-NP O
9 Sey NNP I-NP O
9 Prodo NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 7/7/05 CD O O
11 AT NNP B-NP O
11 01:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Attending NNP I-NP O
12 evaluation NN I-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 MCCLEVE NNP I-NP O
14 , , O O
14 SON NNP B-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ECASA NNP I-NP B-m
19 ( ( O I-m
19 ASPIRIN NNP B-NP I-m
19 ENTERIC NNP I-NP I-m
19 COATED NNP I-NP I-m
19 ) ) O I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QD NNP I-NP B-f
20 ZESTRIL NNP I-NP B-m
20 ( ( O I-m
20 LISINOPRIL NNP B-NP I-m
20 ) ) O I-m
20 2.5 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
21 ZOLOFT NNP I-NP B-m
21 ( ( O I-m
21 SERTRALINE NNP B-NP I-m
21 ) ) O I-m
21 50 CD O B-do
21 MG NNP B-NP I-do
21 PO NNP I-NP B-mo
21 QD NNP I-NP B-f
22 KEFLEX NNP I-NP B-m
22 ( ( O I-m
22 CEPHALEXIN NNP B-NP I-m
22 ) ) O I-m
22 250 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QID NNP I-NP B-f
22 X NNP I-NP B-du
22 12 CD O I-du
22 doses NNS B-NP I-du
23 Starting VBG O O
23 when WRB O O
23 IV NNP B-NP B-mo
23 ANTIBIOTICS NNP I-NP B-m
23 END NNP I-NP O
24 Number NNP I-NP O
24 of IN B-VP O
24 Doses NNP B-NP O
24 Required NNP I-NP O
24 ( ( O O
24 approximate JJ B-NP O
24 ): NN I-NP O
24 20 CD O O
25 ARICEPT NNP B-NP B-m
25 ( ( O I-m
25 DONEPEZIL NNP B-NP I-m
25 HCL NNP I-NP I-m
25 ) ) O I-m
25 10 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 QPM NNP I-NP B-f
26 Number NNP I-NP B-du
26 of IN B-VP I-du
26 Doses NNP B-NP I-du
26 Required NNP I-NP I-du
26 ( ( O I-du
26 approximate JJ B-NP I-du
26 ): NN I-NP I-du
26 1 CD O I-du
27 PLAVIX NNP B-NP B-m
27 ( ( O I-m
27 CLOPIDOGREL NNP B-NP I-m
27 ) ) O I-m
27 75 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QD NNP I-NP B-f
28 TOPROL NNP I-NP B-m
28 XL NNP I-NP I-m
28 ( ( O I-m
28 METOPROLOL NNP B-NP I-m
28 ( ( O I-m
28 SUST NNP B-NP I-m
28 REL NNP I-NP I-m
28 ) ) O I-m
28 ) ) O I-m
28 50 CD O B-do
28 MG NNP B-NP I-do
28 PO NNP I-NP B-mo
28 QD NNP I-NP B-f
29 Food/Drug NNP I-NP O
29 Interaction NNP I-NP O
29 Instruction NNP I-NP O
30 Take NNP I-NP O
30 consistently RB O O
30 with IN B-VP O
30 meals NNS B-NP O
30 or CC O O
30 on IN B-VP O
30 empty JJ B-NP O
30 stomach NN I-NP O
31 LIPITOR NNP I-NP B-m
31 ( ( O I-m
31 ATORVASTATIN NNP B-NP I-m
31 ) ) O I-m
31 80 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QD NNP I-NP B-f
32 GLUCOPHAGE NNP I-NP B-m
32 ( ( O I-m
32 METFORMIN NNP B-NP I-m
32 ) ) O I-m
32 500 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 QD NNP I-NP B-f
33 GLYBURIDE NNP I-NP B-m
33 1.25 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 QD NNP I-NP B-f
34 DIET: NNP I-NP O
34 House NNP I-NP O
34 / VBD B-VP O
34 Low NNP B-NP O
34 chol/low NN I-NP O
34 sat VBD B-VP O
34 fat JJ B-NP O
35 DIET: NNP I-NP O
35 2 CD O O
35 gram NN B-NP O
35 Sodium NNP I-NP O
36 ACTIVITY: NNP I-NP O
36 Walking NNP I-NP O
36 as IN B-VP O
36 tolerated VBN O O
37 FOLLOW NNP B-NP O
37 UP NNP I-NP O
37 APPOINTMENT( NNP I-NP O
37 S NNP I-NP O
37 ): NNP I-NP O
38 Local NNP I-NP O
38 cardiologist NN I-NP O
38 1-2 JJ B-NP O
38 weeks NNS I-NP O
38 , , O O
39 ALLERGY: NNP B-NP O
39 NKA NNP I-NP O
40 ADMIT NNP I-NP O
40 DIAGNOSIS: NNP I-NP O
41 CHB NNP I-NP O
42 PRINCIPAL NNP I-NP O
42 DISCHARGE NNP I-NP O
42 DIAGNOSIS NNP I-NP O
42 ;Responsible JJ O O
42 After IN B-VP O
42 Study NNP B-NP O
42 for IN B-VP O
42 Causing NNP B-NP O
42 Admission NNP I-NP O
42 ) ) O O
43 PPM NNP B-NP O
43 placement NN I-NP O
44 OTHER NNP I-NP O
44 DIAGNOSIS;Conditions NNP I-NP O
44 , , O O
44 Infections NNP B-NP O
44 , , O O
44 Complications NNP B-NP O
44 , , O O
44 affecting VBG O O
44 Treatment/Stay NNP B-NP O
45 DM NNP I-NP O
45 ( ( O O
45 diabetes VBZ O O
45 mellitus VBP O O
45 type JJ O O
45 2 CD O O
45 ) ) O O
45 HTN NNP B-NP O
45 ( ( O O
45 hypertension NN B-NP O
45 ) ) O O
45 CAD NNP B-NP O
45 ( ( O O
45 coronary JJ B-NP O
45 artery NN I-NP O
46 disease NN I-NP O
46 ) ) O O
46 CRI NNP B-NP O
46 ( ( O O
46 chronic JJ B-NP O
46 renal JJ I-NP O
46 dysfunction NN I-NP O
46 ) ) O O
46 mild NN B-NP O
46 dementia NN I-NP O
46 ( ( O O
46 dementia NN B-NP O
46 ) ) O O
47 OPERATIONS NNP B-NP O
47 AND NNP I-NP O
47 PROCEDURES: NNP I-NP O
48 PPM NNP I-NP O
48 placed VBD B-VP O
48 0/7/05 CD O O
48 without IN B-VP O
48 complications NNS B-NP O
49 OTHER NNP I-NP O
49 TREATMENTS/PROCEDURES NNP I-NP O
49 ( ( O O
49 NOT NNP B-NP O
49 IN NNP I-NP O
49 O.R NNP I-NP O
49 ) ) O O
50 none NN B-NP O
51 BRIEF NNP I-NP O
51 RESUME NNP I-NP O
51 OF NNP I-NP O
51 HOSPITAL NNP I-NP O
51 COURSE: NNP I-NP O
52 CC: NNP I-NP O
52 PPM NNP I-NP O
52 placement NN I-NP O
53 HPI: NNP I-NP O
53 74M CD O O
53 w NN B-NP O
53 3VD CD O O
53 s/p JJ B-NP O
53 recent JJ I-NP O
53 MI NNP I-NP O
53 in IN B-VP O
53 11/2 CD O O
53 ( ( O O
53 w JJ B-NP O
53 subsequent JJ I-NP O
53 stent NN I-NP O
53 of IN B-VP O
53 100% CD O O
53 RCA NNP B-NP O
53 , , O O
54 but CC O O
54 residual JJ B-NP O
54 LAD NNP I-NP O
54 dz NN I-NP O
54 ) ) O O
54 transferred VBD B-VP O
54 from IN B-VP O
54 RAMH NNP B-NP O
54 for IN B-VP O
54 PPM NNP B-NP O
54 placement NN I-NP O
54 for IN B-VP O
55 symptomatic JJ B-NP O
55 bradycardia NN I-NP O
55 PPM NNP I-NP O
55 placed VBD B-VP O
55 w JJ O O
55 no DT B-NP O
55 cx JJ I-NP O
56 DAILY NNP I-NP O
56 STATUS/EXAM: NNP I-NP O
56 arm NN I-NP O
56 in IN B-VP O
56 sling NN B-NP O
56 , , O O
56 ox3 NN B-NP O
56 , , O O
56 sleepy NN B-NP O
56 but CC O O
56 easily RB O O
56 rousible JJ O O
56 , , O O
56 cn JJ B-NP O
57 intact NN I-NP O
57 , , O O
57 rrr VB O O
57 s1s2 JJ O O
57 no DT B-NP O
57 m/r/g NN I-NP O
57 , , O O
57 ctab NN B-NP O
57 , , O O
57 no DT B-NP O
57 LEE NNP I-NP O
57 , , O O
57 distal JJ B-NP O
57 pulses NNS I-NP O
57 2+ CD O O
57 , , O O
57 PPM NNP B-NP O
57 site NN I-NP O
58 bandage NN I-NP O
58 C/D/I NNP I-NP O
59 TESTS: NNP I-NP O
59 CXR NNP I-NP O
59 - : O O
59 clear JJ O O
59 , , O O
59 no DT B-NP O
59 PTX NNP I-NP O
59 post NN I-NP O
59 procedure NN I-NP O
60 *********PROBLEM NNP I-NP O
60 LIST************** NNP I-NP O
61 1 CD O O
61 BRADYCARDIA NNP B-NP O
61 s/p NN I-NP O
61 PPM NNP I-NP O
61 placement NN I-NP O
61 PPM NNP I-NP O
61 appears VBZ O O
61 to TO O O
61 be VB O O
61 working VBG O O
61 well RB O O
61 cont VB O O
62 standard NN B-NP O
62 care NN I-NP O
62 ( ( O O
62 post JJ B-NP O
62 procedure NN I-NP O
62 abx NN I-NP O
62 , , O O
62 overnight JJ B-NP O
62 observation NN I-NP O
62 , , O O
62 cxr NN B-NP O
62 to TO O O
62 r/o VB O O
63 PTX NNP B-NP O
63 ) ) O O
64 2 CD O O
64 3VD: CD O O
64 no DT B-NP O
64 evidence NN I-NP O
64 of IN B-VP O
64 active JJ B-NP O
64 ischemia NN I-NP O
64 cont NN I-NP O
64 home NN I-NP O
64 meds NNS I-NP O
64 incl JJ B-NP O
64 plavix NN I-NP B-m
64 , , O O
64 asa NN B-NP B-m
64 , , O O
65 highdose JJ B-NP B-do
65 statin NN I-NP B-m
65 , , O O
65 bb NN B-NP B-m
65 , , O O
65 acei RB O B-m
66 3 CD O O
66 DM: NNP B-NP O
66 we PRP O O
66 held VBD B-VP O
66 oral JJ B-NP B-mo
66 hypoglycemics NNS I-NP B-m
66 in IN B-VP O
66 house NN B-NP O
66 and CC O O
66 used VBD B-VP O
66 a DT B-NP O
66 RISS NNP I-NP B-m
66 Pt NNP I-NP O
66 to TO O O
66 resume VB O O
67 meds NNS B-NP O
67 on IN B-VP O
67 dispo JJ B-NP O
68 ADDITIONAL NNP I-NP O
68 COMMENTS: NNP I-NP O
69 DISCHARGE NNP I-NP O
69 CONDITION: NNP I-NP O
69 Stable NNP I-NP O
70 TO NNP I-NP O
70 DO/PLAN: NNP I-NP O
71 Follow NNP I-NP O
71 up RP O O
71 as RB O O
71 arranged VBN O O
71 by IN B-VP O
71 cardiology NN B-NP O
72 No NNP I-NP O
72 dictated VBD B-VP O
72 summary JJ B-NP O
73 ENTERED NNP I-NP O
73 BY: NNP I-NP O
73 GADLIN NNP I-NP O
73 , , O O
73 TOMAS NNP B-NP O
73 LOGAN NNP I-NP O
73 , , O O
73 M.D NNP B-NP O
73 ( ( O O
73 KW10 NNP B-NP O
73 ) ) O O
73 7/7/05 CD O O
73 @ $ O O
73 01:23 CD O O
73 PM NNP B-NP O
74 ****** JJ B-NP O
74 END NNP I-NP O
74 OF NNP I-NP O
74 DISCHARGE NNP I-NP O
74 ORDERS NNP I-NP O
74 ****** NNP I-NP O
75 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #980280 VBZ O O
2 322074815 CD O O
2 CBMC NNP B-NP O
2 49432110 CD O O
2 299002 CD O O
2 9/1/2000 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 ABDOMINAL NNP I-NP O
2 PAIN NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 10/26/2000 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 0/25/2000 CD O O
4 SERVICE: NNP B-NP O
4 Coll NNP I-NP O
4 Lum NNP I-NP O
4 All NNP I-NP O
5 PRINCIPAL NNP I-NP O
5 DIAGNOSIS: NNP I-NP O
5 Pyelonephritis NNP I-NP O
6 SECONDARY NNP I-NP O
6 DIAGNOSES: NNP I-NP O
6 Urinary NNP I-NP O
6 tract NN I-NP O
6 infection NN I-NP O
6 Bilateral NNP I-NP O
6 adnexal NN I-NP O
7 masses NNS I-NP O
7 Diabetes VBZ O O
7 mellitus JJ B-NP O
8 HISTORY NNP I-NP O
8 OF NNP I-NP O
8 PRESENT NNP I-NP O
8 ILLNESS: NNP I-NP O
8 Cristopher NNP I-NP O
8 Ottilige NNP I-NP O
8 is VBZ O O
8 a DT O O
8 53 CD O O
8 year NN B-NP O
8 old JJ B-NP O
8 woman NN I-NP O
9 with IN B-VP O
9 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 diabetes NNS B-NP O
9 mellitus NNS I-NP O
10 who WP O O
10 presents VBP O O
10 with IN B-VP O
10 abdominal JJ B-NP O
10 pain NN I-NP O
10 and CC O O
10 fevers NNS B-NP O
10 over IN B-VP O
10 two CD O O
10 weeks NNS B-NP O
11 duration VBP O O
11 Two CD O O
11 weeks NNS B-NP O
11 prior RB O O
11 to TO O O
11 admission NN B-NP O
11 , , O O
11 the DT B-NP O
11 patient NN I-NP O
11 had VBD B-VP O
11 headaches NNS B-NP O
11 , , O O
12 nausea NN B-NP O
12 , , O O
12 vomiting VBG O O
12 , , O O
12 presyncope NN B-NP O
12 , , O O
12 anorexia NN B-NP O
12 with IN B-VP O
12 mild JJ B-NP O
12 periumbilical JJ I-NP O
13 pain NN I-NP O
13 She PRP O O
13 also RB O O
13 had VBD B-VP O
13 fevers NNS B-NP O
13 to TO O O
13 101 CD O O
13 degrees NNS B-NP O
13 F NNP I-NP O
13 with IN B-VP O
13 associated JJ B-NP O
13 chills NNS I-NP O
14 and CC O O
14 diaphoresis VB O O
14 The DT B-NP O
14 patient NN I-NP O
14 presented VBD B-VP O
14 to TO O O
14 her PRP$ O O
14 primary JJ B-NP O
14 care NN I-NP O
15 physician JJ O O
15 three CD O O
15 days NNS B-NP O
15 before IN B-VP O
15 admission NN B-NP O
15 and CC O O
15 was VBD B-VP O
15 found VBN O O
15 to TO O O
15 have VB O O
16 elevated VBN O O
16 liver JJ B-NP O
16 function NN I-NP O
16 tests NNS I-NP O
16 with IN B-VP O
16 AST NNP B-NP O
16 of IN B-VP O
16 39 CD O O
16 , , O O
16 ALT NNP B-NP O
16 of IN B-VP O
16 108 CD O O
16 At IN B-VP O
16 that DT B-NP O
17 time NN I-NP O
17 , , O O
17 the DT B-NP O
17 patient NN I-NP O
17 was VBD B-VP O
17 presumed VBN O O
17 to TO O O
17 have VB O O
17 a DT B-NP O
17 viral JJ I-NP O
17 syndrome NN I-NP O
17 Two CD O O
17 days NNS B-NP O
18 prior RB O O
18 to TO O O
18 admission NN B-NP O
18 , , O O
18 the DT B-NP O
18 patient NN I-NP O
18 developed VBD B-VP O
18 worsening VBG O O
18 abdominal JJ B-NP O
18 pain NN I-NP O
19 The DT B-NP O
19 pain NN I-NP O
19 was VBD B-VP O
19 described VBN O O
19 as IN B-VP O
19 sharp JJ O O
19 , , O O
19 constant JJ O O
19 in IN B-VP O
19 character NN B-NP O
19 with IN B-VP O
20 radiation NN B-NP O
20 to TO O O
20 the DT O O
20 back RP O O
20 The DT B-NP O
20 pain NN I-NP O
20 was VBD B-VP O
20 more JJR O O
20 intense JJ O O
20 in IN B-VP O
20 the DT B-NP O
20 right NN I-NP O
21 lower RBR O O
21 quadrant VB O O
21 The DT B-NP O
21 pain NN I-NP O
21 was VBD B-VP O
21 also RB O O
21 noted VBN O O
21 to TO O O
21 be VB O O
21 in IN B-VP O
21 the DT B-NP O
21 lower JJR I-NP O
21 flanks NNS I-NP O
22 and CC O O
22 the DT B-NP O
22 costovertebral JJ I-NP O
22 angle NN I-NP O
22 area NN I-NP O
22 The DT B-NP O
22 patient NN I-NP O
22 has VBZ O O
22 noted VBN O O
22 no DT B-NP O
22 change NN I-NP O
23 in IN B-VP O
23 her PRP$ O O
23 usual JJ B-NP O
23 bowel NN I-NP O
23 habits NNS I-NP O
23 of IN B-VP O
23 one CD O O
23 stool NN B-NP O
23 per IN B-VP O
23 week NN B-NP O
23 She PRP O O
23 has VBZ O O
23 had VBD B-VP O
23 no DT B-NP O
24 diarrhea NN I-NP O
24 , , O O
24 constipation NN B-NP O
24 , , O O
24 melena NN B-NP O
24 , , O O
24 or CC O O
24 hematochezia NN B-NP O
24 She PRP O O
24 has VBZ O O
24 had VBD B-VP O
24 no DT B-NP O
25 hematemesis NN I-NP O
25 She PRP O O
25 denies VBZ O O
25 any DT B-NP O
25 urinary JJ I-NP O
25 symptoms NNS I-NP O
25 but CC O O
25 only RB O O
25 has VBZ O O
26 nocturia NNS B-NP O
26 Of IN B-VP O
26 note NN B-NP O
26 , , O O
26 the DT B-NP O
26 patient NN I-NP O
26 had VBD B-VP O
26 menopause RBR O O
26 approximately RB O O
26 eight CD O O
27 years NNS B-NP O
27 ago RB O O
27 , , O O
27 but CC O O
27 in IN B-VP O
27 each DT O O
27 of IN B-VP O
27 the DT O O
27 last JJ O O
27 three CD O O
27 months NNS B-NP O
27 she PRP O O
27 has VBZ O O
27 noticed VBN O O
28 monthly JJ B-NP O
28 vaginal NN I-NP O
28 bleeding NN I-NP O
28 which WDT O O
28 she PRP O O
28 believes VBZ O O
28 are VBP O O
28 a DT B-NP O
28 resumption NN I-NP O
28 of IN B-VP O
29 menstrual JJ B-NP O
29 cycles NNS I-NP O
29 The DT B-NP O
29 last JJ I-NP O
29 episode NN I-NP O
29 was VBD B-VP O
29 about IN B-VP O
29 one CD O O
29 month NN B-NP O
29 ago IN B-VP O
29 The DT B-NP O
30 patient NN I-NP O
30 also RB O O
30 has VBZ O O
30 a DT B-NP O
30 history NN I-NP O
30 of IN B-VP O
30 nephrolithiasis NN B-NP O
30 but CC O O
30 feels VBZ O O
30 that IN B-VP O
30 this DT B-NP O
31 current JJ I-NP O
31 pain NN I-NP O
31 is VBZ O O
31 different JJ O O
31 from IN B-VP O
31 the DT O O
31 one CD O O
31 she PRP O O
31 has VBZ O O
31 had VBN O O
31 in IN B-VP O
31 the DT B-NP O
31 past JJ I-NP O
32 PAST NNP I-NP O
32 MEDICAL NNP I-NP O
32 HISTORY: NNP I-NP O
32 Significant NNP I-NP O
32 for IN B-VP O
32 hypertension NN B-NP O
32 , , O O
32 diabetes VBZ O O
33 mellitus NNS B-NP O
33 diagnosed VBN O O
33 two CD O O
33 years NNS B-NP O
33 ago RB O O
33 , , O O
33 obesity NN B-NP O
33 , , O O
34 obstructive JJ B-NP O
34 sleep NN I-NP O
34 apnea NN I-NP O
34 , , O O
34 nephrolithiasis NN B-NP O
34 , , O O
34 osteoarthritis NN B-NP O
34 , , O O
34 glaucoma NN B-NP O
35 PAST NNP I-NP O
35 SURGICAL NNP I-NP O
35 HISTORY: NNP I-NP O
35 Notable NNP I-NP O
35 for IN B-VP O
35 cesarean JJ B-NP O
35 section NN I-NP O
35 20 CD O O
35 years NNS B-NP O
35 ago RB O O
36 that IN B-VP O
36 was VBD B-VP O
36 complicated VBN O O
36 by IN B-VP O
36 pulmonary JJ B-NP O
36 embolism NN I-NP O
37 MEDICATIONS NNP I-NP O
37 ON NNP I-NP O
37 ADMISSION: NNP I-NP O
37 1 CD O O
37 Lasix NNP B-NP B-m
37 60 CD O B-do
37 mg NN B-NP I-do
37 q JJ B-NP B-f
37 day NN I-NP I-f
37 2 CD O O
37 Glyburide NNP B-NP B-m
37 5 CD O B-do
37 mg NN B-NP I-do
38 q JJ B-NP B-f
38 day NN I-NP I-f
38 3 CD O O
38 Labetalol NNP B-NP B-m
38 200 CD O B-do
38 mg NN B-NP I-do
38 b.i.d NN I-NP B-f
39 4 CD O O
39 Timoptic NNP B-NP B-m
39 , , O O
39 Xylatan NNP B-NP B-m
39 drops VBZ O I-m
39 for IN B-VP O
39 glaucoma NN B-NP B-r
39 glaucoma NN I-NP B-r
40 ALLERGIES: NNP I-NP O
40 Lidocaine NNP I-NP O
40 leads VBZ O O
40 to TO O O
40 rash VB O O
40 Lisinopril NNP B-NP O
40 leads VBZ O O
40 to TO O O
40 cough VB O O
41 Diltiazem NNP B-NP O
41 leads VBZ O O
41 to TO O O
41 edema VB O O
41 Nifedipine NNP B-NP O
41 leads VBZ O O
41 to TO O O
41 edema VB O O
42 Intravenous NNP B-NP O
42 contrast NN I-NP O
42 leads VBZ O O
42 to TO O O
42 hives VB O O
43 FAMILY NNP B-NP O
43 HISTORY: NNP I-NP O
43 Significant NNP I-NP O
43 for IN B-VP O
43 cardiovascular JJ B-NP O
43 disease NN I-NP O
44 SOCIAL NNP I-NP O
44 HISTORY: NNP I-NP O
44 The DT B-NP O
44 patient NN I-NP O
44 is VBZ O O
44 married VBN O O
44 and CC O O
44 has VBZ O O
44 two CD O O
44 children NNS B-NP O
44 She PRP O O
45 denies VBZ O O
45 any DT B-NP O
45 use NN I-NP O
45 of IN B-VP O
45 alcohol NN B-NP O
45 or CC O O
45 tobacco NN B-NP O
46 PHYSICAL NNP I-NP O
46 EXAMINATION: NNP I-NP O
46 Temperature NNP I-NP O
46 102 CD O O
46 , , O O
46 heart NN B-NP O
46 rate NN I-NP O
46 90 CD O O
46 , , O O
46 respiratory NN B-NP O
47 rate NN I-NP O
47 34 CD O O
47 , , O O
47 blood NN B-NP O
47 pressure NN I-NP O
47 143/48 CD O O
47 Oxygen NNP B-NP O
48 saturation NN I-NP O
48 91% CD O O
48 on IN B-VP O
48 2 CD O O
48 liters NNS B-NP O
48 nasal JJ O O
48 cannula VBP O O
48 HEENT: NNP B-NP O
48 Pupils NNP I-NP O
48 equal JJ O O
48 , , O O
49 round NN B-NP O
49 , , O O
49 reactive JJ O O
49 to TO O O
49 light JJ O O
49 and CC O O
49 accommodation NN B-NP O
49 Extraocular NNP I-NP O
49 muscles NNS I-NP O
50 intact JJ B-NP O
50 Anicteric NNP I-NP O
50 sclerae NN I-NP O
50 Oropharynx NNP I-NP O
50 clear JJ B-NP O
50 No NNP I-NP O
50 jugular NN I-NP O
50 venous JJ B-NP O
51 distension NN I-NP O
51 CHEST: NNP I-NP O
51 Clear NNP I-NP O
51 to TO O O
51 auscultation VB O O
51 bilaterally RB O O
51 HEART: NNP B-NP O
52 Regular NNP I-NP O
52 rate NN I-NP O
52 and CC O O
52 rhythm NN B-NP O
52 Normal NNP I-NP O
52 S1 NNP I-NP O
52 , , O O
52 S2 NNP B-NP O
52 , , O O
52 no DT B-NP O
52 murmurs NNS I-NP O
52 ABDOMEN: NNP I-NP O
53 Obese NNP I-NP O
53 and CC O O
53 fairly RB O O
53 firm JJ O O
53 Diffusely RB O O
53 tender NN B-NP O
53 to TO O O
53 palpation NN B-NP O
53 Increased VBD B-VP O
54 right JJ B-NP O
54 lower JJR I-NP O
54 quadrant NN I-NP O
54 pain NN I-NP O
54 Rebound NNP I-NP O
54 tenderness NN I-NP O
54 and CC O O
54 mild JJ O O
54 guarding VBG O O
55 Bowel NNP B-NP O
55 sounds NNS I-NP O
55 are VBP O O
55 present JJ O O
55 but CC O O
55 decreased VBD B-VP O
55 BACK: NNP B-NP O
55 No NNP I-NP O
55 costovertebral JJ O O
56 angle RB O O
56 tenderness JJ B-NP O
56 CERVIX: NNP I-NP O
56 Cervical NNP I-NP O
56 motion NN I-NP O
56 tenderness NN I-NP O
56 is VBZ O O
56 present JJ B-NP O
57 NEUROLOGIC: NNP I-NP O
57 The DT B-NP O
57 patient NN I-NP O
57 is VBZ O O
57 alert JJ O O
57 and CC O O
57 oriented JJ B-NP O
57 x3 NNP I-NP O
58 LABORATORY: NNP I-NP O
58 Chemistries NNP I-NP O
58 revealed VBD B-VP O
58 sodium NN B-NP O
58 132 CD O O
58 , , O O
58 potassium NN B-NP O
58 4.2 CD O O
58 , , O O
59 chloride RB O O
59 94 CD O O
59 , , O O
59 CO2 NNP B-NP O
59 32 CD O O
59 , , O O
59 BUN NNP B-NP O
59 13 CD O O
59 , , O O
59 creatinine NN B-NP O
59 1 CD O O
59 Glucose NNP B-NP O
60 315 CD O O
60 , , O O
60 calcium NN B-NP O
60 9.9 CD O O
60 Liver NNP B-NP O
60 function NN I-NP O
60 tests NNS I-NP O
60 showed VBD B-VP O
60 ALT NNP B-NP O
60 58 CD O O
60 , , O O
60 AST NNP B-NP O
60 23 CD O O
60 , , O O
60 ALK NNP B-NP O
61 127 CD O O
61 , , O O
61 total JJ B-NP O
61 bilirubin NN I-NP O
61 1.2 CD O O
61 , , O O
61 albumin RB O O
61 4.6 CD O O
61 , , O O
61 globulin NN B-NP O
61 3.1 CD O O
61 , , O O
61 amylase NN B-NP O
61 28 CD O O
61 , , O O
62 lipase NN B-NP O
62 145 CD O O
62 , , O O
62 total JJ B-NP O
62 protein NN I-NP O
62 7.7 CD O O
62 The DT B-NP O
62 complete JJ I-NP O
62 blood NN I-NP O
62 cell NN I-NP O
62 count NN I-NP O
63 revealed VBD B-VP O
63 a DT B-NP O
63 white JJ I-NP O
63 blood NN I-NP O
63 cell NN I-NP O
63 count NN I-NP O
63 of IN B-VP O
63 23.91 CD O O
63 , , O O
63 hemoglobin NN B-NP O
63 14.1 CD O O
63 , , O O
64 hematocrit NN B-NP O
64 41.8 CD O O
64 , , O O
64 platelets NNS B-NP O
64 520 CD O O
64 The DT B-NP O
64 differential NN I-NP O
64 showed VBD B-VP O
64 77 CD O O
64 polys NN B-NP O
64 , , O O
65 7 CD O O
65 bands NNS B-NP O
65 , , O O
65 6 CD O O
65 lymphocytes NNS B-NP O
65 , , O O
65 and CC O O
65 6 CD O O
65 monocytes NNS B-NP O
65 The DT B-NP O
65 urinalysis NN I-NP O
65 was VBD B-VP O
66 notable JJ O O
66 for IN B-VP O
66 pH NN B-NP O
66 5.5 CD O O
66 , , O O
66 protein RB O O
66 1+ CD O O
66 , , O O
66 glucose RB O O
66 1+ CD O O
66 , , O O
66 leukocytes VBZ O O
66 1+ CD O O
66 , , O O
66 nitrite RB O O
67 positive JJ O O
67 , , O O
67 trace JJ B-NP O
67 ketones NNS I-NP O
67 , , O O
67 and CC O O
67 no DT B-NP O
67 blood NN I-NP O
67 Sediments NNS I-NP O
67 showed VBD B-VP O
67 white JJ B-NP O
68 blood NN I-NP O
68 cells NNS I-NP O
68 45 CD O O
68 - : O O
68 50 CD O O
68 , , O O
68 4+ CD O O
68 bacteria NNS B-NP O
68 , , O O
68 1+ CD O O
68 squamous JJ B-NP O
68 epithelial JJ I-NP O
68 cells NNS I-NP O
68 , , O O
68 1 CD O O
68 - : O O
69 2 CD O O
69 casts NNS B-NP O
69 Abdominal NNP I-NP O
69 CT NNP I-NP O
69 was VBD B-VP O
69 notable JJ O O
69 for IN B-VP O
69 a DT O O
69 7 CD O O
69 x NN B-NP O
69 8 CD O O
69 cm NN B-NP O
69 low JJ B-NP O
69 density NN I-NP O
69 fluid NN I-NP O
70 collection NN I-NP O
70 in IN B-VP O
70 the DT B-NP O
70 region NN I-NP O
70 of IN B-VP O
70 the DT B-NP O
70 right JJ I-NP O
70 adnexa NN I-NP O
70 and CC O O
70 a DT O O
70 4 CD O O
70 x NN B-NP O
70 8 CD O O
70 cm NN B-NP O
70 low JJ B-NP O
71 density NN I-NP O
71 fluid NN I-NP O
71 collection NN I-NP O
71 in IN B-VP O
71 the DT B-NP O
71 left NN I-NP O
71 adnexa VBZ O O
71 A DT B-NP O
71 UCG NNP I-NP O
71 was VBD B-VP O
71 negative JJ B-NP O
72 PROCEDURES: NNP I-NP O
72 July NNP I-NP O
72 , , O O
72 2000 CD O O
72 , , O O
72 endometrial JJ B-NP O
72 biopsy NN I-NP O
72 The DT B-NP O
72 procedure NN I-NP O
73 was VBD B-VP O
73 limited VBN O O
73 due JJ O O
73 to TO O O
73 the DT B-NP O
73 patient's NN I-NP O
73 body NN I-NP O
73 habitus VBZ O O
73 The DT B-NP O
74 biopsy NN I-NP O
74 revealed VBD B-VP O
74 no DT B-NP O
74 evidence NN I-NP O
74 of IN B-VP O
74 malignancy NN B-NP O
74 Complications NNP I-NP O
74 none NN I-NP O
75 HOSPITAL NNP I-NP O
75 COURSE: NNP I-NP O
75 By IN B-VP O
75 systems: JJ O O
76 1 CD O O
76 GENITOURINARY NNP B-NP O
76 The DT B-NP O
76 patient's NN I-NP O
76 presenting NN I-NP O
77 symptoms NNS I-NP O
77 and CC O O
77 abdominal JJ B-NP O
77 CT NNP I-NP O
77 findings NNS I-NP O
77 of IN B-VP O
77 bilateral JJ B-NP O
77 adnexal NN I-NP O
77 masses NNS I-NP O
77 were VBD B-VP O
78 suspicious JJ O O
78 for IN B-VP O
78 a DT B-NP O
78 tubo-ovarian JJ I-NP O
78 abscess NN I-NP O
78 However RB O O
78 , , O O
78 the DT B-NP O
78 patient NN I-NP O
78 did VBD B-VP O
79 not RB O O
79 have VB O O
79 any DT O O
79 of IN B-VP O
79 the DT O O
79 associated VBN O O
79 risk NN B-NP O
79 factors NNS I-NP O
79 , , O O
79 given VBN O O
79 that IN B-VP O
79 the DT B-NP O
79 patient NN I-NP O
80 is VBZ O O
80 not RB O O
80 sexually RB O O
80 active JJ O O
80 and CC O O
80 denied VBD B-VP O
80 introducing VBG O O
80 any DT B-NP O
80 foreign JJ I-NP O
80 objects NNS I-NP O
81 into IN B-VP O
81 the DT B-NP O
81 vagina NN I-NP O
81 The DT B-NP O
81 patient NN I-NP O
81 was VBD B-VP O
81 initially RB O O
81 managed VBN O O
81 on IN B-VP O
81 triple JJ B-NP B-m
82 antibiotics NNS I-NP O
82 , , O O
82 ampicillin NN B-NP B-m
82 , , O O
82 gentamicin NN B-NP B-m
82 , , O O
82 and CC O O
82 Clindamycin NNP B-NP B-m
82 Since IN B-VP O
82 a DT B-NP O
82 CT NNP I-NP O
83 scan NN I-NP O
83 is VBZ O O
83 not RB O O
83 the DT B-NP O
83 optimal JJ I-NP O
83 test NN I-NP O
83 to TO O O
83 evaluate VB O O
83 the DT B-NP O
83 adnexa NN I-NP O
83 , , O O
83 a DT B-NP O
83 transvaginal JJ I-NP O
84 ultrasound NN I-NP O
84 was VBD B-VP O
84 ordered VBN O O
84 which WDT O O
84 revealed VBD B-VP O
84 endometrial JJ B-NP O
84 thickness NN I-NP O
84 of IN B-VP O
84 3.6 CD O O
85 mm NNS B-NP O
85 and CC O O
85 bilateral JJ B-NP O
85 cystic JJ I-NP O
85 masses NNS I-NP O
85 The DT B-NP O
85 patient's NN I-NP O
85 right JJ B-NP O
85 upper JJ I-NP O
85 quadrant NN I-NP O
86 pain NN I-NP O
86 and CC O O
86 tenderness NN B-NP O
86 persisted VBN O O
86 for IN B-VP O
86 several JJ B-NP O
86 days NNS I-NP O
86 during IN B-VP O
86 the DT B-NP O
86 admission NN I-NP O
87 with IN B-VP O
87 periodic JJ B-NP O
87 exacerbations NNS I-NP O
87 and CC O O
87 was VBD B-VP O
87 increasingly RB O O
87 suspicious JJ O O
87 for IN B-VP O
88 cholelithiasis NN B-NP O
88 or CC O O
88 pancreatitis VB O O
88 The DT B-NP O
88 patient NN I-NP O
88 then RB O O
88 had VBD B-VP O
88 an DT B-NP O
88 abdominal JJ I-NP O
89 ultrasound NN I-NP O
89 which WDT O O
89 was VBD B-VP O
89 essentially RB O O
89 was VBD B-VP O
89 within IN B-VP O
89 normal JJ B-NP O
89 limits NNS I-NP O
89 and CC O O
90 showed VBD B-VP O
90 no DT B-NP O
90 abnormal JJ I-NP O
90 viscera NN I-NP O
90 The DT B-NP O
90 bilateral JJ I-NP O
90 adnexal NN I-NP O
90 masses NNS I-NP O
90 continued VBD B-VP O
91 to TO O O
91 be VB O O
91 of IN B-VP O
91 major JJ B-NP O
91 concern NN I-NP O
91 , , O O
91 and CC O O
91 interventional JJ B-NP O
91 radiology NN I-NP O
91 was VBD B-VP O
91 consulted VBN O O
92 for IN B-VP O
92 possible JJ B-NP O
92 aspiration NN I-NP O
92 Given NNP I-NP O
92 that IN B-VP O
92 the DT B-NP O
92 etiology NN I-NP O
92 of IN B-VP O
92 the DT B-NP O
92 masses NNS I-NP O
92 was VBD B-VP O
93 unclear JJ O O
93 and CC O O
93 the DT B-NP O
93 risk NN I-NP O
93 of IN B-VP O
93 malignancy NN B-NP O
93 in IN B-VP O
93 a DT B-NP O
93 post NN I-NP O
93 menopausal NN I-NP O
93 woman NN I-NP O
93 , , O O
93 it PRP O O
94 was VBD B-VP O
94 decided VBN O O
94 that IN B-VP O
94 the DT B-NP O
94 best JJS I-NP O
94 approach NN I-NP O
94 would MD O O
94 be VB O O
94 open JJ B-NP O
94 tissue NN I-NP O
94 sampling VBG O O
95 It PRP O O
95 was VBD B-VP O
95 then RB O O
95 decided VBD B-VP O
95 to TO O O
95 postpone VB O O
95 this DT B-NP O
95 procedure NN I-NP O
95 pending VBG O O
95 further JJ B-NP O
96 evaluation NN I-NP O
96 of IN B-VP O
96 the DT B-NP O
96 patient NN I-NP O
96 Of IN B-VP O
96 note NN B-NP O
96 , , O O
96 the DT B-NP O
96 patient NN I-NP O
96 had VBD B-VP O
96 a DT B-NP O
96 CA-125 NNP I-NP O
96 drawn NN I-NP O
97 which WDT O O
97 77 CD O O
97 Serum NNP B-NP O
97 HCG NNP I-NP O
97 was VBD B-VP O
97 negative JJ O O
97 The DT B-NP O
97 patient's JJ I-NP O
97 report NN I-NP O
97 of IN B-VP O
97 new JJ B-NP O
98 onset NN I-NP O
98 of IN B-VP O
98 post NN B-NP O
98 menopausal NN I-NP O
98 bleeding NN I-NP O
98 was VBD B-VP O
98 concerning VBG O O
98 Considering VBG O O
98 the DT B-NP O
99 high JJ I-NP O
99 likelihood NN I-NP O
99 of IN B-VP O
99 malignancy NN B-NP O
99 , , O O
99 the DT B-NP O
99 patient NN I-NP O
99 was VBD B-VP O
99 being VBG O O
99 followed VBN O O
99 by IN B-VP O
100 the DT B-NP O
100 gynecology NN I-NP O
100 oncology NN I-NP O
100 service NN I-NP O
100 and CC O O
100 underwent JJ B-NP O
100 endometrial JJ I-NP O
100 biopsy NN I-NP O
101 for IN B-VP O
101 tissue NN B-NP O
101 sampling VBG O O
101 The DT B-NP O
101 biopsy NN I-NP O
101 revealed VBD B-VP O
101 no DT B-NP O
101 evidence NN I-NP O
101 of IN B-VP O
102 malignancy NN B-NP O
102 The DT B-NP O
102 patient NN I-NP O
102 had VBD B-VP O
102 a DT B-NP O
102 repeat NN I-NP O
102 CT NNP I-NP O
102 scan NN I-NP O
102 on IN B-VP O
102 hospital JJ B-NP O
102 day NN I-NP O
103 number NN I-NP O
103 seven CD O O
103 which WDT O O
103 was VBD B-VP O
103 essentially RB O O
103 unchanged JJ O O
103 from IN B-VP O
103 admission NN B-NP O
103 showing VBG O O
104 persistent JJ B-NP O
104 bilateral JJ I-NP O
104 adnexal NN I-NP O
104 masses NNS I-NP O
104 and CC O O
104 no DT B-NP O
104 free JJ I-NP O
104 fluid NN I-NP O
104 The DT B-NP O
105 patient's NN I-NP O
105 symptoms NNS I-NP O
105 of IN B-VP O
105 right JJ B-NP O
105 lower JJR I-NP O
105 quadrant NN I-NP O
105 pain NN I-NP O
105 persisted VBD B-VP O
105 but CC O O
106 became VBD B-VP O
106 more RBR O O
106 responsive JJ O O
106 to TO O O
106 treatment NN B-NP O
106 toward IN B-VP O
106 the DT B-NP O
106 end NN I-NP O
106 of IN B-VP O
106 the DT B-NP O
107 admission NN I-NP O
107 Throughout IN B-VP O
107 the DT B-NP O
107 admission NN I-NP O
107 the DT B-NP O
107 actual JJ I-NP O
107 etiology NN I-NP O
107 of IN B-VP O
107 the DT B-NP O
108 bilateral JJ I-NP O
108 adnexal NN I-NP O
108 masses NNS I-NP O
108 was VBD B-VP O
108 never RB O O
108 discerned VBN O O
108 As IN B-VP O
108 a DT B-NP O
108 result NN I-NP O
108 , , O O
108 the DT B-NP O
109 patient NN I-NP O
109 was VBD B-VP O
109 referred VBN O O
109 to TO O O
109 the DT B-NP O
109 gynecology NN I-NP O
109 oncology NN I-NP O
109 service NN I-NP O
109 for IN B-VP O
110 continued VBN O O
110 follow VBP O O
110 up RP O O
110 as IN B-VP O
110 an DT O O
110 outpatient JJ O O
111 2 CD O O
111 INFECTIOUS NNP B-NP O
111 DISEASE NNP I-NP O
111 The DT B-NP O
111 patient's JJ I-NP O
111 presentation NN I-NP O
111 of IN B-VP O
111 fevers NNS B-NP O
111 , , O O
112 chills NNS B-NP O
112 , , O O
112 and CC O O
112 diaphoresis NN B-NP O
112 was VBD B-VP O
112 certainly RB O O
112 suspicious JJ O O
112 for IN B-VP O
112 infectious JJ B-NP O
113 process NN I-NP O
113 Initially RB O O
113 the DT B-NP O
113 patient NN I-NP O
113 was VBD B-VP O
113 covered VBN O O
113 with IN B-VP O
113 ampicillin NN B-NP B-m
113 , , O O
114 gentamicin NN B-NP B-m
114 , , O O
114 and CC O O
114 Clindamycin NNP B-NP B-m
114 for IN B-VP O
114 empiric JJ B-NP B-r
114 empiric JJ I-NP B-r
114 empiric JJ I-NP B-r
114 antimicrobial JJ I-NP I-r
114 antimicrobial JJ I-NP I-r
114 antimicrobial JJ I-NP I-r
114 coverage NN I-NP I-r
114 coverage NN I-NP I-r
114 coverage NN I-NP I-r
115 The DT B-NP O
115 urine JJ I-NP O
115 culture NN I-NP O
115 was VBD B-VP O
115 notable JJ O O
115 for IN B-VP O
115 greater JJR O O
115 than IN B-VP O
115 100 CD O O
115 , , O O
115 000 CD O O
115 Escherichia NNP B-NP O
116 coli NN I-NP O
116 which WDT O O
116 was VBD B-VP O
116 pan RBS O O
116 sensitive JJ O O
116 All DT B-NP O
116 blood NN I-NP O
116 cultures NNS I-NP O
116 at IN B-VP O
116 initial JJ B-NP O
117 presentation NN I-NP O
117 had VBD B-VP O
117 been VBN O O
117 negative JJ O O
117 On IN B-VP O
117 March NNP B-NP O
117 , , O O
117 the DT B-NP O
117 creatinine JJ I-NP O
118 level NN I-NP O
118 increased VBD B-VP O
118 to TO O O
118 1.8 CD O O
118 As IN B-VP O
118 a DT B-NP O
118 result NN I-NP O
118 , , O O
118 gentamicin NN B-NP B-m
118 was VBD B-VP O
118 then RB O O
118 switched VBN O O
119 to TO O O
119 Levofloxacin VB O B-m
119 The DT B-NP B-r
119 patient's NN I-NP I-r
119 fever NN I-NP I-r
119 initially RB O O
119 defervesced VBD B-VP O
119 from IN B-VP O
120 102.2 CD O O
120 to TO O O
120 99.3 CD O O
120 , , O O
120 but CC O O
120 spiked VBD B-VP O
120 to TO O O
120 100.1 CD O O
120 after IN B-VP O
120 six CD O B-du
120 days NNS B-NP I-du
120 of IN B-VP O
120 antibiotics NNS B-NP B-m
121 Her NNP I-NP O
121 white JJ B-NP O
121 blood NN I-NP O
121 cell NN I-NP O
121 count NN I-NP O
121 remained VBD B-VP O
121 elevated JJ O O
121 and CC O O
121 ranged VBD B-VP O
121 from IN B-VP O
121 24 CD O O
121 to TO O O
122 32 CD O O
122 However RB O O
122 , , O O
122 by IN B-VP O
122 discharge NN B-NP O
122 the DT B-NP O
122 white JJ I-NP O
122 blood NN I-NP O
122 cell NN I-NP O
122 count NN I-NP O
122 was VBD B-VP O
122 10 CD O O
123 Because IN B-VP O
123 of IN B-VP O
123 the DT B-NP O
123 patient's JJ I-NP O
123 initial JJ I-NP O
123 minimal JJ I-NP O
123 response NN I-NP O
123 to TO O O
123 antibiotics NNS B-NP B-m
123 , , O O
124 repeat NN B-NP O
124 blood NN I-NP O
124 cultures NNS I-NP O
124 and CC O O
124 urine JJ B-NP O
124 cultures NNS I-NP O
124 were VBD B-VP O
124 sent VBN O O
124 which WDT O O
124 were VBD B-VP O
125 negative JJ O O
125 In IN B-VP O
125 addition NN B-NP O
125 , , O O
125 ID NNP B-NP O
125 was VBD B-VP O
125 consulted VBN O O
125 to TO O O
125 provide VB O O
125 further JJ B-NP O
126 guidance NN I-NP O
126 regarding VBG O O
126 antimicrobial JJ B-NP O
126 management NN I-NP O
126 They PRP O O
126 recommended VBD B-VP O
126 to TO O O
127 continue VB O O
127 ampicillin NN B-NP B-m
127 and CC O O
127 Levofloxacin NNP B-NP B-m
127 Clindamycin NNP I-NP B-m
127 was VBD B-VP O
127 changed VBN O O
127 to TO O O
128 Flagyl NNP B-NP B-m
128 By IN B-VP O
128 discharge NN B-NP O
128 , , O O
128 the DT B-NP O
128 patient NN I-NP O
128 was VBD B-VP O
128 afebrile JJ O O
129 3 CD O O
129 CARDIOVASCULAR NNP B-NP O
129 By IN B-VP O
129 hospital JJ B-NP O
129 day NN I-NP O
129 number NN I-NP O
129 two CD O O
129 , , O O
129 the DT B-NP O
129 patient NN I-NP O
129 was VBD B-VP O
130 noted VBN O O
130 to TO O O
130 have VB O O
130 increased VBN O O
130 lower JJR B-NP O
130 extremity NN I-NP O
130 swelling VBG O O
130 and CC O O
130 new JJ B-NP O
130 bibasilar JJ I-NP O
131 crackles NNS I-NP O
131 The DT B-NP O
131 symptoms NNS I-NP O
131 were VBD B-VP O
131 suggestive JJ O O
131 of IN B-VP O
131 volume NN B-NP O
131 overload NN I-NP O
131 and CC O O
132 possibly RB O O
132 congestive JJ B-NP O
132 heart NN I-NP O
132 failure NN I-NP O
132 A DT B-NP O
132 chest NN I-NP O
132 x-ray NN I-NP O
132 was VBD B-VP O
132 notable JJ O O
132 for IN B-VP O
133 bilateral JJ B-NP O
133 atelectasis NN I-NP O
133 in IN B-VP O
133 the DT B-NP O
133 lower JJR I-NP O
133 lobes NNS I-NP O
133 but CC O O
133 no DT B-NP O
133 pulmonary JJ I-NP O
133 edema NN I-NP O
133 or CC O O
134 pleural JJ B-NP O
134 effusions NNS I-NP O
134 A DT B-NP O
134 cardiac JJ I-NP O
134 echocardiogram NN I-NP O
134 revealed VBD B-VP O
134 normal JJ B-NP O
135 systolic JJ I-NP O
135 function NN I-NP O
135 with IN B-VP O
135 ejection NN B-NP O
135 fraction NN I-NP O
135 of IN B-VP O
135 approximately RB O O
135 60% CD O O
135 and CC O O
136 mild JJ O O
136 left VBD B-VP O
136 ventricular JJ B-NP O
136 hypertrophy NN I-NP O
136 The DT B-NP O
136 patient NN I-NP O
136 was VBD B-VP O
136 treated VBN O O
136 with IN B-VP O
137 Lasix NNP B-NP B-m
137 and CC O O
137 was VBD B-VP O
137 aggressively RB O O
137 diuresed VBN O O
137 She PRP O O
137 responded VBD B-VP O
137 well RB O O
137 to TO O O
138 treatment NN B-NP O
139 4 CD O O
139 NEUROLOGIC NNP B-NP O
139 The DT B-NP O
139 patient NN I-NP O
139 presented VBN O O
139 with IN B-VP O
139 abdominal JJ B-NP B-r
139 abdominal JJ I-NP B-r
139 pain NN I-NP I-r
139 pain NN I-NP I-r
139 and CC O O
139 was VBD B-VP O
140 initially RB O O
140 with IN B-VP O
140 Demerol NNP B-NP B-m
140 and CC O O
140 Vistaril NNP B-NP B-m
140 Initially NNP I-NP O
140 the DT B-NP O
140 patient NN I-NP O
140 was VBD B-VP O
141 only RB O O
141 minimally RB O O
141 responsive JJ O O
141 to TO O O
141 treatment NN B-NP O
141 , , O O
141 but CC O O
141 over IN B-VP O
141 time NN B-NP O
141 she PRP O O
141 became VBD B-VP O
142 more RBR O O
142 responsive JJ O O
142 By IN B-VP O
142 discharge NN B-NP O
142 , , O O
142 the DT B-NP O
142 patient NN I-NP O
142 was VBD B-VP O
142 without IN B-VP O
142 pain NN B-NP O
143 MEDICATIONS NNP I-NP O
143 ON NNP I-NP O
143 DISCHARGE: NNP I-NP O
143 Lasix NNP I-NP B-m
143 60 CD O B-do
143 mg NN B-NP I-do
143 p.o NN I-NP B-mo
143 q.i.d VBD B-VP B-f
143 Glyburide NNP B-NP B-m
143 5 CD O B-do
143 mg NN B-NP I-do
144 p.o NN I-NP B-mo
144 q JJ B-NP B-f
144 day NN I-NP I-f
144 Labetalol NNP I-NP B-m
144 200 CD O B-do
144 mg NN B-NP I-do
144 p.o NN I-NP B-mo
145 b.i.d NN I-NP B-f
145 Flagyl NNP I-NP B-m
145 500 CD O B-do
145 mg NN B-NP I-do
145 p.o NN I-NP B-mo
145 q VBD B-VP B-f
145 8 CD O I-f
145 hours NNS B-NP I-f
145 Levofloxacin NNP I-NP B-m
145 500 CD O B-do
145 mg NN B-NP I-do
145 p.o NN I-NP B-mo
145 q VBD B-VP B-f
146 24 CD O O
146 hours NNS B-NP O
146 Xalatan VBD B-VP B-m
146 1 CD O B-do
146 drop NN B-NP I-do
146 OU NNP I-NP B-mo
146 q NN I-NP B-f
146 p.m NN I-NP I-f
146 Timoptic NNP I-NP B-m
146 0.5% CD O I-m
146 1 CD O B-do
146 drop NN B-NP I-do
146 OS NNP I-NP B-mo
146 q NNP I-NP B-f
146 day NN I-NP I-f
147 CONDITION NNP I-NP O
147 ON NNP I-NP O
147 DISCHARGE: NNP I-NP O
147 Stable NNP I-NP O
148 DISPOSITION: NNP I-NP O
148 The DT B-NP O
148 patient NN I-NP O
148 was VBD B-VP O
148 discharged VBN O O
148 to TO O O
148 home NN B-NP O
148 and CC O O
148 required VBN O O
148 no DT B-NP O
149 services NNS I-NP O
150 DISCHARGE NNP I-NP O
150 INSTRUCTIONS: NNP I-NP O
150 The DT B-NP O
150 patient NN I-NP O
150 was VBD B-VP O
150 advised VBN O O
150 to TO O O
150 call VB O O
150 her PRP$ O O
151 primary JJ B-NP O
151 care NN I-NP O
151 physician NN I-NP O
151 for IN B-VP O
151 fevers NNS B-NP O
151 greater JJR O O
152 than IN B-VP O
152 100.5 CD O O
152 , , O O
152 chills NNS B-NP O
152 , , O O
152 nausea NN B-NP O
152 , , O O
152 vomiting VBG O O
152 , , O O
152 abdominal JJ O O
152 pain VBP O O
152 The DT B-NP O
152 patient NN I-NP O
153 was VBD B-VP O
153 also RB O O
153 advised VBN O O
153 to TO O O
153 take VB O O
153 her PRP$ O O
153 temperature NN B-NP O
153 every DT B-NP O
153 day NN I-NP O
153 The DT B-NP O
153 patient NN I-NP O
154 was VBD B-VP O
154 scheduled VBN O O
154 to TO O O
154 follow VB O O
154 up RP O O
154 with IN B-VP O
154 her PRP$ O O
154 primary JJ B-NP O
154 care NN I-NP O
154 physician NN I-NP O
154 in IN B-VP O
154 one CD O O
155 week NN B-NP O
155 She PRP O O
155 will MD O O
155 also RB O O
155 follow VB O O
155 up RP O O
155 with IN B-VP O
155 the DT B-NP O
155 gynecology NN I-NP O
155 oncology NN I-NP O
155 service NN I-NP O
156 for IN B-VP O
156 further JJ B-NP O
156 evaluation NN I-NP O
156 of IN B-VP O
156 bilateral JJ B-NP O
156 adnexal NN I-NP O
156 masses NNS I-NP O
156 and CC O O
156 post NN B-NP O
157 menopausal NN I-NP O
157 bleeding VBG O O
158 Dictated NNP B-NP O
158 By: NNP I-NP O
158 PACO NNP I-NP O
158 , , O O
158 KEVIN NNP B-NP O
158 RENALDO NNP I-NP O
158 DEANDRE NNP I-NP O
159 Attending: NNP I-NP O
159 ARLIE NNP I-NP O
159 S NNP I-NP O
159 PAGANI NNP I-NP O
159 , , O O
159 M.D NNP B-NP O
159 ZA2 NNP I-NP O
160 RP290/8974 NNP I-NP O
161 Batch: NNP I-NP O
161 21380 CD O O
161 Index NNP B-NP O
161 No NNP I-NP O
161 OZTFSV9PK3 NNP I-NP O
161 D: NNP I-NP O
161 10/6 CD O O
162 T: NNP B-NP O
162 10/6 CD O O
163 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #981662 VBZ O O
2 603746432 CD O O
2 PCHAMC NNP B-NP O
2 12716509 CD O O
2 8078262 CD O O
2 0/23/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 3/16/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 4/4/2005 CD O O
4 ATTENDING: NNP B-NP O
4 JASPER NNP I-NP O
4 WISCOMBE NNP I-NP O
4 MD NNP I-NP O
5 PROCEDURES NNP I-NP O
5 DURING NNP I-NP O
5 ADMISSION: NNP I-NP O
6 1 CD O O
6 Insertion NNP B-NP O
6 of IN B-VP O
6 a DT B-NP O
6 pacemaker NN I-NP O
6 , , O O
6 4/0/05 CD O O
7 2 CD O O
7 Electrophysiology NNP B-NP O
7 study NN I-NP O
7 , , O O
7 4/0/05 CD O O
8 3 CD O O
8 Cardiac NNP B-NP O
8 catheterization NN I-NP O
8 , , O O
8 6/11/05 CD O O
9 ADMITTING NNP B-NP O
9 DIAGNOSES: NNP I-NP O
10 1 CD O O
10 Third-degree JJ B-NP O
10 heart NN I-NP O
10 block NN I-NP O
11 2 CD O O
11 Syncope NNP B-NP O
12 3 CD O O
12 Status NNP B-NP O
12 post NN I-NP O
12 motor NN I-NP O
12 vehicle NN I-NP O
12 collision NN I-NP O
13 4 CD O O
13 Rule NN B-NP O
13 out IN B-VP O
13 stroke NN B-NP O
14 PRINCIPAL NNP I-NP O
14 DISCHARGE NNP I-NP O
14 DIAGNOSES: NNP I-NP O
15 1 CD O O
15 Third-degree JJ B-NP O
15 heart NN I-NP O
15 block; VBZ O O
15 resolved VBD B-VP O
16 2 CD O O
16 Status NNP B-NP O
16 post NN I-NP O
16 motor NN I-NP O
16 vehicle NN I-NP O
16 collision NN I-NP O
17 3 CD O O
17 Lateral NNP B-NP O
17 and CC O O
17 medial JJ B-NP O
17 menisci NN I-NP O
17 tears NNS I-NP O
17 , , O O
17 left VBD B-VP O
17 knee NN B-NP O
18 4 CD O O
18 Old NNP B-NP O
18 CVA NNP I-NP O
19 SECONDARY NNP I-NP O
19 DISCHARGE NNP I-NP O
19 DIAGNOSES: NNP I-NP O
20 1 CD O O
20 Coronary NNP B-NP O
20 artery NN I-NP O
20 disease NN I-NP O
21 2 CD O O
21 Diabetes VBZ O O
22 3 CD O O
22 Hypertension NNP B-NP O
23 HISTORY NNP I-NP O
23 OF NNP I-NP O
23 PRESENT NNP I-NP O
23 ILLNESS: NNP I-NP O
24 Mr NNP I-NP O
24 Barriger NNP I-NP O
24 is VBZ O O
24 a DT B-NP O
24 73-year-old JJ I-NP O
24 gentleman NN I-NP O
24 who WP O O
24 is VBZ O O
24 a DT B-NP O
24 restrained JJ I-NP O
24 driver NN I-NP O
25 in IN B-VP O
25 a DT B-NP O
25 single JJ I-NP O
25 car NN I-NP O
25 motor NN I-NP O
25 vehicle NN I-NP O
25 collision NN I-NP O
25 , , O O
25 in IN B-VP O
25 which WDT O O
25 the DT B-NP O
25 car NN I-NP O
25 went VBD B-VP O
26 off IN B-VP O
26 the DT B-NP O
26 road NN I-NP O
26 at IN B-VP O
26 a DT B-NP O
26 moderate JJ I-NP O
26 rate NN I-NP O
26 of IN B-VP O
26 speed NN B-NP O
26 ( ( O O
26 approximately RB O O
26 45 CD O O
26 miles NNS B-NP O
27 an DT B-NP O
27 hour NN I-NP O
27 ) ) O O
27 , , O O
27 and CC O O
27 struck VBD B-VP O
27 a DT B-NP O
27 telephone NN I-NP O
27 pole NN I-NP O
27 There EX O O
27 are VBP O O
27 no DT B-NP O
27 skin JJ I-NP O
27 marks NNS I-NP O
28 noted VBD B-VP O
28 at IN B-VP O
28 the DT B-NP O
28 scene NN I-NP O
28 There EX O O
28 was VBD B-VP O
28 airbag JJ B-NP O
28 deployment NN I-NP O
28 , , O O
28 and CC O O
28 the DT B-NP O
28 patient NN I-NP O
29 was VBD B-VP O
29 wearing VBG O O
29 a DT B-NP O
29 seatbelt NN I-NP O
29 The DT B-NP O
29 patient NN I-NP O
29 reports NNS I-NP O
29 feeling VBG O O
29 "fine" JJ O O
29 prior RB O O
30 to TO O O
30 the DT B-NP O
30 motor NN I-NP O
30 vehicle NN I-NP O
30 collision NN I-NP O
30 However RB O O
30 , , O O
30 he PRP O O
30 has VBZ O O
30 no DT B-NP O
30 recollection NN I-NP O
31 of IN B-VP O
31 the DT B-NP O
31 motor NN I-NP O
31 vehicle NN I-NP O
31 collision NN I-NP O
31 itself PRP O O
31 , , O O
31 and CC O O
31 the DT B-NP O
31 next JJ I-NP O
31 thing NN I-NP O
31 he PRP O O
32 remembers VBZ O O
32 is VBZ O O
32 waking VBG O O
32 up RP O O
32 and CC O O
32 finding VBG O O
32 the DT B-NP O
32 airbag NN I-NP O
32 is VBZ O O
32 deployed VBN O O
32 , , O O
32 and CC O O
33 being VBG O O
33 in IN B-VP O
33 severe JJ B-NP O
33 pain NN I-NP O
33 He PRP O O
33 does VBZ O O
33 remember VB O O
33 EMS NNP B-NP O
33 arriving VBG O O
34 Upon NNP B-NP O
34 arrival NN I-NP O
34 of IN B-VP O
34 the DT B-NP O
34 EMS NNP I-NP O
34 , , O O
34 he PRP O O
34 was VBD B-VP O
34 found VBN O O
34 to TO O O
34 have VB O O
34 a DT B-NP O
34 heart NN I-NP O
34 rate NN I-NP O
34 of IN B-VP O
34 30 CD O O
35 in IN B-VP O
35 a DT B-NP O
35 third-degree JJ I-NP O
35 AV NNP I-NP O
35 block NN I-NP O
35 The DT B-NP O
35 patient NN I-NP O
35 denies VBZ O O
35 any DT B-NP O
35 chest NN I-NP O
35 pain NN I-NP O
35 , , O O
36 shortness NN B-NP O
36 of IN B-VP O
36 breath NN B-NP O
36 , , O O
36 nausea NN B-NP O
36 or CC O O
36 vomiting NN B-NP O
36 before IN B-VP O
36 the DT B-NP O
36 motor NN I-NP O
36 vehicle NN I-NP O
37 collision NN I-NP O
37 He PRP O O
37 also RB O O
37 denies VBZ O O
37 any DT B-NP O
37 fevers NNS I-NP O
37 , , O O
37 chills NNS B-NP O
37 , , O O
37 night NN B-NP O
37 sweats NNS I-NP O
37 , , O O
38 shortness NN B-NP O
38 of IN B-VP O
38 breath NN B-NP O
38 , , O O
38 headaches NNS B-NP O
38 or CC O O
38 visual JJ B-NP O
38 changes NNS I-NP O
38 either CC O O
38 before IN B-VP O
38 or CC O O
39 after IN B-VP O
39 He PRP O O
39 had VBD B-VP O
39 no DT B-NP O
39 recent JJ I-NP O
39 changes NNS I-NP O
39 in IN B-VP O
39 any DT B-NP O
39 doses NNS I-NP O
39 of IN B-VP O
39 his PRP$ O O
39 medications NNS B-NP O
40 He PRP O O
40 was VBD B-VP O
40 also RB O O
40 complaining VBG O O
40 of IN B-VP O
40 knee NN B-NP O
40 pain NN I-NP O
41 ED NNP I-NP O
41 COURSE: NNP I-NP O
41 In IN B-VP O
41 the DT B-NP O
41 Emergency NNP I-NP O
41 Department NNP I-NP O
41 , , O O
41 he PRP O O
41 was VBD B-VP O
41 seen VBN O O
41 by IN B-VP O
41 the DT B-NP O
42 Trauma NNP I-NP O
42 Team NNP I-NP O
42 A NNP I-NP O
42 full JJ B-NP O
42 dictation NN I-NP O
42 of IN B-VP O
42 the DT B-NP O
42 Emergency NNP I-NP O
42 Department NNP I-NP O
43 courses VBZ O O
43 has VBZ O O
43 been VBN O O
43 completed VBN O O
43 Please NNP B-NP O
43 see VB O O
43 the DT B-NP O
43 computer NN I-NP O
43 for IN B-VP O
43 further JJ B-NP O
44 details NNS I-NP O
44 of IN B-VP O
44 this DT B-NP O
44 dictation NN I-NP O
44 However RB O O
44 , , O O
44 in IN B-VP O
44 brief NN B-NP O
44 , , O O
44 he PRP O O
44 had VBD B-VP O
44 numerous JJ B-NP O
45 CAT NNP I-NP O
45 scans NNS I-NP O
45 performed VBN O O
45 while IN B-VP O
45 in IN B-VP O
45 the DT B-NP O
45 Emergency NNP I-NP O
45 Department NNP I-NP O
45 These DT O O
46 included VBD B-VP O
46 a DT B-NP O
46 CAT NNP I-NP O
46 scan NN I-NP O
46 of IN B-VP O
46 the DT B-NP O
46 abdomen NNS I-NP O
46 and CC O O
46 pelvis NN B-NP O
46 , , O O
46 head NN B-NP O
46 , , O O
46 and CC O O
46 chest JJS O O
47 There EX O O
47 was VBD B-VP O
47 also RB O O
47 a DT B-NP O
47 CT NNP I-NP O
47 of IN B-VP O
47 the DT B-NP O
47 cervicothoracic NN I-NP O
47 and CC O O
47 lumbar NN B-NP O
47 spine NN I-NP O
47 , , O O
47 with IN B-VP O
48 reconstructions NNS B-NP O
48 performed VBN O O
48 As RB O O
48 well RB O O
48 as IN B-VP O
48 plain JJ B-NP O
48 x-rays JJ I-NP O
48 films NNS I-NP O
48 of IN B-VP O
48 the DT B-NP O
49 lower JJR I-NP O
49 extremity NN I-NP O
49 as RB O O
49 well RB O O
49 a DT B-NP O
49 pelvis NN I-NP O
49 , , O O
49 C-spine NNP B-NP O
49 , , O O
49 and CC O O
49 chest JJS O O
49 Of IN B-VP O
50 significance NN B-NP O
50 , , O O
50 the DT B-NP O
50 plain NN I-NP O
50 films NNS I-NP O
50 of IN B-VP O
50 the DT B-NP O
50 knee NN I-NP O
50 were VBD B-VP O
50 negative JJ O O
50 The DT B-NP O
50 CAT NNP I-NP O
51 scan NN I-NP O
51 of IN B-VP O
51 the DT B-NP O
51 chest NN I-NP O
51 demonstrated VBD B-VP O
51 a DT B-NP O
51 right JJ I-NP O
51 frontal NN I-NP O
51 periventricular JJ B-NP O
52 hypodensity NN I-NP O
52 , , O O
52 which WDT O O
52 was VBD B-VP O
52 thought VBN O O
52 to TO O O
52 represent VB O O
52 a DT B-NP O
52 subacute NN I-NP O
52 infarct NN I-NP O
53 He PRP O O
53 was VBD B-VP O
53 subsequently RB O O
53 admitted VBN O O
53 to TO O O
53 the DT B-NP O
53 Cardiac NNP I-NP O
53 Step-Down NNP I-NP O
53 Floor NNP I-NP O
53 He PRP O O
54 was VBD B-VP O
54 seen VBN O O
54 by IN B-VP O
54 the DT B-NP O
54 Neurology NNP I-NP O
54 Service NNP I-NP O
54 ( ( O O
54 Dr NNP B-NP O
54 Orban NNP I-NP O
54 , , O O
54 who WP O O
54 is VBZ O O
54 the DT B-NP O
55 Neurology NNP I-NP O
55 resident NN I-NP O
55 ) ) O O
55 , , O O
55 who WP O O
55 initially RB O O
55 saw VBD B-VP O
55 him PRP O O
56 PAST NNP B-NP O
56 MEDICAL NNP I-NP O
56 HISTORY: NNP I-NP O
57 1 CD O O
57 Significant NNP B-NP O
57 for IN B-VP O
57 myocardial JJ B-NP O
57 infarction NN I-NP O
57 , , O O
57 eight CD O O
57 years NNS B-NP O
57 ago RB O O
57 He PRP O O
58 received VBD B-VP O
58 cardiac JJ B-NP O
58 stents NNS I-NP O
58 at IN B-VP O
58 that DT B-NP O
58 time NN I-NP O
59 2 CD O O
59 Hypertension NNP B-NP O
60 3 CD O O
60 Hypercholesterolemia NNP B-NP O
61 4 CD O O
61 Diabetes VBZ O O
62 5 CD O O
62 Renal NNP B-NP O
62 cyst NN I-NP O
63 6 CD O O
63 Cataract NNP B-NP O
64 PAST NNP I-NP O
64 SURGICAL NNP I-NP O
64 HISTORY: NNP I-NP O
65 1 CD O O
65 Significant NNP B-NP O
65 for IN B-VP O
65 coronary JJ B-NP O
65 stenting; NN I-NP O
65 two CD O O
65 were VBD B-VP O
65 placed VBN O O
65 eight CD O O
66 years NNS B-NP O
66 ago RB O O
66 during IN B-VP O
66 his PRP$ O O
66 MI NNP B-NP O
66 , , O O
66 and CC O O
66 he PRP O O
66 had VBD B-VP O
66 an DT O O
66 additional JJ O O
66 two CD O O
66 stents NNS B-NP O
67 placed VBN O O
67 in IN B-VP O
67 July NNP B-NP O
67 of IN B-VP O
67 2004 CD O O
68 2 CD O O
68 Cataract NNP B-NP O
68 removal JJ B-NP O
69 MEDICATIONS NNP I-NP O
69 AT NNP I-NP O
69 HOME: NNP I-NP O
70 1 CD O O
70 Glyburide NNP B-NP B-m
70 100 CD O B-do
70 mg NN B-NP I-do
70 p.o NN I-NP B-mo
70 b.i.d VBD B-VP B-f
71 2 CD O O
71 Metformin NNP B-NP B-m
71 500 CD O B-do
71 mg NN B-NP I-do
71 p.o NN I-NP B-mo
71 b.i.d VBD B-VP B-f
72 3 CD O O
72 Aspirin NNP B-NP B-m
72 81 CD O B-do
72 mg NN B-NP I-do
72 p.o NN I-NP B-mo
72 q JJ B-NP B-f
72 day NN I-NP I-f
73 4 CD O O
73 Zocor NNP B-NP B-m
73 80 CD O B-do
73 mg NN B-NP I-do
73 p.o NN I-NP B-mo
73 q JJ B-NP B-f
73 day NN I-NP I-f
74 5 CD O O
74 Plavix NNP B-NP B-m
74 75 CD O B-do
74 mg NN B-NP I-do
74 p.o NN I-NP B-mo
74 q JJ B-NP B-f
74 day NN I-NP I-f
75 6 CD O O
75 Prilosec NNP B-NP B-m
75 20 CD O B-do
75 mg NN B-NP I-do
75 p.o NN I-NP B-mo
75 q JJ B-NP B-f
75 day NN I-NP I-f
76 7 CD O O
76 Isosorbide NNP B-NP B-m
76 dinitrate NN I-NP I-m
76 40 CD O B-do
76 mg NN B-NP I-do
76 p.o NN I-NP B-mo
76 t.i.d VBD B-VP B-f
77 8 CD O O
77 Atenolol NNP B-NP B-m
77 100 CD O B-do
77 mg NN B-NP I-do
77 p.o NN I-NP B-mo
77 q JJ B-NP B-f
77 day NN I-NP I-f
78 ALLERGIES: NNP I-NP O
79 He PRP O O
79 has VBZ O O
79 no DT O O
79 known VBN O O
79 allergies NNS B-NP O
80 PHYSICAL NNP I-NP O
80 EXAMINATION NNP I-NP O
80 UPON NNP I-NP O
80 ADMISSION: NNP I-NP O
81 Blood NNP I-NP O
81 pressure NN I-NP O
81 of IN B-VP O
81 123/51 CD O O
81 , , O O
81 heart NN B-NP O
81 rate NN I-NP O
81 of IN B-VP O
81 48 CD O O
81 , , O O
81 respiratory JJ B-NP O
81 rate NN I-NP O
81 of IN B-VP O
82 16 CD O O
82 General NNP B-NP O
82 appearance: NN I-NP O
82 He PRP O O
82 is VBZ O O
82 a DT O O
82 well-developed JJ O O
82 , , O O
82 well-nourished JJ O O
82 , , O O
83 and CC O O
83 well-hydrated JJ B-NP O
83 male NN I-NP O
83 , , O O
83 in IN B-VP O
83 mildly RB O O
83 acute JJ B-NP O
83 distress NN I-NP O
83 HEENT: NNP I-NP O
84 Normocephalic NNP I-NP O
84 and CC O O
84 atraumatic JJ B-NP O
84 Extraocular NNP I-NP O
84 motions NNS I-NP O
84 are VBP O O
84 intact JJ B-NP O
85 Pupils NNP I-NP O
85 are VBP O O
85 equal JJ O O
85 , , O O
85 round NN B-NP O
85 , , O O
85 and CC O O
85 reactive JJ O O
85 to TO O O
85 light JJ O O
85 and CC O O
85 accommodation NN B-NP O
86 at IN B-VP O
86 4 CD O O
86 mm NN B-NP O
86 The DT B-NP O
86 conjunctivae NN I-NP O
86 are VBP O O
86 pink VBN O O
86 and CC O O
86 the DT B-NP O
86 sclera NN I-NP O
86 is VBZ O O
86 anicteric JJ O O
87 The DT B-NP O
87 oropharynx NN I-NP O
87 is VBZ O O
87 significant JJ O O
87 for IN B-VP O
87 a DT B-NP O
87 slight JJ I-NP O
87 bite NN I-NP O
87 mark NN I-NP O
87 on IN B-VP O
87 the DT B-NP O
88 tongue NN I-NP O
88 , , O O
88 without IN B-VP O
88 any DT B-NP O
88 active JJ I-NP O
88 bleeding NN I-NP O
88 There EX O O
88 are VBP O O
88 moist JJ B-NP O
88 mucosal NN I-NP O
89 membranes VBZ O O
89 The DT B-NP O
89 neck NN I-NP O
89 is VBZ O O
89 supple JJ O O
89 , , O O
89 and CC O O
89 there EX O O
89 is VBZ O O
89 no DT B-NP O
89 midline NN I-NP O
90 tenderness NN I-NP O
90 There EX O O
90 is VBZ O O
90 no DT B-NP O
90 JVD NNP I-NP O
90 The DT B-NP O
90 chest NN I-NP O
90 is VBZ O O
90 clear JJ O O
90 to TO O O
91 auscultation VB O O
91 There EX O O
91 is VBZ O O
91 tenderness NN B-NP O
91 over IN B-VP O
91 the DT B-NP O
91 right JJ I-NP O
91 ribs NN I-NP O
91 , , O O
91 as RB O O
91 well RB O O
92 as IN B-VP O
92 mild JJ B-NP O
92 sternal JJ I-NP O
92 tenderness NN I-NP O
92 The DT B-NP O
92 heart NN I-NP O
92 is VBZ O O
92 regular JJ B-NP O
92 rhythm NN I-NP O
92 , , O O
93 although IN B-VP O
93 markedly RB O O
93 bradycardiac VBZ O O
93 The DT B-NP O
93 abdomen NNS I-NP O
93 is VBZ O O
93 soft JJ O O
93 , , O O
93 nontender NN B-NP O
93 , , O O
94 and CC O O
94 nondistended VBD B-VP O
94 There EX O O
94 are VBP O O
94 good JJ B-NP O
94 bowel NN I-NP O
94 sounds NNS I-NP O
94 in IN B-VP O
94 all DT O O
94 four CD O O
95 quadrants NNS B-NP O
95 There EX O O
95 is VBZ O O
95 no DT B-NP O
95 CVA NNP I-NP O
95 tenderness VBD B-VP O
95 The DT B-NP O
95 pelvis NN I-NP O
95 is VBZ O O
95 stable JJ O O
95 to TO O O
96 rock VB O O
96 Extremities: NNP B-NP O
96 There EX O O
96 is VBZ O O
96 tenderness NN B-NP O
96 in IN B-VP O
96 the DT B-NP O
96 abrasions NNS I-NP O
96 over IN B-VP O
97 the DT B-NP O
97 left JJ I-NP O
97 knee NN I-NP O
97 The DT B-NP O
97 left NN I-NP O
97 knee NN I-NP O
97 is VBZ O O
97 in IN B-VP O
97 an DT B-NP O
97 immobilizer NN I-NP O
97 , , O O
97 at IN B-VP O
97 the DT B-NP O
97 time NN I-NP O
98 of IN B-VP O
98 admission NN B-NP O
98 to TO O O
98 the DT B-NP O
98 floor NN I-NP O
98 He PRP O O
98 has VBZ O O
98 full JJ B-NP O
98 range NN I-NP O
98 of IN B-VP O
98 motion NN B-NP O
98 in IN B-VP O
99 ankles NNS B-NP O
99 , , O O
99 shoulders NNS B-NP O
99 , , O O
99 and CC O O
99 elbows VBZ O O
99 bilaterally RB O O
99 There EX O O
99 is VBZ O O
99 decreased JJ B-NP O
100 range NN I-NP O
100 of IN B-VP O
100 motion NN B-NP O
100 in IN B-VP O
100 the DT B-NP O
100 left JJ I-NP O
100 knee NN I-NP O
100 There EX O O
100 is VBZ O O
100 no DT B-NP O
100 bony NN I-NP O
100 tenderness RB O O
101 along IN B-VP O
101 any DT O O
101 of IN B-VP O
101 the DT B-NP O
101 long JJ I-NP O
101 bones NNS I-NP O
101 of IN B-VP O
101 the DT O O
101 upper JJ O O
101 or CC O O
101 lower JJR B-NP O
101 extremities NNS I-NP O
101 , , O O
102 with IN B-VP O
102 exception NN B-NP O
102 of IN B-VP O
102 the DT B-NP O
102 knee JJ I-NP O
102 Peripheral NNP I-NP O
102 vascular NN I-NP O
102 , , O O
102 dorsalis NN B-NP O
102 pedis NN I-NP O
102 , , O O
103 posterior RB O O
103 , , O O
103 tibial JJ O O
103 , , O O
103 and CC O O
103 radial JJ B-NP O
103 pulses NNS I-NP O
103 are VBP O O
103 all DT O O
103 equal JJ O O
103 bilaterally RB O O
104 Neuro NNP B-NP O
104 exam: NN I-NP O
104 He PRP O O
104 is VBZ O O
104 awake JJ O O
104 , , O O
104 alert JJ O O
104 , , O O
104 and CC O O
104 oriented VBD B-VP O
104 x3 NNP B-NP O
104 Cranial NNP I-NP O
104 nerves NNS I-NP O
105 II-XII NNP I-NP O
105 are VBP O O
105 intact JJ B-NP O
105 Motor NNP I-NP O
105 is VBZ O O
105 5/5 CD O O
105 in IN B-VP O
105 the DT O O
105 upper JJ O O
105 and CC O O
105 lower JJR B-NP O
106 extremities NNS I-NP O
106 bilaterally RB O O
106 Sensation NNP B-NP O
106 is VBZ O O
106 equal JJ O O
106 bilaterally RB O O
106 , , O O
106 in IN B-VP O
106 the DT B-NP O
107 upper JJ I-NP O
107 extremities NNS I-NP O
107 , , O O
107 lower JJR B-NP O
107 extremities NNS I-NP O
107 , , O O
107 and CC O O
107 face NN B-NP O
107 There EX O O
107 is VBZ O O
107 no DT B-NP O
108 dysmetria NN I-NP O
108 or CC O O
108 dysarthria VB O O
108 Finger-to-nose NNP B-NP O
108 is VBZ O O
108 fast JJ O O
108 and CC O O
108 accurate JJ O O
109 bilaterally RB O O
109 There EX O O
109 is VBZ O O
109 no DT B-NP O
109 drift NN I-NP O
109 Skin NNP I-NP O
109 is VBZ O O
109 warm JJ O O
109 , , O O
109 dry JJ O O
109 , , O O
109 and CC O O
110 well-perfused JJ B-NP O
111 LABORATORY NNP I-NP O
111 DATA NNP I-NP O
111 UPON NNP I-NP O
111 ADMISSION: NNP I-NP O
112 CT NNP I-NP O
112 C-spine NNP I-NP O
112 negative JJ B-NP O
112 CT NNP I-NP O
112 head NN I-NP O
112 shows VBZ O O
112 a DT B-NP O
112 right JJ I-NP O
112 frontal NN I-NP O
112 subacute NN I-NP O
113 infarct NN I-NP O
113 CT NNP I-NP O
113 chest NN I-NP O
113 shows VBZ O O
113 anterior JJ B-NP O
113 fifth JJ I-NP O
113 rib NN I-NP O
113 fractures NNS I-NP O
114 bilaterally RB O O
114 There EX O O
114 was VBD B-VP O
114 also RB O O
114 some DT B-NP O
114 supraclavicular JJ I-NP O
114 stranding NN I-NP O
114 along IN B-VP O
115 the DT B-NP O
115 left JJ I-NP O
115 side NN I-NP O
115 , , O O
115 without IN B-VP O
115 any DT B-NP O
115 evidence NN I-NP O
115 of IN B-VP O
115 vessel JJ B-NP O
115 injury NN I-NP O
115 CT NNP I-NP O
115 of IN B-VP O
115 the DT B-NP O
116 abdomen NNS I-NP O
116 and CC O O
116 pelvis NN B-NP O
116 is VBZ O O
116 negative JJ O O
116 , , O O
116 except IN B-VP O
116 for IN B-VP O
116 a DT B-NP O
116 ruptured JJ I-NP O
116 renal JJ I-NP O
116 cyst NN I-NP O
117 He PRP O O
117 was VBD B-VP O
117 also RB O O
117 incidentally RB O O
117 noted VBN O O
117 to TO O O
117 show VB O O
117 diverticulosis NN B-NP O
117 , , O O
117 without IN B-VP O
118 any DT B-NP O
118 diverticulitis NN I-NP O
118 The DT B-NP O
118 CT NNP I-NP O
118 of IN B-VP O
118 the DT B-NP O
118 thoracic NN I-NP O
118 and CC O O
118 lumbar NN B-NP O
118 spines NNS I-NP O
119 also RB O O
119 demonstrated VBD B-VP O
119 no DT B-NP O
119 fractures NNS I-NP O
119 , , O O
119 although IN B-VP O
119 there EX O O
119 were VBD B-VP O
119 incidentally RB O O
120 noted VBN O O
120 to TO O O
120 be VB O O
120 anterior JJ B-NP O
120 osteophytes NNS I-NP O
120 in IN B-VP O
120 numerous JJ B-NP O
120 levels NNS I-NP O
120 CT NNP I-NP O
120 of IN B-VP O
120 the DT B-NP O
121 chest NN I-NP O
121 demonstrated VBD B-VP O
121 the DT B-NP O
121 rib NN I-NP O
121 fractures NNS I-NP O
121 , , O O
121 but CC O O
121 was VBD B-VP O
121 otherwise RB O O
121 negative JJ B-NP O
122 Laboratory NNP I-NP O
122 , , O O
122 sodium NN B-NP O
122 138 CD O O
122 , , O O
122 potassium NN B-NP O
122 4.4 CD O O
122 , , O O
122 chloride RB O O
122 103 CD O O
122 , , O O
122 bicarbonate NN B-NP O
123 25 CD O O
123 , , O O
123 BUN NNP B-NP O
123 28 CD O O
123 , , O O
123 creatinine NN B-NP O
123 1.3 CD O O
123 , , O O
123 glucose RB O O
123 185 CD O O
123 , , O O
123 and CC O O
123 anion NN B-NP O
123 gap NN I-NP O
123 is VBZ O O
123 10 CD O O
123 , , O O
123 AST NNP B-NP O
124 and CC O O
124 ALT NNP B-NP O
124 are VBP O O
124 20 CD O O
124 and CC O O
124 25 CD O O
124 respectively RB O O
124 Alkaline JJ B-NP O
124 phosphatase NN I-NP O
124 is VBZ O O
124 80 CD O O
125 Lipase NNP B-NP O
125 is VBZ O O
125 51 CD O O
125 Calcium NN B-NP O
125 is VBZ O O
125 8.8 CD O O
125 , , O O
125 the DT B-NP O
125 albumin NN I-NP O
125 is VBZ O O
125 4.6 CD O O
125 , , O O
125 the DT B-NP O
125 CK NNP I-NP O
125 is VBZ O O
125 89 CD O O
125 , , O O
126 CKMB NNP B-NP O
126 is VBZ O O
126 3.6 CD O O
126 , , O O
126 and CC O O
126 troponin NN B-NP O
126 was VBD B-VP O
126 less JJR O O
126 than IN B-VP O
126 assay VB O O
126 His PRP$ O O
126 serum NN B-NP O
127 toxicology NN I-NP O
127 screen NN I-NP O
127 was VBD B-VP O
127 negative JJ O O
127 for IN B-VP O
127 aspirin NN B-NP O
127 , , O O
127 Tylenol NNP B-NP O
127 , , O O
128 benzodiazepine NN B-NP O
128 , , O O
128 barbiturates NNS B-NP O
128 , , O O
128 and CC O O
128 tricyclics NNS B-NP O
128 Urine NNP I-NP O
128 drug NN I-NP O
128 screen NN I-NP O
129 is VBZ O O
129 also RB O O
129 negative JJ B-NP O
129 PT NNP I-NP O
129 , , O O
129 PTT NNP B-NP O
129 , , O O
129 and CC O O
129 INR NNP B-NP O
129 were VBD B-VP O
129 13 CD O O
129 , , O O
129 25.8 CD O O
129 , , O O
129 and CC O O
129 0.9 CD O O
130 respectively RB O O
130 CBC NNP B-NP O
130 was VBD B-VP O
130 significant JJ O O
130 for IN B-VP O
130 white JJ B-NP O
130 count NN I-NP O
130 of IN B-VP O
130 12.0 CD O O
130 , , O O
131 hemoglobin NN B-NP O
131 and CC O O
131 hematocrit NN B-NP O
131 were VBD B-VP O
131 14.6 CD O O
131 and CC O O
131 42.2 CD O O
131 , , O O
131 and CC O O
131 platelets NNS B-NP O
131 are VBP O O
132 250 CD O O
132 Urinalysis NNP B-NP O
132 was VBD B-VP O
132 negative JJ B-NP O
133 Review NNP I-NP O
133 of IN B-VP O
133 the DT B-NP O
133 prehospital JJ I-NP O
133 EKG NNP I-NP O
133 demonstrated VBD B-VP O
133 a DT O O
133 complete JJ O O
134 ( ( O O
134 third-degree JJ O O
134 ) ) O O
134 heart NN B-NP O
134 block NN I-NP O
134 However RB O O
134 , , O O
134 EKG NNP B-NP O
134 done VBN O O
134 immediately RB O O
134 upon JJ B-NP O
135 admission NN I-NP O
135 to TO O O
135 the DT B-NP O
135 Trauma NNP I-NP O
135 Bay NNP I-NP O
135 demonstrated VBD B-VP O
135 a DT B-NP O
135 bifascicular JJ I-NP O
135 block NN I-NP O
135 , , O O
136 with IN B-VP O
136 a DT B-NP O
136 rate NN I-NP O
136 in IN B-VP O
136 the DT O O
136 40s CD O O
137 HOSPITAL NNP B-NP O
137 COURSE NNP I-NP O
137 BY NNP I-NP O
137 SYSTEMS: NNP I-NP O
138 1 CD O O
138 Cardiovascular: NNP B-NP O
138 He PRP O O
138 was VBD B-VP O
138 admitted VBN O O
138 to TO O O
138 the DT B-NP O
138 Cardiac NNP I-NP O
138 Step-Down NNP I-NP O
139 Unit NNP I-NP O
139 He PRP O O
139 had VBD B-VP O
139 Zoll NNP B-NP O
139 pacer NN I-NP O
139 pads NNS I-NP O
139 were VBD B-VP O
139 placed VBN O O
139 upon IN B-VP O
139 his PRP$ O O
139 chest NN B-NP O
139 , , O O
139 and CC O O
140 atropine NN B-NP O
140 remained VBN O O
140 at IN B-VP O
140 his PRP$ O O
140 bedside NN B-NP O
140 He PRP O O
140 also RB O O
140 had VBD B-VP O
140 an DT B-NP O
140 additional JJ I-NP O
140 Zoll NNP I-NP O
141 pacer NN I-NP O
141 pads NNS I-NP O
141 , , O O
141 as RB O O
141 well RB O O
141 as IN B-VP O
141 the DT B-NP O
141 pacemaker NN I-NP O
141 standby NN I-NP O
141 at IN B-VP O
141 the DT B-NP O
141 bedside NN I-NP O
141 , , O O
142 however RB O O
142 , , O O
142 these DT O O
142 were VBD B-VP O
142 not RB O O
142 needed VBN O O
142 , , O O
142 as IN B-VP O
142 he PRP O O
142 has VBZ O O
142 completed VBN O O
142 asymptomatic JJ O O
143 with IN B-VP O
143 his PRP$ O O
143 bifascicular JJ B-NP O
143 block NN I-NP O
143 He PRP O O
143 had VBD B-VP O
143 serial JJ B-NP O
143 enzymes NNS I-NP O
143 , , O O
143 which WDT O O
143 were VBD B-VP O
144 performed VBN O O
144 , , O O
144 he PRP O O
144 was VBD B-VP O
144 ruled VBN O O
144 out RP O O
144 for IN B-VP O
144 myocardial JJ B-NP O
144 infarction NN I-NP O
144 He PRP O O
144 went VBD B-VP O
145 to TO O O
145 the DT B-NP O
145 Cardiac NNP I-NP O
145 Cath NNP I-NP O
145 Lab NNP I-NP O
145 , , O O
145 which WDT O O
145 demonstrated VBD B-VP O
145 some DT B-NP O
145 coronary JJ I-NP O
145 artery NN I-NP O
146 disease NN I-NP O
146 Please NNP I-NP O
146 see VB O O
146 the DT B-NP O
146 dictated JJ I-NP O
146 cardiology NN I-NP O
146 reports NNS I-NP O
146 for IN B-VP O
146 the DT B-NP O
147 findings NNS I-NP O
147 of IN B-VP O
147 the DT B-NP O
147 Cath NNP I-NP O
147 Lab NNP I-NP O
147 It PRP O O
147 was VBD B-VP O
147 felt VBN O O
147 , , O O
147 however RB O O
147 , , O O
147 this DT O O
147 was VBD B-VP O
148 unchanged JJ O O
148 from IN B-VP O
148 prior JJ B-NP O
148 studies NNS I-NP O
148 He PRP O O
148 also RB O O
148 went VBD B-VP O
148 to TO O O
148 the DT B-NP O
149 Electrophysiology NNP I-NP O
149 Lab NNP I-NP O
149 They PRP O O
149 were VBD B-VP O
149 unable JJ O O
149 to TO O O
149 induce VB O O
149 any DT B-NP O
150 ventricular JJ I-NP O
150 tachycardia NN I-NP O
150 or CC O O
150 other JJ B-NP O
150 dysrhythmias NN I-NP O
150 during IN B-VP O
150 the DT B-NP O
151 prolonged JJ I-NP O
151 EP NNP I-NP O
151 studies NNS I-NP O
151 He PRP O O
151 had VBD B-VP O
151 a DT B-NP O
151 pacemaker NN I-NP O
151 inserted VBD B-VP O
151 The DT B-NP O
152 pacemaker NN I-NP O
152 was VBD B-VP O
152 followed VBN O O
152 by IN B-VP O
152 the DT B-NP O
152 Electrophysiology NNP I-NP O
152 Service NNP I-NP O
152 , , O O
152 and CC O O
152 was VBD B-VP O
153 found VBN O O
153 to TO O O
153 be VB O O
153 working VBG O O
153 adequately RB O O
153 The DT B-NP O
153 attending NN I-NP O
153 was VBD B-VP O
153 Dr NNP B-NP O
153 Matt NNP I-NP O
153 Duropan NNP I-NP O
153 , , O O
154 with IN B-VP O
154 the DT B-NP O
154 Electrophysiology NNP I-NP O
154 Service NNP I-NP O
154 Dr NNP I-NP O
154 Caires VBZ O O
154 with IN B-VP O
154 the DT B-NP O
155 Cardiology NNP I-NP O
155 Service NNP I-NP O
155 saw VBD B-VP O
155 him PRP O O
155 and CC O O
155 was VBD B-VP O
155 attending VBG O O
155 on IN B-VP O
155 record NN B-NP O
156 2 CD O O
156 Neurology: NNP B-NP O
156 He PRP O O
156 was VBD B-VP O
156 seen VBN O O
156 by IN B-VP O
156 the DT B-NP O
156 Neurology NNP I-NP O
156 Service NNP I-NP O
156 So NNP I-NP O
156 , , O O
156 this DT O O
157 was VBD B-VP O
157 under IN B-VP O
157 Dr NNP B-NP O
157 Edgardo NNP I-NP O
157 Mccorison NNP I-NP O
157 , , O O
157 the DT O O
157 attending VBG O O
157 neurologist NN B-NP O
157 on IN B-VP O
157 the DT B-NP O
158 case NN I-NP O
158 He PRP O O
158 had VBD B-VP O
158 an DT B-NP O
158 MRI/MRA NNP I-NP O
158 performed NN I-NP O
158 of IN B-VP O
158 his PRP$ O O
158 head NN B-NP O
158 and CC O O
158 neck VB O O
158 The DT B-NP O
159 diffusion-weighted JJ I-NP O
159 images NNS I-NP O
159 demonstrated VBD B-VP O
159 no DT B-NP O
159 evidence NN I-NP O
159 of IN B-VP O
159 any DT B-NP O
160 abnormality NN I-NP O
160 There EX O O
160 was VBD B-VP O
160 a DT B-NP O
160 region NN I-NP O
160 of IN B-VP O
160 increase NN B-NP O
160 signal JJ B-NP O
160 intensity NN I-NP O
160 on IN B-VP O
161 the DT B-NP O
161 T2 NNP I-NP O
161 and CC O O
161 FLAIR NNP B-NP O
161 images NNS I-NP O
161 , , O O
161 involving VBG O O
161 the DT B-NP O
161 vasoganglion NN I-NP O
161 , , O O
161 extending VBG O O
162 the DT B-NP O
162 corona NN I-NP O
162 radiata NN I-NP O
162 Therefore NNP I-NP O
162 , , O O
162 given VBN O O
162 the DT B-NP O
162 fact NN I-NP O
162 that IN B-VP O
162 signal NN B-NP O
162 was VBD B-VP O
163 seen VBN O O
163 on IN B-VP O
163 the DT B-NP O
163 T2 NNP I-NP O
163 and CC O O
163 FLAIR NNP B-NP O
163 , , O O
163 not RB O O
163 on IN B-VP O
163 the DT O O
163 diffusion-weighted JJ O O
163 , , O O
163 it PRP O O
163 was VBD B-VP O
164 felt VBN O O
164 that IN B-VP O
164 this DT O O
164 was VBD B-VP O
164 at IN B-VP O
164 least JJS O O
164 10 CD O O
164 days NNS B-NP O
164 old JJ O O
164 Therefore RB O O
164 , , O O
164 this DT O O
164 was VBD B-VP O
164 not RB O O
165 felt VBN O O
165 to TO O O
165 be VB O O
165 either RB O O
165 the DT B-NP O
165 cause NN I-NP O
165 nor CC O O
165 an DT B-NP O
165 affect NN I-NP O
165 of IN B-VP O
165 the DT B-NP O
165 motor NN I-NP O
165 vehicle NN I-NP O
166 collision NN I-NP O
166 It PRP O O
166 was VBD B-VP O
166 most RBS O O
166 likely JJ O O
166 represented VBD B-VP O
166 an DT B-NP O
166 old JJ I-NP O
166 CVA NNP I-NP O
166 , , O O
166 which WDT O O
166 was VBD B-VP O
167 not RB O O
167 previously RB O O
167 detected VBN O O
167 Given NNP B-NP O
167 the DT B-NP O
167 fact NN I-NP O
167 that IN B-VP O
167 the DT B-NP O
167 patient NN I-NP O
168 remained VBD B-VP O
168 asymptomatic JJ O O
168 , , O O
168 and CC O O
168 had VBD B-VP O
168 a DT B-NP O
168 normal JJ I-NP O
168 neurological JJ I-NP O
168 exam NN I-NP O
168 , , O O
168 and CC O O
169 radiographic JJ B-NP O
169 data NNS I-NP O
169 demonstrated VBD B-VP O
169 that IN B-VP O
169 this DT B-NP O
169 infarct NN I-NP O
169 was VBD B-VP O
169 more JJR O O
169 than IN B-VP O
169 10 CD O O
170 days NNS B-NP O
170 old JJ O O
170 , , O O
170 and CC O O
170 this DT O O
170 was VBD B-VP O
170 not RB O O
170 further RB O O
170 addressed VBD B-VP O
170 An DT B-NP O
170 MRA NNP I-NP O
170 of IN B-VP O
170 his PRP$ O O
170 head NN B-NP O
171 and CC O O
171 neck NN B-NP O
171 demonstrated VBD B-VP O
171 tortuous JJ B-NP O
171 vertebrobasilar NN I-NP O
171 system NN I-NP O
171 The DT B-NP O
172 MRI/MRA NNP I-NP O
172 of IN B-VP O
172 the DT B-NP O
172 neck NN I-NP O
172 was VBD B-VP O
172 essentially RB O O
172 normal JJ O O
172 , , O O
172 however RB O O
172 , , O O
172 the DT B-NP O
172 left JJ I-NP O
173 bifurcation NN I-NP O
173 was VBD B-VP O
173 thought VBN O O
173 to TO O O
173 be VB O O
173 without IN B-VP O
173 any DT B-NP O
173 significant JJ I-NP O
173 stenosis NN I-NP O
174 The DT B-NP O
174 right JJ I-NP O
174 bifurcation NN I-NP O
174 is VBZ O O
174 probably RB O O
174 without IN B-VP O
174 significant JJ B-NP O
174 stenosis NN I-NP O
174 , , O O
175 however RB O O
175 , , O O
175 could MD O O
175 not RB O O
175 be VB O O
175 completed VBN O O
175 excluded JJ B-NP O
175 Given NNP I-NP O
175 artifact NN I-NP O
175 , , O O
175 this DT O O
176 could MD O O
176 be VB O O
176 further RB O O
176 followed VBN O O
176 up RP O O
176 with IN B-VP O
176 an DT B-NP O
176 outpatient NN I-NP O
176 venous JJ B-NP O
176 duplex NN I-NP O
176 of IN B-VP O
177 the DT B-NP O
177 carotid NN I-NP O
177 arteries VBZ O O
178 3 CD O O
178 Musculoskeletal: NNP B-NP O
178 He PRP O O
178 was VBD B-VP O
178 seen VBN O O
178 by IN B-VP O
178 the DT B-NP O
178 Orthopedic NNP I-NP O
178 Service NNP I-NP O
178 in IN B-VP O
179 the DT B-NP O
179 Emergency NNP I-NP O
179 Department NNP I-NP O
179 at IN B-VP O
179 the DT B-NP O
179 time NN I-NP O
179 of IN B-VP O
179 the DT B-NP O
179 trauma NN I-NP O
179 , , O O
179 he PRP O O
179 ultimately RB O O
180 had VBD B-VP O
180 an DT B-NP O
180 MRI NNP I-NP O
180 that WDT O O
180 was VBD B-VP O
180 performed VBN O O
180 of IN B-VP O
180 his PRP$ O O
180 knee NN B-NP O
180 This DT O O
180 showed VBD B-VP O
180 tears NNS B-NP O
180 of IN B-VP O
181 the DT O O
181 medial JJ O O
181 and CC O O
181 lateral JJ B-NP O
181 menisci NN I-NP O
181 There EX O O
181 was VBD B-VP O
181 no DT B-NP O
181 evidence NN I-NP O
181 of IN B-VP O
182 fracture NN B-NP O
182 He PRP O O
182 remained VBD B-VP O
182 in IN B-VP O
182 a DT B-NP O
182 knee NN I-NP O
182 immobilizer NN I-NP O
182 He PRP O O
182 saw VBD B-VP O
182 Physical NNP B-NP O
183 Therapy NNP I-NP O
183 , , O O
183 which WDT O O
183 felt VBD B-VP O
183 that IN B-VP O
183 further JJ B-NP O
183 therapy NN I-NP O
183 would MD O O
183 be VB O O
183 indicated VBN O O
184 With IN B-VP O
184 the DT B-NP O
184 impression NN I-NP O
184 of IN B-VP O
184 the DT B-NP O
184 Orthopedic NNP I-NP O
184 Service NNP I-NP O
184 that IN B-VP O
184 no DT B-NP O
184 acute JJ I-NP O
185 intervention NN I-NP O
185 was VBD B-VP O
185 needed VBN O O
185 , , O O
185 and CC O O
185 that IN B-VP O
185 he PRP O O
185 should MD O O
185 follow-up VB O O
185 with IN B-VP O
185 Sports NNP B-NP O
186 Medicine NNP I-NP O
186 or CC O O
186 Orthopedics NNPS B-NP O
186 in IN B-VP O
186 approximately RB O O
186 3-4 JJ B-NP O
186 weeks NNS I-NP O
186 In IN B-VP O
186 addition NN B-NP O
186 , , O O
187 he PRP O O
187 was VBD B-VP O
187 noted VBN O O
187 to TO O O
187 have VB O O
187 several JJ B-NP O
187 rib NN I-NP O
187 fractures VBZ O O
187 The DT B-NP O
187 rib NN I-NP O
187 fractures NNS I-NP O
188 were VBD B-VP O
188 felt VBN O O
188 to TO O O
188 be VB O O
188 the DT B-NP O
188 source NN I-NP O
188 of IN B-VP O
188 his PRP$ O O
188 pain NN B-NP O
188 , , O O
188 he PRP O O
188 continue VBP O O
188 to TO O O
188 complain VB O O
189 of IN B-VP O
189 some DT B-NP O
189 inspiratory NN I-NP O
189 pain NN I-NP O
189 throughout IN B-VP O
189 his PRP$ O O
189 chest NN B-NP O
189 However RB O O
189 , , O O
189 he PRP O O
190 adamantly RB O O
190 denied VBD B-VP O
190 any DT B-NP O
190 pain NN I-NP O
190 throughout IN B-VP O
190 his PRP$ O O
190 chest JJS B-NP O
190 wall NN I-NP O
190 upon IN B-VP O
191 inspiring VBG O O
191 It PRP O O
191 was VBD B-VP O
191 therefore RB O O
191 felt VBD B-VP O
191 that IN B-VP O
191 given VBN O O
191 the DT B-NP O
191 negative JJ I-NP O
191 enzymes NNS I-NP O
192 and CC O O
192 the DT B-NP O
192 negative JJ I-NP O
192 Cath NNP I-NP O
192 , , O O
192 and CC O O
192 the DT O O
192 known VBN O O
192 rib NN B-NP O
192 fractures NNS I-NP O
192 that IN B-VP O
192 the DT B-NP O
192 chest JJS I-NP O
193 pain NN I-NP O
193 was VBD B-VP O
193 strictly RB O O
193 a DT B-NP O
193 result NN I-NP O
193 of IN B-VP O
193 a DT B-NP O
193 musculoskeletal JJ I-NP O
193 pain NN I-NP O
193 This DT B-NP O
193 pain NN I-NP B-r
193 pain NN I-NP B-r
194 was VBD B-VP O
194 well RB O O
194 controlled VBN O O
194 with IN B-VP O
194 the DT B-NP O
194 combination NN I-NP O
194 of IN B-VP O
194 Dilaudid NNP B-NP B-m
194 and CC O O
195 oxycodone NN B-NP B-m
195 He PRP O O
195 was VBD B-VP O
195 encouraged VBN O O
195 to TO O O
195 take VB O O
195 several JJ B-NP O
195 deep JJ I-NP O
195 breaths NNS I-NP O
195 per IN B-VP O
196 hour NN B-NP O
196 to TO O O
196 reduce VB O O
196 the DT B-NP O
196 risk NN I-NP O
196 of IN B-VP O
196 atelectasis NN B-NP O
196 or CC O O
196 pneumonia NN B-NP O
197 4 CD O O
197 Infectious JJ B-NP O
197 Disease: NNP I-NP O
197 There EX O O
197 was VBD B-VP O
197 no DT B-NP O
197 evidence NN I-NP O
197 of IN B-VP O
197 any DT B-NP O
197 acute JJ I-NP O
198 infection NN I-NP O
198 Of IN B-VP O
198 note NN B-NP O
198 , , O O
198 his PRP$ O O
198 white JJ B-NP O
198 count NN I-NP O
198 was VBD B-VP O
198 trending VBG O O
198 upwards NNS B-NP O
198 , , O O
198 on IN B-VP O
198 the DT O O
199 last JJ O O
199 two CD O O
199 days NNS B-NP O
199 of IN B-VP O
199 admission NN B-NP O
199 It PRP O O
199 was VBD B-VP O
199 felt VBN O O
199 that IN B-VP O
199 this DT O O
199 probably RB O O
200 represented VBN O O
200 stress NN B-NP O
200 , , O O
200 given VBN O O
200 all PDT O O
200 the DT B-NP O
200 recent JJ I-NP O
200 procedures NNS I-NP O
200 that WDT O O
200 were VBD B-VP O
201 done VBN O O
201 , , O O
201 including VBG O O
201 the DT B-NP O
201 catheterization NN I-NP O
201 and CC O O
201 the DT B-NP O
201 electrophysiology NN I-NP O
202 studies NNS I-NP O
202 , , O O
202 rather RB O O
202 than IN B-VP O
202 A2 NNP B-NP O
202 infection NN I-NP O
202 The DT B-NP O
202 chest JJS I-NP O
202 x-ray NN I-NP O
202 was VBD B-VP O
202 performed VBN O O
203 on IN B-VP O
203 the DT O O
203 25th CD O O
203 , , O O
203 which WDT O O
203 demonstrated VBD B-VP O
203 no DT B-NP O
203 infiltrate NN I-NP O
203 This DT O O
203 was VBD B-VP O
203 reviewed VBN O O
204 with IN B-VP O
204 an DT O O
204 attending VBG O O
204 radiologist NN B-NP O
204 who WP O O
204 reported VBD B-VP O
204 low JJ B-NP O
204 lung NN I-NP O
204 volumes NNS I-NP O
205 Otherwise RB O O
205 , , O O
205 it PRP O O
205 was VBD B-VP O
205 essentially RB O O
205 negative JJ O O
205 In IN B-VP O
205 addition NN B-NP O
205 , , O O
205 a DT B-NP O
205 repeat NN I-NP O
206 urinalysis NN I-NP O
206 was VBD B-VP O
206 performed VBN O O
206 The DT B-NP O
206 results NNS I-NP O
206 are VBP O O
206 pending VBG O O
206 at IN B-VP O
206 the DT B-NP O
206 time NN I-NP O
206 of IN B-VP O
207 dictation NN B-NP O
207 , , O O
207 however RB O O
207 , , O O
207 will MD O O
207 be VB O O
207 followed VBN O O
207 up RP O O
207 prior RB O O
207 to TO O O
207 the DT B-NP O
207 patient's NN I-NP O
208 discharge NN I-NP O
208 from IN B-VP O
208 the DT B-NP O
208 hospital NN I-NP O
208 The DT B-NP O
208 patient NN I-NP O
208 appears VBZ O O
208 well RB O O
208 , , O O
208 and CC O O
209 states NNS B-NP O
209 that IN B-VP O
209 he PRP O O
209 is VBZ O O
209 feeling VBG O O
209 at IN B-VP O
209 his PRP$ O O
209 best JJS O O
209 since IN B-VP O
209 the DT B-NP O
209 accident NN I-NP O
210 However RB O O
210 , , O O
210 further JJ B-NP O
210 workup NN I-NP O
210 for IN B-VP O
210 his PRP$ O O
210 white JJ B-NP O
210 count NN I-NP O
210 is VBZ O O
210 not RB O O
210 performed VBN O O
210 at IN B-VP O
211 the DT B-NP O
211 present JJ I-NP O
211 time NN I-NP O
211 , , O O
211 however RB O O
211 , , O O
211 the DT B-NP O
211 patient NN I-NP O
211 is VBZ O O
211 informed VBN O O
211 , , O O
211 as IN B-VP O
211 the DT B-NP O
211 No NNP I-NP O
211 Hospital NNP I-NP O
211 and CC O O
211 the DT B-NP O
211 discharge NN I-NP O
211 summary NN I-NP O
211 , , O O
211 which WDT O O
211 show VBP O O
211 that IN B-VP O
211 the DT B-NP O
211 patient NN I-NP O
212 seem VBP O O
212 to TO O O
212 develop VB O O
212 any DT B-NP O
212 evidence NN I-NP O
212 of IN B-VP O
212 infection NN B-NP O
212 that IN B-VP O
212 he PRP O O
212 should MD O O
212 be VB O O
213 reevaluated VBN O O
213 by IN B-VP O
213 a DT O O
213 physician JJ O O
214 5 CD O O
214 Nutrition: NNP B-NP O
214 The DT B-NP O
214 patient NN I-NP O
214 is VBZ O O
214 able JJ O O
214 to TO O O
214 eat VB O O
214 without IN B-VP O
214 any DT B-NP O
215 difficulty NN I-NP O
215 He PRP O O
215 was VBD B-VP O
215 eating VBG O O
215 regular JJ B-NP O
215 house NN I-NP O
215 diabetic/cardiac NN I-NP O
215 diet JJ O O
216 6 CD O O
216 Hypercholesterolemia: NNP B-NP B-r
216 He PRP O O
216 was VBD B-VP O
216 continued VBN O O
216 on IN B-VP O
216 his PRP$ O O
216 Zocor NN B-NP B-m
217 throughout IN B-VP O
217 the DT B-NP O
217 hospitalization NN I-NP O
218 7 CD O O
218 Prophylaxis: NNP B-NP O
218 He PRP O O
218 was VBD B-VP O
218 initially RB O O
218 treated VBN O O
218 with IN B-VP O
218 Lovenox NNP B-NP B-m
218 40 CD O B-do
218 mg NN B-NP I-do
219 sub-Q JJ B-NP B-mo
219 q JJ I-NP B-f
219 day NN I-NP I-f
219 for IN B-VP O
219 a DT B-NP O
219 prophylaxis NN I-NP B-r
219 against IN B-VP I-r
219 DVTs NNP B-NP I-r
219 He PRP O O
219 is VBZ O O
219 also RB O O
219 on IN B-VP O
220 aspirin NNS B-NP B-m
220 and CC O O
220 Plavix NNP B-NP B-m
220 for IN B-VP O
220 secondary JJ B-NP B-r
220 secondary JJ I-NP B-r
220 cardiac NN I-NP O
220 and CC O O
220 neurological JJ B-NP O
221 prophylaxis NN I-NP O
221 The DT B-NP O
221 Lovenox NNP I-NP B-m
221 is VBZ O O
221 discontinued VBN O O
221 , , O O
221 at IN B-VP O
221 the DT B-NP O
221 request NN I-NP O
221 of IN B-VP O
221 the DT B-NP O
222 Electrophysiology NNP I-NP O
222 Service NNP I-NP O
222 on IN B-VP O
222 the DT O O
222 24th CD O O
223 8 CD O O
223 Endocrine: NNP B-NP O
223 Given NNP I-NP O
223 the DT B-NP O
223 numerous JJ I-NP O
223 contrast NN I-NP O
223 studies NNS I-NP O
223 , , O O
223 initially RB O O
224 his PRP$ O O
224 metformin NN B-NP B-m
224 was VBD B-VP O
224 held VBN O O
224 However RB O O
224 , , O O
224 he PRP O O
224 was VBD B-VP O
224 later RB O O
224 restarted VBN O O
224 on IN B-VP O
224 this DT O O
225 In IN B-VP O
225 addition NN B-NP O
225 , , O O
225 he PRP O O
225 was VBD B-VP O
225 continued VBN O O
225 on IN B-VP O
225 his PRP$ O O
225 glyburide NN B-NP B-m
225 and CC O O
225 covered VBN O O
225 with IN B-VP O
226 sliding VBG O B-do
226 scale JJ B-NP I-do
226 insulin NN I-NP B-m
226 His PRP$ O O
226 blood NN B-NP O
226 sugar NN I-NP O
226 was VBD B-VP O
226 never RB O O
226 any DT B-NP O
226 significant JJ I-NP O
227 problem NN I-NP O
227 during IN B-VP O
227 his PRP$ O O
227 hospitalization NN B-NP O
228 9 CD O O
228 Disposition: NNP B-NP O
228 The DT B-NP O
228 patient NN I-NP O
228 will MD O O
228 be VB O O
228 going VBG O O
228 to TO O O
228 Missp NNP B-NP O
228 Medical NNP I-NP O
228 Center NNP I-NP O
228 , , O O
228 in IN B-VP O
229 stable JJ B-NP O
229 condition NN I-NP O
229 At IN B-VP O
229 the DT B-NP O
229 Rehab NNP I-NP O
229 , , O O
229 he PRP O O
229 will MD O O
229 continue VB O O
229 to TO O O
229 get VB O O
229 physical JJ B-NP O
230 therapy NN I-NP O
230 , , O O
230 which WDT O O
230 he PRP O O
230 has VBZ O O
230 received VBN O O
230 in IN B-VP O
230 the DT B-NP O
230 hospital NN I-NP O
230 It PRP O O
230 was VBD B-VP O
230 felt VBN O O
230 that IN B-VP O
231 a DT B-NP O
231 short JJ I-NP O
231 course NN I-NP O
231 of IN B-VP O
231 rehab NN B-NP O
231 would MD O O
231 benefit VB O O
231 the DT B-NP O
231 patient NN I-NP O
231 to TO O O
231 allow VB O O
231 him PRP O O
231 to TO O O
232 go VB O O
232 back RB O O
232 living VBG O O
232 independently RB O O
232 again RB O O
232 He PRP O O
232 will MD O O
232 be VB O O
232 discharged VBN O O
232 to TO O O
232 the DT B-NP O
233 Rehab NNP I-NP O
233 in IN B-VP O
233 stable JJ B-NP O
233 condition NN I-NP O
234 MEDICATIONS NNP I-NP O
234 AT NNP I-NP O
234 DISCHARGE: NNP I-NP O
235 1 CD O O
235 Tylenol NNP B-NP B-m
235 650 CD O B-do
235 mg NN B-NP I-do
235 p.o NN I-NP B-mo
235 q.4h NN I-NP B-f
235 p.r.n NN I-NP I-f
235 pain VBP O B-r
236 2 CD O O
236 Aspirin NNP B-NP B-m
236 81 CD O B-do
236 mg NN B-NP I-do
236 p.o NN I-NP B-mo
236 q JJ B-NP B-f
236 day NN I-NP I-f
237 3 CD O O
237 Atenolol NNP B-NP B-m
237 100 CD O B-do
237 mg NN B-NP I-do
237 p.o NN I-NP B-mo
237 q JJ B-NP B-f
237 day NN I-NP I-f
238 4 CD O O
238 Colace NNP B-NP B-m
238 100 CD O B-do
238 mg NN B-NP I-do
238 p.o NN I-NP B-mo
238 b.i.d VBD B-VP B-f
239 5 CD O O
239 Glyburide NNP B-NP B-m
239 5 CD O B-do
239 mg NN B-NP I-do
239 p.o NN I-NP B-mo
239 b.i.d VBD B-VP B-f
240 6 CD O O
240 Dilaudid NNP B-NP B-m
240 1-2 JJ B-NP B-do
240 mg NN I-NP I-do
240 IV NNP I-NP B-mo
240 q.4h NN I-NP B-f
240 p.r.n NN I-NP I-f
240 pain VBP O B-r
241 7 CD O O
241 Isosorbide NNP B-NP B-m
241 dinitrate NN I-NP I-m
241 40 CD O B-do
241 mg NN B-NP I-do
241 p.o NN I-NP B-mo
241 t.i.d VBD B-VP B-f
242 8 CD O O
242 Ativan NNP B-NP B-m
242 1-2 JJ B-NP B-do
242 mg NN I-NP I-do
242 IV NNP I-NP B-mo
242 p.r.n NN I-NP B-f
242 anxiety NN I-NP B-r
243 9 CD O O
243 Oxycodone NNP B-NP B-m
243 5-10 JJ B-NP B-do
243 mg NN I-NP I-do
243 p.o NN I-NP B-mo
243 q.6h NN I-NP B-f
243 p.r.n NN I-NP I-f
243 pain VBP O B-r
244 10 CD O O
244 Senna NNP B-NP B-m
244 tablets NNS I-NP I-m
244 2 CD O B-do
244 p.o NN B-NP B-mo
244 b.i.d NN I-NP B-f
245 11 CD O O
245 Keflex NNP B-NP B-m
245 250 CD O B-do
245 mg NN B-NP I-do
245 p.o NN I-NP B-mo
245 q.i.d NN I-NP B-f
245 x12 NN I-NP B-du
245 doses VBZ O I-du
245 Keflex NNP B-NP B-m
245 should MD O O
245 be VB O O
246 completed VBN O B-du
246 on IN B-VP I-du
246 Monday NNP B-NP I-du
246 night NN I-NP I-du
247 12 CD O O
247 Zocor NNP B-NP B-m
247 80 CD O B-do
247 mg NN B-NP I-do
247 p.o NN I-NP B-mo
247 q.h.s VBD B-VP B-f
248 13 CD O O
248 Ambien NNP B-NP B-m
248 5 CD O B-do
248 mg NN B-NP I-do
248 p.o NN I-NP B-mo
248 q.h.s VBD B-VP B-f
249 14 CD O O
249 Tessalon NNP B-NP B-m
249 100 CD O B-do
249 mg NN B-NP I-do
249 p.o NN I-NP B-mo
249 t.i.d NN I-NP B-f
249 p.r.n VBD B-VP I-f
249 cough JJ O B-r
250 15 CD O O
250 Plavix NNP B-NP B-m
250 75 CD O B-do
250 mg NN B-NP I-do
250 p.o NN I-NP B-mo
250 q JJ B-NP B-f
250 day NN I-NP I-f
251 16 CD O O
251 Novalog NNP B-NP B-m
251 slides NNS I-NP B-do
252 17 CD O O
252 Prilosec NNP B-NP B-m
252 20 CD O B-do
252 mg NN B-NP I-do
252 p.o NN I-NP B-mo
252 b.i.d VBD B-VP B-f
253 18 CD O O
253 Maalox NNP B-NP B-m
253 1-2 JJ B-NP B-do
253 tabs NNS I-NP I-do
253 p.o VBP O B-mo
253 q.6h JJ B-NP B-f
253 p.r.n NN I-NP I-f
253 pain VBP O B-r
254 The DT B-NP O
254 patient NN I-NP O
254 has VBZ O O
254 following VBG O O
254 discharge NN B-NP O
254 appointments NNS I-NP O
254 He PRP O O
254 has VBZ O O
255 appointments NNS B-NP O
255 with IN B-VP O
255 Dr NNP B-NP O
255 Jc NNP I-NP O
255 Rizzo NNP I-NP O
255 , , O O
255 with IN B-VP O
255 Sports NNP B-NP O
255 Medicine NNP I-NP O
255 , , O O
255 Dr NNP B-NP O
256 Mac NNP I-NP O
256 Gladwin NNP I-NP O
256 in IN B-VP O
256 10-14 JJ B-NP O
256 days NNS I-NP O
256 , , O O
256 and CC O O
256 Dr NNP B-NP O
256 Aldo NNP I-NP O
256 Helger NNP I-NP O
256 in IN B-VP O
256 one CD O O
257 week NN B-NP O
257 Appointment NN I-NP O
257 with IN B-VP O
257 Dr NNP B-NP O
257 Mittman NNP I-NP O
257 is VBZ O O
257 in IN B-VP O
257 3 CD O O
257 weeks NNS B-NP O
258 ADDENDUM: NNP I-NP O
259 Mr NNP I-NP O
259 Flentge NNP I-NP O
259 had VBD B-VP O
259 this DT B-NP O
259 pacemaker NN I-NP O
259 placed VBD B-VP O
259 and CC O O
259 was VBD B-VP O
259 recovering VBG O O
260 uneventfully RB O O
260 However RB O O
260 , , O O
260 it PRP O O
260 was VBD B-VP O
260 noted VBN O O
260 that IN B-VP O
260 he PRP O O
260 started VBD B-VP O
260 having VBG O O
261 increasing VBG O O
261 white JJ B-NP O
261 count NN I-NP O
261 It PRP O O
261 was VBD B-VP O
261 felt VBN O O
261 this DT O O
261 was VBD B-VP O
261 perhaps RB O O
261 due JJ O O
261 to TO O O
261 a DT B-NP O
262 mild JJ I-NP B-r
262 urine JJ I-NP I-r
262 infection NN I-NP I-r
262 and CC O O
262 was VBD B-VP O
262 started VBN O O
262 on IN B-VP O
262 Levaquin NNP B-NP B-m
262 However RB O O
262 , , O O
262 he PRP O O
263 started VBD B-VP O
263 the DT B-NP O
263 next JJ I-NP O
263 day NN I-NP O
263 complaining VBG O O
263 increasing VBG O O
263 pain NN B-NP O
263 in IN B-VP O
263 his PRP$ O O
263 knee NN B-NP O
263 At IN B-VP O
264 this DT B-NP O
264 time NN I-NP O
264 , , O O
264 his PRP$ O O
264 white JJ B-NP O
264 count NN I-NP O
264 had VBD B-VP O
264 risen VBN O O
264 to TO O O
264 23 CD O O
264 , , O O
264 000 CD O O
264 The DT B-NP O
264 knee NN I-NP O
264 was VBD B-VP O
265 obviously RB O O
265 a DT B-NP O
265 concern NN I-NP O
265 for IN B-VP O
265 possible JJ B-NP O
265 infection NN I-NP O
265 His PRP$ O O
265 knee NN B-NP O
265 was VBD B-VP O
265 warm JJ O O
265 , , O O
266 was VBD B-VP O
266 tender NN B-NP O
266 and CC O O
266 was VBD B-VP O
266 erythematous JJ O O
266 , , O O
266 compared VBN O O
266 to TO O O
266 the DT B-NP O
266 contralateral JJ I-NP O
267 side NN I-NP O
267 As IN B-VP O
267 a DT B-NP O
267 result NN I-NP O
267 , , O O
267 the DT B-NP O
267 Orthopedic NNP I-NP O
267 Service NNP I-NP O
267 was VBD B-VP O
267 again RB O O
267 consulted VBN O O
268 An DT B-NP O
268 arthrocentesis NN I-NP O
268 was VBD B-VP O
268 performed VBN O O
268 on IN B-VP O
268 his PRP$ O O
268 left JJ B-NP O
268 knee NN I-NP O
268 , , O O
268 this DT O O
268 was VBD B-VP O
268 a DT B-NP O
268 dry JJ I-NP O
269 tap; NN I-NP O
269 no DT B-NP O
269 fluid NN I-NP O
269 was VBD B-VP O
269 able JJ O O
269 to TO O O
269 be VB O O
269 obtained VBN O O
269 The DT B-NP O
269 subsequent JJ I-NP O
269 day NN I-NP O
269 , , O O
269 he PRP O O
270 was VBD B-VP O
270 complaining VBG O O
270 of IN B-VP O
270 increasing VBG O O
270 pain NN B-NP O
270 , , O O
270 and CC O O
270 the DT B-NP O
270 sed JJ I-NP O
270 rate NN I-NP O
270 returned VBN O O
270 in IN B-VP O
271 the DT O O
271 99 CD O O
271 with IN B-VP O
271 a DT B-NP O
271 CRP NNP I-NP O
271 of IN B-VP O
271 190 CD O O
271 The DT B-NP O
271 EP NNP I-NP O
271 Service NNP I-NP O
271 again RB O O
271 evaluated VBD B-VP O
271 the DT B-NP O
272 patient NN I-NP O
272 , , O O
272 and CC O O
272 felt VBD B-VP O
272 that IN B-VP O
272 there EX O O
272 was VBD B-VP O
272 no DT B-NP O
272 evidence NN I-NP O
272 of IN B-VP O
272 any DT B-NP O
272 clear JJ I-NP O
273 infection NN I-NP O
273 from IN B-VP O
273 the DT B-NP O
273 pacer NN I-NP O
273 site NN I-NP O
273 He PRP O O
273 continued VBD B-VP O
273 to TO O O
273 have VB O O
273 no DT B-NP O
273 erythema NN I-NP O
274 or CC O O
274 tenderness NN B-NP O
274 around IN B-VP O
274 the DT B-NP O
274 pacer NN I-NP O
274 site NN I-NP O
274 His PRP$ O O
274 chest JJS B-NP O
274 x-ray NN I-NP O
274 was VBD B-VP O
275 essentially RB O O
275 unremarkable JJ O O
275 The DT B-NP O
275 next JJ I-NP O
275 day NN I-NP O
275 ( ( O O
275 5/1/05 CD O O
275 ) ) O O
275 , , O O
275 he PRP O O
275 was VBD B-VP O
275 seen VBN O O
276 by IN B-VP O
276 the DT B-NP O
276 Rheumatology NNP I-NP O
276 Service NNP I-NP O
276 , , O O
276 under IN B-VP O
276 Dr NNP B-NP O
276 Burris NNP I-NP O
276 who WP O O
276 also RB O O
276 felt VBD B-VP O
276 this DT O O
277 was VBD B-VP O
277 most RBS O O
277 likely JJ O O
277 to TO O O
277 be VB O O
277 prepatellar JJ B-NP O
277 bursitis NN I-NP O
277 , , O O
277 probably RB O O
277 septic JJ O O
277 in IN B-VP O
278 nature NN B-NP O
278 , , O O
278 with IN B-VP O
278 a DT B-NP O
278 hematoma NN I-NP O
278 He PRP O O
278 was VBD B-VP O
278 asked VBN O O
278 to TO O O
278 seen VBN O O
278 by IN B-VP O
278 the DT B-NP O
278 Infectious NNP I-NP O
279 Disease NNP I-NP O
279 Service NNP I-NP O
279 , , O O
279 under IN B-VP O
279 Dr NNP B-NP O
279 Ferlic NNP I-NP O
279 and CC O O
279 Lou NNP B-NP O
279 Marzinske NNP I-NP O
280 He PRP O O
280 was VBD B-VP O
280 started VBN O O
280 on IN B-VP O
280 Ancef NNP B-NP B-m
280 1 CD O B-do
280 gm NN B-NP I-do
280 q.8h VBD B-VP B-f
280 A NNP B-NP O
280 PICC NNP I-NP O
280 line NN I-NP O
280 will MD O O
280 be VB O O
280 placed VBN O O
281 later RB O O
281 today NN B-NP O
281 on IN B-VP O
281 the DT O O
281 2/22/05 CD O O
281 and CC O O
281 he PRP O O
281 will MD O O
281 be VB O O
281 discharged VBN O O
281 to TO O O
281 rehab VB O O
282 Of IN B-VP O
282 note NN B-NP O
282 , , O O
282 he PRP O O
282 has VBZ O O
282 been VBN O O
282 afebrile RB O O
282 for IN B-VP O
282 more JJR O O
282 than IN B-VP O
282 48 CD O O
282 hours NNS B-NP O
282 while IN B-VP O
282 on IN B-VP O
282 the DT B-NP O
283 Ancef NNP I-NP B-m
283 , , O O
283 and CC O O
283 his PRP$ O O
283 white JJ B-NP O
283 count NN I-NP O
283 has VBZ O O
283 improved VBN O O
283 dramatically RB O O
283 , , O O
283 into IN B-VP O
283 the DT O O
284 approximately RB O O
284 10000 CD O O
284 range NN B-NP O
284 He PRP O O
284 will MD O O
284 continue VB O O
284 to TO O O
284 get VB O O
284 IV NNP B-NP B-mo
284 Ancef NNP I-NP B-m
285 q.8h NN I-NP B-f
285 for IN B-VP B-du
285 an DT O I-du
285 additional JJ O I-du
285 12 CD O I-du
285 days NNS B-NP I-du
285 New NNP I-NP O
285 consultants NNS I-NP O
285 on IN B-VP O
285 the DT B-NP O
285 case NN I-NP O
285 , , O O
286 again RB O O
286 Dr NNP B-NP O
286 Hempe NNP I-NP O
286 and CC O O
286 Dr NNP B-NP O
286 Bradford NNP I-NP O
286 Mcguigan NNP I-NP O
286 with IN B-VP O
286 Infectious NNP B-NP O
287 Disease NNP I-NP O
287 , , O O
287 Dr NNP B-NP O
287 Borde NNP I-NP O
287 and CC O O
287 Dr NNP B-NP O
287 Frances NNP I-NP O
287 Thackston NNP I-NP O
287 with IN B-VP O
287 Orthopedics NNP B-NP O
287 and CC O O
287 Dr NNP B-NP O
288 Gangwer NNP I-NP O
288 with IN B-VP O
288 Rheumatology NNP B-NP O
289 eScription NN I-NP O
289 document: NN I-NP O
289 5-0149629 JJ B-NP O
289 IS NNP I-NP O
290 CC: NNP I-NP O
290 Claudio NNP I-NP O
290 Shreve NNP I-NP O
290 M.D NNP I-NP O
291 Ynealwell NNP I-NP O
291 Healthcare NNP I-NP O
291 Medicine NNP I-NP O
292 CC: NNP I-NP O
292 Fredrick NNP I-NP O
292 Paciorek NNP I-NP O
292 MD NNP I-NP O
293 O NNP I-NP O
294 H NNP I-NP O
294 Athensph NNP I-NP O
295 CC: NNP I-NP O
295 Jonathan NNP I-NP O
295 Counterman NNP I-NP O
295 M.D NNP I-NP O
296 Stockfay NNP I-NP O
297 CC: NNP I-NP O
297 Michel NNP I-NP O
297 Patera NNP I-NP O
297 MD NNP I-NP O
298 La NNP I-NP O
298 A NNP I-NP O
299 Ver NNP I-NP O
299 Coln NNP I-NP O
300 CC: NNP I-NP O
300 Brian NNP I-NP O
300 Vecellio NNP I-NP O
300 MD NNP I-NP O
301 Cardiac NNP I-NP O
301 Arrhythmia NNP I-NP O
301 Service NNP I-NP O
301 Statesson NNP I-NP O
301 Rankwarmchusetts NNP I-NP O
301 Burg NNP I-NP O
301 Medical NNP I-NP O
302 Andvirg NNP I-NP O
302 E NNP I-NP O
302 Ha NNP I-NP O
303 Son NNP I-NP O
303 St NNP I-NP O
303 , , O O
303 Ette NNP B-NP O
303 Villelau NNP I-NP O
303 Jack NNP I-NP O
303 , , O O
303 Indiana NNP B-NP O
303 51422 CD O O
304 CC: NNP B-NP O
304 Thomas NNP I-NP O
304 Skelly NNP I-NP O
304 MD NNP I-NP O
305 Ette NNP I-NP O
306 A NNP I-NP O
307 Dictated NNP I-NP O
307 By: NNP I-NP O
307 SHANDS NNP I-NP O
307 , , O O
307 WILSON NNP B-NP O
308 Attending: NNP I-NP O
308 RAISBECK NNP I-NP O
308 , , O O
308 CONRAD NNP B-NP O
309 Dictation NNP I-NP O
309 ID NNP I-NP O
309 0461398 CD O O
310 D: NNP B-NP O
310 6/13/05 CD O O
311 T: NNP B-NP O
311 3/23/05 CD O O
312 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #983185 VBZ O O
4 044103237 CD O O
4 MHMC NNP B-NP O
4 31613051 CD O O
4 887222 CD O O
4 2/1/1990 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Unsigned VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 7/12/1990 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Unsigned NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 10/10/1990 CD O O
7 HISTORY NNP B-NP O
7 OF NNP I-NP O
7 PRESENT NNP I-NP O
7 ILLNESS: NNP I-NP O
7 Patient NNP I-NP O
7 is VBZ O O
7 a DT O O
7 40 CD O O
7 year NN B-NP O
7 old JJ B-NP O
7 female NN I-NP O
7 with IN B-VP O
7 a DT B-NP O
8 history NN I-NP O
8 of IN B-VP O
8 cholelithiasis NN B-NP O
8 who WP O O
8 was VBD B-VP O
9 recently RB O O
9 discharged VBN O O
9 from IN B-VP O
9 Asce NNP B-NP O
9 Medical NNP I-NP O
9 Center NNP I-NP O
9 on IN B-VP O
9 June NNP B-NP O
9 , , O O
10 l990 NN B-NP O
10 after IN B-VP O
10 an DT B-NP O
10 incisional JJ I-NP O
10 hernia NN I-NP O
10 repair NN I-NP O
10 who WP O O
10 , , O O
10 soon RB O O
10 after IN B-VP O
10 , , O O
10 noted VBD B-VP O
10 onset NN B-NP O
11 of IN B-VP O
11 right JJ B-NP O
11 upper JJ I-NP O
11 quadrant NN I-NP O
11 pain NN I-NP O
11 , , O O
11 vomiting NN B-NP O
11 , , O O
11 and CC O O
11 fever NN B-NP O
11 and CC O O
11 was VBD B-VP O
12 readmitted VBN O O
12 with IN B-VP O
12 an DT B-NP O
12 ultrasound NN I-NP O
12 at IN B-VP O
12 that DT B-NP O
12 time NN I-NP O
12 showing VBG O O
12 two CD O O
12 8-9 JJ B-NP O
12 mm NN I-NP O
13 gallstones NNS I-NP O
13 in IN B-VP O
13 the DT B-NP O
13 right JJ I-NP O
13 upper JJ I-NP O
13 quadrant JJ I-NP O
13 Patient NNP I-NP O
13 was VBD B-VP O
13 treated VBN O O
13 with IN B-VP O
14 intravenous JJ B-NP B-mo
14 antibiotics NNS I-NP B-m
14 but CC O O
14 deferred VBD B-VP O
14 surgery NN B-NP O
14 at IN B-VP O
14 that DT B-NP O
14 time NN I-NP O
14 and CC O O
14 was VBD B-VP O
15 discharged VBN O O
15 home NN B-NP O
15 after IN B-VP O
15 defervescing VBG O O
15 Approximately RB O O
15 six CD O O
15 weeks NNS B-NP O
15 prior RB O O
16 to TO O O
16 admission NN B-NP O
16 , , O O
16 the DT B-NP O
16 patient NN I-NP O
16 was VBD B-VP O
16 seen VBN O O
16 in IN B-VP O
16 the DT B-NP O
16 Emergency NNP I-NP O
16 Ward NNP I-NP O
16 for IN B-VP O
17 recurrent NN B-NP O
17 right JJ B-NP O
17 upper JJ I-NP O
17 quadrant NN I-NP O
17 pain NN I-NP O
17 without IN B-VP O
17 nausea NN B-NP O
17 , , O O
17 vomiting VBG O O
17 , , O O
17 or CC O O
18 fever VB O O
18 The DT B-NP O
18 patient NN I-NP O
18 then RB O O
18 was VBD B-VP O
18 subsequently RB O O
18 seen VBN O O
18 by IN B-VP O
18 Dr NNP B-NP O
18 Bellman NNP I-NP O
18 in IN B-VP O
18 the DT B-NP O
19 Chica NNP I-NP O
19 Onant NNP I-NP O
19 Hospital NNP I-NP O
19 and CC O O
19 a DT B-NP O
19 cholecystectomy NN I-NP O
19 was VBD B-VP O
19 scheduled VBN O O
19 on IN B-VP O
19 a DT B-NP O
20 routine JJ I-NP O
20 basis NN I-NP O
20 PAST NNP I-NP O
20 MEDICAL NNP I-NP O
20 HISTORY: NNP I-NP O
20 Non-contributory NNP I-NP O
20 PAST NNP I-NP O
21 SURGICAL NNP I-NP O
21 HISTORY: NNP I-NP O
21 Includes VBZ O O
21 a DT B-NP O
21 cesarean JJ I-NP O
21 section NN I-NP O
21 in IN B-VP O
21 l988 NN B-NP O
21 and CC O O
21 a DT B-NP O
22 ventral JJ I-NP O
22 hernia NN I-NP O
22 repair NN I-NP O
22 in IN B-VP O
22 March NNP B-NP O
22 of IN B-VP O
22 l990 JJ B-NP O
22 CURRENT NNP I-NP O
22 MEDICATIONS: NNP I-NP O
23 Naprosyn NNP I-NP B-m
23 as IN B-VP B-f
23 needed VBN O I-f
23 for IN B-VP O
23 right JJ B-NP B-r
23 upper JJ I-NP I-r
23 quadrant NN I-NP I-r
23 pain NN I-NP I-r
23 ALLERGIES: NNP I-NP O
24 Include NNP I-NP O
24 Penicillin NNP I-NP O
24 which WDT O O
24 gives VBZ O O
24 her PRP O O
24 a DT B-NP O
24 rash NN I-NP O
24 and CC O O
24 Compazine NNP B-NP O
24 which WDT O O
24 leads VBZ O O
25 to TO O O
25 a DT B-NP O
25 dystonic JJ I-NP O
25 reaction NN I-NP O
25 SOCIAL NNP I-NP O
25 HISTORY: NNP I-NP O
25 She PRP O O
25 does VBZ O O
25 not RB O O
25 smoke VB O O
25 or CC O O
26 drink VB O O
27 PHYSICAL NNP B-NP O
27 EXAMINATION: NNP I-NP O
27 Patient NNP I-NP O
27 was VBD B-VP O
27 afebrile JJ O O
27 with IN B-VP O
27 stable JJ B-NP O
27 vital JJ I-NP O
28 signs NNS I-NP O
28 SKIN: NNP I-NP O
28 Scattered NNP I-NP O
28 skin NN I-NP O
28 tags NN I-NP O
28 on IN B-VP O
28 her PRP$ O O
29 trunk NN B-NP O
29 NODES: NNP I-NP O
29 Negative NNP I-NP O
29 HEAD/NECK: NNP I-NP O
29 Benign NNP I-NP O
29 BREASTS: NNP I-NP O
29 Without NNP I-NP O
30 masses NNS I-NP O
30 , , O O
30 tenderness NN B-NP O
30 , , O O
30 or CC O O
30 axillary JJ B-NP O
30 adenopathy JJ I-NP O
30 LUNGS: NNP I-NP O
30 Clear NNP I-NP O
30 to TO O O
31 auscultation VB O O
31 HEART: NNP B-NP O
31 Regular NNP I-NP O
31 rate NN I-NP O
31 and CC O O
31 rhythm NN B-NP O
31 with IN B-VP O
31 no DT B-NP O
31 murmurs NNS I-NP O
31 , , O O
32 gallops NNS B-NP O
32 , , O O
32 or CC O O
32 rubs VB O O
32 PULSES: NNP B-NP O
32 2+ CD O O
32 bilaterally RB O O
32 ABDOMEN: NNP B-NP O
32 Obese NNP I-NP O
32 , , O O
33 positive JJ B-NP O
33 bowel NN I-NP O
33 sounds NNS I-NP O
33 , , O O
33 and CC O O
33 non-tender NN B-NP O
33 with IN B-VP O
33 a DT B-NP O
33 small JJ I-NP O
33 fascial JJ I-NP O
33 defect NN I-NP O
34 at IN B-VP O
34 the DT B-NP O
34 umbilicus NN I-NP O
34 and CC O O
34 a DT O O
34 well RB O O
34 healed VBN O O
34 midline NN B-NP O
34 scar NN I-NP O
34 NEUROLOGICAL: NNP I-NP O
35 Non-focal JJ B-NP O
36 LABORATORY NNP I-NP O
36 EXAMINATION: NNP I-NP O
36 Her NNP I-NP O
36 EKG NNP I-NP O
36 showed VBD B-VP O
36 normal JJ B-NP O
36 sinus NN I-NP O
36 rhythm NN I-NP O
36 at IN B-VP O
36 7l CD O O
37 beats NNS B-NP O
37 per IN B-VP O
37 minute NN B-NP O
37 with IN B-VP O
37 an DT B-NP O
37 axis NN I-NP O
37 of IN B-VP O
37 positive JJ O O
38 40 CD O O
38 degrees NNS B-NP O
38 , , O O
38 normal JJ B-NP O
38 intervals NNS I-NP O
38 , , O O
38 and CC O O
38 no DT B-NP O
38 ischemic JJ I-NP O
38 changes NNS I-NP O
38 Her PRP$ O O
38 chest JJS B-NP O
39 X-Ray NN I-NP O
39 was VBD B-VP O
39 clear JJ B-NP O
39 Her NNP I-NP O
39 electrolytes NNS I-NP O
39 were VBD B-VP O
39 all DT O O
39 within IN B-VP O
39 normal JJ B-NP O
39 limits NNS I-NP O
39 , , O O
40 her PRP$ O O
40 BUN NNP B-NP O
40 was VBD B-VP O
40 22 CD O O
40 , , O O
40 and CC O O
40 her PRP$ O O
40 creatinine NN B-NP O
40 was VBD B-VP O
40 l.0 JJ B-NP O
40 Her NNP I-NP O
40 glucose NN I-NP O
40 was VBD B-VP O
40 88 CD O O
41 Her NNP B-NP O
41 white JJ B-NP O
41 count NN I-NP O
41 was VBD B-VP O
41 6.4 CD O O
41 , , O O
41 her PRP$ O O
41 hematocrit NN B-NP O
41 was VBD B-VP O
41 33.l CD O O
41 , , O O
41 and CC O O
41 her PRP$ O O
41 platelets NNS B-NP O
42 were VBD B-VP O
42 259 CD O O
42 Her NNP B-NP O
42 PT NNP I-NP O
42 was VBD B-VP O
42 l2.3 JJ O O
42 and CC O O
42 her PRP$ O O
42 PTT NNP B-NP O
42 was VBD B-VP O
42 29.9 CD O O
42 Her NNP B-NP O
42 urinalysis NN I-NP O
43 showed VBD B-VP O
43 3-4 JJ B-NP O
43 white JJ I-NP O
43 blood NN I-NP O
43 cells NNS I-NP O
43 and CC O O
43 l+ JJ B-NP O
43 bacteria NNS I-NP O
44 HOSPITAL NNP I-NP O
44 COURSE: NNP I-NP O
44 The DT B-NP O
44 patient NN I-NP O
44 arrived VBD B-VP O
44 the DT B-NP O
44 same JJ I-NP O
44 day NN I-NP O
44 as IN B-VP O
44 her PRP$ O O
44 surgery NN B-NP O
45 and CC O O
45 was VBD B-VP O
45 taken VBN O O
45 directly RB O O
45 to TO O O
45 the DT B-NP O
45 Operating NN I-NP O
45 Room NNP I-NP O
46 Patient NNP I-NP O
46 was VBD B-VP O
46 placed VBN O O
46 under IN B-VP O
46 general JJ B-NP B-m
46 anesthesia NN I-NP I-m
46 and CC O O
46 her PRP$ O O
46 intubation NN B-NP O
46 was VBD B-VP O
47 particularly RB O O
47 difficult JJ O O
47 secondary JJ O O
47 to TO O O
47 obesity VB O O
47 requiring VBG O O
47 fiberoptic JJ B-NP O
48 intubation NN I-NP O
48 and CC O O
48 Anesthesia NNP B-NP O
48 elected VBD B-VP O
48 , , O O
48 at IN B-VP O
48 this DT B-NP O
48 time NN I-NP O
48 , , O O
48 to TO O O
48 place VB O O
48 both DT O O
48 an DT B-NP O
49 A-line NNP I-NP O
49 and CC O O
49 a DT B-NP O
49 central JJ I-NP O
49 venous JJ I-NP O
49 access NN I-NP O
49 in IN B-VP O
49 order NN B-NP O
49 to TO O O
49 be VB O O
49 able JJ O O
49 to TO O O
49 optimally RB O O
50 monitor VB O O
50 this DT B-NP O
50 difficult JJ I-NP O
50 obese JJ I-NP O
50 patient NN I-NP O
50 Patient NNP I-NP O
50 then RB O O
50 underwent VBD B-VP O
50 a DT O O
51 very RB O O
51 uncomplicated JJ B-NP O
51 cholecystectomy NN I-NP O
51 at IN B-VP O
51 which WDT O O
51 time NN B-NP O
51 a DT B-NP O
51 distended JJ I-NP O
52 gallbladder NN I-NP O
52 with IN B-VP O
52 several JJ B-NP O
52 stones NNS I-NP O
52 was VBD B-VP O
52 found VBN O O
52 The DT B-NP O
52 patient NN I-NP O
52 was VBD B-VP O
52 taken VBN O O
53 to TO O O
53 the DT B-NP O
53 Recovery NNP I-NP O
53 Room NNP I-NP O
53 in IN B-VP O
53 stable JJ B-NP O
53 condition NN I-NP O
53 after IN B-VP O
53 being VBG O O
53 extubated VBD B-VP O
53 Her NNP B-NP O
54 O2 NNP I-NP O
54 saturation NN I-NP O
54 on IN B-VP O
54 40% CD O O
54 facemask NN B-NP O
54 was VBD B-VP O
54 96% CD O O
54 in IN B-VP O
54 the DT B-NP O
54 Recovery NNP I-NP O
54 Room NNP I-NP O
54 and CC O O
54 both DT O O
55 her PRP$ O O
55 nasogastric JJ B-NP O
55 tube NN I-NP O
55 and CC O O
55 Foley NNP B-NP O
55 tube NN I-NP O
55 were VBD B-VP O
55 removed VBN O O
55 without IN B-VP O
55 incident NN B-NP O
56 Her PRP$ O O
56 A-line NNP B-NP O
56 was VBD B-VP O
56 also RB O O
56 removed VBN O O
56 before RB O O
56 transfer NN B-NP O
56 to TO O O
56 the DT B-NP O
56 floor NN I-NP O
56 but CC O O
56 her PRP$ O O
57 central JJ B-NP O
57 line NN I-NP O
57 remained VBN O O
57 in IN B-VP O
57 place NN B-NP O
57 until IN B-VP O
57 the DT B-NP O
57 following JJ I-NP O
57 day NN I-NP O
57 Patient NNP I-NP O
58 received VBD B-VP O
58 two CD O B-do
58 doses NNS B-NP I-do
58 of IN B-VP O
58 Gentamicin NNP B-NP B-m
58 as IN B-VP O
58 prophylaxis JJ O B-r
58 post-operatively RB O O
59 The DT B-NP O
59 patient NN I-NP O
59 had VBD B-VP O
59 an DT B-NP O
59 unremarkable JJ I-NP O
59 post-operative JJ I-NP O
59 course NN I-NP O
59 with IN B-VP O
59 a DT B-NP O
60 post-operative JJ I-NP O
60 hematocrit NN I-NP O
60 of IN B-VP O
60 3l.5 CD O O
60 and CC O O
60 white JJ B-NP O
60 count NN I-NP O
60 of IN B-VP O
60 8.4 CD O O
60 Her PRP$ O O
60 diet NN B-NP O
61 was VBD B-VP O
61 slowly RB O O
61 advanced JJ O O
61 and CC O O
61 she PRP O O
61 remained VBD B-VP O
61 afebrile JJ O O
61 with IN B-VP O
61 good JJ B-NP O
61 oxygen NN I-NP O
62 saturations NNS I-NP O
62 on IN B-VP O
62 room NN B-NP O
62 air NN I-NP O
62 and CC O O
62 good JJ B-NP O
62 urine NN I-NP O
62 output NN I-NP O
63 DISOSITION: NNP I-NP O
63 She PRP O O
63 was VBD B-VP O
63 discharged VBN O O
63 to TO O O
63 home VB O O
63 on IN B-VP O
63 post-operative JJ B-NP O
63 day NN I-NP O
64 number NN I-NP O
64 five CD O O
64 with IN B-VP O
64 an DT B-NP O
64 appointment NN I-NP O
64 to TO O O
64 follow-up NN B-NP O
64 in IN B-VP O
64 the DT B-NP O
65 Ingtondi NNP I-NP O
65 Community NNP I-NP O
65 Healthcare NNP I-NP O
65 on IN B-VP O
65 Thursday NNP B-NP O
65 , , O O
65 March NNP B-NP O
65 , , O O
65 for IN B-VP O
65 a DT B-NP O
65 wound NN I-NP O
65 check NN I-NP O
66 ________________________________ NNP I-NP O
66 EO942/9894 NNP I-NP O
67 QUENTIN NNP I-NP O
67 A NNP I-NP O
67 MENDELSOHN NNP I-NP O
67 , , O O
67 JR NNP B-NP O
67 , , O O
67 M.D NNP B-NP O
67 BP9 NNP I-NP O
67 D: NNP I-NP O
67 2/20/90 CD O O
68 Batch: NNP B-NP O
68 8112 CD O O
68 Report: NNP B-NP O
68 J2215G66 NNP I-NP O
68 T: NNP I-NP O
68 6/1/90 CD O O
69 Dictated NNP B-NP O
69 By: NNP I-NP O
69 THADDEUS NNP I-NP O
69 LORCH NNP I-NP O
69 , , O O
69 M.D NNP B-NP O
70 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #984247 VBZ O O
2 742668784 CD O O
2 IHC NNP B-NP O
2 48808234 CD O O
2 703320 CD O O
2 1/27/1993 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 Discharge NNP I-NP O
2 Summary NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 0/29/1993 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/7/1993 CD O O
4 ADMISSION NNP B-NP O
4 DIAGNOSIS: NNP I-NP O
4 COMPLETE NNP I-NP O
4 HEART NNP I-NP O
4 BLOCK NNP I-NP O
5 HISTORY NNP I-NP O
5 OF NNP I-NP O
5 PRESENT NNP I-NP O
5 ILLNESS: NNP I-NP O
5 Mr NNP I-NP O
5 Lahm NNP I-NP O
5 is VBZ O O
5 a DT O O
5 43 CD O O
5 year NN B-NP O
5 old JJ B-NP O
5 male NN I-NP O
6 with IN B-VP O
6 Down's NNP B-NP O
6 syndrome NN I-NP O
6 who WP O O
6 was VBD B-VP O
6 admitted VBN O O
7 with IN B-VP O
7 multiple JJ B-NP O
7 episodes NNS I-NP O
7 of IN B-VP O
7 syncope NN B-NP O
7 over IN B-VP O
7 the DT B-NP O
7 prior JJ I-NP O
7 8-10 JJ I-NP O
7 years NNS I-NP O
7 These DT O O
8 were VBD B-VP O
8 characterized VBN O O
8 by IN B-VP O
8 emesis NN B-NP O
8 followed VBN O O
8 by IN B-VP O
8 loss NN B-NP O
8 of IN B-VP O
8 consciousness NN B-NP O
8 with IN B-VP O
9 a DT B-NP O
9 question NN I-NP O
9 of IN B-VP O
9 seizure NN B-NP O
9 like IN B-VP O
9 activity NN B-NP O
9 This DT O O
9 had VBD B-VP O
9 occurred VBN O O
9 on IN B-VP O
9 a DT B-NP O
9 yearly JJ I-NP O
10 basis NN I-NP O
10 for IN B-VP O
10 8-10 JJ B-NP O
10 years NNS I-NP O
10 Such JJ O O
10 an DT B-NP O
10 episode NN I-NP O
10 occurred VBD B-VP O
10 on IN B-VP O
10 March NNP B-NP O
10 At IN B-VP O
10 that DT B-NP O
11 time NN I-NP O
11 , , O O
11 his PRP$ O O
11 mother NN B-NP O
11 brought VBD B-VP O
11 him PRP O O
11 to TO O O
11 the DT B-NP O
11 Harwelliew NNP I-NP O
11 Oker NNP I-NP O
11 Medical NNP I-NP O
11 Centers NNP I-NP O
11 Emergency NNP I-NP O
11 Room NNP I-NP O
12 because IN B-VP O
12 he PRP O O
12 developed VBD B-VP O
12 a DT B-NP O
12 facial JJ I-NP O
12 hematoma NN I-NP O
12 after IN B-VP O
12 one CD O O
12 of IN B-VP O
12 these DT B-NP O
12 episodes NNS I-NP O
13 PHYSICAL NNP I-NP O
13 EXAMINATION: NNP I-NP O
13 In IN B-VP O
13 the DT B-NP O
13 Emergency NNP I-NP O
13 Room NNP I-NP O
13 he PRP O O
13 was VBD B-VP O
13 noted VBN O O
13 to TO O O
13 be VB O O
14 somewhat RB O O
14 groggy JJ O O
14 with IN B-VP O
14 a DT B-NP O
14 brief JJ I-NP O
14 episode NN I-NP O
14 of IN B-VP O
15 apparent JJ B-NP O
15 loss NN I-NP O
15 of IN B-VP O
15 consciousness NN B-NP O
15 with IN B-VP O
15 a DT B-NP O
15 question NN I-NP O
15 of IN B-VP O
15 apnea NN B-NP O
15 He PRP O O
15 was VBD B-VP O
16 sent VBN O O
16 to TO O O
16 head VB O O
16 CT NNP B-NP O
16 for IN B-VP O
16 a DT O O
16 scan JJ O O
16 and CC O O
16 at IN B-VP O
16 that DT B-NP O
16 time NN I-NP O
16 he PRP O O
16 vomiting VBG O O
16 with IN B-VP O
16 loss NN B-NP O
17 of IN B-VP O
17 consciousness NN B-NP O
17 and CC O O
17 a DT B-NP O
17 decrease NN I-NP O
17 in IN B-VP O
17 heart NN B-NP O
17 rate NN I-NP O
17 to TO O O
17 30 CD O O
17 beats NNS B-NP O
17 per IN B-VP O
18 minute NN B-NP O
18 He PRP O O
18 was VBD B-VP O
18 intubated VBN O O
18 in IN B-VP O
18 the DT B-NP O
18 CT NNP I-NP O
18 scan JJ B-NP O
18 room NN I-NP O
18 , , O O
18 sedated VBN O O
18 and CC O O
18 paralyzed VBN O O
19 while IN B-VP O
19 the DT B-NP O
19 study NN I-NP O
19 was VBD B-VP O
19 completed VBN O O
19 When WRB O O
19 he PRP O O
19 arrived VBD B-VP O
19 in IN B-VP O
19 the DT B-NP O
19 Intensive NNP I-NP O
20 Care NNP I-NP O
20 Unit NNP I-NP O
20 , , O O
20 he PRP O O
20 had VBD B-VP O
20 a DT B-NP O
20 heart NN I-NP O
20 beat NN I-NP O
20 in IN B-VP O
20 the DT O O
20 20s CD O O
20 with IN B-VP O
20 complete JJ B-NP O
20 heart NN I-NP O
21 block NN I-NP O
21 , , O O
21 which WDT O O
21 was VBD B-VP O
21 transient NN B-NP O
21 and CC O O
21 with IN B-VP O
21 subsequent JJ B-NP O
21 return NN I-NP O
21 to TO O O
21 normal JJ B-NP O
22 sinus NN I-NP O
22 rhythm VBD B-VP O
22 The DT B-NP O
22 remainder NN I-NP O
22 of IN B-VP O
22 his PRP$ O O
22 exam NN B-NP O
22 was VBD B-VP O
22 remarkable JJ O O
22 for IN B-VP O
22 an DT B-NP O
22 S4 NNP I-NP O
23 and CC O O
23 I/VI NNP B-NP O
23 systolic JJ B-NP O
23 ejection NN I-NP O
23 murmur NN I-NP O
23 NEURO: NNP I-NP O
23 The DT B-NP O
23 neurological JJ I-NP O
23 exam NN I-NP O
23 was VBD B-VP O
24 nonfocal JJ B-NP O
25 LABORATORY NNP I-NP O
25 DATA: NNP I-NP O
25 Electrolytes NNP I-NP O
25 were VBD B-VP O
25 normal JJ O O
25 His PRP$ O O
25 EKG NN B-NP O
25 showed VBD B-VP O
25 sinus JJ B-NP O
26 tachycardia NN I-NP O
26 with IN B-VP O
26 an DT B-NP O
26 axis NN I-NP O
26 of IN B-VP O
26 0 CD O O
26 , , O O
26 ST NNP B-NP O
26 flattening VBG O O
26 in IN B-VP O
27 leads NNS B-NP O
27 V5 NNP I-NP O
27 and CC O O
27 V6 NNP B-NP O
27 , , O O
27 I PRP O O
27 in IN B-VP O
27 L NNP B-NP O
27 and CC O O
27 a DT B-NP O
27 question NN I-NP O
27 of IN B-VP O
27 a DT B-NP O
27 Q NNP I-NP O
27 in IN B-VP O
27 III NNP B-NP O
27 Chest NNP I-NP O
27 X-ray NN I-NP O
28 raised VBD B-VP O
28 the DT B-NP O
28 question NN I-NP O
28 of IN B-VP O
28 an DT B-NP O
28 infiltrate NN I-NP O
28 in IN B-VP O
28 the DT B-NP O
28 left JJ I-NP O
28 base NN I-NP O
28 The DT B-NP O
28 head NN I-NP O
28 CT NNP I-NP O
29 was VBD B-VP O
29 negative JJ O O
29 His PRP$ O O
29 course NN B-NP O
29 in IN B-VP O
29 the DT B-NP O
29 MICU NNP I-NP O
29 was VBD B-VP O
29 as IN B-VP O
29 follows: NN B-NP O
29 He PRP O O
29 ruled VBD B-VP O
29 out RP O O
30 for IN B-VP O
30 myocardial JJ B-NP O
30 infarction NN I-NP O
30 , , O O
30 despite IN B-VP O
30 an DT B-NP O
30 elevated JJ I-NP O
30 CK NNP I-NP O
30 The DT B-NP O
30 MB NNP I-NP O
30 fraction NN I-NP O
31 was VBD B-VP O
31 negative JJ O O
31 on IN B-VP O
31 electrophoresis NN B-NP O
31 On IN B-VP O
31 the DT B-NP O
31 morning NN I-NP O
31 of IN B-VP O
31 February NNP B-NP O
31 , , O O
31 he PRP O O
32 spiked VBD B-VP O
32 a DT B-NP O
32 temperature NN I-NP O
32 to TO O O
32 102.3 CD O O
32 and CC O O
32 was VBD B-VP O
32 begun VBN O O
32 on IN B-VP O
32 Penicillin NNP B-NP B-m
32 Later NNP I-NP O
32 on IN B-VP O
33 February NNP B-NP O
33 he PRP O O
33 had VBD B-VP O
33 an DT B-NP O
33 episode NN I-NP O
33 of IN B-VP O
33 complete JJ B-NP O
33 heart NN I-NP O
33 block NN I-NP O
33 with IN B-VP O
33 asystole NN B-NP O
33 for IN B-VP O
34 9 CD O O
34 seconds NNS B-NP O
34 Otherwise RB O O
34 , , O O
34 he PRP O O
34 alternated VBD B-VP O
34 sinus JJ B-NP O
34 tachycardia NN I-NP O
34 and CC O O
34 second JJ B-NP O
35 degree JJ I-NP O
35 heart NN I-NP O
35 block NN I-NP O
35 with IN B-VP O
35 runs NNS B-NP O
35 of IN B-VP O
35 bradycardia NN B-NP O
35 at IN B-VP O
35 the DT B-NP O
35 rate NN I-NP O
35 of IN B-VP O
35 30-40 JJ O O
36 and CC O O
36 also RB O O
36 tachycardia JJ B-NP O
37 HOSPITAL NNP I-NP O
37 COURSE: NNP I-NP O
37 A NNP I-NP O
37 temporary JJ B-NP O
37 pacemaker NN I-NP O
37 was VBD B-VP O
37 placed VBN O O
37 on IN B-VP O
37 February NNP B-NP O
38 through IN B-VP O
38 the DT B-NP O
38 left NN I-NP O
38 subclavian JJ B-NP O
38 approach NN I-NP O
38 At IN B-VP O
38 that DT B-NP O
39 time NN I-NP O
39 , , O O
39 he PRP O O
39 was VBD B-VP O
39 hemodynamically RB O O
39 stable JJ O O
39 , , O O
39 except IN B-VP O
39 for IN B-VP O
39 intermittent JJ B-NP B-r
40 hypertension NN I-NP O
40 , , O O
40 which WDT O O
40 was VBD B-VP O
40 treated VBN O O
40 with IN B-VP O
40 Nifedipine NNP B-NP B-m
40 He PRP O O
40 was VBD B-VP O
41 transferred VBN O O
41 to TO O O
41 the DT B-NP O
41 Cardiology NNP I-NP O
41 Wa NNP I-NP O
41 Nas NNP I-NP O
41 O NNP I-NP O
41 on IN B-VP O
41 March NNP B-NP O
41 , , O O
41 1993 CD O O
41 to TO O O
41 await VB O O
42 pacemaker NN B-NP O
42 placement NN I-NP O
42 He PRP O O
42 was VBD B-VP O
42 switched VBN O O
42 from IN B-VP O
42 Nifedipine NNP B-NP B-m
42 to TO O O
42 Captopril NNP B-NP B-m
43 for IN B-VP O
43 treatment NN B-NP O
43 of IN B-VP O
43 his PRP$ O B-r
43 his PRP$ O B-r
43 hypertension NN B-NP I-r
43 hypertension NN I-NP I-r
43 and CC O O
43 his PRP$ O O
43 fever NN B-NP O
43 was VBD B-VP O
43 treated VBN O O
43 with IN B-VP O
44 Cefotetan NNP B-NP B-m
44 for IN B-VP O
44 presumed JJ B-NP B-r
44 aspiration NN I-NP I-r
44 pneumonia NN I-NP I-r
44 This DT O O
44 has VBZ O O
44 resulted VBN O O
44 in IN B-VP O
44 a DT B-NP O
45 delay NN I-NP O
45 in IN B-VP O
45 his PRP$ O O
45 pacemaker NN B-NP O
45 placement NN I-NP O
45 He PRP O O
45 intermittently RB O O
45 had VBD B-VP O
45 a DT B-NP O
46 pericardial JJ I-NP O
46 friction NN I-NP O
46 rub NN I-NP O
46 on IN B-VP O
46 physical JJ B-NP O
46 examination NN I-NP O
46 that WDT O O
46 was VBD B-VP O
46 thought VBN O O
47 to TO O O
47 be VB O O
47 most RBS O O
47 likely JJ O O
47 due JJ O O
47 to TO O O
47 myocardial JJ B-NP O
47 irritation NN I-NP O
47 by IN B-VP O
47 the DT B-NP O
47 pacing NN I-NP O
47 wire NN I-NP O
48 implantation NN I-NP O
48 One CD O O
48 echocardiogram NN B-NP O
48 in IN B-VP O
48 a DT B-NP O
48 series NN I-NP O
48 did VBD B-VP O
48 reveal VB O O
48 a DT B-NP O
48 regional JJ I-NP O
49 wall NN I-NP O
49 motion NN I-NP O
49 abnormality NN I-NP O
49 that WDT O O
49 may MD O O
49 have VB O O
49 been VBN O O
49 a DT B-NP O
49 function NN I-NP O
49 of IN B-VP O
49 the DT B-NP O
50 pacemaker NN I-NP O
50 wire NN I-NP O
50 as RB O O
50 well RB O O
50 He PRP O O
50 remained VBD B-VP O
50 afebrile JJ O O
50 and CC O O
50 completed VBD B-VP O
50 a DT B-NP O
50 course NN I-NP O
51 of IN B-VP O
51 antibiotics NNS B-NP B-m
51 for IN B-VP O
51 his PRP$ O B-r
51 presumed JJ B-NP I-r
51 aspiration NN I-NP I-r
51 pneumonia NN I-NP I-r
51 , , O O
51 although IN B-VP O
52 subsequent JJ B-NP O
52 chest JJS I-NP O
52 x-rays NNS I-NP O
52 did VBD B-VP O
52 not RB O O
52 support VB O O
52 that IN B-VP O
52 diagnosis NN B-NP O
52 He PRP O O
53 required VBD B-VP O
53 replacement NN B-NP O
53 of IN B-VP O
53 his PRP$ O O
53 temporary JJ B-NP O
53 pacemaker NN I-NP O
53 wire NN I-NP O
53 while IN B-VP O
53 awaiting VBG O O
54 permanent JJ B-NP O
54 pacemaker NN I-NP O
54 placement NN I-NP O
54 to TO O O
54 decrease VB O O
54 the DT B-NP O
54 risk NN I-NP O
54 of IN B-VP O
54 infection NN B-NP O
55 He PRP O O
55 underwent JJ B-NP O
55 permanent JJ I-NP O
55 pacemaker NN I-NP O
55 placement NN I-NP O
55 in IN B-VP O
55 the DT B-NP O
55 Operating NN I-NP O
55 Room NN I-NP O
56 with IN B-VP O
56 anesthesia JJ B-NP O
56 backup NN I-NP O
56 in IN B-VP O
56 case NN B-NP O
56 there EX O O
56 was VBD B-VP O
56 need NN B-NP O
56 for IN B-VP O
56 intubation NN B-NP O
57 because IN B-VP O
57 the DT B-NP O
57 patient NN I-NP O
57 had VBD B-VP O
57 difficulty NN B-NP O
57 remaining VBG O O
57 still RB O O
57 The DT B-NP O
57 pacemaker NN I-NP O
58 replacement NN I-NP O
58 was VBD B-VP O
58 performed VBN O O
58 on IN B-VP O
58 August NNP B-NP O
58 , , O O
58 1993 CD O O
58 Intubation NNP B-NP O
58 was VBD B-VP O
58 not RB O O
59 necessary JJ B-NP O
60 DISPOSITION: NNP I-NP O
60 He PRP O O
60 tolerated VBD B-VP O
60 the DT B-NP O
60 procedure NN I-NP O
60 well RB O O
60 and CC O O
60 was VBD B-VP O
60 discharged VBN O O
60 to TO O O
61 home NN B-NP O
61 on IN B-VP O
61 March NNP B-NP O
61 , , O O
61 1993 CD O O
61 MEDICATIONS: NNP B-NP O
61 The DT B-NP O
61 medications NNS I-NP O
61 at IN B-VP O
62 discharge NN B-NP O
62 were: NN I-NP O
62 Kefzol NNP I-NP B-m
62 500mg CD O B-do
62 q.i.d NN B-NP B-f
62 for IN B-VP B-du
62 3 CD O I-du
62 days NNS B-NP I-du
62 , , O O
62 and CC O O
62 Lisinopril NNP B-NP B-m
62 10mg CD O B-do
63 p.o NN B-NP B-mo
63 q NN I-NP B-f
63 day NN I-NP I-f
63 He PRP O O
63 will MD O O
63 followup VB O O
63 with IN B-VP O
63 Dr NNP B-NP O
63 Antis NNP I-NP O
63 on IN B-VP O
63 January NNP B-NP O
63 , , O O
63 1993 CD O O
63 and CC O O
63 in IN B-VP O
64 TYTAZE NNP B-NP O
64 TH NNP I-NP O
64 IONO NNP I-NP O
64 VALLEY NNP I-NP O
64 HEALTH NNP I-NP O
64 with IN B-VP O
64 Dr NNP B-NP O
64 Filiberto NNP I-NP O
64 Schie NNP I-NP O
64 Secondary NNP I-NP O
64 Diagnoses NNP I-NP O
64 were VBD B-VP O
64 pacemaker VBN O O
65 placement NN B-NP O
65 and CC O O
65 Down's NNP B-NP O
65 syndrome VBP O O
66 Dictated NNP B-NP O
66 By: NNP I-NP O
66 OLIN NNP I-NP O
66 E NNP I-NP O
66 ZELEDON NNP I-NP O
66 , , O O
66 M.D NNP B-NP O
66 HJ25 NNP I-NP O
67 Attending: NNP I-NP O
67 ULYSSES NNP I-NP O
67 J NNP I-NP O
67 DRANE NNP I-NP O
67 , , O O
67 M.D NNP B-NP O
67 TS0 NNP I-NP O
68 SO547/1452 NNP I-NP O
69 Batch: NNP I-NP O
69 2399 CD O O
69 Index NNP B-NP O
69 No NNP I-NP O
69 D5GQOZ62V6 NNP I-NP O
69 D: NNP I-NP O
69 3/5/93 CD O O
70 T: NNP B-NP O
70 3/5/93 CD O O
71 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #984424 VBZ O O
2 929972643 CD O O
2 LOH NNP B-NP O
2 49110992 CD O O
2 3533188 CD O O
2 8/3/2005 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 COPD NNP I-NP O
2 flare NN I-NP O
2 , , O O
2 right JJ B-NP O
2 heart NN I-NP O
2 failure NN I-NP O
2 DIS NNP I-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/0/2005 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 2/17/2005 CD O O
4 ****** NNP B-NP O
4 FINAL NNP I-NP O
4 DISCHARGE NNP I-NP O
4 ORDERS NNP I-NP O
4 ****** NNP I-NP O
5 SCARBERRY NNP I-NP O
5 , , O O
5 DION NNP B-NP O
5 926-57-39-3 CD O O
6 A NNP B-NP O
6 Clearland NNP I-NP O
6 Cale NNP I-NP O
7 Service: NNP I-NP O
7 MED NNP I-NP O
8 DISCHARGE NNP I-NP O
8 PATIENT NNP I-NP O
8 ON: NNP I-NP O
8 5/28/05 CD O O
8 AT NNP B-NP O
8 02:00 CD O O
8 PM NNP B-NP O
9 CONTINGENT NNP I-NP O
9 UPON NNP I-NP O
9 Not RB O O
9 Applicable NNP B-NP O
10 WILL MD O O
10 D/C VB O O
10 ORDER NNP B-NP O
10 BE NNP I-NP O
10 USED NNP I-NP O
10 AS IN B-VP O
10 THE NNP B-NP O
10 D/C NNP I-NP O
10 SUMMARY: NNP I-NP O
10 YES NNP I-NP O
11 Attending: NNP I-NP O
11 PRASAD NNP I-NP O
11 , , O O
11 AMOS NNP B-NP O
11 , , O O
11 M.D NNP B-NP O
12 CODE NNP I-NP O
12 STATUS: NNP I-NP O
13 Full NNP I-NP O
13 code NN I-NP O
14 DISPOSITION: NNP I-NP O
14 Home NNP I-NP O
14 w/ NN I-NP O
14 services NNS I-NP O
15 DISCHARGE NNP I-NP O
15 MEDICATIONS: NNP I-NP O
16 ACETYLSALICYLIC NNP I-NP B-m
16 ACID NNP I-NP I-m
16 81 CD O B-do
16 MG NNP B-NP I-do
16 PO NNP I-NP B-mo
16 QD NNP I-NP B-f
16 Starting NNP I-NP O
16 IN NNP I-NP O
16 AM NNP I-NP O
16 ( ( O O
16 7/17 CD O O
16 ) ) O O
17 ELAVIL NNP B-NP B-m
17 ( ( O I-m
17 AMITRIPTYLINE NNP B-NP I-m
17 HCL NNP I-NP I-m
17 ) ) O I-m
17 10 CD O B-do
17 MG NNP B-NP I-do
17 PO NNP I-NP B-mo
17 QHS NNP I-NP B-f
18 ATENOLOL NNP I-NP B-m
18 25 CD O B-do
18 MG NNP B-NP I-do
18 PO NNP I-NP B-mo
18 QD NNP I-NP B-f
18 Starting NNP I-NP O
18 IN NNP I-NP O
18 AM NNP I-NP O
18 ( ( O O
18 7/17 CD O O
18 ) ) O O
19 COLACE NNP B-NP B-m
19 ( ( O I-m
19 DOCUSATE NNP B-NP I-m
19 SODIUM NNP I-NP I-m
19 ) ) O I-m
19 100 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 BID NNP I-NP B-f
20 FUROSEMIDE NNP I-NP B-m
20 20 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 QD NNP I-NP B-f
20 Starting VBG O O
20 Today NNP B-NP O
20 ( ( O O
20 6/25 CD O O
20 ) ) O O
21 GUAIFENESIN NNP B-NP B-m
21 10 CD O B-do
21 MILLILITERS NNP B-NP I-do
21 PO NNP I-NP B-mo
21 TID NNP I-NP O
21 Starting VBG O O
21 Today NNP B-NP O
21 ( ( O O
21 6/25 CD O O
21 ) ) O O
22 PRN NNP B-NP O
22 Other:cough NNP I-NP O
23 OXYCODONE NNP I-NP B-m
23 5 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 TID NNP I-NP O
23 Starting VBG O O
23 Today NNP B-NP O
23 ( ( O O
23 6/25 CD O O
23 ) ) O O
23 PRN NNP B-NP B-f
23 Pain NNP I-NP B-r
24 Instructions: NNP I-NP O
24 please NN I-NP O
24 give VB O O
24 am VBP O O
24 and CC O O
24 pm VBP O O
24 dose NN B-NP O
24 with IN B-VP O
24 his PRP$ O O
24 doses NNS B-NP O
24 of IN B-VP O
25 morphine NN B-NP B-m
25 midday NN I-NP O
25 dose VB O O
25 2-3pm.thank JJ O O
25 you PRP O O
26 QUININE VBP O B-m
26 SULFATE JJ O I-m
26 325 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 HS NNP I-NP B-f
26 Starting VBG O O
26 Today NNP B-NP O
26 ( ( O O
26 6/25 CD O O
26 ) ) O O
27 Food/Drug NNP B-NP O
27 Interaction NNP I-NP O
27 Instruction NNP I-NP O
27 Take NNP I-NP O
27 with IN B-VP O
27 food NN B-NP O
28 SENNA NNP I-NP B-m
28 TABLETS NNP I-NP I-m
28 ( ( O I-m
28 SENNOSIDES NNP B-NP I-m
28 ) ) O I-m
28 2 CD O B-do
28 TAB NNP B-NP I-do
28 PO NNP I-NP B-mo
28 BID NNP I-NP B-f
29 MVI NNP I-NP B-m
29 THERAPEUTIC NNP I-NP I-m
29 ( ( O I-m
29 THERAPEUTIC NNP B-NP I-m
29 MULTIVITAMINS NNP I-NP I-m
29 ) ) O I-m
29 1 CD O B-do
29 TAB NNP B-NP I-do
29 PO NNP I-NP B-mo
29 QD NNP I-NP B-f
30 Alert NNP I-NP O
30 overridden: NNP I-NP O
30 Override NNP I-NP O
30 added VBD B-VP O
30 on IN B-VP O
30 2/11/05 CD O O
30 by IN B-VP O
31 BURKS NNP B-NP O
31 , , O O
31 LEVI NNP B-NP O
31 A NNP I-NP O
31 , , O O
31 M.D NNP B-NP O
32 POTENTIALLY NNP I-NP O
32 SERIOUS NNP I-NP O
32 INTERACTION: NNP I-NP O
32 SIMVASTATIN NNP I-NP B-m
32 &amp; NNP I-NP O
32 NIACIN NNP I-NP B-m
32 , , O O
33 VIT NNP B-NP B-m
33 B-3 NNP I-NP I-m
33 Reason NNP I-NP O
33 for IN B-VP O
33 override: NN B-NP O
33 will MD O O
33 monitor VB O O
34 ZOCOR NNP B-NP B-m
34 ( ( O I-m
34 SIMVASTATIN NNP B-NP I-m
34 ) ) O I-m
34 20 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 QHS NNP I-NP B-f
35 Food/Drug NNP I-NP O
35 Interaction NNP I-NP O
35 Instruction NNP I-NP O
36 Avoid NNP I-NP O
36 grapefruit NN I-NP O
36 unless IN B-VP O
36 MD NNP B-NP O
36 instructs NNS I-NP O
36 otherwise RB O O
37 Override NNP B-NP O
37 Notice: NNP I-NP O
37 Override NNP I-NP O
37 added VBD B-VP O
37 on IN B-VP O
37 2/11/05 CD O O
37 by IN B-VP O
38 PITTELKOW NNP B-NP O
38 , , O O
38 TUAN NNP B-NP O
38 B NNP I-NP O
38 , , O O
38 M.D NNP B-NP O
39 on IN B-VP O
39 order NN B-NP O
39 for IN B-VP O
39 MVI NNP B-NP O
39 THERAPEUTIC NNP I-NP O
39 PO NNP I-NP O
39 ( ( O O
39 ref JJ O O
39 # # O O
39 17152641 CD O O
39 ) ) O O
40 POTENTIALLY NNP B-NP O
40 SERIOUS NNP I-NP O
40 INTERACTION: NNP I-NP O
40 SIMVASTATIN NNP I-NP B-m
40 &amp; NNP I-NP O
40 NIACIN NNP I-NP B-m
40 , , O O
41 VIT NNP B-NP B-m
41 B-3 NNP I-NP I-m
41 Reason NNP I-NP O
41 for IN B-VP O
41 override: NN B-NP O
41 will MD O O
41 monitor VB O O
42 MORPHINE NNP B-NP B-m
42 CONTROLLED NNP I-NP I-m
42 RELEASE NNP I-NP I-m
42 15 CD O B-do
42 MG NNP B-NP I-do
42 PO NNP I-NP B-mo
42 Q12H NNP I-NP B-f
43 FELODIPINE NNP I-NP B-m
43 5 CD O B-do
43 MG NNP B-NP I-do
43 PO NNP I-NP B-mo
43 QD NNP I-NP B-f
43 Food/Drug NNP I-NP O
43 Interaction NNP I-NP O
43 Instruction NNP I-NP O
44 Avoid NNP I-NP O
44 grapefruit NN I-NP O
44 unless IN B-VP O
44 MD NNP B-NP O
44 instructs VBZ O O
44 otherwise RB O O
45 Number NNP B-NP B-du
45 of IN B-VP I-du
45 Doses NNP B-NP I-du
45 Required NNP I-NP I-du
45 ( ( O I-du
45 approximate JJ B-NP I-du
45 ): NN I-NP I-du
45 5 CD O I-du
46 FLONASE NNP B-NP B-m
46 ( ( O I-m
46 FLUTICASONE NNP B-NP I-m
46 NASAL NNP I-NP I-m
46 SPRAY NNP I-NP I-m
46 ) ) O I-m
46 1 CD O B-do
46 SPRAY NNP B-NP I-do
46 INH NNP I-NP B-mo
46 QD NNP I-NP B-f
47 Number NNP I-NP B-du
47 of IN B-VP I-du
47 Doses NNP B-NP I-du
47 Required NNP I-NP I-du
47 ( ( O I-du
47 approximate JJ B-NP I-du
47 ): NN I-NP I-du
47 5 CD O I-du
48 ADVAIR NNP B-NP B-m
48 DISKUS NNP I-NP I-m
48 500/50 CD O I-m
48 ( ( O I-m
48 FLUTICASONE NNP B-NP I-m
48 PROPIONATE/ NNP I-NP I-m
48 ) ) O I-m
49 1 CD O B-do
49 PUFF NNP B-NP I-do
49 INH NNP I-NP O
49 BID NNP I-NP O
50 CALTRATE NNP I-NP B-m
50 + NNP I-NP I-m
50 D NNP I-NP I-m
50 ( ( O I-m
50 CALCIUM NNP B-NP I-m
50 CARBONATE NNP I-NP I-m
50 1 CD O I-m
50 , , O I-m
50 500 CD O I-m
50 MG NNP B-NP I-m
50 ( ( O I-m
50 600 CD O I-m
50 ) ) O I-m
51 1 CD O B-do
51 TAB NNP B-NP I-do
51 PO NNP I-NP B-mo
51 BID NNP I-NP B-f
52 NOVOLOG NNP I-NP B-m
52 NOVOLOG NNP I-NP B-m
52 NOVOLOG NNP I-NP B-m
52 MIX NNP I-NP I-m
52 MIX NNP I-NP I-m
52 MIX NNP I-NP I-m
52 70/30 CD O I-m
52 70/30 CD O I-m
52 70/30 CD O I-m
52 ( ( O I-m
52 ( ( O I-m
52 ( ( O I-m
52 INSULIN NNP B-NP I-m
52 INSULIN NNP I-NP I-m
52 INSULIN NNP I-NP I-m
52 ASPART NNP I-NP I-m
52 ASPART NNP I-NP I-m
52 ASPART NNP I-NP I-m
52 70/30 CD O I-m
52 70/30 CD O I-m
52 70/30 CD O I-m
52 ) ) O I-m
52 ) ) O I-m
52 ) ) O I-m
53 35 CD O B-do
53 UNITS NNP B-NP I-do
53 QAM; NNP I-NP B-f
53 22 CD O B-do
53 UNITS NNP B-NP I-do
53 QPM NNP I-NP B-f
53 SC NNP I-NP B-mo
53 SC NNP I-NP B-mo
53 35 CD O B-do
53 UNITS NNP B-NP I-do
53 QAM NNP I-NP B-f
53 22 CD O O
53 UNITS NNP B-NP O
53 QPM NNP I-NP O
54 PREDNISONE NNP I-NP B-m
54 PREDNISONE NNP I-NP B-m
54 PREDNISONE NNP I-NP B-m
54 PREDNISONE NNP I-NP B-m
54 PREDNISONE NNP I-NP B-m
54 PREDNISONE NNP I-NP B-m
54 PREDNISONE NNP I-NP B-m
54 Taper NNP I-NP O
54 PO NNP I-NP B-mo
54 Give NNP I-NP O
54 60 CD O B-do
54 mg NN B-NP I-do
54 q NN I-NP B-f
54 24 CD O I-f
54 h NN B-NP I-f
54 X NNP I-NP B-du
54 5 CD O I-du
54 dose( NN B-NP I-du
54 s NN I-NP I-du
54 ) ) O I-du
54 , , O O
54 then RB O O
55 Give VB O O
55 50 CD O B-do
55 mg NN B-NP I-do
55 q NN I-NP B-f
55 24 CD O I-f
55 h NN B-NP I-f
55 X NNP I-NP B-du
55 3 CD O I-du
55 dose( NN B-NP I-du
55 s NN I-NP I-du
55 ) ) O I-du
55 , , O O
55 then RB O O
56 Give VB O O
56 40 CD O B-do
56 mg NN B-NP I-do
56 q NN I-NP B-f
56 24 CD O I-f
56 h NN B-NP I-f
56 X NNP I-NP B-du
56 3 CD O I-du
56 dose( NN B-NP I-du
56 s NN I-NP I-du
56 ) ) O I-du
56 , , O O
56 then RB O O
57 Give VB O O
57 30 CD O B-do
57 mg NN B-NP I-do
57 q NN I-NP B-f
57 24 CD O I-f
57 h NN B-NP I-f
57 X NNP I-NP B-du
57 3 CD O I-du
57 dose( NN B-NP I-du
57 s NN I-NP I-du
57 ) ) O I-du
57 , , O O
57 then RB O O
58 Give VB O O
58 20 CD O B-do
58 mg NN B-NP I-do
58 q NN I-NP B-f
58 24 CD O I-f
58 h NN B-NP I-f
58 X NNP I-NP B-du
58 3 CD O I-du
58 dose( NN B-NP I-du
58 s NN I-NP I-du
58 ) ) O I-du
58 , , O O
58 then RB O O
59 Give VB O O
59 10 CD O B-do
59 mg NN B-NP I-do
59 q NN I-NP B-f
59 24 CD O I-f
59 h NN B-NP I-f
59 X NNP I-NP B-du
59 3 CD O I-du
59 dose( NN B-NP I-du
59 s NN I-NP I-du
59 ) ) O I-du
59 , , O O
59 then RB O O
60 Give VB O O
60 5 CD O B-do
60 mg NN B-NP I-do
60 q NN I-NP B-f
60 24 CD O I-f
60 h NN B-NP I-f
60 X NNP I-NP B-du
60 3 CD O I-du
60 dose( NN B-NP I-du
60 s NN I-NP I-du
60 ) ) O I-du
60 , , O O
60 then RB O O
60 Starting VBG O O
60 Today NNP B-NP O
60 ( ( O O
60 6/25 CD O O
60 ) ) O O
61 COMBIVENT NNP B-NP B-m
61 ( ( O I-m
61 IPRATROPIUM NNP B-NP I-m
61 AND NNP I-NP I-m
61 ALBUTEROL NNP I-NP I-m
61 SULFATE NNP I-NP I-m
61 ) ) O I-m
62 2 CD O B-do
62 PUFF NNP B-NP I-do
62 INH NNP I-NP B-mo
62 QID NNP I-NP B-f
63 DIET: NNP I-NP O
63 4 CD O O
63 gram NN B-NP O
63 Sodium NNP I-NP O
64 ACTIVITY: NNP I-NP O
64 Resume NNP I-NP O
64 regular JJ B-NP O
64 exercise NN I-NP O
65 FOLLOW NNP I-NP O
65 UP NNP I-NP O
65 APPOINTMENT( NNP I-NP O
65 S NNP I-NP O
65 ): NNP I-NP O
66 Please NNP I-NP O
66 schedule NN I-NP O
66 appointment NN I-NP O
66 with IN B-VP O
66 primary JJ B-NP O
66 care NN I-NP O
66 doctor NN I-NP O
66 at IN B-VP O
66 the DT B-NP O
66 BCCMC NNP I-NP O
66 early JJ B-NP O
66 next JJ I-NP O
66 week NN I-NP O
66 , , O O
67 ALLERGY: NNP B-NP O
67 Erythromycins NNP I-NP O
68 ADMIT NNP I-NP O
68 DIAGNOSIS: NNP I-NP O
69 pneumonia NN I-NP O
70 PRINCIPAL NNP I-NP O
70 DISCHARGE NNP I-NP O
70 DIAGNOSIS NNP I-NP O
70 ;Responsible JJ O O
70 After IN B-VP O
70 Study NNP B-NP O
70 for IN B-VP O
70 Causing NNP B-NP O
70 Admission NNP I-NP O
70 ) ) O O
71 COPD NNP B-NP O
71 flare NN I-NP O
71 , , O O
71 right JJ B-NP O
71 heart NN I-NP O
71 failure NN I-NP O
72 OTHER NNP I-NP O
72 DIAGNOSIS;Conditions NNP I-NP O
72 , , O O
72 Infections NNP B-NP O
72 , , O O
72 Complications NNP B-NP O
72 , , O O
72 affecting VBG O O
72 Treatment/Stay NNP B-NP O
73 prostate NN I-NP O
73 CA NNP I-NP O
73 , , O O
73 DM NNP B-NP O
73 , , O O
73 hypertension NN B-NP O
73 , , O O
73 R NNP B-NP O
73 breast NN I-NP O
73 cancer NN I-NP O
73 , , O O
73 recurrent NN B-NP O
74 pneumothorax NN I-NP O
74 , , O O
74 COPD NNP B-NP O
74 on IN B-VP O
74 home NN B-NP O
74 O2 NNP I-NP O
74 , , O O
74 hypercholesterolemia NN B-NP O
74 , , O O
74 OA NNP B-NP O
74 , , O O
74 chronic JJ B-NP O
74 pain NN I-NP O
75 BPH NNP I-NP O
75 , , O O
75 peripheral JJ B-NP O
75 neuopathy JJ I-NP O
76 OPERATIONS NNP I-NP O
76 AND NNP I-NP O
76 PROCEDURES: NNP I-NP O
77 none NN I-NP O
78 OTHER NNP I-NP O
78 TREATMENTS/PROCEDURES NNP I-NP O
78 ( ( O O
78 NOT NNP B-NP O
78 IN NNP I-NP O
78 O.R NNP I-NP O
78 ) ) O O
79 cardiac VBP O O
79 MR NNP B-NP O
80 v/q FW O O
80 scan JJ B-NP O
81 BRIEF NNP I-NP O
81 RESUME NNP I-NP O
81 OF NNP I-NP O
81 HOSPITAL NNP I-NP O
81 COURSE: NNP I-NP O
82 --HPI: NNP I-NP O
82 Mr NNP I-NP O
82 Gump NNP I-NP O
82 is VBZ O O
82 a DT B-NP O
82 77yo JJ I-NP O
82 African JJ I-NP O
82 American JJ I-NP O
82 male NN I-NP O
82 with IN B-VP O
82 PMH NNP B-NP O
82 notable JJ O O
82 for IN B-VP O
82 COPD NNP B-NP O
82 , , O O
83 HTN NNP B-NP O
83 , , O O
83 NIDDM NNP B-NP O
83 and CC O O
83 recent JJ B-NP O
83 PNA NNP I-NP O
83 who WP O O
83 presented VBD B-VP O
83 to TO O O
83 SHH NNP B-NP O
83 ED NNP I-NP O
83 on IN B-VP O
83 7/26/05 CD O O
83 via IN B-VP O
83 EMS NNP B-NP O
83 with IN B-VP O
83 a DT B-NP O
84 CC NNP I-NP O
84 of IN B-VP O
84 SOB NNP B-NP O
84 x NNP I-NP O
84 3d CD O O
84 He PRP O O
84 was VBD B-VP O
84 seen VBN O O
84 2 CD O O
84 days NNS B-NP O
84 earlier RBR O O
84 at IN B-VP O
84 the DT B-NP O
84 Dis.ry NNP I-NP O
84 Medical NNP I-NP O
84 Center NNP I-NP O
84 where WRB O O
84 he PRP O O
85 was VBD B-VP O
85 diagosed VBN O O
85 with IN B-VP O
85 pneumonia NN B-NP O
85 and CC O O
85 given VBN O O
85 Azithromycin NNP B-NP B-m
85 The DT B-NP O
85 day NN I-NP O
85 of IN B-VP O
85 admissio NN B-NP O
86 he PRP O O
86 said VBD B-VP O
86 his PRP$ O O
86 breathing NN B-NP O
86 felt VBD B-VP O
86 more RBR O O
86 labored JJ O O
86 and CC O O
86 he PRP O O
86 contacted VBD B-VP O
86 EMS NNP B-NP O
86 to TO O O
86 take VB O O
86 him PRP O O
86 to TO O O
87 the DT B-NP O
87 CHA NNP I-NP O
87 ED NNP I-NP O
87 He PRP O O
87 also RB O O
87 reported VBD B-VP O
87 worsening VBG O O
87 exercise NN B-NP O
87 tolerance NN I-NP O
87 and CC O O
87 an DT B-NP O
87 increase NN I-NP O
88 in IN B-VP O
88 bilateral JJ B-NP O
88 lower JJR I-NP O
88 extremity NN I-NP O
88 edema NN I-NP O
88 over IN B-VP O
88 the DT B-NP O
88 past JJ I-NP O
88 few JJ I-NP O
88 months NNS I-NP O
88 , , O O
88 accompanied VBN O O
88 by IN B-VP O
89 a DT O O
89 20lb CD O O
89 weight NN B-NP O
89 gain NN I-NP O
89 He PRP O O
89 also RB O O
89 noted VBD B-VP O
89 left VBD B-VP O
89 sided JJ B-NP O
89 pleuritic JJ I-NP O
89 pain NN I-NP O
89 made VBD B-VP O
89 worse JJR O O
89 by IN B-VP O
90 physical JJ B-NP O
90 movement NN I-NP O
90 and CC O O
90 deep JJ B-NP O
90 breathing NN I-NP O
90 He PRP O O
90 was VBD B-VP O
90 treated VBN O O
90 in IN B-VP O
90 the DT B-NP O
90 ED NNP I-NP O
90 with IN B-VP O
91 supplemental JJ B-NP O
91 O2 NNP I-NP B-m
91 and CC O O
91 Levofloxacin NNP B-NP B-m
91 and CC O O
91 admitted VBN O O
91 with IN B-VP O
91 a DT B-NP O
91 diagnosis NN I-NP O
91 of IN B-VP O
91 COPD NNP B-NP O
91 flare NN I-NP O
92 and CC O O
92 right JJ B-NP O
92 heart NN I-NP O
92 failure NN I-NP O
93 --Home NNP I-NP O
93 meds: NN I-NP O
93 atenolol VBD B-VP B-m
93 25mg CD O B-do
93 PO NNP B-NP O
93 qd NN I-NP B-f
93 , , O O
93 HCTZ NNP B-NP B-m
93 25mg CD O B-do
93 PO NNP B-NP B-mo
93 PO NNP I-NP B-mo
93 qd NN I-NP B-f
93 , , O O
93 felodipine VBP O B-m
93 5mg CD O B-do
93 PO NNP B-NP B-mo
93 qd NN I-NP B-f
93 , , O O
94 zocor NN B-NP B-m
94 20mg CD O B-do
94 PO NNP B-NP B-mo
94 qhs NN I-NP B-f
94 , , O O
94 ASA NNP B-NP B-m
94 81mg CD O B-do
94 PO NNP B-NP B-mo
94 qd NN I-NP B-f
94 , , O O
94 Advair NNP B-NP B-m
94 1 CD O B-do
94 puff NN B-NP I-do
94 bid NN I-NP B-f
94 , , O O
94 Combivent NNP B-NP B-m
94 2 CD O B-do
94 puffs NNS B-NP I-do
95 qid RB O B-f
95 , , O O
95 loratidine JJ O B-m
95 10mg CD O B-do
95 PO NNP B-NP B-mo
95 qd NN I-NP B-f
95 , , O O
95 guqifenesin NN B-NP B-m
95 600mg CD O B-do
95 PO NNP B-NP B-mo
95 q12h NN I-NP B-f
95 , , O O
95 morphine VBP O B-m
95 15mg CD O B-do
95 PO NNP B-NP B-mo
96 q8-12h NN I-NP B-f
96 , , O O
96 Percocet NNP B-NP B-m
96 1-2 JJ B-NP B-do
96 tab NN I-NP I-do
96 PO NNP I-NP B-mo
96 q6h NN I-NP B-f
96 , , O O
96 quinine JJ B-NP B-m
96 sulfate NN I-NP I-m
96 325mg CD O B-do
96 PO NNP B-NP B-mo
96 qhs NN I-NP B-f
96 , , O O
96 Colace NNP B-NP B-m
97 100mg CD O B-do
97 PO NNP B-NP B-mo
97 bid NN I-NP B-f
97 , , O O
97 Senna NNP B-NP B-m
97 2 CD O B-do
97 tab NN B-NP I-do
97 PO NNP I-NP B-mo
97 qd NN I-NP B-f
97 , , O O
97 calcium+vim NN B-NP B-m
97 D NNP I-NP I-m
97 125 CD O B-do
97 units NNS B-NP I-do
97 PO NNP I-NP B-mo
97 qd NN I-NP B-f
97 , , O O
97 Elavil NNP B-NP B-m
98 10mg CD O B-do
98 PO NNP B-NP B-mo
98 qhs NN I-NP B-f
99 --Allergies: NNP I-NP O
99 NKDA NNP I-NP O
100 --Social NNP I-NP O
100 Hx: NNP I-NP O
100 veteran NN I-NP O
100 and CC O O
100 retired JJ B-NP O
100 school NN I-NP O
100 bus NN I-NP O
100 driver NN I-NP O
100 lives VBZ O O
100 with IN B-VP O
100 close JJ B-NP O
100 friend NN I-NP O
101 in IN B-VP O
101 Thou NNP B-NP O
101 son NN I-NP O
101 checks NNS I-NP O
101 in IN B-VP O
101 on IN B-VP O
101 him PRP O O
101 multiple JJ B-NP O
101 times NNS I-NP O
101 during IN B-VP O
101 the DT B-NP O
101 week NN I-NP O
102 --PE NNP I-NP O
102 upon IN B-VP O
102 admission: NN B-NP O
102 afebrile NN I-NP O
102 , , O O
102 P NNP B-NP O
102 101 CD O O
102 , , O O
102 R NNP B-NP O
102 28 CD O O
102 , , O O
102 BP NNP B-NP O
102 150/70 CD O O
102 , , O O
102 O2 NNP B-NP O
102 sat VBD B-VP O
102 99% CD O O
102 2L CD O O
102 NC NNP B-NP O
103 Pulm- NNP I-NP O
103 labored VBD B-VP O
103 breathing NN B-NP O
103 , , O O
103 accessory JJ B-NP O
103 muscle NN I-NP O
103 use NN I-NP O
103 , , O O
103 rhonchi NN B-NP O
103 and CC O O
103 expiratory NN B-NP O
104 wheezes NNS I-NP O
104 present JJ O O
104 throughout IN B-VP O
104 both DT B-NP O
104 lung NN I-NP O
104 fields NNS I-NP O
104 egophony VBP O O
104 in IN B-VP O
104 LLL NNP B-NP O
105 CV- NNP I-NP O
105 normal JJ B-NP O
105 PMI NNP I-NP O
105 , , O O
105 no DT B-NP O
105 RV NNP I-NP O
105 heave VBP O O
105 RRR NNP B-NP O
105 Unable NNP I-NP O
105 to TO O O
105 appreciate VB O O
105 heart NN B-NP O
105 sounds VBZ O O
105 weak JJ B-NP O
106 peripheral JJ I-NP O
106 pulses NNS I-NP O
106 12cm CD O O
106 JVD NNP B-NP O
107 Abd- NNP I-NP O
107 +BS NNP I-NP O
107 , , O O
107 nontender NN B-NP O
107 , , O O
107 nondistended VBD B-VP O
107 hepatomegaly JJ O O
108 Ext- JJ O O
108 2+ CD O O
108 bilateral JJ O O
108 pitting VBG O O
108 edema JJ B-NP O
109 Neuro- JJ I-NP O
109 AAOx3 NNP I-NP O
109 CN NNP I-NP O
109 intact JJ B-NP O
109 strength NN I-NP O
109 5/5 CD O O
109 , , O O
109 symmetric JJ O O
109 unable JJ O O
109 to TO O O
109 elicit VB O O
110 reflexes NNS B-NP O
111 --Sig NNP I-NP O
111 labs NN I-NP O
111 and CC O O
111 tests NNS B-NP O
111 upon IN B-VP O
111 admission: JJ B-NP O
111 BUN NNP I-NP O
111 17 CD O O
111 , , O O
111 Cr NNP B-NP O
111 1.4 CD O O
111 , , O O
111 Glucose NNP B-NP O
111 179 CD O O
111 WBC NNP B-NP O
111 8.7 CD O O
111 , , O O
112 Hct NNP B-NP O
112 38 CD O O
112 , , O O
112 MCV NNP B-NP O
112 84 CD O O
112 LFTs NNP B-NP O
112 normal JJ B-NP O
112 Albumin NNP I-NP O
112 4.3 CD O O
112 , , O O
112 Amylast NNP B-NP O
112 83 CD O O
112 , , O O
112 Lipase NNP B-NP O
112 33 CD O O
112 Cardiac NNP B-NP O
113 enzymes- JJ B-NP O
113 negative JJ I-NP O
114 CXR NNP I-NP O
114 showed VBD B-VP O
114 old JJ B-NP O
114 RLL NNP I-NP O
114 infiltrate NN I-NP O
114 unchanged JJ O O
114 from IN B-VP O
114 previous JJ B-NP O
114 tests NNS I-NP O
115 ECG NNP I-NP O
115 demonstrated VBD B-VP O
115 nonspecific JJ B-NP O
115 ST NNP I-NP O
115 changes NNS I-NP O
115 unchanged JJ O O
115 from IN B-VP O
115 previous JJ B-NP O
115 tests NNS I-NP O
116 --Hospital VBP O O
116 course: JJ O O
117 1 CD O O
117 ) ) O O
117 Pulm- NNP B-NP O
117 Pt NNP I-NP O
117 treated VBD B-VP O
117 for IN B-VP O
117 COPD NNP B-NP B-r
117 COPD NNP I-NP B-r
117 COPD NNP I-NP B-r
117 flare NN I-NP I-r
117 flare NN I-NP I-r
117 flare NN I-NP I-r
117 with IN B-VP O
117 supplemental JJ B-NP O
117 O2 NNP I-NP B-m
117 , , O O
117 DuoNebs NNP B-NP B-m
117 , , O O
117 and CC O O
118 steroids NNS B-NP B-m
118 Since IN B-VP O
118 he PRP O O
118 reported VBD B-VP O
118 left RB O O
118 sided VBN O O
118 pleuritic JJ B-NP O
118 chest NN I-NP O
118 pain NN I-NP O
118 , , O O
118 we PRP O O
118 evaluated VBD B-VP O
119 the DT B-NP O
119 possibility NN I-NP O
119 of IN B-VP O
119 PE NNP B-NP O
119 with IN B-VP O
119 a DT B-NP O
119 V/Q NNP I-NP O
119 scan NN I-NP O
119 that WDT O O
119 reported VBD B-VP O
119 a DT B-NP O
119 low JJ I-NP O
119 probability NN I-NP O
119 of IN B-VP O
119 PE NNP B-NP O
120 2 CD O O
120 ) ) O O
120 CV- NNP B-NP O
120 Pt's NNP I-NP O
120 physical JJ B-NP O
120 exam NN I-NP O
120 demonstrated VBD B-VP O
120 signs NNS B-NP O
120 of IN B-VP O
120 right-sided JJ B-NP O
120 heart NN I-NP O
120 failure NN I-NP O
120 , , O O
121 notably RB O O
121 12 CD O O
121 cm NN B-NP O
121 JVD NNP I-NP O
121 , , O O
121 hepatomegaly NN B-NP O
121 and CC O O
121 later RB O O
121 hepatojugular JJ B-NP O
121 reflex NN I-NP O
121 , , O O
121 and CC O O
121 2+ CD O O
122 bilateral JJ B-NP O
122 lower JJR I-NP O
122 extremity NN I-NP O
122 pitting VBG O O
122 edema NN B-NP O
122 We PRP O O
122 proceeded VBD B-VP O
122 to TO O O
122 treat VB O O
122 his PRP$ O B-r
122 his PRP$ O B-r
122 heart NN B-NP O
123 failure NN I-NP O
123 by IN B-VP O
123 diuresis NN B-NP O
123 with IN B-VP O
123 Lasix NNP B-NP B-m
123 Lasix NNP I-NP B-m
123 , , O O
123 initially RB O O
123 PO NNP B-NP B-mo
123 and CC O O
123 then RB O O
123 IV NNP B-NP B-mo
123 Overall NNP I-NP O
123 , , O O
123 he PRP O O
124 diuresed VBD B-VP O
124 approximately RB O O
124 1L CD O O
124 fluid NN B-NP O
124 To TO O O
124 further JJ O O
124 evaluate VB O O
124 his PRP$ O O
124 heart NN B-NP O
124 failure NN I-NP O
124 , , O O
124 a DT B-NP O
125 cardiac JJ I-NP O
125 MRI NNP I-NP O
125 was VBD B-VP O
125 obtained VBN O O
125 and CC O O
125 demonstrated VBN O O
125 normal JJ B-NP O
125 cardiac JJ I-NP O
125 anatomy NN I-NP O
125 and CC O O
126 function NN B-NP O
126 His PRP$ O O
126 LVEF NNP B-NP O
126 was VBD B-VP O
126 73% CD O O
126 and CC O O
126 he PRP O O
126 had VBD B-VP O
126 no DT B-NP O
126 valvular JJ I-NP O
126 dysfunction NN I-NP O
127 3 CD O O
127 ) ) O O
127 ID- NNP B-NP O
127 Sputum NNP I-NP O
127 was VBD B-VP O
127 cultured VBN O O
127 which WDT O O
127 showed VBD B-VP O
127 few JJ B-NP O
127 polys NNS I-NP O
127 , , O O
127 moderate JJ B-NP O
127 cocci NN I-NP O
127 , , O O
127 2+ CD O O
128 suspected VBD B-VP O
128 oral JJ B-NP O
128 flora NNS I-NP O
128 Since IN B-VP O
128 he PRP O O
128 remained VBD B-VP O
128 afebrile JJ O O
128 and CC O O
128 did VBD B-VP O
128 not RB O O
128 demonstrate VB O O
128 an DT B-NP O
129 elevated JJ I-NP O
129 WBC NNP I-NP O
129 , , O O
129 we PRP O O
129 did VBD B-VP O
129 not RB O O
129 treat VB O O
129 with IN B-VP O
129 antibiotics NNS B-NP O
130 4 CD O O
130 ) ) O O
130 Endo- NNP B-NP O
130 His PRP$ O B-r
130 diabetes NN B-NP I-r
130 was VBD B-VP O
130 managed VBN O O
130 with IN B-VP O
130 his PRP$ O O
130 home NN B-NP O
130 regimen NNS I-NP O
130 of IN B-VP O
130 Novolog NNP B-NP B-m
131 Steroids NNP I-NP B-m
131 may MD O O
131 have VB O O
131 contributed VBN O O
131 to TO O O
131 his PRP$ O O
131 elevated JJ B-NP O
131 blood NN I-NP O
131 sugars NNS I-NP O
131 In IN B-VP O
131 a DT B-NP O
131 previous JJ I-NP O
132 discharge NN I-NP O
132 summary NN I-NP O
132 , , O O
132 it PRP O O
132 was VBD B-VP O
132 noted VBN O O
132 that IN B-VP O
132 he PRP O O
132 had VBD B-VP O
132 an DT O O
132 elevated VBN O O
132 TSH NNP B-NP O
132 level NN I-NP O
132 We PRP O O
133 followed VBD B-VP O
133 up RP O O
133 on IN B-VP O
133 this DT O O
133 by IN B-VP O
133 rechecking VBG O O
133 his PRP$ O O
133 TSH NNP B-NP O
133 , , O O
133 which WDT O O
133 was VBD B-VP O
133 normal JJ O O
134 5 CD O O
134 ) ) O O
134 Renal- NN B-NP O
134 He PRP O O
134 an DT B-NP O
134 elevated JJ I-NP O
134 baseline NN I-NP O
134 level NN I-NP O
134 of IN B-VP O
134 Cr NNP B-NP O
134 We PRP O O
134 monitored VBD B-VP O
134 his PRP$ O O
134 Cr NNP B-NP O
134 and CC O O
135 BUN NNP B-NP O
135 for IN B-VP O
135 an DT B-NP O
135 increase NN I-NP O
135 with IN B-VP O
135 diuresis NN B-NP O
135 While IN B-VP O
135 the DT B-NP O
135 BUN NNP I-NP O
135 increased VBD B-VP O
135 to TO O O
135 the DT O O
135 low JJ O O
135 30s CD O O
135 , , O O
136 his PRP$ O O
136 Cr NNP B-NP O
136 was VBD B-VP O
136 stable JJ O O
137 6 CD O O
137 ) ) O O
137 Prophylaxis- NNP B-NP O
137 Chronic NNP I-NP B-r
137 Chronic NNP I-NP B-r
137 pain NN I-NP I-r
137 pain NN I-NP I-r
137 and CC O O
137 insomnia NN B-NP B-r
137 insomnia NN I-NP B-r
137 were VBD B-VP O
137 managed VBN O O
137 with IN B-VP O
137 his PRP$ O O
137 out-pt JJ B-NP O
138 regimen NNS I-NP O
138 of IN B-VP O
138 morphine NN B-NP B-m
138 morphine NN I-NP B-m
138 and CC O O
138 oxycodone NN B-NP B-m
138 oxycodone NN I-NP B-m
138 He PRP O O
138 was VBD B-VP O
138 given VBN O O
138 Elavil NNP B-NP B-m
138 for IN B-VP O
138 sleep NN B-NP B-r
138 Because IN B-VP O
139 of IN B-VP O
139 his PRP$ O O
139 history NN B-NP O
139 of IN B-VP O
139 cancer NN B-NP O
139 , , O O
139 he PRP O O
139 was VBD B-VP O
139 placed VBN O O
139 on IN B-VP O
139 Lovenox NNP B-NP B-m
139 for IN B-VP O
139 anticoagulation NN B-NP B-r
140 ADDITIONAL NNP I-NP O
140 COMMENTS: NNP I-NP O
140 Please NNP I-NP O
140 use VB O O
140 your PRP$ O O
140 home NN B-NP O
140 oxygen NN I-NP B-m
140 when WRB O O
140 you PRP O O
140 are VBP O O
140 sleeping VBG O O
140 at IN B-VP B-f
140 night NN B-NP I-f
140 We PRP O O
140 have VBP O O
140 added VBN O O
141 combivent NN B-NP B-m
141 inhalers NNS I-NP I-m
141 and CC O O
141 a DT B-NP O
141 steroid JJ I-NP B-m
141 taper NN I-NP O
141 to TO O O
141 your PRP$ O O
141 medicines NNS B-NP O
141 Please NNP I-NP O
141 stop VB O O
141 the DT B-NP O
142 hydrochlorathiazide NN I-NP B-m
142 ( ( O I-m
142 hctz NN B-NP I-m
142 ) ) O I-m
142 25mg CD O B-do
142 Instead RB O O
142 you PRP O O
142 will MD O O
142 be VB O O
142 taking VBG O O
142 lasix JJ O B-m
142 20mg CD O B-do
143 once RB O B-f
143 a DT B-NP I-f
143 day NN I-NP I-f
144 DISCHARGE NNP I-NP O
144 CONDITION: NNP I-NP O
144 Stable NNP I-NP O
145 TO NNP I-NP O
145 DO/PLAN: NNP I-NP O
146 - : O O
146 Continue NNP B-NP O
146 Lasix NNP I-NP B-m
146 40mg CD O B-do
146 PO NNP B-NP B-mo
146 QD NNP I-NP B-f
146 at IN B-VP O
146 home NN B-NP O
146 and CC O O
146 D/C NNP B-NP O
146 home NN I-NP O
146 HTCZ NNP I-NP O
147 - : O O
147 Slow NNP B-NP O
147 Prednisone NNP I-NP B-m
147 taper NN I-NP O
147 over IN B-VP O
147 next JJ O O
147 20 CD O B-du
147 days NNS B-NP I-du
148 - : O O
148 Have VBP O O
148 PCP NNP B-NP O
148 address JJ B-NP O
148 management NN I-NP O
148 of IN B-VP O
148 HTN NNP B-NP B-m
148 medications NNS I-NP I-m
148 and CC O O
148 OSA NNP B-NP O
148 Check NNP I-NP O
148 lytes VBZ O O
148 on IN B-VP O
149 new JJ B-NP O
149 dose NN I-NP O
149 of IN B-VP O
149 lasix JJ B-NP B-m
149 Consider NNP I-NP O
149 adding VBG O O
149 ACE NNP B-NP B-m
149 inhibitor NN I-NP I-m
149 considering VBG O O
149 hx NN B-NP O
149 of IN B-VP O
149 NIDDM NNP B-NP O
150 Episodic NNP I-NP O
150 hypoxia NN I-NP O
150 while IN B-VP O
150 sleeping VBG O O
150 may MD O O
150 contribute VB O O
150 to TO O O
150 pulmonary JJ B-NP O
150 HTN NNP I-NP O
150 and CC O O
150 signs NNS B-NP O
151 of IN B-VP O
151 right JJ B-NP O
151 heart NN I-NP O
151 failure NN I-NP O
151 observed VBD B-VP O
152 No NNP B-NP O
152 dictated VBD B-VP O
152 summary JJ B-NP O
153 ENTERED NNP I-NP O
153 BY: NNP I-NP O
153 WEIBEL NNP I-NP O
153 , , O O
153 RANDALL NNP B-NP O
153 R NNP I-NP O
153 , , O O
153 M.D NNP B-NP O
153 ( ( O O
153 TC12 NNP B-NP O
153 ) ) O O
153 5/28/05 CD O O
153 @ $ O O
153 05 CD O O
154 ****** JJ B-NP O
154 END NN I-NP O
154 OF NNP I-NP O
154 DISCHARGE NNP I-NP O
154 ORDERS NNP I-NP O
154 ****** NNP I-NP O
155 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #988921 VBZ O O
2 739139580 CD O O
2 DGMC NNP B-NP O
2 18296522 CD O O
2 304474 CD O O
2 7/2/2000 CD O O
2 12:00:00 CD O O
2 AM NNP B-NP O
2 CONGESTIVE NNP I-NP O
2 HEART NNP I-NP O
2 FAILURE NNP I-NP O
2 Signed VBD B-VP O
2 DIS NNP B-NP O
2 Admission NNP I-NP O
2 Date: NNP I-NP O
2 9/21/2000 CD O O
2 Report NNP B-NP O
2 Status: NNP I-NP O
2 Signed NNP I-NP O
3 Discharge NNP I-NP O
3 Date: NNP I-NP O
3 3/0/2000 CD O O
4 SERVICE: NNP B-NP O
4 The DT B-NP O
4 service NN I-NP O
4 on IN B-VP O
4 which WDT O O
4 the DT B-NP O
4 patient NN I-NP O
4 received VBD B-VP O
4 care NN B-NP O
4 was VBD B-VP O
5 Cardiology NNP B-NP O
5 Broketroit NNP I-NP O
5 Ma NNP I-NP O
5 Ri NNP I-NP O
6 HISTORY NNP I-NP O
6 OF NNP I-NP O
6 PRESENT NNP I-NP O
6 ILLNESS: NNP I-NP O
6 Mrs NNP I-NP O
6 Wetterauer NNP I-NP O
6 is VBZ O O
6 a DT B-NP O
6 54-year-old JJ I-NP O
6 female NN I-NP O
7 with IN B-VP O
7 coronary JJ B-NP O
7 artery NN I-NP O
7 disease NN I-NP O
7 status NN I-NP O
8 post NN I-NP O
8 inferior JJ B-NP O
8 myocardial JJ I-NP O
8 infarction NN I-NP O
8 in IN B-VP O
8 March NNP B-NP O
8 of IN B-VP O
8 1997 CD O O
8 , , O O
8 with IN B-VP O
8 sick JJ B-NP O
9 sinus NN I-NP O
9 syndrome NN I-NP O
9 , , O O
9 status NN B-NP O
9 post NN I-NP O
9 permanent JJ B-NP O
9 pacemaker NN I-NP O
9 placement NN I-NP O
9 , , O O
9 and CC O O
10 paroxysmal JJ B-NP B-r
10 atrial JJ I-NP I-r
10 fibrillation NN I-NP I-r
10 controlled VBN O O
10 with IN B-VP O
10 amiodarone; NN B-NP B-m
10 also RB O O
11 with IN B-VP O
11 history NN B-NP O
11 of IN B-VP O
11 diabetes NNS B-NP O
11 mellitus NNS I-NP O
11 and CC O O
11 hypertension NN B-NP O
11 She PRP O O
11 was VBD B-VP O
12 admitted VBN O O
12 to TO O O
12 the DT B-NP O
12 Crotamp NNP I-NP O
12 Hospital NNP I-NP O
12 for IN B-VP O
12 severe JJ B-NP O
12 respiratory NN I-NP O
13 distress NN I-NP O
13 on IN B-VP O
13 3/28 CD O O
13 The DT B-NP O
13 summary NN I-NP O
13 of IN B-VP O
13 clinical JJ B-NP O
13 events NNS I-NP O
13 is VBZ O O
13 as IN B-VP O
13 follows VBZ O O
14 The DT B-NP O
14 evening NN I-NP O
14 of IN B-VP O
14 1/11 CD O O
14 , , O O
14 the DT B-NP O
14 patient NN I-NP O
14 was VBD B-VP O
14 having VBG O O
14 intercourse NN B-NP O
14 and CC O O
15 "collapsed." VB O O
15 She PRP O O
15 was VBD B-VP O
15 very RB O O
15 short JJ O O
15 of IN B-VP O
15 breath NN B-NP O
15 with IN B-VP O
15 this DT O O
15 , , O O
15 and CC O O
15 presented VBD B-VP O
16 to TO O O
16 the DT B-NP O
16 Emergency NNP I-NP O
16 Department NNP I-NP O
16 via IN B-VP O
16 the DT B-NP O
16 paramedics NNS I-NP O
16 They PRP O O
16 attempted VBD B-VP O
16 to TO O O
17 intubate VB O O
17 her PRP O O
17 on IN B-VP O
17 the DT B-NP O
17 field NN I-NP O
17 and CC O O
17 found VBD B-VP O
17 her PRP$ O O
17 pulse JJ B-NP O
17 oxygen NN I-NP O
17 to TO O O
17 be VB O O
17 about IN B-VP O
17 60 CD O O
18 percent NN B-NP O
18 on IN B-VP O
18 bag NN B-NP O
18 valve NN I-NP O
18 mask NN I-NP O
18 They PRP O O
18 were VBD B-VP O
18 unable JJ O O
18 to TO O O
18 do VB O O
18 so RB O O
18 She PRP O O
18 was VBD B-VP O
19 described VBN O O
19 during IN B-VP O
19 this DT B-NP O
19 episode NN I-NP O
19 by IN B-VP O
19 her PRP$ O O
19 husband NN B-NP O
19 as IN B-VP O
19 to TO O O
19 have VB O O
19 been VBN O O
20 "gurgling." NNP B-NP O
20 She PRP O O
20 began VBD B-VP O
20 to TO O O
20 describe VB O O
20 shortness NN B-NP O
20 of IN B-VP O
20 breath NN B-NP O
20 , , O O
20 and CC O O
20 took VBD B-VP O
21 her PRP$ O O
21 inhalers NNS B-NP O
21 which WDT O O
21 did VBD B-VP O
21 not RB O O
21 help VB O O
21 She PRP O O
21 began VBD B-VP O
21 to TO O O
21 cough VB O O
21 quite RB O O
21 a DT B-NP O
21 bit NN I-NP O
22 and CC O O
22 coughed VBD B-VP O
22 up RP O O
22 some DT B-NP O
22 frothy JJ I-NP O
22 white JJ I-NP O
22 sputum NN I-NP O
22 At IN B-VP O
22 the DT B-NP O
22 Emergency NNP I-NP O
23 Department NNP I-NP O
23 , , O O
23 she PRP O O
23 was VBD B-VP O
23 immediately RB O O
23 intubated VBN O O
23 at IN B-VP O
23 Sirose NNP B-NP O
24 There EX O O
24 was VBD B-VP O
24 some DT B-NP O
24 difficulty NN I-NP O
24 intubating VBG O O
24 her PRP O O
24 , , O O
24 and CC O O
24 she PRP O O
24 was VBD B-VP O
24 ultimately RB O O
25 intubated VBN O O
25 by IN B-VP O
25 the DT O O
25 attending VBG O O
25 anesthesiologist NN B-NP O
25 there RB O O
25 An DT B-NP O
26 echocardiogram NN I-NP O
26 showed VBD B-VP O
26 an DT B-NP O
26 ejection NN I-NP O
26 fraction NN I-NP O
26 of IN B-VP O
26 25 CD O O
26 to TO O O
26 30 CD O O
26 percent NN B-NP O
26 with IN B-VP O
27 flat JJ B-NP O
27 CKs NNP I-NP O
27 She PRP O O
27 was VBD B-VP O
27 diuresed VBN O O
27 six CD O O
27 liters NNS B-NP O
27 with IN B-VP O
27 a DT B-NP O
27 stable JJ I-NP O
27 BUN NNP I-NP O
27 and CC O O
28 creatinine NN B-NP O
28 and CC O O
28 was VBD B-VP O
28 extubated VBN O O
28 on IN B-VP O
28 1/19 CD O O
28 A NNP B-NP O
28 right JJ B-NP O
28 heart NN I-NP O
29 catheterization NN I-NP O
29 there RB O O
29 showed VBD B-VP O
29 a DT B-NP O
29 pulmonary JJ I-NP O
29 artery NN I-NP O
29 pressure NN I-NP O
29 of IN B-VP O
29 40/15 CD O O
29 , , O O
30 wedge NN B-NP O
30 of IN B-VP O
30 12 CD O O
30 , , O O
30 cardiac JJ B-NP O
30 output NN I-NP O
30 of IN B-VP O
30 5.2 CD O O
30 Hemodymanics NNS B-NP O
30 in IN B-VP O
30 the DT B-NP O
30 Intensive NNP I-NP O
31 Care NNP I-NP O
31 Unit NNP I-NP O
31 at IN B-VP O
31 Chebanks NNP B-NP O
31 Hospital NNP I-NP O
31 indicate VBP O O
31 the DT B-NP O
31 patient's NN I-NP O
31 cardiac NN I-NP O
31 output NN I-NP O
32 was VBD B-VP O
32 quite RB O O
32 dependent JJ O O
32 on IN B-VP O
32 her PRP$ O O
32 SVR NNP B-NP O
32 Her NNP I-NP O
32 cardiac JJ B-NP O
32 index NN I-NP O
32 fell VBD B-VP O
32 into IN B-VP O
32 the DT B-NP O
33 high JJ I-NP O
33 two's NN I-NP O
33 when WRB O O
33 her PRP$ O O
33 SVR NNP B-NP O
33 was VBD B-VP O
33 in IN B-VP O
33 the DT O O
33 1340 CD O O
33 range NN B-NP O
33 , , O O
33 but CC O O
33 jumped VBD B-VP O
33 up RB O O
33 into IN B-VP O
34 the DT B-NP O
34 high JJ I-NP O
34 three's NN I-NP O
34 at IN B-VP O
34 about RB O O
34 3.8 CD O O
34 when WRB O O
34 her PRP$ O O
34 SVR NNP B-NP O
34 was VBD B-VP O
34 much RB O O
34 lower JJR O O
34 down RP O O
34 in IN B-VP O
35 the DT O O
35 800s CD O O
35 At IN B-VP O
35 the DT B-NP O
35 outside JJ I-NP O
35 hospital NN I-NP O
35 , , O O
35 a DT B-NP B-r
35 right JJ I-NP I-r
35 upper JJ I-NP I-r
35 lobe NN I-NP I-r
35 infiltrate NN I-NP I-r
36 was VBD B-VP O
36 also RB O O
36 noted VBN O O
36 and CC O O
36 she PRP O O
36 was VBD B-VP O
36 given VBN O O
36 gentamicin JJ O B-m
36 250 CD O B-do
36 mg NN B-NP I-do
36 times NNS I-NP B-du
36 one CD O I-du
36 , , O O
36 and CC O O
37 clindamycin VBZ O B-m
37 600 CD O B-do
37 mg NN B-NP I-do
37 She PRP O O
37 was VBD B-VP O
37 diagnosed VBN O O
37 with IN B-VP O
37 pneumonia NN B-NP B-r
37 and CC O O
37 treated VBN O O
38 with IN B-VP O
38 clindamycin NN B-NP B-m
38 , , O O
38 this DT B-NP O
38 caused JJ I-NP O
38 resolution NN I-NP O
38 of IN B-VP O
38 her PRP$ O O
38 white JJ B-NP O
38 count NN I-NP O
38 at IN B-VP O
38 the DT B-NP O
39 outside JJ I-NP O
39 hospital NN I-NP O
39 She PRP O O
39 also RB O O
39 had VBD B-VP O
39 an DT B-NP O
39 increase NN I-NP O
39 in IN B-VP O
39 her PRP$ O O
39 Lasix NNP B-NP B-m
39 and CC O O
40 lisinopril RB O B-m
40 dose VB O O
40 there RB O O
40 , , O O
40 as RB O O
40 well RB O O
40 as IN B-VP O
40 her PRP$ O O
40 amiodarone NN B-NP B-m
40 She PRP O O
40 was VBD B-VP O
40 started VBN O O
41 on IN B-VP O
41 Solu-Medrol NNP B-NP B-m
41 40 CD O B-do
41 mg NN B-NP I-do
41 intravenous JJ B-NP B-mo
41 q.6 NN I-NP B-f
41 hours NNS I-NP I-f
41 for IN B-VP O
41 possible JJ B-NP B-r
41 asthma NN I-NP I-r
42 She PRP O O
42 did VBD B-VP O
42 quite RB O O
42 well RB O O
42 after IN B-VP O
42 her PRP$ O O
42 treatment NN B-NP O
42 for IN B-VP O
42 pneumonia NN B-NP O
42 and CC O O
42 treatment NN B-NP O
43 for IN B-VP O
43 pulmonary JJ B-NP O
43 edema NN I-NP O
43 , , O O
43 and CC O O
43 was VBD B-VP O
43 transferred VBN O O
43 to TO O O
43 the DT B-NP O
43 Misutch NNP I-NP O
43 University NNP I-NP O
43 Hospital NNP I-NP O
43 for IN B-VP O
43 further JJ B-NP O
43 management NN I-NP O
44 Her NNP I-NP O
44 last JJ B-NP O
44 admission NN I-NP O
44 was VBD B-VP O
44 on IN B-VP O
44 10/6 CD O O
44 to TO O O
44 the DT B-NP O
44 Ceter NNP I-NP O
44 Medical NNP I-NP O
44 Center NNP I-NP O
45 for IN B-VP O
45 atypical JJ B-NP O
45 chest NN I-NP O
45 pain NN I-NP O
45 , , O O
45 when WRB O O
45 she PRP O O
45 had VBD B-VP O
45 a DT B-NP O
45 nondiagnostic JJ I-NP O
45 exercise NN I-NP O
46 tolerance NN I-NP O
46 test NN I-NP O
46 She PRP O O
46 went VBD B-VP O
46 6 CD O O
46 minutes NNS B-NP O
46 and CC O O
46 19 CD O O
46 seconds NNS B-NP O
46 with IN B-VP O
46 a DT B-NP O
46 maximum JJ I-NP O
47 heart NN I-NP O
47 rate NN I-NP O
47 of IN B-VP O
47 94 CD O O
47 Her PRP$ O O
47 chest NN B-NP O
47 pain NN I-NP O
47 then RB O O
47 was VBD B-VP O
47 ultimately RB O O
47 attributed VBN O O
47 to TO O O
48 a DT B-NP O
48 gastrointestinal JJ I-NP O
48 cause NN I-NP O
49 PAST NNP I-NP O
49 MEDICAL NNP I-NP O
49 HISTORY: NNP I-NP O
49 Coronary NNP I-NP O
49 artery NN I-NP O
49 disease NN I-NP O
49 status NN I-NP O
49 post NN I-NP O
49 inferior JJ B-NP O
50 myocardial JJ I-NP O
50 infarction NN I-NP O
50 on IN B-VP O
50 9/16 CD O O
50 She PRP O O
50 was VBD B-VP O
50 last JJ O O
51 admitted JJ O O
51 , , O O
51 as IN B-VP O
51 noted VBN O O
51 above IN B-VP O
51 , , O O
51 on IN B-VP O
51 10/6 CD O O
51 to TO O O
51 the DT B-NP O
51 Lordchild NNP I-NP O
51 Hospital NNP I-NP O
51 for IN B-VP O
51 atypical JJ B-NP O
52 chest NN I-NP O
52 pain NN I-NP O
52 The DT B-NP O
52 patient NN I-NP O
52 has VBZ O O
52 sick JJ B-NP O
52 sinus NN I-NP O
52 syndrome NN I-NP O
52 and CC O O
52 is VBZ O O
52 status NN B-NP O
52 post NN I-NP O
53 dual JJ B-NP O
53 chamber NN I-NP O
53 pacemaker NN I-NP O
53 in IN B-VP O
53 6/15 CD O O
53 Diabetes NNS B-NP O
53 mellitus JJ B-NP O
53 Hypertension NNP I-NP O
54 Paroxysmal NNP I-NP B-r
54 atrial JJ B-NP I-r
54 fibrillation NN I-NP I-r
54 , , O O
54 well-controlled JJ O O
54 in IN B-VP O
54 the DT B-NP O
54 past NN I-NP O
54 on IN B-VP O
55 amiodarone NN B-NP B-m
55 Past NNP I-NP O
55 rhythm NN I-NP O
55 monitoring NN I-NP O
55 has VBZ O O
55 revealed VBN O O
55 brief JJ B-NP O
55 runs NNS I-NP O
55 of IN B-VP O
56 ventricular JJ B-NP O
56 tachycardia NN I-NP O
56 Negative NNP I-NP O
56 breast NN I-NP O
56 biopsy NN I-NP O
56 in IN B-VP O
56 2/13 CD O O
57 MEDICATIONS: NNP B-NP O
57 Home NNP I-NP O
57 medications NNS I-NP O
57 include VBP O O
57 amiodarone RB O B-m
57 200 CD O B-do
57 mg NNS B-NP I-do
57 p.o JJ B-NP B-mo
57 q.d NN I-NP B-f
57 , , O O
58 Glyburide NNP B-NP B-m
58 5 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
58 q.d NN I-NP B-f
58 , , O O
58 Lopressor NNP B-NP B-m
58 50 CD O B-do
58 mg NN B-NP I-do
58 p.o NN I-NP B-mo
59 b.i.d NN I-NP B-f
59 , , O O
59 Prempro NNP B-NP B-m
59 0.625/2.5 CD O B-do
59 p.o NN B-NP B-mo
59 q.d NN I-NP B-f
59 , , O O
59 lisinopril VBZ O B-m
59 40 CD O B-do
59 mg NN B-NP I-do
59 p.o NN I-NP B-mo
59 q.d NN I-NP B-f
59 , , O O
60 Coumadin NNP B-NP B-m
60 , , O O
60 nitroglycerin JJ O B-m
60 sublingual JJ O B-mo
60 , , O O
60 Zantac NNP B-NP B-m
60 , , O O
60 beclomethasone NN B-NP B-m
60 , , O O
60 and CC O O
61 Ventolin NNP B-NP B-m
62 Medications NNP I-NP O
62 on IN B-VP O
62 transfer NN B-NP O
62 , , O O
62 Lovenox NNP B-NP B-m
62 60 CD O B-do
62 mg NN B-NP I-do
62 b.i.d NN I-NP B-f
62 , , O O
62 aspirin RB O B-m
62 325 CD O B-do
62 p.o NN B-NP B-mo
63 q.d NN I-NP B-f
63 , , O O
63 lisinopril VBZ O B-m
63 40 CD O B-do
63 mg NN B-NP I-do
63 p.o NN I-NP B-mo
63 b.i.d NN I-NP B-f
63 , , O O
63 clindamycin VBP O B-m
63 600 CD O B-do
63 intravenous JJ B-NP B-mo
64 q.8 NNS I-NP B-f
64 , , O O
64 digoxin NN B-NP B-m
64 0.25 CD O B-do
64 , , O O
64 Lopressor NNP B-NP B-m
64 100 CD O B-do
64 mg NN B-NP I-do
64 b.i.d NN I-NP B-f
64 , , O O
64 Zantac NNP B-NP B-m
64 , , O O
64 Albuterol NNP B-NP B-m
64 , , O O
65 Flovent NNP B-NP B-m
65 , , O O
65 Solu-Medrol NNP B-NP B-m
65 , , O O
65 and CC O O
65 amiodarone RB O B-m
65 300 CD O B-do
65 mg NN B-NP I-do
65 once RB O B-f
65 a DT B-NP I-f
65 day NN I-NP I-f
66 ALLERGIES: NNP I-NP O
66 The DT B-NP O
66 patient NN I-NP O
66 is VBZ O O
66 allergic JJ O O
66 to TO O O
66 penicillin VB O O
67 SOCIAL NNP B-NP O
67 HISTORY: NNP I-NP O
67 The DT B-NP O
67 patient NN I-NP O
67 has VBZ O O
67 a DT B-NP O
67 ten NN I-NP O
67 pack NN I-NP O
67 year NN I-NP O
67 smoking VBG O O
67 history NN B-NP O
68 and CC O O
68 quit NN B-NP O
68 in IN B-VP O
68 1968 CD O O
68 No NNP B-NP O
68 intravenous JJ B-NP O
68 drug NN I-NP O
68 use NN I-NP O
68 She PRP O O
69 is VBZ O O
69 retired VBN O O
69 from IN B-VP O
69 Medical JJ B-NP O
69 Records NNS I-NP O
69 at IN B-VP O
69 SGH NNP B-NP O
69 She PRP O O
69 has VBZ O O
69 three CD O O
69 grown JJ B-NP O
70 children NNS I-NP O
70 and CC O O
70 she PRP O O
70 is VBZ O O
70 married JJ B-NP O
71 PHYSICAL NNP I-NP O
71 EXAMINATION: NNP I-NP O
71 Physical NNP I-NP O
71 examination NN I-NP O
71 on IN B-VP O
71 admission NN B-NP O
71 is VBZ O O
72 significant JJ O O
72 for IN B-VP O
72 a DT B-NP O
72 blood NN I-NP O
72 pressure NN I-NP O
72 of IN B-VP O
72 114/93 CD O O
72 , , O O
73 this DT O O
73 is VBZ O O
73 down RB O O
73 from IN B-VP O
73 a DT O O
73 very RB O O
73 high JJ B-NP O
73 blood NN I-NP O
73 pressure NN I-NP O
73 on IN B-VP O
73 admission NN B-NP O
73 at IN B-VP O
73 the DT B-NP O
74 outside JJ I-NP O
74 hospital NN I-NP O
74 which WDT O O
74 was VBD B-VP O
74 in IN B-VP O
74 the DT O O
74 200s CD O O
74 Pulse NNP B-NP O
74 is VBZ O O
74 60 CD O O
74 , , O O
74 temperature NN B-NP O
75 is VBZ O O
75 96.5 CD O O
75 , , O O
75 saturating VBG O O
75 97 CD O O
75 percent NN B-NP O
75 on IN B-VP O
75 two CD O O
75 liters NNS B-NP O
75 General NNP I-NP O
75 , , O O
75 this DT O O
75 is VBZ O O
75 an DT B-NP O
76 agitated JJ I-NP O
76 woman NN I-NP O
76 in IN B-VP O
76 no DT B-NP O
76 acute NN I-NP O
76 distress NN I-NP O
76 Her NNP I-NP O
76 neck NN I-NP O
76 veins NNS I-NP O
76 were VBD B-VP O
76 about RB O O
76 5.0 CD O O
77 to TO O O
77 6.0 CD O O
77 cm NN B-NP O
77 of IN B-VP O
77 water NN B-NP O
77 The DT B-NP O
77 lung NN I-NP O
77 examination NN I-NP O
77 showed VBD B-VP O
77 a DT B-NP O
77 few JJ I-NP O
77 crackles NNS I-NP O
77 in IN B-VP O
78 the DT B-NP O
78 left JJ I-NP O
78 base NN I-NP O
78 with IN B-VP O
78 the DT O O
78 right JJ O O
78 one CD O O
78 clear JJ B-NP O
78 Cardiovascular NNP I-NP O
78 examination NN I-NP O
79 revealed VBD B-VP O
79 a DT B-NP O
79 split NN I-NP O
79 S1 NNP I-NP O
79 and CC O O
79 normal JJ B-NP O
79 S2 NNP I-NP O
79 , , O O
79 also RB O O
79 a DT B-NP O
79 soft JJ I-NP O
79 S3 NNP I-NP O
79 , , O O
79 the DT B-NP O
79 presence NN I-NP O
79 of IN B-VP O
80 a DT O O
80 2/6 CD O O
80 systolic JJ B-NP O
80 ejection NN I-NP O
80 murmur NN I-NP O
80 at IN B-VP O
80 the DT B-NP O
80 right JJ I-NP O
80 upper JJ I-NP O
80 sternal JJ I-NP O
80 border NN I-NP O
81 was VBD B-VP O
81 noted VBN O O
81 The DT B-NP O
81 abdomen NNS I-NP O
81 was VBD B-VP O
81 benign JJ O O
81 , , O O
81 no DT B-NP O
81 hepatosplenomegaly NN I-NP O
81 noted VBD B-VP O
82 The DT B-NP O
82 extremities NNS I-NP O
82 showed VBD B-VP O
82 no DT B-NP O
82 edema NN I-NP O
82 , , O O
82 with IN B-VP O
82 intact JJ B-NP O
82 distal JJ I-NP O
82 pulses NNS I-NP O
83 Neurologically RB O O
83 , , O O
83 the DT B-NP O
83 patient NN I-NP O
83 was VBD B-VP O
83 alert JJ O O
83 and CC O O
83 oriented VBD B-VP O
83 times NNS B-NP O
83 three CD O O
83 with IN B-VP O
84 no DT B-NP O
84 focal JJ I-NP O
84 deficits NNS I-NP O
84 , , O O
84 but CC O O
84 careful JJ B-NP O
84 neurologic JJ I-NP O
84 examination NN I-NP O
84 was VBD B-VP O
85 impossible JJ O O
85 due JJ O O
85 to TO O O
85 severe JJ B-NP O
85 agitation NN I-NP O
85 and CC O O
85 anxiety NN B-NP O
86 LABORATORY NNP I-NP O
86 DATA: NNP I-NP O
86 Laboratory NNP I-NP O
86 on IN B-VP O
86 admission NN B-NP O
86 was VBD B-VP O
86 significant JJ O O
86 for IN B-VP O
86 a DT B-NP O
87 Troponin NNP I-NP O
87 of IN B-VP O
87 0.02 CD O O
87 , , O O
87 CK NNP B-NP O
87 of IN B-VP O
87 80 CD O O
87 , , O O
87 INR NNP B-NP O
87 of IN B-VP O
87 1.3 CD O O
87 , , O O
88 hematocrit NN B-NP O
88 of IN B-VP O
88 38.0 CD O O
88 , , O O
88 BUN/creatinine NNP B-NP O
88 of IN B-VP O
88 24/0.6 CD O O
89 HOSPITAL NNP B-NP O
89 COURSE: NNP I-NP O
89 Mrs NNP I-NP O
89 Digerolamo NNP I-NP O
89 was VBD B-VP O
89 admitted VBN O O
89 to TO O O
89 the DT B-NP O
89 Aley NNP I-NP O
89 Coness-o NNP I-NP O
89 Meoak NNP I-NP O
89 Medical NNP I-NP O
89 Center NNP I-NP O
89 and CC O O
89 managed VBN O O
89 by IN B-VP O
89 problems NNS B-NP O
89 as IN B-VP O
89 follows VBZ O O
90 Flash NNP B-NP O
90 Pulmonary NNP I-NP O
90 Edema: NNP I-NP O
90 The DT B-NP O
90 initial JJ I-NP O
90 concern NN I-NP O
90 for IN B-VP O
90 Mrs NNP B-NP O
90 Kozicki NNP I-NP O
90 was VBD B-VP O
90 of IN B-VP O
91 this DT O O
91 being VBG O O
91 an DT B-NP O
91 ischemic JJ I-NP O
91 event NN I-NP O
91 causing VBG O O
91 her PRP O O
91 to TO O O
91 have VB O O
91 flash JJ B-NP O
91 pulmonary JJ I-NP O
92 edema NN I-NP O
92 However RB O O
92 , , O O
92 coronary JJ B-NP O
92 catheterization NN I-NP O
92 revealed VBD B-VP O
92 the DT B-NP O
92 patient NN I-NP O
92 to TO O O
93 have VB O O
93 clean JJ B-NP O
93 coronaries NNS I-NP O
93 Echocardiogram NNP I-NP O
93 revealed VBD B-VP O
93 a DT B-NP O
93 left JJ I-NP O
93 ventricular JJ I-NP O
94 hypertrophy NN I-NP O
94 with IN B-VP O
94 a DT B-NP O
94 low JJ I-NP O
94 normal JJ I-NP O
94 systolic JJ I-NP O
94 function NN I-NP O
94 , , O O
94 with IN B-VP O
94 an DT B-NP O
94 ejection NN I-NP O
95 fraction NN I-NP O
95 of IN B-VP O
95 50 CD O O
95 to TO O O
95 55 CD O O
95 percent NN B-NP O
95 There EX O O
95 was VBD B-VP O
95 akinesis NN B-NP O
95 of IN B-VP O
95 the DT B-NP O
95 inferior JJ I-NP O
96 wall NN I-NP O
96 present JJ O O
96 She PRP O O
96 had VBD B-VP O
96 normal JJ B-NP O
96 right JJ I-NP O
96 ventricular NN I-NP O
96 size NN I-NP O
96 and CC O O
96 function NN B-NP O
97 She PRP O O
97 had VBD B-VP O
97 1 CD O O
97 to TO O O
97 2+ CD O O
97 mitral JJ B-NP O
97 regurgitation NN I-NP O
97 with IN B-VP O
97 mild JJ B-NP O
97 left JJ I-NP O
97 atrial JJ I-NP O
98 enlargement NN I-NP O
98 and CC O O
98 1+ CD O O
98 tricuspid JJ B-NP O
98 regurgitation NN I-NP O
98 with IN B-VP O
98 a DT B-NP O
98 regurgitive JJ I-NP O
99 velocity NN I-NP O
99 of IN B-VP O
99 about IN B-VP O
99 2.7 CD O O
99 meters NNS B-NP O
99 per IN B-VP O
99 second JJ B-NP O
99 consistent NN I-NP O
99 with IN B-VP O
99 minimal JJ B-NP O
100 pulmonary JJ I-NP O
100 systolic NN I-NP O
100 pressures NNS I-NP O
100 Subsequently RB O O
100 the DT B-NP O
100 patient NN I-NP O
100 was VBD B-VP O
100 noted VBN O O
101 to TO O O
101 have VB O O
101 had VBN O O
101 a DT B-NP O
101 history NN I-NP O
101 of IN B-VP O
101 hypothyroidism NN B-NP O
101 in IN B-VP O
101 the DT B-NP O
101 past NN I-NP O
101 , , O O
101 and CC O O
101 she PRP O O
101 had VBD B-VP O
102 normal JJ B-NP O
102 TSH NNP I-NP O
102 recently RB O O
102 checked VBD B-VP O
102 by IN B-VP O
102 her PRP$ O O
102 primary JJ B-NP O
102 care NN I-NP O
102 physician NN I-NP O
102 , , O O
102 Dr NNP B-NP O
103 Slipper NNP I-NP O
103 , , O O
103 of IN B-VP O
103 TCH NNP B-NP O
103 However RB O O
103 , , O O
103 with IN B-VP O
103 no DT B-NP O
103 other JJ I-NP O
103 etiology NN I-NP O
103 present JJ O O
103 , , O O
103 we PRP O O
104 were VBD B-VP O
104 worried VBN O O
104 about IN B-VP O
104 the DT B-NP O
104 patient NN I-NP O
104 having VBG O O
104 had VBD B-VP O
104 tachyarrhythmia VBN O O
104 from IN B-VP O
104 some DT B-NP O
105 other JJ I-NP O
105 source NN I-NP O
105 causing VBG O O
105 this DT O O
105 The DT B-NP O
105 Electrophysiology NNP I-NP O
105 Service NNP I-NP O
106 interrogated VBD B-VP O
106 the DT B-NP O
106 patient's NN I-NP O
106 pacer NN I-NP O
106 which WDT O O
106 revealed VBD B-VP O
106 a DT B-NP O
106 number NN I-NP O
106 of IN B-VP O
107 tachyarrhythmias NN B-NP O
107 A NNP I-NP O
107 TSH NNP I-NP O
107 panel NN I-NP O
107 was VBD B-VP O
107 checked VBN O O
107 which WDT O O
107 revealed VBD B-VP O
107 a DT B-NP O
107 TSH NNP I-NP O
107 of IN B-VP O
108 less JJR O O
108 than IN B-VP O
108 assay NN B-NP O
108 , , O O
108 and CC O O
108 T4 NNP B-NP O
108 free JJ B-NP O
108 thyroxin NN I-NP O
108 index NN I-NP O
108 elevated VBD B-VP O
108 An DT B-NP O
109 Endocrinology NNP I-NP O
109 consultation NN I-NP O
109 was VBD B-VP O
109 obtained VBN O O
109 , , O O
109 and CC O O
109 they PRP O O
109 believed VBD B-VP O
109 that IN B-VP O
109 the DT B-NP O
110 patient's NN I-NP O
110 thyrotoxicosis NN I-NP O
110 was VBD B-VP O
110 amiodarone RB O O
110 induced JJ O O
110 She PRP O O
110 was VBD B-VP O
110 started VBN O O
111 on IN B-VP O
111 Tapazole NNP B-NP B-m
111 10 CD O B-do
111 mg NN B-NP I-do
111 p.o NN I-NP B-mo
111 b.i.d NN I-NP B-f
111 They PRP O O
111 also RB O O
111 suggested VBD B-VP O
111 prednisone NN B-NP B-m
111 , , O O
111 but CC O O
112 the DT B-NP O
112 patient NN I-NP O
112 did VBD B-VP O
112 refuse VB O O
112 this DT O O
112 They PRP O O
112 recommended VBD B-VP O
112 follow-up NN B-NP O
112 with IN B-VP O
113 Endocrine NNP B-NP O
113 in IN B-VP O
113 about RB O O
113 four CD O O
113 to TO O O
113 six CD O O
113 weeks NNS B-NP O
113 Therefore RB O O
113 , , O O
113 the DT B-NP O
113 final JJ I-NP O
114 etiology NN I-NP O
114 for IN B-VP O
114 the DT B-NP O
114 patient's NN I-NP O
114 flash NN I-NP O
114 pulmonary JJ B-NP O
114 edema NN I-NP O
114 was VBD B-VP O
114 amiodarone RB O B-m
115 induced JJ B-NP O
115 thyrotoxicosis NN I-NP O
115 causing VBG O O
115 increased VBN O O
115 susceptibility NN B-NP O
115 to TO O O
116 tachyarrhythmia VB O O
116 , , O O
116 left VBD B-VP O
116 ventricular JJ B-NP O
116 hypertrophy NN I-NP O
116 , , O O
116 and CC O O
116 possible JJ B-NP O
117 diastolic JJ I-NP O
117 dysfunction NN I-NP O
117 , , O O
117 resulting VBG O O
117 in IN B-VP O
117 acute JJ B-NP O
117 pump NN I-NP O
117 dysfunction NN I-NP O
117 , , O O
117 causing VBG O O
118 flash JJ B-NP O
118 pulmonary JJ I-NP O
118 edema NN I-NP O
118 The DT B-NP O
118 final JJ I-NP O
118 therapy NN I-NP O
118 for IN B-VP O
118 this DT B-NP O
118 problem NN I-NP O
118 will MD O O
119 consist VB O O
119 of IN B-VP O
119 heavy JJ B-NP O
119 nodal NNS I-NP O
119 blockade VBD B-VP O
119 The DT B-NP O
119 patient NN I-NP O
119 will MD O O
119 be VB O O
119 blockaded VBN O O
120 with IN B-VP O
120 calcium NN B-NP B-m
120 channel NN I-NP I-m
120 blockers NNS I-NP I-m
120 , , O O
120 as RB O O
120 well RB O O
120 as IN B-VP O
120 Lopressor NNP B-NP B-m
121 Pneumonia: NNP I-NP B-r
121 The DT B-NP O
121 patient NN I-NP O
121 was VBD B-VP O
121 treated VBN O O
121 with IN B-VP O
121 clindamycin NN B-NP B-m
121 and CC O O
121 did VBD B-VP O
121 quite RB O O
122 well RB O O
122 Her NNP B-NP O
122 white JJ B-NP O
122 count NN I-NP O
122 fully RB O O
122 resolved VBN O O
122 and CC O O
122 she PRP O O
122 had VBD B-VP O
122 no DT B-NP O
122 fever NN I-NP O
122 or CC O O
122 other JJ B-NP O
123 symptoms NNS I-NP O
123 of IN B-VP O
123 pneumonia NN B-NP O
123 She PRP O O
123 will MD O O
123 be VB O O
123 discharged VBN O O
123 without IN B-VP O
123 any DT B-NP O
123 further JJ I-NP O
124 antibiotics NNS I-NP B-m
125 Urinary JJ B-NP O
125 Tract NNP I-NP O
125 Infection: NNP I-NP O
125 She PRP O O
125 had VBD B-VP O
125 a DT B-NP O
125 lot NN I-NP O
125 of IN B-VP O
125 uric JJ B-NP B-r
125 crystals NNS I-NP I-r
125 , , O O
125 therefore IN B-VP O
126 she PRP O O
126 was VBD B-VP O
126 placed VBN O O
126 on IN B-VP O
126 Bactrim NNP B-NP B-m
126 Double NNP I-NP I-m
126 Strength NNP I-NP I-m
126 b.i.d NN I-NP B-f
126 times VBZ O O
126 a DT B-NP B-du
126 total NN I-NP O
126 of IN B-VP O
127 seven CD O O
127 days NNS B-NP O
128 Psychiatry: NNP I-NP O
128 The DT B-NP O
128 patient NN I-NP O
128 has VBZ O O
128 clearly RB O O
128 severe JJ B-NP B-r
128 anxiety NN I-NP I-r
128 and CC O O
128 was VBD B-VP O
128 in IN B-VP O
128 a DT B-NP B-r
129 full JJ I-NP O
129 panic NN I-NP O
129 attack NN I-NP O
129 on IN B-VP O
129 admission NN B-NP O
129 She PRP O O
129 was VBD B-VP O
129 treated VBN O O
129 acutely RB O O
129 with IN B-VP O
130 Ativan NNP B-NP B-m
130 Ativan NNP I-NP B-m
130 and CC O O
130 her PRP$ O O
130 problem NN B-NP O
130 resolved VBD B-VP O
130 quite RB O O
130 well RB O O
130 , , O O
130 and CC O O
130 she PRP O O
130 became VBD B-VP O
130 more RBR O O
131 comfortable JJ O O
131 in IN B-VP O
131 the DT B-NP O
131 hospital NN I-NP O
132 Diabetes NNP I-NP B-r
132 Diabetes NNP I-NP B-r
132 Diabetes NNP I-NP B-r
132 Mellitus: NNP I-NP I-r
132 Mellitus: NNP I-NP I-r
132 Mellitus: NNP I-NP I-r
132 Glyburide NNP I-NP B-m
132 was VBD B-VP O
132 held VBN O O
132 initially RB O O
132 on IN B-VP O
132 admission NN B-NP O
132 She PRP O O
133 was VBD B-VP O
133 covered VBN O O
133 with IN B-VP O
133 insulin NN B-NP B-m
133 sliding VBG O B-do
133 scale JJ B-NP I-do
133 Glyburide NNP I-NP B-m
133 was VBD B-VP O
133 restarted VBN O O
133 on IN B-VP O
134 the DT B-NP O
134 day NN I-NP O
134 of IN B-VP O
134 discharge NN B-NP O
134 The DT B-NP O
134 patient NN I-NP O
134 was VBD B-VP O
134 noted VBN O O
134 to TO O O
134 have VB O O
134 relatively RB O O
135 high JJ B-NP O
135 blood NN I-NP O
135 sugars NNS I-NP O
135 , , O O
135 and CC O O
135 these DT O O
135 should MD O O
135 be VB O O
135 followed VBN O O
135 as IN B-VP O
135 an DT B-NP O
135 outpatient JJ I-NP O
136 Blood NNP I-NP O
136 sugars NNS I-NP O
136 as RB O O
136 high JJ O O
136 as IN B-VP O
136 the DT B-NP O
136 mid NN I-NP O
136 300s CD O O
136 were VBD B-VP O
136 noted VBN O O
137 Edema: NNP B-NP O
137 The DT B-NP O
137 patient NN I-NP O
137 clearly RB O O
137 had VBD B-VP O
137 some DT B-NP O
137 fluid NN I-NP B-r
137 accumulation NN I-NP I-r
137 which WDT O O
138 resolved VBD B-VP O
138 with IN B-VP O
138 20 CD O B-do
138 mg NNS B-NP I-do
138 of IN B-VP O
138 Lasix NNP B-NP B-m
138 p.o NN I-NP B-mo
138 q.d NN I-NP B-f
138 We PRP O O
138 will MD O O
138 continue VB O O
138 this DT O O
138 and CC O O
139 allow VB O O
139 outpatient JJ B-NP O
139 follow-up NN I-NP O
139 to TO O O
139 determine VB O O
139 whether IN B-VP O
139 or CC O O
139 not RB O O
139 she PRP O O
139 will MD O O
140 need VB O O
140 this DT O O
140 in IN B-VP O
140 the DT B-NP O
140 future NN I-NP O
141 DISCHARGE NNP I-NP O
141 MEDICATIONS NNP I-NP O
141 INCLUDE: NNP I-NP O
141 Amiodarone NNP I-NP B-m
141 200 CD O B-do
141 mg NN B-NP I-do
141 p.o NN I-NP B-mo
141 q.d NN I-NP B-f
141 , , O O
142 lisinopril VBZ O B-m
142 40 CD O B-do
142 mg NN B-NP I-do
142 p.o NN I-NP B-mo
142 b.i.d NN I-NP B-f
142 , , O O
143 Tapazole NNP B-NP B-m
143 10 CD O B-do
143 mg NN B-NP I-do
143 p.o NN I-NP B-mo
143 b.i.d NN I-NP B-f
143 , , O O
143 Zantac NNP B-NP B-m
143 150 CD O B-do
143 mg NN B-NP I-do
143 p.o NN I-NP B-mo
143 b.i.d NN I-NP B-f
143 , , O O
143 Coumadin NNP B-NP B-m
143 5.0 CD O B-do
144 mg NN B-NP O
144 p.o NN I-NP B-mo
144 q.p.m NN I-NP B-f
144 , , O O
144 Bactrim NNP B-NP B-m
144 Double NNP I-NP I-m
144 Strength NNP I-NP I-m
144 one CD O B-do
144 tablet NN B-NP I-do
144 p.o NN I-NP B-mo
144 b.i.d NN I-NP B-f
145 times NNS I-NP B-du
145 four CD O I-du
145 days NNS B-NP I-du
145 after IN B-VP O
145 discharge NN B-NP O
145 , , O O
145 Prempro NNP B-NP B-m
145 0.625/2.5 CD O B-do
145 mg NN B-NP I-do
145 p.o NN I-NP B-mo
145 q.d NN I-NP B-f
145 , , O O
146 Glyburide NNP B-NP B-m
146 5 CD O B-do
146 mg NN B-NP I-do
146 p.o NN I-NP B-mo
146 q.d NN I-NP B-f
146 , , O O
146 Lasix NNP B-NP B-m
146 20 CD O B-do
146 mg NN B-NP I-do
146 p.o NN I-NP B-mo
146 q.d NN I-NP B-f
146 , , O O
146 atenolol RB O B-m
146 150 CD O B-do
146 mg NNS B-NP I-do
147 p.o JJ B-NP B-mo
147 q.d NN I-NP B-f
147 , , O O
147 diltiazem JJ B-NP B-m
147 CD NN I-NP I-m
147 240 CD O B-do
147 mg NN B-NP I-do
147 p.o NN I-NP B-mo
147 q.d NN I-NP B-f
148 DISPOSITION: NNP I-NP O
148 The DT B-NP O
148 patient NN I-NP O
148 was VBD B-VP O
148 discharged VBN O O
148 home NN B-NP O
148 in IN B-VP O
148 good JJ B-NP O
148 condition NN I-NP O
149 FINAL NNP I-NP O
149 DIAGNOSIS: NNP I-NP O
149 Thyrotoxicosis NNP I-NP O
150 FOLLOW-UP: NNP I-NP O
150 She PRP O O
150 will MD O O
150 follow-up VB O O
150 with IN B-VP O
150 Dr NNP B-NP O
150 Provins NNP I-NP O
150 on IN B-VP O
150 Monday NNP B-NP O
150 , , O O
150 3/22 CD O O
151 at IN B-VP O
151 9:30 CD O O
151 a.m NN B-NP O
151 , , O O
151 and CC O O
151 Dr NNP B-NP O
151 Orejel NNP I-NP O
151 of IN B-VP O
151 Chia NNP B-NP O
151 Memorial NNP I-NP O
151 Hospital NNP I-NP O
151 Endocrinology NNP I-NP O
151 at IN B-VP O
151 U NNP B-NP O
151 Hay NNP I-NP O
151 Rill NNP I-NP O
151 , , O O
151 on IN B-VP O
151 6/5 CD O O
151 at IN B-VP O
151 3:00 CD O O
152 p.m RB O O
153 Dictated NNP B-NP O
153 By: NNP I-NP O
153 MARKUS NNP I-NP O
153 TRAFICANTE NNP I-NP O
153 , , O O
153 M.D NNP B-NP O
153 TF37 NNP I-NP O
154 Attending: NNP I-NP O
154 OSVALDO NNP I-NP O
154 H NNP I-NP O
154 CONDUFF NNP I-NP O
154 , , O O
154 M.D NNP B-NP O
154 IK5 NNP I-NP O
155 WN271/0715 NNP I-NP O
156 Batch: NNP I-NP O
156 41277 CD O O
156 Index NNP B-NP O
156 No NNP I-NP O
156 H4SU0M28CE NNP I-NP O
156 D: NNP I-NP O
156 1/7 CD O O
157 T: NNP B-NP O
157 6/29 CD O O
158 CC: NNP B-NP O
158 1 CD O O
158 BOYCE NNP B-NP O
158 F NNP I-NP O
158 MARWICK NNP I-NP O
158 , , O O
158 M.D NNP B-NP O
158 VO67 NNP I-NP O
158 , , O O
158 BLOOBY NNP B-NP O
158 HONOR NNP I-NP O
158 HOSPITAL NNP I-NP O
158 , , O O
158 Ette NNP B-NP O
158 , , O O
158 Utah NNP B-NP O
158 08029 CD O O
159 2 CD O O
159 LENNY NNP B-NP O
159 M NNP I-NP O
159 PANNY NNP I-NP O
159 , , O O
159 M.D NNP B-NP O
159 FF0 NNP I-NP O
160 3 CD O O
160 COLUMBUS NNP B-NP O
160 SHIHADEH NNP I-NP O
160 , , O O
160 M.D NNP B-NP O
160 GC6 NNP I-NP O
161 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #992321 VBZ O O
4 419885223 CD O O
4 SVMC NNP B-NP O
4 11356075 CD O O
4 3131842 CD O O
4 2/2/2007 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 atypical JJ B-NP O
4 chest NN I-NP O
4 pain NN I-NP O
4 , , O O
4 hypertension NN B-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 9/12/2007 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/2/2007 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 SAGASER NNP I-NP O
8 , , O O
8 SCOT NNP B-NP O
8 105-81-88-0 CD O O
9 Ba NNP B-NP O
9 Ch NNP I-NP O
9 Wi NNP I-NP O
9 , , O O
9 West NNP B-NP O
9 Virginia NNP I-NP O
9 75512 CD O O
10 Service: NNP B-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 5/23/07 CD O O
11 AT NNP B-NP O
11 12:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 INGWELL NNP I-NP O
14 , , O O
14 MOSES NNP B-NP O
14 HERMAN NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
14 , , O O
14 M.P.H NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 MEDICATIONS NNP I-NP O
18 ON NNP I-NP O
18 ADMISSION: NNP I-NP O
19 1 CD O O
19 FLUTICASONE NNP B-NP B-m
19 PROPIONATE/SALMETEROL NNP I-NP I-m
19 250/50 CD O I-m
19 1 CD O B-do
19 PUFF NNP B-NP I-do
19 INH NNP I-NP B-mo
19 BID NNP I-NP B-f
20 2 CD O O
20 ALBUTEROL NNP B-NP B-m
20 NEBULIZER NNP I-NP I-m
20 2.5 CD O B-do
20 MG NNP B-NP I-do
20 NEB NNP I-NP B-mo
20 Q4H NNP I-NP B-f
21 3 CD O O
21 ARTIFICIAL NNP B-NP B-m
21 TEARS NNP I-NP I-m
21 2 CD O B-do
21 DROP NNP B-NP I-do
21 OD NNP I-NP B-mo
21 TID NNP I-NP B-f
22 4 CD O O
22 LORATADINE NNP B-NP B-m
22 10 CD O B-do
22 MG NNP B-NP I-do
22 PO NNP I-NP B-mo
22 QD NNP I-NP B-f
23 5 CD O O
23 HYDROCHLOROTHIAZIDE NNP B-NP B-m
23 25 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QD NNP I-NP B-f
24 6 CD O O
24 ALBUTEROL NNP B-NP B-m
24 INHALER NNP I-NP I-m
24 2 CD O B-do
24 PUFF NNP B-NP I-do
24 INH NNP I-NP B-mo
24 QID NNP I-NP B-f
25 MEDICATIONS NNP I-NP O
25 ON NNP I-NP O
25 DISCHARGE: NNP I-NP O
26 ACETYLSALICYLIC NNP I-NP B-m
26 ACID NNP I-NP I-m
26 81 CD O B-do
26 MG NNP B-NP I-do
26 PO NNP I-NP B-mo
26 DAILY NNP I-NP B-f
27 ALBUTEROL NNP I-NP B-m
27 INHALER NNP I-NP I-m
27 2 CD O B-do
27 PUFF NNP B-NP I-do
27 INH NNP I-NP B-mo
27 QID NNP I-NP B-f
27 PRN NNP I-NP I-f
27 Shortness NNP I-NP B-r
27 of IN B-VP I-r
27 Breath NNP B-NP I-r
28 ALBUTEROL NNP I-NP B-m
28 ALBUTEROL NNP I-NP B-m
28 NEBULIZER NNP I-NP I-m
28 NEBULIZER NNP I-NP I-m
28 2.5 CD O B-do
28 2.5 CD O B-do
28 MG NNP B-NP I-do
28 MG NNP I-NP I-do
28 NEB NNP I-NP B-mo
28 NEB NNP I-NP B-mo
28 Q2H NNP I-NP B-f
28 Q2H NNP I-NP B-f
29 PRN NNP I-NP O
29 Shortness NNP I-NP B-r
29 of IN B-VP I-r
29 Breath NNP B-NP I-r
29 , , O O
29 Wheezing NNP B-NP B-r
30 ATENOLOL NNP I-NP B-m
30 50 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 DAILY NNP I-NP B-f
31 ADVAIR NNP I-NP B-m
31 DISKUS NNP I-NP I-m
31 500/50 CD O I-m
31 ( ( O I-m
31 FLUTICASONE NNP B-NP I-m
31 PROPIONATE/ NNP I-NP I-m
31 ) ) O I-m
32 1 CD O B-do
32 PUFF NNP B-NP I-do
32 INH NNP I-NP B-mo
32 BID NNP I-NP B-f
33 HYDROCHLOROTHIAZIDE NNP I-NP B-m
33 25 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 DAILY NNP I-NP B-f
34 MICONAZOLE NNP I-NP B-m
34 NITRATE NNP I-NP I-m
34 2% CD O I-m
34 POWDER NNP B-NP I-m
34 TOPICAL NNP I-NP B-mo
34 TP NNP I-NP I-mo
34 DAILY NNP I-NP B-f
35 Instructions: NNP I-NP O
35 to TO O O
35 affected VB O O
35 areas NNS B-NP O
35 ( ( O O
35 abdominal JJ B-NP O
35 folds NNS I-NP O
35 ) ) O O
36 DIET: NNP B-NP O
36 House NNP I-NP O
36 / NNP I-NP O
36 ADA NNP I-NP O
36 2100 CD O O
36 cals/dy NN B-NP O
37 DIET: NNP I-NP O
37 2 CD O O
37 gram NN B-NP O
37 Sodium NNP I-NP O
38 ACTIVITY: NNP I-NP O
38 Resume NNP I-NP O
38 regular JJ B-NP O
38 exercise NN I-NP O
39 FOLLOW NNP I-NP O
39 UP NNP I-NP O
39 APPOINTMENT( NNP I-NP O
39 S NNP I-NP O
39 ): NNP I-NP O
40 Dr NNP I-NP O
40 Blackledge NNP I-NP O
40 Cardiology NNP I-NP O
40 clinic JJ B-NP O
40 Worth NNP I-NP O
40 Yonkers NNP I-NP O
40 Juan NNP I-NP O
40 724-105-6354 JJ O O
40 11/0 CD O O
40 @ JJ O O
40 2pm CD O O
40 , , O O
41 Dr NNP B-NP O
41 Rownd NNP I-NP O
41 10/14 CD O O
41 at IN B-VP O
41 1:50pm CD O O
41 , , O O
42 Kendall NNP B-NP O
42 Burvine NNP I-NP O
42 nutrition NN I-NP O
42 10/14 CD O O
42 at IN B-VP O
42 1:15pm CD O O
42 , , O O
43 ALLERGY: NNP B-NP O
43 NKA NNP I-NP O
44 ADMIT NNP I-NP O
44 DIAGNOSIS: NNP I-NP O
45 chest JJS B-NP O
45 pain NN I-NP O
45 , , O O
45 cough NN B-NP O
46 PRINCIPAL NNP I-NP O
46 DISCHARGE NNP I-NP O
46 DIAGNOSIS NNP I-NP O
46 ;Responsible JJ O O
46 After IN B-VP O
46 Study NNP B-NP O
46 for IN B-VP O
46 Causing NNP B-NP O
46 Admission NNP I-NP O
46 ) ) O O
47 atypical JJ B-NP O
47 chest NN I-NP O
47 pain NN I-NP O
47 , , O O
47 hypertension NN B-NP O
48 OTHER NNP I-NP O
48 DIAGNOSIS;Conditions NNP I-NP O
48 , , O O
48 Infections NNP B-NP O
48 , , O O
48 Complications NNP B-NP O
48 , , O O
48 affecting VBG O O
48 Treatment/Stay NNP B-NP O
49 Asthma NNP I-NP O
49 , , O O
49 Morbid NNP B-NP O
49 Obesity NNP I-NP O
49 , , O O
49 Pneumonia NNP B-NP O
49 , , O O
49 intertrigo NN B-NP O
49 , , O O
49 UTI NNP B-NP O
49 , , O O
49 otitis NN B-NP O
49 media NNS I-NP O
50 OPERATIONS NNP I-NP O
50 AND NNP I-NP O
50 PROCEDURES: NNP I-NP O
51 none NN I-NP O
52 OTHER NNP I-NP O
52 TREATMENTS/PROCEDURES NNP I-NP O
52 ( ( O O
52 NOT NNP B-NP O
52 IN NNP I-NP O
52 O.R NNP I-NP O
52 ) ) O O
53 Cardiac NNP B-NP O
53 PET NNP I-NP O
54 BRIEF NNP I-NP O
54 RESUME NNP I-NP O
54 OF NNP I-NP O
54 HOSPITAL NNP I-NP O
54 COURSE: NNP I-NP O
55 CC: NNP I-NP O
55 chest JJS B-NP O
55 pain NN I-NP O
55 , , O O
55 cough NN B-NP O
56 **** NNP I-NP O
57 HPI: NNP I-NP O
57 45 CD O O
57 yo NN B-NP O
57 male NN I-NP O
57 w/ NN I-NP O
57 morbid NN I-NP O
57 obesity NN I-NP O
57 and CC O O
57 asthma JJ B-NP O
57 presents NNS I-NP O
57 with IN B-VP O
57 chest NN B-NP O
57 pain NN I-NP O
58 and CC O O
58 cough NN B-NP O
58 Pt NNP I-NP O
58 c/o NN I-NP O
58 SSCP NNP I-NP O
58 x18h NNP I-NP O
58 , , O O
58 described VBD B-VP O
58 as IN B-VP O
58 tightness NN B-NP O
58 , , O O
58 radiating VBG O O
58 to TO O O
58 his PRP$ O O
59 back RP O O
59 that DT O O
59 began VBD B-VP O
59 at IN B-VP O
59 night NN B-NP O
59 while IN B-VP O
59 he PRP O O
59 was VBD B-VP O
59 sleeping VBG O O
59 Pain NNP B-NP O
59 is VBZ O O
59 worse JJR O O
59 with IN B-VP O
60 cough JJ B-NP O
60 Denies NNPS I-NP O
60 exertional JJ B-NP O
60 CP NNP I-NP O
60 but CC O O
60 very RB O O
60 limited JJ B-NP O
60 activity NN I-NP O
60 2/2 CD O O
60 obesityNo NN B-NP O
61 associated VBN O O
61 SOB NNP B-NP O
61 , , O O
61 but CC O O
61 mild JJ B-NP O
61 nausea NN I-NP O
61 and CC O O
61 +diaphoresis NN B-NP O
61 Denies NNP I-NP O
61 leg VBZ O O
61 swelling VBG O O
61 He PRP O O
62 c/o VBZ O O
62 worsening VBG O O
62 nonproductive JJ B-NP O
62 cough NN I-NP O
62 x1 NN I-NP O
62 day NN I-NP O
62 He PRP O O
62 often RB O O
62 has VBZ O O
62 nighttime JJ B-NP O
62 symptoms NNS I-NP O
63 of IN B-VP O
63 cough NN B-NP B-r
63 , , O O
63 relieved VBN O O
63 by IN B-VP O
63 nebulizer NN B-NP B-m
63 treatments NNS I-NP I-m
63 No DT B-NP O
63 fevers NNS I-NP O
63 , , O O
63 chills NNS B-NP O
63 , , O O
63 no DT B-NP O
63 other JJ I-NP O
64 URI NNP I-NP O
64 sx NN I-NP O
65 **** NNP I-NP O
66 ED NNP I-NP O
66 COURSE: NNP I-NP O
66 96.0 CD O O
66 p106 NN B-NP O
66 209/94 CD O O
66 rr20 NN B-NP O
66 95%RA CD O O
66 , , O O
66 CTA NNP B-NP O
66 Chest NNP I-NP O
66 peformed VBD B-VP O
66 and CC O O
66 was VBD B-VP O
67 neg VBN O O
67 for IN B-VP O
67 dissection NN B-NP O
67 , , O O
67 rx'd FW O O
67 nitro FW O B-m
67 gtt NN B-NP O
67 , , O O
67 labetalol NN B-NP B-m
67 , , O O
67 ASA NNP B-NP B-m
67 , , O O
67 nexium NN B-NP B-m
67 , , O O
67 albuterol NN B-NP B-m
68 neb JJ B-NP B-mo
68 Pt NNP I-NP O
68 had VBD B-VP O
68 emesis NN B-NP B-r
68 x1 NN I-NP O
68 , , O O
68 rx'd NN B-NP O
69 zofran NN I-NP B-m
70 **** NNP I-NP O
71 PMH: NNP I-NP O
71 Asthma NNP I-NP O
71 - : O O
71 Peak NNP B-NP O
71 flow VB O O
71 400 CD O O
71 at IN B-VP O
71 baseline NN B-NP O
71 No NNP I-NP O
71 intubations NNS I-NP O
71 , , O O
72 but CC O O
72 many JJ B-NP O
72 admissions NNS I-NP O
72 Obesity NNP I-NP O
72 - : O O
73 morbid NN B-NP O
73 Nephrolithiasis NNP I-NP O
74 Atypical NNP I-NP O
74 chest NN I-NP O
74 pain NN I-NP O
74 - : O O
74 negative JJ B-NP O
74 ETT NNP I-NP O
74 2002 CD O O
74 Umbilical NNP B-NP O
74 hernia NN I-NP O
74 repair NN I-NP O
74 2001 CD O O
75 -- : O O
75 incarcerated VBD B-VP B-r
75 HTN NNP B-NP I-r
75 -- : O O
75 recent JJ B-NP O
75 dx NN I-NP O
75 , , O O
75 started VBD B-VP O
75 on IN B-VP O
76 HCTZ NNP B-NP B-m
77 **** NNP I-NP O
78 EXAM: NNP I-NP O
78 afeb VBD B-VP O
78 p98 JJ O O
78 155/64 CD O O
78 rr18 NN B-NP O
79 93%RA CD O O
79 NAD NNP B-NP O
80 mmm NN I-NP O
80 , , O O
80 OP NNP B-NP O
80 clear JJ B-NP O
80 +diffuse NNP I-NP O
80 expiratory NN I-NP O
80 wheezes NNS I-NP O
80 and CC O O
80 rhonchi NN B-NP O
80 , , O O
80 +cough NN B-NP O
80 on IN B-VP O
81 forced JJ B-NP O
81 exhalation NN I-NP O
81 rrr NN I-NP O
81 , , O O
81 nl JJ B-NP O
81 S1S2 NNP I-NP O
81 , , O O
81 no DT B-NP O
82 m/g/r NN I-NP O
82 abd VBZ O O
82 obese JJ O O
82 , , O O
82 BS+ NNP B-NP O
82 , , O O
83 NT/ND NNP B-NP O
83 wwp NN I-NP O
83 , , O O
83 TR NNP B-NP O
83 edema VBZ O O
84 bilat JJ B-NP O
85 **** NNP I-NP O
86 LABS: NNP I-NP O
86 enzymes VBZ O O
86 neg JJ B-NP O
86 x3 NNP I-NP O
86 STUDIES: NNP I-NP O
87 EKG: NNP I-NP O
87 poor JJ B-NP O
87 study NN I-NP O
87 with IN B-VP O
87 wavering VBG O O
87 baseline NN B-NP O
87 , , O O
87 sinus JJ B-NP O
87 tach NN I-NP O
87 at IN B-VP O
87 100 CD O O
87 , , O O
87 no DT B-NP O
87 sig NN I-NP O
88 STTw NNP I-NP O
88 changes NNS I-NP O
88 , , O O
88 +low JJ B-NP O
88 voltage NN I-NP O
88 criteria NNS I-NP O
88 CTA NNP I-NP O
88 Chest: NNP I-NP O
88 negative JJ O O
88 for IN B-VP O
89 dissection NN B-NP O
89 Limited NNP I-NP O
89 study NN I-NP O
89 due JJ O O
89 to TO O O
89 body NN B-NP O
89 habitus JJ B-NP O
89 Incidental NNP I-NP O
89 finding NN I-NP O
89 of IN B-VP O
90 3 CD O O
90 subcentimeter NN B-NP O
90 nodules NNS I-NP O
90 in IN B-VP O
90 periphery NN B-NP O
90 of IN B-VP O
90 R NNP B-NP O
90 lung NNP I-NP O
90 Focal NNP I-NP O
91 thickening NN I-NP O
91 of IN B-VP O
91 lateral JJ B-NP O
91 limb NN I-NP O
91 of IN B-VP O
91 L NNP B-NP O
91 adrenal JJ B-NP O
91 gland NN I-NP O
92 **** NNP I-NP O
93 HOSPITAL NNP I-NP O
93 COURSE: NNP I-NP O
93 45 CD O O
93 yo NN B-NP O
93 M NNP I-NP O
93 w/ NN I-NP O
93 morbid NN I-NP O
93 obesity NN I-NP O
93 presents NNS I-NP O
93 with IN B-VP O
93 chest NN B-NP O
93 pain NN I-NP O
93 and CC O O
94 hypertensive JJ B-NP O
94 urgency NN I-NP O
95 * NNP I-NP O
95 CV: NNP I-NP O
95 Ischemia- NNP I-NP O
95 Pt NNP I-NP O
95 ruled VBD B-VP O
95 out RP O O
95 for IN B-VP O
95 MI NNP B-NP O
95 with IN B-VP O
95 negative JJ B-NP O
95 serial JJ I-NP O
95 enzymes NNS I-NP O
95 and CC O O
96 EKGs NNP B-NP O
96 Cardiac NNP I-NP O
96 PET NNP I-NP O
96 showed VBD B-VP O
96 2 CD O O
96 small JJ B-NP O
96 areas NNS I-NP O
96 of IN B-VP O
96 of IN B-VP O
96 reversible JJ B-NP O
96 ischemia NN I-NP O
96 in IN B-VP O
96 the DT B-NP O
97 mid NN I-NP O
97 PDA NNP I-NP O
97 and CC O O
97 distal JJ B-NP O
97 LAD NNP I-NP O
97 territory NN I-NP O
97 Cards NNP I-NP O
97 f/u NN I-NP O
97 was VBD B-VP O
97 arranged VBN O O
97 as IN B-VP O
97 an DT B-NP O
97 oupatient NN I-NP O
98 He PRP O O
98 was VBD B-VP O
98 given VBN O O
98 ASA NNP B-NP B-m
98 , , O O
98 and CC O O
98 beta NN B-NP B-m
98 blocker NN I-NP I-m
98 Total NNP I-NP O
98 cholesterol NN I-NP O
98 was VBD B-VP O
98 111 CD O O
98 , , O O
99 triglycerides NNS B-NP O
99 44 CD O O
99 , , O O
99 HDL NNP B-NP O
99 49 CD O O
99 , , O O
99 LDL NNP B-NP O
99 53 CD O O
99 Despites NNP B-NP O
99 evidence NN I-NP O
99 of IN B-VP O
99 CAD NNP B-NP O
99 on IN B-VP O
99 PET NNP B-NP O
99 , , O O
99 a DT B-NP O
100 statin NN I-NP B-m
100 was VBD B-VP O
100 not RB O O
100 started VBN O O
100 since IN B-VP O
100 patient NN B-NP O
100 has VBZ O O
100 a DT B-NP O
100 difficult JJ I-NP O
100 time NN I-NP O
100 with IN B-VP O
100 medication NN B-NP O
101 adherence NN I-NP O
101 and CC O O
101 understanding NN B-NP O
101 Will NNP I-NP O
101 defer VB O O
101 statin JJ B-NP B-m
101 initiation NN I-NP O
101 to TO O O
101 cardiology VB O O
102 as IN B-VP O
102 an DT B-NP O
102 outpatient NN I-NP O
102 if IN B-VP O
102 necessary JJ O O
103 For IN B-VP O
103 HTN NNP B-NP B-r
103 HTN NNP I-NP B-r
103 control NN I-NP I-r
103 control NN I-NP I-r
103 , , O O
103 pt NN B-NP O
103 was VBD B-VP O
103 given VBN O O
103 HCTZ NNP B-NP B-m
103 and CC O O
103 lopressor NN B-NP B-m
103 which WDT O O
103 sufficiently RB O O
104 controlled VBD B-VP O
104 his PRP$ O O
104 BP NNP B-NP O
104 Pt NNP I-NP O
104 was VBD B-VP O
104 sent VBN O O
104 home NN B-NP O
104 on IN B-VP O
104 HCTZ NNP B-NP B-m
104 25mg CD O B-do
104 daily RB O B-f
104 and CC O O
104 atenolol VB O B-m
104 50mg CD O B-do
105 daily JJ B-NP B-f
105 Consider NNP I-NP O
105 outpatient NN I-NP O
105 w/u NN I-NP O
105 of IN B-VP O
105 thickened JJ B-NP O
105 adrenal JJ I-NP O
105 gland NN I-NP O
105 if IN B-VP O
105 BP NNP B-NP O
105 is VBZ O O
106 difficult JJ O O
106 to TO O O
106 control VB O O
107 * NNP B-NP O
107 PULM NNP I-NP O
107 - : O O
107 Pt NNP B-NP O
107 thought VBD B-VP O
107 to TO O O
107 have VB O O
107 very RB O B-r
107 very RB O B-r
107 very RB O B-r
107 mild JJ B-NP I-r
107 mild JJ I-NP I-r
107 mild JJ I-NP I-r
107 asthma NN I-NP I-r
107 asthma NN I-NP I-r
107 asthma JJ B-NP I-r
107 exacerbation NN I-NP I-r
107 exacerbation NN I-NP I-r
107 exacerbation NN I-NP I-r
107 and CC O O
107 likely RB O O
107 has VBZ O O
108 a DT B-NP B-r
108 restrictive JJ I-NP I-r
108 ventilatory NN I-NP I-r
108 defect NN I-NP I-r
108 from IN B-VP I-r
108 obesity NN B-NP I-r
108 Advair NNP I-NP B-m
108 Advair NNP I-NP B-m
108 Advair NNP I-NP B-m
108 was VBD B-VP O
108 increased VBN O O
108 to TO O O
109 500/50 CD O B-do
109 500/50 CD O B-do
109 BID NNP B-NP B-f
109 BID NNP I-NP B-f
109 Pt NNP I-NP O
109 was VBD B-VP O
109 given VBN O O
109 nebs JJ B-NP B-m
109 ATC NNP I-NP I-m
109 and CC O O
109 prednisone VB O B-m
109 prednisone NN B-NP B-m
109 60mg CD O B-do
109 60mg CD O B-do
109 qd NN B-NP B-f
109 qd NN I-NP B-f
109 x NNP I-NP B-du
109 x VBD B-VP I-f
109 3 CD O I-du
109 3 CD O I-f
109 doses NNS B-NP I-du
109 doses NNS I-NP I-f
109 and CC O O
110 then RB O O
110 stopped VBD B-VP O
110 when WRB O O
110 respiratory NN B-NP O
110 status NN I-NP O
110 significantly RB O O
110 improved VBN O O
111 * JJ B-NP O
111 GI: NNP I-NP O
111 Pt NNP I-NP O
111 had VBD B-VP O
111 trace NN B-NP O
111 guaiac NN I-NP O
111 + NNP I-NP O
111 stool NN I-NP O
111 HCT NNP I-NP O
111 remained VBD B-VP O
111 stable JJ B-NP O
111 Outpt NNP I-NP O
111 colonoscopy NN I-NP O
112 is VBZ O O
112 recommended VBN O O
112 Pt NNP B-NP O
112 also RB O O
112 c/o VBP O O
112 loose JJ B-NP O
112 stool NN I-NP O
112 , , O O
112 c VB O O
112 diff NN B-NP O
112 was VBD B-VP O
112 negative JJ B-NP O
112 Pt NNP I-NP O
112 likely RB O O
113 has VBZ O O
113 a DT B-NP O
113 viral JJ I-NP O
113 gastroenteritis NN I-NP O
113 causing VBG O O
113 diarrhea NN B-NP O
113 and CC O O
113 some DT B-NP O
113 nausea NN I-NP O
114 * NNP I-NP O
114 ENDO: NNP I-NP O
114 A1C NNP I-NP O
114 was VBD B-VP O
114 7.4 CD O O
114 and CC O O
114 BS NNP B-NP O
114 was VBD B-VP O
114 in IN B-VP O
114 mid JJ O O
114 100s CD O O
114 multiple JJ B-NP O
114 times NNS I-NP O
114 during IN B-VP O
114 admit NN B-NP O
115 Pt NNP I-NP O
115 educated VBD B-VP O
115 on IN B-VP O
115 low JJ B-NP O
115 sugar NN I-NP O
115 , , O O
115 low JJ B-NP O
115 carbohydrate NN I-NP O
115 diet NN I-NP O
115 He PRP O O
115 was VBD B-VP O
115 seen VBN O O
115 by IN B-VP O
115 nutrition NN B-NP O
116 and CC O O
116 will MD O O
116 follow VB O O
116 up RP O O
116 with IN B-VP O
116 his PRP$ O O
116 outpatient JJ B-NP O
116 nutritionist NN I-NP O
117 * NNP I-NP O
117 PPX: NNP I-NP O
117 lovenox VBZ O B-m
117 BID NNP B-NP B-f
117 ( ( O O
117 for IN B-VP O
117 weight NN B-NP B-r
117 ) ) O O
118 ADDITIONAL NNP B-NP O
118 COMMENTS: NNP I-NP O
118 1 CD O O
118 ) ) O O
118 Take VB O O
118 hydrochlorothiazide JJ O B-m
118 25mg CD O B-do
118 daily JJ O B-f
118 and CC O O
118 atenolol JJ O B-m
118 50mg CD O B-do
118 daily JJ O B-f
118 for IN B-VP O
118 your PRP$ O B-r
118 your PRP$ O B-r
119 blood NN B-NP O
119 pressure NN I-NP O
119 You PRP O O
119 should MD O O
119 also RB O O
119 take VB O O
119 aspirin JJ O B-m
119 81mg CD O B-do
119 daily RB O B-f
120 2 CD O O
120 ) ) O O
120 Your PRP$ O O
120 blood NN B-NP O
120 sugar NN I-NP O
120 has VBZ O O
120 been VBN O O
120 slightly RB O O
120 elevtaed IN B-VP O
120 You PRP O O
120 need VBP O O
120 to TO O O
120 eat VB O O
120 a DT B-NP O
120 low JJ I-NP O
121 sugar NN I-NP O
121 , , O O
121 low JJ B-NP O
121 carbohydrate NN I-NP O
121 diet JJ B-NP O
121 Please NNP I-NP O
121 discuss NN I-NP O
121 with IN B-VP O
121 your PRP$ O O
121 nutritionist JJ O O
122 3 CD O O
122 ) ) O O
122 Follow NNP B-NP O
122 up RP O O
122 with IN B-VP O
122 cardiology NN B-NP O
122 ( ( O O
122 heart NN B-NP O
122 clinic NN I-NP O
122 ) ) O O
122 on IN B-VP O
122 11/0 CD O O
122 at IN B-VP O
122 Peobrid NNP B-NP O
122 Robrid NNP I-NP O
122 Clevery NNP I-NP O
122 Xand NNP I-NP O
122 O NNP I-NP O
122 Ee NNP I-NP O
123 on IN B-VP O
123 the DT B-NP O
123 Montcar NNP I-NP O
123 Erv NNP I-NP O
123 Pkwy NNP I-NP O
123 , , O O
123 Ton-ster NNP B-NP O
123 Fallsbi NNP I-NP O
123 Saant NNP I-NP O
123 , , O O
123 Minnesota NNP B-NP O
123 16637 CD O O
124 4 CD O O
124 ) ) O O
124 Call VB O O
124 Dr NNP B-NP O
124 Lampkin NNP I-NP O
124 or CC O O
124 come VBN O O
124 back RB O O
124 to TO O O
124 the DT B-NP O
124 emergency NN I-NP O
124 room NN I-NP O
124 if IN B-VP O
124 you PRP O O
125 have VBP O O
125 chest VBN O O
125 pain NN B-NP O
125 , , O O
125 difficulty NN B-NP O
125 breathing NN I-NP O
125 , , O O
125 fever NN B-NP O
125 , , O O
125 or CC O O
125 lightheadedness JJ B-NP O
126 DISCHARGE NNP I-NP O
126 CONDITION: NNP I-NP O
126 Stable NNP I-NP O
127 TO NNP I-NP O
127 DO/PLAN: NNP I-NP O
128 1 CD O O
128 ) ) O O
128 Monitor NNP B-NP O
128 blood NN I-NP O
128 sugars NNS I-NP O
128 and CC O O
128 A1C- NNP B-NP O
128 pt NN I-NP O
128 is VBZ O O
128 borderline JJ O O
128 diabetic JJ O O
128 and CC O O
128 will MD O O
128 try VB O O
129 diet JJ B-NP O
129 modification NN I-NP O
130 2 CD O O
130 ) ) O O
130 Recommend NNP B-NP O
130 outpatient NN I-NP O
130 colonoscopy NN I-NP O
131 3 CD O O
131 ) ) O O
131 Consider NNP B-NP O
131 statin NN I-NP B-m
131 therapy NN I-NP O
132 No NNP I-NP O
132 dictated VBD B-VP O
132 summary JJ B-NP O
133 ENTERED NNP I-NP O
133 BY: NNP I-NP O
133 PICKELL NNP I-NP O
133 , , O O
133 MARKUS NNP B-NP O
133 L NNP I-NP O
133 ( ( O O
133 GN51 NNP B-NP O
133 ) ) O O
133 5/23/07 CD O O
133 @ $ O O
133 01:27 CD O O
133 PM NNP B-NP O
134 ****** JJ B-NP O
134 END NNP I-NP O
134 OF NNP I-NP O
134 DISCHARGE NNP I-NP O
134 ORDERS NNP I-NP O
134 ****** NNP I-NP O
135 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #992839 VBZ O O
4 753215669 CD O O
4 KRCH NNP B-NP O
4 33656807 CD O O
4 3752166 CD O O
4 9/2/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 Discharge NNP I-NP O
4 Summary NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/21/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 2/29/2005 CD O O
7 ATTENDING: NNP B-NP O
7 MACCARONE NNP I-NP O
7 , , O O
7 HERB NNP B-NP O
7 M.D NNP I-NP O
8 SERVICE: NNP I-NP O
8 General NNP I-NP O
8 Medical NNP I-NP O
8 Service NNP I-NP O
8 , , O O
8 Na NNP B-NP O
9 ADMIT NNP I-NP O
9 DIAGNOSIS: NNP I-NP O
9 Congestive NNP I-NP O
9 heart NN I-NP O
9 failure NN I-NP O
10 DISCHARGE NNP I-NP O
10 DIAGNOSES: NNP I-NP O
10 Congestive NNP I-NP O
10 heart NN I-NP O
10 failure NN I-NP O
10 , , O O
10 aortic JJ B-NP O
10 valve NN I-NP O
10 and CC O O
11 mitral JJ B-NP O
11 valve NN I-NP O
11 dysfunction NN I-NP O
12 CHIEF NNP I-NP O
12 COMPLAINT: NNP I-NP O
12 Shortness NNP I-NP O
12 of IN B-VP O
12 breath JJ B-NP O
13 HISTORY NNP I-NP O
13 OF NNP I-NP O
13 PRESENT NNP I-NP O
13 ILLNESS: NNP I-NP O
13 This DT O O
13 is VBZ O O
13 59-year-old JJ B-NP O
13 female NN I-NP O
13 who WP O O
13 is VBZ O O
14 status NN B-NP O
14 post NN I-NP O
14 mitral JJ B-NP O
14 valve NN I-NP O
14 repair NN I-NP O
14 , , O O
14 aortic JJ B-NP O
14 valve NN I-NP O
14 repair NN I-NP O
14 , , O O
14 history NN B-NP O
14 of IN B-VP O
15 endocarditis NN B-NP O
15 , , O O
15 history NN B-NP O
15 of IN B-VP O
15 rheumatic JJ B-NP O
15 heart NN I-NP O
15 disease NN I-NP O
15 , , O O
15 hypertension NN B-NP O
15 , , O O
16 diabetes VBZ O O
16 mellitus NN B-NP O
16 , , O O
16 and CC O O
16 congestive JJ B-NP O
16 heart NN I-NP O
16 failure NN I-NP O
16 who WP O O
16 presents VBZ O O
16 with IN B-VP O
17 increasing VBG O O
17 shortness NN B-NP O
17 of IN B-VP O
17 breath NN B-NP O
17 , , O O
17 nausea NN B-NP O
17 , , O O
17 vomiting NN B-NP O
17 , , O O
17 and CC O O
17 abdominal JJ B-NP O
18 pain NN I-NP O
18 She PRP O O
18 has VBZ O O
18 been VBN O O
18 under IN B-VP O
18 significant JJ B-NP O
18 stress NN I-NP O
18 at IN B-VP O
18 home NN B-NP O
18 since IN B-VP O
18 last JJ B-NP O
19 summer NN I-NP O
19 and CC O O
19 notes NNS B-NP O
19 slowly RB O O
19 declining VBG O O
19 health NN B-NP O
19 since IN B-VP O
19 that DT B-NP O
19 time NN I-NP O
19 She PRP O O
20 has VBZ O O
20 had VBD B-VP O
20 increasing VBG O O
20 shortness NN B-NP O
20 of IN B-VP O
20 breath NN B-NP O
20 as RB O O
20 well RB O O
20 as IN B-VP O
20 dyspnea NN B-NP O
20 on IN B-VP O
21 exertion NN B-NP O
21 since IN B-VP O
21 July NNP B-NP O
21 2004 CD O O
21 and CC O O
21 has VBZ O O
21 gotten VBN O O
21 worse RBR O O
21 in IN B-VP O
21 the DT O O
21 past JJ O O
21 one CD O O
22 month NN B-NP O
22 , , O O
22 and CC O O
22 even RB O O
22 significantly RB O O
22 worse JJR O O
22 in IN B-VP O
22 the DT B-NP O
22 past JJ I-NP O
22 week NN I-NP O
22 The DT B-NP O
23 patient NN I-NP O
23 notes NNS I-NP O
23 increasing VBG O O
23 lower JJR B-NP O
23 extremity NN I-NP O
23 edema NN I-NP O
23 on IN B-VP O
23 the DT B-NP O
23 right JJ I-NP O
23 side NN I-NP O
24 greater JJR O O
24 than IN B-VP O
24 the DT O O
24 left JJ O O
24 She PRP O O
24 states VBZ O O
24 that IN B-VP O
24 this DT O O
24 is VBZ O O
24 her PRP$ O O
24 baseline NN B-NP O
24 with IN B-VP O
25 the DT B-NP O
25 right JJ I-NP O
25 side NN I-NP O
25 being VBG O O
25 more JJR O O
25 than IN B-VP O
25 the DT B-NP O
25 left NN I-NP O
25 She PRP O O
25 has VBZ O O
25 no DT B-NP O
25 increase NN I-NP O
25 in IN B-VP O
26 her PRP$ O O
26 abdominal JJ B-NP O
26 girth NN I-NP O
26 , , O O
26 the DT B-NP O
26 patient NN I-NP O
26 has VBZ O O
26 two-to JJ B-NP O
26 three-pillow JJ I-NP O
27 orthopnea NN I-NP O
27 ( ( O O
27 from IN B-VP O
27 one-pillow JJ B-NP O
27 orthopnea NN I-NP O
27 , , O O
27 one CD O O
27 month NN B-NP O
27 ago RB O O
27 ) ) O O
27 , , O O
27 she PRP O O
27 does VBZ O O
28 have VB O O
28 some DT B-NP O
28 paroxysmal JJ I-NP O
28 nocturnal JJ I-NP O
28 dyspnea NN I-NP O
28 , , O O
28 she PRP O O
28 has VBZ O O
28 no DT O O
28 increased VBN O O
29 nocturia RB O O
29 The DT B-NP O
29 patient NN I-NP O
29 notes VBZ O O
29 that IN B-VP O
29 the DT B-NP O
29 shortness NN I-NP O
29 of IN B-VP O
29 breath NN B-NP O
29 is VBZ O O
29 "not JJ B-NP O
30 angina; NN I-NP O
30 I PRP O O
30 do VBP O O
30 not RB O O
30 have VB O O
30 that." VBN O O
30 She PRP O O
30 does VBZ O O
30 not RB O O
30 have VB O O
30 any DT B-NP O
31 lightheadedness NN I-NP O
31 , , O O
31 diaphoresis NN B-NP O
31 , , O O
31 or CC O O
31 radiation NN B-NP O
31 of IN B-VP O
31 pain NN B-NP O
31 The DT B-NP O
31 patient NN I-NP O
32 says VBZ O O
32 that IN B-VP O
32 she PRP O O
32 does VBZ O O
32 not RB O O
32 check VB O O
32 her PRP$ O O
32 weigh NN B-NP O
32 at IN B-VP O
32 home NN B-NP O
32 , , O O
32 but CC O O
32 "knows" NNP B-NP O
32 she PRP O O
33 is VBZ O O
33 in IN B-VP O
33 failure NN B-NP O
33 when WRB O O
33 she PRP O O
33 is VBZ O O
33 short JJ O O
33 of IN B-VP O
33 breath NN B-NP O
33 She PRP O O
33 also RB O O
33 notes VBZ O O
34 nausea NN B-NP O
34 , , O O
34 vomiting NN B-NP O
34 , , O O
34 and CC O O
34 some DT B-NP O
34 abdominal JJ I-NP O
34 pain NN I-NP O
34 stating VBG O O
34 that IN B-VP O
34 it PRP O O
34 started VBD B-VP O
35 about IN B-VP O
35 a DT B-NP O
35 week NN I-NP O
35 and CC O O
35 a DT B-NP O
35 half NN I-NP O
35 ago IN B-VP O
35 She PRP O O
35 had VBD B-VP O
35 gone VBN O O
35 to TO O O
35 see VB O O
35 the DT B-NP O
35 ED NNP I-NP O
35 on IN B-VP O
35 the DT B-NP O
36 Sunday NNP I-NP O
36 prior RB O O
36 to TO O O
36 admission VB O O
36 where WRB O O
36 the DT B-NP O
36 patient NN I-NP O
36 reportedly RB O O
36 had VBD B-VP O
36 a DT B-NP O
37 benign JJ I-NP O
37 exam NN I-NP O
37 , , O O
37 low-grade JJ B-NP O
37 temperature NN I-NP O
37 , , O O
37 given VBN O O
37 recent JJ B-NP O
37 Levaquin NNP I-NP B-m
37 for IN B-VP O
37 an DT B-NP B-r
38 upper JJ I-NP O
38 respiratory NN I-NP O
38 tract NN I-NP O
38 infection NN I-NP O
38 , , O O
38 she PRP O O
38 was VBD B-VP O
38 then RB O O
38 started VBN O O
38 on IN B-VP O
38 Flagyl NNP B-NP B-m
39 for IN B-VP O
39 a DT B-NP B-r
39 possible JJ I-NP I-r
39 C NNP I-NP I-r
39 difficile NN I-NP I-r
39 infection NN I-NP I-r
39 The DT B-NP O
39 patient's NN I-NP O
39 diarrhea NN I-NP O
40 stopped VBD B-VP O
40 , , O O
40 but CC O O
40 she PRP O O
40 had VBD B-VP O
40 still RB O O
40 remained VBN O O
40 some DT B-NP O
40 abdominal JJ I-NP O
40 pain NN I-NP O
40 and CC O O
41 increased VBD B-VP O
41 cough NN B-NP O
41 , , O O
41 which WDT O O
41 was VBD B-VP O
41 nonproductive JJ O O
41 She PRP O O
41 went VBD B-VP O
41 to TO O O
41 her PRP$ O O
41 PCP NNP B-NP O
41 on IN B-VP O
42 the DT B-NP O
42 day NN I-NP O
42 of IN B-VP O
42 admission NN B-NP O
42 for IN B-VP O
42 increasing VBG O O
42 shortness NN B-NP O
42 of IN B-VP O
42 breath NN B-NP O
42 and CC O O
42 was VBD B-VP O
43 sent VBN O O
43 to TO O O
43 the DT B-NP O
43 ED NNP I-NP O
43 for IN B-VP O
43 diuresis NN B-NP O
43 In IN B-VP O
43 the DT B-NP O
43 ED NNP I-NP O
43 , , O O
43 she PRP O O
43 was VBD B-VP O
43 given VBN O O
43 60 CD O B-do
43 mg NN B-NP I-do
43 of IN B-VP O
44 IV NNP B-NP B-mo
44 Lasix NNP I-NP B-m
44 with IN B-VP O
44 good JJ B-NP O
44 output NN I-NP O
44 per IN B-VP O
44 report NN B-NP O
44 She PRP O O
44 did VBD B-VP O
44 have VB O O
44 some DT B-NP O
44 decrease NN I-NP O
45 in IN B-VP O
45 her PRP$ O O
45 shortness NN B-NP O
45 of IN B-VP O
45 breath NN B-NP O
45 shortly RB O O
45 thereafter RB O O
45 She PRP O O
45 also RB O O
46 complained VBD B-VP O
46 of IN B-VP O
46 10/10 CD O B-r
46 abdominal JJ B-NP I-r
46 pain NN I-NP I-r
46 and CC O O
46 was VBD B-VP O
46 given VBN O O
46 some DT B-NP O
46 Dilaudid NNP I-NP B-m
47 On IN B-VP O
47 the DT B-NP O
47 floor NN I-NP O
47 during IN B-VP O
47 the DT B-NP O
47 interview NN I-NP O
47 , , O O
47 she PRP O O
47 did VBD B-VP O
47 have VB O O
47 some DT B-NP O
47 projectile NN I-NP O
48 vomiting VBG O O
48 She PRP O O
48 was VBD B-VP O
48 able JJ O O
48 to TO O O
48 pass VB O O
48 gas NN B-NP O
48 She PRP O O
48 reported VBD B-VP O
48 no DT B-NP O
48 fevers NNS I-NP O
48 , , O O
49 chills NNS B-NP O
49 , , O O
49 or CC O O
49 night NN B-NP O
49 sweats NNS I-NP O
49 She PRP O O
49 reported VBD B-VP O
49 no DT B-NP O
49 bright JJ I-NP O
49 red JJ I-NP O
49 blood NN I-NP O
49 per IN B-VP O
50 rectum NN B-NP O
50 She PRP O O
50 reported VBD B-VP O
50 no DT B-NP O
50 change NN I-NP O
50 in IN B-VP O
50 her PRP$ O O
50 bowel NN B-NP O
50 , , O O
50 bladder NN B-NP O
50 , , O O
50 or CC O O
50 urinary JJ B-NP O
51 habits NNS I-NP O
52 PAST NNP I-NP O
52 MEDICAL NNP I-NP O
52 HISTORY: NNP I-NP O
53 1 CD O O
53 Rheumatic NNP B-NP O
53 heart NN I-NP O
53 disease NN I-NP O
53 , , O O
53 status NN B-NP O
53 post NN I-NP O
53 mitral JJ B-NP O
53 valve NN I-NP O
53 repair NN I-NP O
53 and CC O O
54 aortic JJ B-NP O
54 valve NN I-NP O
54 repair NN I-NP O
54 In IN B-VP O
54 1981 CD O O
54 , , O O
54 she PRP O O
54 had VBD B-VP O
54 porcine JJ B-NP O
54 mitral JJ I-NP O
54 valve NN I-NP O
55 repair NN I-NP O
55 In IN B-VP O
55 1991 CD O O
55 , , O O
55 she PRP O O
55 had VBD B-VP O
55 St NNP B-NP O
55 Jude NNP I-NP O
55 valve NN I-NP O
55 , , O O
55 mitral JJ B-NP O
55 valve NN I-NP O
55 , , O O
55 and CC O O
55 AVR NNP B-NP O
56 2 CD O O
56 Endocarditis NNP B-NP O
56 in IN B-VP O
56 1991 CD O O
56 and CC O O
56 porcine VB O O
56 mitral JJ B-NP O
56 valve NNS I-NP O
57 3 CD O O
57 Diabetes NNPS B-NP O
57 mellitus VBD B-VP O
58 4 CD O O
58 Hypertension NNP B-NP O
59 5 CD O O
59 Status NNP B-NP O
59 post NN I-NP O
59 ankle NN I-NP O
59 fracture NN I-NP O
59 and CC O O
59 subsequent JJ B-NP O
59 ORIF NNP I-NP O
59 in IN B-VP O
59 2001 CD O O
60 6 CD O O
60 Status NNP B-NP O
60 post NN I-NP O
60 ventral JJ B-NP O
60 hernia NN I-NP O
60 repair NN I-NP O
61 7 CD O O
61 Status NNP B-NP O
61 post NN I-NP O
61 laparoscopic NN I-NP O
61 cholecystectomy VBD B-VP O
62 8 CD O O
62 Status NNP B-NP O
62 post NN I-NP O
62 breast NN I-NP O
62 biopsy NN I-NP O
63 9 CD O O
63 Congestive NNP B-NP O
63 heart NN I-NP O
63 failure NN I-NP O
64 10 CD O O
64 Atrial NNP B-NP O
64 fibrillation NN I-NP O
65 11 CD O O
65 TIA NNP B-NP O
66 ALLERGIES: NNP I-NP O
66 No NNP I-NP O
66 known VBN O O
66 drug NN B-NP O
66 allergies NNS I-NP O
66 Dove NNP I-NP O
66 soap NN I-NP O
66 does VBZ O O
66 give VB O O
66 her PRP$ O O
67 hives NNS B-NP O
68 MEDICATIONS: NNP I-NP O
69 1 CD O O
69 Lasix NNP B-NP B-m
69 40 CD O B-do
69 mg NN B-NP I-do
69 p.o NN I-NP B-mo
69 q.o.d NN I-NP B-f
69 alternating VBG O O
69 with IN B-VP O
69 80 CD O B-do
69 mg NNS B-NP I-do
69 p.o JJ B-NP B-mo
69 Lasix NNP I-NP B-m
70 q.o.d NN I-NP B-f
71 2 CD O O
71 Digoxin NNP B-NP B-m
71 Digoxin NNP I-NP B-m
71 0.125 CD O B-do
71 mg NN B-NP I-do
71 q.o.d NN I-NP B-f
71 alternating VBG O O
71 with IN B-VP O
71 0.25 CD O B-do
71 q.o.d NNS B-NP B-f
72 3 CD O O
72 Lisinopril NNP B-NP B-m
72 20 CD O B-do
72 mg NN B-NP I-do
72 p.o NN I-NP B-mo
72 q.d VBD B-VP B-f
73 4 CD O O
73 Coumadin NNP B-NP B-m
73 Coumadin NNP I-NP B-m
73 6 CD O B-do
73 mg NN B-NP I-do
73 p.o NN I-NP B-mo
73 q.o.d NN I-NP B-f
73 , , O O
73 alternating VBG O O
73 with IN B-VP O
73 4 CD O B-do
73 mg NNS B-NP I-do
73 q.o.d RB O B-f
74 5 CD O O
74 Omeprazole NNP B-NP B-m
74 20 CD O B-do
74 mg NN B-NP I-do
74 b.i.d NN I-NP B-f
75 6 CD O O
75 Metformin NNP B-NP B-m
75 500 CD O B-do
75 mg VBD B-VP I-do
75 daily RB O B-f
76 7 CD O O
76 Insulin NNP B-NP B-m
76 Insulin NNP I-NP B-m
76 70/30 CD O I-m
76 70/30 CD O I-m
76 65 CD O B-do
76 units NNS B-NP I-do
76 q.a.m RB O B-f
76 , , O O
76 35 CD O B-do
76 units NNS B-NP I-do
76 q.p.m RB O B-f
77 8 CD O O
77 Calcium NNP B-NP B-m
77 600 CD O B-do
77 mg NN B-NP I-do
77 p.o NN I-NP B-mo
77 b.i.d VBD B-VP B-f
78 9 CD O O
78 Magnesium NNP B-NP B-m
78 400 CD O B-do
78 mg NN B-NP I-do
78 p.o NN I-NP B-mo
78 b.i.d VBD B-VP B-f
79 10 CD O O
79 Multivitamin NNP B-NP B-m
80 11 CD O O
80 Iron NNP B-NP B-m
80 tablets NNS I-NP I-m
81 12 CD O O
81 Actonel NNP B-NP B-m
81 every DT B-NP B-f
81 Wednesday NNP I-NP I-f
82 SOCIAL NNP I-NP O
82 HISTORY: NNP I-NP O
82 The DT B-NP O
82 patient NN I-NP O
82 quit NN I-NP O
82 smoking NN I-NP O
82 in IN B-VP O
82 2001 CD O O
82 Her NNP B-NP O
82 maximum NN I-NP O
83 was VBD B-VP O
83 three CD O O
83 to TO O O
83 four CD O O
83 packs NNS B-NP O
83 per IN B-VP O
83 day NN B-NP O
83 for IN B-VP O
83 35 CD O O
83 years NNS B-NP O
83 As RB O O
83 far RB O O
83 as IN B-VP O
83 her PRP$ O O
84 alcohol NN B-NP O
84 history NN I-NP O
84 , , O O
84 she PRP O O
84 drinks VBZ O O
84 occasional JJ B-NP O
84 alcohol NN I-NP O
84 She PRP O O
84 does VBZ O O
84 not RB O O
85 take VB O O
85 any DT B-NP O
85 illicit NN I-NP O
85 drugs NNS I-NP O
85 She PRP O O
85 used VBD B-VP O
85 to TO O O
85 work VB O O
85 as IN B-VP O
85 a DT B-NP O
85 hairdresser NN I-NP O
85 She PRP O O
86 has VBZ O O
86 had VBN O O
86 increased VBN O O
86 stress NN B-NP O
86 at IN B-VP O
86 home NN B-NP O
86 secondary NN I-NP O
86 to TO O O
86 a DT B-NP O
86 son NN I-NP O
86 who WP O O
86 has VBZ O O
87 schizophrenia NN B-NP O
87 and CC O O
87 another DT B-NP O
87 son NN I-NP O
87 who WP O O
87 abuses VBZ O O
87 drugs NNS B-NP O
87 and CC O O
87 has VBZ O O
87 violent JJ B-NP O
88 tendencies NNS I-NP O
89 FAMILY NNP I-NP O
89 HISTORY: NNP I-NP O
89 Noncontributory NNP I-NP O
90 PHYSICAL NNP I-NP O
90 EXAMINATION NNP I-NP O
90 ON NNP I-NP O
90 ADMISSION: NNP I-NP O
90 Vital NNP I-NP O
90 signs NNS I-NP O
90 are VBP O O
90 remarkable JJ O O
91 for IN B-VP O
91 temperature NN B-NP O
91 of IN B-VP O
91 98.7 CD O O
91 , , O O
91 pulse RB O O
91 60 CD O O
91 , , O O
91 blood NN B-NP O
91 pressure NN I-NP O
91 111/61 CD O O
91 , , O O
92 respiratory NN B-NP O
92 rate NN I-NP O
92 30 CD O O
92 , , O O
92 O2 NNP B-NP O
92 saturation NN I-NP O
92 96% CD O O
92 on IN B-VP O
92 room NN B-NP O
92 air NN I-NP O
92 These DT O O
92 were VBD B-VP O
93 vitals NNS B-NP O
93 when WRB O O
93 the DT B-NP O
93 patient NN I-NP O
93 arrived VBD B-VP O
93 to TO O O
93 the DT B-NP O
93 floor NN I-NP O
93 General: NNP I-NP O
93 She PRP O O
93 is VBZ O O
94 alert JJ O O
94 and CC O O
94 oriented JJ B-NP O
94 x3 NN I-NP O
94 She PRP O O
94 is VBZ O O
94 anxious JJ O O
94 , , O O
94 but CC O O
94 pleasant NN B-NP O
94 in IN B-VP O
94 nature NN B-NP O
95 HEENT: NNP I-NP O
95 Her NNP I-NP O
95 left VBD B-VP O
95 eye NN B-NP O
95 is VBZ O O
95 artificial JJ B-NP O
95 Her NNP I-NP O
95 right NN I-NP O
95 eye NN I-NP O
95 is VBZ O O
96 approximately RB O O
96 3 CD O O
96 mm NN B-NP O
96 She PRP O O
96 has VBZ O O
96 moist RB O O
96 mucous JJ B-NP O
96 membrane NN I-NP O
96 She PRP O O
96 has VBZ O O
96 a DT B-NP O
97 small JJ I-NP O
97 erosion NN I-NP O
97 on IN B-VP O
97 the DT B-NP O
97 right JJ I-NP O
97 upper JJ I-NP O
97 gum NN I-NP O
97 There EX O O
97 is VBZ O O
97 no DT B-NP O
97 erythema NN I-NP O
97 or CC O O
98 exudate NN B-NP O
98 seen VBN O O
98 within IN B-VP O
98 the DT B-NP O
98 tonsils NNS I-NP O
98 Neck: NNP I-NP O
98 JVP NNP I-NP O
98 noted VBD B-VP O
98 to TO O O
98 be VB O O
99 approximately RB O O
99 6 CD O O
99 cm NN B-NP O
99 Her NNP I-NP O
99 neck NN I-NP O
99 is VBZ O O
99 supple JJ O O
99 There EX O O
99 was VBD B-VP O
99 full JJ B-NP O
99 range NN I-NP O
99 of IN B-VP O
100 motion NN B-NP O
100 There EX O O
100 are VBP O O
100 no DT B-NP O
100 carotid JJ I-NP O
100 bruits NNS I-NP O
100 and CC O O
100 there EX O O
100 is VBZ O O
100 no DT B-NP O
101 lymphadenopathy JJ I-NP O
101 present JJ I-NP O
101 Cardiovascular: NNP I-NP O
101 Heart NNP I-NP O
101 is VBZ O O
101 of IN B-VP O
101 regular JJ B-NP O
102 rate NN I-NP O
102 and CC O O
102 rhythm NN B-NP O
102 with IN B-VP O
102 occasional JJ B-NP O
102 premature NN I-NP O
102 beats VBZ O O
102 She PRP O O
102 has VBZ O O
102 a DT B-NP O
102 S1 NNP I-NP O
103 and CC O O
103 S2 NNP B-NP O
103 that WDT O O
103 are VBP O O
103 mechanical JJ O O
103 in IN B-VP O
103 nature NN B-NP O
103 She PRP O O
103 has VBZ O O
103 a DT O O
103 3/6 CD O O
103 holosystolic JJ O O
104 murmur FW O O
104 heard NN B-NP O
104 at IN B-VP O
104 the DT B-NP O
104 apex NN I-NP O
104 There EX O O
104 are VBP O O
104 no DT B-NP O
104 rubs NN I-NP O
104 or CC O O
104 gallops NNS B-NP O
105 appreciated VBN O O
105 She PRP O O
105 additionally RB O O
105 has VBZ O O
105 a DT B-NP O
105 right JJ I-NP O
105 RV NNP I-NP O
105 heave VBP O O
105 Her NNP B-NP O
105 PMI NNP I-NP O
105 is VBZ O O
106 diffuse RB O O
106 , , O O
106 but CC O O
106 nondisplaced VBD B-VP O
106 Chest: NNP B-NP O
106 Faint NNP I-NP O
106 crackles NNS I-NP O
106 at IN B-VP O
106 the DT B-NP O
106 left JJ I-NP O
107 base NN I-NP O
107 , , O O
107 otherwise RB O O
107 clear JJ B-NP O
107 No NNP I-NP O
107 wheezes NN I-NP O
107 or CC O O
107 rhonchi NN B-NP O
107 are VBP O O
107 heard VBN O O
108 Abdomen: NNP B-NP O
108 Slightly NNP I-NP O
108 tympanic VBD B-VP O
108 Her PRP$ O O
108 right JJ B-NP O
108 lower JJR I-NP O
108 quadrant NN I-NP O
108 is VBZ O O
109 slightly RB O O
109 tender NN B-NP O
109 She PRP O O
109 has VBZ O O
109 active JJ B-NP O
109 bowel NN I-NP O
109 sounds VBZ O O
109 Her PRP$ O O
109 liver NN B-NP O
109 edge NN I-NP O
109 is VBZ O O
110 not RB O O
110 palpable JJ O O
110 The DT B-NP O
110 spleen JJ I-NP O
110 tip NN I-NP O
110 is VBZ O O
110 nonpalpable JJ B-NP O
110 Extremities: NNP I-NP O
111 Warm NNP I-NP O
111 , , O O
111 1+ CD O O
111 dorsalis NN B-NP O
111 pedis NN I-NP O
111 pulses VBZ O O
111 bilaterally RB O O
111 She PRP O O
111 does VBZ O O
111 have VB O O
111 some DT O O
112 1+ CD O O
112 lower JJR B-NP O
112 extremity NN I-NP O
112 edema NN I-NP O
112 on IN B-VP O
112 the DT B-NP O
112 right NN I-NP O
112 greater JJR O O
112 than IN B-VP O
112 the DT B-NP O
112 left NN I-NP O
112 It PRP O O
113 is VBZ O O
113 slightly RB O O
113 pitting VBG O O
114 LABORATORY NNP B-NP O
114 EXAM NNP I-NP O
114 ON NNP I-NP O
114 ADMISSION: NNP I-NP O
114 Sodium NNP I-NP O
114 126 CD O O
114 , , O O
114 potassium NN B-NP O
114 4.4 CD O O
114 , , O O
115 chloride RB O O
115 93 CD O O
115 , , O O
115 bicarbonate NN B-NP O
115 24 CD O O
115 , , O O
115 BUN NNP B-NP O
115 28 CD O O
115 , , O O
115 creatinine NN B-NP O
115 1.4 CD O O
115 with IN B-VP O
115 a DT B-NP O
116 baseline NN I-NP O
116 of IN B-VP O
116 1.2 CD O O
116 and CC O O
116 1.3 CD O O
116 , , O O
116 glucose VBD B-VP O
116 160 CD O O
116 CBC NNP B-NP O
116 is VBZ O O
116 notable JJ O O
116 for IN B-VP O
116 a DT B-NP O
116 white JJ I-NP O
117 blood NN I-NP O
117 cell NN I-NP O
117 count NN I-NP O
117 of IN B-VP O
117 9.9 CD O O
117 , , O O
117 hematocrit NN B-NP O
117 27.9 CD O O
117 , , O O
117 platelet NN B-NP O
117 count NN I-NP O
117 274 CD O O
117 , , O O
117 000 CD O O
118 Her PRP$ O O
118 liver NN B-NP O
118 function NN I-NP O
118 tests NNS I-NP O
118 are VBP O O
118 notable JJ O O
118 for IN B-VP O
118 ALT NNP B-NP O
118 56 CD O O
118 , , O O
118 AST NNP B-NP O
118 83 CD O O
118 , , O O
119 alkaline JJ B-NP O
119 phosphatase NN I-NP O
119 is VBZ O O
119 52 CD O O
119 , , O O
119 total JJ B-NP O
119 bilirubin NN I-NP O
119 0.1 CD O O
119 , , O O
119 albumin RB O O
119 4.2 CD O O
119 , , O O
119 and CC O O
120 total JJ B-NP O
120 protein NN I-NP O
120 7.4 CD O O
121 STUDIES: NNP B-NP O
121 Her NNP I-NP O
121 EKG NNP I-NP O
121 showed VBD B-VP O
121 no DT B-NP O
121 change NN I-NP O
121 It PRP O O
121 was VBD B-VP O
121 in IN B-VP O
121 junctional JJ B-NP O
121 rhythm NN I-NP O
122 at IN B-VP O
122 65 CD O O
122 beats NNS B-NP O
122 per IN B-VP O
122 minute NN B-NP O
122 She PRP O O
122 had VBD B-VP O
122 frequent JJ B-NP O
122 PVCs NNP I-NP O
122 There EX O O
122 was VBD B-VP O
122 a DT B-NP O
123 normal JJ I-NP O
123 access NN I-NP O
123 There EX O O
123 were VBD B-VP O
123 some DT B-NP O
123 nonspecific JJ I-NP O
123 T-wave JJ I-NP O
123 inversions NNS I-NP O
124 CHEST NNP I-NP O
124 X-RAY: NN I-NP O
124 Showed NNP I-NP O
124 mild IN B-VP O
124 vascular JJ B-NP O
124 congestion NN I-NP O
124 There EX O O
124 was VBD B-VP O
124 no DT B-NP O
125 evidence NN I-NP O
125 of IN B-VP O
125 any DT B-NP O
125 effusion NN I-NP O
126 IMPRESSION: NNP I-NP O
126 This DT O O
126 is VBZ O O
126 a DT B-NP O
126 59-year-old JJ I-NP O
126 female NN I-NP O
126 with IN B-VP O
126 a DT B-NP O
126 rheumatic JJ I-NP O
126 heart NN I-NP O
127 disease NN I-NP O
127 , , O O
127 status NN B-NP O
127 post NN I-NP O
127 St NNP I-NP O
127 Jude's NNP I-NP O
127 MVR NNP I-NP O
127 and CC O O
127 AVR NNP B-NP O
127 , , O O
127 congestive JJ B-NP O
127 heart NN I-NP O
128 failure NN I-NP O
128 who WP O O
128 presents VBZ O O
128 with IN B-VP O
128 mild JJ B-NP O
128 volume NN I-NP O
128 overload NN I-NP O
128 and CC O O
128 abdominal JJ B-NP O
128 pain NN I-NP O
129 with IN B-VP O
129 nausea NN B-NP O
129 and CC O O
129 vomiting VBG O O
130 BRIEF NNP B-NP O
130 HOSPITAL NNP I-NP O
130 COURSE NNP I-NP O
130 BY NNP I-NP O
130 SYSTEMS: NNP I-NP O
131 1 CD O O
131 Cardiovascular: NNP B-NP O
132 a DT B-NP O
132 Ischemia: NNP I-NP O
132 When WRB O O
132 the DT B-NP O
132 patient NN I-NP O
132 was VBD B-VP O
132 admitted VBN O O
132 , , O O
132 she PRP O O
132 was VBD B-VP O
132 ruled VBN O O
132 out RP O O
133 for IN B-VP O
133 an DT B-NP O
133 MI NNP I-NP O
133 She PRP O O
133 did VBD B-VP O
133 have VB O O
133 a DT B-NP O
133 slight JJ I-NP O
133 increase NN I-NP O
133 of IN B-VP O
133 her PRP$ O O
133 troponins NNS B-NP O
133 , , O O
134 which WDT O O
134 were VBD B-VP O
134 attributed VBN O O
134 to TO O O
134 mild VB O O
134 demand NN B-NP O
134 ischemia NN I-NP O
134 In IN B-VP O
134 addition NN B-NP O
134 , , O O
134 she PRP O O
135 had VBD B-VP O
135 some DT B-NP O
135 slight JJ I-NP O
135 anemia NN I-NP O
135 , , O O
135 which WDT O O
135 could MD O O
135 also RB O O
135 be VB O O
135 contributed VBN O O
135 to TO O O
135 the DT B-NP O
136 demand NN I-NP O
136 as RB O O
136 well RB O O
136 in IN B-VP O
136 addition NN B-NP O
136 to TO O O
136 the DT B-NP O
136 clear JJ I-NP O
136 volume NN I-NP O
136 overload IN B-VP O
136 She PRP O O
136 did VBD B-VP O
137 fine VB O O
137 from IN B-VP O
137 the DT B-NP O
137 standpoint NN I-NP O
137 , , O O
137 had VBD B-VP O
137 no DT B-NP O
137 ST NNP I-NP O
137 changes NNS I-NP O
137 on IN B-VP O
137 any DT O O
137 of IN B-VP O
137 her PRP$ O O
137 EKGs NNP B-NP O
138 The DT B-NP O
138 patient NN I-NP O
138 laid VBD B-VP O
138 her PRP$ O O
138 head NN B-NP O
138 workup NN I-NP O
138 for IN B-VP O
138 future JJ B-NP O
138 AVR NNP I-NP O
138 and CC O O
138 MVR NNP B-NP O
138 with IN B-VP O
138 the DT B-NP O
139 Surgical NNP I-NP O
139 Service NNP I-NP O
139 , , O O
139 with IN B-VP O
139 Dr NNP B-NP O
139 Bio NNP I-NP O
139 Her NNP I-NP O
139 workup NN I-NP O
139 was VBD B-VP O
139 extensive JJ O O
139 and CC O O
140 included VBD B-VP O
140 a DT B-NP O
140 cardiac JJ I-NP O
140 catheterization NN I-NP O
140 , , O O
140 which WDT O O
140 showed VBD B-VP O
140 no DT B-NP O
140 significant JJ I-NP O
141 coronary JJ I-NP O
141 artery NN I-NP O
141 disease NN I-NP O
141 The DT B-NP O
141 hemodynamics NNS I-NP O
141 were VBD B-VP O
141 notable JJ O O
141 for IN B-VP O
141 the DT B-NP O
142 following: JJ I-NP O
142 RA NNP I-NP O
142 of IN B-VP O
142 12 CD O O
142 , , O O
142 PA NNP B-NP O
142 of IN B-VP O
142 92/23/44 CD O O
142 , , O O
142 pulmonary JJ B-NP O
142 capillary JJ I-NP O
142 wedge NN I-NP O
143 pressure NN I-NP O
143 of IN B-VP O
143 22 CD O O
143 with IN B-VP O
143 V NNP B-NP O
143 waves NNS I-NP O
143 to TO O O
143 42 CD O O
143 The DT B-NP O
143 mitral JJ I-NP O
143 valve NN I-NP O
143 was VBD B-VP O
143 grossly RB O O
144 normal JJ O O
144 with IN B-VP O
144 appropriate JJ B-NP O
144 leaflet NN I-NP O
144 motion NN I-NP O
144 The DT B-NP O
144 AV NNP I-NP O
144 was VBD B-VP O
144 also RB O O
144 grossly RB O O
145 The DT B-NP O
145 overall JJ I-NP O
145 conclusion NN I-NP O
145 was VBD B-VP O
145 elevated VBN O O
145 right-sided JJ B-NP O
145 heart NN I-NP O
145 pressures VBZ O O
146 She PRP O O
146 had VBD B-VP O
146 no DT B-NP O
146 evidence NN I-NP O
146 of IN B-VP O
146 major JJ B-NP O
146 atherosclerotic JJ I-NP O
146 disease NN I-NP O
146 of IN B-VP O
146 the DT B-NP O
147 coronary JJ I-NP O
147 arteries NNS I-NP O
148 b VBP O O
148 Pump: NNP B-NP O
148 Please NNP I-NP O
148 see VB O O
148 cath JJ B-NP O
148 report NN I-NP O
148 as IN B-VP O
148 above IN B-VP O
148 The DT B-NP O
148 patient NN I-NP O
148 was VBD B-VP O
149 admitted VBN O O
149 and CC O O
149 diuresed VBN O O
149 with IN B-VP O
149 IV NNP B-NP B-mo
149 Lasix NNP I-NP B-m
149 , , O O
149 so IN B-VP O
149 she PRP O O
149 came VBD B-VP O
149 down RB O O
149 to TO O O
149 a DT B-NP O
150 euvolemic JJ I-NP O
150 state NN I-NP O
150 Her PRP$ O B-r
150 diuresis NN B-NP I-r
150 was VBD B-VP O
150 continued VBN O O
150 with IN B-VP O
150 80 CD O B-do
150 mg NNS B-NP I-do
150 IV NNP I-NP B-mo
150 Lasix NNP I-NP B-m
151 on IN B-VP O
151 a DT B-NP O
151 b.i.d JJ I-NP B-f
151 basis NN I-NP O
151 She PRP O O
151 was VBD B-VP O
151 diuresed VBN O O
151 until IN B-VP O
151 there EX O O
151 was VBD B-VP O
151 a DT B-NP O
151 subsequent JJ I-NP O
152 bump NN I-NP O
152 in IN B-VP O
152 her PRP$ O O
152 creatinine NN B-NP O
152 to TO O O
152 1.8 CD O O
152 , , O O
152 1.9 CD O O
152 After IN B-VP O
152 that DT B-NP O
152 point NN I-NP O
152 , , O O
152 diuresis NN B-NP O
153 was VBD B-VP O
153 slowly RB O O
153 modified VBN O O
153 She PRP O O
153 was VBD B-VP O
153 then RB O O
153 placed VBN O O
153 back RP O O
153 on IN B-VP O
153 a DT B-NP O
153 regimen NN I-NP O
153 of IN B-VP O
154 120 CD O B-do
154 mg NN B-NP I-do
154 of IN B-VP O
154 p.o NN B-NP B-mo
154 Lasix NNP I-NP B-m
154 q.o.d NN I-NP B-f
154 That WDT O O
154 is VBZ O O
154 the DT B-NP O
154 dosing NN I-NP O
154 of IN B-VP O
154 Lasix NNP B-NP B-m
154 on IN B-VP O
154 which WDT O O
155 she PRP O O
155 is VBZ O O
155 discharged VBN O O
156 c NNS B-NP O
156 Rhythm: NNP I-NP O
156 The DT B-NP O
156 patient NN I-NP O
156 has VBZ O O
156 a DT B-NP O
156 history NN I-NP O
156 of IN B-VP O
156 paroxysmal JJ B-NP O
156 atrial JJ I-NP O
157 fibrillation NN I-NP O
157 that WDT O O
157 has VBZ O O
157 been VBN O O
157 rate NN B-NP O
157 controlled VBN O O
157 with IN B-VP O
157 a DT B-NP O
157 beta-blocker NN I-NP B-m
158 On IN B-VP O
158 admission NN B-NP O
158 , , O O
158 her PRP$ O O
158 digoxin NN B-NP B-m
158 was VBD B-VP O
158 stopped VBN O O
158 She PRP O O
158 was VBD B-VP O
158 evaluated VBN O O
158 by IN B-VP O
158 the DT B-NP O
159 EP NNP I-NP O
159 Service NNP I-NP O
159 They PRP O O
159 recommended VBD B-VP O
159 epicardial JJ B-NP O
159 lead NN I-NP O
159 placement NN I-NP O
159 at IN B-VP O
160 surgery NN B-NP O
160 due JJ O O
160 to TO O O
160 her PRP$ O O
160 tachybrady JJ O O
160 syndrome VB O O
160 The DT B-NP O
160 patient NN I-NP O
160 was VBD B-VP O
161 discharged VBN O O
161 on IN B-VP O
161 diltiazem NN B-NP B-m
161 30 CD O B-do
161 mg NN B-NP I-do
161 q.i.d NN I-NP B-f
161 She PRP O O
161 will MD O O
161 have VB O O
161 her PRP$ O O
162 medications NNS B-NP O
162 modified VBD B-VP O
162 status NN B-NP O
162 post NN I-NP O
162 her PRP$ O O
162 valvular JJ B-NP O
162 repair NN I-NP O
162 in IN B-VP O
162 the DT O O
162 very RB O O
163 near IN B-VP O
163 future JJ B-NP O
164 d JJ I-NP O
164 Presurgical NNP I-NP O
164 workup: NN I-NP O
164 In IN B-VP O
164 addition NN B-NP O
164 to TO O O
164 echo VB O O
164 , , O O
164 right JJ O O
164 and CC O O
164 left JJ B-NP O
165 heart NN I-NP O
165 cath NN I-NP O
165 , , O O
165 the DT B-NP O
165 patient NN I-NP O
165 had VBD B-VP O
165 a DT B-NP O
165 TEE NNP I-NP O
165 performed VBN O O
165 TEE NNP B-NP O
165 showed VBD B-VP O
165 normal JJ B-NP O
166 left JJ I-NP O
166 atrial JJ I-NP O
166 appendage NN I-NP O
166 without IN B-VP O
166 evidence NN B-NP O
166 of IN B-VP O
166 localized JJ B-NP O
166 thrombus NN I-NP O
167 St NNP I-NP O
167 Jude's NNP I-NP O
167 valve NN I-NP O
167 was VBD B-VP O
167 well RB O O
167 seated VBN O O
167 in IN B-VP O
167 the DT B-NP O
167 aortic JJ I-NP O
167 position NN I-NP O
167 There EX O O
168 was VBD B-VP O
168 no DT B-NP O
168 significant JJ I-NP O
168 aortic JJ I-NP O
168 regurg NN I-NP O
168 that WDT O O
168 was VBD B-VP O
168 noted VBN O O
168 A NNP B-NP O
168 St NNP I-NP O
168 Jude's NNP I-NP O
169 valve NN I-NP O
169 was VBD B-VP O
169 well RB O O
169 seated VBN O O
169 in IN B-VP O
169 the DT B-NP O
169 mitral JJ I-NP O
169 position NN I-NP O
169 as RB O O
169 well RB O O
169 There EX O O
169 was VBD B-VP O
170 trace NN B-NP O
170 mild JJ B-NP O
170 regurgitation NN I-NP O
170 noted VBD B-VP O
170 There EX O O
170 was VBD B-VP O
170 slight JJ B-NP O
170 asynchronous JJ I-NP O
171 motion NN I-NP O
171 of IN B-VP O
171 the DT B-NP O
171 prosthetic JJ I-NP O
171 valve NN I-NP O
171 apparatus NN I-NP O
171 that WDT O O
171 was VBD B-VP O
171 noted VBN O O
171 The DT B-NP O
172 tricuspid JJ I-NP O
172 valve NN I-NP O
172 was VBD B-VP O
172 normal JJ O O
172 in IN B-VP O
172 appearance NN B-NP O
172 There EX O O
172 was VBD B-VP O
172 mild JJ B-NP O
173 regurgitation NN I-NP O
173 present JJ B-NP O
173 Visualized NNP I-NP O
173 portion NN I-NP O
173 of IN B-VP O
173 the DT B-NP O
173 thoracic NN I-NP O
173 aorta NN I-NP O
174 revealed VBD B-VP O
174 minimal JJ B-NP O
174 atheromatous JJ I-NP O
174 plaque NN I-NP O
175 2 CD O O
175 Pulmonary: NNP B-NP O
175 The DT B-NP O
175 patient NN I-NP O
175 remained VBD B-VP O
175 stable JJ O O
175 from IN B-VP O
175 her PRP$ O O
175 pulmonary JJ B-NP O
176 standpoint NN I-NP O
176 She PRP O O
176 continued VBD B-VP O
176 to TO O O
176 sat VB O O
176 well RB O O
176 on IN B-VP O
176 room NN B-NP O
176 air NN I-NP O
176 She PRP O O
176 did VBD B-VP O
176 not RB O O
177 required VBN O O
177 any DT B-NP O
177 nebulizers NNS I-NP O
177 during IN B-VP O
177 her PRP$ O O
177 stay NN B-NP O
178 3 CD O O
178 GI: NNP B-NP O
178 The DT B-NP O
178 patient NN I-NP O
178 was VBD B-VP O
178 initially RB O O
178 admitted VBN O O
178 with IN B-VP O
178 some DT B-NP O
178 abdominal JJ I-NP O
179 pain NN I-NP O
179 and CC O O
179 also RB O O
179 nausea NN B-NP O
179 and CC O O
179 vomiting NN B-NP O
179 She PRP O O
179 had VBD B-VP O
179 a DT B-NP O
179 KUB NNP I-NP O
179 performed VBN O O
179 for IN B-VP O
179 a DT B-NP O
180 question NN I-NP O
180 of IN B-VP O
180 potential JJ B-NP O
180 bowel NN I-NP O
180 obstruction NN I-NP O
180 A NNP I-NP O
180 single JJ B-NP O
180 frontal JJ I-NP O
180 view NN I-NP O
181 of IN B-VP O
181 the DT B-NP O
181 abdomen NNS I-NP O
181 was VBD B-VP O
181 obtained VBN O O
181 and CC O O
181 is VBZ O O
181 reported VBN O O
181 in IN B-VP O
181 the DT B-NP O
181 final JJ I-NP O
182 radiology NN I-NP O
182 report NN I-NP O
182 There EX O O
182 was VBD B-VP O
182 gas NN B-NP O
182 seen VBN O O
182 within IN B-VP O
182 the DT B-NP O
182 loops NNS I-NP O
182 of IN B-VP O
182 small JJ B-NP O
183 bowel NN I-NP O
183 as RB O O
183 well RB O O
183 as IN B-VP O
183 the DT B-NP O
183 colon NN I-NP O
183 There EX O O
183 is VBZ O O
183 no DT B-NP O
183 bowel NN I-NP O
183 dilatation NN I-NP O
183 seen VBN O O
184 The DT B-NP O
184 overall JJ I-NP O
184 impression NN I-NP O
184 was VBD B-VP O
184 no DT B-NP O
184 evidence NN I-NP O
184 of IN B-VP O
184 any DT B-NP O
184 high-grade JJ I-NP O
184 bowel NN I-NP O
185 obstruction NN I-NP O
185 It PRP O O
185 is VBZ O O
185 likely JJ O O
185 that IN B-VP O
185 some DT O O
185 of IN B-VP O
185 her PRP$ O O
185 pain NN B-NP O
185 was VBD B-VP O
185 secondary JJ O O
185 to TO O O
186 hepatic JJ B-NP O
186 congestion NN I-NP O
186 The DT B-NP O
186 nausea NN I-NP O
186 and CC O O
186 vomiting VBG O O
186 eventually RB O O
186 resolved VBN O O
187 and CC O O
187 perhaps RB O O
187 this DT O O
187 is VBZ O O
187 some DT B-NP O
187 type NN I-NP O
187 of IN B-VP O
187 viral JJ B-NP O
187 illness NN I-NP O
187 or CC O O
188 gastroenteritis NN B-NP O
188 She PRP O O
188 did VBD B-VP O
188 have VB O O
188 some DT B-NP O
188 episode NN I-NP O
188 of IN B-VP O
188 diarrhea NN B-NP O
188 prior RB O O
188 to TO O O
189 admission VB O O
189 along RP O O
189 with IN B-VP O
189 some DT O O
189 abdominal JJ O O
189 cramping VBG O O
189 The DT B-NP O
189 patient NN I-NP O
189 was VBD B-VP O
190 continued VBN O O
190 on IN B-VP O
190 her PRP$ O O
190 PPI NNP B-NP B-m
190 for IN B-VP O
190 GERD NNP B-NP B-r
190 prophylaxis NN I-NP I-r
190 At IN B-VP O
190 one CD O O
190 point NN B-NP O
190 , , O O
190 she PRP O O
191 required VBD B-VP O
191 increasing VBG O O
191 her PRP$ O O
191 dosage NN B-NP O
191 of IN B-VP O
191 Nexium NNP B-NP B-m
191 secondary JJ O O
191 to TO O O
191 GERD-like NNP B-NP B-r
192 symptoms NNS I-NP O
192 It PRP O O
192 seemed VBD B-VP O
192 that IN B-VP O
192 increasing VBG O O
192 the DT B-NP O
192 amount NN I-NP O
192 of IN B-VP O
192 Nexium NNP B-NP B-m
192 she PRP O O
193 received VBD B-VP O
193 , , O O
193 precipitated VBD B-VP O
193 some DT B-NP O
193 diarrhea NN I-NP O
193 She PRP O O
193 was VBD B-VP O
193 returned VBN O O
193 to TO O O
193 a DT B-NP O
194 normal JJ I-NP O
194 dosing NN I-NP O
194 of IN B-VP O
194 Nexium NNP B-NP B-m
194 40 CD O B-do
194 mg NN B-NP I-do
194 p.o NN I-NP B-mo
194 q.d NN I-NP B-f
194 while IN B-VP B-du
194 in-house NN B-NP I-du
194 She PRP O O
194 was VBD B-VP O
195 discharged VBN O O
195 on IN B-VP O
195 omeprazole JJ O B-m
195 20 CD O B-do
195 mg NN B-NP I-do
195 p.o NN I-NP B-mo
195 b.i.d NN I-NP B-f
195 , , O O
195 which WDT O O
195 she PRP O O
195 will MD O O
196 continue VB O O
196 to TO O O
196 take VB O O
196 as IN B-VP O
196 an DT B-NP O
196 outpatient NN I-NP O
196 In IN B-VP O
196 addition NN B-NP O
196 , , O O
196 she PRP O O
196 was VBD B-VP O
196 given VBN O O
197 prescription NN B-NP O
197 for IN B-VP O
197 Colace NNP B-NP B-m
197 and CC O O
197 also RB O O
197 Senokot NNP B-NP B-m
197 today NN I-NP O
197 She PRP O O
197 should MD O O
198 continue VB O O
198 using VBG O O
199 4 CD O O
199 Heme: NNP B-NP O
199 Her NNP I-NP O
199 hematocrit NN I-NP O
199 remained VBD B-VP O
199 relatively RB O O
199 stable JJ O O
199 during IN B-VP O
199 her PRP$ O O
200 stay NN B-NP O
200 with IN B-VP O
200 averaging NN B-NP O
200 of IN B-VP O
200 26 CD O O
200 to TO O O
200 27 CD O O
200 as RB O O
200 far RB O O
200 as IN B-VP O
200 her PRP$ O O
200 hematocrit NN B-NP O
200 We PRP O O
201 were VBD B-VP O
201 not RB O O
201 concerned VBN O O
201 with IN B-VP O
201 keeping VBG O O
201 her PRP$ O O
201 hematocrit NN B-NP O
201 30 CD O O
201 or CC O O
201 above VB O O
201 at IN B-VP O
201 all DT B-NP O
202 times NNS I-NP O
202 given VBN O O
202 her PRP$ O O
202 clean JJ B-NP O
202 coronary JJ I-NP O
202 arteries NNS I-NP O
202 seen VBN O O
202 from IN B-VP O
202 the DT B-NP O
202 left NN I-NP O
202 and CC O O
203 also RB O O
203 right JJ B-NP O
203 heart NN I-NP O
203 catheterization NN I-NP O
203 She PRP O O
203 did VBD B-VP O
203 have VB O O
203 a DT B-NP O
203 slight JJ I-NP O
203 dip NN I-NP O
203 in IN B-VP O
204 her PRP$ O O
204 hematocrit NN B-NP O
204 at IN B-VP O
204 one CD O O
204 point NN B-NP O
204 requiring VBG O O
204 two CD O B-do
204 units NNS B-NP I-do
204 of IN B-VP O
204 packed JJ B-NP B-m
204 red JJ I-NP O
205 blood NN I-NP O
205 cells NNS I-NP O
205 Her PRP$ O O
205 hematocrit NN B-NP O
205 bumped VBD B-VP O
205 appropriately RB O O
205 to TO O O
205 30 CD O O
205 or CC O O
205 31 CD O O
206 She PRP O O
206 required VBD B-VP O
206 no DT B-NP O
206 subsequent JJ I-NP O
206 transfusions NNS I-NP O
206 thereafter RB O O
206 With IN B-VP O
206 regard NN B-NP O
207 to TO O O
207 anticoagulation NN B-NP B-r
207 , , O O
207 she PRP O O
207 was VBD B-VP O
207 placed VBN O O
207 on IN B-VP O
207 the DT B-NP O
207 heparin NN I-NP B-m
207 drip NN I-NP I-m
207 at IN B-VP O
207 950 CD O B-do
208 units NNS B-NP O
208 per IN B-VP B-f
208 hour NN B-NP I-f
208 to TO O O
208 maintain VB O O
208 a DT B-NP O
208 PTT NNP I-NP O
208 between IN B-VP O
208 60 CD O O
208 and CC O O
208 80 CD O O
208 secondary JJ O O
208 to TO O O
209 her PRP$ O O
209 mechanical JJ B-NP O
209 valves NNS I-NP O
209 that WDT O O
209 are VBP O O
209 in IN B-VP O
209 place NN B-NP O
209 On IN B-VP O
209 discharge NN B-NP O
209 , , O O
209 the DT B-NP O
210 patient NN I-NP O
210 was VBD B-VP O
210 transitioned VBN O O
210 to TO O O
210 Lovenox VB O B-m
210 60 CD O B-do
210 mg NNS B-NP I-do
210 b.i.d NN I-NP B-f
210 with IN B-VP O
210 a DT B-NP O
210 renal JJ I-NP O
211 dosing NN I-NP O
211 She PRP O O
211 will MD O O
211 continue VB O O
211 to TO O O
211 take VB O O
211 this DT B-NP O
211 Lovenox NNP I-NP B-m
211 as IN B-VP O
211 an DT B-NP O
211 outpatient NN I-NP O
212 and CC O O
212 stop VB O O
212 it PRP O O
212 one CD O O
212 to TO O O
212 two CD O O
212 days NNS B-NP O
212 prior RB O O
212 to TO O O
212 her PRP$ O O
212 surgery NN B-NP O
212 as IN B-VP O
212 instructed VBN O O
213 She PRP O O
213 has VBZ O O
213 home NN B-NP O
213 VNA NNP I-NP O
213 in IN B-VP O
213 place NN B-NP O
214 5 CD O O
214 Renal: NNP B-NP O
214 Her NNP I-NP O
214 BUN NNP I-NP O
214 and CC O O
214 creatinine NN B-NP O
214 was VBD B-VP O
214 relatively RB O O
214 stable JJ O O
214 on IN B-VP O
215 admission NN B-NP O
215 It PRP O O
215 did VBD B-VP O
215 elevate VB O O
215 to TO O O
215 as RB O O
215 high JJ O O
215 as IN B-VP O
215 3.3 CD O O
215 , , O O
215 3.4 CD O O
215 on IN B-VP O
215 her PRP$ O O
216 admission NN B-NP O
216 secondary JJ O O
216 to TO O O
216 her PRP$ O O
216 ongoing JJ B-NP O
216 diuresis NN I-NP O
216 When WRB O O
216 diuresis NN B-NP O
216 was VBD B-VP O
217 held VBN O O
217 for IN B-VP O
217 several JJ B-NP O
217 days NNS I-NP O
217 given VBN O O
217 her PRP$ O O
217 markedly RB O O
217 increased JJ B-NP O
217 urine NN I-NP O
217 output NN I-NP O
218 and CC O O
218 as IN B-VP O
218 she PRP O O
218 became VBD B-VP O
218 more RBR O O
218 hydrated JJ O O
218 and CC O O
218 euvolemic JJ O O
218 , , O O
218 her PRP$ O O
218 creatinine NN B-NP O
219 returned VBN O O
219 to TO O O
219 its PRP$ O O
219 baseline NN B-NP O
219 of IN B-VP O
219 1.2 CD O O
219 , , O O
219 1.3 CD O O
219 She PRP O O
219 has VBZ O O
219 no DT B-NP O
219 active JJ I-NP O
219 issues NNS I-NP O
220 now RB O O
221 6 CD O O
221 Endocrine: NNP B-NP O
221 We PRP O O
221 appreciated VBD B-VP O
221 the DT B-NP O
221 Diabetes NNP I-NP O
221 Service NNP I-NP O
221 for IN B-VP O
221 following VBG O O
222 her PRP$ O O
222 very RB O O
222 closely RB O O
222 while IN B-VP O
222 in-house JJ B-NP O
222 Several JJ I-NP O
222 modifications NNS I-NP O
222 were VBD B-VP O
222 made VBN O O
223 to TO O O
223 her PRP$ O O
223 regimen NNS B-NP O
223 while IN B-VP O
223 here RB O O
223 to TO O O
223 get VB O O
223 good JJ B-NP O
223 control NN I-NP O
223 of IN B-VP O
223 her PRP$ O B-r
223 blood NN B-NP O
224 glucose NN I-NP O
224 She PRP O O
224 was VBD B-VP O
224 maintained VBN O O
224 on IN B-VP O
224 a DT B-NP O
224 stable JJ I-NP O
224 regimen NN I-NP O
224 of IN B-VP O
224 NPH NNP B-NP B-m
224 60 CD O B-do
224 units NNS B-NP I-do
225 in IN B-VP B-f
225 the DT B-NP I-f
225 morning NN I-NP I-f
225 , , O O
225 NPH NNP B-NP B-m
225 30 CD O B-do
225 units NNS B-NP I-do
225 in IN B-VP B-f
225 the DT B-NP I-f
225 evening NN I-NP I-f
225 She PRP O O
225 also RB O O
225 was VBD B-VP O
225 placed VBN O O
226 on IN B-VP O
226 a DT O O
226 sliding VBG O O
226 scale NN B-NP O
226 She PRP O O
226 also RB O O
226 received VBD B-VP O
226 NovoLog NNP B-NP B-m
226 of IN B-VP O
226 15 CD O B-do
226 units NNS B-NP I-do
226 in IN B-VP B-f
226 the DT B-NP O
227 morning NN I-NP O
227 with IN B-VP O
227 breakfast NN B-NP O
227 and CC O O
227 also RB O O
227 15 CD O O
227 at IN B-VP O
227 dinner NN B-NP O
227 She PRP O O
227 was VBD B-VP O
227 not RB O O
228 receiving VBG O O
228 any DT O O
228 of IN B-VP O
228 the DT B-NP O
228 NovoLog NNP I-NP B-m
228 while IN B-VP O
228 at IN B-VP O
228 lunch NN B-NP O
228 She PRP O O
228 will MD O O
228 continue VB O O
229 to TO O O
229 take VB O O
229 this DT B-NP O
229 regimen NNS I-NP O
229 in IN B-VP O
229 home NN B-NP O
229 All NNP I-NP O
229 of IN B-VP O
229 her PRP$ O O
229 prescriptions NNS B-NP O
229 were VBD B-VP O
230 provided VBN O O
230 by IN B-VP O
230 Carl NNP B-NP O
230 Mcclenahan NNP I-NP O
230 , , O O
230 who WP O O
230 is VBZ O O
230 following VBG O O
230 with IN B-VP O
230 the DT B-NP O
230 Diabetes NNP I-NP O
231 Service NNP I-NP O
231 They PRP O O
231 will MD O O
231 become VB O O
231 again RB O O
231 involved JJ O O
231 with IN B-VP O
231 her PRP$ O O
231 care NN B-NP O
231 as IN B-VP O
231 she PRP O O
232 plans VBZ O O
232 for IN B-VP O
232 surgery NN B-NP O
232 in IN B-VP O
232 the DT O O
232 very RB O O
232 near IN B-VP O
232 future JJ O O
233 7 CD O O
233 Infectious JJ O O
233 disease: VBD B-VP O
233 The DT B-NP O
233 patient NN I-NP O
233 was VBD B-VP O
233 stable JJ O O
233 from IN B-VP O
233 an DT B-NP O
233 ID NNP I-NP O
234 standpoint NN I-NP O
234 during IN B-VP O
234 her PRP$ O O
234 entire JJ B-NP O
234 admission NN I-NP O
234 On IN B-VP O
234 July NNP B-NP O
234 , , O O
234 2005 CD O O
234 , , O O
234 the DT B-NP O
235 patient NN I-NP O
235 was VBD B-VP O
235 noted VBN O O
235 to TO O O
235 have VB O O
235 an DT B-NP O
235 increase NN I-NP O
235 in IN B-VP O
235 her PRP$ O O
235 white JJ B-NP O
235 blood NN I-NP O
235 cell NN I-NP O
236 count NN I-NP O
236 upwards NNS I-NP O
236 towards IN B-VP O
236 the DT O O
236 20 CD O O
236 , , O O
236 000 CD O O
236 This DT O O
236 was VBD B-VP O
236 one CD O O
236 day NN B-NP O
236 prior VBZ O O
236 to TO O O
236 a DT O O
237 planned VBN O O
237 surgery NN B-NP O
237 on IN B-VP O
237 May NNP B-NP O
237 , , O O
237 2005 CD O O
237 with IN B-VP O
237 Dr NNP B-NP O
237 Villata NNP I-NP O
237 to TO O O
237 repair VB O O
237 her PRP$ O O
238 aortic JJ B-NP O
238 valve NN I-NP O
238 and CC O O
238 also RB O O
238 her PRP$ O O
238 mitral JJ B-NP O
238 valve NN I-NP O
238 The DT B-NP O
238 surgery NN I-NP O
238 was VBD B-VP O
238 delayed VBN O O
239 as IN B-VP O
239 a DT B-NP O
239 result NN I-NP O
239 of IN B-VP O
239 this DT O O
239 , , O O
239 so IN B-VP O
239 an DT B-NP O
239 infectious JJ I-NP O
239 workup NN I-NP O
239 could MD O O
239 ensue VB O O
239 She PRP O O
240 had VBD B-VP O
240 a DT B-NP O
240 urine JJ I-NP O
240 sent NN I-NP O
240 that WDT O O
240 showed VBD B-VP O
240 , , O O
240 the DT B-NP O
240 suggestion NN I-NP O
240 of IN B-VP O
240 a DT B-NP O
240 urinary JJ I-NP O
240 tract NN I-NP O
241 infection NN I-NP O
241 Levaquin NNP I-NP B-m
241 was VBD B-VP O
241 given VBN O O
241 for IN B-VP O
241 treatment NN B-NP O
241 of IN B-VP O
241 her PRP$ O B-r
241 UTI NNP B-NP I-r
242 Surveillance NNP I-NP O
242 cultures NNS I-NP O
242 were VBD B-VP O
242 drawn VBN O O
242 daily RB O O
242 Given VBN O O
242 the DT B-NP O
242 fact NN I-NP O
242 that IN B-VP O
242 she PRP O O
243 had VBD B-VP O
243 a DT B-NP O
243 right JJ I-NP O
243 groin NN I-NP O
243 hematoma NN I-NP O
243 that WDT O O
243 performed VBD B-VP O
243 after IN B-VP O
243 the DT B-NP O
243 heart NN I-NP O
244 catheterization NN I-NP O
244 we PRP O O
244 questioned VBD B-VP O
244 whether IN B-VP O
244 or CC O O
244 not RB O O
244 this DT O O
244 could MD O O
244 be VB O O
244 some DT B-NP O
245 type NN I-NP O
245 of IN B-VP O
245 infectious JJ B-NP O
245 source NN I-NP O
245 She PRP O O
245 had VBD B-VP O
245 the DT B-NP O
245 hematoma NN I-NP O
245 aspirated VBD B-VP O
245 , , O O
245 it PRP O O
246 was VBD B-VP O
246 negative JJ O O
246 for IN B-VP O
246 any DT O O
246 organisms JJ O O
246 She PRP O O
246 had VBD B-VP O
246 no DT B-NP O
246 other JJ I-NP O
246 identified JJ I-NP O
247 places NNS I-NP O
247 as RB O O
247 far RB O O
247 as IN B-VP O
247 source NN B-NP O
247 of IN B-VP O
247 infection NN B-NP O
247 It PRP O O
247 was VBD B-VP O
247 believed VBN O O
247 that IN B-VP O
247 she PRP O O
248 could MD O O
248 potential VB O O
248 have VB O O
248 endocarditis VBN O O
248 as IN B-VP O
248 she PRP O O
248 has VBZ O O
248 had VBN O O
248 in IN B-VP O
248 the DT O O
248 past JJ O O
249 One CD O O
249 of IN B-VP O
249 her PRP$ O O
249 cultures NNS B-NP O
249 actually RB O O
249 grew VBD B-VP O
249 out RP O O
249 a DT B-NP O
249 species NNS I-NP O
249 of IN B-VP O
249 Abiotrophia NNP B-NP O
250 There EX O O
250 is VBZ O O
250 only RB O O
250 one CD O O
250 culture NN B-NP O
250 positive JJ O O
250 , , O O
250 that WDT O O
250 was VBD B-VP O
250 taken VBN O O
250 on IN B-VP O
250 February NNP B-NP O
251 She PRP O O
251 has VBZ O O
251 had VBD B-VP O
251 no DT B-NP O
251 subsequent JJ I-NP O
251 cultures NNS I-NP O
251 growing VBG O O
251 out RP O O
251 at IN B-VP O
251 the DT B-NP O
251 time NN I-NP O
251 of IN B-VP O
252 this DT B-NP O
252 dictation NN I-NP O
252 We PRP O O
252 appreciate VBP O O
252 the DT B-NP O
252 Infectious NNP I-NP O
252 Disease NNP I-NP O
252 Team NNP I-NP O
253 following VBG O O
253 Their PRP$ O O
253 recommendations NNS B-NP O
253 were VBD B-VP O
253 to TO O O
253 hold VB O O
253 antibiotics NNS B-NP B-m
253 unless IN B-VP O
254 subsequent JJ B-NP O
254 cultures NNS I-NP O
254 began VBD B-VP O
254 to TO O O
254 grow VB O O
254 out RP O O
254 Their PRP$ O O
254 recommendations NNS B-NP O
255 were VBD B-VP O
255 to TO O O
255 continue VB O O
255 to TO O O
255 follow VB O O
255 all DT B-NP O
255 cultures NNS I-NP O
255 and CC O O
255 to TO O O
255 perform VB O O
255 a DT B-NP O
255 TEE NNP I-NP O
255 A NNP I-NP O
256 repeat NN I-NP O
256 TEE NNP I-NP O
256 was VBD B-VP O
256 performed VBN O O
256 and CC O O
256 showed VBD B-VP O
256 no DT B-NP O
256 evidence NN I-NP O
256 of IN B-VP O
256 any DT B-NP O
256 lesions NNS I-NP O
256 or CC O O
257 change NN B-NP O
257 in IN B-VP O
257 bowel NN B-NP O
257 function NN I-NP O
257 There EX O O
257 were VBD B-VP O
257 clearly RB O O
257 no DT B-NP O
257 vegetation NN I-NP O
257 seen VBN O O
258 on IN B-VP O
258 either DT O O
258 any DT B-NP O
258 transthoracic JJ I-NP O
258 echos NN I-NP O
258 or CC O O
258 TEEs NNP B-NP O
258 ID NNP I-NP O
258 made VBD B-VP O
259 recommendations NNS B-NP O
259 as RB O O
259 far RB O O
259 as IN B-VP O
259 perioperative JJ B-NP O
259 antibiotics NNS I-NP B-m
259 , , O O
259 which WDT O O
259 would MD O O
260 include VB O O
260 two CD O B-du
260 weeks NNS B-NP I-du
260 of IN B-VP O
260 ceftriaxone NN B-NP B-m
260 1 CD O B-do
260 g NN B-NP I-do
260 IV NNP I-NP B-mo
260 b.i.d NN I-NP B-f
260 under IN B-VP O
260 the DT B-NP O
261 assumption NN I-NP O
261 that IN B-VP O
261 this DT O O
261 would MD O O
261 be VB O O
261 completing VBG O O
261 a DT B-NP O
261 course NN I-NP O
261 of IN B-VP O
261 her PRP$ O O
261 therapy NN B-NP O
262 after IN B-VP O
262 SBE NNP B-NP O
262 They PRP O O
262 would MD O O
262 also RB O O
262 recommend VB O O
262 sending VBG O O
262 all DT B-NP O
262 valve NNS I-NP O
262 tissue NN I-NP O
263 for IN B-VP O
263 Gram NNP B-NP O
263 stain NN I-NP O
263 and CC O O
263 culture NN B-NP O
263 as RB O O
263 well RB O O
263 as IN B-VP O
263 pathology NN B-NP O
263 If IN B-VP O
263 the DT B-NP O
263 Gram NNP I-NP O
264 stain NN I-NP O
264 and CC O O
264 culture NN B-NP O
264 were VBD B-VP O
264 positive JJ O O
264 , , O O
264 they PRP O O
264 would MD O O
264 suggest VB O O
264 extending VBG O O
264 the DT B-NP O
265 course NN I-NP O
265 of IN B-VP O
265 the DT B-NP O
265 above-mentioned JJ I-NP O
265 antibiotic JJ I-NP B-m
265 therapy NN I-NP O
266 8 CD O O
266 Neurologic: NNP B-NP O
266 The DT B-NP O
266 patient NN I-NP O
266 was VBD B-VP O
266 given VBN O O
266 Darvon NNP B-NP B-m
266 and CC O O
266 also RB O O
266 codeine NN B-NP B-m
266 as IN B-VP B-f
267 needed VBN O O
267 for IN B-VP O
267 her PRP$ O B-r
267 pain NN B-NP I-r
267 She PRP O O
267 complained VBD B-VP O
267 of IN B-VP O
267 right JJ B-NP O
267 groin NN I-NP O
267 pain NN I-NP O
268 secondary JJ O O
268 to TO O O
268 the DT B-NP O
268 hematoma NN I-NP O
268 Her NNP I-NP O
268 pain NN I-NP O
268 is VBZ O O
268 much RB O O
268 improved VBN O O
268 that IN B-VP O
268 she PRP O O
268 is VBZ O O
269 able JJ O O
269 to TO O O
269 ambulate VB O O
269 easily RB O O
269 around IN B-VP O
269 the DT B-NP O
269 Tl NNP I-NP O
269 Brown NNP I-NP O
269 Vo NNP I-NP O
269 on IN B-VP O
269 discharge NN B-NP O
269 The DT B-NP O
270 hematoma NN I-NP O
270 is VBZ O O
270 resolving VBG O O
270 and CC O O
270 her PRP$ O O
270 pain NN B-NP O
270 is VBZ O O
270 resolving VBG O O
270 as RB O O
270 well RB O O
271 9 CD O O
271 Fluids NNS B-NP O
271 , , O O
271 electrolytes NNS B-NP O
271 , , O O
271 and CC O O
271 nutrition: VBZ O O
271 The DT B-NP O
271 patient NN I-NP O
271 is VBZ O O
272 tolerating VBG O O
272 p.o RB O O
272 well RB O O
272 Her PRP$ O O
272 electrolytes NNS B-NP O
272 were VBD B-VP O
272 repleted VBN O O
272 as IN B-VP O
272 needed VBN O O
273 daily RB O O
274 10 CD O O
274 Psychologic: NNP B-NP O
274 The DT B-NP O
274 patient NN I-NP O
274 was VBD B-VP O
274 seen VBN O O
274 by IN B-VP O
274 social JJ B-NP O
274 work NN I-NP O
274 It PRP O O
274 is VBZ O O
275 clear JJ O O
275 that IN B-VP O
275 she PRP O O
275 has VBZ O O
275 many JJ B-NP O
275 anxieties NNS I-NP O
275 about IN B-VP O
275 the DT B-NP O
275 surgery NN I-NP O
275 and CC O O
275 also RB O O
275 in IN B-VP O
276 going VBG O O
276 home NN B-NP O
276 and CC O O
276 returning VBG O O
276 to TO O O
276 her PRP$ O O
276 social JJ B-NP O
276 environment NN I-NP O
276 She PRP O O
277 necessitated VBD B-VP O
277 volume NN B-NP O
277 prior RB O O
277 to TO O O
277 many JJ B-NP O
277 procedures NNS I-NP O
277 given VBN O O
277 her PRP$ O O
277 severe JJ B-NP O
278 anxiety NN I-NP O
279 11 CD O O
279 Disposition: NNP B-NP O
279 The DT B-NP O
279 patient NN I-NP O
279 is VBZ O O
279 stable JJ O O
279 from IN B-VP O
279 a DT B-NP O
279 medical JJ I-NP O
280 standpoint NN I-NP O
280 with IN B-VP O
280 all DT B-NP O
280 cultures NNS I-NP O
280 clear JJ O O
280 and CC O O
280 no DT B-NP O
280 evidence NN I-NP O
280 of IN B-VP O
280 active JJ B-NP O
281 infection NN I-NP O
281 Her NNP I-NP O
281 white JJ B-NP O
281 blood NN I-NP O
281 cell NN I-NP O
281 count NN I-NP O
281 is VBZ O O
281 now RB O O
281 normal JJ O O
281 She PRP O O
281 is VBZ O O
281 now RB O O
282 awaiting VBG O O
282 surgical JJ B-NP O
282 repair NN I-NP O
282 of IN B-VP O
282 her PRP$ O O
282 valve NN B-NP O
282 and CC O O
282 will MD O O
282 have VB O O
282 a DT B-NP O
282 surgery NN I-NP O
283 scheduled VBN O O
283 with IN B-VP O
283 Dr NNP B-NP O
283 Berreth NNP I-NP O
283 office NN I-NP O
283 in IN B-VP O
283 the DT O O
283 next JJ O O
283 one CD O O
283 to TO O O
283 two CD O O
283 weeks NNS B-NP O
284 DISCHARGE NNP I-NP O
284 MEDICATIONS: NNP I-NP O
285 1 CD O O
285 Diltiazem NNP B-NP B-m
285 30 CD O B-do
285 mg NN B-NP I-do
285 p.o NN I-NP B-mo
285 q.6h VBD B-VP B-f
286 2 CD O O
286 Colace NNP B-NP B-m
286 100 CD O B-do
286 mg NN B-NP I-do
286 p.o NN I-NP B-mo
286 b.i.d VBD B-VP B-f
287 3 CD O O
287 Lasix NNP B-NP B-m
287 120 CD O B-do
287 mg NN B-NP I-do
287 p.o NN I-NP B-mo
287 q NN I-NP B-f
287 other JJ B-NP I-f
287 day NN I-NP I-f
288 4 CD O O
288 NPH NNP B-NP B-m
288 60 CD O B-do
288 units NNS B-NP I-do
288 in IN B-VP B-f
288 the DT B-NP I-f
288 morning NN I-NP I-f
289 5 CD O O
289 NPH NNP B-NP B-m
289 30 CD O B-do
289 units NNS B-NP I-do
289 in IN B-VP B-f
289 the DT B-NP I-f
289 evening NN I-NP I-f
290 6 CD O O
290 Lisinopril NNP B-NP B-m
290 40 CD O B-do
290 mg NN B-NP I-do
290 p.o NN I-NP B-mo
290 q JJ B-NP B-f
290 day NN I-NP I-f
291 7 CD O O
291 Senokot NNP B-NP B-m
291 three CD O B-do
291 tablets NNS B-NP I-do
291 p.o VBP O B-mo
291 b.i.d RB O B-f
292 8 CD O O
292 Multivitamin NNP B-NP B-m
292 one CD O B-do
292 tablet NN B-NP I-do
292 p.o NN I-NP B-mo
292 q.d VBD B-VP B-f
293 9 CD O O
293 Lovenox NNP B-NP B-m
293 60 CD O B-do
293 mg NN B-NP I-do
293 subcutaneously RB O B-mo
293 b.i.d VBZ O B-f
294 10 CD O O
294 Caltrate NNP B-NP B-m
294 plus CC O I-m
294 vitamin JJ B-NP I-m
294 D NNP I-NP I-m
294 600 CD O B-do
294 mg NN B-NP I-do
294 one CD O I-do
294 tablet NN B-NP I-do
294 p.o NN I-NP B-mo
294 b.i.d VBD B-VP B-f
295 11 CD O O
295 NovoLog NNP B-NP B-m
295 NovoLog NNP I-NP B-m
295 sliding VBG O B-do
295 sliding VBG O B-do
295 scale JJ B-NP I-do
295 scale NN I-NP I-do
295 q.a.c NN I-NP B-f
295 and CC O O
295 h.s $ O B-f
296 12 CD O O
296 NovoLog NNP B-NP B-m
296 15 CD O B-do
296 units NNS B-NP I-do
296 subcutaneously RB O B-mo
296 with IN B-VP B-f
296 breakfast NN B-NP I-f
296 and CC O I-f
296 dinner NN B-NP I-f
297 did VBD B-VP O
297 not RB O O
297 give VB O O
297 at IN B-VP O
297 lunch NN B-NP O
298 13 CD O O
298 Maalox NNP B-NP B-m
298 tablets NNS I-NP I-m
298 quick VBP O O
298 dissolve VB O O
299 14 CD O O
299 Codeine NNP B-NP B-m
299 15 CD O B-do
299 mg NN B-NP I-do
299 to TO O I-do
299 30 CD O I-do
299 mg NNS B-NP I-do
299 p.o JJ B-NP B-mo
299 q.4h JJ I-NP B-f
299 p.r.n NN I-NP I-f
299 pain NN I-NP B-r
300 15 CD O O
300 Magnesium NNP B-NP B-m
300 oxide RB O I-m
300 400 CD O B-do
300 mg NNS B-NP I-do
300 p.o JJ O B-mo
300 b.i.d RB O B-f
301 16 CD O O
301 Omeprazole NNP B-NP B-m
301 20 CD O B-do
301 mg NN B-NP I-do
301 p.o NN I-NP B-mo
301 b.i.d VBD B-VP B-f
302 17 CD O O
302 Niferex NNP B-NP B-m
302 150 CD O B-do
302 mg NN B-NP I-do
302 p.o NN I-NP B-mo
302 b.i.d IN B-VP B-f
303 FOLLOW-UP NNP B-NP O
303 PLANS: NNP I-NP O
304 1 CD O O
304 The DT B-NP O
304 patient NN I-NP O
304 was VBD B-VP O
304 given VBN O O
304 instructions NNS B-NP O
304 to TO O O
304 call VB O O
304 Dr NNP B-NP O
304 Mccutchan NNP I-NP O
305 office NN I-NP O
305 to TO O O
305 coordinate VB O O
305 her PRP$ O O
305 appointment NN B-NP O
305 for IN B-VP O
305 her PRP$ O O
305 valve NN B-NP O
305 repair NN I-NP O
305 in IN B-VP O
305 the DT O O
306 next JJ O O
306 one CD O O
306 to TO O O
306 two CD O O
306 weeks NNS B-NP O
306 pending VBG O O
306 her PRP$ O O
306 surgeon's JJ B-NP O
306 return NN I-NP O
307 2 CD O O
307 The DT B-NP O
307 patient NN I-NP O
307 instructed VBD B-VP O
307 to TO O O
307 call VB O O
307 Dr NNP B-NP O
307 Doug NNP I-NP O
307 Schlanger NNP I-NP O
307 on IN B-VP O
307 March NNP B-NP O
307 , , O O
308 2005 CD O O
308 , , O O
308 to TO O O
308 discuss VB O O
308 surgical JJ B-NP O
308 plans NNS I-NP O
308 and CC O O
308 also RB O O
308 to TO O O
308 follow VB O O
308 up RP O O
309 3 CD O O
309 The DT B-NP O
309 patient NN I-NP O
309 should MD O O
309 have VB O O
309 all DT O O
309 her PRP$ O O
309 blood NN B-NP O
309 cultures NNS I-NP O
309 followed VBD B-VP O
309 up RP O O
310 prior RB O O
310 to TO O O
310 her PRP$ O O
310 surgery NN B-NP O
310 If IN B-VP O
310 any DT O O
310 of IN B-VP O
310 her PRP$ O O
310 blood NN B-NP O
310 cultures VBZ O O
310 become VBN O O
311 positive JJ O O
311 in IN B-VP O
311 the DT O O
311 interim JJ O O
311 , , O O
311 we PRP O O
311 will MD O O
311 begin VB O O
311 a DT B-NP O
311 long JJ I-NP O
311 course NN I-NP O
311 of IN B-VP O
312 antibiotic JJ B-NP B-m
312 therapy NN I-NP O
312 and CC O O
312 delay NN B-NP O
312 surgery NN I-NP O
312 at IN B-VP O
312 the DT B-NP O
312 discussion NN I-NP O
312 of IN B-VP O
312 the DT B-NP O
313 Cardiovascular NNP I-NP O
313 Service NNP I-NP O
314 DISCHARGE NNP I-NP O
314 CONDITION: NNP I-NP O
314 Stable NNP I-NP O
315 eScription NN I-NP O
315 document: NN I-NP O
315 6-8225657 JJ B-NP O
315 IS NNP I-NP O
316 Dictated NNP I-NP O
316 By: NNP I-NP O
316 CURLESS NNP I-NP O
316 , , O O
316 OLIVER NNP B-NP O
317 Attending: NNP I-NP O
317 HERD NNP I-NP O
317 , , O O
317 ANDREAS NNP B-NP O
318 Dictation NNP I-NP O
318 ID NNP I-NP O
318 3110866 CD O O
319 D: NNP B-NP O
319 4/7/05 CD O O
320 T: NNP B-NP O
320 6/13/05 CD O O
321 [report_end] NNP B-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #993109 VBZ O O
4 980908629 CD O O
4 RTH NNP B-NP O
4 25854739 CD O O
4 1468461 CD O O
4 4/7/2005 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 atypical JJ B-NP O
4 chest NN I-NP O
4 pain NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 4/7/2005 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 11/10/2005 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 WHITLACH NNP I-NP O
8 , , O O
8 REGINALD NNP B-NP O
8 273-89-77-3 JJ B-NP O
9 Ter NNP I-NP O
9 Highway NNP I-NP O
9 , , O O
9 Cra NNP B-NP O
9 Raldi NNP I-NP O
9 Kanenard NNP I-NP O
10 Service: NNP I-NP O
10 CAR NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 2/1/05 CD O O
11 AT NNP B-NP O
11 12:00 CD O O
11 PM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 Not RB O O
12 Applicable NNP B-NP O
13 WILL MD O O
13 D/C VB O O
13 ORDER NNP B-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 KAMANSKY NNP I-NP O
14 , , O O
14 HOUSTON NNP B-NP O
14 ASHLEY NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 Full NNP I-NP O
16 code NN I-NP O
17 DISPOSITION: NNP I-NP O
17 Home NNP I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 DIAZEPAM NNP I-NP B-m
19 10 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 QAM NNP I-NP B-f
19 Starting VBG O O
19 Today NNP B-NP O
19 March NNP I-NP O
20 LOPRESSOR NNP I-NP B-m
20 ( ( O I-m
20 METOPROLOL NNP B-NP I-m
20 TARTRATE NNP I-NP I-m
20 ) ) O I-m
20 25 CD O B-do
20 MG NNP B-NP I-do
20 PO NNP I-NP B-mo
20 BID NNP I-NP B-f
21 Starting VBG O O
21 Today NNP B-NP O
21 March NNP I-NP O
21 Food/Drug NNP I-NP O
21 Interaction NNP I-NP O
21 Instruction NNP I-NP O
22 Take NNP I-NP O
22 consistently RB O O
22 with IN B-VP O
22 meals NNS B-NP O
22 or CC O O
22 on IN B-VP O
22 empty JJ B-NP O
22 stomach NN I-NP O
23 PAXIL NNP I-NP B-m
23 ( ( O I-m
23 PAROXETINE NNP B-NP I-m
23 ) ) O I-m
23 20 CD O B-do
23 MG NNP B-NP I-do
23 PO NNP I-NP B-mo
23 QD NNP I-NP B-f
24 ZOCOR NNP I-NP B-m
24 ( ( O I-m
24 SIMVASTATIN NNP B-NP I-m
24 ) ) O I-m
24 40 CD O B-do
24 MG NNP B-NP I-do
24 PO NNP I-NP B-mo
24 QHS NNP I-NP B-f
25 Food/Drug NNP I-NP O
25 Interaction NNP I-NP O
25 Instruction NNP I-NP O
26 Avoid NNP I-NP O
26 grapefruit NN I-NP O
26 unless IN B-VP O
26 MD NNP B-NP O
26 instructs NNS I-NP O
26 otherwise RB O O
27 LISINOPRIL NNP B-NP B-m
27 10 CD O B-do
27 MG NNP B-NP I-do
27 PO NNP I-NP B-mo
27 QD NNP I-NP B-f
28 Alert NNP I-NP O
28 overridden: NNP I-NP O
28 Override NNP I-NP O
28 added VBD B-VP O
28 on IN B-VP O
28 2/1/05 CD O O
28 by IN B-VP O
28 : : O O
29 POTENTIALLY NNP B-NP O
29 SERIOUS NNP I-NP O
29 INTERACTION: NNP I-NP O
29 POTASSIUM NNP I-NP B-m
29 CHLORIDE NNP I-NP I-m
29 &amp; NNP I-NP O
30 LISINOPRIL NNP I-NP B-m
30 Reason NNP I-NP O
30 for IN B-VP O
30 override: NN B-NP O
30 md NN I-NP O
30 aware JJ B-NP O
31 ACETYLSALICYLIC NNP I-NP B-m
31 ACID NNP I-NP I-m
31 81 CD O B-do
31 MG NNP B-NP I-do
31 PO NNP I-NP B-mo
31 QOD NNP I-NP B-f
32 DIET: NNP I-NP O
32 House NNP I-NP O
32 / VBD B-VP O
32 Low NNP B-NP O
32 chol/low NN I-NP O
32 sat VBD B-VP O
32 fat JJ B-NP O
33 RETURN NNP I-NP O
33 TO NNP I-NP O
33 WORK: NNP I-NP O
33 After IN B-VP O
33 Appt NNP B-NP O
33 with IN B-VP O
33 local JJ B-NP O
33 physician NN I-NP O
34 FOLLOW NNP I-NP O
34 UP NNP I-NP O
34 APPOINTMENT( NNP I-NP O
34 S NNP I-NP O
34 ): NNP I-NP O
35 Dr NNP I-NP O
35 Shanberg NNP I-NP O
35 1-2 JJ B-NP O
35 weeks NNS I-NP O
35 , , O O
36 ALLERGY: NNP B-NP O
36 Codeine NNP I-NP O
37 ADMIT NNP I-NP O
37 DIAGNOSIS: NNP I-NP O
38 chest JJS B-NP O
38 pain NN I-NP O
39 PRINCIPAL NNP I-NP O
39 DISCHARGE NNP I-NP O
39 DIAGNOSIS NNP I-NP O
39 ;Responsible JJ O O
39 After IN B-VP O
39 Study NNP B-NP O
39 for IN B-VP O
39 Causing NNP B-NP O
39 Admission NNP I-NP O
39 ) ) O O
40 atypical JJ B-NP O
40 chest NN I-NP O
40 pain NN I-NP O
41 OTHER NNP I-NP O
41 DIAGNOSIS;Conditions NNP I-NP O
41 , , O O
41 Infections NNP B-NP O
41 , , O O
41 Complications NNP B-NP O
41 , , O O
41 affecting VBG O O
41 Treatment/Stay NNP B-NP O
42 Htn NNP I-NP O
42 , , O O
42 hyperlipidemia NN B-NP O
42 , , O O
42 CAD NNP B-NP O
42 , , O O
42 anxiety NN B-NP O
42 disorder NN I-NP O
42 , , O O
42 obesity NN B-NP O
43 OPERATIONS NNP I-NP O
43 AND NNP I-NP O
43 PROCEDURES: NNP I-NP O
44 Cardiac NNP I-NP O
44 catheterization NN I-NP O
44 10/20 CD O O
44 40% CD O O
44 LAD NNP B-NP O
44 lesion NN I-NP O
44 , , O O
44 no DT B-NP O
44 intervention NN I-NP O
45 OTHER NNP I-NP O
45 TREATMENTS/PROCEDURES NNP I-NP O
45 ( ( O O
45 NOT NNP B-NP O
45 IN NNP I-NP O
45 O.R NNP I-NP O
45 ) ) O O
46 None NN B-NP O
47 BRIEF NNP I-NP O
47 RESUME NNP I-NP O
47 OF NNP I-NP O
47 HOSPITAL NNP I-NP O
47 COURSE: NNP I-NP O
48 46 CD O O
48 y/o NN B-NP O
48 f NN I-NP O
48 with IN B-VP O
48 h/o NN B-NP O
48 HTN NNP I-NP O
48 , , O O
48 high JJ B-NP O
48 lipids NNS I-NP O
48 with IN B-VP O
48 h/o NN B-NP O
48 abnormal JJ B-NP O
48 ETT NNP I-NP O
48 2/5 CD O O
48 by IN B-VP O
48 report NN B-NP O
49 who WP O O
49 p/w VBZ O O
49 several JJ B-NP O
49 months NNS I-NP O
49 of IN B-VP O
49 SSCP NNP B-NP O
49 , , O O
49 tightness NN B-NP O
49 Occas NNP I-NP O
49 SOB NNP I-NP O
49 Seen NNP I-NP O
49 by IN B-VP O
49 PCP NNP B-NP O
49 on IN B-VP O
49 DOA NNP B-NP O
50 and CC O O
50 sent VBD B-VP O
50 to TO O O
50 ED NNP B-NP O
50 4d CD O O
50 worsning VBG O O
50 sx NN B-NP O
50 Improved VBD B-VP O
50 pain NN B-NP B-r
50 with IN B-VP O
50 SL NNP B-NP B-mo
50 NTG NNP I-NP B-m
51 In IN B-VP O
51 ED NNP B-NP O
51 , , O O
51 afeb NN B-NP O
51 , , O O
51 168/74 CD O O
51 , , O O
51 HR NNP B-NP O
51 94 CD O O
51 , , O O
51 EKG NNP B-NP O
51 unchaged VBD B-VP O
51 , , O O
51 neg FW O O
51 first RB O O
51 set VBN O O
51 enzymes RB O O
52 Started VBN O O
52 on IN B-VP O
52 heparin NN B-NP B-m
53 === NNP I-NP O
54 Exam: NNP I-NP O
55 98.0 CD O O
55 , , O O
55 58-60 JJ O O
55 , , O O
55 132/60 CD O O
55 , , O O
55 18 CD O O
55 , , O O
55 98% CD O O
55 2L CD O O
55 general: NN B-NP O
55 nad NN I-NP O
55 , , O O
55 euvolemic JJ O O
55 , , O O
55 clear JJ B-NP O
55 chest NN I-NP O
55 , , O O
56 rrr VBZ O O
56 no DT B-NP O
56 mgr NN I-NP O
56 , , O O
56 no DT B-NP O
56 edema NN I-NP O
57 === VBZ O O
58 Labs: NNP B-NP O
58 TNI NNP I-NP O
58 neg VBD B-VP O
58 x $ O O
58 2 CD O O
59 === NNP B-NP O
60 CATH NNP I-NP O
60 10/20 CD O O
60 40% CD O O
60 LAD NNP B-NP O
60 , , O O
60 no DT B-NP O
60 intervention NN I-NP O
61 === VBZ O O
62 EKG: NNP B-NP O
62 Intial NNP I-NP O
62 ECG NNP I-NP O
62 unchanged JJ O O
62 from IN B-VP O
62 baseline NN B-NP O
62 with IN B-VP O
62 old JJ B-NP O
62 TWI NNP I-NP O
62 in IN B-VP O
62 v5-6 NN B-NP O
62 , , O O
62 1 CD O O
62 , , O O
63 avl RB O O
63 1/10/5 CD O O
63 am VBP O O
63 ECG: NNP B-NP O
63 TWI NNP I-NP O
63 in IN B-VP O
63 1 CD O O
63 , , O O
63 2 CD O O
63 , , O O
63 l NN B-NP O
63 , , O O
63 f NN B-NP O
63 , , O O
63 v4-v5 JJ B-NP O
64 === NNP I-NP O
65 Assessment: NNP I-NP O
65 46 CD O O
65 y/o NN B-NP O
65 f NN I-NP O
65 with IN B-VP O
65 HTN NNP B-NP O
65 , , O O
65 high JJ B-NP O
65 lipds NN I-NP O
65 with IN B-VP O
65 chest NN B-NP O
65 pain NN I-NP O
65 , , O O
65 non-specific JJ B-NP O
66 TW NNP I-NP O
66 changes NNS I-NP O
66 and CC O O
66 negative JJ B-NP O
66 enzymes NNS I-NP O
66 x VBP O O
66 2 CD O O
67 === JJ B-NP O
68 COURSE: NNP I-NP O
68 1 CD O O
68 Ischemia: NNP B-NP O
68 asa NN I-NP B-m
68 , , O O
68 statin RB O B-m
68 high JJ B-NP B-do
68 dose NN I-NP I-do
68 , , O O
68 BB NNP B-NP B-m
68 , , O O
68 ACE-I NNP B-NP B-m
68 On IN B-VP O
68 heparin NN B-NP B-m
68 until IN B-VP B-du
69 cathed VBN O O
69 on IN B-VP O
69 4/10 CD O O
69 -&gt; JJ O O
69 no DT B-NP O
69 significant JJ I-NP O
69 CAD NNP I-NP O
69 Discharged NNP I-NP O
69 on IN B-VP O
69 lisinopril NN B-NP B-m
69 and CC O O
70 lopressor NN B-NP B-m
70 , , O O
70 zocor NN B-NP B-m
70 , , O O
70 ASA; NNP B-NP B-m
70 d/c'd VBZ O O
70 HCTZ NNP B-NP B-m
70 for IN B-VP O
70 now RB O O
70 Chest NNP B-NP O
70 pain NN I-NP O
70 not RB O O
70 thought VBN O O
70 to TO O O
70 be VB O O
71 ischemic JJ O O
71 in IN B-VP O
71 origin JJ B-NP O
72 ADDITIONAL NNP I-NP O
72 COMMENTS: NNP I-NP O
73 DISCHARGE NNP I-NP O
73 CONDITION: NNP I-NP O
73 Stable NNP I-NP O
74 TO NNP I-NP O
74 DO/PLAN: NNP I-NP O
75 1 CD O O
75 Liver NNP B-NP O
75 function NN I-NP O
75 tests NNS I-NP O
75 and CC O O
75 fasting VBG O O
75 lipid JJ B-NP O
75 profile NN I-NP O
75 pending VBG O O
75 at IN B-VP O
75 time NN B-NP O
75 of IN B-VP O
76 discharge NN B-NP O
77 No NNP I-NP O
77 dictated VBD B-VP O
77 summary JJ B-NP O
78 ENTERED NNP I-NP O
78 BY: NNP I-NP O
78 PUERTAS NNP I-NP O
78 , , O O
78 CLEO NNP B-NP O
78 L NNP I-NP O
78 , , O O
78 M.D NNP B-NP O
78 ( ( O O
78 AS91 NNP B-NP O
78 ) ) O O
78 2/1/05 CD O O
78 @ $ O O
78 11:41 CD O O
78 AM NNP B-NP O
79 ****** JJ B-NP O
79 END NN I-NP O
79 OF NNP I-NP O
79 DISCHARGE NNP I-NP O
79 ORDERS NNP I-NP O
79 ****** NNP I-NP O
80 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #993550 VBZ O O
4 859846912 CD O O
4 SH NNP B-NP O
4 27937230 CD O O
4 8076199 CD O O
4 10/20/2006 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 CHF NNP I-NP O
4 exacerbation NN I-NP O
4 , , O O
4 PNA NNP B-NP O
4 , , O O
4 viral JJ B-NP O
4 gastroenteritis NN I-NP O
4 DIS NNP I-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 6/16/2006 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 8/30/2006 CD O O
7 ****** NNP B-NP O
7 FINAL NNP I-NP O
7 DISCHARGE NNP I-NP O
7 ORDERS NNP I-NP O
7 ****** NNP I-NP O
8 MICHALES NNP I-NP O
8 , , O O
8 DAREN NNP B-NP O
8 M NNP I-NP O
8 573-58-18-1 JJ B-NP O
9 Dego NNP I-NP O
9 Louisbi NNP I-NP O
9 Do NNP I-NP O
10 Service: NNP I-NP O
10 MED NNP I-NP O
11 DISCHARGE NNP I-NP O
11 PATIENT NNP I-NP O
11 ON: NNP I-NP O
11 3/17/06 CD O O
11 AT NNP B-NP O
11 10:00 CD O O
11 AM NNP B-NP O
12 CONTINGENT NNP I-NP O
12 UPON NNP I-NP O
12 2PM CD O O
12 K+ NNP B-NP O
13 WILL NNP I-NP O
13 D/C NNP I-NP O
13 ORDER NNP I-NP O
13 BE NNP I-NP O
13 USED NNP I-NP O
13 AS IN B-VP O
13 THE NNP B-NP O
13 D/C NNP I-NP O
13 SUMMARY: NNP I-NP O
13 YES NNP I-NP O
14 Attending: NNP I-NP O
14 JOELSON NNP I-NP O
14 , , O O
14 EFREN NNP B-NP O
14 M NNP I-NP O
14 , , O O
14 M.D NNP B-NP O
15 CODE NNP I-NP O
15 STATUS: NNP I-NP O
16 No NNP I-NP O
16 CPR NNP I-NP O
16 / VBZ O O
16 No DT B-NP O
16 defib NN I-NP O
16 / VBZ O O
16 No DT B-NP O
16 intubation NN I-NP O
16 / VBZ O O
17 DISPOSITION: NNP B-NP O
17 Home NNP I-NP O
17 w/ NN I-NP O
17 services NNS I-NP O
18 DISCHARGE NNP I-NP O
18 MEDICATIONS: NNP I-NP O
19 ACETYLSALICYLIC NNP I-NP B-m
19 ACID NNP I-NP I-m
19 325 CD O B-do
19 MG NNP B-NP I-do
19 PO NNP I-NP B-mo
19 DAILY NNP I-NP B-f
20 Override NNP I-NP O
20 Notice: NNP I-NP O
20 Override NNP I-NP O
20 added VBD B-VP O
20 on IN B-VP O
20 10/22/06 CD O O
20 by IN B-VP O
21 LINEA NNP B-NP O
21 , , O O
21 ALLEN NNP B-NP O
21 , , O O
21 M.D NNP B-NP O
22 on IN B-VP O
22 order NN B-NP O
22 for IN B-VP O
22 COUMADIN NNP B-NP B-m
22 PO NNP I-NP B-mo
22 ( ( O O
22 ref JJ O O
22 # # O O
22 515597259 CD O O
22 ) ) O O
23 POTENTIALLY NNP B-NP O
23 SERIOUS NNP I-NP O
23 INTERACTION: NNP I-NP O
23 ASPIRIN NNP I-NP B-m
23 &amp; NNP I-NP O
23 WARFARIN NNP I-NP B-m
24 Reason NNP I-NP O
24 for IN B-VP O
24 override: NN B-NP O
24 aware JJ B-NP O
25 ALLOPURINOL NNP I-NP B-m
25 100 CD O B-do
25 MG NNP B-NP I-do
25 PO NNP I-NP B-mo
25 DAILY NNP I-NP B-f
26 Alert NNP I-NP O
26 overridden: NNP I-NP O
26 Override NNP I-NP O
26 added VBD B-VP O
26 on IN B-VP O
26 10/22/06 CD O O
26 by IN B-VP O
27 CORKRON NNP B-NP O
27 , , O O
27 FERDINAND NNP B-NP O
27 , , O O
27 M.D NNP B-NP O
28 SERIOUS NNP I-NP O
28 INTERACTION: NNP I-NP O
28 WARFARIN NNP I-NP B-m
28 &amp; NNP I-NP O
28 ALLOPURINOL NNP I-NP B-m
29 Reason NNP I-NP O
29 for IN B-VP O
29 override: NN B-NP O
29 aware JJ B-NP O
30 TESSALON NNP I-NP B-m
30 PERLES NNP I-NP I-m
30 ( ( O I-m
30 BENZONATATE NNP B-NP I-m
30 ) ) O I-m
30 100 CD O B-do
30 MG NNP B-NP I-do
30 PO NNP I-NP B-mo
30 TID NNP I-NP B-f
31 PRN NNP I-NP O
31 Other:Cough NNP I-NP B-r
32 COLACE NNP I-NP B-m
32 ( ( O I-m
32 DOCUSATE NNP B-NP I-m
32 SODIUM NNP I-NP I-m
32 ) ) O I-m
32 100 CD O B-do
32 MG NNP B-NP I-do
32 PO NNP I-NP B-mo
32 BID NNP I-NP B-f
33 NEXIUM NNP I-NP B-m
33 ( ( O I-m
33 ESOMEPRAZOLE NNP B-NP I-m
33 ) ) O I-m
33 20 CD O B-do
33 MG NNP B-NP I-do
33 PO NNP I-NP B-mo
33 DAILY NNP I-NP B-f
34 FERROUS NNP I-NP B-m
34 SULFATE NNP I-NP I-m
34 325 CD O B-do
34 MG NNP B-NP I-do
34 PO NNP I-NP B-mo
34 TID NNP I-NP B-f
35 Food/Drug NNP I-NP O
35 Interaction NNP I-NP O
35 Instruction NNP I-NP O
35 Avoid NNP I-NP O
35 milk NN I-NP O
35 and CC O O
35 antacid JJ B-NP O
36 GLIPIZIDE NNP I-NP B-m
36 5 CD O B-do
36 MG NNP B-NP I-do
36 PO NNP I-NP B-mo
36 BID NNP I-NP B-f
37 GUIATUSS NNP I-NP B-m
37 ( ( O I-m
37 GUAIFENESIN NNP B-NP I-m
37 ) ) O I-m
37 10 CD O B-do
37 MILLILITERS NNP B-NP I-do
37 PO NNP I-NP B-mo
37 Q4H NNP I-NP B-f
38 PRN NNP I-NP O
38 Other:Cough NNP I-NP B-r
39 KCL NNP I-NP B-m
39 SLOW NNP I-NP I-m
39 RELEASE NNP I-NP I-m
39 20 CD O B-do
39 MEQ NNP B-NP I-do
39 PO NNP I-NP B-mo
39 BID NNP I-NP B-f
39 Starting VBG O O
39 Today NNP B-NP O
39 August NNP I-NP O
40 As IN B-VP O
40 per IN B-VP O
40 MH NNP B-NP O
40 Potassium NNP I-NP O
40 Chloride NNP I-NP O
40 Policy: NNP I-NP O
41 each DT O O
41 20 CD O O
41 mEq NNS B-NP O
41 dose VB O O
41 to TO O O
41 be VB O O
41 given VBN O O
41 with IN B-VP O
41 4 CD O O
41 oz NNS B-NP O
41 of IN B-VP O
41 fluid NN B-NP O
42 LEVOXYL NNP I-NP B-m
42 ( ( O I-m
42 LEVOTHYROXINE NNP B-NP I-m
42 SODIUM NNP I-NP I-m
42 ) ) O I-m
42 100 CD O B-do
42 MCG NNP B-NP I-do
42 PO NNP I-NP B-mo
42 DAILY NNP I-NP B-f
43 Override NNP I-NP O
43 Notice: NNP I-NP O
43 Override NNP I-NP O
43 added VBD B-VP O
43 on IN B-VP O
43 10/22/06 CD O O
43 by IN B-VP O
44 PIZZULO NNP B-NP O
44 , , O O
44 CARLOS NNP B-NP O
44 , , O O
44 M.D NNP B-NP O
45 on IN B-VP O
45 order NN B-NP O
45 for IN B-VP O
45 COUMADIN NNP B-NP B-m
45 PO NNP I-NP B-mo
45 ( ( O O
45 ref JJ O O
45 # # O O
45 515597259 CD O O
45 ) ) O O
46 SERIOUS NNP B-NP O
46 INTERACTION: NNP I-NP O
46 LEVOTHYROXINE NNP I-NP B-m
46 SODIUM NNP I-NP I-m
46 &amp; NNP I-NP O
46 WARFARIN NNP I-NP B-m
47 Reason NNP I-NP O
47 for IN B-VP O
47 override: NN B-NP O
47 aware JJ B-NP O
48 LOPERAMIDE NNP I-NP B-m
48 HCL NNP I-NP I-m
48 2 CD O B-do
48 MG NNP B-NP I-do
48 PO NNP I-NP B-mo
48 Q6H NNP I-NP B-f
48 PRN NNP I-NP I-f
48 Diarrhea NNP I-NP B-r
49 ATIVAN NNP I-NP B-m
49 ( ( O I-m
49 LORAZEPAM NNP B-NP I-m
49 ) ) O I-m
49 0.5 CD O B-do
49 MG NNP B-NP I-do
49 PO NNP I-NP B-mo
49 DAILY NNP I-NP B-f
49 PRN NNP I-NP I-f
49 Anxiety NNP I-NP B-r
50 METOLAZONE NNP I-NP B-m
50 2.5 CD O B-do
50 MG NNP B-NP I-do
50 PO NNP I-NP B-mo
50 DAILY NNP I-NP O
50 Starting VBG O O
50 Today NNP B-NP O
50 August NNP I-NP O
51 PRN NNP I-NP O
51 Other:Weight NNP I-NP B-r
51 gain NN I-NP I-r
52 TOPROL NNP I-NP B-m
52 XL NNP I-NP I-m
52 ( ( O I-m
52 METOPROLOL NNP B-NP I-m
52 SUCCINATE NNP I-NP I-m
52 EXTENDED NNP I-NP I-m
52 RELEASE NNP I-NP I-m
52 ) ) O I-m
53 100 CD O B-do
53 MG NNP B-NP I-do
53 PO NNP I-NP B-mo
53 DAILY NNP I-NP B-f
53 Food/Drug NNP I-NP O
53 Interaction NNP I-NP O
53 Instruction NNP I-NP O
54 Take NNP I-NP O
54 consistently RB O O
54 with IN B-VP O
54 meals NNS B-NP O
54 or CC O O
54 on IN B-VP O
54 empty JJ B-NP O
54 stomach NN I-NP O
55 PRAVACHOL NNP I-NP B-m
55 ( ( O I-m
55 PRAVASTATIN NNP B-NP I-m
55 ) ) O I-m
55 40 CD O B-do
55 MG NNP B-NP I-do
55 PO NNP I-NP B-mo
55 BEDTIME NNP I-NP B-f
56 Instructions: NNP I-NP O
56 pt NN I-NP O
56 reports NNS I-NP O
56 problems NNS I-NP O
56 with IN B-VP O
56 simvastatin NN B-NP B-m
56 in IN B-VP O
56 the DT B-NP O
57 past JJ I-NP O
57 please NN I-NP O
57 do VB O O
57 not RB O O
57 substitute VB O O
57 thank NN B-NP O
57 you PRP O O
58 Food/Drug NNP B-NP O
58 Interaction NNP I-NP O
58 Instruction NNP I-NP O
59 Avoid NNP I-NP O
59 grapefruit NN I-NP O
59 unless IN B-VP O
59 MD NNP B-NP O
59 instructs NNS I-NP O
59 otherwise RB O O
60 Alert NNP B-NP O
60 overridden: NNP I-NP O
60 Override NNP I-NP O
60 added VBD B-VP O
60 on IN B-VP O
60 2/17/06 CD O O
60 by IN B-VP O
61 VOEDISCH NNP B-NP O
61 , , O O
61 MYLES NNP B-NP O
61 R NNP I-NP O
61 , , O O
61 M.D NNP B-NP O
62 POTENTIALLY NNP I-NP O
62 SERIOUS NNP I-NP O
62 INTERACTION: NNP I-NP O
62 NIACIN NNP I-NP B-m
62 , , O O
62 VIT NNP B-NP B-m
62 B-3 NNP I-NP I-m
62 &amp; NNP I-NP O
63 PRAVASTATIN NNP I-NP B-m
63 SODIUM NNP I-NP I-m
63 Reason NNP I-NP O
63 for IN B-VP O
63 override: NN B-NP O
64 MULTIVITAMIN NNP I-NP B-m
64 THERAPEUTIC NNP I-NP I-m
64 ( ( O I-m
64 THERAPEUTIC NNP B-NP I-m
64 MULTIVI NNP I-NP I-m
64 ) ) O I-m
65 1 CD O B-do
65 TAB NNP B-NP I-do
65 PO NNP I-NP B-mo
65 DAILY NNP I-NP B-f
66 Override NNP I-NP O
66 Notice: NNP I-NP O
66 Override NNP I-NP O
66 added VBD B-VP O
66 on IN B-VP O
66 2/17/06 CD O O
66 by IN B-VP O
67 BOYES NNP B-NP O
67 , , O O
67 GERARDO NNP B-NP O
67 R NNP I-NP O
67 , , O O
67 M.D NNP B-NP O
68 on IN B-VP O
68 order NN B-NP O
68 for IN B-VP O
68 PRAVACHOL NNP B-NP B-m
68 PO NNP I-NP B-mo
68 ( ( O O
68 ref JJ O O
68 # # O O
68 302238564 CD O O
68 ) ) O O
69 POTENTIALLY NNP B-NP O
69 SERIOUS NNP I-NP O
69 INTERACTION: NNP I-NP O
69 NIACIN NNP I-NP B-m
69 , , O O
69 VIT NNP B-NP B-m
69 B-3 NNP I-NP I-m
69 &amp; NNP I-NP O
70 PRAVASTATIN NNP I-NP B-m
70 SODIUM NNP I-NP I-m
70 Reason NNP I-NP O
70 for IN B-VP O
70 override: RB O O
71 Previous NNP B-NP O
71 override IN B-VP O
71 information: JJ B-NP O
72 Override NNP I-NP O
72 added VBD B-VP O
72 on IN B-VP O
72 10/22/06 CD O O
72 by IN B-VP O
72 STEWART NNP B-NP O
72 , , O O
72 BRENDON NNP B-NP O
72 , , O O
72 M.D NNP B-NP O
73 on IN B-VP O
73 order NN B-NP O
73 for IN B-VP O
73 SIMVASTATIN NNP B-NP B-m
73 PO NNP I-NP B-mo
73 ( ( O O
73 ref JJ O O
73 # # O O
73 392909312 CD O O
73 ) ) O O
74 POTENTIALLY NNP B-NP O
74 SERIOUS NNP I-NP O
74 INTERACTION: NNP I-NP O
74 NIACIN NNP I-NP B-m
74 , , O O
74 VIT NNP B-NP B-m
74 B-3 NNP I-NP I-m
74 &amp; NNP I-NP O
75 SIMVASTATIN NNP I-NP B-m
75 Reason NNP I-NP O
75 for IN B-VP O
75 override: NN B-NP O
75 aware JJ B-NP O
76 TORSEMIDE NNP I-NP B-m
76 20 CD O B-do
76 MG NNP B-NP I-do
76 PO NNP I-NP B-mo
76 BID NNP I-NP B-f
77 COUMADIN NNP I-NP B-m
77 ( ( O I-m
77 WARFARIN NNP B-NP I-m
77 SODIUM NNP I-NP I-m
77 ) ) O I-m
77 1 CD O B-do
77 MG NNP B-NP I-do
77 PO NNP I-NP B-mo
77 QPM NNP I-NP B-f
78 Starting NNP I-NP O
78 ROUTINE NNP I-NP O
78 , , O O
78 20:00 CD O O
78 ( ( O O
78 Standard NNP B-NP O
78 Admin NNP I-NP O
78 Time NNP I-NP O
78 ) ) O O
79 Food/Drug NNP B-NP O
79 Interaction NNP I-NP O
79 Instruction NNP I-NP O
80 No NNP I-NP O
80 high JJ B-NP O
80 Vitamin-K NNP I-NP O
80 containing VBG O O
80 foods NNS B-NP O
81 Alert NNP I-NP O
81 overridden: VBD B-VP O
81 Override NNP B-NP O
81 added VBD B-VP O
81 on IN B-VP O
81 7/20/06 CD O O
81 by IN B-VP O
81 : : O O
82 POTENTIALLY NNP B-NP O
82 SERIOUS NNP I-NP O
82 INTERACTION: NNP I-NP O
82 ASPIRIN NNP I-NP B-m
82 &amp; NNP I-NP O
82 WARFARIN NNP I-NP B-m
83 SERIOUS NNP I-NP O
83 INTERACTION: NNP I-NP O
83 ALLOPURINOL NNP I-NP B-m
83 &amp; NNP I-NP O
83 WARFARIN NNP I-NP B-m
84 SERIOUS NNP I-NP O
84 INTERACTION: NNP I-NP O
84 LEVOTHYROXINE NNP I-NP B-m
84 SODIUM NNP I-NP I-m
84 &amp; NNP I-NP O
84 WARFARIN NNP I-NP B-m
85 POTENTIALLY NNP I-NP O
85 SERIOUS NNP I-NP O
85 INTERACTION: NNP I-NP O
85 PRAVASTATIN NNP I-NP B-m
85 SODIUM NNP I-NP I-m
85 &amp; NNP I-NP O
86 WARFARIN NNP I-NP B-m
87 POTENTIALLY NNP I-NP O
87 SERIOUS NNP I-NP O
87 INTERACTION: NNP I-NP O
87 LEVOFLOXACIN NNP I-NP B-m
87 &amp; NNP I-NP O
87 WARFARIN NNP I-NP B-m
88 POTENTIALLY NNP I-NP O
88 SERIOUS NNP I-NP O
88 INTERACTION: NNP I-NP O
88 LEVOFLOXACIN NNP I-NP B-m
88 &amp; NNP I-NP O
88 WARFARIN NNP I-NP B-m
89 Reason NNP I-NP O
89 for IN B-VP O
89 override: NN B-NP O
89 md NN I-NP O
89 aware JJ B-NP O
90 DIET: NNP I-NP O
90 Patient NNP I-NP O
90 should MD O O
90 measure VB O O
90 weight JJ B-NP O
90 daily JJ I-NP O
91 DIET: NNP I-NP O
91 House NNP I-NP O
91 / VBD B-VP O
91 Low NNP B-NP O
91 chol/low NN I-NP O
91 sat VBD B-VP O
91 fat JJ B-NP O
92 DIET: NNP I-NP O
92 House NNP I-NP O
92 / NNP I-NP O
92 ADA NNP I-NP O
92 1800 CD O O
92 cals/dy NN B-NP O
93 DIET: NNP I-NP O
93 2 CD O O
93 gram NN B-NP O
93 Sodium NNP I-NP O
94 ACTIVITY: NNP I-NP O
94 Resume NNP I-NP O
94 regular JJ B-NP O
94 exercise NN I-NP O
95 FOLLOW NNP I-NP O
95 UP NNP I-NP O
95 APPOINTMENT( NNP I-NP O
95 S NNP I-NP O
95 ): NNP I-NP O
96 Please NNP I-NP O
96 go VB O O
96 to TO O O
96 your PRP$ O O
96 scheduled VBN O O
96 appt NN B-NP O
96 with IN B-VP O
96 Dr NNP B-NP O
96 Loparo NNP I-NP O
96 5/13/06 CD O O
96 scheduled VBN O O
96 , , O O
97 Arrange NNP B-NP O
97 INR NNP I-NP O
97 to TO O O
97 be VB O O
97 drawn VBN O O
97 on IN B-VP O
97 2/8/06 CD O O
97 with IN B-VP O
97 f/u JJ B-NP O
97 INR's NNP I-NP O
97 to TO O O
97 be VB O O
97 drawn VBN O O
97 every DT O O
98 3 CD O O
98 days NNS B-NP O
98 INR's NNP I-NP O
98 will MD O O
98 be VB O O
98 followed VBN O O
98 by IN B-VP O
98 Jerald NNP B-NP O
98 Delguidice NNP I-NP O
98 via IN B-VP O
98 VNA NNP B-NP O
98 report NN I-NP O
98 to TO O O
98 Jordge NNP B-NP O
98 Tine NNP I-NP O
98 Medical NNP I-NP O
98 Center NNP I-NP O
98 Medicine NNP I-NP O
99 ALLERGY: NNP I-NP O
99 NKA NNP I-NP O
100 ADMIT NNP I-NP O
100 DIAGNOSIS: NNP I-NP O
101 CHF NNP I-NP O
101 exacerbation NN I-NP O
102 PRINCIPAL NNP I-NP O
102 DISCHARGE NNP I-NP O
102 DIAGNOSIS NNP I-NP O
102 ;Responsible JJ O O
102 After IN B-VP O
102 Study NNP B-NP O
102 for IN B-VP O
102 Causing NNP B-NP O
102 Admission NNP I-NP O
102 ) ) O O
103 CHF NNP B-NP O
103 exacerbation NN I-NP O
103 , , O O
103 PNA NNP B-NP O
103 , , O O
103 viral JJ B-NP O
103 gastroenteritis NN I-NP O
104 OTHER NNP I-NP O
104 DIAGNOSIS;Conditions NNP I-NP O
104 , , O O
104 Infections NNP B-NP O
104 , , O O
104 Complications NNP B-NP O
104 , , O O
104 affecting VBG O O
104 Treatment/Stay NNP B-NP O
105 CHF NNP I-NP O
105 ( ( O O
105 congestive JJ B-NP O
105 heart NN I-NP O
105 failure NN I-NP O
105 ) ) O O
105 cad NN B-NP O
105 ( ( O O
105 coronary JJ B-NP O
105 artery NN I-NP O
105 disease NN I-NP O
105 ) ) O O
105 htn NN B-NP O
106 ( ( O O
106 hypertension NN B-NP O
106 ) ) O O
106 dm NN B-NP O
106 ( ( O O
106 diabetes VBZ O O
106 mellitus NN B-NP O
106 ) ) O O
106 gerd NN B-NP O
106 ( ( O O
106 gastroesophageal JJ B-NP O
106 reflux NN I-NP O
107 disease NN I-NP O
107 ) ) O O
107 hypothyroidism NN B-NP O
107 ( ( O O
107 hypothyroidism NN B-NP O
107 ) ) O O
107 mitral JJ B-NP O
107 regurgitation NN I-NP O
108 ( ( O O
108 2 CD O O
108 ) ) O O
108 lung NN B-NP O
108 ca MD O O
108 s/p VB O O
108 lobectomy NN B-NP O
108 ( ( O O
108 lung JJ B-NP O
108 cancer NN I-NP O
108 ) ) O O
108 endometrial NN B-NP O
108 ca MD O O
108 s/p VB O O
108 TAH/BSO NNP B-NP O
109 ( ( O O
109 endometrial JJ B-NP O
109 cancer NN I-NP O
109 ) ) O O
109 basal NN B-NP O
109 cell NN I-NP O
109 ca MD O O
109 ( ( O O
109 basal VB O O
109 cell NN B-NP O
110 carcinoma NN I-NP O
110 ) ) O O
110 CRI NNP B-NP O
110 ( ( O O
110 chronic JJ B-NP O
110 renal JJ I-NP O
110 dysfunction NN I-NP O
110 ) ) O O
110 renal JJ B-NP O
110 artery NN I-NP O
110 stenosis NN I-NP O
110 s/p NN I-NP O
111 L NNP I-NP O
111 stent NN I-NP O
111 ( ( O O
111 renal JJ B-NP O
111 artery NN I-NP O
111 stenosis NN I-NP O
111 ) ) O O
111 recurrent NN B-NP O
111 flash NN I-NP O
111 pulm NN I-NP O
111 edema NN I-NP O
111 ( ( O O
111 pulmonary JJ B-NP O
112 edema NN I-NP O
112 ) ) O O
113 OPERATIONS NNP B-NP O
113 AND NNP I-NP O
113 PROCEDURES: NNP I-NP O
114 OTHER NNP I-NP O
114 TREATMENTS/PROCEDURES NNP I-NP O
114 ( ( O O
114 NOT NNP B-NP O
114 IN NNP I-NP O
114 O.R NNP I-NP O
114 ) ) O O
115 CXR NNP B-NP O
115 , , O O
115 diuresis NN B-NP O
115 with IN B-VP O
115 IV NNP B-NP B-mo
115 medications NNS I-NP B-m
115 , , O O
115 EKG NNP B-NP O
115 , , O O
115 R/O NNP B-NP O
115 MI NNP I-NP O
115 , , O O
115 Abdo NNP B-NP O
115 CT NNP I-NP O
116 BRIEF NNP I-NP O
116 RESUME NNP I-NP O
116 OF NNP I-NP O
116 HOSPITAL NNP I-NP O
116 COURSE: NNP I-NP O
117 Pt: NNP I-NP O
117 Ms NNP I-NP O
117 Watterson NNP I-NP O
117 , , O O
117 75M CD O O
118 **** NN B-NP O
119 CC: NNP I-NP O
119 increasing VBG O O
119 SOB NNP B-NP O
119 , , O O
119 weight VBD B-VP O
119 gain NN B-NP O
120 **** NN I-NP O
121 HPI: NNP I-NP O
121 Pt NNP I-NP O
121 is VBZ O O
121 a DT O O
121 75F JJ O O
121 with IN B-VP O
121 a DT B-NP O
121 h/o NN I-NP O
121 CHF/CAD NNP I-NP O
121 , , O O
121 A-fib NNP B-NP O
121 , , O O
121 lung NN B-NP O
121 CA NNP I-NP O
121 s/p NN I-NP O
121 R NNP I-NP O
121 wedge NN I-NP O
122 resection NN I-NP O
122 She PRP O O
122 has VBZ O O
122 been VBN O O
122 admitted VBN O O
122 5-6 JJ B-NP O
122 times NNS I-NP O
122 this DT B-NP O
122 year NN I-NP O
122 for IN B-VP O
122 CHF NNP B-NP O
123 exacerbation NN I-NP O
123 She PRP O O
123 was VBD B-VP O
123 in IN B-VP O
123 her PRP$ O O
123 USOH NN B-NP O
123 when WRB O O
123 over IN B-VP O
123 the DT O O
123 last JJ O O
123 6 CD O O
123 days NNS B-NP O
123 she PRP O O
123 has VBZ O O
124 noticed VBN O O
124 a DT O O
124 6lb CD O O
124 weight NN B-NP O
124 gain NN I-NP O
124 Additionally NNP I-NP O
124 , , O O
124 pt NN B-NP O
124 experienced VBD B-VP O
124 increasing VBG O O
124 SOB NNP B-NP O
124 , , O O
125 and CC O O
125 required VBD B-VP O
125 more JJR B-NP O
125 pillows NNS I-NP O
125 to TO O O
125 sleep VB O O
125 She PRP O O
125 uses VBZ O O
125 2 CD O O
125 pillows NNS B-NP O
125 at IN B-VP O
125 baseline NN B-NP O
125 Her NNP I-NP O
126 SOB/orthopnea NNP I-NP O
126 worsened VBD B-VP O
126 to TO O O
126 the DT B-NP O
126 point NN I-NP O
126 when WRB O O
126 on IN B-VP O
126 the DT B-NP O
126 night NN I-NP O
126 before IN B-VP O
126 admission NN B-NP O
126 , , O O
127 she PRP O O
127 was VBD B-VP O
127 unable JJ O O
127 to TO O O
127 fall VB O O
127 asleep RB O O
127 even RB O O
127 when WRB O O
127 almost RB O O
127 sitting VBG O O
127 up RP O O
127 Per NNP B-NP O
127 her PRP$ O O
127 PCP's NNP B-NP O
128 instructions NNS I-NP O
128 , , O O
128 pt NN B-NP O
128 took VBD B-VP O
128 Metolazone NNP B-NP B-m
128 2.5mg CD O B-do
128 and CC O O
128 Torsamide NNP B-NP B-m
128 40mg CD O B-do
128 x1 NNP B-NP B-f
128 which WDT O O
128 did VBD B-VP O
129 not RB O O
129 increase VB O O
129 her PRP$ O O
129 UOP NNP B-NP O
129 Pt NNP I-NP O
129 also RB O O
129 noticed VBD B-VP O
129 a DT B-NP O
129 fever NN I-NP O
129 to TO O O
129 101 CD O O
129 the DT B-NP O
129 night NN I-NP O
129 before IN B-VP O
130 admission NN B-NP O
131 **** NNP I-NP O
132 ROS: NNP I-NP O
132 +SOB NNP I-NP O
132 +PND NNP I-NP O
132 +orthopnea NNP I-NP O
132 +fever NNP I-NP O
132 +chills( NNP I-NP O
132 chronic NN I-NP O
132 ) ) O O
132 +decreased VBD B-VP O
132 UOP NNP B-NP O
132 x NNP I-NP O
133 1-2 JJ B-NP O
133 days NNS I-NP O
133 + VBP O O
133 L NNP B-NP O
133 leg NN I-NP O
133 swelling VBG O O
133 for IN B-VP O
133 weeks NNS B-NP O
133 , , O O
133 no DT B-NP O
133 CP NNP I-NP O
133 , , O O
133 no DT B-NP O
133 N/V/D NNP I-NP O
133 , , O O
133 no DT B-NP O
133 pyuria NN I-NP O
133 , , O O
133 no DT B-NP O
134 dizziness NN I-NP O
134 , , O O
134 no DT B-NP O
134 palpitations NNS I-NP O
135 Vitals NNS I-NP O
135 in IN B-VP O
135 ED: NNP B-NP O
135 T98.6 NNP I-NP O
135 P72 NNP I-NP O
135 BP121/65 NNP I-NP O
135 RR18 NNP I-NP O
135 SaO2 NNP I-NP O
135 on IN B-VP O
135 2L:98% CD O O
136 Pt NNP B-NP O
136 recieved VBD B-VP O
136 O2 NNP B-NP B-do
136 and CC O I-do
136 40 CD O I-do
136 Lasix NNP B-NP B-m
136 IV NNP I-NP B-mo
136 in IN B-VP O
136 the DT B-NP O
136 ED NNP I-NP O
137 **** NNP I-NP O
138 Rx NNP I-NP O
138 on IN B-VP O
138 admit: NN B-NP O
139 1 CD O O
139 ASA NNP B-NP B-m
139 ( ( O I-m
139 Acetylsalicylic NNP B-NP I-m
139 Acid NNP I-NP I-m
139 ) ) O I-m
139 PO NNP B-NP B-mo
139 QD NNP I-NP B-f
139 325MG CD O B-do
140 2 CD O O
140 Allopurinol NNP B-NP B-m
140 PO NNP I-NP B-mo
140 100 CD O B-do
140 MG NNP B-NP I-do
140 QD NNP I-NP B-f
141 3 CD O O
141 Docusate NNP B-NP B-m
141 Sodium NNP I-NP I-m
141 ( ( O I-m
141 Colace NNP B-NP I-m
141 ) ) O I-m
141 PO NNP B-NP B-mo
141 100 CD O B-do
141 MG NNP B-NP I-do
141 BID NNP I-NP B-f
142 4 CD O O
142 Esomeprazole NNP B-NP B-m
142 ( ( O I-m
142 Nexium NNP B-NP I-m
142 ) ) O I-m
142 PO NNP B-NP B-mo
142 20 CD O B-do
142 MG NNP B-NP I-do
142 QD NNP I-NP B-f
143 5 CD O O
143 Ferrous NNP B-NP B-m
143 Sulfate NNP I-NP I-m
143 PO NNP I-NP B-mo
143 325 CD O B-do
143 MG NNP B-NP I-do
143 TID NNP I-NP B-f
144 6 CD O O
144 Glipizide NNP B-NP B-m
144 PO NNP I-NP B-mo
144 5 CD O B-do
144 MG NNP B-NP I-do
144 BID NNP I-NP B-f
145 7 CD O O
145 Kcl NNP B-NP B-m
145 Slow NNP I-NP I-m
145 Release NNP I-NP I-m
145 ( ( O I-m
145 Potassium NNP B-NP I-m
145 Chloride NNP I-NP I-m
145 Slow NNP I-NP I-m
145 Rel NNP I-NP I-m
145 ) ) O I-m
145 20 CD O B-do
145 MEQ NNP B-NP I-do
145 QD NNP I-NP B-f
146 8 CD O O
146 Levoxyl NNP B-NP B-m
146 ( ( O I-m
146 Levothyroxine NNP B-NP I-m
146 Sodium NNP I-NP I-m
146 ) ) O I-m
146 PO NNP B-NP B-mo
146 100 CD O B-do
146 MCG NNP B-NP I-do
146 QD NNP I-NP B-f
147 9 CD O O
147 Lorazepam NNP B-NP B-m
147 Lorazepam NNP I-NP B-m
147 ( ( O I-m
147 ( ( O I-m
147 Ativan NNP B-NP I-m
147 Ativan NNP I-NP I-m
147 ) ) O I-m
147 ) ) O I-m
147 PO NNP B-NP B-mo
147 PO NNP I-NP B-mo
147 0.5 CD O B-do
147 0.5 CD O B-do
147 MG NNP B-NP I-do
147 MG NNP I-NP I-do
147 QD NNP I-NP B-f
147 QD NNP I-NP B-f
147 prn NN I-NP I-f
147 prn NN I-NP I-f
147 Insomnia NNP I-NP B-r
147 , , O O
147 Anxiety NNP B-NP B-r
148 10 CD O O
148 Metolazone NNP B-NP B-m
148 PO NNP I-NP B-mo
148 2.5 CD O B-do
148 MG NNP B-NP I-do
148 QAM NNP I-NP B-f
149 11 CD O O
149 Metoprolol NNP B-NP B-m
149 Succinate NNP I-NP I-m
149 Extended NNP I-NP I-m
149 Release NNP I-NP I-m
149 ( ( O I-m
149 Toprol NNP B-NP I-m
149 Xl NNP I-NP I-m
149 ) ) O I-m
149 PO NNP B-NP B-mo
149 100 CD O B-do
149 MG NNP B-NP I-do
149 QD NNP I-NP B-f
150 12 CD O O
150 Multivitamins NNP B-NP B-m
150 ( ( O I-m
150 Ocuvite NNP B-NP I-m
150 ) ) O I-m
150 PO NNP B-NP B-mo
150 1 CD O B-do
150 TAB NNP B-NP I-do
150 BID NNP I-NP B-f
151 13 CD O O
151 Pravastatin NNP B-NP B-m
151 PO NNP I-NP B-mo
151 40 CD O B-do
151 MG NNP B-NP I-do
151 QHS NNP I-NP B-f
152 14 CD O O
152 Torsemide NNP B-NP B-m
152 PO NNP I-NP B-mo
152 20 CD O B-do
152 MG NNP B-NP I-do
152 BID NNP I-NP B-f
153 15 CD O O
153 Warfarin NNP B-NP B-m
153 Sodium NNP I-NP I-m
153 ( ( O I-m
153 Coumadin NNP B-NP I-m
153 ) ) O I-m
153 PO NNP B-NP B-mo
153 2 CD O B-do
153 MG NNP B-NP I-do
153 QD NNP I-NP B-f
154 **** NNP I-NP O
155 Allergies: NNP I-NP O
155 NKDA NNP I-NP O
156 **** NNP I-NP O
157 PMH: NNP I-NP O
157 CRI NNP I-NP O
157 , , O O
157 hypothyroidism NN B-NP O
157 , , O O
157 paroxysmal JJ B-NP O
157 a-fib NN I-NP O
157 , , O O
157 DM NNP B-NP O
157 , , O O
157 CHF NNP B-NP O
157 , , O O
157 CAD NNP B-NP O
157 , , O O
157 lung NN B-NP O
157 CA NNP I-NP O
157 s/p NN I-NP O
158 R NNP I-NP O
158 wedge NN I-NP O
158 resection NN I-NP O
158 , , O O
158 basal NN B-NP O
158 cell NN I-NP O
158 CA NNP I-NP O
158 on IN B-VP O
158 lip NN B-NP O
158 s/p NN I-NP O
158 resection NN I-NP O
158 , , O O
158 uterine JJ B-NP O
158 CA NNP I-NP O
158 s/p NN I-NP O
159 TAH NNP I-NP O
160 **** NNP I-NP O
161 FHx: NNP I-NP O
161 non MD O O
161 contrib VB O O
162 **** NNP B-NP O
163 Social: NNP I-NP O
163 Lives VBZ O O
163 with IN B-VP O
163 husband NN B-NP O
163 across IN B-VP O
163 street NN B-NP O
163 from IN B-VP O
163 CCH NNP B-NP O
163 +tob NNP I-NP O
163 history NN I-NP O
163 , , O O
164 -EtOH NNP B-NP O
164 , , O O
164 -IVDU NNP B-NP O
165 **** NNP I-NP O
166 PE NNP I-NP O
166 on IN B-VP O
166 admit: NN B-NP O
166 VS:T: NNP I-NP O
166 97.6 CD O O
166 P77 NNP B-NP O
166 BP:NR NNP I-NP O
166 RR20 NNP I-NP O
166 SaO2100% NNP I-NP O
166 on IN B-VP O
167 2L CD O O
167 C/V NNP B-NP O
167 irreg NN I-NP O
167 irreg NN I-NP O
167 , , O O
167 no DT B-NP O
167 m/g/r NN I-NP O
167 Lungs VBZ O O
167 crackles NNS B-NP O
167 at IN B-VP O
167 L NNP B-NP O
167 base NN I-NP O
167 , , O O
167 faint NN B-NP O
167 crackles NNS I-NP O
167 at IN B-VP O
168 R NNP B-NP O
168 base NN I-NP O
168 Legs NNP I-NP O
168 trace NN I-NP O
168 edema NN I-NP O
168 but CC O O
168 equal JJ B-NP O
168 No NNP I-NP O
168 redness NN I-NP O
168 , , O O
168 +tenderness NN B-NP O
168 on IN B-VP O
168 L NNP B-NP O
168 shin JJ B-NP O
169 +faint NN I-NP O
169 ecchymosis NN I-NP O
170 CXR: NNP I-NP O
170 Small NNP I-NP O
170 L NNP I-NP O
170 effusion NN I-NP O
170 , , O O
170 +mild JJ B-NP O
170 pulm NN I-NP O
170 edema NN I-NP O
171 EKG: NNP I-NP O
171 A-fib NNP I-NP O
171 , , O O
171 unchanged JJ B-NP O
172 **** NNP I-NP O
173 A/P: NNP I-NP O
173 75F CD O O
173 with IN B-VP O
173 h/o NN B-NP O
173 CAD/CHF/lung NNP I-NP O
173 CA/Afib NNP I-NP O
173 with IN B-VP O
173 6 CD O O
173 days NNS B-NP O
173 of IN B-VP O
173 weight JJ B-NP O
173 gain NN I-NP O
173 , , O O
174 worsening VBG O O
174 SOB NNP B-NP O
174 and CC O O
174 PND NNP B-NP O
174 , , O O
174 with IN B-VP O
174 borderline NN B-NP O
174 elevated VBN O O
174 WBC NNP B-NP O
174 and CC O O
174 dysuria $ O O
175 1 CD O O
175 )C/V JJ B-NP O
176 +I- JJ I-NP O
176 Pt NNP I-NP O
176 was VBD B-VP O
176 R/OMI'ed VBN O O
176 with IN B-VP O
176 all DT O O
176 three CD O O
176 sets NNS B-NP O
176 negative JJ O O
176 for IN B-VP O
176 ischemia NN B-NP O
176 This DT O O
176 was VBD B-VP O
177 to TO O O
177 examine VB O O
177 for IN B-VP O
177 causes NNS B-NP O
177 of IN B-VP O
177 CHF NNP B-NP O
177 exacerbation NN I-NP O
177 Pt NNP I-NP O
177 was VBD B-VP O
177 continued VBN O O
177 on IN B-VP O
177 her PRP$ O O
177 home NN B-NP O
178 rx NN I-NP O
178 of IN B-VP O
178 betablocker NN B-NP B-m
178 , , O O
178 asa NN B-NP B-m
178 , , O O
178 statin JJ B-NP B-m
179 +P- JJ I-NP O
179 Pt NNP I-NP O
179 normotensive MD O O
179 Likely RB O O
179 fluid VB O O
180 overloaded VBD B-VP O
180 given VBN O O
180 CXR NNP B-NP O
180 , , O O
180 physical JJ B-NP O
180 exam NN I-NP O
180 , , O O
180 and CC O O
180 HPI NNP B-NP O
180 Pt NNP I-NP O
180 was VBD B-VP O
180 diuresed VBN O O
180 with IN B-VP O
180 IV NNP B-NP B-mo
181 Lasix NNP I-NP B-m
181 in IN B-VP O
181 the DT B-NP O
181 ED NNP I-NP O
181 On IN B-VP O
181 the DT B-NP O
181 floor NN I-NP O
181 she PRP O O
181 received VBD B-VP O
181 2.5mg CD O B-do
181 of IN B-VP O
181 Metolazone NN B-NP B-m
181 followed VBN O O
182 by IN B-VP O
182 60mg CD O B-do
182 of IN B-VP O
182 Torsemide NNP B-NP B-m
182 She PRP O O
182 was VBD B-VP O
182 then RB O O
182 diuresed VBN O O
182 with IN B-VP O
182 5mg CD O B-do
182 of IN B-VP O
182 Metolazone NN B-NP B-m
183 followed VBN O O
183 by IN B-VP O
183 120mg CD O B-do
183 of IN B-VP O
183 Torsemide NNP B-NP B-m
183 She PRP O O
183 was VBD B-VP O
183 roughly RB O O
183 negative JJ O O
183 1.3L CD O O
183 Pt NNP B-NP O
183 was VBD B-VP O
184 doing VBG O O
184 clinically RB O O
184 well RB O O
184 when WRB O O
184 on IN B-VP O
184 1/16 CD O O
184 pt's JJ B-NP O
184 Cr NNP I-NP O
184 increased VBD B-VP O
184 to TO O O
184 3.2 CD O O
184 from IN B-VP O
184 her PRP$ O O
185 baseline NN B-NP O
185 of IN B-VP O
185 about RB O O
185 2.5 CD O O
185 At IN B-VP O
185 that DT B-NP O
185 time NN I-NP O
185 Torsemide NNP I-NP B-m
185 and CC O O
185 Metolazone NNP B-NP B-m
185 were VBD B-VP O
185 held VBN O O
186 Pt's NNP B-NP O
186 daily JJ B-NP O
186 weights NNS I-NP O
186 continued VBD B-VP O
186 to TO O O
186 decrease VB O O
186 even RB O O
186 off IN B-VP O
186 of IN B-VP O
186 diuretics NNS B-NP B-m
186 On IN B-VP O
186 2/22 CD O O
186 , , O O
187 however RB O O
187 pt's JJ B-NP O
187 weight NN I-NP O
187 increased VBD B-VP O
187 to TO O O
187 72.9 CD O O
187 kg NNS B-NP O
187 from IN B-VP O
187 70.6kg CD O O
187 At IN B-VP O
187 this DT B-NP O
187 time NN I-NP O
187 pt NN I-NP O
187 was VBD B-VP O
188 restarted VBN O O
188 on IN B-VP O
188 her PRP$ O O
188 home NN B-NP O
188 rx NN I-NP O
188 of IN B-VP O
188 torsemide JJ O B-m
188 20mg CD O B-do
188 po NN B-NP B-mo
188 bid NN I-NP B-f
188 A NNP I-NP O
188 repeat NN I-NP O
188 weight NN I-NP O
188 was VBD B-VP O
189 checked VBN O O
189 in IN B-VP O
189 the DT B-NP O
189 pm NN I-NP O
189 returning VBG O O
189 as IN B-VP O
189 71.7kg CD O O
189 Pt NNP B-NP O
189 was VBD B-VP O
189 discharged VBN O O
189 on IN B-VP O
189 2/22 CD O O
189 at IN B-VP O
189 a DT B-NP O
190 weight NN I-NP O
190 of IN B-VP O
190 158 CD O O
190 lbs NN B-NP O
191 of IN B-VP O
191 discharge NN B-NP O
191 pt NN I-NP O
191 was VBD B-VP O
191 at IN B-VP O
191 or CC O O
191 better JJR O O
191 than IN B-VP O
191 her PRP$ O O
191 baseline JJ B-NP O
191 function NN I-NP O
191 in IN B-VP O
191 terms NNS B-NP O
191 of IN B-VP O
192 her PRP$ O O
192 orthopnea/SOB JJ O O
193 +R- JJ O O
193 During IN B-VP O
193 her PRP$ O O
193 stay NN B-NP O
193 the DT B-NP O
193 patient NN I-NP O
193 remained VBD B-VP O
193 in IN B-VP O
193 afib NN B-NP O
193 with IN B-VP O
193 good JJ B-NP O
193 rate NN I-NP B-r
193 control NN I-NP I-r
194 on IN B-VP O
194 her PRP$ O O
194 bblocker NN B-NP B-m
195 2 CD O O
195 ) ) O O
195 Heme: NNP B-NP O
195 Pt NNP I-NP O
195 was VBD B-VP O
195 found VBN O O
195 to TO O O
195 be VB O O
195 supertheraputic JJ O O
195 during IN B-VP O
195 her PRP$ O O
195 stay NN B-NP O
195 Her PRP$ O O
195 coumadin NN B-NP B-m
196 was VBD B-VP O
196 held VBN O O
196 throughout IN B-VP B-du
196 her PRP$ O I-du
196 admission NN B-NP I-du
196 as IN B-VP O
196 her PRP$ O O
196 INR NNP B-NP O
196 remained VBD B-VP O
196 3.9 CD O O
196 to TO O O
196 4.0 CD O O
196 in IN B-VP O
196 the DT B-NP O
197 setting NN I-NP O
197 of IN B-VP O
197 hemoptysis NN B-NP O
197 On IN B-VP O
198 discharge NN B-NP O
198 pt NN I-NP O
198 was VBD B-VP O
198 started VBN O O
198 on IN B-VP O
198 1/2 CD O B-do
198 her PRP$ O O
198 home NN B-NP O
198 coumadin NN I-NP B-m
198 with IN B-VP O
198 VNA/PCP NNP B-NP O
198 f/u NN I-NP O
198 in IN B-VP O
198 2 CD O O
199 days NNS B-NP O
199 Pt NNP I-NP O
199 d/ced VBD B-VP O
199 on IN B-VP O
199 Coumadin NNP B-NP B-m
199 1mg CD O B-do
199 qpm RB O B-f
200 3 CD O O
200 ) ) O O
200 ID- NNP B-NP O
200 Pt NNP I-NP O
200 had VBD B-VP O
200 a DT B-NP O
200 negative JJ I-NP O
200 UA NNP I-NP O
200 and CC O O
200 urine JJ B-NP O
200 CTX NNP I-NP O
200 However RB O O
200 during IN B-VP O
200 her PRP$ O O
200 admission NN B-NP O
200 pt NN I-NP O
201 developed VBD B-VP O
201 diarrhea NN B-NP O
201 Because IN B-VP O
201 of IN B-VP O
201 concern NN B-NP O
201 for IN B-VP O
201 c.diff NN B-NP O
201 colitis NN I-NP O
201 Pt NNP I-NP O
201 recieved VBD B-VP O
201 an DT B-NP O
202 abdominal JJ I-NP O
202 CT NNP I-NP O
202 CT NNP I-NP O
202 showed VBD B-VP O
202 no DT B-NP O
202 colitis NN I-NP O
202 but CC O O
202 did VBD B-VP O
202 show VB O O
202 a DT B-NP O
202 LLL NNP I-NP O
202 consolidation NN I-NP O
202 likely RB O O
203 PNA NNP B-NP B-r
203 Pt NNP I-NP O
203 was VBD B-VP O
203 initially RB O O
203 treated VBN O O
203 with IN B-VP O
203 azithromycin NN B-NP B-m
203 but CC O O
203 as IN B-VP O
203 her PRP$ O O
203 cough NN B-NP O
203 and CC O O
203 o2 JJ B-NP O
204 requirement NN I-NP O
204 did VBD B-VP O
204 not RB O O
204 improve VB O O
204 , , O O
204 as RB O O
204 well RB O O
204 as IN B-VP O
204 because IN B-VP O
204 pt NN B-NP O
204 began VBD B-VP O
204 to TO O O
204 spike VB O O
204 fevers NNS B-NP O
204 , , O O
205 pt NN B-NP O
205 was VBD B-VP O
205 begun VBN O O
205 on IN B-VP O
205 ceftaz NN B-NP B-m
205 and CC O O
205 levo NN B-NP B-m
205 for IN B-VP O
205 gram NN B-NP O
205 pos NN I-NP O
205 coverage NN I-NP O
205 ( ( O O
205 levo NN B-NP B-m
205 ) ) O O
205 double JJ B-NP O
205 gram NN I-NP O
206 neg NN I-NP O
206 coverage NN I-NP O
206 , , O O
206 and CC O O
206 atypical JJ B-NP O
206 coverage NN I-NP O
206 ( ( O O
206 levo NN B-NP B-m
206 ) ) O O
206 for IN B-VP O
206 presumed VBN O B-r
206 presumed JJ O B-r
206 presumed VBN O B-r
206 presumed JJ B-NP B-r
206 hospital NN I-NP O
206 aquired VBD B-VP O
207 PNA NNP B-NP O
207 in IN B-VP O
207 the DT B-NP O
207 setting NN I-NP O
207 of IN B-VP O
207 pt's JJ B-NP O
207 multiple JJ I-NP O
207 hosp NN I-NP O
207 for IN B-VP O
207 CHF NNP B-NP O
207 exacerbation NN I-NP O
207 this DT B-NP O
207 year NN I-NP O
208 PT NNP I-NP O
208 improved VBD B-VP O
208 clinically RB O O
208 and CC O O
208 was VBD B-VP O
208 d/ced VBN O O
208 on IN B-VP O
208 levofloxacin NN B-NP B-m
208 500mg CD O B-do
208 q48h NN B-NP B-f
208 x VBD B-VP B-du
208 7 CD O I-du
208 days NNS B-NP I-du
209 and CC O O
209 ceftaz NNS B-NP B-m
209 changed VBD B-VP O
209 to TO O O
209 cefpodoxime VB O B-m
209 200mg CD O B-do
209 po NN B-NP B-mo
209 qd NN I-NP B-f
209 x $ O B-du
209 7 CD O I-du
209 days NNS B-NP I-du
210 Pt's NNP I-NP O
210 diarrhea NN I-NP O
210 was VBD B-VP O
210 concerning VBG O O
210 for IN B-VP O
210 c.diff NN B-NP O
210 given VBN O O
210 fever NN B-NP O
210 and CC O O
210 high JJ B-NP O
210 whitecount NN I-NP O
211 however RB O O
211 pt NN B-NP O
211 had VBD B-VP O
211 only RB O O
211 been VBN O O
211 on IN B-VP O
211 azithromycin JJ O B-m
211 x JJ O B-du
211 1 CD O I-du
211 day NN B-NP I-du
211 Cdiff NNP I-NP O
211 , , O O
211 fecal JJ B-NP O
211 leuks NN I-NP O
211 , , O O
211 and CC O O
212 all DT B-NP O
212 stool JJ I-NP O
212 studies NNS I-NP O
212 were VBD B-VP O
212 negative JJ O O
212 during IN B-VP O
212 admission NN B-NP O
212 Presumed NNP I-NP O
212 viral JJ B-NP O
213 gastroenteritis NN I-NP O
213 Pt NNP I-NP O
213 started VBD B-VP O
213 on IN B-VP O
213 loperamide NN B-NP B-m
213 before IN B-VP O
213 discharge NN B-NP O
213 to TO O O
213 be VB O O
213 continued VBN O O
214 prn JJ O B-f
214 diarrhea RB O B-r
215 4 CD O O
215 ) ) O O
215 Endocrine NNP B-NP O
215 - : O O
215 Pt's NNP B-NP O
215 po NN I-NP B-mo
215 DM NNP I-NP B-m
215 rx NN I-NP I-m
215 were VBD B-VP O
215 held VBN O O
215 during IN B-VP O
215 her PRP$ O O
215 admission NN B-NP O
215 - : O O
215 she PRP O O
215 was VBD B-VP O
216 covered VBN O O
216 with IN B-VP O
216 Lantus NNP B-NP B-m
216 and CC O O
216 Insulin NNP B-NP B-m
216 Asp NNP I-NP I-m
216 SS NNP I-NP B-do
216 HgA1c NNP I-NP O
216 was VBD B-VP O
216 sent VBN O O
216 and CC O O
216 was VBD B-VP O
216 in IN B-VP O
216 nl JJ B-NP O
217 range NN I-NP O
217 Home NNP I-NP O
217 po NN I-NP B-mo
217 rx NN I-NP O
217 were VBD B-VP O
217 restarted VBN O O
217 on IN B-VP O
218 discharge NN B-NP O
218 Pt NNP I-NP O
218 was VBD B-VP O
218 kept VBN O O
218 on IN B-VP O
218 her PRP$ O O
218 home NN B-NP B-do
218 dose NN I-NP I-do
218 of IN B-VP O
218 levoxyl; JJ B-NP B-m
218 TSH NNP I-NP O
218 was VBD B-VP O
218 rechecked VBN O O
219 and CC O O
219 within IN B-VP O
219 nl JJ B-NP O
219 range NN I-NP O
219 Pt's NNP I-NP O
219 home NN I-NP O
219 rx NN I-NP O
219 Allopurinol NNP I-NP B-m
219 was VBD B-VP O
219 also RB O O
219 continued VBN O O
220 **** NNP B-NP O
221 PE NNP I-NP O
221 on IN B-VP O
221 D/C NNP B-NP O
222 C/V NNP I-NP O
222 irreg NN I-NP O
222 irreg NN I-NP O
222 no DT B-NP O
222 m/g/r NN I-NP O
222 Lungs VBZ O O
222 CTA NNP B-NP O
222 with IN B-VP O
222 faint NN B-NP O
222 bibasalar NN I-NP O
222 crackles NNS I-NP O
222 Trace NNP I-NP O
223 pedal VBP O O
223 edema NN B-NP O
224 **** NNP I-NP O
225 Code: NNP I-NP O
225 DNR/DNI NNP I-NP O
226 ADDITIONAL NNP I-NP O
226 COMMENTS: NNP I-NP O
226 Please NNP I-NP O
226 resume VB O O
226 your PRP$ O O
226 normal JJ B-NP O
226 home NN I-NP O
226 medications NNS I-NP O
227 The DT B-NP O
227 following JJ I-NP O
227 antibiotics NNS I-NP B-m
227 were VBD B-VP O
227 added: JJ B-NP O
228 Levofloxacin NNP I-NP B-m
228 500mg CD O B-do
228 by IN B-VP B-mo
228 mouth NN B-NP I-mo
228 every DT O B-f
228 48 CD O I-f
228 hours NNS B-NP I-f
228 for IN B-VP B-du
228 7 CD O I-du
228 days NNS B-NP I-du
229 Cefpodoxime NNP I-NP B-m
229 200mg CD O B-do
229 by IN B-VP B-mo
229 moouth NN B-NP I-mo
229 once RB O B-f
229 daily JJ O I-f
229 for IN B-VP B-du
229 7 CD O I-du
229 days NNS B-NP I-du
230 ** VBP O O
231 The DT B-NP O
231 following JJ I-NP O
231 medications NNS I-NP O
231 were VBD B-VP O
231 added: JJ B-NP O
232 Tessalon NNP I-NP B-m
232 Perels NNP I-NP I-m
232 100mg CD O B-do
232 by IN B-VP B-mo
232 mouth NN B-NP I-mo
232 three CD O B-f
232 times NNS B-NP I-f
232 daily RB O I-f
232 as IN B-VP I-f
232 needed VBN O I-f
232 for IN B-VP O
232 cough NN B-NP B-r
233 Guiatuss NNP I-NP B-m
233 10ml CD O B-do
233 by IN B-VP B-mo
233 mouth NN B-NP I-mo
233 every DT O B-f
233 4 CD O I-f
233 hours NNS B-NP I-f
233 as IN B-VP I-f
233 needed VBN O I-f
233 for IN B-VP O
233 cough JJ B-NP B-r
234 Loperamide NNP I-NP B-m
234 2mg CD O B-do
234 by IN B-VP B-mo
234 mouth NN B-NP I-mo
234 every DT O B-f
234 6 CD O I-f
234 hours NNS B-NP I-f
234 as IN B-VP I-f
234 needed VBN O I-f
234 for IN B-VP O
234 diarrhea NN B-NP B-r
235 ** VBP O O
236 The DT B-NP O
236 following JJ I-NP O
236 medications NNS I-NP O
236 were VBD B-VP O
236 changed: JJ B-NP O
237 Coumadin: NNP I-NP B-m
237 Coumadin: NNP I-NP B-m
237 Were NNP I-NP O
237 taking VBG O O
237 2mg CD O B-do
237 by IN B-VP B-mo
237 by IN B-VP B-mo
237 mouth NN B-NP I-mo
237 mouth NN I-NP I-mo
237 in IN B-VP B-f
237 in IN B-VP B-f
237 the DT O I-f
237 the DT B-NP I-f
237 pm NN I-NP I-f
237 pm NN I-NP I-f
237 , , O O
237 now RB O O
237 take VBP O O
237 1mg CD O B-do
237 by IN B-VP O
237 mouth NN B-NP O
237 in IN B-VP O
237 the DT B-NP O
238 pm NN I-NP O
239 **** NNP I-NP O
240 Please NNP I-NP O
240 have VB O O
240 your PRP$ O O
240 VNA NNP B-NP O
240 draw VB O O
240 your PRP$ O O
240 INR NNP B-NP O
240 to TO O O
240 be VB O O
240 reported VBN O O
240 to TO O O
240 Antsaint NNP B-NP O
240 Hospital NNP I-NP O
240 Medicine NNP I-NP O
240 in IN B-VP O
241 2 CD O O
241 days NNS B-NP O
242 **** VBP O O
243 Call VB O O
243 your PRP$ O O
243 PCP/go NNP B-NP O
243 to TO O O
243 the DT B-NP O
243 ED NNP I-NP O
243 if IN B-VP O
243 you PRP O O
243 experience VBP O O
243 any DT O O
243 of IN B-VP O
243 the DT B-NP O
243 following: JJ I-NP O
244 increase NN I-NP O
244 in IN B-VP O
244 shortness NN B-NP O
244 of IN B-VP O
244 breath NN B-NP O
244 , , O O
244 chest NN B-NP O
244 pain NN I-NP O
244 , , O O
244 nausea NN B-NP O
244 , , O O
244 vomiting VBG O O
244 , , O O
244 decrease NN B-NP O
245 in IN B-VP O
245 urine JJ B-NP O
245 output NN I-NP O
245 , , O O
245 requiring VBG O O
245 more JJR O O
245 than IN B-VP O
245 2 CD O O
245 pillows NNS B-NP O
245 to TO O O
245 sleep VB O O
245 at IN B-VP O
245 night NN B-NP O
245 , , O O
245 any DT B-NP O
246 other JJ I-NP O
246 symptom NN I-NP O
246 that IN B-VP O
246 concerns NNS B-NP O
246 you PRP O O
247 DISCHARGE VBP O O
247 CONDITION: NNP B-NP O
247 Stable NNP I-NP O
248 TO NNP I-NP O
248 DO/PLAN: NNP I-NP O
249 To TO O O
249 PCP: NNP B-NP O
250 Pt NNP I-NP O
250 was VBD B-VP O
250 restarted VBN O O
250 on IN B-VP O
250 her PRP$ O O
250 home NN B-NP O
250 RX NNP I-NP O
250 Please NNP I-NP O
250 f/u NN I-NP O
250 with IN B-VP O
250 pt's JJ B-NP O
250 recurrent NN I-NP O
250 need NN I-NP O
250 for IN B-VP O
251 admission NN B-NP O
251 for IN B-VP O
251 CHF NNP B-NP O
251 exacerbation NN I-NP O
252 Pt NNP I-NP O
252 was VBD B-VP O
252 supertheraputic JJ O O
252 on IN B-VP O
252 her PRP$ O O
252 coumadin NN B-NP B-m
252 It PRP O O
252 was VBD B-VP O
252 held VBN O O
252 during IN B-VP O
252 this DT B-NP O
252 admission NN I-NP O
253 but CC O O
253 restarted VBN O O
253 on IN B-VP O
253 discharge NN B-NP O
253 Please NNP I-NP O
253 check VB O O
253 her PRP$ O O
253 coags JJ B-NP O
254 No NNP I-NP O
254 dictated VBD B-VP O
254 summary JJ B-NP O
255 ENTERED NNP I-NP O
255 BY: NNP I-NP O
255 BARRIS NNP I-NP O
255 , , O O
255 WM NNP B-NP O
255 , , O O
255 M.D NNP B-NP O
255 ( ( O O
255 DD31 NNP B-NP O
255 ) ) O O
255 7/20/06 CD O O
255 @ $ O O
255 01:12 CD O O
255 PM NNP B-NP O
256 ****** JJ B-NP O
256 END NNP I-NP O
256 OF NNP I-NP O
256 DISCHARGE NNP I-NP O
256 ORDERS NNP I-NP O
256 ****** NNP I-NP O
257 [report_end] NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
0 -DOCSTART- NNP I-NP O
0 -EMPTYLINE- NNP I-NP O
1 RECORD NNP I-NP O
1 #995723 VBZ O O
4 042186535 CD O O
4 SH NNP B-NP O
4 79373526 CD O O
4 115656 CD O O
4 1/23/2000 CD O O
4 12:00:00 CD O O
4 AM NNP B-NP O
4 ARRYTHMIA NNP I-NP O
4 Signed VBD B-VP O
4 DIS NNP B-NP O
4 Admission NNP I-NP O
4 Date: NNP I-NP O
4 2/25/2000 CD O O
4 Report NNP B-NP O
4 Status: NNP I-NP O
4 Signed NNP I-NP O
6 Discharge NNP I-NP O
6 Date: NNP I-NP O
6 1/28/2000 CD O O
7 IDENTIFICATION: NNP B-NP O
7 Ms NNP I-NP O
7 Leezer NNP I-NP O
7 is VBZ O O
7 a DT O O
7 50 CD O O
7 year-old JJ B-NP O
7 woman NN I-NP O
7 with IN B-VP O
7 a DT B-NP O
7 history NN I-NP O
8 of IN B-VP O
8 end NN B-NP O
8 stage NN I-NP O
8 renal JJ B-NP O
8 disease NN I-NP O
8 , , O O
8 status NN B-NP O
8 post NN I-NP O
8 renal JJ B-NP O
9 transplant NN I-NP O
9 and CC O O
9 a DT B-NP O
9 history NN I-NP O
9 of IN B-VP O
9 coronary JJ B-NP O
9 artery NN I-NP O
9 disease NN I-NP O
9 , , O O
9 status NN B-NP O
9 post NN I-NP O
10 coronary JJ B-NP O
10 artery NN I-NP O
10 bypass NN I-NP O
10 grafting NN I-NP O
10 , , O O
10 now RB O O
10 with IN B-VP O
10 syncope NN B-NP O
10 and CC O O
10 palpitations NNS B-NP O
11 HISTORY NNP I-NP O
11 OF IN B-VP O
11 THE NNP B-NP O
11 PRESENT NNP I-NP O
11 ILLNESS: NNP I-NP O
11 This DT O O
11 is VBZ O O
11 a DT O O
11 50 CD O O
11 year-old JJ B-NP O
11 woman NN I-NP O
11 with IN B-VP O
11 a DT B-NP O
12 history NN I-NP O
12 of IN B-VP O
12 end NN B-NP O
12 stage NN I-NP O
12 renal JJ B-NP O
13 disease NN I-NP O
13 , , O O
13 status NN B-NP O
13 post NN I-NP O
13 transplant NN I-NP O
13 ( ( O O
13 cadaveric JJ O O
13 ) ) O O
13 in IN B-VP O
13 February NNP B-NP O
13 of IN B-VP O
13 1997 CD O O
13 , , O O
14 history NN B-NP O
14 of IN B-VP O
14 insulin NN B-NP O
14 dependent NN I-NP O
14 diabetes VBZ O O
14 mellitus RBS O O
14 , , O O
14 and CC O O
14 coronary JJ B-NP O
14 artery NN I-NP O
15 disease NN I-NP O
15 , , O O
15 status NN B-NP O
15 post NN I-NP O
15 coronary JJ B-NP O
15 artery NN I-NP O
15 bypass NN I-NP O
15 grafting NN I-NP O
15 in IN B-VP O
15 February NNP B-NP O
16 of IN B-VP O
16 1996 CD O O
16 , , O O
16 left VBD B-VP O
16 internal JJ B-NP O
16 mammary JJ I-NP O
16 artery NN I-NP O
16 to TO O O
16 the DT O O
16 left VBN O O
16 anterior JJ B-NP O
17 descending NN I-NP O
17 and CC O O
17 saphenous JJ B-NP O
17 vein NN I-NP O
17 graft NN I-NP O
17 to TO O O
17 obtuse VB O O
17 marginal JJ O O
17 , , O O
17 who WP O O
17 reports VBZ O O
18 having VBG O O
18 done VBN O O
18 fairly RB O O
18 well RB O O
18 until IN B-VP O
18 six CD O O
18 months NNS B-NP O
18 ago RB O O
18 when WRB O O
18 she PRP O O
18 had VBD B-VP O
18 an DT B-NP O
19 episode NN I-NP O
19 of IN B-VP O
19 chest NN B-NP B-r
19 pain NN I-NP I-r
19 which WDT O O
19 was VBD B-VP O
19 relieved VBN O O
19 by IN B-VP O
19 Nitroglycerin NNP B-NP B-m
20 Approximately RB O O
20 one CD O O
20 month NN B-NP O
20 ago RB O O
20 , , O O
20 she PRP O O
20 was VBD B-VP O
20 standing VBG O O
20 in IN B-VP O
20 her PRP$ O O
20 kitchen NN B-NP O
20 saying VBG O O
21 good-bye NN B-NP O
21 to TO O O
21 her PRP$ O O
21 husband NN B-NP O
21 at IN B-VP O
21 which WDT O O
21 point NN B-NP O
21 she PRP O O
21 passed VBD B-VP O
21 out RP O O
21 Her PRP$ O O
21 husband NN B-NP O
22 noted VBD B-VP O
22 her PRP$ O O
22 getting VBG O O
22 pale JJ O O
22 and CC O O
22 rolling VBG O O
22 her PRP$ O O
22 eyes NNS B-NP O
22 back RB O O
22 , , O O
22 states VBZ O O
22 that IN B-VP O
22 this DT O O
23 lasted VBD B-VP O
23 approximately RB O O
23 13 CD O O
23 seconds NNS B-NP O
23 She PRP O O
23 had VBD B-VP O
23 no DT B-NP O
23 symptoms NNS I-NP O
23 afterwards VBP O O
24 A DT B-NP O
24 few JJ I-NP O
24 months NNS I-NP O
24 prior RB O O
24 to TO O O
24 this DT O O
24 , , O O
24 the DT B-NP O
24 patient NN I-NP O
24 reports NNS I-NP O
24 having VBG O O
24 had VBD B-VP O
24 slurred VBN O O
25 speech NN B-NP O
25 for IN B-VP O
25 a DT B-NP O
25 few JJ I-NP O
25 minutes NNS I-NP O
25 More RBR O O
25 recently RB O O
25 , , O O
25 she PRP O O
25 has VBZ O O
25 had VBD B-VP O
25 several JJ B-NP O
26 episodes NNS I-NP O
26 of IN B-VP O
26 skipped JJ B-NP O
26 heart NN I-NP O
26 beats NNS I-NP O
26 during IN B-VP O
26 and CC O O
26 after IN B-VP O
26 which WDT O O
26 she PRP O O
26 feels VBZ O O
27 short JJ O O
27 of IN B-VP O
27 breath NN B-NP O
27 These DT B-NP O
27 episodes NNS I-NP O
27 last JJ O O
27 a DT B-NP O
27 few JJ I-NP O
27 minutes NNS I-NP O
27 and CC O O
27 are VBP O O
28 sometimes RB O O
28 relieved VBN O O
28 by IN B-VP O
28 sitting VBG O O
28 up RP O O
28 The DT O O
28 mostly RB O O
28 happen VBP O O
28 at IN B-VP O
28 night NN B-NP O
28 She PRP O O
29 had VBD B-VP O
29 one CD O O
29 episode NN B-NP O
29 of IN B-VP O
29 rapid JJ B-NP O
29 heart NN I-NP O
29 rate NN I-NP O
29 last JJ B-NP O
29 week NN I-NP O
29 which WDT O O
29 was VBD B-VP O
29 also RB O O
30 associated VBN O O
30 with IN B-VP O
30 shortness NN B-NP O
30 of IN B-VP O
30 breath NN B-NP O
31 REVIEW NNP I-NP O
31 OF NNP I-NP O
31 SYSTEMS: NNP I-NP O
31 No NNP I-NP O
31 fevers NNS I-NP O
31 , , O O
31 no DT B-NP O
31 bowel NN I-NP O
31 changes NNS I-NP O
31 , , O O
31 no DT B-NP O
31 urinary JJ I-NP O
32 changes NNS I-NP O
32 , , O O
32 no DT B-NP O
32 shortness NN I-NP O
32 of IN B-VP O
32 breath NN B-NP O
32 , , O O
32 no DT B-NP O
32 paroxysmal JJ I-NP O
33 nocturnal JJ I-NP O
33 dyspnea NN I-NP O
33 , , O O
33 and CC O O
33 no DT B-NP O
33 orthopnea NN I-NP O
34 PAST NNP I-NP O
34 MEDICAL NNP I-NP O
34 HISTORY: NNP I-NP O
34 1 CD O O
34 End NNP B-NP O
34 stage NN I-NP O
34 renal JJ B-NP O
34 disease NN I-NP O
34 2 CD O O
35 Hypertension NNP B-NP O
35 3 CD O O
35 Status NNP B-NP O
35 post NN I-NP O
35 renal NN I-NP O
36 transplant NN I-NP O
36 4 CD O O
36 Insulin NNP B-NP O
36 dependent NN I-NP O
36 diabetes VBZ O O
36 mellitus $ O O
36 5 CD O O
36 Coronary NNP B-NP O
37 artery NN I-NP O
37 disease NN I-NP O
37 , , O O
37 status NN B-NP O
37 post NN I-NP O
37 coronary JJ B-NP O
37 artery NN I-NP O
37 bypass NN I-NP O
37 grafting NN I-NP O
37 in IN B-VP O
38 1996 CD O O
38 6 CD O O
38 Hypertension NNP B-NP O
38 7 CD O O
38 Hypercholesterolemia NNP B-NP O
38 8 CD O O
38 Chronic NNP B-NP O
39 renal JJ B-NP O
39 insufficiency NN I-NP O
39 with IN B-VP O
39 a DT B-NP O
39 creatinine NN I-NP O
39 of IN B-VP O
39 1.7 CD O O
39 last JJ O O
39 in IN B-VP O
39 March NNP B-NP O
39 of IN B-VP O
39 1999 CD O O
40 9 CD O O
40 Cataracts NNPS B-NP O
41 ALLERGIES: NNP I-NP O
41 Erythromycin NNP I-NP O
41 , , O O
41 which WDT O O
41 causes VBZ O O
41 hives NNS B-NP O
41 , , O O
41 Benadryl NNP B-NP O
41 , , O O
41 which WDT O O
42 causes VBZ O O
42 hives NNS B-NP O
42 , , O O
42 Penicillin NNP B-NP O
42 , , O O
42 which WDT O O
42 causes VBZ O O
42 a DT B-NP O
42 rash NN I-NP O
42 , , O O
42 and CC O O
43 Dramamine NNP B-NP O
43 which WDT O O
43 causes VBZ O O
43 hives NNS B-NP O
44 MEDICATIONS: NNP I-NP O
44 1 CD O O
44 Aspirin NNP B-NP B-m
44 81 CD O B-do
44 mg NN B-NP I-do
44 p.o NN I-NP B-mo
44 q JJ B-NP B-f
44 day NN I-NP I-f
44 2 CD O O
44 Prilosec NNP B-NP B-m
44 20 CD O B-do
44 mg NN B-NP I-do
45 p.o NN I-NP B-mo
45 q JJ B-NP B-f
45 day NN I-NP I-f
45 3 CD O O
45 Simvastatin NNP B-NP B-m
45 40 CD O B-do
45 mg NN B-NP I-do
45 p.o NN I-NP B-mo
45 q JJ B-NP B-f
45 day NN I-NP I-f
45 4 CD O O
45 Cyclosporine NNP B-NP B-m
45 Cyclosporine NNP I-NP B-m
46 125 CD O B-do
46 mg NN B-NP I-do
46 p.o NN I-NP B-mo
46 in IN B-VP B-f
46 the DT B-NP I-f
46 morning NN I-NP I-f
46 and CC O O
46 100 CD O B-do
46 mg NN B-NP I-do
46 p.o NN I-NP B-mo
46 in IN B-VP B-f
46 the DT B-NP I-f
46 afternoon NN I-NP I-f
46 5 CD O O
47 Insulin NNP B-NP B-m
47 sliding VBG O B-do
47 scale JJ O I-do
47 6 CD O O
47 Lasix NNP B-NP B-m
47 60 CD O B-do
47 mg NN B-NP I-do
47 p.o NN I-NP B-mo
47 q JJ B-NP B-f
47 day NN I-NP I-f
47 7 CD O O
47 Atenolol NNP B-NP B-m
48 75 CD O B-do
48 mg NN B-NP I-do
48 p.o NN I-NP B-mo
48 q JJ B-NP B-f
48 day NN I-NP I-f
48 8 CD O O
48 Prednisone NNP B-NP B-m
48 Prednisone NNP I-NP B-m
48 5 CD O B-do
48 mg NN B-NP I-do
48 p.o NN I-NP B-mo
48 p.o NN I-NP B-mo
48 on IN B-VP B-f
48 even JJ B-NP I-f
48 days NNS I-NP I-f
48 , , O O
48 10 CD O B-do
48 mg NN B-NP I-do
49 p.o NN I-NP O
49 on IN B-VP B-f
49 odd JJ B-NP I-f
49 days NNS I-NP I-f
49 9 CD O O
49 Cellcept NNP B-NP B-m
49 1 CD O B-do
49 , , O I-do
49 000 CD O I-do
49 mg NN B-NP I-do
49 p.o NN I-NP B-mo
49 b.i.d VBD B-VP B-f
49 10 CD O O
49 Prempro NNP B-NP B-m
50 0.625 CD O B-do
50 mg NN B-NP I-do
50 p.o NN I-NP B-mo
50 q JJ B-NP B-f
50 day NN I-NP I-f
51 SOCIAL NNP I-NP O
51 HISTORY: NNP I-NP O
51 Cigarettes NNP I-NP O
51 one-half JJ B-NP O
51 pack NN I-NP O
51 per IN B-VP O
51 day NN B-NP O
51 x31 CD O O
51 years NNS B-NP O
52 Alcohol NNP I-NP O
52 none NN I-NP O
52 The DT B-NP O
52 patient NN I-NP O
52 is VBZ O O
52 on IN B-VP O
52 disability NN B-NP O
53 FAMILY NNP I-NP O
53 HISTORY: NNP I-NP O
53 The DT B-NP O
53 patient's NN I-NP O
53 mother NN I-NP O
53 passed VBD B-VP O
53 away RB O O
53 with IN B-VP O
53 diabetes NNS B-NP O
54 mellitus VBP O O
55 PHYSICAL NNP B-NP O
55 EXAMINATION NNP I-NP O
55 ON NNP I-NP O
55 ADMISSION: NNP I-NP O
55 Temperature NNP I-NP O
55 98.8 CD O O
55 , , O O
55 pulse RB O O
55 96 CD O O
55 , , O O
56 blood NN B-NP O
56 pressure NN I-NP O
56 120/70 CD O O
56 , , O O
56 and CC O O
57 respirations NNS B-NP O
57 18 CD O O
57 GENERAL: NNP B-NP O
57 In IN B-VP O
57 no DT B-NP O
57 apparent JJ I-NP O
57 distress NN I-NP O
57 HEENT: NNP I-NP O
58 Pupils NNP I-NP O
58 equal JJ O O
58 , , O O
58 round NN B-NP O
58 , , O O
58 and CC O O
58 reactive JJ O O
58 to TO O O
58 light JJ B-NP O
58 Extraocular JJ I-NP O
58 movements NNS I-NP O
59 were VBD B-VP O
59 intact JJ B-NP O
59 Cranial JJ I-NP O
59 nerves NNS I-NP O
59 II-XII NNP I-NP O
59 normal JJ O O
59 with IN B-VP O
59 bilateral JJ B-NP O
59 carotid NN I-NP O
60 bruits NNS I-NP O
60 , , O O
60 right RB O O
60 more JJR O O
60 than IN B-VP O
60 left VBD B-VP O
60 LUNGS: NNP B-NP O
60 Clear NNP I-NP O
60 to TO O O
60 auscultation VB O O
61 bilaterally RB O O
61 HEART: NNP B-NP O
61 Regular NNP I-NP O
61 rate NN I-NP O
61 and CC O O
61 rhythm NN B-NP O
61 with IN B-VP O
61 S1 NNP B-NP O
61 and CC O O
61 S2 NNP B-NP O
61 No NNP I-NP O
62 murmurs NN I-NP O
62 appreciated VBD B-VP O
62 ABDOMEN: NNP B-NP O
62 Soft NNP I-NP O
62 , , O O
62 non-tender NN B-NP O
62 , , O O
62 and CC O O
63 non-distended JJ B-NP O
63 Bowel NNP I-NP O
63 sounds VBZ O O
63 positive JJ B-NP O
63 EXTREMITIES: NNP I-NP O
63 Without NNP I-NP O
63 edema NN I-NP O
64 and CC O O
64 warm JJ B-NP O
65 LABORATORY NNP I-NP O
65 DATA: NNP I-NP O
65 The DT B-NP O
65 patient NN I-NP O
65 had VBD B-VP O
65 a DT B-NP O
65 sodium NN I-NP O
65 of IN B-VP O
65 137 CD O O
65 , , O O
65 potassium NN B-NP O
65 4.4 CD O O
65 , , O O
66 chloride RB O O
66 104 CD O O
66 , , O O
66 bicarbonate NN B-NP O
66 15 CD O O
66 , , O O
66 BUN NNP B-NP O
66 86 CD O O
66 , , O O
66 creatinine NN B-NP O
67 3.1 CD O O
67 Creatinine NNP B-NP O
67 on IN B-VP O
67 November NNP B-NP O
67 , , O O
67 1999 CD O O
67 was VBD B-VP O
67 2.7 CD O O
67 and CC O O
67 creatinine VB O O
67 on IN B-VP O
68 March NNP B-NP O
68 , , O O
68 1999 CD O O
68 was VBD B-VP O
68 3.0 CD O O
68 ALT NNP B-NP O
68 was VBD B-VP O
68 6 CD O O
68 , , O O
68 AST NNP B-NP O
68 11 CD O O
68 , , O O
68 alkaline JJ B-NP O
68 phosphatase NN I-NP O
69 44 CD O O
69 , , O O
69 bilirubin VBD B-VP O
69 total JJ O O
69 0.4 CD O O
69 , , O O
69 direct JJ B-NP O
69 bilirubin NN I-NP O
69 0.1 CD O O
69 , , O O
69 calcium NN B-NP O
69 9.5 CD O O
69 , , O O
70 cholesterol NN B-NP O
70 360 CD O O
70 , , O O
70 and CC O O
70 HDL NNP B-NP O
70 40 CD O O
70 White NNP B-NP O
70 blood NN I-NP O
70 cell NN I-NP O
70 count NN I-NP O
70 was VBD B-VP O
70 7.08 CD O O
70 , , O O
71 hematocrit NN B-NP O
71 25.9; CD O O
71 on IN B-VP O
71 November NNP B-NP O
71 , , O O
71 1999 CD O O
71 , , O O
71 the DT B-NP O
71 patient's NN I-NP O
71 hematocrit NN I-NP O
71 was VBD B-VP O
72 31.9 CD O O
72 , , O O
72 and CC O O
72 platelets NNS B-NP O
72 279 CD O O
72 Echocardiogram NNP B-NP O
72 from IN B-VP O
72 July NNP B-NP O
72 of IN B-VP O
72 1999 CD O O
72 had VBD B-VP O
73 moderate VBN O O
73 to TO O O
73 severe VB O O
73 left JJ B-NP O
73 ventricular JJ I-NP O
73 hypertrophy NN I-NP O
73 , , O O
73 ejection NN B-NP O
73 fraction NN I-NP O
74 of IN B-VP O
74 55% CD O O
74 , , O O
74 borderline NN B-NP O
74 hypokinetic JJ B-NP O
74 inferior NN I-NP O
74 left VBD B-VP O
74 ventricular JJ B-NP O
74 wall NN I-NP O
74 , , O O
74 mild JJ B-NP O
75 mitral JJ I-NP O
75 regurgitation NN I-NP O
75 , , O O
75 and CC O O
75 left VBD B-VP O
75 atrial JJ B-NP O
75 dilatation NN I-NP O
75 Carotid NNP I-NP O
76 noninvasives NNS I-NP O
76 from IN B-VP O
76 March NNP B-NP O
76 of IN B-VP O
76 1999 CD O O
76 showed VBD B-VP O
76 no DT B-NP O
76 significant JJ I-NP O
76 right NN I-NP O
76 or CC O O
77 left VBD B-VP O
77 internal JJ B-NP O
77 carotid NN I-NP O
77 stenosis NN I-NP O
78 HOSPITAL NNP I-NP O
78 COURSE: NNP I-NP O
78 This DT O O
78 is VBZ O O
78 a DT O O
78 50 CD O O
78 year NN B-NP O
78 old JJ B-NP O
78 woman NN I-NP O
78 with IN B-VP O
78 a DT B-NP O
78 history NN I-NP O
78 of IN B-VP O
79 end NN B-NP O
79 stage NN I-NP O
79 renal JJ B-NP O
79 disease NN I-NP O
79 , , O O
79 status NN B-NP O
79 post NN I-NP O
79 renal JJ B-NP O
80 transplant NN I-NP O
80 in IN B-VP O
80 February NNP B-NP O
80 of IN B-VP O
80 1997 CD O O
80 , , O O
80 history NN B-NP O
80 of IN B-VP O
80 insulin NN B-NP O
80 dependent NN I-NP O
80 diabetes VBZ O O
81 mellitus RBS O O
81 , , O O
81 coronary JJ B-NP O
81 artery NN I-NP O
81 disease NN I-NP O
81 , , O O
81 status NN B-NP O
81 post NN I-NP O
81 coronary JJ B-NP O
81 artery NN I-NP O
82 bypass NN I-NP O
82 grafting NN I-NP O
82 in IN B-VP O
82 1996 CD O O
82 ( ( O O
82 left VBN O O
82 internal JJ B-NP O
82 mammary JJ I-NP O
82 artery NN I-NP O
82 to TO O O
82 left VB O O
83 anterior JJ B-NP O
83 descending NN I-NP O
83 and CC O O
83 saphenous JJ B-NP O
83 vein NN I-NP O
83 graft NN I-NP O
83 to TO O O
83 obtuse VB O O
83 marginal JJ O O
83 ) ) O O
83 , , O O
84 now RB O O
84 with IN B-VP O
84 episodes NNS B-NP O
84 of IN B-VP O
84 rapid JJ B-NP O
84 heart NN I-NP O
84 rate NN I-NP O
84 and CC O O
84 episodes NNS B-NP O
84 of IN B-VP O
84 skipped JJ B-NP O
84 beats NNS I-NP O
85 in IN B-VP O
85 association NN B-NP O
85 without IN B-VP O
85 shortness NN B-NP O
85 of IN B-VP O
85 breath NN B-NP O
85 Also RB O O
85 , , O O
85 the DT B-NP O
85 patient NN I-NP O
85 has VBZ O O
86 had VBN O O
86 a DT B-NP O
86 hematocrit JJ I-NP O
86 drop NN I-NP O
86 from IN B-VP O
86 31 CD O O
86 to TO O O
86 26 CD O O
86 on IN B-VP O
86 admission NN B-NP O
86 and CC O O
86 a DT B-NP O
86 history NN I-NP O
86 of IN B-VP O
87 blood NN B-NP O
87 in IN B-VP O
87 stool NN B-NP O
87 over IN B-VP O
87 the DT B-NP O
87 last JJ I-NP O
87 month NN I-NP O
87 The DT B-NP O
87 patient NN I-NP O
87 was VBD B-VP O
87 guaiaced VBN O O
87 on IN B-VP O
88 admission NN B-NP O
88 and CC O O
88 during IN B-VP O
88 her PRP$ O O
88 stay NN B-NP O
88 and CC O O
88 remained VBD B-VP O
88 guaiac JJ O O
88 negative JJ O O
89 throughout IN B-VP O
89 the DT B-NP O
89 whole JJ I-NP O
89 time NN I-NP O
89 The DT B-NP O
89 patient NN I-NP O
89 was VBD B-VP O
89 placed VBN O O
89 on IN B-VP O
89 cardiac JJ B-NP O
90 monitoring NN I-NP O
90 and CC O O
90 had VBD B-VP O
90 no DT B-NP O
90 events NNS I-NP O
90 recorded VBN O O
90 on IN B-VP O
90 the DT B-NP O
90 monitor NN I-NP O
90 On IN B-VP O
90 July NNP B-NP O
90 , , O O
90 2000 CD O O
90 , , O O
90 the DT B-NP O
90 patient's NN I-NP O
90 hematocrit NN I-NP O
90 dropped VBD B-VP O
90 to TO O O
90 21 CD O O
90 She PRP O O
90 was VBD B-VP O
91 transfused VBN O O
91 two CD O B-do
91 units NNS B-NP I-do
91 of IN B-VP O
91 blood NN B-NP B-m
91 and CC O O
91 her PRP$ O O
91 hematocrit NN B-NP O
91 went VBD B-VP O
91 up RB O O
91 to TO O O
91 31 CD O O
91 An DT B-NP O
92 exercise NN I-NP O
92 tolerance NN I-NP O
92 test NN I-NP O
92 MIBI NNP I-NP O
92 was VBD B-VP O
92 performed VBN O O
92 which WDT O O
92 was VBD B-VP O
92 negative JJ O O
92 for IN B-VP O
93 ischemia NN B-NP O
93 The DT B-NP O
93 patient's NN I-NP O
93 ejection NN I-NP O
93 fraction NN I-NP O
93 from IN B-VP O
93 the DT B-NP O
93 MIBI NNP I-NP O
93 was VBD B-VP O
94 approximated VBN O O
94 to TO O O
94 be VB O O
94 69% CD O O
94 On IN B-VP O
94 November NNP B-NP O
94 , , O O
94 2000 CD O O
94 , , O O
94 carotid VBD B-VP O
95 non-invasives NNS B-NP O
95 were VBD B-VP O
95 repeated VBN O O
95 which WDT O O
95 revealed VBD B-VP O
95 moderate JJ B-NP O
95 internal JJ I-NP O
96 carotid NN I-NP O
96 plaque NN I-NP O
96 on IN B-VP O
96 the DT B-NP O
96 right JJ I-NP O
96 Otherwise NNP I-NP O
96 , , O O
96 she PRP O O
96 had VBD B-VP O
96 mild JJ B-NP O
96 stenosis NN I-NP O
96 of IN B-VP O
97 the DT B-NP O
97 other JJ I-NP O
97 arteries NNS I-NP O
97 An DT B-NP O
97 echocardiogram NN I-NP O
97 was VBD B-VP O
97 also RB O O
97 performed VBN O O
97 which WDT O O
98 revealed VBD B-VP O
98 concentric NN B-NP O
98 left VBD B-VP O
98 ventricular JJ B-NP O
98 hypertrophy NN I-NP O
98 with IN B-VP O
98 an DT B-NP O
98 ejection NN I-NP O
99 fraction NN I-NP O
99 of IN B-VP O
99 65% CD O O
99 The DT B-NP O
99 patient NN I-NP O
99 was VBD B-VP O
99 taken VBN O O
99 to TO O O
99 Electrophysiology NNP B-NP O
99 Study NNP I-NP O
100 on IN B-VP O
100 March NNP B-NP O
100 , , O O
100 2000 CD O O
100 which WDT O O
100 revealed VBD B-VP O
100 nonsustained VBD B-VP O
100 ventricular JJ B-NP O
101 tachycardia NN I-NP O
101 with IN B-VP O
101 possible JJ B-NP O
101 right JJ I-NP O
101 ventricular NN I-NP O
101 outflow IN B-VP O
101 tract NN B-NP O
101 origin IN B-VP O
102 It PRP O O
102 was VBD B-VP O
102 hoped VBN O O
102 that IN B-VP O
102 she PRP O O
102 could MD O O
102 be VB O O
102 maintained VBN O O
102 on IN B-VP O
102 Lopressor NNP B-NP B-m
102 and CC O O
103 Verapamil NNP B-NP B-m
103 Due NNP I-NP O
103 to TO O O
103 the DT B-NP O
103 results NNS I-NP O
103 of IN B-VP O
103 this DT B-NP O
103 study NN I-NP O
103 , , O O
103 the DT B-NP O
103 patient NN I-NP O
103 was VBD B-VP O
104 already RB O O
104 on IN B-VP O
104 Atenolol NNP B-NP B-m
104 for IN B-VP O
104 Beta NNP B-NP B-r
104 blockade NN I-NP I-r
104 and CC O O
104 Verapamil NNP B-NP B-m
104 was VBD B-VP O
104 tried VBN O O
105 However RB O O
105 , , O O
105 her PRP O O
105 blood NN B-NP O
105 pressure NN I-NP O
105 did VBD B-VP O
105 not RB O O
105 tolerate VB O O
105 this DT B-NP O
105 medication NN I-NP O
105 The DT B-NP O
106 day NN I-NP O
106 after IN B-VP O
106 the DT B-NP O
106 electrophysiology NN I-NP O
106 procedure NN I-NP O
106 on IN B-VP O
106 January NNP B-NP O
106 , , O O
106 2000 CD O O
106 , , O O
106 the DT B-NP O
107 patient NN I-NP O
107 was VBD B-VP O
107 orthostatic JJ O O
107 She PRP O O
107 was VBD B-VP O
107 given VBN O O
107 a DT O O
107 250 CD O B-do
107 cc NN B-NP I-do
107 fluid NN I-NP B-m
107 bolus NN I-NP I-m
107 and CC O O
108 encouraged VBD B-VP O
108 to TO O O
108 drink VB O O
108 more JJR B-NP O
108 p.o JJ I-NP O
108 fluids NNS I-NP O
108 and CC O O
108 she PRP O O
108 was VBD B-VP O
108 discharged VBN O O
108 in IN B-VP O
109 stable JJ B-NP O
109 condition NN I-NP O
109 the DT B-NP O
109 next JJ I-NP O
109 day NN I-NP O
109 The DT B-NP O
109 patient NN I-NP O
109 remained VBD B-VP O
109 symptom JJ O O
109 free JJ O O
110 during IN B-VP O
110 the DT B-NP O
110 entire JJ I-NP O
110 hospital NN I-NP O
110 course NN I-NP O
110 The DT B-NP O
110 patient's NN I-NP O
110 triglycerides NNS I-NP O
111 were VBD B-VP O
111 checked VBN O O
111 during IN B-VP O
111 the DT B-NP O
111 hospitalization NN I-NP O
111 and CC O O
111 found VBD B-VP O
111 to TO O O
111 be VB O O
111 very RB O O
111 high JJ O O
112 in IN B-VP O
112 the DT O O
112 1 CD O O
112 , , O O
112 500 CD O O
112 range NN B-NP O
112 The DT B-NP O
112 patient NN I-NP O
112 was VBD B-VP O
112 therefore RB O O
112 taken VBN O O
112 off RP O O
113 Simvastatin NNP B-NP B-m
113 and CC O O
113 started VBD B-VP O
113 on IN B-VP O
113 Gemfibrozil NNP B-NP B-m
114 DISCHARGE NNP I-NP O
114 MEDICATIONS: NNP I-NP O
114 1 CD O O
114 Aspirin NNP B-NP B-m
114 81 CD O B-do
114 mg NN B-NP I-do
114 p.o NN I-NP B-mo
114 q JJ B-NP B-f
114 day NN I-NP I-f
114 2 CD O O
114 Vitamin NNP B-NP B-m
115 C NNP I-NP O
115 100 CD O B-do
115 mg NN B-NP I-do
115 p.o NN I-NP B-mo
115 q JJ B-NP B-f
115 day NN I-NP I-f
115 x14 NNP I-NP B-du
115 days NNS I-NP I-du
115 3 CD O O
115 Epogen NNP B-NP B-m
116 2 CD O B-do
116 , , O I-do
116 000 CD O I-do
116 subcu NN B-NP B-mo
116 q NN I-NP B-f
116 week NN I-NP I-f
116 4 CD O O
116 Lasix NNP B-NP B-m
116 60 CD O B-do
116 mg NN B-NP I-do
116 p.o NN I-NP B-mo
116 q JJ B-NP B-f
116 day NN I-NP I-f
116 5 CD O O
116 Gemfibrozil NNP B-NP B-m
117 300 CD O B-do
117 mg NN B-NP I-do
117 p.o NN I-NP B-mo
117 b.i.d VBD B-VP B-f
117 6 CD O O
117 Lisinopril NNP B-NP B-m
117 5 CD O B-do
117 mg NN B-NP I-do
117 p.o NN I-NP B-mo
117 q JJ B-NP B-f
117 day NN I-NP I-f
117 7 CD O O
117 Prilosec NNP B-NP B-m
118 20 CD O B-do
118 mg NN B-NP I-do
118 p.o NN I-NP B-mo
118 q JJ B-NP B-f
118 day NN I-NP I-f
118 8 CD O O
118 Prednisone NNP B-NP B-m
118 Prednisone NNP I-NP B-m
118 5 CD O B-do
118 mg NN B-NP I-do
118 p.o NN I-NP B-mo
118 on IN B-VP B-f
118 even JJ B-NP I-f
118 days NNS I-NP I-f
118 , , O O
118 10 CD O B-do
118 mg NN B-NP I-do
119 p.o NN I-NP B-mo
119 on IN B-VP B-f
119 odd JJ B-NP I-f
119 days NNS I-NP I-f
119 9 CD O O
119 MVI NNP B-NP B-m
119 with IN B-VP I-m
119 minerals NNS B-NP I-m
119 one CD O B-do
119 tablet NN B-NP I-do
119 p.o NN I-NP B-mo
119 q JJ B-NP B-f
119 day NN I-NP I-f
120 10 CD O O
120 Thiamine NNP B-NP B-m
120 50 CD O B-do
120 mg NN B-NP I-do
120 p.o NN I-NP B-mo
120 b.i.d VBD B-VP B-f
120 11 CD O O
120 Bicitra NNP B-NP B-m
120 15 CD O B-do
120 ml NN B-NP I-do
120 p.o NN I-NP B-mo
120 b.i.d VBD B-VP B-f
121 12 CD O O
121 Cyclosporine NNP B-NP B-m
121 Cyclosporine NNP I-NP B-m
121 micromeral JJ O I-m
121 micromeral JJ O I-m
121 125 CD O B-do
121 mg NN B-NP I-do
121 p.o NN I-NP B-mo
121 q NN I-NP B-f
121 a.m NN I-NP I-f
121 and CC O O
121 100 CD O B-do
121 mg NN B-NP I-do
121 p.o NN I-NP B-mo
121 q NN I-NP B-f
122 p.m VBD B-VP O
122 13 CD O O
122 Cellcept NNP B-NP B-m
122 1 CD O B-do
122 , , O I-do
122 000 CD O I-do
122 mg NN B-NP I-do
122 p.o NN I-NP B-mo
122 b.i.d VBD B-VP B-f
122 14 CD O O
122 Prempro NNP B-NP B-m
122 0.625/0.25 CD O B-do
123 mg NN B-NP O
123 p.o NN I-NP B-mo
123 q JJ B-NP B-f
123 day NN I-NP I-f
123 15 CD O O
123 Nephrocaps NNP B-NP B-m
123 one CD O B-do
123 tablet NN B-NP I-do
123 p.o NN I-NP B-mo
123 q JJ B-NP B-f
123 day NN I-NP I-f
124 Dictated NNP I-NP O
124 By: NNP I-NP O
124 BRAIN NNP I-NP O
124 LINMAN NNP I-NP O
124 , , O O
124 M.D NNP B-NP O
124 JA25 NNP I-NP O
125 Attending: NNP I-NP O
125 SYDNEY NNP I-NP O
125 DUESTERHAUS NNP I-NP O
125 , , O O
125 M.D NNP B-NP O
125 MG85 NNP I-NP O
125 EQ681/3978 NNP I-NP O
126 Batch: NNP I-NP O
126 37609 CD O O
126 Index NNP B-NP O
126 No NNP I-NP O
126 FHOW8875S8 NNP I-NP O
126 D: NNP I-NP O
126 6/10 CD O O
127 T: NNP B-NP O
127 1/22 CD O O
128 [report_end] NNP B-NP O
0 -EMPTYLINE- NN I-NP O
